manager_id,treatment,region,organization,job_family,performance_rating,gender,age,tenure_months,is_new_manager,team_size,baseline_manager_efficacy,baseline_workload,baseline_turnover_intention,retention_3month,retention_6month,retention_9month,retention_12month,manager_efficacy_index,workload_index_mgr,turnover_intention_index_mgr
1,0,Latin America,Manufacturing,Market Access,Meets,Male,38,9,0,5,1.7,4,3.2,1,1,1,1,2.1,5,2.5
2,0,Middle East & Africa,Commercial,Regulatory Affairs,Exceeds,Male,43,5,1,9,,2.1,4,1,1,1,1,3.5,2.7,4.3
3,0,Asia Pacific,Manufacturing,Market Access,Exceeds,Male,38,7,0,6,2.3,2.9,2.8,0,0,0,0,3.2,4.8,3.2
4,0,Middle East & Africa,Commercial,Pharmacovigilance,Exceeds,Male,28,16,0,11,4.6,1,3.4,1,1,1,1,4.7,1.7,3.5
5,0,Middle East & Africa,HR,IT & Digital,Meets,Male,45,10,0,11,3.1,3.1,2.5,1,1,1,1,2.8,3.6,2.2
6,0,Europe,Digital,Quality Assurance,Meets,Male,39,32,0,7,4.1,3.5,2.7,1,1,1,1,3.2,3.6,2.4
7,0,Asia Pacific,Finance,Data Science,Below,Female,28,14,0,7,5,3.8,2.2,1,0,0,0,4.1,3.2,1.8
8,1,Asia Pacific,Commercial,Clinical Operations,Exceeds,Female,47,15,0,5,2,3.2,2.4,1,1,1,1,1.8,2.8,2.8
9,0,Asia Pacific,Digital,Medical Affairs,Meets,Male,47,9,0,12,3.3,3.1,2.7,1,1,1,1,3.5,3.7,2.3
10,0,Middle East & Africa,Digital,Quality Assurance,Below,Female,32,14,0,7,2.6,3.1,2.6,1,1,1,1,2.9,3.4,2.3
11,0,Latin America,Commercial,Data Science,Meets,Female,29,9,0,11,3.1,2.5,2.4,1,1,1,1,3,1.5,2.3
12,0,Asia Pacific,HR,Market Access,Meets,Male,45,12,1,12,,3.3,1.3,1,1,1,1,3.8,4.2,2
13,0,Middle East & Africa,R&D,IT & Digital,Meets,Female,45,17,1,10,,4.7,3,1,1,1,1,1.8,4.2,3.8
14,0,Europe,Digital,Regulatory Affairs,Below,Male,41,5,0,8,3.9,3.9,2.4,1,1,1,1,2.9,3.7,4.3
15,0,Latin America,Digital,Supply Chain,Meets,Male,35,14,0,6,4.3,3.5,2.5,1,1,1,1,4.2,3.5,2.1
16,0,Europe,HR,Medical Affairs,Below,Female,33,12,0,7,3.7,3,2.8,0,0,0,0,4,3.4,3
17,0,Latin America,HR,Marketing,Meets,Male,42,29,0,9,3.8,3.1,3.5,1,1,1,1,4.2,1.8,3
18,0,Middle East & Africa,Manufacturing,Sales,Exceeds,Male,34,6,0,11,3.1,4.1,1.8,1,1,1,1,3.4,3.2,2.2
19,0,North America,HR,Regulatory Affairs,Meets,Female,34,10,1,7,,3.9,2.5,1,1,1,1,1.7,5,2
20,0,Latin America,Digital,Market Access,Meets,Female,43,8,0,11,3.2,4,1,1,1,1,1,2.6,3.5,1.5
21,0,Europe,Commercial,Regulatory Affairs,Meets,Female,44,5,0,11,3.3,4.8,3.2,1,1,1,1,4,3.7,4.4
22,0,Middle East & Africa,R&D,Legal & Compliance,Meets,Female,47,13,0,10,3.1,3.7,4.2,1,1,1,1,4,3.7,4.6
23,0,Latin America,Manufacturing,Pharmacovigilance,Meets,Female,28,2,1,10,,4.7,3.6,1,1,1,1,2.4,3.5,1.9
24,0,North America,Commercial,Human Resources,Far Exceeds,Female,35,9,1,12,,5,1.7,1,1,1,1,2.5,4.3,2.7
25,0,North America,R&D,Market Access,Meets,Male,36,9,0,10,4.1,1.6,2.2,1,0,0,0,3.7,4.3,3.3
26,0,Asia Pacific,R&D,Regulatory Affairs,Meets,Female,38,8,0,9,3.2,3.1,2.8,1,1,1,1,4.2,2.9,3.2
27,0,Asia Pacific,R&D,Quality Assurance,Meets,Female,30,7,0,12,4.7,2.4,1,1,1,1,1,4.2,3.9,1
28,0,Europe,Finance,Quality Assurance,Exceeds,Male,41,4,1,8,,3,2.2,1,1,1,1,2.9,2.5,2.6
29,0,Latin America,Commercial,Clinical Operations,Below,Female,49,9,1,10,,4.9,2.7,1,1,1,1,2.9,2.5,3.2
30,0,Latin America,Manufacturing,Clinical Operations,Meets,Female,31,21,0,9,2.9,4.6,2.1,1,1,1,1,3.3,4.2,3.5
31,0,Asia Pacific,Manufacturing,Finance & Accounting,Exceeds,Male,39,14,0,5,3,3.4,3.8,1,1,1,1,2.6,2.5,2
32,0,Latin America,R&D,Medical Affairs,Exceeds,Male,46,14,0,11,3.2,3.5,1.7,1,1,0,0,2.8,3.9,1.9
33,0,Latin America,Commercial,Regulatory Affairs,Meets,Male,37,15,0,6,3.6,2.5,2,1,1,1,1,1.8,2.9,2.3
34,0,North America,Finance,IT & Digital,Meets,Female,34,11,0,5,3.7,4.3,4.4,1,1,1,1,2.9,4.9,2.9
35,0,Asia Pacific,R&D,Communications,Meets,Male,39,7,0,7,3,2.6,4.3,1,1,1,1,4.6,4.1,4
36,0,Middle East & Africa,HR,Clinical Operations,Meets,Male,42,26,0,11,5,3.7,4.5,1,1,0,0,4.3,2.8,3.3
37,0,Asia Pacific,Manufacturing,Pharmacovigilance,Exceeds,Male,30,8,0,6,2.9,2.5,2,1,1,1,1,2.6,3.3,1.9
38,0,Middle East & Africa,Digital,Finance & Accounting,Below,Female,44,19,0,7,1.1,2.5,2.5,1,1,1,1,2.8,2.8,2.3
39,1,North America,R&D,Data Science,Meets,Female,37,27,0,6,2.6,4.1,1,1,1,1,1,2.1,4.4,1
40,0,Europe,HR,Legal & Compliance,Exceeds,Female,34,9,0,7,3.4,2.8,2,1,1,1,1,2,3.8,1
41,0,Latin America,Manufacturing,Legal & Compliance,Meets,Male,29,6,0,11,3,3.3,3.2,1,1,1,1,3,4.5,4.1
42,0,North America,Finance,Legal & Compliance,Meets,Female,34,22,0,9,3.7,2.7,2.3,0,0,0,0,4.5,1.7,3
43,0,Latin America,Commercial,Clinical Operations,Meets,Female,34,8,1,12,,3.4,3.9,1,1,1,1,3.1,2.2,4.6
44,0,Europe,Manufacturing,Regulatory Affairs,Exceeds,Female,31,19,1,7,,3.1,2.8,1,1,1,1,3,2.5,4.7
45,0,Europe,Commercial,Quality Assurance,Far Exceeds,Female,41,15,0,11,2.5,3.3,2.7,1,1,1,1,3.6,3.4,1.8
46,0,North America,Commercial,Sales,Meets,Male,39,10,0,10,4,3.4,1.8,1,1,1,1,4.6,2.3,3
47,0,Europe,Finance,Human Resources,Exceeds,Male,44,3,0,7,2.3,4.5,3.5,1,1,1,1,3.2,2.6,1.7
48,0,Middle East & Africa,Finance,Supply Chain,Far Exceeds,Male,42,13,0,9,2.6,2.6,1.8,1,1,1,1,2.6,4.2,1.7
49,0,Europe,R&D,Marketing,Far Exceeds,Female,34,12,0,11,4.6,5,3.1,1,1,1,1,4.9,3.9,3.2
50,0,Latin America,R&D,Finance & Accounting,Meets,Female,36,16,0,8,3,2.7,2.7,1,1,1,1,3.5,3.3,3.6
51,0,Latin America,Manufacturing,Clinical Operations,Meets,Female,34,22,0,9,1.4,2.5,3.1,1,1,1,1,1.7,3.9,3.1
52,0,Latin America,Finance,Marketing,Meets,Female,28,28,0,11,4,2.9,4.2,1,1,1,1,5,4.4,3.4
53,0,Latin America,HR,Human Resources,Meets,Female,40,14,0,8,4.7,3.7,4,1,1,1,1,3.9,2.3,3.9
54,0,Middle East & Africa,Manufacturing,Supply Chain,Meets,Male,39,7,1,12,,2.2,2.7,1,1,1,1,2.5,2.2,2.7
55,0,Asia Pacific,Digital,Medical Affairs,Meets,Male,34,19,0,11,3.2,4.1,3.1,1,1,1,1,3.1,3.3,3
56,0,North America,Commercial,Quality Assurance,Meets,Female,43,8,0,8,5,3,4,1,1,1,1,4.8,3.8,3.4
57,0,Latin America,Commercial,Quality Assurance,Meets,Non-Binary/Other,36,3,1,11,,1,1.7,1,1,1,1,3.5,1.4,3.3
58,0,Europe,R&D,Supply Chain,Exceeds,Female,45,9,1,11,,4.1,3.3,1,1,1,1,4.2,3.2,4.3
59,1,Latin America,HR,Human Resources,Exceeds,Female,37,8,1,8,,2.8,3.7,1,1,1,1,3.6,3.8,3.7
60,0,Europe,Finance,Communications,Meets,Male,30,14,0,7,3,2.6,3.6,1,1,1,1,3.4,3.3,2.9
61,0,Europe,Finance,Regulatory Affairs,Meets,Male,47,31,0,9,4.4,3.8,3.8,0,0,0,0,3.5,4.4,2.1
62,0,Latin America,R&D,Marketing,Meets,Female,40,23,0,9,3.5,3,3.1,1,1,1,1,3.7,3.5,3.3
63,0,Middle East & Africa,Digital,Marketing,Below,Female,32,26,0,6,4.4,2.3,2.2,1,1,1,1,5,2.5,3.2
64,0,Europe,Manufacturing,IT & Digital,Far Below,Female,36,5,1,7,,2.6,1.3,1,1,1,1,3.6,3.2,2.9
65,0,Europe,Manufacturing,Communications,Exceeds,Female,33,30,0,5,4.1,1.9,4.3,1,1,1,1,3.9,2.7,5
66,0,Latin America,HR,IT & Digital,Below,Male,44,13,0,10,2.9,3.2,3.6,1,1,1,1,2.9,3.1,1.3
67,0,Europe,R&D,Supply Chain,Exceeds,Male,28,16,0,11,2.4,3.8,3.1,1,1,1,1,1.8,4.6,5
68,0,Europe,R&D,Marketing,Exceeds,Female,40,6,0,5,3.5,4.8,2.3,1,1,1,1,4.5,4,2.3
69,0,Latin America,Digital,Regulatory Affairs,Meets,Male,28,22,0,10,2.7,1.7,3.6,1,1,1,1,2.6,2,2.5
70,0,Latin America,Manufacturing,Quality Assurance,Exceeds,Female,28,10,1,7,,3.3,2.4,1,1,1,1,1.2,2.9,3.1
71,0,North America,R&D,Communications,Meets,Female,40,7,1,9,,2.7,2.3,1,1,1,1,2.6,3.2,2.6
72,0,Middle East & Africa,Finance,Medical Affairs,Exceeds,Female,31,8,0,7,3.8,3.5,3.1,1,1,1,1,3.6,4,2
73,0,Middle East & Africa,HR,Pharmacovigilance,Exceeds,Non-Binary/Other,42,8,1,5,,3.2,5,1,1,1,1,2.4,4,3.4
74,0,Europe,Manufacturing,Quality Assurance,Below,Male,44,15,0,11,2.5,1.9,1,1,1,1,1,3,2.6,1.9
75,0,Middle East & Africa,Digital,Legal & Compliance,Meets,Female,35,5,0,8,3.4,2.7,2.6,1,1,1,0,4.1,2.1,2.4
76,0,Europe,HR,Data Science,Meets,Male,41,6,1,8,,3.4,2.5,1,1,1,1,3.8,3.3,3.2
77,0,North America,Commercial,Data Science,Far Below,Male,47,9,0,10,3.7,2.8,2.2,1,0,0,0,3.4,1,1.5
78,0,Latin America,Finance,Quality Assurance,Far Exceeds,Female,32,4,0,11,3.7,1.4,3.7,1,1,1,1,4.1,2.3,4.9
79,1,Latin America,Digital,Regulatory Affairs,Meets,Male,43,19,0,9,3.7,2.8,4.2,1,1,1,1,4.2,2.9,5
80,0,Latin America,HR,Pharmacovigilance,Meets,Female,33,17,0,11,2.8,3.8,3.6,1,1,1,1,2.9,4.5,4.8
81,0,Middle East & Africa,R&D,Medical Affairs,Below,Female,38,8,0,12,3.8,3.9,1.9,1,1,1,1,3.4,5,2
82,0,North America,Commercial,Communications,Meets,Male,34,11,0,11,2.3,4,3.3,0,0,0,0,2.1,4.4,4.2
83,0,Middle East & Africa,Digital,Marketing,Exceeds,Male,34,16,0,10,3.6,3,3.3,1,1,1,1,2.2,3.8,3.6
84,0,Middle East & Africa,R&D,Data Science,Meets,Male,36,8,1,12,,2.6,2.4,0,0,0,0,3.3,2.9,2.1
85,0,North America,Finance,Data Science,Meets,Female,34,12,0,6,1.8,3.5,2.7,1,1,1,1,3.4,3.2,3.1
86,0,North America,Commercial,Data Science,Meets,Female,37,13,0,10,1.8,3,4.2,1,0,0,0,2.1,3.2,4.2
87,0,North America,Manufacturing,Human Resources,Meets,Female,45,22,0,8,1.7,1.8,1,1,1,1,0,2.5,2.8,2.6
88,0,North America,R&D,Finance & Accounting,Meets,Male,30,19,1,8,,2.2,4.5,1,1,1,1,3.6,2.6,2.9
89,0,Latin America,HR,Market Access,Below,Male,41,14,1,8,,3.7,2.1,1,1,1,1,3.8,4.2,2.6
90,0,Asia Pacific,Digital,IT & Digital,Far Below,Male,32,12,0,9,4.4,2.9,2.6,1,1,1,1,4.7,3.5,1
91,0,Asia Pacific,Commercial,Legal & Compliance,Below,Female,32,5,1,9,,2.1,2.6,1,1,1,1,2.7,2.6,2.3
92,0,North America,R&D,Legal & Compliance,Exceeds,Male,28,22,0,11,3.2,2.3,2.2,1,1,1,1,4.8,4.5,2
93,0,Asia Pacific,Manufacturing,Legal & Compliance,Far Exceeds,Male,44,14,0,7,2.1,3.5,1.9,1,1,1,1,2.4,5,2.9
94,0,Asia Pacific,Digital,IT & Digital,Below,Male,37,30,0,5,3.7,1.3,2.8,1,0,0,0,4.1,4.1,4.2
95,0,North America,Digital,Regulatory Affairs,Meets,Female,33,17,0,8,4,3,1.1,1,1,1,1,3.6,2.1,4.3
96,0,Asia Pacific,R&D,Quality Assurance,Below,Female,39,13,0,10,3.2,3.5,2.4,1,1,1,1,3.4,3.8,2.7
97,0,Middle East & Africa,Manufacturing,Pharmacovigilance,Exceeds,Female,36,10,0,5,4.2,4,3.5,0,0,0,0,3.1,2.3,2.7
98,0,Europe,Finance,Communications,Meets,Female,45,5,0,6,2.6,3.1,2.7,1,1,1,1,3.3,3.5,4.5
99,0,Europe,Finance,Quality Assurance,Meets,Female,32,14,0,8,4,1.3,2.3,1,1,1,1,4.2,3.4,2.5
100,0,North America,Commercial,Communications,Meets,Male,37,6,1,8,,3.6,3,1,1,1,1,3.3,2.3,3.2
101,0,Latin America,R&D,Market Access,Meets,Male,43,34,0,6,3.9,3.5,4,1,0,0,0,2.5,4.4,3.6
102,0,North America,Commercial,Data Science,Meets,Female,32,7,0,11,4.4,4.5,3.8,1,1,0,0,3.4,5,3.1
103,0,Latin America,Finance,Supply Chain,Below,Male,35,9,0,11,2.5,4.5,1.2,1,1,1,1,1.7,3.4,1.8
104,0,Europe,Digital,Human Resources,Far Below,Male,30,12,1,9,,3.1,3.6,1,1,1,1,2.6,2.8,4
105,0,North America,Commercial,Market Access,Meets,Male,33,11,0,7,2.8,2.2,2.8,1,1,1,1,2.2,1,4.3
106,0,Middle East & Africa,Manufacturing,Regulatory Affairs,Exceeds,Male,29,7,1,12,,3.6,1.8,0,0,0,0,4.8,5,3.4
107,0,Asia Pacific,HR,Medical Affairs,Meets,Male,32,11,1,9,,4,2.5,1,1,1,1,4.4,3.2,1.8
108,0,Latin America,Finance,IT & Digital,Below,Female,30,27,0,10,3,3.2,2.6,1,1,1,1,5,2.4,3.9
109,0,Asia Pacific,Finance,Finance & Accounting,Exceeds,Male,34,14,0,11,3.8,2.9,2,1,1,1,1,4.4,2.8,2.7
110,0,Asia Pacific,Manufacturing,Legal & Compliance,Below,Male,44,12,1,5,,4.7,3.7,1,1,1,1,1.8,4.1,2.1
111,0,North America,Commercial,Finance & Accounting,Below,Male,40,3,0,10,2.6,2.3,4.4,1,1,1,1,2.8,3.9,3.5
112,0,Asia Pacific,R&D,Marketing,Exceeds,Female,46,13,0,6,3.7,2.7,2.1,1,1,1,1,2.2,2.3,2.1
113,0,Middle East & Africa,Digital,Human Resources,Meets,Female,36,27,0,11,3.8,3.5,1.8,1,1,1,1,4.3,3.5,1.7
114,0,Asia Pacific,HR,Sales,Meets,Male,33,5,0,12,2.5,2.9,2.7,1,1,1,1,3.7,3.7,2.7
115,0,North America,R&D,Finance & Accounting,Meets,Female,37,10,1,11,,3.4,3.7,1,1,1,1,3.2,2.5,3.1
116,0,Middle East & Africa,R&D,Pharmacovigilance,Meets,Male,34,10,0,8,3.1,4,1,0,0,0,0,3.1,3.8,2.6
117,0,Europe,Manufacturing,Market Access,Far Below,Female,40,25,0,8,1.7,2,2.8,1,1,1,1,3,2.8,1.5
118,0,Asia Pacific,Commercial,Medical Affairs,Meets,Female,29,7,0,5,2.9,2.6,3.4,1,1,1,1,4,3.3,3.5
119,0,North America,Finance,Sales,Meets,Female,38,7,0,10,3.4,4.7,2.3,1,1,1,1,3.3,2,3.5
120,0,Europe,Finance,Medical Affairs,Far Exceeds,Female,47,5,0,8,2.7,3.3,3.2,1,1,0,0,1.9,3.6,2.8
121,0,Europe,Manufacturing,Legal & Compliance,Far Exceeds,Male,32,12,0,11,2.6,3,2.6,1,1,1,1,1.7,3.2,3.6
122,0,Latin America,Commercial,Finance & Accounting,Meets,Female,35,25,0,9,3.3,2.7,3.4,1,1,1,1,2.5,2.9,2.8
123,0,Middle East & Africa,Manufacturing,Legal & Compliance,Meets,Male,28,10,1,10,,3.9,3.9,1,1,1,1,3.6,2.1,3.2
124,0,Asia Pacific,Finance,Quality Assurance,Below,Non-Binary/Other,45,8,0,10,3.5,2.3,3,1,1,1,1,4.3,3,1
125,0,North America,R&D,Finance & Accounting,Below,Male,37,28,0,11,3.3,4,3.5,1,1,1,1,3.9,2.6,3.7
126,0,Latin America,Digital,Quality Assurance,Meets,Male,35,9,0,6,3.9,2.6,1,1,1,1,1,3.7,2.4,2.2
127,0,Middle East & Africa,Commercial,Communications,Meets,Male,38,13,0,11,3.9,2.3,1.6,1,1,1,1,4,3.3,2
128,0,Latin America,HR,Data Science,Meets,Male,38,9,0,9,4,2,2.6,1,1,1,1,3,2,3.5
129,0,Middle East & Africa,HR,Clinical Operations,Meets,Female,34,19,0,9,4.3,3,1.6,0,0,0,0,3.3,1.1,2.2
130,0,Middle East & Africa,R&D,Marketing,Exceeds,Female,30,15,0,11,4.1,3.1,2.3,1,1,1,1,3.4,4.4,2.1
131,1,Asia Pacific,Manufacturing,Regulatory Affairs,Meets,Male,39,7,0,7,2.7,2.2,3,1,1,0,0,1.8,3.9,3.2
132,0,Middle East & Africa,Manufacturing,Regulatory Affairs,Meets,Male,38,31,0,6,2.3,2.4,2.6,0,0,0,0,2.8,2.4,3.6
133,0,Latin America,Finance,Data Science,Below,Female,36,18,1,10,,1.2,3.3,1,1,1,1,3.7,2.4,3.3
134,0,Middle East & Africa,R&D,Quality Assurance,Meets,Male,36,11,0,7,4.4,2.7,3.8,1,1,1,1,3.3,2.6,1.5
135,0,Asia Pacific,Finance,Data Science,Exceeds,Male,44,23,0,7,2.7,5,3.3,1,0,0,0,3.4,4.1,3
136,0,Asia Pacific,Finance,Supply Chain,Below,Female,40,13,0,8,4,1,2.8,1,1,1,1,3.4,2.7,1
137,0,Latin America,HR,Market Access,Meets,Male,30,8,0,5,4.8,3.4,2.2,1,1,1,1,3.1,4,3.5
138,0,Europe,Finance,Legal & Compliance,Far Exceeds,Male,46,11,0,10,3.2,3.5,4.1,1,1,1,1,3.3,5,2.4
139,0,Europe,Finance,Market Access,Meets,Female,42,9,1,7,,2.7,2.8,1,1,1,1,3.6,1.5,3.6
140,0,Middle East & Africa,HR,Pharmacovigilance,Meets,Male,42,17,0,12,4.5,3.2,1,1,1,1,1,3,4.5,2.1
141,0,North America,Manufacturing,Finance & Accounting,Below,Male,33,5,0,11,3.8,2.4,3.6,1,1,1,1,3.3,2.4,3.5
142,0,Middle East & Africa,Commercial,Quality Assurance,Meets,Female,43,11,1,8,,2.4,3.3,1,1,1,1,2,1.9,3.9
143,0,Latin America,Digital,Clinical Operations,Meets,Male,39,4,1,8,,3.7,2.8,1,1,1,1,3.3,3.3,2.3
144,0,Latin America,Finance,Supply Chain,Below,Male,31,13,0,6,3.1,1,3,1,1,1,1,4.6,2.7,3.2
145,0,Latin America,Commercial,Supply Chain,Meets,Female,40,18,0,7,4.6,2.7,1.9,0,0,0,0,3.9,1.5,2.4
146,0,Latin America,HR,Quality Assurance,Below,Female,44,9,1,9,,3.4,2.2,1,1,1,1,2.4,3.4,1.8
147,0,Latin America,Commercial,Market Access,Meets,Female,41,10,1,10,,2.9,2.2,1,1,1,1,1.9,2.8,2.9
148,0,Asia Pacific,Digital,Sales,Far Exceeds,Male,28,15,0,11,3,4.2,4.1,1,1,1,1,2.8,2.8,3.8
149,0,Europe,Commercial,Market Access,Meets,Male,40,8,0,12,1.7,3.2,2.2,1,1,1,1,1.6,2.7,3.1
150,0,Latin America,Commercial,Pharmacovigilance,Meets,Female,36,9,0,5,3.4,3.3,1.7,0,0,0,0,4,2.9,2.5
151,0,North America,Commercial,Pharmacovigilance,Meets,Male,28,6,0,10,5,3.4,3.1,1,1,1,1,5,5,3.4
152,0,North America,Commercial,Quality Assurance,Below,Male,42,9,0,9,2.3,2.2,1.1,1,1,1,1,2.4,1.3,1.9
153,0,North America,R&D,Marketing,Far Exceeds,Female,42,25,0,7,2.9,3.6,2.3,1,1,1,1,2.9,2.8,2
154,0,North America,Finance,Marketing,Below,Male,38,23,0,9,2.1,4.7,3.3,1,1,1,1,3.7,2.8,2.5
155,0,Asia Pacific,HR,Clinical Operations,Below,Male,32,8,0,7,3.2,1.3,2.4,0,0,0,0,3.2,1.8,1.5
156,0,North America,Digital,Finance & Accounting,Meets,Male,46,11,0,9,3.5,2.2,2,1,1,1,1,4.9,3.4,2.7
157,0,Latin America,HR,Communications,Meets,Female,41,18,0,10,1.6,3.5,1.3,1,1,1,1,2.8,1.9,2
158,0,Middle East & Africa,R&D,Marketing,Meets,Male,42,10,0,11,3.9,2.8,1.9,1,1,1,1,3.9,2.3,2.1
159,0,North America,R&D,Legal & Compliance,Below,Male,44,7,1,7,,3,2.7,1,1,1,1,3.7,2.8,1.9
160,0,Asia Pacific,R&D,Medical Affairs,Exceeds,Male,45,18,0,6,3.1,3.3,2.6,1,1,1,1,3.1,3.6,3.2
161,0,Asia Pacific,Finance,Medical Affairs,Meets,Female,40,9,0,8,2.4,1.9,3.7,1,1,1,1,2.4,2.5,2.7
162,0,North America,R&D,Legal & Compliance,Below,Female,31,11,0,8,3.4,2.4,2.3,1,1,1,1,3,3.5,2.3
163,0,Middle East & Africa,Commercial,Regulatory Affairs,Meets,Male,34,10,1,10,,3.4,1,1,1,1,1,3.8,4.1,1.9
164,0,North America,HR,Finance & Accounting,Meets,Female,35,6,1,6,,2.6,3.7,1,1,1,1,2.8,2.8,1
165,0,Asia Pacific,Manufacturing,Human Resources,Meets,Male,45,9,1,8,,1.8,4.3,1,1,1,1,3.4,2.2,3.3
166,0,Europe,Digital,Legal & Compliance,Meets,Male,39,5,1,11,,2.6,1,1,1,1,1,2.1,3.8,1.2
167,0,Latin America,R&D,Medical Affairs,Meets,Female,34,11,0,10,5,3.3,3.4,1,1,1,1,2.6,3.5,4
168,0,Asia Pacific,HR,Sales,Meets,Female,37,10,1,7,,4.7,4.5,1,1,1,1,4.2,4,2.8
169,0,North America,R&D,Finance & Accounting,Below,Male,46,2,0,10,3.8,2.8,2.1,1,1,1,1,3.2,1.3,3.2
170,0,Latin America,Finance,IT & Digital,Far Below,Female,42,5,1,9,,3.2,3.1,0,0,0,0,3.2,2.3,3.4
171,0,North America,R&D,Sales,Meets,Male,44,5,0,12,3.4,2,3.2,1,1,1,1,3,3.1,2.4
172,0,North America,R&D,Sales,Far Below,Non-Binary/Other,31,9,0,12,4.1,1.1,2.5,1,1,1,1,4.2,4.3,2.2
173,0,Europe,R&D,Medical Affairs,Meets,Female,37,28,0,5,4.2,2,4.4,1,1,1,1,3.8,2.1,1.8
174,0,Latin America,R&D,Clinical Operations,Below,Non-Binary/Other,34,6,0,5,2,3,1.8,1,1,1,1,3,2.9,3.4
175,0,Latin America,Digital,Legal & Compliance,Meets,Male,47,13,0,6,2.1,3.7,5,1,1,1,1,3.1,3.2,4.3
176,0,Europe,HR,Market Access,Meets,Male,37,21,0,8,3.2,2.4,5,1,1,1,1,2.7,3.1,3.7
177,0,Asia Pacific,Finance,Quality Assurance,Below,Female,35,6,0,10,3.7,3,2.9,1,1,0,0,3.2,2.5,2.4
178,0,North America,R&D,Data Science,Meets,Female,28,1,0,11,3.3,3.5,5,1,1,1,1,2.9,3.1,2.1
179,0,Middle East & Africa,R&D,Regulatory Affairs,Meets,Female,46,4,0,9,2.5,1,2.3,1,1,1,1,2.1,3.2,3.1
180,0,North America,R&D,Pharmacovigilance,Meets,Male,47,4,0,5,4,3.9,1.5,0,0,0,0,3.5,4.1,2.2
181,0,North America,R&D,Supply Chain,Meets,Female,28,24,0,9,4.6,2.3,3.6,1,1,1,1,3.6,2.9,4
182,0,Asia Pacific,Commercial,Pharmacovigilance,Below,Female,39,8,1,11,,3.7,3.5,1,1,1,1,4.2,3.6,3.6
183,0,North America,Commercial,Finance & Accounting,Meets,Female,44,20,0,5,3.7,3.7,2.6,1,1,1,1,4.8,3.9,1.9
184,0,Europe,Manufacturing,Regulatory Affairs,Meets,Male,41,6,0,9,2,4.2,4.4,1,1,1,1,1.8,4.2,4.7
185,0,Europe,R&D,Pharmacovigilance,Meets,Female,35,13,0,8,3,3.3,2.1,1,1,1,1,2,5,2.2
186,0,Latin America,Manufacturing,Market Access,Far Exceeds,Female,32,7,0,7,3.9,3.5,4.3,1,1,1,1,4.5,2.4,3.9
187,0,Middle East & Africa,Digital,Pharmacovigilance,Far Below,Male,45,8,0,7,3.4,4.3,3.1,1,1,1,1,4.5,3.2,3.4
188,0,North America,Manufacturing,Human Resources,Meets,Female,43,24,0,9,2.6,2.2,3.1,1,1,1,1,2.3,3.2,2.9
189,0,North America,HR,Pharmacovigilance,Meets,Male,42,12,0,8,3,3.3,2.5,1,1,1,1,2.7,3.2,4.1
190,0,Asia Pacific,Commercial,Market Access,Below,Female,45,21,0,7,4,3.1,3.5,0,0,0,0,3.1,1.1,2.8
191,0,Europe,Commercial,Finance & Accounting,Far Below,Female,51,7,1,7,,4.5,2,1,1,1,1,3.5,3.7,3.8
192,0,Middle East & Africa,R&D,Market Access,Exceeds,Male,36,15,0,11,2.8,2.6,1.9,1,1,1,1,3.8,3.9,1.7
193,1,Latin America,R&D,Medical Affairs,Meets,Female,36,6,1,7,,4,2.7,1,1,1,1,3.1,5,2.8
194,1,Europe,Digital,Market Access,Far Exceeds,Female,36,8,0,9,3.2,3.1,2.7,1,1,1,1,3.2,5,3.9
195,0,Latin America,Finance,Data Science,Meets,Female,32,11,0,11,4.2,2.5,2.2,1,1,1,1,3.1,2.1,4.4
196,0,Asia Pacific,Digital,Marketing,Below,Female,45,7,1,12,,4.2,2.6,1,1,1,1,1.9,4.7,2
197,0,Asia Pacific,HR,Data Science,Meets,Male,46,3,0,11,3.6,2.8,1.4,1,1,1,1,2.2,3.7,1.4
198,0,North America,R&D,Human Resources,Exceeds,Female,44,1,0,5,2.2,2.4,3.2,1,1,1,1,3.8,2.4,2.4
199,0,Middle East & Africa,R&D,Pharmacovigilance,Exceeds,Male,48,11,0,5,3.4,2.3,1,1,1,1,1,3.1,2.7,2.2
200,0,Latin America,Digital,Data Science,Meets,Male,39,5,1,12,,4,3.1,1,1,1,0,3.9,3.5,3.1
201,1,Europe,Digital,Regulatory Affairs,Meets,Male,40,17,0,11,1.4,3.4,2.4,1,1,1,1,2.6,3.6,3.4
202,0,Asia Pacific,Digital,Quality Assurance,Below,Female,42,8,1,6,,2.2,2.7,1,1,1,1,3.2,4.7,2
203,0,North America,Commercial,Marketing,Meets,Female,35,17,0,11,3,3.3,2.5,1,1,1,1,3.6,4.4,2.8
204,0,North America,Manufacturing,Quality Assurance,Meets,Female,32,15,0,10,3.3,3.2,1.5,1,1,1,1,4.2,3.5,2
205,0,Latin America,Manufacturing,Communications,Far Exceeds,Female,39,5,0,6,3,3.8,2.1,0,0,0,0,2.9,3.1,2.1
206,0,Asia Pacific,R&D,Finance & Accounting,Meets,Female,35,9,0,8,3.3,4.3,2.1,1,1,1,1,2.7,4.2,2.8
207,0,Middle East & Africa,Commercial,Supply Chain,Exceeds,Female,51,3,1,11,,2.4,2.2,1,1,1,1,4.1,2.3,2.9
208,0,Asia Pacific,Digital,Data Science,Meets,Male,29,16,0,5,2.1,2,3.6,1,1,1,1,3.5,2.2,4.7
209,0,Latin America,R&D,Quality Assurance,Meets,Female,38,9,0,7,3.8,4.1,2.9,0,0,0,0,2.6,2.8,3.3
210,0,Latin America,Commercial,Market Access,Exceeds,Male,40,12,0,9,4.7,3.2,1.6,1,1,1,1,4.6,4,2.9
211,0,Asia Pacific,HR,Clinical Operations,Meets,Female,33,15,0,5,3.1,3.6,2.4,1,1,1,0,4.6,3.1,3.8
212,0,Latin America,Finance,Clinical Operations,Meets,Male,35,9,0,10,2.8,2.8,3.4,1,1,1,1,3,3.5,3.6
213,0,Asia Pacific,Commercial,Finance & Accounting,Meets,Male,38,36,0,11,3.1,2.8,1.8,1,1,1,1,3.7,2.1,1.6
214,0,Europe,R&D,Finance & Accounting,Meets,Male,31,30,0,11,3.5,2,4.9,1,1,1,1,3.3,1.3,4.3
215,0,Asia Pacific,Manufacturing,Market Access,Far Exceeds,Male,40,8,1,7,,4,3.2,1,1,1,1,3.3,3.1,2
216,0,Asia Pacific,Digital,Finance & Accounting,Meets,Male,47,14,1,10,,3.2,3.3,1,1,1,1,4.5,2.2,1
217,0,Latin America,Finance,Quality Assurance,Below,Male,36,14,0,5,5,3.8,2.8,1,1,1,1,4.3,3.4,3.6
218,0,Latin America,HR,Finance & Accounting,Meets,Male,43,20,0,5,4.7,3.6,3,0,0,0,0,4,3.5,1
219,0,North America,Finance,Pharmacovigilance,Meets,Male,48,11,0,10,4.1,2.7,2,1,1,1,1,3.8,2.4,1.3
220,0,North America,Finance,Market Access,Meets,Male,44,5,0,8,4.1,3.8,2.5,1,1,1,1,3.9,4.3,1.8
221,0,Europe,Commercial,Marketing,Below,Male,34,11,0,12,4.3,3.5,2.5,1,1,1,1,4.3,1.6,2.1
222,0,North America,R&D,Sales,Exceeds,Female,29,15,0,12,3.3,3.6,3.7,1,1,1,1,3.9,3.9,3.3
223,0,Asia Pacific,R&D,Regulatory Affairs,Exceeds,Female,36,3,0,12,2.1,1.7,4.2,1,1,1,1,2.2,3.3,2.3
224,0,Latin America,Finance,Human Resources,Below,Female,38,11,0,7,4.1,1.1,4.3,1,1,1,1,3.7,1.9,3.6
225,0,North America,Digital,Pharmacovigilance,Below,Female,28,10,0,10,2,1.5,2.6,1,1,1,1,2.7,2.9,4
226,0,North America,R&D,Marketing,Meets,Female,38,21,0,5,2.8,4.9,2.3,1,1,1,1,3.1,4.8,3.1
227,0,Europe,Finance,Quality Assurance,Meets,Female,33,6,0,5,3.8,2.6,2.9,1,1,1,1,2.9,3.1,3.3
228,0,Europe,R&D,Pharmacovigilance,Meets,Male,37,4,0,5,2.6,2.1,1.5,1,1,1,1,3.1,2.7,2.6
229,0,Asia Pacific,Digital,Pharmacovigilance,Below,Female,36,10,0,9,4.9,4.5,4.3,1,1,1,1,4.6,3.7,4
230,0,Latin America,HR,Quality Assurance,Meets,Male,37,13,0,12,2.9,3.6,4.7,1,1,1,1,3.8,3.6,3.5
231,0,Europe,Finance,IT & Digital,Meets,Female,43,12,0,8,2.2,2.3,1,1,1,1,1,2.3,2.6,1
232,1,North America,Manufacturing,Market Access,Meets,Female,32,10,0,9,3.6,1.4,2.1,1,1,1,1,4.3,2.6,3.1
233,0,Latin America,Manufacturing,Quality Assurance,Meets,Female,28,16,0,5,2.7,3.2,1,1,1,1,1,4,3.1,1
234,0,Latin America,Finance,Data Science,Far Exceeds,Male,43,5,0,9,2.9,2.5,2,1,1,1,1,2.3,3.6,3.4
235,0,North America,Commercial,Finance & Accounting,Below,Female,42,16,1,10,,3.7,2.8,1,1,1,1,2.3,4.2,2.1
236,0,Europe,HR,Data Science,Meets,Non-Binary/Other,41,4,0,5,4,4.2,1,1,1,1,1,3.1,5,2.1
237,0,North America,Commercial,Regulatory Affairs,Below,Female,33,15,0,10,3.8,3.9,3.6,1,1,0,0,4,4.2,3.3
238,0,Latin America,Manufacturing,Clinical Operations,Meets,Female,42,12,1,12,,2.7,1.1,1,1,1,1,3.1,2,2.5
239,0,Middle East & Africa,Digital,Medical Affairs,Below,Male,30,7,1,9,,3,4.8,1,1,1,0,2.4,3.5,3
240,0,Middle East & Africa,Finance,Regulatory Affairs,Meets,Male,36,17,0,9,3.7,4.1,2.4,1,0,0,0,2.6,2.6,3
241,1,Asia Pacific,R&D,Legal & Compliance,Exceeds,Male,47,14,0,8,3.4,2.5,3.7,1,1,1,1,5,1.9,3.5
242,0,North America,Manufacturing,Legal & Compliance,Meets,Female,42,4,0,10,3.4,2.9,2,1,1,1,1,3.7,4.8,1.6
243,0,North America,HR,Regulatory Affairs,Meets,Male,38,3,0,12,2.8,5,2.9,1,1,0,0,2.3,2.8,2.9
244,0,Asia Pacific,Manufacturing,Finance & Accounting,Far Below,Male,37,36,0,7,3.5,2.2,4.3,1,1,1,1,4.8,2.8,4.2
245,0,Asia Pacific,HR,Human Resources,Meets,Male,31,6,1,9,,3.8,2,1,1,1,1,2.8,2.8,3
246,0,Asia Pacific,HR,Human Resources,Below,Male,48,34,0,12,3.5,3.1,2.8,1,1,1,1,3.7,5,3.7
247,0,Latin America,Finance,Sales,Meets,Male,44,28,0,12,1.8,3,3.2,0,0,0,0,2.8,3.8,2.5
248,0,North America,HR,Medical Affairs,Meets,Male,43,24,0,8,4.6,3.1,1.6,0,0,0,0,4.9,5,1
249,0,Latin America,Commercial,Clinical Operations,Exceeds,Female,37,4,0,5,3.5,1.4,1,0,0,0,0,4.3,1.7,1.6
250,0,Asia Pacific,Digital,Communications,Below,Male,36,8,0,11,3,3.7,2.5,1,1,1,1,3.9,2.1,2.5
251,0,North America,Manufacturing,Communications,Meets,Male,33,34,0,6,3,2.3,2.7,1,1,1,1,4,3,2.1
252,0,Latin America,Digital,Pharmacovigilance,Far Below,Female,47,9,0,7,4.4,3.2,3.6,1,1,1,1,3.4,3.2,4
253,0,Latin America,R&D,Legal & Compliance,Meets,Non-Binary/Other,28,12,0,5,2.4,2.5,4,1,1,1,1,2.5,2.7,4.2
254,0,Asia Pacific,Manufacturing,Medical Affairs,Meets,Male,41,6,0,10,2.8,2.8,1.3,1,1,1,1,2.7,4.2,4.6
255,0,North America,Digital,Sales,Exceeds,Male,29,16,0,7,2.3,2.5,1.8,1,1,1,1,2.5,2.8,1.4
256,0,Asia Pacific,Digital,Supply Chain,Meets,Female,37,6,0,11,3.4,2.8,2.1,1,1,1,1,3.5,1.9,3.3
257,0,North America,Finance,Regulatory Affairs,Meets,Female,38,2,0,11,3.8,1.8,1,1,1,1,1,3.5,2.4,3.7
258,0,Middle East & Africa,Finance,Quality Assurance,Meets,Female,30,12,0,6,3.5,5,3.7,1,1,1,1,3,4.6,3.1
259,0,Europe,R&D,Human Resources,Below,Male,33,9,0,7,3.7,2.9,3.9,1,1,1,1,3.6,3.9,3.5
260,0,Europe,HR,Regulatory Affairs,Meets,Male,42,17,0,5,4.2,4.7,4.5,1,1,1,1,3.4,2.7,2.8
261,0,Europe,Manufacturing,Human Resources,Exceeds,Female,47,16,0,5,3.2,2.7,1.4,1,1,1,1,3.4,2,1.4
262,0,Asia Pacific,Finance,Market Access,Meets,Female,40,8,0,8,2.6,2.9,1.8,0,0,0,0,4.1,2.2,1.6
263,0,Middle East & Africa,Manufacturing,Sales,Meets,Male,34,9,0,7,2.5,2.2,2.6,1,1,1,1,3.8,2.7,2.6
264,0,North America,R&D,Finance & Accounting,Meets,Male,32,24,0,6,2.6,3.9,4.2,1,1,1,1,3.1,3.7,3.2
265,0,Latin America,Finance,IT & Digital,Meets,Female,34,9,1,11,,2.2,1.8,1,1,1,1,5,4.6,3.1
266,0,North America,Finance,Regulatory Affairs,Meets,Male,38,4,0,5,3.9,2.1,2.9,1,1,1,1,4.5,2.3,3.6
267,0,Latin America,HR,Regulatory Affairs,Below,Female,40,7,0,9,1.2,3.1,2.5,1,1,1,1,3.2,3.9,3.4
268,0,North America,Manufacturing,Medical Affairs,Meets,Male,45,13,1,9,,3.1,2.2,0,0,0,0,3.9,1.9,2.5
269,0,Middle East & Africa,Manufacturing,Medical Affairs,Meets,Male,38,16,1,5,,2.4,2.9,1,1,1,1,4.3,2.2,3.6
270,0,Latin America,Manufacturing,Finance & Accounting,Meets,Male,34,8,0,5,2.7,3.5,2.4,1,1,1,1,2.2,3.5,2.1
271,0,Asia Pacific,HR,Quality Assurance,Meets,Female,31,6,0,9,3,1.1,2.3,1,1,1,1,2.9,1,2.3
272,0,North America,Finance,Finance & Accounting,Meets,Male,37,13,0,10,2.5,2.5,3.2,1,1,1,1,2.3,4.1,4.6
273,0,North America,R&D,Marketing,Meets,Female,28,13,0,6,2.2,1.8,2.9,0,0,0,0,3.6,1.4,4.6
274,0,Latin America,Manufacturing,Market Access,Meets,Male,34,13,0,9,2.9,2.9,3.4,1,1,1,1,1.7,2.9,4.1
275,0,Asia Pacific,Digital,Quality Assurance,Meets,Non-Binary/Other,30,11,0,7,4.7,4.4,2.3,1,1,1,1,4.3,4.8,2.9
276,0,Asia Pacific,HR,Finance & Accounting,Meets,Non-Binary/Other,36,13,0,8,2.7,1.2,2.5,1,1,1,1,4,2.2,2.9
277,0,Middle East & Africa,Commercial,Supply Chain,Meets,Female,41,16,0,10,3.1,3.5,1.8,1,1,1,1,4.2,1.7,2.2
278,0,Asia Pacific,R&D,Finance & Accounting,Below,Non-Binary/Other,40,13,0,10,2.5,2.7,3,1,1,1,1,3.1,3.8,2.3
279,0,Asia Pacific,Digital,Market Access,Meets,Male,42,7,0,11,1.6,2.5,3,1,1,1,1,2.8,4.1,2.5
280,0,Asia Pacific,Manufacturing,Medical Affairs,Exceeds,Non-Binary/Other,32,26,0,8,3.1,3.9,2.3,1,1,1,1,3.7,3.4,4.2
281,0,Europe,Commercial,Regulatory Affairs,Meets,Male,47,16,0,12,4.1,1.2,3.4,1,1,1,1,4.4,2.1,3.8
282,0,Middle East & Africa,R&D,Communications,Below,Male,42,13,1,11,,2.2,1.6,1,1,1,1,2.6,3.7,2.6
283,0,North America,HR,Pharmacovigilance,Meets,Male,42,14,0,5,2.9,2,3.3,1,1,1,1,3.5,1.2,1.5
284,0,Latin America,Commercial,Regulatory Affairs,Meets,Female,45,15,0,12,3.7,1.4,3.9,1,1,1,1,2.3,3.4,3.2
285,0,North America,Finance,Clinical Operations,Meets,Female,39,14,0,9,3,3.5,2.7,1,1,1,1,4.3,4.2,5
286,0,Middle East & Africa,Commercial,Quality Assurance,Meets,Female,37,8,0,12,2.2,3.1,1.8,1,1,1,1,1,2,2.4
287,0,Latin America,Digital,Market Access,Meets,Non-Binary/Other,46,5,1,5,,3.5,2.5,1,1,1,1,2.9,2.7,1.9
288,0,Middle East & Africa,R&D,Communications,Meets,Female,33,7,0,11,3.1,3.7,2.5,1,1,1,1,2.7,1.5,2.8
289,0,Asia Pacific,Digital,Pharmacovigilance,Far Exceeds,Female,37,15,1,9,,4.1,2.4,1,1,1,1,3.1,2.3,3
290,0,Latin America,Digital,Clinical Operations,Meets,Male,45,36,0,12,2.3,3.4,1.9,1,1,1,0,3,4.9,1.9
291,0,Asia Pacific,Manufacturing,Supply Chain,Far Exceeds,Female,37,5,1,7,,2.7,3.3,1,1,1,1,2.7,3.2,4.1
292,0,North America,HR,Regulatory Affairs,Meets,Non-Binary/Other,34,17,0,10,4.1,3.5,2.4,1,1,1,1,3.6,3.6,2
293,0,North America,Commercial,Marketing,Below,Non-Binary/Other,32,16,0,11,2.4,2.8,3.1,1,1,1,1,2.2,3.6,3.8
294,0,Latin America,R&D,Finance & Accounting,Meets,Male,39,23,0,10,3.4,4,3.6,1,1,1,0,1.1,3.5,2.4
295,1,Latin America,Finance,Human Resources,Meets,Male,35,22,0,6,2.5,4,2.4,1,1,1,1,2.7,2.3,3.4
296,0,Middle East & Africa,HR,Sales,Exceeds,Male,41,19,0,11,2,2.3,3.7,1,1,1,1,2.7,2.9,3.2
297,0,Middle East & Africa,HR,Clinical Operations,Meets,Male,48,25,0,11,2.2,1.6,1,1,1,1,1,2.7,3.6,3.5
298,0,Asia Pacific,R&D,Regulatory Affairs,Exceeds,Male,44,18,0,7,3.3,2.3,2.5,0,0,0,0,3.5,1.4,3
299,0,Latin America,HR,Regulatory Affairs,Below,Female,28,9,0,8,4.9,4.4,1,1,1,1,1,4.6,2.2,1.9
300,0,North America,Manufacturing,Market Access,Far Below,Female,42,13,0,9,3.2,5,1,1,1,1,1,4.5,4.1,1.1
301,0,Middle East & Africa,HR,Market Access,Meets,Female,43,14,0,7,4.1,1.5,1,0,0,0,0,3,2.1,1.7
302,0,Middle East & Africa,Manufacturing,Marketing,Meets,Male,36,10,0,9,2.6,4.1,4.1,1,1,1,1,3.9,3.4,3.4
303,1,North America,Commercial,Human Resources,Meets,Male,45,13,0,9,3.3,2.4,1.9,1,1,1,1,3.3,3,2.1
304,0,Middle East & Africa,Commercial,IT & Digital,Meets,Male,40,8,1,6,,2.6,1.8,1,1,1,1,4,2.7,2.7
305,0,Asia Pacific,Digital,Clinical Operations,Meets,Male,28,5,0,9,3.1,4.3,2.3,1,1,0,0,3.1,4.6,1.9
306,0,Latin America,Manufacturing,Human Resources,Below,Male,39,10,0,10,2.9,3.5,1.1,1,1,1,1,2.7,2.6,2.2
307,0,North America,Finance,Finance & Accounting,Meets,Male,36,11,0,10,4.3,4.1,3.4,1,1,1,1,4.8,3.1,2.3
308,0,Latin America,Commercial,Medical Affairs,Meets,Female,34,13,1,5,,2.7,3.2,1,0,0,0,3.1,3.7,1.7
309,1,Middle East & Africa,HR,IT & Digital,Meets,Male,40,6,0,12,3.2,4.2,2.7,1,1,1,1,2,4,3.2
310,0,Middle East & Africa,R&D,Market Access,Meets,Female,42,13,0,11,4.3,2.8,2.5,1,1,1,1,4.3,3.7,1
311,0,North America,R&D,Human Resources,Exceeds,Female,42,6,0,8,3.9,3.1,2.1,1,1,1,1,3.8,2.3,2.6
312,0,Asia Pacific,Manufacturing,Sales,Below,Female,42,29,0,9,3.9,3.6,2.8,1,1,1,1,2.8,2.9,2.3
313,0,Europe,Finance,Regulatory Affairs,Meets,Female,31,12,1,8,,2.8,2.3,1,1,1,1,3.7,3.7,2
314,0,North America,Digital,Regulatory Affairs,Meets,Female,32,23,1,5,,5,1,1,1,1,1,3.2,4.3,2.1
315,0,Europe,HR,Communications,Meets,Female,40,28,0,6,4.5,2.3,3.3,1,0,0,0,4.4,2.8,2.3
316,0,Europe,Manufacturing,Supply Chain,Meets,Female,44,10,0,9,4.1,3.8,2.8,1,1,1,1,4.3,4.3,3.8
317,0,Asia Pacific,R&D,Supply Chain,Exceeds,Male,40,8,0,6,3.9,2.7,1,1,0,0,0,5,3.2,2.6
318,0,Europe,Manufacturing,Marketing,Meets,Male,28,5,1,8,,3.9,1.7,1,1,1,1,3.6,2.4,2.5
319,0,Europe,HR,Clinical Operations,Far Below,Female,41,8,0,12,4.6,3.3,1.6,1,1,1,1,3.2,2.8,2.1
320,0,Asia Pacific,Finance,IT & Digital,Below,Male,29,18,0,9,3.3,3.9,1.2,1,1,1,1,3.4,4,2
321,0,Europe,Finance,Finance & Accounting,Meets,Female,42,8,0,7,4.1,2.2,3.1,1,1,1,1,5,3.8,3.8
322,0,Europe,Commercial,IT & Digital,Meets,Female,35,6,0,5,3.9,3.2,3.2,1,1,1,1,5,2.4,1.6
323,0,Europe,HR,Data Science,Below,Male,40,22,0,12,3.7,2.8,2.4,1,1,1,1,2.8,1.1,1.9
324,0,North America,Commercial,Pharmacovigilance,Below,Female,51,19,0,12,4.2,2.4,2.7,1,1,1,1,2.2,3.7,3.8
325,0,North America,Commercial,Market Access,Meets,Female,36,4,1,12,,2.7,4.5,1,1,1,1,3.4,4.1,2.1
326,0,North America,Commercial,Clinical Operations,Meets,Female,33,25,0,7,4.1,2.8,2.2,0,0,0,0,3.2,5,2.5
327,0,Asia Pacific,Manufacturing,Regulatory Affairs,Below,Female,35,26,0,6,4,3.2,4.5,1,1,1,1,3.7,2.9,4.4
328,0,Middle East & Africa,R&D,Quality Assurance,Meets,Female,29,11,0,5,3.1,2.7,2.2,1,1,1,1,2.9,3.2,2.1
329,0,Europe,Finance,Supply Chain,Meets,Female,32,10,0,6,3.8,2.1,2.1,1,1,1,1,4.5,2.4,2.3
330,0,Europe,Manufacturing,Pharmacovigilance,Exceeds,Female,44,20,0,5,2,3.9,2.7,1,1,1,1,3.5,3.4,3.6
331,0,Asia Pacific,R&D,Market Access,Meets,Male,28,4,0,7,3.8,3,3.8,1,1,1,1,5,3.1,2.8
332,1,Europe,Finance,IT & Digital,Meets,Male,34,4,1,12,,2.7,3.2,1,1,1,1,2.3,4.2,2.9
333,0,North America,HR,Communications,Meets,Male,39,15,0,11,4.4,3,2.3,1,1,1,1,3.1,4.1,2.1
334,0,Middle East & Africa,Finance,Communications,Far Below,Male,36,31,0,10,2.1,3.2,2.5,1,1,1,1,3.5,5,3.4
335,0,Latin America,Finance,Communications,Meets,Male,46,8,0,7,3.1,1.6,2.3,1,1,1,1,3.1,3.4,2.9
336,0,Europe,Finance,IT & Digital,Below,Female,37,15,1,9,,1,3.9,1,1,1,1,4.8,2.4,4
337,0,North America,Digital,Medical Affairs,Meets,Female,36,15,0,12,3.7,4.7,2.2,1,1,1,1,3.8,2.9,3
338,0,Latin America,HR,Medical Affairs,Meets,Female,39,7,0,6,2.8,3,3.3,1,1,1,1,3.7,4.2,3.5
339,0,Middle East & Africa,Manufacturing,Supply Chain,Far Below,Female,40,14,0,9,3,3.2,3.8,1,1,1,1,3.3,3,4.6
340,0,Latin America,Manufacturing,Clinical Operations,Meets,Male,38,18,0,10,4,4,2.9,1,1,1,1,3.3,3.9,2
341,0,North America,R&D,Market Access,Meets,Male,38,14,0,7,2.6,2.2,3.9,1,1,1,1,4.5,3.8,2.1
342,0,Latin America,Manufacturing,IT & Digital,Meets,Female,28,5,1,11,,2.1,3.9,1,0,0,0,3.7,2.5,3.5
343,0,Asia Pacific,Commercial,Pharmacovigilance,Meets,Male,31,5,0,5,2.8,3.4,1.5,1,1,1,1,2.8,2.4,1.6
344,1,Latin America,Finance,Regulatory Affairs,Meets,Female,41,12,0,5,3.7,3.4,3.6,1,1,1,1,2.9,3.9,3.7
345,0,Europe,Manufacturing,Communications,Exceeds,Male,44,7,0,10,3.7,2.9,4.5,1,1,1,1,3.6,4.3,3
346,0,Europe,R&D,Clinical Operations,Meets,Male,46,13,0,11,3,3.2,3.7,1,0,0,0,2.5,3.1,2
347,1,Asia Pacific,R&D,Supply Chain,Meets,Male,29,15,0,11,2.5,3.6,4.6,1,1,1,1,3.2,2.3,4.3
348,0,North America,Commercial,Marketing,Below,Female,33,14,0,10,2.8,1,2.6,1,1,1,1,4.4,1.8,2.9
349,0,Europe,R&D,IT & Digital,Far Below,Female,47,11,1,5,,2.7,2.6,0,0,0,0,3.9,1.1,2.9
350,0,Middle East & Africa,Digital,Data Science,Meets,Female,36,5,1,6,,3,1,1,1,1,1,2,2.5,1.9
351,0,Europe,Finance,Clinical Operations,Meets,Female,42,11,0,9,4.1,1,2.5,1,1,1,1,3.1,2.2,2.4
352,0,Europe,Finance,IT & Digital,Meets,Female,55,13,0,8,3.6,2.7,2.6,1,1,0,0,4.2,4,3.2
353,0,North America,Finance,Sales,Meets,Female,44,17,0,10,2.7,2.8,4.3,1,0,0,0,1.8,3.1,5
354,0,Latin America,HR,Market Access,Meets,Female,37,10,1,7,,1.5,3,1,1,1,1,4.4,2.1,3.2
355,0,Europe,Manufacturing,Legal & Compliance,Meets,Male,37,5,1,11,,5,3.6,1,1,1,1,3,4.7,3.2
356,0,Asia Pacific,Digital,Medical Affairs,Below,Female,41,12,0,12,3.7,3,1.3,1,1,1,1,3,2.8,3.1
357,0,Latin America,Manufacturing,Sales,Below,Female,28,12,0,11,4.2,5,3.2,1,1,1,1,4.1,5,2.7
358,0,Middle East & Africa,Digital,Clinical Operations,Exceeds,Male,41,4,1,11,,1.6,3.2,0,0,0,0,3.3,3.1,4.4
359,0,North America,Manufacturing,Clinical Operations,Meets,Male,36,10,0,5,3.9,2,2.9,0,0,0,0,2.4,3.1,3.2
360,0,Middle East & Africa,Commercial,Sales,Meets,Male,38,11,0,10,3.2,1.5,3.6,1,1,1,1,3.7,1,2.2
361,0,Latin America,R&D,Marketing,Meets,Male,39,8,0,8,3.3,3.6,2.2,1,1,1,1,2.6,4.9,1.6
362,0,Latin America,R&D,Sales,Meets,Female,47,10,1,12,,3.6,3.2,1,1,1,1,1.8,3.6,2.7
363,0,Latin America,Commercial,Regulatory Affairs,Below,Female,40,5,0,12,3.6,3.6,2.6,1,1,1,1,3.9,4.1,3.5
364,0,Middle East & Africa,Digital,Pharmacovigilance,Exceeds,Female,39,6,0,10,3.8,1.9,4.1,1,1,1,1,2.8,4.1,3.4
365,0,Latin America,HR,Sales,Meets,Female,42,17,0,12,3.3,4.6,2.2,1,1,1,1,2.8,4,1
366,0,Middle East & Africa,Digital,Human Resources,Below,Female,38,9,0,5,1.5,4.7,3.3,1,1,1,1,1.9,1.8,3.5
367,0,Latin America,R&D,Human Resources,Exceeds,Male,42,9,1,12,,4.4,3.6,1,1,1,1,3.2,3.6,2.5
368,0,Asia Pacific,HR,Sales,Meets,Female,37,11,0,11,1.4,2.1,1.6,1,1,1,1,2.5,2.9,1.5
369,1,Latin America,Manufacturing,Market Access,Meets,Female,45,6,0,8,2,4.6,2.3,1,1,1,0,3.1,3.5,3.4
370,0,Middle East & Africa,HR,Pharmacovigilance,Far Below,Female,46,26,0,10,3.4,3.9,2.1,1,1,1,1,3.3,4.1,1.3
371,0,Europe,Digital,Data Science,Far Below,Female,42,11,0,10,3.3,2.9,4,1,1,1,1,2.7,2.2,4.4
372,0,Latin America,Commercial,Sales,Below,Female,28,14,0,12,3.3,2.1,1.5,1,0,0,0,2.9,3.2,3.1
373,0,Europe,Manufacturing,Communications,Meets,Male,39,8,0,10,3,3,2.2,1,1,1,1,3.2,2.4,1.9
374,0,Asia Pacific,Digital,Finance & Accounting,Meets,Female,28,2,1,8,,4.3,2.2,1,1,1,1,1.9,3.7,1.4
375,0,North America,Manufacturing,IT & Digital,Meets,Female,40,7,0,7,2.8,3.7,1.4,1,1,1,1,2.6,4.2,1.1
376,0,Asia Pacific,HR,Sales,Meets,Female,48,7,0,10,3.1,2.5,3.3,1,1,1,1,2.3,3,2.4
377,0,Latin America,R&D,Regulatory Affairs,Exceeds,Male,45,5,1,12,,3.1,1.5,1,1,1,1,5,2.1,2.7
378,0,Europe,Digital,Human Resources,Meets,Male,36,11,0,8,3.9,2,3.1,1,1,1,1,3.7,2.7,3.9
379,0,Europe,Commercial,Medical Affairs,Exceeds,Male,37,11,0,6,3.4,3.1,3.6,1,1,0,0,4.7,2.4,3.4
380,0,Middle East & Africa,HR,Human Resources,Exceeds,Female,28,31,0,5,1.7,1.5,1.7,1,1,1,1,2.3,1.1,1.4
381,0,Europe,Digital,Human Resources,Meets,Male,38,22,0,10,3.1,2.6,1.5,1,1,1,1,2.4,2.7,1.6
382,0,Middle East & Africa,Commercial,Regulatory Affairs,Below,Female,37,8,1,12,,4.4,4.2,1,1,1,1,4.2,3.5,3.4
383,0,North America,Digital,Sales,Meets,Male,30,12,0,7,2.6,4.9,4.2,1,1,1,1,2.7,4.3,5
384,0,Latin America,HR,Market Access,Meets,Male,32,9,0,6,5,2.7,2,1,1,1,1,4,3.5,3.9
385,0,Middle East & Africa,Digital,Finance & Accounting,Meets,Female,31,6,0,8,2.8,3.7,1.7,1,1,1,1,3.4,2.6,1.2
386,0,North America,Manufacturing,IT & Digital,Below,Female,51,9,0,11,3,5,2.1,1,1,1,1,3.5,3.9,1.8
387,0,Europe,HR,Regulatory Affairs,Meets,Female,39,3,1,7,,5,3.1,1,1,1,1,4.1,5,4
388,0,Europe,Digital,Market Access,Meets,Male,43,7,0,6,2.2,2.7,1.9,1,0,0,0,2.9,2.4,1.3
389,0,North America,R&D,Communications,Below,Male,43,8,0,7,1.8,2,2,1,1,1,1,2.6,2.8,1.3
390,0,Europe,Digital,Legal & Compliance,Meets,Male,48,13,0,10,2.8,3.1,3.4,1,1,1,1,4.1,4.1,3.2
391,0,North America,Manufacturing,Pharmacovigilance,Below,Male,47,12,0,12,1,5,1.7,1,1,1,1,1.8,5,2.4
392,0,Middle East & Africa,Commercial,Market Access,Meets,Female,44,5,1,9,,2.1,3.1,1,1,1,1,4.3,2.9,4
393,0,Middle East & Africa,Commercial,Marketing,Exceeds,Male,29,14,0,7,2.9,1.2,2.4,0,0,0,0,3.7,1,2.6
394,0,North America,Commercial,Quality Assurance,Meets,Non-Binary/Other,44,17,1,10,,3.7,3.5,1,1,1,1,3.1,4.1,4.3
395,0,Middle East & Africa,R&D,Pharmacovigilance,Meets,Female,36,14,0,6,3.7,3.3,5,1,1,1,1,3.6,3.4,3.9
396,0,Middle East & Africa,Manufacturing,Communications,Below,Female,30,16,0,10,2.7,3.3,1.3,1,1,1,0,2.5,3.3,2.5
397,0,Middle East & Africa,HR,Finance & Accounting,Meets,Non-Binary/Other,36,16,0,5,2.5,3.1,2.1,0,0,0,0,3.4,2.8,1.7
398,0,Asia Pacific,Commercial,Quality Assurance,Exceeds,Male,39,21,0,8,1.8,3,2.3,1,1,1,1,2,2.4,2.9
399,0,Latin America,Manufacturing,Sales,Meets,Male,28,14,1,5,,1.9,2.2,0,0,0,0,3.6,2.2,1.3
400,0,Europe,Digital,Sales,Exceeds,Female,40,17,0,10,4.1,3.5,2.9,0,0,0,0,2.5,2.6,2.6
401,0,Asia Pacific,R&D,Marketing,Meets,Male,45,12,0,12,2.7,3.1,3.3,1,1,1,1,4.1,3.4,3.9
402,0,Middle East & Africa,Manufacturing,Legal & Compliance,Meets,Non-Binary/Other,39,16,0,12,3.2,5,2.2,1,1,1,1,4.6,4.8,1.5
403,0,North America,Manufacturing,Clinical Operations,Exceeds,Non-Binary/Other,32,8,0,6,2.8,2.8,2.7,1,0,0,0,4.2,3.3,2.1
404,0,Middle East & Africa,HR,Finance & Accounting,Far Below,Female,42,12,0,10,3.8,3.2,2.3,0,0,0,0,4.2,2,3.5
405,0,Latin America,Manufacturing,Human Resources,Far Below,Female,38,12,1,9,,1.6,1.4,1,1,1,1,2.9,2.9,1.1
406,0,Middle East & Africa,HR,Quality Assurance,Meets,Female,48,10,0,11,2.4,2,1.6,1,1,1,1,2.5,2.1,1.7
407,0,North America,R&D,Regulatory Affairs,Meets,Female,28,7,0,9,1.9,3.7,3.1,1,1,1,1,3,1.4,2.4
408,0,Latin America,R&D,Marketing,Meets,Male,28,7,0,9,3.5,5,4.6,1,1,1,1,3.7,4.3,3.8
409,0,Middle East & Africa,Digital,Legal & Compliance,Below,Female,37,13,0,5,3.9,3.4,2.6,1,1,1,1,4.2,2.9,2.7
410,0,Latin America,HR,Legal & Compliance,Far Exceeds,Male,35,7,0,7,3.8,2.8,2.3,1,1,1,1,3.9,2.8,2.4
411,0,Europe,HR,Pharmacovigilance,Meets,Female,40,14,0,11,4.1,1.4,2.1,1,1,1,1,3.3,2.4,1.9
412,0,Europe,Commercial,Finance & Accounting,Exceeds,Non-Binary/Other,41,14,0,11,3.4,3.3,4.6,1,1,0,0,4,2.6,3.5
413,0,Middle East & Africa,Commercial,Data Science,Meets,Male,47,5,0,7,3.7,4.4,2.6,0,0,0,0,3.4,4.7,2.5
414,0,Latin America,Digital,Regulatory Affairs,Meets,Male,37,14,0,7,4,2.5,1.3,1,1,1,1,4.4,1.6,1
415,1,North America,R&D,Market Access,Exceeds,Female,41,9,1,12,,2.5,3,1,1,1,1,4.7,1.9,3.2
416,0,Middle East & Africa,Finance,Sales,Meets,Female,30,13,1,7,,2.1,2.8,1,1,1,1,4.3,3,2.6
417,0,Europe,Commercial,Human Resources,Far Exceeds,Female,53,34,0,11,3.7,4,4,1,1,0,0,3.3,4.2,1.3
418,0,Europe,Manufacturing,Pharmacovigilance,Meets,Female,45,29,0,10,4.1,3.1,2.4,0,0,0,0,4,2.4,2.4
419,0,Middle East & Africa,R&D,Marketing,Meets,Female,43,12,0,9,3.9,2.8,2.3,1,1,1,0,4.2,2.6,3.5
420,0,Latin America,Finance,Legal & Compliance,Exceeds,Male,33,8,1,10,,3.8,1.5,1,1,1,1,1.9,3.5,1.9
421,0,Europe,Manufacturing,Quality Assurance,Far Exceeds,Female,46,12,1,12,,2.4,1.9,1,1,1,1,3.7,3.1,1.1
422,0,Latin America,HR,Quality Assurance,Meets,Female,44,3,0,7,3.5,1.9,1.5,1,1,1,1,3.1,3.3,2.9
423,0,Europe,R&D,Supply Chain,Below,Male,42,10,0,8,2.9,3.3,2.6,1,1,1,1,4.4,2.5,1.2
424,0,Europe,Digital,Sales,Meets,Male,37,18,0,9,3.7,2.9,3.5,1,1,1,1,2.9,3.5,3.1
425,0,Asia Pacific,HR,Regulatory Affairs,Exceeds,Female,32,18,0,5,3.8,3.2,1.7,1,1,1,1,3.7,3.6,1.9
426,0,Europe,HR,Legal & Compliance,Meets,Non-Binary/Other,38,13,0,5,4.5,4.5,4.3,1,1,1,1,4.6,3.6,4
427,0,North America,Manufacturing,Communications,Meets,Female,33,14,0,6,4.8,3.7,4.3,1,1,1,1,3.9,3.1,3.7
428,0,Middle East & Africa,HR,Market Access,Meets,Female,40,11,0,11,3.7,2,4,1,1,1,1,2.8,3.1,3
429,0,Middle East & Africa,Commercial,Market Access,Below,Male,31,6,0,11,3.7,3,2.2,1,0,0,0,3.7,3.8,2.6
430,1,Latin America,R&D,Sales,Far Exceeds,Non-Binary/Other,34,17,0,6,3.9,2.7,1.5,1,1,1,1,4.7,3.9,4.3
431,0,Europe,Commercial,IT & Digital,Meets,Male,28,14,1,8,,2.8,2.7,1,1,1,1,4.3,4.4,2.7
432,0,North America,Manufacturing,Supply Chain,Meets,Female,41,6,1,5,,2,4,1,1,1,1,3.9,2.4,3.3
433,0,Latin America,Finance,IT & Digital,Meets,Male,41,2,1,12,,2.8,4.4,1,1,1,1,2.9,3.8,4.3
434,0,Asia Pacific,Manufacturing,IT & Digital,Meets,Female,35,9,0,5,3.1,2.4,4,1,1,1,1,3.2,2.3,5
435,0,Latin America,R&D,Supply Chain,Meets,Male,28,14,0,12,2.8,2.7,4.6,1,1,1,1,3.6,4.1,2.5
436,1,Latin America,HR,Human Resources,Far Exceeds,Male,28,7,1,10,,3.1,3.8,1,1,1,1,4.1,2.8,4.2
437,0,Europe,Digital,Finance & Accounting,Meets,Male,39,14,1,8,,2.8,2,0,0,0,0,4.4,3.4,1.1
438,0,Asia Pacific,Manufacturing,Communications,Meets,Male,44,8,0,8,3.4,1.5,4.2,1,1,1,1,3.1,1.3,3.7
439,0,Latin America,R&D,Regulatory Affairs,Far Below,Male,32,9,0,10,3.7,2.6,1.5,1,1,1,1,4.6,3.6,2.4
440,0,North America,Digital,Supply Chain,Exceeds,Female,45,8,0,8,3.7,2.5,4,1,1,1,1,3.1,3.2,3.3
441,1,North America,HR,Marketing,Meets,Male,48,6,1,5,,3.7,2.2,1,1,1,1,3.6,4,2.1
442,0,Middle East & Africa,Finance,Supply Chain,Below,Male,41,5,1,11,,3.4,3,1,1,1,1,2.3,3.6,3.7
443,0,Asia Pacific,Manufacturing,Human Resources,Below,Male,44,8,0,8,4.8,3.8,1.7,1,1,0,0,3.3,3.9,1.6
444,0,Asia Pacific,Finance,Quality Assurance,Meets,Male,31,18,0,9,2.7,3.3,3,1,1,1,1,3.6,4.7,3.3
445,0,Middle East & Africa,R&D,Medical Affairs,Far Exceeds,Female,28,6,0,8,3.6,3.2,3.7,1,1,1,1,4.4,2.6,2.8
446,0,Latin America,Finance,Clinical Operations,Meets,Female,49,9,0,7,3.2,3.1,3.1,1,1,1,1,1.9,3.4,1.3
447,0,Asia Pacific,Finance,Quality Assurance,Meets,Male,32,7,0,10,3.2,4.2,3.3,1,1,0,0,2.2,3.2,3.3
448,1,North America,R&D,Quality Assurance,Meets,Male,45,9,0,6,3.9,4.5,3.3,1,1,1,0,5,4.1,3.1
449,0,North America,R&D,Data Science,Meets,Female,41,26,1,5,,3.5,2.6,1,0,0,0,1.3,1.9,2.8
450,0,Europe,Manufacturing,Data Science,Below,Female,49,6,0,5,3,3.6,3,1,1,1,1,2.9,3.8,3.7
451,0,Asia Pacific,Finance,Sales,Meets,Male,43,15,1,9,,2,1.5,1,1,1,1,5,1.8,2.2
452,0,Latin America,Digital,Legal & Compliance,Meets,Male,31,26,0,10,3.3,2.8,3.5,1,1,1,1,2.3,2.9,4.5
453,1,Middle East & Africa,R&D,Data Science,Far Exceeds,Male,36,10,0,11,4.4,3,2.9,1,1,1,1,4.9,1.5,3.1
454,0,Middle East & Africa,HR,Communications,Meets,Male,42,7,0,8,3.8,2.6,2.3,1,1,1,1,3.9,2.8,3.2
455,0,Latin America,Finance,Legal & Compliance,Meets,Male,35,12,0,6,3.9,4.8,1.6,1,1,1,1,3.7,3.6,2.7
456,1,Europe,R&D,Sales,Exceeds,Male,44,10,1,7,,3.3,2.5,1,1,1,1,3.6,3.8,2.5
457,0,Middle East & Africa,Digital,Communications,Meets,Male,39,9,0,10,5,2.9,1.2,1,1,1,1,4.1,3.3,1.8
458,0,Asia Pacific,Manufacturing,Quality Assurance,Exceeds,Female,44,8,0,5,2.7,1.8,2.5,1,0,0,0,3.4,1.2,2.2
459,0,Europe,Finance,Clinical Operations,Meets,Female,45,15,0,11,1.9,3.8,3.7,1,1,1,0,3.3,5,4
460,0,Asia Pacific,R&D,Regulatory Affairs,Meets,Female,40,9,1,5,,3.6,3.1,1,1,1,1,2.7,3.5,2.4
461,0,North America,R&D,Regulatory Affairs,Far Exceeds,Female,37,5,0,8,3.1,2.4,1.6,1,1,1,1,3.8,4.1,1.3
462,0,Europe,HR,IT & Digital,Below,Male,35,16,0,7,5,2.6,3.1,1,1,1,1,4.1,3.3,4.1
463,0,Middle East & Africa,HR,Medical Affairs,Meets,Male,31,12,0,7,4,2.5,2.7,1,1,1,1,3.6,3.6,2.7
464,0,Europe,Finance,Pharmacovigilance,Meets,Male,48,13,0,8,4.3,3.3,2.5,1,1,1,1,4.1,3.4,1.6
465,1,Europe,R&D,Regulatory Affairs,Meets,Female,38,9,0,5,1.5,2.7,2,1,1,1,1,3.3,2.6,2.9
466,1,Europe,Finance,IT & Digital,Exceeds,Female,37,6,0,7,2.9,2.1,2.3,1,1,1,1,4.9,3,2.7
467,0,Europe,R&D,Legal & Compliance,Meets,Female,37,21,0,12,3.9,4.9,2.4,1,1,1,1,2.6,1.7,1.8
468,0,Asia Pacific,HR,Human Resources,Exceeds,Male,38,12,0,12,3.5,3.3,2.5,1,1,1,1,4.4,4.3,2.4
469,0,North America,Digital,Finance & Accounting,Meets,Male,35,16,0,8,2,1.9,2.8,1,1,1,1,3.9,3.1,2.2
470,0,Latin America,Commercial,Communications,Far Exceeds,Female,35,6,0,12,3.6,1.9,4.5,1,1,1,1,4.5,2.2,3.2
471,0,Europe,Commercial,IT & Digital,Meets,Female,30,6,0,6,2.7,3.8,3.9,1,1,1,1,3.3,2.4,4.1
472,0,Middle East & Africa,R&D,Pharmacovigilance,Below,Male,38,11,1,7,,2.1,2.9,1,1,1,0,2.5,2.8,3.2
473,0,Europe,HR,Supply Chain,Meets,Female,46,20,0,5,2.2,2.5,3.6,1,1,1,1,1.9,2,2.1
474,0,Middle East & Africa,Manufacturing,Market Access,Meets,Male,34,8,0,7,3.3,1.9,2.1,1,1,1,1,2.4,2.1,2.3
475,0,Asia Pacific,Manufacturing,Quality Assurance,Exceeds,Female,41,16,0,6,4.4,2.4,1.5,0,0,0,0,3.3,3,2.5
476,0,Middle East & Africa,Commercial,Clinical Operations,Meets,Male,41,7,1,11,,3.8,4.6,1,1,1,0,4,2.2,4.6
477,0,Latin America,Digital,Finance & Accounting,Meets,Female,40,6,0,8,4.5,3.1,2.6,1,0,0,0,4.9,2.9,2.2
478,0,North America,Commercial,Sales,Exceeds,Female,49,7,1,10,,2.5,3.4,1,1,1,1,3.5,4.9,2.5
479,0,Middle East & Africa,R&D,Pharmacovigilance,Exceeds,Non-Binary/Other,42,2,1,7,,1.6,2.6,1,1,1,1,4.2,3.2,2.9
480,0,Middle East & Africa,Digital,IT & Digital,Meets,Female,38,8,0,6,3.7,2,3.7,1,1,1,1,3.9,2.5,3.1
481,0,North America,Manufacturing,Medical Affairs,Exceeds,Female,40,10,1,6,,2.6,5,1,1,1,1,3,1,4.2
482,0,Latin America,HR,Regulatory Affairs,Meets,Female,43,5,0,6,3,3.1,2,1,1,1,1,3.1,2.9,4
483,0,Europe,HR,Marketing,Far Below,Male,48,8,0,7,2.3,3.5,3.3,1,1,1,1,3.2,3.6,3.5
484,0,Middle East & Africa,R&D,Regulatory Affairs,Far Below,Male,37,7,1,9,,2,2.3,1,1,1,1,1.6,2.5,3.5
485,0,North America,Commercial,Data Science,Far Exceeds,Male,39,6,0,8,3.6,3.5,2.7,1,1,1,1,3.7,3,2.2
486,0,Asia Pacific,R&D,Legal & Compliance,Below,Male,55,17,0,12,3,3.4,1.5,1,1,1,1,2.2,2.8,4.5
487,0,North America,HR,Quality Assurance,Meets,Female,38,5,0,6,4.3,3.3,2.5,1,1,1,1,4.1,3.2,3.5
488,0,Asia Pacific,Manufacturing,Communications,Exceeds,Male,37,7,0,12,2.3,1.2,2.2,1,0,0,0,2.2,2.5,3.3
489,0,Latin America,HR,Data Science,Below,Male,33,2,1,8,,3.2,3.9,0,0,0,0,3.4,3.1,2.2
490,1,Europe,Digital,Regulatory Affairs,Exceeds,Female,39,5,1,12,,2.8,2.2,1,1,1,1,4.5,3.9,1.9
491,0,North America,Finance,Marketing,Exceeds,Female,38,8,0,10,2.5,2.9,2.7,0,0,0,0,2.5,3.1,3.8
492,0,Middle East & Africa,HR,Legal & Compliance,Far Exceeds,Female,40,13,0,6,4.4,4.8,3.7,1,1,1,1,4.4,3.4,2.8
493,0,Latin America,HR,Data Science,Meets,Female,40,18,0,10,2.5,1.5,3.5,1,1,1,1,3,3,2.6
494,0,North America,Finance,Clinical Operations,Meets,Male,28,14,0,10,3.3,5,4.1,1,1,1,0,4,3.8,5
495,0,Middle East & Africa,Digital,IT & Digital,Exceeds,Male,30,2,1,12,,1,3.7,1,1,1,1,3.3,3.5,2.4
496,0,North America,Commercial,Legal & Compliance,Meets,Female,37,10,1,5,,2.8,3.1,1,1,1,1,3.5,2,2.8
497,0,Asia Pacific,HR,Communications,Meets,Male,35,12,0,11,4,3.6,2.6,1,1,1,1,4.4,1.9,2.4
498,0,North America,R&D,Communications,Meets,Female,32,18,0,10,2.3,2,2.5,1,1,1,1,3.1,3.9,3.5
499,0,North America,HR,Legal & Compliance,Meets,Female,28,2,0,11,4.3,3.4,2.7,1,1,1,1,1.2,2.4,3.6
500,1,North America,R&D,Data Science,Exceeds,Female,48,15,1,5,,2.4,1.8,1,1,1,1,4.1,2.8,2.9
501,0,Latin America,Digital,Marketing,Meets,Female,48,17,0,5,3.7,3.3,2.3,1,1,1,1,3.4,3.8,3.1
502,0,North America,HR,Data Science,Far Below,Female,43,8,0,8,5,2.9,3.1,1,1,1,1,3.9,4,3.9
503,0,Middle East & Africa,Digital,Pharmacovigilance,Below,Male,34,36,0,6,4.2,2.9,1.2,1,1,1,0,2.8,3.4,3
504,0,Asia Pacific,Digital,Supply Chain,Below,Female,47,5,0,5,2.2,4.5,1,1,1,1,1,1.6,3.1,1.9
505,0,Asia Pacific,Commercial,Legal & Compliance,Meets,Female,34,16,0,8,1.1,4.1,1,1,1,1,1,2.7,3.2,3.5
506,0,North America,HR,Sales,Meets,Male,41,13,0,5,4.5,2.5,1.3,0,0,0,0,3.4,3.9,2.3
507,0,Latin America,R&D,Regulatory Affairs,Below,Female,33,4,0,6,3.5,3.7,2.4,1,1,1,1,2.4,2.4,2.3
508,0,Latin America,R&D,Communications,Meets,Male,38,28,0,5,4.6,3.3,2.5,1,1,1,1,3.8,1.8,1.8
509,0,Middle East & Africa,HR,Pharmacovigilance,Exceeds,Male,41,23,0,7,4,2.3,1.8,1,1,1,1,3.9,3.1,3.4
510,0,North America,Finance,Sales,Meets,Male,29,13,0,10,3.3,2.8,1.8,1,1,1,1,3.6,3.2,2.3
511,0,Asia Pacific,Commercial,Supply Chain,Meets,Female,35,16,0,5,4.4,3.9,1.6,1,1,1,1,4,4.6,3.2
512,0,Latin America,Commercial,Pharmacovigilance,Far Exceeds,Female,40,21,0,7,3,2.2,2.9,0,0,0,0,2.8,4.3,3.4
513,0,North America,Commercial,Medical Affairs,Meets,Female,30,6,0,9,4.8,2.7,2.4,1,1,1,1,5,3.1,2.8
514,0,Latin America,R&D,Pharmacovigilance,Exceeds,Female,32,5,0,9,2.9,3.9,2.9,0,0,0,0,2.5,4.6,4
515,0,Latin America,Digital,Clinical Operations,Meets,Female,40,10,1,11,,4,2.4,1,1,1,1,3.4,3.3,3.1
516,0,Asia Pacific,Finance,IT & Digital,Meets,Male,35,21,0,5,3.8,3.3,2.3,1,1,1,1,2.9,3.2,2.5
517,0,Europe,Commercial,Marketing,Meets,Male,31,6,0,11,3,2.4,2.8,1,1,1,1,3.1,2.8,4.3
518,0,Middle East & Africa,R&D,Regulatory Affairs,Meets,Male,38,11,1,11,,3.6,3,1,1,1,1,3,2.3,1.5
519,0,Middle East & Africa,R&D,Quality Assurance,Exceeds,Male,41,5,0,11,3.1,1.5,3.9,1,1,0,0,2.2,3.7,3.1
520,0,Asia Pacific,Digital,Sales,Exceeds,Female,51,21,0,10,3.7,2.1,3.3,1,1,1,1,3.5,3.1,2.3
521,0,Latin America,HR,Communications,Meets,Female,39,10,0,8,4.4,4.4,4.3,1,1,1,1,5,3.2,3.4
522,0,North America,HR,Data Science,Meets,Male,38,8,1,8,,4.3,1.9,1,1,1,1,4.1,3.7,1.3
523,0,Latin America,Commercial,Regulatory Affairs,Exceeds,Male,36,12,0,11,3.1,2.4,1.7,1,1,1,1,2.2,2.7,2.9
524,0,Asia Pacific,Commercial,Quality Assurance,Meets,Female,45,10,0,8,3.1,1.8,2.2,0,0,0,0,2.5,1.6,1.9
525,0,Middle East & Africa,Finance,Supply Chain,Exceeds,Male,40,17,0,8,4,1.9,3.4,1,1,1,1,4.9,2.7,2.7
526,0,Latin America,Digital,Pharmacovigilance,Meets,Female,43,6,1,8,,2.4,2.1,0,0,0,0,4.7,3.3,2.4
527,0,Middle East & Africa,Commercial,Quality Assurance,Meets,Male,39,12,0,12,1.8,3.3,3.9,1,1,1,1,2.3,5,2.4
528,0,North America,Digital,Human Resources,Far Below,Female,43,21,0,7,3.9,2.3,1.5,1,1,1,1,5,3.9,2
529,0,Middle East & Africa,R&D,Medical Affairs,Meets,Female,40,9,0,5,2.4,2.7,1.6,1,1,1,1,2.9,3,1.8
530,0,Middle East & Africa,Commercial,Regulatory Affairs,Meets,Female,30,7,0,11,2.9,2.8,2.8,1,1,1,1,3.1,4.4,1
531,0,Europe,R&D,Legal & Compliance,Meets,Female,36,5,0,11,3.3,3.8,4.7,1,1,1,1,2.6,1,3.5
532,0,Europe,Manufacturing,Finance & Accounting,Meets,Female,36,32,0,5,3.3,2.3,3.3,1,1,1,1,2.6,2.1,1.8
533,0,Europe,Digital,Regulatory Affairs,Meets,Female,41,30,0,5,3.2,3,3.3,1,0,0,0,4,2.2,4.2
534,0,Middle East & Africa,Manufacturing,Regulatory Affairs,Meets,Male,39,4,0,8,3.6,5,1.8,1,1,0,0,2.2,3.2,3.1
535,0,Asia Pacific,Commercial,Legal & Compliance,Exceeds,Male,46,11,0,10,2.8,3,2.3,1,1,1,1,3.7,3.3,2.6
536,0,Middle East & Africa,R&D,Human Resources,Meets,Non-Binary/Other,40,7,0,11,3.8,3,3.1,1,1,1,1,3.9,2.6,1
537,0,Asia Pacific,Commercial,IT & Digital,Meets,Male,41,13,0,8,3.1,2.8,1,1,1,1,1,3.7,2.8,2.1
538,0,Asia Pacific,Manufacturing,Marketing,Below,Male,32,15,0,9,3.6,3.2,2.5,1,1,1,1,2.5,3.4,1.7
539,0,Europe,Commercial,Supply Chain,Meets,Female,39,8,0,10,2.9,3.1,4.1,1,1,1,1,2.4,4.1,3.4
540,0,Latin America,Finance,IT & Digital,Meets,Non-Binary/Other,37,7,1,7,,3.5,3.9,1,1,1,1,2.7,4.9,4.1
541,0,North America,HR,Marketing,Meets,Female,28,25,0,10,2.4,4.5,4.9,1,1,1,1,2.1,4,3.5
542,0,Europe,Manufacturing,Regulatory Affairs,Meets,Female,30,10,0,10,3,2.7,2.4,0,0,0,0,4.6,2.6,2.3
543,0,Europe,Commercial,Medical Affairs,Below,Female,42,11,1,5,,2.7,1.3,1,1,1,1,2.8,2.2,1
544,0,Latin America,R&D,Data Science,Meets,Female,42,11,0,5,4.1,4.6,2.3,1,1,1,1,3.3,3.9,2.7
545,0,North America,Commercial,Human Resources,Far Exceeds,Female,34,17,0,10,3.7,2.6,2.8,0,0,0,0,4.4,2,1.6
546,0,Middle East & Africa,R&D,Finance & Accounting,Meets,Female,35,7,0,6,2.3,2.9,3.6,1,1,1,1,3.8,2.6,3.4
547,0,Middle East & Africa,HR,Medical Affairs,Meets,Female,31,23,0,9,1.8,3.2,2.9,1,1,1,1,1,2.8,2.1
548,0,Europe,Commercial,Sales,Meets,Male,44,15,0,11,4,2.6,3.2,1,1,1,1,2.3,3.3,1.9
549,0,North America,HR,Supply Chain,Meets,Female,33,12,0,12,3.8,3.3,2.3,1,1,1,1,3.3,1.8,3.2
550,0,Europe,Manufacturing,Legal & Compliance,Below,Female,35,24,0,5,2.2,2,2.4,1,0,0,0,1.8,2,3.3
551,0,Asia Pacific,R&D,Pharmacovigilance,Meets,Male,44,4,0,5,2.8,1.4,2,1,1,1,1,3.1,2.3,2.1
552,0,Europe,Finance,Communications,Meets,Male,44,4,1,12,,1.8,1.4,1,1,1,1,4.7,1,1
553,0,Europe,Manufacturing,Human Resources,Meets,Female,37,8,1,12,,4.2,2.2,1,1,1,1,2.8,3.2,1.8
554,0,Middle East & Africa,R&D,Regulatory Affairs,Below,Male,38,8,0,8,2.4,5,3.1,1,1,1,1,3.4,3.3,4.7
555,0,Middle East & Africa,HR,Quality Assurance,Meets,Female,41,7,0,6,2.8,1.6,3.3,1,1,1,1,4.6,2.3,3.5
556,0,Middle East & Africa,Digital,Data Science,Meets,Male,36,26,0,11,4,3.2,3.1,1,1,1,1,3.3,3.4,3.9
557,0,Asia Pacific,Commercial,Pharmacovigilance,Meets,Female,37,13,0,11,3,3.8,2.9,1,1,1,1,2.6,3,3.6
558,0,Middle East & Africa,HR,Market Access,Meets,Female,37,28,0,7,4,2.2,2.3,1,1,1,1,3.6,2.9,2.1
559,1,North America,R&D,IT & Digital,Meets,Female,42,15,0,6,2.7,3.7,4.2,1,1,1,1,3.5,3.2,2.6
560,0,Latin America,R&D,Medical Affairs,Meets,Male,47,9,0,8,3.6,3.7,2.9,1,1,1,1,3.7,4.2,2.9
561,0,North America,R&D,Communications,Far Below,Male,45,5,0,12,3.4,3.2,2.5,1,1,1,1,2.6,3.4,3.4
562,0,North America,R&D,Data Science,Meets,Female,44,10,0,8,2.6,4,3.5,1,1,1,0,3.5,3.6,3
563,0,Middle East & Africa,Commercial,Market Access,Meets,Female,31,4,0,11,2.9,3,4.2,1,1,1,1,2.4,3.6,3.1
564,0,Latin America,Manufacturing,Marketing,Meets,Female,46,17,0,7,3.6,4.1,3.5,1,1,1,1,4.1,5,3.2
565,0,Latin America,Finance,Market Access,Meets,Female,34,14,1,7,,3.4,3.5,1,1,1,1,3.4,2.5,2.5
566,0,Latin America,Digital,Finance & Accounting,Meets,Female,28,12,1,6,,3.7,2.4,1,1,1,1,4.6,2.8,2.9
567,0,Asia Pacific,Commercial,Pharmacovigilance,Meets,Female,33,18,0,6,4,4.6,4.4,1,1,1,1,4.1,4.8,3.8
568,0,Middle East & Africa,R&D,Supply Chain,Meets,Female,37,3,1,12,,2.8,4.1,1,1,1,1,2.7,3.6,3.2
569,0,Latin America,Commercial,Medical Affairs,Meets,Female,28,13,1,12,,2.5,2.9,1,1,1,1,2.9,3.3,3.1
570,0,Asia Pacific,HR,Data Science,Meets,Male,42,6,1,8,,3.2,2.7,1,1,1,1,1.9,1,3.3
571,0,Europe,Finance,Market Access,Below,Male,43,10,0,10,2,2.1,3.5,1,1,1,1,2.1,2.6,3.5
572,0,Europe,R&D,Medical Affairs,Exceeds,Female,36,3,1,9,,1.3,2.8,1,1,1,1,2.7,3,1.7
573,0,Asia Pacific,Digital,Data Science,Meets,Male,31,2,0,8,3.2,1.5,4.6,1,1,1,1,5,2,4.4
574,0,Asia Pacific,R&D,IT & Digital,Meets,Female,44,11,0,9,3.7,3.9,4.1,1,1,1,1,3.4,4.7,2.9
575,0,Middle East & Africa,Finance,Data Science,Meets,Female,32,11,0,12,2.2,2.6,2.3,1,1,1,1,3.2,2.6,2
576,0,Middle East & Africa,Digital,IT & Digital,Far Below,Male,28,12,0,8,3.9,1.5,2.5,1,1,1,1,3.4,2.6,2.9
577,0,Europe,Finance,Legal & Compliance,Meets,Female,38,12,0,6,4,2.6,1.6,1,1,1,1,4,3.9,2
578,0,Latin America,Digital,Finance & Accounting,Meets,Male,38,9,0,10,5,2.3,4.3,1,1,1,1,4.3,3.5,4.2
579,0,Europe,Manufacturing,Pharmacovigilance,Below,Female,40,36,0,6,4.1,2.1,3.4,1,1,1,1,2.2,3.1,2.7
580,0,Latin America,Manufacturing,Medical Affairs,Exceeds,Male,43,10,0,12,4.2,2.7,1.3,1,1,1,1,4.5,2.7,2.9
581,0,Latin America,Commercial,Pharmacovigilance,Meets,Female,43,10,0,11,3.4,4.1,2.3,1,1,1,1,2.9,4.5,3.9
582,0,Middle East & Africa,Commercial,IT & Digital,Below,Male,30,7,0,6,2.5,3.5,1.3,1,1,1,1,3.5,2.7,2.7
583,0,North America,Digital,Communications,Meets,Female,28,7,0,6,3.1,2.8,2.9,1,1,1,1,3.6,2.3,3.4
584,0,North America,R&D,Market Access,Below,Female,41,6,0,5,4.2,3.4,2.2,1,1,1,1,2.4,2,3.3
585,0,Asia Pacific,HR,Sales,Exceeds,Male,38,10,1,11,,3.7,2.4,1,0,0,0,4.8,3.9,2.7
586,0,Middle East & Africa,HR,Supply Chain,Meets,Female,35,20,0,9,3.5,3.5,4.1,1,1,1,1,3.8,2.7,3
587,0,Latin America,R&D,Legal & Compliance,Meets,Female,37,7,1,6,,3.5,3,1,1,1,1,3.3,2.3,3.2
588,0,North America,R&D,Sales,Meets,Male,33,5,1,8,,2.8,3,0,0,0,0,3.1,2.1,3.8
589,0,Latin America,Manufacturing,Clinical Operations,Meets,Male,48,6,0,11,3.1,4.9,2.4,1,1,1,1,3.4,5,1.4
590,0,North America,HR,Regulatory Affairs,Meets,Male,28,3,0,6,2.8,3,2.7,1,1,0,0,2.8,2.7,2.2
591,0,North America,Digital,Human Resources,Meets,Male,41,4,0,6,5,3.5,3.2,1,1,1,1,3.8,4.8,3.5
592,0,North America,Finance,Communications,Meets,Female,30,10,1,6,,2.5,4.3,1,1,1,1,3.9,2.8,3.3
593,0,Middle East & Africa,Commercial,Sales,Meets,Male,34,11,0,8,2.3,3.8,2.9,1,1,1,0,3.4,4.8,3.6
594,1,Europe,Finance,Marketing,Meets,Female,35,11,0,9,2.7,4.1,2.2,1,1,1,1,2.9,4,2.5
595,0,Latin America,Manufacturing,Supply Chain,Far Below,Male,32,19,0,6,3.3,3.5,3,1,0,0,0,2,3.7,4.9
596,0,Middle East & Africa,HR,Regulatory Affairs,Below,Male,37,19,0,6,3.8,4,2.8,1,1,1,1,3.7,3.8,2.2
597,0,Middle East & Africa,R&D,Market Access,Meets,Male,28,2,0,8,3.2,4.1,5,1,1,1,1,4.3,5,5
598,0,Middle East & Africa,HR,Pharmacovigilance,Meets,Male,29,16,0,12,2,4,2.5,1,0,0,0,3,3.5,1
599,0,Middle East & Africa,Digital,Marketing,Exceeds,Female,28,28,1,8,,3,2.9,1,1,1,1,3.5,3.2,2.5
600,0,Middle East & Africa,Manufacturing,Regulatory Affairs,Far Below,Male,31,19,1,10,,3.7,3.5,1,1,1,1,1,2.8,3.6
601,0,Asia Pacific,R&D,Regulatory Affairs,Meets,Female,33,36,0,7,3.7,2.8,3,1,1,1,1,3.1,1.7,4
602,0,Latin America,Finance,Data Science,Meets,Female,38,12,0,5,3.4,3.2,3.8,1,1,1,1,2.7,2.5,3.4
603,0,Middle East & Africa,Digital,Clinical Operations,Exceeds,Male,34,9,0,7,2.7,2.7,2.9,1,1,1,1,2.3,2.5,2.1
604,0,Latin America,Finance,Pharmacovigilance,Exceeds,Male,33,16,0,11,5,1.8,2.4,1,1,1,1,3.3,1.5,3
605,0,Asia Pacific,Commercial,Legal & Compliance,Meets,Male,35,21,0,11,3.3,3.8,3.2,1,1,1,1,2.6,2.7,4.2
606,0,Asia Pacific,Manufacturing,Market Access,Meets,Male,34,8,0,7,1.9,2.4,3.1,1,1,1,1,2.9,1.3,1.9
607,0,Latin America,Digital,Human Resources,Meets,Female,36,8,0,7,3.2,3.7,3.4,0,0,0,0,3.7,2.7,2.3
608,0,North America,Digital,Medical Affairs,Below,Female,36,6,0,5,3.7,3.9,2.3,1,1,1,1,2.5,4.3,2.2
609,0,Europe,Finance,Sales,Meets,Female,33,6,0,9,2.9,2.9,3.3,1,1,1,1,4.7,4.3,2.7
610,0,North America,R&D,Supply Chain,Meets,Female,29,6,0,9,3.1,4.2,4.1,1,1,0,0,4,1.7,2.5
611,0,North America,Commercial,Clinical Operations,Far Below,Male,38,17,0,11,3.8,2.7,1.1,1,1,1,1,4.8,3.1,2.6
612,0,North America,Finance,Data Science,Meets,Male,43,11,0,5,3.5,2.7,2.8,1,1,1,1,3.1,3.2,2.7
613,0,Middle East & Africa,Digital,Legal & Compliance,Below,Non-Binary/Other,32,8,0,7,3.8,2.7,1.9,1,1,1,1,3,2.5,1.8
614,0,Asia Pacific,Manufacturing,Data Science,Meets,Female,37,5,0,7,3.9,2.8,3.6,1,1,1,1,3.6,2.3,3.1
615,0,North America,Digital,Regulatory Affairs,Exceeds,Male,35,10,0,5,2,2.8,2.8,1,1,1,1,2.6,2.3,2.2
616,0,Asia Pacific,HR,Quality Assurance,Meets,Male,41,17,0,8,3.8,2.9,2.1,1,1,1,1,3.7,2.4,2.4
617,0,Latin America,Manufacturing,Sales,Far Below,Male,33,12,0,8,3.8,5,2.2,1,1,1,1,3.9,5,3.4
618,0,Europe,Manufacturing,Clinical Operations,Far Below,Female,37,23,0,6,3.5,2.2,4.5,1,1,1,1,4.4,3.6,1.8
619,0,Latin America,Digital,IT & Digital,Meets,Female,37,5,0,5,3.6,4.3,2.6,1,1,1,1,3.9,4.5,3.8
620,0,Latin America,R&D,Regulatory Affairs,Meets,Male,40,11,1,12,,3,2.8,1,1,1,1,3,2.7,2.2
621,0,Middle East & Africa,Manufacturing,Clinical Operations,Meets,Male,31,12,1,10,,2.8,3.1,1,1,1,1,4.9,2.4,2.2
622,0,Europe,HR,Communications,Below,Male,40,20,0,6,3.8,3.7,1.8,1,1,1,1,4.3,3.8,2.1
623,0,Latin America,Finance,Marketing,Meets,Male,35,2,0,12,3.9,3.6,3.7,1,1,1,1,4.1,3.5,3.4
624,0,Latin America,R&D,Pharmacovigilance,Exceeds,Female,41,18,0,12,4.5,2.4,1.6,1,1,1,1,3.3,3.7,1.8
625,0,Europe,R&D,Human Resources,Exceeds,Female,36,9,0,8,4,4.6,3.5,1,1,1,1,3.3,3.5,3.7
626,0,Europe,R&D,Supply Chain,Meets,Male,46,7,1,6,,2.1,2.1,1,1,1,1,2.8,2.4,1.6
627,0,Latin America,Manufacturing,Sales,Meets,Female,28,1,1,6,,3.4,2.7,1,1,1,1,1,4.1,1.7
628,1,Europe,R&D,IT & Digital,Meets,Male,41,13,0,6,1,2.3,3.8,1,1,1,1,2.8,3,3.9
629,0,Latin America,Digital,Finance & Accounting,Meets,Female,40,8,1,12,,2.3,2,0,0,0,0,3.4,1.3,2.5
630,0,Latin America,R&D,Data Science,Below,Female,41,20,0,7,3.5,4.1,2.5,1,1,1,1,2.8,4.7,3
631,0,Middle East & Africa,HR,IT & Digital,Meets,Male,44,8,0,5,3.6,2.9,2.2,1,1,1,1,2.8,4.7,3.6
632,0,North America,Commercial,IT & Digital,Meets,Female,28,7,1,9,,3.8,3.1,1,1,1,1,3.3,4.1,4.2
633,0,Latin America,HR,Quality Assurance,Exceeds,Male,51,11,0,5,3.5,2.4,1.6,1,1,1,1,3.7,3.2,1.9
634,0,Asia Pacific,Manufacturing,Market Access,Meets,Male,41,6,0,11,3.4,1.5,2.2,1,1,1,1,3.3,3.3,2.2
635,0,North America,R&D,Medical Affairs,Meets,Male,50,7,1,5,,3.6,3,1,1,1,1,3.5,4,2.4
636,0,North America,R&D,Pharmacovigilance,Exceeds,Male,49,11,0,7,2.1,3.6,4.7,1,1,1,1,2.3,4.2,4.1
637,0,North America,Digital,Sales,Meets,Female,41,20,0,7,3.2,2.7,3,0,0,0,0,3.4,2.5,3.3
638,1,Middle East & Africa,Finance,Legal & Compliance,Far Exceeds,Male,40,16,0,10,2.8,3.5,2.6,1,1,1,1,4.6,1,4.8
639,0,Latin America,R&D,Marketing,Meets,Female,42,16,0,6,2.9,2.7,2.5,1,1,1,1,4.6,3.1,2.2
640,0,Middle East & Africa,HR,Sales,Far Exceeds,Female,28,13,1,7,,4.5,4.7,1,1,1,1,2.3,3,2.7
641,0,Latin America,Manufacturing,Market Access,Below,Male,37,36,0,6,3.1,4.2,3.6,1,1,1,1,3.4,3.2,1
642,0,Middle East & Africa,Commercial,IT & Digital,Meets,Male,44,7,0,7,3.5,2.6,1.6,1,1,1,1,3.5,4.4,1.9
643,0,Middle East & Africa,R&D,Human Resources,Meets,Male,47,10,0,7,2.1,3,1,1,1,1,1,3.2,2.6,2.3
644,1,Asia Pacific,Commercial,Supply Chain,Exceeds,Male,36,5,1,8,,4.8,1.5,1,1,1,1,4.2,3.6,2.7
645,0,Middle East & Africa,R&D,Supply Chain,Far Below,Male,40,17,0,11,2.1,3.5,2.9,1,1,1,1,4.3,4.3,1.8
646,0,Europe,Manufacturing,Clinical Operations,Far Below,Female,41,8,1,11,,3.4,2.8,1,1,1,1,3.1,3.7,2.3
647,0,Asia Pacific,Finance,Regulatory Affairs,Meets,Male,38,20,0,6,2.6,3.7,2.9,1,1,1,1,3.5,3.2,3.1
648,0,Middle East & Africa,HR,Supply Chain,Exceeds,Female,32,10,0,7,4.2,4.5,4.4,1,1,1,1,4.8,3.1,2.8
649,0,North America,Manufacturing,Quality Assurance,Meets,Male,34,4,0,10,2.6,2.5,2.9,1,1,1,1,4.2,2.9,2.8
650,0,Europe,Commercial,Medical Affairs,Meets,Male,32,16,0,9,2.4,4,2.8,1,1,1,1,3.9,3.4,3.9
651,0,Europe,R&D,Marketing,Far Below,Male,29,8,1,9,,3.1,2.5,1,1,1,1,4.4,2.5,1.3
652,0,Europe,Commercial,Human Resources,Meets,Male,37,11,0,11,3.6,4,3,1,1,1,1,3.6,3.2,2.9
653,0,Asia Pacific,HR,IT & Digital,Meets,Male,51,15,0,10,4.1,2.6,3.4,1,1,1,1,3.5,3.3,3.7
654,0,Middle East & Africa,Manufacturing,Market Access,Meets,Female,39,19,0,5,3.8,4.1,2.8,1,1,1,1,3.8,2.4,3.5
655,0,Middle East & Africa,Commercial,Data Science,Meets,Female,36,4,1,11,,2.1,1.5,0,0,0,0,3.9,2.4,1.6
656,0,North America,Commercial,Supply Chain,Meets,Male,40,4,1,7,,1.6,1.7,1,1,1,1,1.9,2.9,2.6
657,0,North America,HR,Human Resources,Exceeds,Female,33,11,1,6,,3.6,3.3,1,0,0,0,2.8,2.8,2.9
658,0,Europe,R&D,Data Science,Meets,Male,28,20,0,8,4.1,4,1.8,1,1,1,1,3.2,4.1,2.5
659,0,North America,Commercial,Human Resources,Meets,Male,34,11,1,5,,3.3,2.4,1,1,1,1,3.1,3.8,1.3
660,0,Asia Pacific,HR,Supply Chain,Meets,Female,31,5,0,12,3.4,4.9,1,1,1,0,0,3.1,3.2,1
661,0,Middle East & Africa,R&D,IT & Digital,Meets,Female,28,8,0,7,3,2.8,3.6,1,1,1,0,3.4,3.8,2.7
662,0,Europe,Finance,Human Resources,Exceeds,Female,35,5,0,11,4.6,4.3,2.1,1,1,1,1,4.3,3.2,2.6
663,0,North America,R&D,IT & Digital,Below,Male,41,13,0,11,4.4,2.2,1,0,0,0,0,4.5,2.2,2.3
664,0,Asia Pacific,Finance,Human Resources,Exceeds,Non-Binary/Other,40,13,0,11,1.6,3.3,3.4,0,0,0,0,3.4,2.3,4.1
665,0,Asia Pacific,Manufacturing,Quality Assurance,Below,Female,40,9,0,9,3.7,4.1,1.3,1,1,1,1,5,3.7,1
666,0,North America,HR,Data Science,Below,Female,48,15,0,8,3.1,4.4,1.5,0,0,0,0,3.1,4.6,2.1
667,0,Middle East & Africa,R&D,Regulatory Affairs,Meets,Female,35,9,1,11,,2.5,3.5,1,1,1,1,3.3,3.5,3
668,0,North America,Finance,IT & Digital,Far Exceeds,Female,41,18,0,8,4.6,1.8,2.1,1,1,1,1,4.6,4.1,1.9
669,0,Europe,Finance,Marketing,Far Exceeds,Female,36,18,0,8,2.5,3.2,4.5,1,1,1,1,2.1,3.9,2.7
670,0,North America,Manufacturing,Medical Affairs,Meets,Female,47,9,1,11,,3.9,1.3,0,0,0,0,4.5,3.4,1
671,0,Asia Pacific,Digital,Quality Assurance,Below,Male,33,5,1,6,,1.8,4.3,1,1,1,1,3.1,1.4,3.5
672,0,North America,HR,Finance & Accounting,Meets,Female,42,15,0,8,2.2,3.9,1.7,1,1,1,1,3,4,3.4
673,0,Middle East & Africa,Digital,Communications,Meets,Male,39,20,0,5,3.3,5,2.4,1,1,1,1,3,5,2.8
674,0,Latin America,R&D,Legal & Compliance,Meets,Non-Binary/Other,45,16,0,12,1.9,1.6,1.7,0,0,0,0,2.4,1.9,2.9
675,0,North America,HR,Regulatory Affairs,Meets,Female,38,10,0,10,5,1,3.8,1,1,1,1,4.7,1.8,3.2
676,0,Middle East & Africa,Manufacturing,Medical Affairs,Meets,Female,37,3,1,5,,1.5,4.2,1,1,1,1,3.9,2.7,2.9
677,0,Middle East & Africa,R&D,Regulatory Affairs,Meets,Male,36,5,1,7,,4.5,2.3,1,1,1,1,4.1,3.5,2.7
678,0,Asia Pacific,HR,Legal & Compliance,Meets,Female,37,23,0,12,3.1,2.6,2.4,1,1,1,1,3.2,2.8,2.6
679,0,Middle East & Africa,HR,Regulatory Affairs,Exceeds,Male,28,12,0,7,2.5,2.4,1.2,1,1,1,1,3.6,1.8,1
680,0,Middle East & Africa,Digital,Regulatory Affairs,Below,Female,35,9,0,10,3.5,2.5,3.9,1,1,1,1,4.2,4.6,2.7
681,0,Middle East & Africa,R&D,Clinical Operations,Below,Female,35,10,1,10,,3.6,1.7,1,1,1,1,2.1,3.8,1
682,0,Middle East & Africa,Manufacturing,Medical Affairs,Meets,Male,31,11,0,6,1.9,4.2,1.4,1,1,1,1,1.8,4.7,2.9
683,0,Europe,Manufacturing,Regulatory Affairs,Meets,Male,35,11,0,8,3.5,4.2,2.7,1,1,1,1,3,4.7,3.3
684,0,Europe,R&D,Pharmacovigilance,Far Below,Female,33,10,0,10,4.6,4,2.2,1,1,1,1,4.7,4.5,3.2
685,0,Asia Pacific,R&D,Pharmacovigilance,Exceeds,Male,35,9,0,10,2.5,2.9,2,1,1,1,1,3.4,3.6,1.4
686,0,North America,Finance,Human Resources,Meets,Male,42,14,0,5,2.6,3,2.5,0,0,0,0,3,2.5,2.3
687,0,Middle East & Africa,Commercial,Human Resources,Meets,Male,42,24,0,12,2.9,2.1,2,1,1,1,1,3.4,2.9,1.9
688,0,North America,Digital,Supply Chain,Meets,Male,47,9,0,10,2.8,4.5,2.9,1,1,1,1,2.1,2.5,3.2
689,0,North America,R&D,Marketing,Meets,Female,40,16,0,5,3,3.6,3.9,1,1,1,1,3.2,2.5,2.9
690,1,Asia Pacific,R&D,IT & Digital,Far Exceeds,Female,29,7,0,10,3.6,3.2,1,1,1,1,1,4.8,3.3,2.5
691,0,Middle East & Africa,Commercial,Data Science,Below,Female,36,6,0,6,3,2,3,1,1,1,1,3.4,2.6,2
692,0,Middle East & Africa,Commercial,Legal & Compliance,Meets,Male,34,5,1,9,,1,4,1,1,1,1,2.3,2.2,4
693,0,Latin America,HR,IT & Digital,Meets,Female,32,13,1,11,,1.9,3,1,1,1,1,3.4,1.4,3.9
694,0,North America,Manufacturing,Legal & Compliance,Meets,Female,44,21,1,10,,3.6,3.9,1,1,1,1,2.9,3.3,5
695,0,North America,Digital,Communications,Meets,Female,41,9,0,11,2.6,2.5,3.4,1,1,1,1,2.8,3.3,3.4
696,0,Europe,HR,Supply Chain,Exceeds,Male,38,15,0,5,3.7,4.5,3,1,1,1,1,3.7,4.2,2.4
697,0,Latin America,R&D,Clinical Operations,Meets,Male,29,6,0,8,4.1,1.9,1.3,1,1,1,1,3.3,2.3,4.1
698,0,Europe,Commercial,Pharmacovigilance,Meets,Female,38,1,1,12,,3.1,1.2,1,1,1,1,2.8,2.4,3.6
699,0,Europe,Finance,Medical Affairs,Meets,Male,52,3,1,11,,3.4,1.6,1,1,1,1,3.7,5,2.2
700,0,Europe,Manufacturing,Marketing,Exceeds,Female,33,11,0,9,4.5,1.1,3.7,1,1,1,1,3.8,1.7,5
701,0,Asia Pacific,HR,Marketing,Meets,Female,37,12,0,11,4.2,4,2.5,0,0,0,0,2.8,3.6,4
702,0,Asia Pacific,Finance,Human Resources,Meets,Male,46,11,1,10,,2.8,2.9,1,1,1,1,3.2,4.5,4.1
703,0,Europe,Manufacturing,Data Science,Meets,Female,35,10,1,8,,1,3,1,1,1,0,3.6,1.8,3.9
704,0,Latin America,Finance,Medical Affairs,Below,Female,35,12,0,12,4.1,2.8,2.4,1,1,1,1,2.3,2.9,1.3
705,0,North America,Commercial,Finance & Accounting,Below,Male,37,8,0,12,3.5,4.1,2.6,0,0,0,0,3.6,3.7,2.7
706,0,Latin America,HR,Human Resources,Far Exceeds,Male,40,16,0,11,4.1,2.2,3.8,1,1,1,1,3.2,3.3,3.7
707,0,Middle East & Africa,HR,Market Access,Meets,Male,32,12,0,11,3,1.6,2.3,1,1,1,1,3.4,2.4,3.2
708,0,Asia Pacific,Manufacturing,Data Science,Below,Male,44,19,0,8,2.9,1.6,3,1,1,1,1,2.6,2.3,2.4
709,0,North America,Finance,Finance & Accounting,Exceeds,Male,36,20,0,10,1.8,2.7,2,1,1,1,1,2.7,3.5,2
710,0,North America,Commercial,Marketing,Meets,Male,39,13,0,5,4.6,3.8,2.6,1,1,1,1,4.6,5,3
711,0,Middle East & Africa,R&D,Clinical Operations,Meets,Male,35,19,0,8,4.4,3.4,3.8,1,1,1,1,4.1,3.7,1.5
712,0,Middle East & Africa,HR,Quality Assurance,Below,Female,30,4,1,6,,1.2,2.7,1,1,1,1,1.8,3.5,1.5
713,0,Europe,R&D,Quality Assurance,Exceeds,Male,28,6,0,5,3.4,2.5,2.1,1,1,1,1,4,3.5,2.1
714,0,Asia Pacific,Commercial,Pharmacovigilance,Meets,Male,39,6,1,8,,3.7,3.8,1,1,1,1,4.1,3.1,2.7
715,0,Asia Pacific,HR,Marketing,Meets,Male,28,18,0,6,3.8,2,4,0,0,0,0,3.4,1.7,5
716,0,Latin America,HR,Clinical Operations,Far Below,Male,43,8,1,9,,2.7,5,1,1,1,1,2.1,2.7,5
717,0,Europe,Finance,Data Science,Meets,Non-Binary/Other,39,27,0,6,2.9,1.6,3,1,1,1,1,2.6,2.6,1.9
718,0,Europe,R&D,Communications,Meets,Female,50,7,0,10,3,3,1.8,1,1,1,1,3.7,3.3,1.2
719,0,Europe,Finance,Clinical Operations,Exceeds,Female,34,13,0,11,3.3,3.3,2,0,0,0,0,3.1,1,3
720,0,Europe,Digital,Communications,Below,Female,48,7,0,12,3,4.7,2.4,1,1,1,1,3.1,5,3.9
721,0,Asia Pacific,R&D,Finance & Accounting,Meets,Female,36,5,0,5,4.9,3.2,3.3,1,1,1,1,4.3,2.9,3.4
722,0,Asia Pacific,R&D,Communications,Far Below,Non-Binary/Other,44,2,1,8,,3.4,1.8,1,1,1,1,4.2,4.2,1
723,0,Europe,Digital,Sales,Below,Male,41,4,1,5,,3.3,3.3,1,1,1,1,3,4.5,2.9
724,0,Latin America,Commercial,Data Science,Meets,Female,28,13,0,12,3,2.6,1.6,1,1,1,1,4,4.6,2.2
725,0,North America,Commercial,Legal & Compliance,Meets,Female,55,10,0,10,2.3,3.2,2.5,0,0,0,0,3.3,3.3,3.4
726,0,North America,HR,Regulatory Affairs,Meets,Non-Binary/Other,48,16,1,10,,4.8,1.8,1,1,1,1,4.9,3.9,3.5
727,0,Latin America,Manufacturing,Data Science,Far Exceeds,Male,40,16,0,8,1.8,2.7,2.1,1,1,1,1,1.8,3.4,2.7
728,0,Europe,Finance,Pharmacovigilance,Exceeds,Female,46,1,0,11,3.6,2,3.9,1,1,1,1,3.6,2.8,2.4
729,0,Asia Pacific,Manufacturing,Human Resources,Below,Male,40,17,0,8,2.2,3.6,1.2,1,1,1,1,4.1,2.4,2
730,0,North America,HR,Quality Assurance,Exceeds,Female,43,8,1,12,,1.9,3.4,1,1,1,1,3.8,1.6,2.3
731,0,Middle East & Africa,Manufacturing,Finance & Accounting,Meets,Female,39,2,0,7,4.2,3.9,2.9,1,1,1,0,3.7,2.4,3.2
732,0,Middle East & Africa,R&D,Data Science,Exceeds,Female,32,12,0,9,3.8,1.9,2.8,1,1,1,1,3.2,1.7,2.2
733,0,Latin America,R&D,Human Resources,Below,Female,37,3,0,8,2.7,4.7,3.3,1,1,1,1,3.7,3.8,2.8
734,0,Europe,Digital,Regulatory Affairs,Exceeds,Female,35,6,1,10,,3.4,2.7,1,0,0,0,3.3,3.5,3.2
735,0,North America,Digital,Sales,Below,Female,42,23,0,10,3.2,2.6,1.7,1,1,1,1,2.9,2.4,2.3
736,0,Europe,HR,IT & Digital,Meets,Female,32,8,1,7,,3.6,5,1,0,0,0,3.7,4.3,4.9
737,0,North America,HR,IT & Digital,Far Below,Male,39,18,0,6,2.6,3.6,1.7,1,1,1,1,4.4,2.5,1.4
738,0,Latin America,HR,Finance & Accounting,Below,Male,30,9,0,11,2.9,3.5,4,1,1,1,1,3.1,4.4,2
739,0,Latin America,R&D,IT & Digital,Meets,Male,43,23,0,5,3.8,3.1,1.5,1,1,1,0,3.9,3.8,2.5
740,0,Middle East & Africa,Manufacturing,Clinical Operations,Exceeds,Male,31,6,0,8,5,2.8,5,1,1,0,0,4.1,3,3.6
741,0,Europe,Finance,Medical Affairs,Meets,Non-Binary/Other,42,7,0,5,3.4,4.4,1.5,1,1,1,1,3.2,3.5,2
742,0,Middle East & Africa,HR,Quality Assurance,Meets,Male,39,14,0,11,2.8,2.9,2.2,1,1,1,1,3.5,3.4,2.2
743,0,Europe,HR,Clinical Operations,Below,Female,44,13,0,12,4.3,2.7,1,1,1,1,1,4.1,2.8,3
744,0,Middle East & Africa,R&D,Sales,Meets,Male,37,18,0,11,4.2,3.5,2.1,1,1,1,1,3.2,2,1.9
745,0,Asia Pacific,Finance,IT & Digital,Exceeds,Male,43,7,1,10,,3.4,3,1,1,1,1,4.1,3.8,2.8
746,0,Asia Pacific,R&D,Medical Affairs,Below,Male,39,11,1,12,,2.1,2.4,0,0,0,0,3.1,3.8,1.4
747,0,Asia Pacific,Finance,Marketing,Meets,Male,41,2,0,5,4.9,4.6,4,0,0,0,0,5,4.4,2.3
748,0,Asia Pacific,R&D,Supply Chain,Below,Male,28,11,0,10,1.2,1.8,2.7,1,1,1,1,3.7,2.8,3.1
749,0,North America,Manufacturing,Pharmacovigilance,Meets,Female,34,9,0,12,3.2,1.8,3.1,1,1,1,1,2.4,2.9,2.4
750,0,Asia Pacific,HR,Clinical Operations,Below,Female,37,8,1,7,,4.8,2.7,1,1,1,1,3.3,2.8,3.1
751,0,Latin America,Commercial,Human Resources,Below,Female,46,12,0,10,3.7,3,2,1,1,1,1,3.5,3.8,2.7
752,0,Latin America,Commercial,Market Access,Below,Female,40,13,0,8,3.6,3.3,4.8,1,1,1,1,3.7,3.3,3.2
753,0,North America,HR,Medical Affairs,Meets,Female,28,7,0,10,3.6,2.6,3.1,1,0,0,0,4.7,3.1,2.6
754,0,Asia Pacific,HR,Marketing,Meets,Female,41,10,0,8,2.9,2.8,2.6,0,0,0,0,1.7,1.7,2.5
755,0,Asia Pacific,HR,Market Access,Meets,Male,33,2,0,11,3.6,4.1,1.4,1,1,1,1,3,2.6,2.8
756,0,Asia Pacific,HR,Supply Chain,Below,Male,33,5,0,7,3.7,3.7,3.4,1,1,1,1,4.5,3.4,2.4
757,0,Middle East & Africa,Finance,Supply Chain,Below,Male,38,8,1,11,,3.6,2.5,1,1,1,1,2.1,5,3.5
758,0,Europe,Manufacturing,Quality Assurance,Below,Male,40,13,0,5,2.4,2,3.3,1,1,1,1,2.6,2.1,1.9
759,0,Middle East & Africa,Commercial,Legal & Compliance,Exceeds,Female,33,11,0,11,4.6,2.9,2.7,1,1,1,1,4.4,2.7,2.3
760,0,Europe,Digital,Market Access,Meets,Female,28,17,0,9,4,3.8,3.9,1,1,1,1,3.6,2.6,3
761,0,Asia Pacific,Commercial,Quality Assurance,Meets,Female,37,9,0,8,1,1.2,4.4,1,1,1,1,2.6,3.3,3.6
762,0,Asia Pacific,Commercial,Quality Assurance,Meets,Female,37,13,0,12,2.3,2.3,2.4,1,1,1,1,3.7,2,2.1
763,0,Middle East & Africa,R&D,Quality Assurance,Meets,Male,47,13,0,8,2.9,3.8,3,1,1,1,1,3.8,4.6,2.7
764,0,Middle East & Africa,HR,IT & Digital,Far Below,Male,38,7,1,12,,2.1,1.5,1,1,1,1,3.4,3.3,1.5
765,0,Europe,HR,Communications,Meets,Female,45,16,0,7,1.6,2.5,2.1,1,1,1,1,3.5,3.6,2.7
766,0,Latin America,HR,Quality Assurance,Meets,Male,51,10,0,6,2.2,4.1,2.1,1,1,1,1,4.2,4.4,3.9
767,0,Europe,R&D,Marketing,Exceeds,Female,31,5,1,12,,3.6,2.6,1,1,1,1,2.6,2.2,2.7
768,0,Middle East & Africa,Manufacturing,Pharmacovigilance,Exceeds,Male,47,6,0,10,3.4,3.8,1.6,1,1,1,0,2.9,2.2,1.5
769,0,Middle East & Africa,Manufacturing,Data Science,Meets,Female,44,14,0,8,2.7,3.5,2.4,1,1,1,1,3.6,2,1.6
770,1,North America,Digital,Marketing,Meets,Female,28,8,0,9,3.6,3.6,2.3,1,1,1,0,4.8,4.6,1.9
771,0,Middle East & Africa,Manufacturing,Sales,Below,Female,37,20,0,7,2.8,3.2,5,1,1,1,1,3.6,1,4.2
772,0,North America,Manufacturing,Communications,Meets,Female,42,23,0,9,2,1.9,2,1,1,1,1,2.8,2.5,3.1
773,0,Latin America,HR,Communications,Exceeds,Male,40,15,0,8,3.6,2.7,4.6,1,1,1,1,3.8,5,3.4
774,0,Europe,Finance,Quality Assurance,Below,Male,48,6,0,5,3.9,2.9,1.9,1,1,1,1,3.9,2.3,1.8
775,0,Europe,Commercial,Medical Affairs,Far Exceeds,Male,42,23,0,7,4.1,1.6,3,1,1,1,1,3.8,2.9,3.6
776,0,North America,Manufacturing,Medical Affairs,Meets,Male,29,10,0,9,2.2,2.6,2.9,1,1,1,0,2.6,2.2,2.2
777,0,Europe,Manufacturing,Finance & Accounting,Meets,Male,43,11,0,12,3.8,2.7,3.9,1,1,1,1,4.5,2.1,3.8
778,0,Middle East & Africa,R&D,Communications,Below,Female,31,20,0,10,3.6,4.5,3.8,1,1,1,1,3.6,3.9,2.4
779,0,Asia Pacific,Digital,Market Access,Meets,Male,35,20,0,7,4.9,1.4,4.5,1,1,1,1,4.1,1.8,3.5
780,0,North America,Finance,Human Resources,Meets,Female,45,8,1,9,,3.2,2.9,1,1,1,1,3,1.8,2.3
781,1,Europe,R&D,Market Access,Meets,Female,44,10,0,7,3.4,3.4,3.7,1,1,1,1,3.7,2.2,3.5
782,0,North America,HR,Finance & Accounting,Meets,Female,38,21,0,8,3.3,3.8,2,0,0,0,0,2.9,3.6,2.8
783,0,North America,Commercial,Sales,Below,Female,34,11,0,7,1.9,4.1,2,1,1,1,1,2.3,3.6,3.1
784,0,Asia Pacific,Digital,Human Resources,Meets,Female,37,20,0,12,4.5,2,3.4,1,1,1,1,4.7,2.5,2
785,0,Middle East & Africa,R&D,Finance & Accounting,Meets,Female,37,5,1,7,,2.7,3.2,1,1,1,1,3.1,3.1,1.7
786,0,North America,Manufacturing,Finance & Accounting,Meets,Female,35,17,0,6,2.6,3.7,4.1,1,1,1,1,3.7,3.6,3.3
787,0,Europe,Manufacturing,Communications,Meets,Female,45,8,0,12,3.1,2.7,2.6,1,1,1,1,4.1,1.9,4.4
788,0,Latin America,Digital,Marketing,Meets,Male,36,10,1,10,,3.2,2.8,1,1,1,1,2.4,1.9,1.2
789,0,North America,Manufacturing,Communications,Meets,Male,36,9,0,11,3.8,4.2,1.5,0,0,0,0,3.5,4.9,3.4
790,0,North America,R&D,Human Resources,Meets,Female,37,18,1,5,,4,4,1,1,1,1,4.6,3.9,3.5
791,0,Asia Pacific,R&D,Medical Affairs,Meets,Male,42,7,0,9,1.6,3.6,2.6,1,1,1,1,2.6,3.4,1.7
792,0,Middle East & Africa,Manufacturing,Regulatory Affairs,Far Below,Non-Binary/Other,40,5,1,8,,4.3,1,1,1,1,1,3,2.6,1.6
793,0,Latin America,Manufacturing,IT & Digital,Below,Female,39,3,1,7,,2.4,4.4,1,1,1,1,3.4,2.1,4.1
794,0,Europe,HR,IT & Digital,Meets,Male,32,17,0,6,2.7,2.9,4,1,1,1,1,4.4,1.7,1.8
795,0,Latin America,Commercial,Legal & Compliance,Meets,Male,39,18,1,7,,3.2,2.6,1,1,1,1,3,4.6,2.5
796,0,Europe,Digital,Regulatory Affairs,Below,Male,42,14,0,11,3.6,2.2,2.8,1,1,1,1,3.3,3.6,2.7
797,0,Middle East & Africa,R&D,IT & Digital,Below,Male,36,4,1,8,,4.3,4.8,1,1,0,0,3.1,3.5,5
798,0,Europe,Digital,Data Science,Meets,Male,39,4,0,8,2.2,3.7,3.8,1,1,1,1,3,3,3.5
799,0,Asia Pacific,HR,Regulatory Affairs,Far Below,Non-Binary/Other,44,8,0,7,3.8,3.5,2.9,1,1,1,1,3.3,4.9,3.1
800,0,Asia Pacific,R&D,Clinical Operations,Meets,Male,33,30,0,12,3,1.8,2.2,1,1,1,1,4,1.1,2.9
801,0,Asia Pacific,HR,Legal & Compliance,Meets,Female,33,25,0,5,4.3,2,3.7,1,1,1,1,4.7,1.4,3
802,0,Asia Pacific,HR,Quality Assurance,Exceeds,Male,37,16,0,9,3.8,2.1,2.8,1,1,1,1,3.1,2.8,3.7
803,0,Latin America,Finance,IT & Digital,Far Below,Female,43,9,0,11,3.6,1,2.7,1,1,1,1,3.2,2.5,2.8
804,0,Middle East & Africa,Manufacturing,Sales,Meets,Female,28,4,1,8,,3.2,2.6,1,1,1,1,3.9,2.7,2.1
805,0,Europe,Finance,Market Access,Meets,Female,37,9,0,12,2.8,1,5,1,1,1,1,2.7,3.1,5
806,0,Europe,Digital,Clinical Operations,Meets,Female,34,10,0,5,2.9,2.9,3.5,1,1,1,1,3.9,4,4.8
807,0,Asia Pacific,Digital,Finance & Accounting,Meets,Female,40,5,1,10,,4.4,1.6,1,1,1,1,3.5,4.7,1.8
808,0,Asia Pacific,Manufacturing,Pharmacovigilance,Meets,Male,37,14,1,9,,3.3,1.9,1,1,1,1,3.4,3.2,2.6
809,0,North America,Finance,Quality Assurance,Meets,Male,45,6,0,7,2.7,2.5,3.5,1,1,1,1,2.9,5,4.3
810,0,Middle East & Africa,Digital,Medical Affairs,Far Below,Male,42,13,0,7,2.7,2.9,1.3,1,0,0,0,3.6,2.8,1.4
811,0,Latin America,Finance,Quality Assurance,Meets,Female,37,9,0,5,2.2,4,3.1,1,1,1,1,1,4.1,3.4
812,0,Europe,Manufacturing,Finance & Accounting,Meets,Male,32,5,1,12,,3.3,1.8,1,1,1,1,5,3.8,3.5
813,0,North America,R&D,IT & Digital,Exceeds,Female,40,26,0,9,3.9,2.2,2,0,0,0,0,3.8,2.7,2.4
814,0,North America,HR,Finance & Accounting,Meets,Male,36,7,1,12,,3.2,2.9,1,1,1,1,3.4,3.1,3.3
815,0,Europe,HR,Market Access,Far Below,Male,37,4,0,9,4,3,2.4,0,0,0,0,2.6,3,3.3
816,0,Latin America,Finance,Supply Chain,Meets,Female,31,5,0,6,3.3,1.9,1,1,1,1,1,4.8,1,2.1
817,0,North America,Digital,Human Resources,Far Exceeds,Female,39,16,0,8,3.1,4.1,2.5,1,1,1,1,2.5,2,1.7
818,0,North America,Finance,Communications,Meets,Non-Binary/Other,35,4,1,9,,1,3.4,1,1,1,1,5,1,2.7
819,0,Middle East & Africa,Finance,Human Resources,Meets,Female,36,11,0,9,3.1,3.1,3.1,1,1,1,1,3,3.9,2.1
820,0,Latin America,Commercial,Supply Chain,Meets,Male,28,8,0,5,3.2,2.9,4,1,1,1,1,4,4.4,4.3
821,0,North America,HR,Clinical Operations,Meets,Female,38,18,0,12,3.2,2.4,1.6,1,1,0,0,2.6,3,2.9
822,0,Latin America,Manufacturing,Marketing,Far Below,Male,32,23,0,12,2.2,2.3,3.3,0,0,0,0,4.1,2.2,1.3
823,0,Europe,Finance,Finance & Accounting,Below,Male,41,17,0,5,3.5,5,2.6,1,1,1,1,2.9,4,1.1
824,0,Asia Pacific,Commercial,Medical Affairs,Meets,Male,38,8,1,11,,2.5,2.5,1,1,1,1,2.4,2.3,3.3
825,0,North America,Commercial,Legal & Compliance,Meets,Female,29,3,1,8,,2.7,3.1,1,1,1,1,2.6,2.6,1
826,0,Middle East & Africa,HR,Market Access,Below,Male,37,13,0,5,5,3.3,2.2,1,1,1,1,4.9,4.3,2.2
827,0,Europe,HR,Market Access,Meets,Female,39,13,0,11,4.2,2.6,2.1,1,1,1,1,3.5,2.1,2
828,0,Latin America,HR,Market Access,Meets,Male,51,34,0,8,2.7,2.4,1.9,1,1,1,1,3.7,3,2.4
829,0,Europe,Manufacturing,Human Resources,Meets,Male,42,23,0,12,2.5,2.4,2.8,1,1,1,1,2.4,3.7,3.3
830,0,North America,Commercial,IT & Digital,Below,Male,30,11,0,12,3,2.8,2.8,1,1,1,1,3.9,3.4,2.3
831,0,Latin America,Digital,Regulatory Affairs,Meets,Male,50,9,1,12,,4.1,2.3,1,1,1,1,4,3.3,2.9
832,0,Asia Pacific,Manufacturing,Market Access,Meets,Non-Binary/Other,36,25,0,7,1.8,3.2,3.6,1,1,1,1,2.7,2.4,2.8
833,0,Europe,R&D,Supply Chain,Meets,Non-Binary/Other,36,14,0,11,3,4.6,2.6,1,1,1,1,4.2,3.5,2.9
834,0,North America,Finance,Pharmacovigilance,Meets,Male,50,10,0,8,4.3,4.2,4.8,1,1,1,1,4.4,3.4,3.6
835,0,Middle East & Africa,HR,Finance & Accounting,Meets,Female,34,13,0,8,3,4.2,4.2,1,0,0,0,2.8,5,4.9
836,0,Latin America,Commercial,Sales,Exceeds,Female,37,15,1,6,,3.4,1,0,0,0,0,4.2,2,1.6
837,0,Europe,Finance,Quality Assurance,Meets,Male,28,7,0,6,2.3,3.3,1.7,1,1,1,1,3.8,3.9,3.7
838,0,Europe,Manufacturing,Sales,Meets,Female,38,6,0,6,2.3,3.7,2.3,1,1,1,1,3.5,3.4,2.1
839,0,Asia Pacific,R&D,Legal & Compliance,Meets,Female,37,4,0,10,4.4,4,4.1,1,1,1,1,3.8,3.2,3.4
840,0,Asia Pacific,Manufacturing,Supply Chain,Below,Male,36,7,1,9,,1.9,1,0,0,0,0,3.4,2.7,2.1
841,0,Middle East & Africa,Manufacturing,Supply Chain,Meets,Male,39,14,1,5,,3.6,1.1,1,1,1,1,2.3,4.3,2.1
842,0,Middle East & Africa,Digital,Pharmacovigilance,Below,Male,33,25,0,6,4,2.7,3.3,0,0,0,0,2.7,3.8,3.2
843,0,North America,Finance,Data Science,Meets,Male,47,6,1,5,,2.9,3.8,1,1,0,0,4.5,4,4
844,1,North America,Digital,Legal & Compliance,Meets,Male,38,24,0,8,3.2,3.4,2,1,1,1,1,2.9,3.9,4.2
845,0,Middle East & Africa,Manufacturing,Clinical Operations,Below,Female,33,8,1,8,,1.5,2.6,1,1,1,1,3.4,2.4,4.4
846,0,Middle East & Africa,R&D,Regulatory Affairs,Exceeds,Female,30,23,0,11,2.2,4.6,2.3,1,1,1,1,3.5,3.7,2.2
847,0,Latin America,Commercial,IT & Digital,Meets,Male,38,4,0,11,3.2,2.8,4.3,1,1,1,1,2.1,5,5
848,0,Asia Pacific,Commercial,Marketing,Meets,Male,44,5,1,7,,2.5,4.2,1,1,1,1,3.5,4,4.3
849,0,North America,Finance,Legal & Compliance,Meets,Female,40,9,0,11,2.1,3.6,1.1,1,1,0,0,3.2,3.6,1.3
850,0,Asia Pacific,HR,Market Access,Meets,Male,50,11,0,6,3,3.5,2.2,1,1,1,1,3,3.1,1
851,0,Asia Pacific,HR,Market Access,Meets,Female,50,10,1,10,,2,2.3,1,1,1,1,3.5,3.2,1.8
852,0,Middle East & Africa,Commercial,IT & Digital,Meets,Non-Binary/Other,30,7,0,8,3.7,4.6,3.4,1,1,1,1,2.9,3.4,2.4
853,0,Latin America,Manufacturing,Finance & Accounting,Exceeds,Non-Binary/Other,29,3,0,8,3.2,2,4.7,1,1,1,1,4,3.9,3.4
854,1,Europe,Manufacturing,Legal & Compliance,Meets,Female,33,10,1,8,,2.9,2.4,1,1,1,1,2.9,3.7,2.7
855,0,Latin America,Digital,Pharmacovigilance,Meets,Male,42,25,0,9,4.8,1.5,3.5,1,1,1,1,3.4,4.3,2.7
856,0,Latin America,Finance,Data Science,Meets,Male,40,17,0,9,4.2,5,1.6,1,1,1,1,3.8,4,2.8
857,1,Asia Pacific,Digital,Market Access,Meets,Female,44,2,1,11,,3.6,2.7,1,1,1,1,3.9,1.4,4.6
858,0,Latin America,HR,Regulatory Affairs,Below,Non-Binary/Other,32,14,0,11,2.9,2.7,3.5,1,1,1,1,3.9,3.8,3.3
859,0,North America,Commercial,Human Resources,Below,Male,28,20,0,6,1.4,3,2.9,1,1,1,1,3.6,3.6,3.7
860,0,Asia Pacific,Manufacturing,Clinical Operations,Exceeds,Male,34,15,0,5,4.4,2,3.2,1,1,1,1,2.6,2.5,2.3
861,0,North America,Commercial,Regulatory Affairs,Meets,Female,42,4,0,6,4.5,4,4.3,1,1,1,1,3.8,4.3,4.6
862,0,Europe,R&D,Data Science,Exceeds,Male,39,4,0,8,3.3,1.6,5,1,1,1,1,4.5,2.7,4.2
863,1,Asia Pacific,Commercial,Supply Chain,Meets,Male,45,16,1,5,,3.7,3.2,1,1,1,1,2.6,2.7,3.8
864,0,Europe,R&D,Regulatory Affairs,Meets,Female,34,16,0,5,3.6,2.2,4.1,1,1,1,1,3.5,3.2,3.2
865,0,Asia Pacific,Digital,Finance & Accounting,Meets,Male,44,13,1,9,,4.4,4.3,1,1,1,1,4.6,3.5,4
866,0,Middle East & Africa,Digital,Sales,Below,Male,34,24,0,12,4.6,2.5,4.9,1,1,1,1,3.5,2.5,4.6
867,0,Latin America,HR,Regulatory Affairs,Meets,Female,43,7,0,5,3.3,3.2,2.1,1,1,1,1,3.9,4.2,2.5
868,0,Middle East & Africa,Commercial,Supply Chain,Meets,Female,43,3,0,11,3.2,4.7,1,0,0,0,0,3.3,4,2.6
869,0,Europe,Commercial,Market Access,Meets,Male,47,18,1,7,,3.5,3.4,1,1,0,0,4,3,2.1
870,0,Latin America,R&D,Quality Assurance,Meets,Male,30,14,1,12,,3.6,4,1,1,1,1,3.8,3.9,2.2
871,0,Asia Pacific,Digital,Quality Assurance,Below,Female,46,10,1,6,,3.1,2.8,1,1,1,1,2.4,4.4,2.4
872,1,Latin America,R&D,Finance & Accounting,Meets,Female,41,11,1,11,,2.7,2.9,1,1,1,1,3.3,2.7,3.8
873,0,North America,Digital,Communications,Below,Male,38,12,0,10,2.2,3.4,3.4,1,1,1,1,2.4,3.7,3.2
874,0,Latin America,R&D,Quality Assurance,Meets,Male,37,20,0,9,3.2,3.2,2.3,1,1,1,1,2.6,1.9,3
875,0,North America,Digital,Market Access,Exceeds,Female,38,9,0,7,3.6,3.7,1.4,0,0,0,0,3.7,4,2.3
876,1,Latin America,R&D,Communications,Meets,Female,38,11,0,5,1.9,4.5,1,1,1,1,1,2.1,3.4,2.3
877,0,North America,Digital,Pharmacovigilance,Meets,Female,28,7,0,12,2.8,2.9,1,1,1,1,1,2.2,3.4,1
878,0,Europe,Finance,Clinical Operations,Meets,Female,39,17,0,12,3.4,2.6,2.4,1,1,1,1,2.5,3.8,1.4
879,0,Middle East & Africa,R&D,IT & Digital,Below,Female,39,8,0,10,3.2,2.3,2.7,1,1,1,1,1.7,2,3
880,0,Asia Pacific,Commercial,Clinical Operations,Meets,Male,34,7,0,6,3.3,3.3,2.3,1,1,1,1,3,3.2,3.3
881,0,Latin America,HR,Legal & Compliance,Meets,Female,38,14,0,12,2.1,3.9,1.3,0,0,0,0,2.9,3.4,2
882,0,Middle East & Africa,Finance,Communications,Below,Female,45,9,0,8,2.2,2.8,2.4,1,1,1,1,2.7,2.7,2.3
883,0,Asia Pacific,Finance,Legal & Compliance,Exceeds,Female,34,10,1,8,,3.5,2.4,1,1,1,1,1.1,2.7,1.4
884,1,Asia Pacific,R&D,Legal & Compliance,Meets,Male,31,9,1,6,,2.6,3.7,1,1,1,1,5,3,3.9
885,0,North America,HR,Market Access,Far Below,Female,34,8,1,7,,3.6,3,1,0,0,0,3.3,4.3,3
886,0,Europe,Commercial,Regulatory Affairs,Meets,Female,28,4,1,12,,2.5,2.6,1,1,1,1,3.5,2.6,1
887,0,Europe,Finance,Human Resources,Meets,Male,49,14,0,5,3.8,3.5,2.7,1,1,1,1,5,3.6,3.6
888,0,Middle East & Africa,Commercial,Communications,Meets,Female,33,5,1,10,,2.8,1.5,1,1,1,1,3.9,1,2.3
889,0,Europe,Digital,Marketing,Meets,Female,46,18,0,9,2.2,1.1,3,1,1,1,1,2,2,1.8
890,0,Latin America,HR,Legal & Compliance,Exceeds,Female,31,26,0,6,3,3.3,3.6,0,0,0,0,3.1,3.5,2.7
891,0,Europe,Manufacturing,Clinical Operations,Meets,Male,34,20,0,5,3.2,3.4,2.9,1,1,1,1,5,3.2,3.9
892,0,Middle East & Africa,Digital,Sales,Exceeds,Male,38,12,0,11,2.9,2.7,1.9,1,1,1,1,2.3,3.2,2.3
893,0,Europe,HR,Communications,Exceeds,Female,42,5,1,9,,1.4,3.6,0,0,0,0,2.8,1.3,4.4
894,0,Latin America,R&D,Sales,Exceeds,Female,38,12,1,5,,3.6,3.3,1,1,1,1,2.4,2.9,2.1
895,0,North America,R&D,Communications,Below,Female,29,18,0,7,2.8,2.9,3.6,1,1,1,1,1.2,3.1,4.6
896,0,Middle East & Africa,Commercial,Communications,Meets,Female,38,20,0,6,2.1,3,2.9,1,1,0,0,3.2,2.8,3.4
897,0,North America,Finance,Medical Affairs,Far Below,Male,46,14,0,6,4.3,3.2,3.3,1,1,1,1,4,4.3,3.2
898,0,North America,Manufacturing,Human Resources,Meets,Female,40,5,0,7,2.4,4,2.7,1,1,1,1,3.9,5,3.7
899,1,North America,R&D,Sales,Exceeds,Non-Binary/Other,51,4,0,8,3.9,2.1,3.1,1,1,1,1,3.8,2.1,3
900,0,Asia Pacific,HR,IT & Digital,Below,Female,39,6,1,7,,2.2,2.3,1,1,1,1,3.2,2.3,1.8
901,0,Asia Pacific,Finance,Clinical Operations,Meets,Female,44,9,1,6,,3.8,2.7,1,1,1,1,4.3,4.2,2.4
902,1,North America,Finance,Human Resources,Meets,Female,41,8,0,5,3.3,4.5,2.6,1,1,1,1,4.5,3.8,3.1
903,0,Middle East & Africa,HR,Human Resources,Below,Female,34,10,0,12,2.9,4.1,3.4,1,1,1,1,3,3.5,4.3
904,0,Latin America,Finance,Marketing,Meets,Male,38,8,0,6,2.9,2.9,2.4,1,1,1,1,3.2,3.7,3.1
905,0,Latin America,R&D,Supply Chain,Meets,Male,45,11,0,5,4.1,2.5,3.7,1,1,1,1,3,2,4.1
906,0,Europe,HR,Quality Assurance,Below,Male,36,31,0,7,2.7,4.3,1.5,1,1,1,1,4.2,5,1.8
907,0,Middle East & Africa,HR,Communications,Meets,Female,40,9,0,12,3.1,4.3,1,0,0,0,0,4.2,4.1,1.5
908,0,Asia Pacific,Commercial,Regulatory Affairs,Meets,Male,34,10,1,12,,2.7,1.5,0,0,0,0,4.8,4.4,2.4
909,0,North America,Manufacturing,Communications,Meets,Female,44,12,0,10,3,4,2.6,1,1,1,1,2.7,5,3.1
910,0,Europe,Commercial,Communications,Below,Female,38,13,0,10,3.3,4.2,3.6,1,1,1,1,3.4,3.1,4.7
911,0,Latin America,Manufacturing,Supply Chain,Meets,Female,43,11,0,5,1.8,2,1.9,0,0,0,0,2.9,1.7,2.4
912,0,Asia Pacific,HR,Marketing,Far Below,Male,45,20,0,5,3.1,2,1.4,1,1,1,1,3.1,2,1.8
913,0,Asia Pacific,Finance,Pharmacovigilance,Exceeds,Female,42,14,1,12,,3.1,1.9,1,1,1,1,3.2,1.6,2.4
914,0,North America,Manufacturing,Communications,Meets,Female,37,1,0,7,3.1,1.6,3.4,1,1,1,1,2.9,3.2,2.1
915,0,Latin America,HR,Quality Assurance,Exceeds,Female,37,4,0,5,3.7,2.6,2.4,1,1,1,1,2.9,2.3,1.7
916,0,Middle East & Africa,HR,Legal & Compliance,Meets,Female,28,6,0,6,3.2,3.1,2.5,1,1,1,1,2.4,3.7,3
917,0,Asia Pacific,Commercial,Human Resources,Meets,Non-Binary/Other,41,11,1,12,,2.9,3.7,0,0,0,0,3.9,2.6,3.2
918,0,North America,Commercial,Legal & Compliance,Meets,Female,44,13,0,7,2.9,1.4,2.3,1,1,1,1,2.8,1.1,1.9
919,0,Middle East & Africa,Finance,Communications,Meets,Female,31,9,0,8,3.7,3.7,3.7,1,1,1,1,3.6,5,2.3
920,0,Latin America,Digital,Medical Affairs,Meets,Female,37,30,0,5,2.2,2.7,2.6,1,1,1,1,3,2.3,3.7
921,0,Asia Pacific,R&D,Legal & Compliance,Far Below,Female,37,17,0,9,3.1,1.4,1.9,1,1,1,1,3.8,2.1,1.8
922,0,Middle East & Africa,Digital,Finance & Accounting,Exceeds,Female,41,9,1,9,,3.4,3.4,1,0,0,0,4.7,3.3,4
923,0,Middle East & Africa,Digital,Pharmacovigilance,Meets,Female,39,6,1,9,,3.2,3.3,1,1,1,1,4.2,4.5,3.4
924,0,Middle East & Africa,Finance,Clinical Operations,Far Exceeds,Male,33,8,0,10,4.6,3.8,3.1,1,1,1,1,4.2,3.1,3.3
925,0,Asia Pacific,Manufacturing,Human Resources,Meets,Female,48,25,0,10,3.7,3.1,4.8,1,1,0,0,4,2.2,3
926,0,Asia Pacific,Finance,Marketing,Below,Male,28,26,0,8,3.2,3.2,3.5,1,1,1,1,2.4,2.4,3.6
927,0,Europe,Finance,Quality Assurance,Meets,Female,34,9,0,7,4.3,3.4,1.6,0,0,0,0,4.6,2.9,2.7
928,0,Latin America,HR,Human Resources,Meets,Female,30,24,0,11,4.1,2.5,2.9,1,1,1,1,4.2,2.7,3.9
929,0,North America,HR,Human Resources,Meets,Female,40,6,1,10,,3.2,3.4,0,0,0,0,4,3.3,2.6
930,0,Middle East & Africa,HR,Medical Affairs,Meets,Male,41,14,1,9,,3.9,3,1,1,1,1,3.4,4,4.1
931,0,Europe,R&D,Regulatory Affairs,Exceeds,Female,37,6,0,12,3,4.2,1.9,0,0,0,0,2.9,4.5,1.6
932,0,North America,Manufacturing,Human Resources,Meets,Female,31,13,0,12,2.1,4.8,1.9,1,1,1,1,3.1,4.6,1.9
933,0,Europe,Manufacturing,Regulatory Affairs,Meets,Female,32,14,0,5,4,3.7,1.5,1,1,1,1,3.6,3,1
934,0,Asia Pacific,HR,Market Access,Meets,Female,43,13,1,11,,2.1,3,1,1,1,1,3.8,3,3.1
935,0,Middle East & Africa,Digital,Clinical Operations,Meets,Male,38,22,0,11,3.3,3.8,2.2,1,1,1,1,3.5,4,2.3
936,0,North America,R&D,Sales,Meets,Female,35,8,0,10,3.4,2.9,1.9,1,1,1,1,3.5,3.1,1.8
937,0,North America,Digital,Finance & Accounting,Meets,Female,34,14,0,5,4.1,4.5,2.2,1,1,1,1,3.2,3.3,3.3
938,0,North America,Commercial,Marketing,Meets,Male,37,18,0,5,2.7,2.2,1.8,1,1,1,1,1,2.9,2
939,0,North America,Manufacturing,Medical Affairs,Meets,Male,41,6,1,6,,4.4,3,1,1,1,1,3,3.7,4.4
940,0,North America,Manufacturing,Medical Affairs,Meets,Female,37,11,0,12,3.5,4.6,2.6,1,1,0,0,3.5,4.9,3.8
941,1,Europe,Digital,Sales,Meets,Male,41,10,1,11,,3.6,3.3,1,1,1,1,4.5,3.1,3.1
942,0,Middle East & Africa,R&D,Legal & Compliance,Far Exceeds,Female,29,27,0,9,2.1,4.6,2.1,0,0,0,0,3.3,3.6,3.7
943,0,Asia Pacific,Manufacturing,Communications,Below,Male,45,15,0,7,3.4,4.4,2.8,1,1,0,0,2.5,4.5,1.7
944,0,Asia Pacific,Digital,Sales,Meets,Female,38,11,1,7,,3.1,2.9,1,1,1,1,3.1,3.4,2.8
945,0,Asia Pacific,Finance,Legal & Compliance,Below,Female,32,11,0,11,4.8,1.8,3.1,1,1,1,1,3.9,3.4,2.2
946,0,Asia Pacific,Finance,Legal & Compliance,Far Below,Female,41,17,0,12,3.8,2.3,2.8,1,1,1,1,4.9,3.1,2.9
947,0,Europe,R&D,Legal & Compliance,Exceeds,Female,39,13,0,6,2.4,1.8,1.6,1,1,1,0,3.4,2.2,1.5
948,0,Latin America,Digital,Legal & Compliance,Exceeds,Female,31,17,0,5,3.7,3.9,3.2,1,1,1,1,2.1,5,4.4
949,0,Middle East & Africa,Finance,Pharmacovigilance,Meets,Female,37,5,1,6,,2.5,3.4,1,1,1,1,3,1.8,3.5
950,0,North America,R&D,Quality Assurance,Exceeds,Female,35,4,0,5,3.6,2.7,2.8,1,1,1,1,3.8,3.4,3.9
951,0,Latin America,HR,Pharmacovigilance,Exceeds,Female,30,6,0,10,1.9,3.6,2.4,1,1,1,1,2.4,3.4,2.1
952,0,Asia Pacific,R&D,Finance & Accounting,Meets,Male,35,19,1,8,,3.5,4,1,1,1,0,2.7,2.5,4.6
953,0,Latin America,Commercial,Legal & Compliance,Exceeds,Female,32,25,0,9,2.4,2.6,3.2,1,1,1,1,3.3,3.6,4.7
954,0,Middle East & Africa,HR,Data Science,Meets,Male,31,5,1,6,,3.6,3.1,1,1,1,1,2.8,4,2.6
955,0,North America,Digital,Legal & Compliance,Meets,Female,41,6,0,10,3.3,4.7,2.9,1,1,1,1,2.9,4.9,3.8
956,0,North America,HR,Data Science,Meets,Male,40,29,0,5,2.5,4.1,2.3,1,1,1,1,2.8,4.2,1.7
957,0,Middle East & Africa,HR,Clinical Operations,Below,Male,36,9,1,9,,3,3.4,1,1,1,1,3.1,3.2,2.9
958,0,Middle East & Africa,Digital,Legal & Compliance,Exceeds,Male,28,27,0,8,3.5,3.9,2.3,1,1,1,1,2.8,5,3.3
959,0,Asia Pacific,Digital,Market Access,Below,Male,38,3,0,9,3.7,1.8,3.3,1,1,1,1,4.5,1.5,1.9
960,0,North America,Finance,Finance & Accounting,Exceeds,Male,43,14,1,7,,2.9,1.5,1,1,1,1,2.6,3.7,2
961,0,Latin America,Commercial,Marketing,Meets,Female,45,13,0,7,3.5,2.9,3.5,1,1,1,1,5,3.6,4.5
962,0,Europe,Digital,Medical Affairs,Meets,Female,44,20,1,10,,3.6,2.9,0,0,0,0,3.7,4.6,3.1
963,0,Europe,Manufacturing,Human Resources,Below,Male,31,18,0,11,2.7,1.6,3,1,1,1,1,1.7,3.2,3.2
964,0,Middle East & Africa,Manufacturing,Communications,Exceeds,Male,33,6,0,5,4.4,3.7,4.1,1,1,1,1,4.4,3.9,3.5
965,0,Asia Pacific,Commercial,Communications,Below,Female,37,7,0,7,4.4,1.3,2.6,1,1,1,1,2.9,2.7,2.6
966,0,Europe,R&D,Legal & Compliance,Meets,Male,38,14,0,8,3.5,5,2.8,1,1,1,1,4.2,4.7,2.3
967,1,North America,R&D,Quality Assurance,Meets,Female,38,9,0,11,2.8,1.6,2.5,1,1,1,1,3.5,4,1
968,0,Middle East & Africa,Manufacturing,Regulatory Affairs,Meets,Male,45,18,0,9,3.4,2.8,3.8,1,1,1,1,4,2.2,4.5
969,0,Latin America,Digital,Human Resources,Far Exceeds,Female,39,8,1,12,,5,1.9,0,0,0,0,2.1,3.1,3.9
970,0,Middle East & Africa,Commercial,Regulatory Affairs,Below,Male,45,3,0,5,4.6,4,2.5,1,1,1,1,2.9,3.1,2.4
971,0,Latin America,R&D,Supply Chain,Meets,Male,33,10,1,11,,4.7,3.4,1,1,1,1,2.9,3.1,3.8
972,1,Middle East & Africa,R&D,Finance & Accounting,Meets,Female,36,19,0,12,4.6,3.3,4,1,1,1,1,5,3.9,4.2
973,0,Middle East & Africa,HR,Communications,Meets,Male,35,11,0,10,2.6,4.6,3.3,1,1,1,1,1.9,4.7,3.2
974,0,Middle East & Africa,Manufacturing,Sales,Below,Non-Binary/Other,38,9,1,12,,4.1,2.3,1,1,1,1,3.5,2.8,2.6
975,0,Latin America,Digital,Finance & Accounting,Meets,Female,30,13,0,5,4.4,4,2.5,1,1,1,1,3.6,2.6,1
976,0,Latin America,Commercial,Clinical Operations,Exceeds,Female,50,20,0,9,2.1,2.6,2.6,1,1,1,1,4.2,2.5,3.2
977,0,Middle East & Africa,R&D,Supply Chain,Below,Non-Binary/Other,39,4,0,11,3.5,3.4,3.2,1,1,1,1,3.9,2.2,3.3
978,0,Europe,HR,Supply Chain,Below,Male,31,6,0,5,2.9,2.8,1.8,0,0,0,0,1.6,2.3,2.7
979,1,Asia Pacific,Manufacturing,Market Access,Far Exceeds,Female,31,10,0,12,1.5,3.4,2.4,1,1,1,1,3.3,4.5,4.2
980,0,Asia Pacific,Manufacturing,Marketing,Far Below,Male,38,4,0,6,3.8,1.5,2.5,1,1,1,1,3,2.2,2.9
981,0,Asia Pacific,Commercial,Medical Affairs,Meets,Female,42,7,0,12,3.5,3.9,4,1,1,1,1,4,4.6,3.8
982,0,Latin America,R&D,IT & Digital,Meets,Female,44,12,0,7,3.4,4,3.6,0,0,0,0,4.8,3,3.1
983,0,Latin America,Commercial,Finance & Accounting,Meets,Male,38,10,0,6,2.3,3.3,2.2,1,1,1,1,3.1,2,2.3
984,0,Europe,Commercial,Quality Assurance,Meets,Male,42,8,0,6,4.3,3.3,3.2,1,1,1,1,3.1,3.6,2.6
985,0,Asia Pacific,Finance,IT & Digital,Exceeds,Female,40,18,0,11,3.6,3.4,3.4,1,1,1,1,1.9,2.7,2.4
986,0,Asia Pacific,HR,Human Resources,Meets,Female,37,4,0,5,3.7,3.1,1,1,1,1,1,3.5,3.5,1.2
987,0,Middle East & Africa,Manufacturing,Regulatory Affairs,Meets,Female,36,23,1,9,,4.4,2.1,1,1,1,1,4.4,4.6,1.7
988,0,Latin America,Finance,Regulatory Affairs,Meets,Female,38,10,0,6,3.8,3,5,1,1,1,1,4,4.6,3.3
989,0,Asia Pacific,Digital,Regulatory Affairs,Meets,Male,37,9,0,9,2.8,4.1,3.4,1,1,1,1,3.1,3.8,2.7
990,0,Europe,Manufacturing,Data Science,Far Below,Female,38,5,1,9,,3.3,4.3,0,0,0,0,2.1,5,3.5
991,0,Europe,Manufacturing,Marketing,Meets,Female,41,3,1,12,,3,3.1,1,0,0,0,2.2,3.8,2.4
992,0,Asia Pacific,HR,Clinical Operations,Meets,Male,48,10,0,6,3.4,5,2.9,1,0,0,0,3.3,4.2,2.9
993,0,Latin America,Digital,Human Resources,Meets,Male,32,13,0,8,3.8,2.2,2.2,1,1,1,1,3.7,3.5,3.8
994,0,Europe,R&D,Regulatory Affairs,Exceeds,Female,39,17,0,5,2.4,2.4,4.6,1,1,1,1,3.5,1.3,3.2
995,0,Middle East & Africa,Digital,Market Access,Meets,Female,40,11,1,11,,3.3,3.2,1,1,1,1,2.2,3.2,3.3
996,0,Europe,R&D,Communications,Far Exceeds,Male,36,24,0,9,3,1.8,3.3,1,1,1,1,3.5,1.5,1.9
997,0,North America,Digital,Regulatory Affairs,Meets,Non-Binary/Other,44,9,0,10,1.9,1.8,4.3,1,1,1,1,3.3,3.5,3.3
998,0,North America,Commercial,Legal & Compliance,Exceeds,Female,35,5,0,6,3,4,2.3,0,0,0,0,3.7,4,2.4
999,0,Latin America,Digital,IT & Digital,Meets,Non-Binary/Other,42,15,0,5,1.9,4.2,2.6,1,1,1,1,1,2.8,2.4
1000,0,Asia Pacific,Finance,Clinical Operations,Far Exceeds,Male,46,2,1,8,,2.5,3.7,1,1,1,1,2.8,1.2,3.6
1001,0,Latin America,Finance,Data Science,Exceeds,Female,40,24,0,10,3.2,2,2.2,0,0,0,0,2.8,3.1,3.7
1002,0,Latin America,HR,Market Access,Far Exceeds,Male,37,11,0,12,3.2,3.3,1.4,1,1,1,1,3.7,2,1.5
1003,0,Latin America,R&D,Supply Chain,Far Exceeds,Female,41,22,0,10,3.8,2.9,3.3,0,0,0,0,3.4,3.2,2.5
1004,0,Latin America,Manufacturing,Communications,Far Below,Male,36,6,0,7,4.3,1.9,3.3,1,1,1,1,3.7,4.3,3.7
1005,0,Middle East & Africa,HR,Finance & Accounting,Meets,Female,34,10,1,12,,3.9,2.1,1,1,1,1,1.8,4.1,1.9
1006,0,Middle East & Africa,Finance,Clinical Operations,Meets,Male,40,4,0,9,3.5,2.8,2.8,1,1,1,1,4.3,2,1.7
1007,0,Europe,Finance,Supply Chain,Meets,Female,42,9,1,5,,3.6,2.8,1,1,1,1,4.2,3.3,3.5
1008,0,North America,R&D,Sales,Far Exceeds,Female,39,7,0,10,2.1,2.9,2.4,1,1,1,1,1.9,3.5,1.3
1009,0,Latin America,Finance,Pharmacovigilance,Far Below,Male,41,3,0,12,4.1,3,2.9,1,1,1,1,3.1,3.1,1.8
1010,0,Europe,Finance,Regulatory Affairs,Meets,Male,52,10,0,10,2.5,1.6,4.3,1,1,1,0,2.4,2.9,4.4
1011,0,North America,R&D,Clinical Operations,Meets,Male,45,9,0,6,2.7,5,2.7,1,1,1,1,2.9,4.2,2.1
1012,0,Asia Pacific,Finance,Pharmacovigilance,Meets,Female,35,29,0,7,3,3.3,5,1,1,1,1,4.6,3.2,2.6
1013,0,Middle East & Africa,Manufacturing,Quality Assurance,Meets,Male,39,8,0,8,2.4,3.2,2.8,1,1,1,1,3.2,2.1,2.5
1014,0,North America,Commercial,Market Access,Below,Male,40,19,1,11,,3.4,2,1,1,1,1,2.8,3.3,3.6
1015,0,Asia Pacific,HR,Marketing,Below,Male,33,10,0,12,3.7,1.4,4.8,1,1,1,1,3.5,2.7,5
1016,1,North America,Manufacturing,Communications,Meets,Female,42,1,1,8,,3.2,1.8,1,1,1,1,3.2,2.4,3.9
1017,0,Middle East & Africa,Manufacturing,Sales,Meets,Male,33,25,0,7,4.1,1.7,1,0,0,0,0,4.6,3.1,3.6
1018,0,Middle East & Africa,Commercial,Quality Assurance,Far Below,Male,42,22,0,10,2.5,2.7,3.5,1,1,1,1,3.3,2.6,3.1
1019,0,Europe,HR,Quality Assurance,Far Exceeds,Female,50,16,0,8,4,2.7,5,1,1,1,1,3.1,3.6,4.6
1020,0,Latin America,Manufacturing,Legal & Compliance,Meets,Female,37,11,1,12,,3.6,2.3,1,1,1,1,3.8,3.6,2.7
1021,0,North America,Finance,Sales,Meets,Female,41,10,0,11,2.4,2.9,2.8,1,1,1,1,2.5,2.1,3.2
1022,0,North America,Commercial,IT & Digital,Meets,Male,40,7,0,12,2.5,2,1.9,1,1,1,1,2.8,3.4,2
1023,0,Asia Pacific,HR,Supply Chain,Meets,Male,32,10,1,5,,4.5,2.6,1,1,1,1,3.5,3.1,3.6
1024,0,Middle East & Africa,Digital,Finance & Accounting,Meets,Female,34,4,0,8,4.2,2,1.9,1,1,1,1,3.9,2.8,2.2
1025,0,North America,R&D,Finance & Accounting,Meets,Female,40,9,0,6,3.3,3.6,3.6,1,1,1,1,3.3,4.5,4
1026,0,Middle East & Africa,Finance,Clinical Operations,Meets,Female,39,8,1,10,,3.7,4,1,1,1,1,4.2,3.4,3
1027,0,North America,Commercial,Medical Affairs,Below,Male,37,8,0,8,4.3,3.3,1.4,1,1,1,0,4.4,3.1,3.6
1028,0,Europe,R&D,Regulatory Affairs,Exceeds,Female,44,19,0,7,2.6,3.2,4,1,1,1,1,2.5,2.8,2.1
1029,0,Latin America,Digital,Market Access,Meets,Female,41,2,0,12,4.4,3.7,1.8,1,1,1,1,3.6,1.9,3
1030,0,North America,Manufacturing,Data Science,Meets,Female,51,15,0,10,3.9,2.8,3.1,1,1,1,1,2.5,2.1,3.2
1031,0,Middle East & Africa,Manufacturing,IT & Digital,Far Exceeds,Female,32,8,0,11,2.6,4,3.6,1,1,1,1,4,3.6,4.5
1032,0,Europe,HR,Clinical Operations,Meets,Male,36,17,0,9,2.8,2.8,2.5,1,1,1,1,2.7,2.6,2.9
1033,0,North America,Commercial,Human Resources,Meets,Female,47,6,1,6,,3.8,1.5,1,1,0,0,4.9,4.2,1
1034,0,Asia Pacific,Commercial,Human Resources,Meets,Female,48,20,1,6,,3.6,1.8,0,0,0,0,4.4,2.9,1.3
1035,0,Latin America,HR,Regulatory Affairs,Below,Female,33,28,0,9,3.1,3.3,3.6,1,1,1,1,4.7,2.6,3.3
1036,1,North America,R&D,Finance & Accounting,Far Exceeds,Female,36,17,0,5,5,1.5,3.8,1,1,1,1,5,3.1,3.7
1037,0,Europe,Manufacturing,Clinical Operations,Meets,Female,37,19,0,7,4.6,3.6,1.1,1,1,0,0,5,3.5,1
1038,1,Asia Pacific,Manufacturing,Quality Assurance,Meets,Female,46,21,0,5,3.9,2.5,4.2,1,0,0,0,4.7,2.6,4.1
1039,1,Europe,Commercial,Medical Affairs,Exceeds,Female,37,14,0,7,3.8,3.4,2,1,1,1,1,4,1.5,3.4
1040,0,Europe,Commercial,Data Science,Meets,Male,37,13,0,10,3.8,3.8,2.2,1,1,1,1,4.4,3.1,2.9
1041,0,Asia Pacific,HR,Clinical Operations,Meets,Female,36,8,1,12,,2.8,3.2,1,1,1,1,3.1,3.7,4.2
1042,0,Europe,Digital,Regulatory Affairs,Exceeds,Female,39,7,1,6,,1.6,1,1,1,1,1,3.6,1.8,1.8
1043,0,Asia Pacific,R&D,Data Science,Meets,Male,40,3,0,11,3.3,3.5,3,1,1,1,1,2.7,3.8,2.7
1044,0,North America,Finance,Data Science,Below,Male,49,3,0,9,3,2.6,2.6,1,1,1,1,4.8,3.8,2.3
1045,0,Asia Pacific,Digital,Marketing,Below,Male,47,15,0,7,3.9,4.4,3.3,1,1,1,1,3.8,2.5,3.9
1046,0,Asia Pacific,Digital,Market Access,Exceeds,Male,32,14,1,11,,1.7,2.6,1,1,1,1,3.5,2.4,2.4
1047,0,Latin America,Commercial,Quality Assurance,Meets,Female,37,12,0,5,3.8,3.5,3.8,1,1,1,1,3.4,3,4.6
1048,1,Asia Pacific,Commercial,Marketing,Meets,Male,38,14,0,5,3.1,3,1.9,1,1,1,1,3.9,2.6,1
1049,1,Asia Pacific,Commercial,Regulatory Affairs,Meets,Female,35,17,0,8,4.4,3,3.3,1,1,1,1,4.2,2.9,3.2
1050,0,North America,Digital,Regulatory Affairs,Meets,Male,44,12,0,8,3.5,4,2.4,0,0,0,0,3,4.9,1.9
1051,0,Latin America,R&D,Legal & Compliance,Meets,Male,46,6,0,11,3.1,3.4,1,1,1,1,1,2.9,2.3,1.5
1052,0,Middle East & Africa,Commercial,Supply Chain,Far Exceeds,Female,35,6,1,8,,3.1,2,0,0,0,0,2.8,2.7,3.7
1053,1,North America,Manufacturing,Clinical Operations,Meets,Female,38,5,0,9,4,2.7,2.8,1,1,1,1,3.7,4,4.6
1054,0,North America,R&D,Clinical Operations,Meets,Male,43,8,0,6,3.4,3.1,2.6,1,1,1,1,2.8,2.6,3.7
1055,0,Middle East & Africa,Manufacturing,Supply Chain,Meets,Non-Binary/Other,44,15,0,12,2,1.4,2.1,1,1,1,1,3.8,2.6,2.4
1056,1,Asia Pacific,R&D,Pharmacovigilance,Meets,Female,35,30,0,8,4.1,2.8,1.9,1,0,0,0,4.9,3.1,2
1057,0,Europe,Commercial,Sales,Exceeds,Male,41,4,0,10,2,2.6,2.7,1,1,1,1,3.2,4.9,2.9
1058,0,Latin America,Finance,Human Resources,Meets,Female,34,8,0,7,2.2,3.1,4.2,1,1,1,1,4.2,4.8,4
1059,0,Europe,HR,Clinical Operations,Meets,Male,44,14,0,12,3.4,3.2,2.6,1,1,1,1,4.5,3.9,1.4
1060,0,Middle East & Africa,Commercial,Sales,Far Exceeds,Female,34,13,0,11,3,3,1.5,1,1,1,1,4,3.3,1.6
1061,0,North America,Digital,Human Resources,Meets,Female,39,6,1,12,,3.3,5,1,1,1,1,2.4,3.1,5
1062,0,North America,Finance,Clinical Operations,Meets,Male,35,5,1,10,,2.8,1,1,1,1,1,5,1.6,1.6
1063,0,Latin America,Digital,Market Access,Below,Female,32,8,0,7,3.7,1.1,4.5,1,1,1,1,3.7,3.3,4.2
1064,0,North America,R&D,Communications,Far Exceeds,Male,35,27,0,10,2.7,1,2.9,0,0,0,0,4.1,2.5,1.7
1065,0,North America,Digital,IT & Digital,Meets,Female,36,16,0,9,4.1,2.9,2.4,1,1,1,1,4.6,4.6,2
1066,0,Latin America,Finance,Pharmacovigilance,Meets,Male,45,5,1,6,,1.5,2.3,1,1,1,1,3.1,4.3,2.9
1067,0,Latin America,Finance,Medical Affairs,Exceeds,Female,35,5,1,6,,5,2.5,1,1,1,1,4,4.5,2.4
1068,0,Middle East & Africa,Commercial,Pharmacovigilance,Meets,Female,38,9,0,7,3.3,3,2.5,1,1,1,1,2.9,2.7,3.4
1069,0,North America,Manufacturing,Regulatory Affairs,Meets,Male,34,22,0,12,2.8,5,4.5,1,1,1,1,4,4.7,4.7
1070,0,North America,Commercial,Supply Chain,Meets,Female,44,10,1,9,,1.8,1.6,0,0,0,0,3.2,3.7,3.2
1071,0,Middle East & Africa,R&D,Communications,Meets,Female,44,8,1,11,,3.9,2.5,0,0,0,0,4.3,3.8,3.2
1072,0,Asia Pacific,Digital,IT & Digital,Meets,Female,43,7,0,12,3.6,2.9,2.6,1,1,1,1,4.2,2,2.9
1073,0,Asia Pacific,Manufacturing,Finance & Accounting,Far Below,Female,36,10,0,11,3.4,1.6,2.7,1,1,1,1,3.2,2.4,3.7
1074,0,Asia Pacific,HR,Regulatory Affairs,Below,Male,34,7,0,6,4.1,3.1,4.5,1,0,0,0,4.5,3.5,3.9
1075,0,Middle East & Africa,Finance,IT & Digital,Meets,Male,32,3,0,8,2.5,2.2,2.5,1,1,1,1,2.3,2,1
1076,0,North America,Manufacturing,Medical Affairs,Exceeds,Male,43,22,0,12,1.9,4,1.8,1,1,1,1,2.1,4.2,2.6
1077,0,Middle East & Africa,Manufacturing,Marketing,Meets,Male,35,3,1,5,,2.6,4.7,1,1,1,1,3.1,1.5,5
1078,0,Middle East & Africa,Commercial,Legal & Compliance,Exceeds,Male,43,11,0,5,2.7,2.1,2.1,1,1,1,1,2.8,3.1,1.5
1079,0,Asia Pacific,HR,Regulatory Affairs,Meets,Female,33,6,0,8,2.5,3.9,2.8,0,0,0,0,3.1,3.1,2.6
1080,0,Europe,Finance,Regulatory Affairs,Exceeds,Male,37,12,0,10,3.5,4.8,2,1,1,1,1,4.5,3.3,1.6
1081,0,North America,R&D,Regulatory Affairs,Below,Female,35,29,0,8,3.5,2.9,2.4,0,0,0,0,4.1,3.7,4.4
1082,1,Asia Pacific,R&D,Data Science,Meets,Male,34,8,0,8,4.3,3.1,3.4,1,1,1,1,4.6,3.5,3.1
1083,0,Europe,Manufacturing,Sales,Meets,Male,28,10,0,7,3.4,2.8,2.9,1,1,1,1,3.7,1,3.5
1084,0,Europe,Manufacturing,Pharmacovigilance,Meets,Male,30,12,0,7,3.4,2.2,2.2,0,0,0,0,3.1,1.8,2
1085,0,Latin America,Digital,Marketing,Meets,Female,45,18,0,5,2.8,3.1,2.9,1,1,1,1,3.6,4.4,2.2
1086,0,North America,HR,Communications,Exceeds,Female,33,18,0,11,4.6,3.3,4.2,1,1,1,1,4.3,1.2,2.2
1087,0,Europe,Finance,Communications,Meets,Male,42,11,0,11,4.3,1.6,1.9,1,1,1,1,3.8,3.3,2.3
1088,0,Asia Pacific,Manufacturing,IT & Digital,Exceeds,Female,38,32,0,8,1.8,1.6,3.4,0,0,0,0,3.9,1,3.8
1089,0,Latin America,Digital,Legal & Compliance,Meets,Female,36,5,0,10,4.5,2.1,1.4,1,1,1,1,4.8,1.3,3.3
1090,0,North America,HR,Pharmacovigilance,Meets,Non-Binary/Other,35,11,0,9,2.8,2.1,1.8,1,1,1,1,3.9,2.5,1
1091,0,Middle East & Africa,Finance,Market Access,Meets,Female,38,5,0,11,4.2,2.4,2.9,1,1,1,1,4.5,3.3,3.8
1092,0,Asia Pacific,R&D,Communications,Meets,Male,42,6,0,6,3.7,4.9,2.3,0,0,0,0,3.4,5,3.3
1093,0,Europe,Digital,Legal & Compliance,Meets,Male,31,7,0,7,4.1,3.5,4.3,1,1,1,1,4.2,2.8,4.5
1094,1,Europe,HR,Finance & Accounting,Meets,Male,38,18,1,9,,2.9,3.6,1,1,1,1,4.2,3.2,1.9
1095,0,Asia Pacific,Digital,Sales,Exceeds,Female,40,21,0,12,3.7,3.2,3.6,1,1,1,1,3.5,3.6,2.5
1096,0,Europe,Manufacturing,Human Resources,Meets,Female,42,2,0,6,3.9,3.1,4.7,1,1,1,1,3.5,2.6,3.9
1097,0,Latin America,Commercial,Marketing,Meets,Female,44,25,0,12,2.6,2.8,1.9,1,1,1,1,2,3.3,4
1098,0,North America,R&D,Market Access,Far Below,Male,37,23,1,5,,3,1.8,1,1,1,1,2.8,2.8,2
1099,1,Latin America,Manufacturing,IT & Digital,Far Exceeds,Male,30,11,0,6,2.7,2.5,3.1,1,1,1,1,5,3.8,2
1100,0,Europe,Manufacturing,Quality Assurance,Meets,Non-Binary/Other,40,6,0,9,3.7,2.7,2.8,1,1,1,1,5,3.8,2.9
1101,0,Middle East & Africa,HR,Data Science,Exceeds,Non-Binary/Other,37,14,1,9,,2.9,2.9,1,0,0,0,4.5,3.2,3
1102,0,North America,Digital,Regulatory Affairs,Meets,Female,45,23,0,10,3.6,3.2,2.3,1,1,1,1,2.8,2.8,3.5
1103,0,North America,R&D,Data Science,Meets,Male,39,17,0,5,2.4,3,1.9,1,1,1,1,2.1,2.4,1.3
1104,0,Asia Pacific,Manufacturing,Legal & Compliance,Meets,Female,45,6,1,9,,2.2,2.5,1,1,1,1,3.7,3.9,1.3
1105,0,Asia Pacific,HR,Pharmacovigilance,Meets,Male,35,30,0,7,2.6,4.1,2.1,1,1,1,1,3,4.4,1.9
1106,0,Middle East & Africa,R&D,Communications,Meets,Female,45,30,0,9,1.9,2.8,3.8,1,1,1,1,1.8,3.4,3.5
1107,0,North America,Digital,Marketing,Meets,Male,39,7,1,8,,2.2,2.7,1,1,1,1,3.5,3,3
1108,0,Middle East & Africa,Manufacturing,Market Access,Meets,Female,41,11,0,12,4.8,5,3.8,1,1,1,1,4.5,4.9,3.4
1109,0,Asia Pacific,Finance,IT & Digital,Exceeds,Female,28,11,0,6,2.8,1,1.8,1,1,1,1,2.5,1.6,4
1110,0,Asia Pacific,Manufacturing,Medical Affairs,Below,Female,45,10,0,11,3.7,3.2,2.8,1,1,1,1,4.5,5,3.1
1111,0,North America,Manufacturing,Market Access,Meets,Female,37,4,0,5,3.7,2.8,2,1,1,1,1,3.5,4.5,1.4
1112,0,Latin America,R&D,Data Science,Below,Female,41,24,0,9,4.1,4.5,2.5,1,1,1,1,3.5,4.2,3
1113,0,Europe,R&D,Finance & Accounting,Below,Female,36,23,0,6,3.5,4.3,3.7,1,1,1,1,3.5,4.3,1.4
1114,0,Asia Pacific,R&D,Regulatory Affairs,Meets,Female,45,16,1,8,,3.5,4.2,1,1,1,1,2.7,3.5,4.2
1115,0,Asia Pacific,R&D,Communications,Below,Male,39,6,1,10,,3.2,4.1,1,1,1,1,4.2,2.4,4
1116,1,Latin America,HR,Legal & Compliance,Meets,Male,39,4,1,12,,2.1,1.8,1,1,1,1,5,2.8,1.3
1117,0,Latin America,Commercial,Medical Affairs,Meets,Female,49,4,1,12,,4.2,3.5,1,1,1,1,2.1,4,4
1118,0,Middle East & Africa,HR,Pharmacovigilance,Meets,Female,28,12,1,5,,2.8,1.9,1,1,1,1,4.2,3,1.5
1119,0,Middle East & Africa,Manufacturing,Medical Affairs,Below,Male,36,11,1,9,,4.3,3.5,1,1,1,1,2.9,2.9,3.8
1120,0,Europe,HR,Finance & Accounting,Meets,Male,37,36,0,12,2.9,3.3,1.6,1,1,1,1,2.3,3.4,2.1
1121,0,Europe,Digital,IT & Digital,Exceeds,Male,33,10,0,6,3.3,2.6,3,1,1,1,1,3.4,1.3,3.1
1122,0,North America,Finance,Sales,Meets,Female,40,14,0,5,4.8,3.7,1.8,1,1,1,1,5,3.5,2.2
1123,1,Middle East & Africa,R&D,Communications,Exceeds,Male,30,17,0,7,3.2,2.9,3.7,1,1,1,1,2.2,4.6,4.2
1124,0,Asia Pacific,Digital,Quality Assurance,Far Below,Male,30,13,0,7,4.1,2.8,1.7,1,1,1,1,3.4,3.4,1
1125,0,Middle East & Africa,Finance,Regulatory Affairs,Meets,Male,41,26,0,11,3.5,3,3.1,1,1,1,1,5,2.7,1.8
1126,0,Asia Pacific,Digital,IT & Digital,Meets,Male,33,7,1,11,,3.7,3.4,1,1,1,1,3.4,3.8,4.8
1127,0,Latin America,Manufacturing,Human Resources,Meets,Female,41,36,0,11,3.2,3.5,2.1,0,0,0,0,4.4,2.5,3.5
1128,0,Middle East & Africa,R&D,Legal & Compliance,Meets,Female,34,6,1,12,,2.2,2.3,0,0,0,0,2.9,2.1,2
1129,0,Latin America,Digital,Data Science,Meets,Male,33,16,1,12,,4.3,3,0,0,0,0,3.6,2.2,3.3
1130,0,Europe,Manufacturing,Marketing,Meets,Male,32,11,0,9,3.5,2.1,3.6,1,1,1,1,3.3,2.1,1
1131,0,Europe,R&D,IT & Digital,Meets,Female,32,25,1,12,,3,4.4,1,1,1,1,3.1,3.3,4.8
1132,0,North America,Commercial,Supply Chain,Meets,Female,35,12,0,6,2.5,2.6,3.6,1,1,1,1,2.3,2.8,3
1133,0,Middle East & Africa,Manufacturing,Medical Affairs,Meets,Male,33,15,1,11,,3.7,3.8,1,1,1,1,2.9,4,4
1134,0,Latin America,HR,Legal & Compliance,Meets,Male,37,6,0,8,3.2,2.6,3.2,1,1,1,1,4,2.4,3.1
1135,0,Asia Pacific,R&D,Communications,Exceeds,Non-Binary/Other,28,14,0,11,1.9,4.2,2.5,0,0,0,0,3.6,3.6,2
1136,1,Europe,Digital,Clinical Operations,Meets,Female,33,32,0,6,3.5,4,3.2,1,1,1,1,3.6,3.2,2.1
1137,0,Europe,Finance,Supply Chain,Meets,Female,45,8,1,11,,2.5,2.7,1,1,1,1,3.7,2.2,4
1138,0,Asia Pacific,Digital,IT & Digital,Meets,Male,30,7,0,8,2.5,4,3.2,1,1,1,1,4.5,2.9,3.9
1139,0,Latin America,HR,Pharmacovigilance,Meets,Female,34,11,0,11,4.2,4.4,1,1,1,1,1,4.3,2.8,2
1140,0,Latin America,HR,Clinical Operations,Meets,Female,45,3,0,12,3.4,3.5,4.2,1,1,1,1,4.3,4.4,3.9
1141,0,Middle East & Africa,Digital,Legal & Compliance,Far Below,Female,38,10,0,8,2.5,3.4,4.7,1,0,0,0,2.1,2.5,3.3
1142,0,Middle East & Africa,Finance,Clinical Operations,Meets,Non-Binary/Other,28,7,0,6,4,3.2,1.4,1,1,1,1,2.4,3.1,2.7
1143,0,North America,R&D,Clinical Operations,Meets,Male,42,13,0,9,1.7,3.6,3.7,1,1,1,1,1.9,2.8,2.3
1144,0,Europe,Manufacturing,Market Access,Meets,Female,45,12,0,7,1.9,2.9,3.8,1,1,1,1,2.2,3.4,3.2
1145,0,Middle East & Africa,HR,Supply Chain,Meets,Male,38,9,0,12,2.1,2.4,2.9,1,1,1,1,3.3,2.5,3
1146,0,Latin America,HR,Human Resources,Meets,Female,35,20,0,5,3.5,3.9,1,0,0,0,0,3.4,5,2.9
1147,0,Asia Pacific,HR,Pharmacovigilance,Exceeds,Female,28,3,0,7,3.8,3.8,2.4,1,1,1,1,4.3,2.9,3.1
1148,0,Latin America,Finance,Data Science,Meets,Female,35,5,0,5,2.6,2.9,2,1,1,1,1,3.3,2.9,2.2
1149,0,Europe,Commercial,Quality Assurance,Meets,Male,31,9,0,5,3.6,3.1,4.2,1,1,1,1,3.5,2.4,3.9
1150,0,Latin America,Finance,Pharmacovigilance,Meets,Male,38,11,0,7,4.5,3.3,2.7,1,1,1,1,4.5,4.8,2.3
1151,0,North America,R&D,Data Science,Below,Male,43,3,1,10,,4.6,3,1,1,1,1,2.6,2.2,1.8
1152,0,Europe,R&D,IT & Digital,Far Exceeds,Male,32,30,0,6,2.1,2,3.5,1,1,1,0,2.2,2.8,4
1153,0,Asia Pacific,R&D,IT & Digital,Meets,Male,42,7,0,7,5,3.4,2.5,1,1,1,1,4.6,3.8,2.9
1154,0,North America,R&D,Data Science,Meets,Female,28,6,0,9,3.5,3.3,2,0,0,0,0,4.1,3.5,2.8
1155,0,Europe,R&D,Communications,Meets,Female,37,21,0,5,2.3,4,3.6,1,1,1,1,3.2,4.6,2.2
1156,0,Asia Pacific,Digital,Clinical Operations,Below,Female,28,12,0,11,2.9,2.7,3,1,1,1,1,3.5,3.9,1.9
1157,0,North America,HR,Regulatory Affairs,Exceeds,Female,39,1,1,9,,2.9,2.5,1,1,1,1,2,3.1,2.2
1158,0,North America,Finance,Supply Chain,Meets,Female,45,15,0,11,2.4,3.9,2.2,1,1,1,1,4.2,3.6,3
1159,0,Europe,Digital,Data Science,Meets,Female,35,20,0,10,3.4,2.4,1,1,1,1,1,2.7,2.7,3.5
1160,0,Middle East & Africa,Finance,Supply Chain,Far Below,Male,39,10,0,12,3.5,4,4.1,1,1,1,0,2.8,3.1,4.1
1161,0,North America,Commercial,Sales,Meets,Male,35,25,0,9,1.8,2.5,3.7,1,1,1,1,2.5,3.6,1.8
1162,0,North America,Manufacturing,Market Access,Below,Male,40,17,0,7,3.7,2.5,4.7,1,1,1,1,3.4,2.4,5
1163,0,Asia Pacific,HR,Quality Assurance,Meets,Female,43,32,0,7,3,3.5,4.1,1,1,1,1,1.9,3.8,2.4
1164,0,Latin America,Commercial,Sales,Meets,Female,38,12,0,5,3.6,2.9,3.7,1,1,1,1,2.7,2.9,3.9
1165,0,Europe,Digital,Data Science,Below,Female,35,7,0,7,4.5,3.3,3.1,1,1,1,1,4.6,2,3.1
1166,0,Europe,Manufacturing,Pharmacovigilance,Meets,Female,40,4,0,10,4,3.8,2,1,1,1,1,5,3.6,1.3
1167,0,Middle East & Africa,Commercial,Communications,Meets,Female,49,10,0,9,3.3,4.3,3.4,0,0,0,0,3.5,3.7,4.6
1168,0,Middle East & Africa,Finance,Supply Chain,Exceeds,Non-Binary/Other,40,24,0,7,3,2.3,2.7,1,1,1,1,2.7,2.2,3.9
1169,0,Europe,Manufacturing,Sales,Meets,Female,30,14,0,8,2.5,3,4.1,1,1,1,1,3.6,2.9,4.4
1170,0,Middle East & Africa,Finance,Supply Chain,Meets,Male,49,14,0,5,2.2,3.2,2.8,1,1,1,1,3,2.5,2.3
1171,0,Asia Pacific,Commercial,Human Resources,Meets,Male,33,9,1,7,,4,2.7,1,1,1,1,2.6,3,3.8
1172,1,Europe,Digital,Market Access,Exceeds,Male,33,7,1,8,,3,1.8,1,1,1,1,5,1.9,1.3
1173,0,Middle East & Africa,Finance,Pharmacovigilance,Meets,Female,44,6,1,6,,2.1,4,1,1,1,1,3.2,2.1,2.9
1174,0,Europe,Manufacturing,Sales,Meets,Female,35,5,0,7,1.9,2.9,1.9,1,0,0,0,3.6,3.6,1.7
1175,0,Latin America,Commercial,Supply Chain,Far Below,Male,41,12,1,6,,2.3,3.4,1,1,1,1,4.9,3.1,1.8
1176,0,North America,Finance,Human Resources,Meets,Female,41,13,0,12,4.3,2.8,4.1,1,1,1,1,4.5,4.2,2.8
1177,0,Europe,Digital,Pharmacovigilance,Exceeds,Male,41,14,0,11,3,2.6,2.8,1,1,1,1,2.2,3.6,1.9
1178,0,North America,HR,Clinical Operations,Meets,Female,47,10,0,11,2.1,2.6,3,1,1,1,1,2.6,2.7,2.3
1179,0,Middle East & Africa,Digital,Medical Affairs,Meets,Male,36,19,0,10,3.6,3.7,1.3,1,1,1,1,3,3.7,2.5
1180,0,North America,Digital,Clinical Operations,Meets,Male,38,15,0,12,3.4,1.9,1.4,1,1,1,1,3.4,3.1,1
1181,0,Europe,HR,Quality Assurance,Below,Male,32,24,0,10,2.7,3.7,1.5,0,0,0,0,3.6,5,1
1182,1,Latin America,Digital,Data Science,Far Exceeds,Male,42,15,1,12,,4.4,3.6,1,1,1,1,4.3,4.1,2.2
1183,0,Middle East & Africa,HR,Regulatory Affairs,Meets,Male,39,5,1,7,,3.7,1.7,1,1,1,1,4.1,4.3,2.1
1184,0,Europe,HR,Legal & Compliance,Meets,Female,46,20,0,11,3.3,2.9,3.6,1,1,1,1,3.8,3.9,2.7
1185,0,Middle East & Africa,Finance,Medical Affairs,Meets,Male,40,3,0,5,4.4,3.8,1.5,0,0,0,0,4.2,5,1.9
1186,0,Asia Pacific,Finance,Human Resources,Exceeds,Female,48,5,1,5,,2,2.6,1,1,1,1,2.4,3.1,3.3
1187,0,North America,HR,Data Science,Exceeds,Male,37,8,0,8,3.2,2.9,2.1,1,1,1,1,4.5,1.6,1.6
1188,0,Asia Pacific,Commercial,Human Resources,Far Below,Male,39,17,0,11,3.4,2.5,2.4,1,1,1,1,2.8,3,2.6
1189,0,Europe,Manufacturing,Sales,Far Exceeds,Female,38,12,0,5,3.5,3.3,4,1,1,1,1,3.9,3.4,3
1190,0,Latin America,Commercial,Communications,Exceeds,Male,34,6,0,10,3.7,2.7,1,1,1,1,1,4.3,3.1,2.8
1191,0,Middle East & Africa,HR,Finance & Accounting,Meets,Female,28,15,0,6,3.2,2.1,4.2,0,0,0,0,2.8,3.8,3.8
1192,0,North America,Manufacturing,Quality Assurance,Exceeds,Male,39,2,0,7,4.6,2.4,3.2,1,1,1,1,3.5,1.4,3.4
1193,0,Middle East & Africa,Finance,Market Access,Meets,Male,28,27,0,11,2.4,2.1,1.5,1,1,1,1,2.3,2.3,2.5
1194,0,Europe,Manufacturing,Quality Assurance,Meets,Male,41,2,0,10,4,2,3.5,1,1,1,1,3.9,4.7,1.7
1195,0,Middle East & Africa,HR,Human Resources,Meets,Female,45,10,0,5,2.9,3.1,2.1,1,1,1,1,2.7,3,3.5
1196,0,North America,Finance,Supply Chain,Meets,Male,38,19,0,10,3.3,3.8,2.5,1,1,1,1,2.3,4.3,1.8
1197,0,Europe,Manufacturing,Quality Assurance,Far Below,Female,40,9,0,8,4.3,3.6,4.1,1,1,1,1,3.5,2,4.1
1198,0,Middle East & Africa,Manufacturing,Finance & Accounting,Exceeds,Female,40,14,0,12,3.8,2,1.4,1,1,1,1,5,2.1,2.8
1199,0,Latin America,Commercial,Finance & Accounting,Far Exceeds,Male,44,11,1,5,,2.3,2.6,1,1,1,1,4.8,4.2,1.4
1200,0,Europe,Manufacturing,Sales,Meets,Female,37,15,0,11,3.2,2.2,3.5,1,1,1,1,3.3,3.3,2.5
1201,0,Europe,HR,Market Access,Meets,Male,31,9,0,6,2.3,1.7,2,0,0,0,0,3.8,3,1
1202,0,Latin America,R&D,Market Access,Meets,Female,28,4,1,8,,1,1,0,0,0,0,3.2,2.3,2.3
1203,0,Asia Pacific,R&D,Human Resources,Meets,Female,36,15,0,10,3.4,1.5,1.8,1,1,1,1,4.9,2.5,4.1
1204,0,North America,R&D,IT & Digital,Meets,Male,28,3,0,7,3.7,3.4,3.2,1,1,1,1,2.8,4,3.1
1205,0,Asia Pacific,HR,Human Resources,Meets,Female,38,12,1,6,,2.9,1,1,1,1,1,4.7,1.7,2.1
1206,0,Middle East & Africa,R&D,Finance & Accounting,Below,Male,40,10,0,7,3,3.3,1,1,0,0,0,2.9,3.8,2.8
1207,0,Latin America,Commercial,Marketing,Below,Male,35,5,0,7,2.3,3.2,3.1,1,1,1,1,1.8,2.3,3.2
1208,0,Asia Pacific,HR,Quality Assurance,Meets,Female,42,6,0,9,2.7,5,1.6,0,0,0,0,2,4.2,2
1209,0,Europe,Finance,Communications,Meets,Non-Binary/Other,39,11,1,10,,3.4,3.7,1,1,1,1,2.7,3,3.9
1210,0,Middle East & Africa,HR,Finance & Accounting,Exceeds,Female,34,13,0,12,4.8,3.6,3.2,1,1,1,1,3.9,3.3,2.4
1211,0,Middle East & Africa,HR,Clinical Operations,Meets,Male,35,12,0,9,2.9,4.5,2.3,1,1,1,1,3.8,4.1,2.9
1212,0,Asia Pacific,Manufacturing,Marketing,Far Below,Female,46,10,0,7,1.7,3.4,3.5,1,1,1,1,2.5,2.8,3
1213,0,Asia Pacific,Manufacturing,Marketing,Meets,Male,28,28,0,11,2.1,4.9,2.8,1,1,0,0,3.6,4.6,1.8
1214,0,Latin America,Manufacturing,Communications,Meets,Male,37,21,0,9,5,3.3,2.6,1,1,1,1,5,2.2,2.5
1215,0,North America,Digital,Human Resources,Meets,Female,39,3,0,9,3.5,3.1,3,1,1,1,0,3.2,3.5,1.9
1216,0,Asia Pacific,Commercial,Finance & Accounting,Meets,Male,34,5,0,8,4.1,4.3,2.4,1,1,1,1,5,4.4,2.4
1217,0,Asia Pacific,HR,Sales,Meets,Female,34,2,0,6,2.2,3,3,1,1,0,0,2.4,3.9,1.5
1218,0,Europe,HR,Medical Affairs,Meets,Female,45,22,0,11,4.2,1.6,1.4,1,1,1,1,4.1,2.5,2.8
1219,0,Middle East & Africa,Manufacturing,Clinical Operations,Far Below,Female,50,14,0,7,2.2,3.7,4.9,0,0,0,0,2.8,4.4,4
1220,0,North America,HR,Human Resources,Meets,Female,36,14,1,6,,1.9,3.8,0,0,0,0,2.5,2.7,2.7
1221,0,Europe,Finance,Market Access,Meets,Male,38,20,0,7,3.6,2.1,3.1,1,1,1,1,3,3.5,1.9
1222,0,Latin America,HR,Human Resources,Below,Non-Binary/Other,41,9,0,12,3.3,3.8,3.8,1,1,1,1,2.9,2.6,3.1
1223,0,Latin America,R&D,Quality Assurance,Meets,Male,32,5,0,11,3.5,4.3,3.9,1,1,1,1,3.1,3.6,3.2
1224,0,Asia Pacific,Finance,Marketing,Below,Female,38,12,0,5,2.6,2.3,2.7,1,1,1,1,4.4,2.6,2.6
1225,0,Asia Pacific,Finance,Data Science,Far Exceeds,Female,47,16,0,10,3.1,3.5,1.9,1,1,1,1,3.6,3.1,2.6
1226,0,Latin America,HR,IT & Digital,Meets,Female,52,22,0,9,2.4,3.1,1.5,1,1,1,1,5,2.2,2.1
1227,0,Asia Pacific,Digital,Data Science,Meets,Male,31,16,0,5,4.5,1.5,3.5,1,1,1,1,4,1.9,4.2
1228,0,North America,Manufacturing,IT & Digital,Exceeds,Male,33,17,0,10,3.2,2.9,4.2,1,0,0,0,2.4,2,2.2
1229,0,Asia Pacific,Commercial,Marketing,Meets,Female,35,4,0,10,2.4,4.1,2.2,0,0,0,0,2.1,3.8,3.2
1230,0,Middle East & Africa,Commercial,IT & Digital,Meets,Male,36,19,0,9,4.8,2.8,3.1,1,1,1,1,4.2,5,2.8
1231,0,Asia Pacific,R&D,Communications,Meets,Female,45,8,0,9,2.9,2.1,3.9,1,1,1,1,4.1,1.7,3.2
1232,0,Europe,Commercial,Supply Chain,Meets,Male,38,8,1,6,,4.4,3.5,1,1,1,1,4.6,4.6,2.4
1233,0,North America,Commercial,Quality Assurance,Meets,Male,44,21,0,5,2.9,1.7,3.3,0,0,0,0,2.6,1.6,4.9
1234,0,Europe,Manufacturing,Sales,Meets,Male,39,6,0,7,3.4,1.9,5,1,1,1,1,2.9,3.3,5
1235,0,Europe,Manufacturing,Market Access,Exceeds,Male,37,3,0,8,3.9,3.4,2.3,1,1,1,0,3.7,3.5,3.3
1236,0,Middle East & Africa,Digital,Marketing,Below,Female,41,11,0,9,3.1,3.5,2.6,1,1,1,1,4.3,3.4,1.3
1237,0,North America,R&D,IT & Digital,Below,Female,28,16,0,10,3.7,2.5,1.9,1,1,1,1,3.7,2.4,2.7
1238,0,North America,Commercial,Clinical Operations,Meets,Female,36,5,1,8,,1.8,1.6,1,1,1,1,4.4,3.8,1.8
1239,0,North America,Digital,Marketing,Meets,Male,36,12,0,6,2.5,3.9,2.9,1,1,1,1,2.6,5,3.1
1240,0,North America,R&D,Pharmacovigilance,Meets,Male,30,8,0,12,1.8,2.2,1.5,1,1,1,1,2.2,2.9,1.5
1241,0,North America,Finance,Market Access,Exceeds,Male,46,19,0,7,2.9,1.9,1,0,0,0,0,3.8,3.8,2.9
1242,0,Middle East & Africa,Commercial,Medical Affairs,Exceeds,Male,37,20,1,9,,2.2,2.2,1,1,1,1,2.7,2.9,3.2
1243,0,Asia Pacific,Commercial,Legal & Compliance,Meets,Female,40,5,1,12,,3.1,2.4,1,1,1,1,4.2,3.6,1.9
1244,0,Europe,Manufacturing,Legal & Compliance,Meets,Non-Binary/Other,43,7,1,7,,2.9,3.9,1,1,1,1,5,2,4.4
1245,0,North America,HR,Market Access,Far Exceeds,Female,33,11,0,7,3.8,2.5,1.1,0,0,0,0,3.3,2.5,1.1
1246,0,Asia Pacific,R&D,Finance & Accounting,Meets,Female,40,20,0,5,3.9,2.9,1.4,1,1,1,1,2.8,3.7,3.7
1247,0,Asia Pacific,Commercial,Clinical Operations,Below,Female,28,9,0,6,3.2,3.8,2.1,1,1,1,1,3.6,5,3
1248,0,Europe,R&D,Legal & Compliance,Meets,Female,41,4,1,8,,3.6,2.3,1,1,1,1,2.5,3.1,2.8
1249,0,Middle East & Africa,Digital,Human Resources,Meets,Female,35,5,1,5,,4.5,1.4,1,1,1,1,4.2,4.7,1.4
1250,0,Latin America,Digital,Pharmacovigilance,Below,Female,36,7,0,6,3.3,2.8,2.8,1,1,1,1,3.2,2.9,2.8
1251,0,Latin America,HR,Medical Affairs,Meets,Female,45,25,0,7,3.3,3.8,3,1,0,0,0,3.7,3.4,4
1252,0,Asia Pacific,Commercial,Regulatory Affairs,Exceeds,Female,49,11,0,12,3.4,3.6,1.2,1,1,1,1,3.3,2.4,1.8
1253,0,Europe,Manufacturing,Clinical Operations,Meets,Female,34,9,0,5,3,2.6,3.3,1,1,1,1,3.6,4.7,3
1254,0,Latin America,Commercial,Data Science,Meets,Female,33,14,0,5,3,4.5,3.4,1,1,1,1,2.8,4.9,2.6
1255,0,Asia Pacific,R&D,Supply Chain,Meets,Female,42,18,0,8,4.2,5,1.4,1,1,1,0,4.4,3.7,2.5
1256,0,Middle East & Africa,Finance,Human Resources,Meets,Female,42,12,0,11,2.5,3,4,1,1,1,1,3.3,3.5,2.2
1257,0,Latin America,Digital,Market Access,Meets,Male,31,17,0,7,3.1,3,3.6,1,1,1,1,2.4,2.7,4.2
1258,0,Asia Pacific,R&D,Regulatory Affairs,Meets,Female,38,11,0,7,4.6,3.7,2.1,1,1,1,1,3.4,3.9,1.9
1259,0,Asia Pacific,HR,Communications,Meets,Male,38,8,0,9,3.2,2.4,1.9,1,1,1,1,2.6,3,2.4
1260,0,North America,Digital,Pharmacovigilance,Exceeds,Female,38,6,1,9,,3.8,1.1,0,0,0,0,4.1,2.2,2.4
1261,0,Middle East & Africa,Manufacturing,IT & Digital,Far Exceeds,Male,42,13,0,9,2.8,4.7,1.3,1,1,1,1,4.8,5,3.3
1262,0,North America,Digital,Finance & Accounting,Exceeds,Male,47,23,0,7,2.4,3.8,2.2,1,1,1,1,2.2,3.5,3.1
1263,0,Europe,Finance,Human Resources,Below,Female,37,9,0,10,4.8,2.6,2.5,1,1,1,1,3.7,3.7,1.6
1264,0,North America,Commercial,Regulatory Affairs,Far Below,Female,49,7,1,7,,3.5,3.1,1,1,1,1,4.1,3.2,4
1265,0,North America,Finance,Sales,Meets,Male,37,23,0,5,3.3,3.3,3.6,1,1,1,1,4.1,3,1
1266,0,Latin America,Finance,Quality Assurance,Meets,Male,48,8,0,11,4.6,1.9,1.6,1,1,1,1,5,1.7,1.9
1267,0,Asia Pacific,Commercial,Finance & Accounting,Far Exceeds,Female,41,5,1,5,,3.9,2.7,1,1,1,1,2.5,4.5,2.7
1268,1,Middle East & Africa,Digital,Finance & Accounting,Meets,Male,45,25,0,11,3.9,2.6,3.2,1,1,1,1,5,3.5,2.3
1269,0,North America,HR,IT & Digital,Meets,Male,44,11,0,7,3.7,4.6,3.4,1,1,1,1,5,3.3,1.8
1270,0,Middle East & Africa,Commercial,Market Access,Far Below,Female,33,1,0,11,3.3,4.4,2.1,1,1,1,1,4.1,4,3.2
1271,0,North America,Commercial,Quality Assurance,Exceeds,Female,40,13,1,12,,4.5,3.2,1,1,1,1,5,4.1,2.3
1272,0,Europe,Manufacturing,Data Science,Below,Female,33,20,0,5,3.5,3.4,3.2,1,0,0,0,2.1,3.8,2.3
1273,0,North America,Digital,Regulatory Affairs,Below,Female,37,14,0,8,3.4,3.8,4.2,1,1,1,1,5,4.7,3.4
1274,0,Latin America,Commercial,Pharmacovigilance,Exceeds,Female,31,7,1,7,,4,2.6,1,1,0,0,3.6,2.9,2.2
1275,0,Asia Pacific,HR,Data Science,Meets,Female,37,25,0,8,3.3,4.7,2.5,1,1,1,1,3.8,4.6,2.6
1276,0,Europe,R&D,Quality Assurance,Below,Female,38,11,0,5,3.8,2.8,2,1,1,1,1,4.1,3.8,3.8
1277,0,North America,Digital,Regulatory Affairs,Meets,Male,33,18,0,11,4,2.5,1.7,1,1,1,1,3.6,3.2,2
1278,0,Middle East & Africa,Manufacturing,Data Science,Below,Male,38,5,1,9,,1.6,2.3,1,0,0,0,3.6,1.7,2.3
1279,0,Europe,Finance,Clinical Operations,Meets,Female,43,19,0,8,1.9,2.8,1.4,1,1,1,1,3.6,3.1,3.3
1280,0,Europe,Commercial,Legal & Compliance,Meets,Female,32,8,0,5,3.3,3.1,2.2,1,1,1,1,4.7,1.4,2.5
1281,0,North America,HR,Human Resources,Exceeds,Male,43,17,0,8,2.6,1.9,1.4,1,1,1,1,1,2.4,2.8
1282,0,Europe,Digital,Marketing,Meets,Female,44,15,0,5,2.1,3.5,1.4,1,1,1,1,2.3,2.5,2.2
1283,0,Middle East & Africa,HR,Finance & Accounting,Meets,Female,32,9,0,11,2.8,4.1,1.8,1,1,1,1,3.7,4.4,1.6
1284,0,Europe,HR,Supply Chain,Below,Male,28,17,0,8,2.9,2.3,3.1,1,1,1,1,3.7,3.2,1.6
1285,0,Middle East & Africa,Finance,Medical Affairs,Meets,Female,45,14,0,6,2.5,3.5,3.3,1,1,1,1,2.4,2.5,3.1
1286,0,North America,Manufacturing,Clinical Operations,Meets,Female,37,9,0,11,3.3,2.9,2.6,1,1,1,1,4.2,4.8,3
1287,0,Asia Pacific,Digital,Data Science,Meets,Male,38,13,0,6,3.9,3.3,2.8,1,1,1,1,2.5,4.7,3.7
1288,0,Europe,Commercial,Pharmacovigilance,Meets,Female,50,10,0,10,3.7,3.7,3.3,1,1,1,1,2.7,3.8,2.9
1289,0,Asia Pacific,Manufacturing,Sales,Meets,Male,41,10,0,6,2.9,2.7,2.3,1,0,0,0,3.1,1.8,3.3
1290,0,Middle East & Africa,Commercial,Marketing,Exceeds,Female,41,5,0,7,4,2.7,2.9,1,1,1,1,3.7,3.4,2.4
1291,0,Europe,R&D,Medical Affairs,Meets,Female,38,8,0,9,2.8,2.1,1.7,0,0,0,0,3.5,2.8,1.5
1292,0,Latin America,HR,Clinical Operations,Below,Female,37,24,0,9,4.6,2.4,3.1,1,1,1,1,4.5,4.2,2.8
1293,0,Asia Pacific,R&D,Legal & Compliance,Meets,Male,38,16,0,9,3.5,3.5,2.5,1,1,1,1,3.3,2.2,3.1
1294,0,Europe,HR,Sales,Meets,Male,37,12,0,5,4,3.2,3,1,1,1,1,4.7,2.9,3.4
1295,0,Asia Pacific,Finance,Sales,Far Below,Female,28,29,0,11,2.9,2,2.4,1,1,1,1,2.8,3.8,3.7
1296,0,Europe,Manufacturing,Sales,Meets,Male,32,3,1,10,,2.3,4.1,1,1,1,1,3.9,3.5,3.8
1297,0,North America,Commercial,Communications,Meets,Male,38,2,1,12,,3.3,4,0,0,0,0,2.7,2.8,4.8
1298,0,Asia Pacific,Finance,Marketing,Far Exceeds,Male,50,6,1,7,,4.6,4,1,1,1,1,2.6,4.6,4.3
1299,0,Latin America,Commercial,Human Resources,Meets,Female,30,7,0,7,3,2.5,1,1,1,1,1,3.2,2.7,1
1300,0,Latin America,Manufacturing,Regulatory Affairs,Below,Female,35,24,0,5,2.2,2,3.1,1,1,1,1,1.6,2,3.9
1301,0,Middle East & Africa,Digital,Clinical Operations,Meets,Non-Binary/Other,35,21,0,11,2.8,2.4,4.4,1,1,1,1,2.9,3.6,4.6
1302,0,Europe,R&D,Communications,Meets,Male,42,9,0,10,2.4,3,2.8,1,1,1,1,3.7,3.9,3.3
1303,0,Asia Pacific,R&D,Regulatory Affairs,Meets,Male,39,8,1,10,,2.1,3,1,1,1,1,2.1,2.5,3.2
1304,0,Middle East & Africa,Commercial,Finance & Accounting,Meets,Female,34,6,0,12,3.5,3.2,2.9,0,0,0,0,3.7,2.5,3
1305,0,Asia Pacific,Commercial,Market Access,Exceeds,Female,45,15,0,8,2.6,3.7,4.9,1,1,1,1,3.9,3,2.9
1306,0,Europe,Commercial,Marketing,Exceeds,Male,32,13,0,12,4.3,3,3.4,1,1,1,1,4.2,3.4,1.8
1307,0,Latin America,Manufacturing,Sales,Below,Male,35,7,1,10,,3,3.7,1,1,1,1,3.7,1.8,2.5
1308,0,North America,Digital,Communications,Meets,Male,31,9,0,8,2.6,3.9,2.6,1,1,1,1,3.6,4,4.3
1309,0,Latin America,R&D,Sales,Meets,Female,44,6,0,10,4.2,3.9,3.3,1,1,1,1,3.5,3.6,4.2
1310,0,Middle East & Africa,Finance,IT & Digital,Meets,Male,38,19,0,11,3.8,2.5,2.3,1,1,1,1,3.5,3,2.8
1311,1,North America,HR,IT & Digital,Exceeds,Non-Binary/Other,34,10,1,7,,2.9,4.5,1,1,1,1,3.5,3.7,4.2
1312,0,Middle East & Africa,Manufacturing,Communications,Exceeds,Female,41,9,0,9,3.1,4.7,1.8,1,1,1,1,4,2.7,3.4
1313,0,Europe,R&D,Marketing,Below,Male,47,17,0,9,1.9,3.4,1.5,1,1,1,1,1,2.8,2.2
1314,0,North America,Digital,Legal & Compliance,Below,Male,28,16,0,7,3.8,4.1,1.5,1,1,1,1,3.2,3.9,4.4
1315,0,Middle East & Africa,Manufacturing,Market Access,Meets,Male,42,12,0,8,4.1,2.5,3.1,1,1,1,1,4.1,3.1,2.9
1316,0,Europe,Finance,Supply Chain,Meets,Female,48,6,1,5,,2.2,4.6,1,1,1,1,3.1,2.9,4.1
1317,0,Latin America,R&D,Pharmacovigilance,Exceeds,Female,47,12,0,6,4.7,2.6,2.8,1,1,1,1,5,3,1.9
1318,0,Europe,Manufacturing,Supply Chain,Below,Male,37,9,0,8,3.8,2.8,5,1,1,0,0,4.3,2.2,3
1319,0,Asia Pacific,R&D,Regulatory Affairs,Meets,Female,39,25,0,10,3.3,3.4,4.1,1,1,1,1,2.9,4.1,3.9
1320,0,Europe,R&D,Marketing,Meets,Female,39,5,0,7,3.8,3.7,3.3,1,1,1,1,4.8,3.1,3.8
1321,0,Europe,Digital,Pharmacovigilance,Far Below,Male,36,9,0,12,2.6,2.7,1.6,1,1,1,1,3,2.8,1.4
1322,0,Asia Pacific,HR,Supply Chain,Meets,Male,44,20,0,6,3.4,2,3.5,1,1,1,0,4,2.6,4.4
1323,0,Middle East & Africa,Digital,Regulatory Affairs,Exceeds,Male,28,8,1,10,,3.2,5,1,1,1,0,2.5,2.1,4.9
1324,0,Middle East & Africa,R&D,Data Science,Meets,Male,41,19,0,9,3.4,4.4,3.8,0,0,0,0,4,5,1.8
1325,0,Europe,Manufacturing,Quality Assurance,Below,Female,38,10,0,5,3.5,4.8,3.8,0,0,0,0,4.4,3.1,4.4
1326,0,Asia Pacific,Finance,Human Resources,Below,Male,44,21,0,11,3.5,1.2,1.9,1,1,1,1,4.5,2.5,2.3
1327,0,Asia Pacific,Digital,Pharmacovigilance,Meets,Male,45,24,0,12,3.2,3.7,3.1,1,1,1,1,2.3,2.3,2.6
1328,0,Latin America,HR,Medical Affairs,Meets,Female,39,4,0,5,2.5,4.5,4.4,1,1,1,1,2.8,3,3.1
1329,0,Middle East & Africa,R&D,Pharmacovigilance,Meets,Male,34,25,0,11,5,2.6,3.4,1,1,1,1,4.5,3.9,3.4
1330,0,North America,Finance,Regulatory Affairs,Meets,Male,44,10,0,9,2.5,3.2,1.5,0,0,0,0,2.3,2.6,1.7
1331,0,Middle East & Africa,Digital,Finance & Accounting,Meets,Female,30,9,0,11,2.3,3.8,3.1,1,1,1,1,2.7,3.6,5
1332,0,Middle East & Africa,Digital,Human Resources,Meets,Male,32,3,1,8,,3.9,2.8,0,0,0,0,2.3,3.8,2.3
1333,0,Latin America,Digital,Sales,Below,Male,38,23,0,12,3.2,2.6,2.4,1,1,1,1,4.7,4,4.8
1334,0,North America,Digital,Human Resources,Meets,Male,35,9,1,12,,4.4,3.3,1,1,1,1,3.4,3.7,3.5
1335,0,Latin America,Finance,Regulatory Affairs,Meets,Female,37,12,0,6,3.9,3.1,2.2,1,1,1,1,3.8,2.3,2.9
1336,0,North America,Manufacturing,Human Resources,Exceeds,Male,36,9,0,10,2.5,2.5,3.1,0,0,0,0,2.7,1,3.8
1337,0,Europe,HR,Clinical Operations,Far Below,Female,38,18,0,12,4.4,2.1,2.3,1,1,1,1,3.3,1,2.5
1338,0,North America,HR,Finance & Accounting,Meets,Female,47,20,1,12,,3.9,2.1,1,1,1,1,4.2,4.7,3
1339,0,Latin America,R&D,Legal & Compliance,Below,Female,31,9,0,10,2,2.2,1.8,1,1,1,1,1.9,3.1,3.2
1340,0,Middle East & Africa,Commercial,Sales,Far Exceeds,Female,35,6,0,6,3.7,4.3,2.4,1,1,1,1,4.3,5,4.4
1341,0,North America,Manufacturing,Regulatory Affairs,Meets,Male,43,13,0,11,3.2,4,3,1,1,1,1,1.7,4,3.6
1342,0,North America,R&D,Legal & Compliance,Meets,Male,38,14,1,8,,1.6,3.1,1,1,1,1,2.3,2.7,3.3
1343,0,Asia Pacific,R&D,Finance & Accounting,Meets,Male,32,7,0,12,4,3.6,2.3,1,0,0,0,4,2.2,2.4
1344,0,Middle East & Africa,Digital,Supply Chain,Exceeds,Male,37,13,0,12,4.4,1.6,3.5,1,1,1,1,3.6,1.9,3.6
1345,0,Europe,Commercial,Quality Assurance,Exceeds,Non-Binary/Other,29,10,0,8,2.5,2.2,4.9,1,1,1,1,4.5,4.1,4.7
1346,0,Latin America,Commercial,Regulatory Affairs,Exceeds,Female,44,3,0,10,1.3,4.8,3.9,0,0,0,0,3.8,4.5,2.5
1347,0,Europe,Manufacturing,Supply Chain,Exceeds,Female,39,9,0,11,3,3.1,2.5,1,1,1,1,3.6,2.4,3
1348,0,Middle East & Africa,Commercial,Medical Affairs,Exceeds,Female,51,9,0,5,2.8,2.5,2.7,1,1,0,0,2.6,5,4.3
1349,0,North America,R&D,Clinical Operations,Meets,Non-Binary/Other,31,13,0,5,3.1,2,3.7,1,1,1,1,3.7,3.3,2.9
1350,0,North America,Commercial,Human Resources,Far Below,Female,34,7,0,7,2,4.3,2.8,1,1,1,1,3,3.6,2.4
1351,0,Middle East & Africa,Commercial,Communications,Below,Female,39,10,0,10,3,4.2,3.4,1,1,1,1,3.5,4.3,2.6
1352,0,North America,HR,Data Science,Meets,Male,46,15,0,8,2.6,3.3,2.4,1,1,1,1,1.5,2.6,2.1
1353,1,North America,R&D,Human Resources,Meets,Male,35,17,0,5,2.4,3.4,4.3,1,1,1,1,5,2.9,4.3
1354,0,North America,Finance,IT & Digital,Meets,Male,34,12,0,6,1.8,3.4,2.8,0,0,0,0,2.8,4.6,2.9
1355,0,Latin America,Commercial,Clinical Operations,Meets,Male,38,13,0,8,2.9,3.4,2.9,1,1,1,1,3.5,2.6,1.7
1356,0,Latin America,Commercial,Sales,Meets,Male,34,5,0,8,4.3,3.9,3.8,1,1,1,1,3.3,4,3.6
1357,0,Asia Pacific,Digital,Communications,Meets,Female,41,15,0,5,3,2.5,2.4,1,0,0,0,2.6,2.3,3.8
1358,0,Europe,Commercial,Finance & Accounting,Meets,Female,38,7,1,9,,1.6,2.6,1,1,1,1,2.8,1.3,1.6
1359,0,Middle East & Africa,Commercial,Quality Assurance,Meets,Female,42,12,0,8,4.7,4.4,3.4,1,1,0,0,3.5,2.8,1.3
1360,0,Middle East & Africa,HR,Clinical Operations,Below,Female,43,14,0,11,1.8,2,2.3,1,1,1,1,2.2,3.2,3.4
1361,0,Middle East & Africa,R&D,Legal & Compliance,Exceeds,Female,40,3,0,11,3.2,3.7,2.3,1,1,1,1,3.4,4.3,1.6
1362,1,Asia Pacific,Manufacturing,Pharmacovigilance,Meets,Male,45,4,1,8,,3.5,2.4,1,1,1,1,3.3,4.3,4.7
1363,0,Latin America,R&D,Data Science,Exceeds,Female,36,9,0,8,2.8,2.9,2.6,1,1,1,1,3.7,4.2,2.1
1364,0,Asia Pacific,Digital,Sales,Meets,Male,29,16,1,9,,2.5,2.1,1,1,1,1,3.6,1.8,1.4
1365,0,Middle East & Africa,R&D,Pharmacovigilance,Below,Female,32,17,0,10,3.8,3.3,2.4,1,1,1,1,3.4,3.5,1.6
1366,0,Europe,Commercial,Sales,Far Below,Male,37,5,0,7,3.2,4.3,3.4,0,0,0,0,2.4,4.2,1.6
1367,0,North America,Digital,Pharmacovigilance,Below,Female,41,18,0,12,4,1.9,4.5,1,1,1,1,5,1.3,3.7
1368,0,Latin America,R&D,Market Access,Below,Female,42,23,0,5,5,3.1,2.8,1,1,1,1,4.3,3.7,2.7
1369,0,Latin America,Digital,Quality Assurance,Below,Female,34,6,0,9,3.9,4.8,2.5,1,1,1,1,1.6,5,3.1
1370,0,Asia Pacific,Manufacturing,Supply Chain,Exceeds,Male,43,6,1,10,,3.9,1.8,1,1,1,1,3,5,1.7
1371,1,Latin America,R&D,Human Resources,Exceeds,Male,28,3,1,8,,2,3.2,1,1,1,1,3.8,1.5,2.6
1372,0,Middle East & Africa,Finance,Clinical Operations,Exceeds,Female,35,2,0,7,4,2.3,3,1,1,1,1,4.4,3.7,3.1
1373,1,Middle East & Africa,Commercial,Medical Affairs,Far Exceeds,Male,41,20,0,8,3.5,4,1.8,1,1,1,1,4.2,2.1,3.3
1374,0,Asia Pacific,Digital,Pharmacovigilance,Meets,Female,43,14,0,6,2.8,1.9,2.6,1,1,1,0,2.3,2.2,2.1
1375,0,Middle East & Africa,Finance,Market Access,Meets,Female,43,16,0,5,3.3,2.8,2.4,1,1,1,1,4.5,3.5,2.8
1376,0,Europe,Finance,Quality Assurance,Below,Female,44,16,0,8,2.9,2.5,2,0,0,0,0,1.9,2.8,3
1377,0,Asia Pacific,HR,Medical Affairs,Below,Male,39,18,0,8,3.9,3,2.5,1,1,1,1,3.9,2.5,2.5
1378,0,Europe,Digital,IT & Digital,Meets,Female,37,5,1,10,,4,3.5,1,1,1,1,2.2,3.2,1.3
1379,0,North America,Finance,Clinical Operations,Exceeds,Male,28,19,0,12,3.2,3,1,1,1,1,1,4.7,3.4,3.4
1380,0,Europe,HR,Market Access,Meets,Male,37,3,0,5,4,2.7,3.2,1,1,1,1,4.9,2.3,3.2
1381,0,North America,Finance,Medical Affairs,Exceeds,Male,31,6,0,12,4.3,3.3,2.5,1,1,0,0,4.7,4.7,3.9
1382,0,North America,Commercial,Communications,Meets,Male,42,5,1,8,,3.1,3.6,1,1,1,1,3.2,2.8,2.5
1383,0,Europe,Manufacturing,Data Science,Meets,Female,30,13,0,5,3.9,2.3,1.4,1,1,1,1,4,3.8,2.4
1384,0,Asia Pacific,HR,Marketing,Meets,Male,37,8,0,12,4.2,2.7,1,1,1,1,1,3.6,2.3,2.3
1385,0,Middle East & Africa,Manufacturing,Human Resources,Far Exceeds,Female,31,10,0,10,3.2,1.5,3.4,1,1,1,1,3.1,2.4,2.9
1386,0,Middle East & Africa,Digital,Sales,Exceeds,Female,38,15,0,8,4.5,2.6,2.4,1,1,1,1,3.5,3,4.2
1387,0,North America,Commercial,Sales,Meets,Female,37,7,1,5,,4.4,2,1,1,1,1,4.6,4,3.1
1388,0,North America,HR,Regulatory Affairs,Below,Male,28,8,0,6,2.2,3.7,2.2,1,1,1,1,3.4,4,3
1389,0,Asia Pacific,Digital,IT & Digital,Meets,Female,40,3,0,8,2.7,2.8,2.5,1,1,1,1,2.4,1.9,2.4
1390,0,Latin America,Finance,Data Science,Meets,Female,36,17,0,6,3.2,3.9,1.9,1,1,1,1,3.8,4.2,2.8
1391,0,Europe,R&D,Human Resources,Exceeds,Male,38,3,0,8,4,4.4,3.8,1,1,1,1,3.6,4.4,2.8
1392,0,North America,Digital,Marketing,Below,Female,36,23,0,8,2.1,3.1,2,1,1,1,1,3.1,4.4,3
1393,0,Middle East & Africa,Manufacturing,Regulatory Affairs,Meets,Male,34,8,0,12,3.3,2.4,3,1,1,1,1,3,3,2.3
1394,0,Asia Pacific,Commercial,Communications,Meets,Male,43,10,1,7,,2.8,4.2,1,1,1,1,4.9,2.5,3.6
1395,0,Europe,Commercial,Medical Affairs,Exceeds,Non-Binary/Other,44,9,1,11,,3.6,2.8,1,1,1,1,3.4,2.7,3.1
1396,0,Asia Pacific,Digital,Regulatory Affairs,Meets,Male,44,17,0,9,3.7,4.1,2.6,1,1,1,1,4.3,3.5,3.5
1397,0,Europe,Finance,Pharmacovigilance,Meets,Female,30,9,0,5,3.3,3.2,3.5,1,1,1,1,3.1,2.9,4.2
1398,0,Europe,R&D,Data Science,Meets,Male,46,22,0,11,3.3,2.9,1.7,1,1,1,1,2.5,2,1
1399,0,North America,Manufacturing,Market Access,Below,Female,41,4,0,10,2.4,4,2.9,0,0,0,0,2.4,3.3,2.4
1400,0,Asia Pacific,Digital,Market Access,Meets,Male,45,5,0,8,2.3,2.2,3.5,1,1,1,1,3.3,3.4,3.9
1401,0,Asia Pacific,Digital,Marketing,Exceeds,Male,45,21,0,6,3.4,3.1,4.7,1,1,1,1,2.6,3.5,4
1402,0,Middle East & Africa,Commercial,Communications,Exceeds,Female,40,8,0,5,3.8,4.2,5,1,1,1,1,3.5,3.6,3.7
1403,0,Middle East & Africa,Manufacturing,Clinical Operations,Meets,Female,33,8,1,9,,3.2,1.3,1,1,1,1,3.4,3,2.6
1404,0,North America,R&D,Finance & Accounting,Meets,Female,33,13,0,11,3.9,2.9,1.7,1,1,1,1,4.1,3.2,2.1
1405,0,North America,Commercial,Human Resources,Exceeds,Female,34,10,0,7,3.7,1.9,3.3,1,1,1,1,2.9,1.3,3.3
1406,0,Latin America,Digital,Legal & Compliance,Meets,Male,37,31,0,12,3.1,2.7,2.5,1,1,1,1,3.5,2.2,2.6
1407,0,Middle East & Africa,Commercial,Communications,Far Below,Male,32,5,0,12,2.7,3.2,2,1,1,1,1,3.3,3.4,4.5
1408,0,Europe,Commercial,Communications,Meets,Female,28,18,1,9,,4,2.1,1,1,1,1,3.2,4.3,3.4
1409,0,Asia Pacific,HR,Market Access,Meets,Female,28,18,1,11,,1.8,4.1,1,1,1,1,4,3.7,2.9
1410,0,North America,Commercial,Data Science,Meets,Male,38,7,0,7,3.3,2.5,3.6,1,1,1,1,3.5,2.7,3.9
1411,0,Asia Pacific,Finance,Quality Assurance,Far Exceeds,Female,36,5,1,12,,2.8,3.4,1,1,1,1,2.2,4.3,3.6
1412,0,Asia Pacific,Commercial,Sales,Exceeds,Female,41,12,1,9,,3.4,2.6,1,1,1,1,4.5,3.9,1.7
1413,0,Latin America,Finance,Quality Assurance,Below,Female,37,9,0,12,2.9,2.3,2.2,1,1,0,0,3.7,3.2,3
1414,0,Middle East & Africa,Manufacturing,Communications,Meets,Male,45,19,1,6,,2.6,3.2,1,1,1,1,2.9,3.3,1.8
1415,0,North America,Commercial,Regulatory Affairs,Meets,Male,34,10,0,8,4.5,4.5,2.8,1,1,1,1,4.8,3,3.2
1416,0,Asia Pacific,R&D,Supply Chain,Meets,Male,40,8,0,10,3.3,3.3,1.5,1,1,1,1,3.6,1,2.4
1417,0,North America,Finance,Pharmacovigilance,Meets,Male,41,5,0,9,3.3,2.7,3.2,1,1,1,1,4.4,3.7,3.7
1418,0,Europe,Finance,Supply Chain,Meets,Female,38,14,0,12,4.7,3.6,3.8,1,1,1,1,3.3,2.8,2.4
1419,0,Latin America,Digital,Data Science,Exceeds,Male,44,2,1,8,,1.7,1,0,0,0,0,3.2,1,1.8
1420,0,Europe,Manufacturing,Supply Chain,Meets,Male,41,5,1,8,,2.7,3,0,0,0,0,3.7,3.9,2.4
1421,0,North America,Commercial,Communications,Exceeds,Male,43,9,1,6,,2.4,4,1,1,1,1,2.9,4.9,3.7
1422,1,North America,R&D,Quality Assurance,Meets,Male,34,7,1,12,,2.5,3,1,1,1,1,5,2.3,3.3
1423,0,Middle East & Africa,Digital,Legal & Compliance,Meets,Male,37,15,0,10,3.6,2.3,3.3,1,1,0,0,3.1,3,3.8
1424,0,Asia Pacific,Manufacturing,Clinical Operations,Meets,Male,28,12,1,6,,2.9,1.3,1,1,1,1,3.9,4.4,2.5
1425,0,Asia Pacific,Finance,Finance & Accounting,Far Exceeds,Male,38,5,0,12,2.5,2.9,3,1,1,1,0,2.1,4.3,2.3
1426,1,Europe,R&D,Finance & Accounting,Meets,Male,30,6,1,6,,2.6,2,0,0,0,0,4.6,3.1,3.6
1427,0,Latin America,Commercial,Data Science,Far Below,Female,52,4,0,6,5,1.5,3.7,1,1,1,1,4.3,3.5,3.2
1428,0,Asia Pacific,HR,Sales,Meets,Female,40,9,0,8,4.2,2.4,2,1,1,1,1,3.7,2.9,2.3
1429,0,Middle East & Africa,HR,IT & Digital,Meets,Male,36,29,0,10,3.1,2.5,2.4,1,1,1,1,4.3,1.4,2.5
1430,0,Europe,Manufacturing,Marketing,Exceeds,Female,43,24,0,11,3.8,1.8,2.6,1,0,0,0,3.6,4.6,3.9
1431,0,Europe,R&D,Data Science,Meets,Male,30,14,0,7,2.8,4.4,2.1,0,0,0,0,3.8,3.9,2.4
1432,0,Middle East & Africa,Digital,Communications,Far Exceeds,Female,35,16,0,11,3.4,1.6,2.4,1,1,1,1,3.7,1,2.1
1433,0,Latin America,R&D,Medical Affairs,Meets,Male,36,10,0,9,2.6,4.6,1.9,1,1,1,1,3.4,3.9,2.6
1434,0,Middle East & Africa,Finance,Sales,Meets,Female,42,18,0,8,3.2,1.4,2.2,1,1,1,1,5,4.4,1.6
1435,0,Latin America,HR,Communications,Meets,Male,32,7,1,11,,1.9,3.6,0,0,0,0,3.1,3.3,3.9
1436,0,Middle East & Africa,Manufacturing,Data Science,Meets,Male,34,15,0,6,4.8,2.8,3.7,1,1,1,1,4.6,3.4,4.9
1437,0,Middle East & Africa,Commercial,Medical Affairs,Far Exceeds,Male,39,13,0,5,3.2,4.1,3.1,1,1,1,1,2.1,5,3.3
1438,0,North America,R&D,Sales,Below,Female,42,14,0,11,2.7,2.4,4.3,1,1,1,1,1.8,2.5,4
1439,0,Europe,HR,Regulatory Affairs,Below,Male,39,15,0,7,2.5,5,3.1,1,1,1,1,2.9,4.5,1.4
1440,0,Middle East & Africa,Digital,Market Access,Below,Male,33,11,0,11,4.7,1.9,3.1,1,1,1,1,3.5,3.8,4.2
1441,0,Middle East & Africa,Manufacturing,Pharmacovigilance,Meets,Male,39,15,0,10,3.3,3.5,3.2,1,1,1,1,2.8,4.7,3.3
1442,0,Asia Pacific,Commercial,Market Access,Below,Female,34,13,0,10,4.5,3.3,1.9,1,1,1,1,3.4,2.4,1.6
1443,0,Europe,R&D,Quality Assurance,Meets,Male,32,6,1,7,,2.2,1.9,1,1,1,1,4.9,3,2
1444,0,Asia Pacific,Digital,IT & Digital,Exceeds,Female,40,15,0,10,3.8,1.8,2.2,1,1,1,1,4,3.5,2.1
1445,1,Europe,Commercial,Marketing,Meets,Male,41,6,0,9,3.5,3.2,2.2,1,1,1,1,4.8,5,2.3
1446,0,Asia Pacific,Finance,Market Access,Meets,Female,38,7,0,8,2.3,3.2,3,1,1,1,1,4.5,2.6,3.6
1447,0,Middle East & Africa,HR,Human Resources,Exceeds,Male,41,9,0,5,4.4,1.8,4.1,1,1,1,1,3.4,4,3.2
1448,0,Middle East & Africa,Finance,Data Science,Meets,Male,43,29,0,11,3.6,3.6,2.3,1,1,1,1,4.7,3.7,1.3
1449,0,North America,HR,Human Resources,Meets,Female,28,15,0,9,2.8,3.6,1.9,1,1,1,1,2,4.7,1
1450,0,Asia Pacific,Digital,Regulatory Affairs,Meets,Female,40,6,1,8,,3.9,1.6,1,1,1,1,4.4,2.9,1
1451,0,Latin America,Finance,Supply Chain,Meets,Non-Binary/Other,47,19,0,9,3.6,2.2,3.1,1,1,1,1,3.3,1.5,3
1452,0,North America,HR,Quality Assurance,Below,Female,36,4,0,8,3,5,2.7,1,1,1,1,3.2,2.8,2.2
1453,0,Asia Pacific,Manufacturing,Market Access,Meets,Male,47,14,0,9,2.6,2.7,4.6,1,1,1,1,4.1,3.3,2.6
1454,0,Asia Pacific,Digital,Clinical Operations,Far Exceeds,Female,40,6,0,7,2.4,2.9,2.1,1,1,1,1,3.2,3.1,3
1455,0,North America,HR,Legal & Compliance,Meets,Female,38,22,0,6,3.1,2.1,4,1,1,1,1,3.7,3.1,3.6
1456,0,Middle East & Africa,R&D,Communications,Meets,Male,40,11,1,9,,3.1,1,1,1,1,1,3.2,3.1,1
1457,0,Asia Pacific,HR,Marketing,Meets,Male,29,13,1,8,,2.1,1.1,1,1,1,1,3.4,5,1
1458,0,Middle East & Africa,Finance,Supply Chain,Exceeds,Male,48,14,0,11,2.8,3.2,3.7,1,1,1,1,3.1,4.8,3.5
1459,0,North America,Manufacturing,Communications,Exceeds,Male,35,8,0,12,3.1,1.2,2.7,1,1,1,1,3.1,2.5,2.2
1460,0,Middle East & Africa,Commercial,Finance & Accounting,Meets,Male,31,11,1,12,,3.7,2.5,1,1,1,1,3.4,3.5,3.7
1461,0,Europe,Commercial,Pharmacovigilance,Meets,Female,35,13,0,11,3.5,1.6,2.2,0,0,0,0,3,1.3,3.6
1462,0,Latin America,HR,IT & Digital,Meets,Female,38,15,0,7,3.2,3.5,3.5,1,1,1,1,4.1,3.1,2.9
1463,0,Asia Pacific,Commercial,Data Science,Meets,Female,45,5,1,11,,2.5,3.6,1,1,1,1,3.6,2.6,3.8
1464,0,Latin America,HR,Regulatory Affairs,Below,Male,38,8,1,10,,3.8,4.5,1,1,1,1,3.3,2.2,5
1465,0,Middle East & Africa,Manufacturing,Sales,Meets,Male,36,3,0,10,4.1,3.2,3.2,1,1,1,1,3.1,3,1.6
1466,0,Asia Pacific,Commercial,Finance & Accounting,Meets,Female,36,25,0,12,3.9,3.2,3.6,1,1,1,1,3.6,3.5,2.4
1467,0,Middle East & Africa,Finance,Communications,Meets,Female,30,7,1,9,,4.4,1.4,1,1,1,1,2.8,4.9,3
1468,0,Europe,Finance,Market Access,Meets,Female,35,25,0,6,3.8,2.5,1.6,0,0,0,0,4.7,4.5,2.6
1469,0,North America,R&D,Clinical Operations,Far Below,Female,34,2,0,8,3.3,2,3.2,1,1,1,1,3.4,2.5,4
1470,0,Asia Pacific,HR,Finance & Accounting,Meets,Male,40,3,1,12,,3.8,3.6,1,1,1,1,3.8,3.7,2.5
1471,0,Europe,Commercial,Marketing,Meets,Male,28,3,1,9,,2.9,4.1,1,1,1,1,2.8,2.2,2.3
1472,0,Europe,Finance,Pharmacovigilance,Below,Male,35,15,0,11,3.6,3.9,1.2,1,1,1,1,3.2,3.8,1.5
1473,0,Asia Pacific,Manufacturing,Market Access,Exceeds,Male,46,9,1,8,,2.2,2.2,1,1,1,1,4.3,3.6,1.8
1474,0,Middle East & Africa,Manufacturing,Communications,Meets,Male,41,29,0,12,4,2,2.3,1,1,1,1,2.5,1.9,2.9
1475,0,Europe,R&D,Pharmacovigilance,Far Below,Female,44,12,0,8,4.8,3.4,1.9,0,0,0,0,4.6,1.9,2.8
1476,0,Latin America,Manufacturing,Supply Chain,Meets,Non-Binary/Other,36,7,0,9,2.6,2.2,1,0,0,0,0,3.3,2.6,2.5
1477,0,Europe,Manufacturing,Legal & Compliance,Meets,Female,48,15,0,10,2.2,2.2,3.2,1,1,1,1,3.3,2.9,2.2
1478,0,Middle East & Africa,Commercial,Human Resources,Meets,Female,43,5,1,11,,3.6,1,0,0,0,0,2.8,2.1,2.2
1479,0,Middle East & Africa,HR,Supply Chain,Below,Non-Binary/Other,38,19,1,9,,2.5,3.3,0,0,0,0,1.9,3.9,2.8
1480,0,Latin America,Digital,Communications,Meets,Female,42,20,0,6,3,3.4,3.5,1,1,1,1,3.3,2,3.1
1481,0,Europe,Manufacturing,Quality Assurance,Meets,Female,31,22,0,9,3.4,1.3,3.6,1,1,1,1,3.7,1.7,3.9
1482,0,Middle East & Africa,Manufacturing,Market Access,Meets,Male,30,13,0,6,3.2,1.8,3.1,1,1,0,0,4.2,2.4,2.2
1483,0,Asia Pacific,Digital,Legal & Compliance,Meets,Male,43,7,0,7,4.1,3.2,3.1,1,1,1,1,3.8,4.2,3.1
1484,0,North America,Manufacturing,Regulatory Affairs,Far Exceeds,Male,45,9,0,11,3.3,2.7,1.2,1,1,1,1,2.7,3.3,2.5
1485,0,North America,Commercial,Legal & Compliance,Below,Male,32,7,1,11,,2.7,1.7,1,1,1,1,3.6,2.2,2.5
1486,0,North America,Commercial,Marketing,Far Below,Female,43,10,1,11,,1.9,2.4,0,0,0,0,2.5,1.9,2.3
1487,0,Europe,Digital,Sales,Far Exceeds,Female,41,17,0,10,4.1,3.2,1.2,1,1,1,1,3.9,4.8,1.5
1488,0,Latin America,Finance,Sales,Meets,Male,33,11,0,5,2.8,4.7,1.4,0,0,0,0,2.7,3.3,2.9
1489,0,Middle East & Africa,Manufacturing,Finance & Accounting,Meets,Male,32,23,0,12,3.8,3.2,2.1,1,1,1,1,4,2.7,1.3
1490,0,Asia Pacific,Finance,Data Science,Below,Male,34,20,0,5,3.4,3,2.7,1,0,0,0,3.9,1.9,1.8
1491,0,Asia Pacific,Manufacturing,Data Science,Below,Male,35,19,0,5,4,3.6,3.4,1,1,1,0,3.6,3.3,2.9
1492,0,Europe,HR,Marketing,Below,Male,36,5,1,11,,1.5,1.1,1,1,1,1,5,2.4,1.5
1493,0,North America,Manufacturing,IT & Digital,Meets,Male,28,18,0,6,2.7,3.8,3.1,1,1,1,1,4.1,3.4,1.4
1494,0,Europe,Commercial,Market Access,Below,Male,35,8,0,5,4.3,5,1.9,1,1,1,1,4.3,2.9,2.5
1495,0,Latin America,R&D,Finance & Accounting,Meets,Female,40,15,0,8,2.5,2.2,2.8,1,1,0,0,2.5,1,1.6
1496,0,Latin America,R&D,Market Access,Meets,Male,42,11,0,7,4,3.6,3.8,1,1,1,1,4.4,3.6,2.5
1497,0,Middle East & Africa,R&D,Supply Chain,Far Below,Female,34,5,0,10,2.9,2.7,2.3,0,0,0,0,3.4,3.1,2.3
1498,0,Middle East & Africa,R&D,Legal & Compliance,Below,Male,47,6,0,7,1.5,3.9,3.2,1,1,1,1,2.1,3.3,2.5
1499,0,Latin America,Finance,Clinical Operations,Meets,Male,38,12,0,5,5,3.5,3.6,0,0,0,0,5,4,3.3
1500,0,Latin America,Finance,Legal & Compliance,Below,Female,53,8,0,12,3.2,2.1,2.9,0,0,0,0,3.4,3.6,2.7
1501,0,Latin America,Manufacturing,Data Science,Below,Male,34,6,0,10,3.9,4.4,3.1,1,1,1,1,4,5,3
1502,0,Europe,Finance,IT & Digital,Meets,Male,40,19,0,8,3.1,3.4,1,0,0,0,0,3.9,1.5,1.2
1503,0,Latin America,Manufacturing,Clinical Operations,Meets,Female,37,5,0,6,4,2.4,2.8,1,1,1,1,3.4,3.2,2.3
1504,0,Asia Pacific,HR,Market Access,Meets,Female,34,3,1,10,,2.1,1.2,1,1,1,1,2.9,1.4,2.4
1505,0,North America,Manufacturing,Data Science,Below,Male,43,18,0,11,2.9,2,3.5,1,1,1,1,4.7,4.4,1
1506,0,Latin America,R&D,Sales,Meets,Female,43,6,0,6,3.8,3.1,2.7,1,1,1,1,4.2,5,3.1
1507,1,North America,Digital,Pharmacovigilance,Exceeds,Female,36,4,0,5,3.2,3.3,1.5,1,1,1,1,3.8,5,1.6
1508,1,Europe,Digital,Data Science,Meets,Male,40,14,1,7,,1.4,3.2,1,1,1,1,2.3,1,3.4
1509,0,North America,Commercial,Market Access,Far Below,Female,40,9,0,5,3.7,3.1,3.6,1,1,1,1,2.5,4.7,4.2
1510,0,Europe,Commercial,Legal & Compliance,Meets,Female,36,18,0,12,3.6,2.4,2.1,1,1,1,1,4,1.9,2
1511,1,Asia Pacific,Manufacturing,Market Access,Meets,Male,33,24,0,11,3.2,2.4,3.2,1,1,1,1,3.7,3.4,3.9
1512,0,Europe,Digital,Pharmacovigilance,Far Exceeds,Female,38,2,1,6,,2.8,1,1,1,1,1,3.5,2.2,4.4
1513,1,Europe,R&D,Clinical Operations,Far Exceeds,Male,37,8,0,12,3.2,4.1,2.9,1,1,1,1,4,2.9,3.7
1514,0,Middle East & Africa,Finance,Marketing,Meets,Female,32,3,1,7,,5,3.3,0,0,0,0,4.4,4.2,2.6
1515,0,Latin America,R&D,Pharmacovigilance,Meets,Female,42,16,0,7,3,2.2,2.8,0,0,0,0,3.7,5,2.4
1516,0,Latin America,R&D,IT & Digital,Exceeds,Male,38,7,0,5,1.9,3.1,3.9,1,1,1,1,4.2,3.7,2.8
1517,0,Asia Pacific,Manufacturing,Sales,Exceeds,Female,37,4,1,10,,2.5,1.3,0,0,0,0,3.5,3,1
1518,0,Asia Pacific,Manufacturing,Human Resources,Meets,Female,29,8,0,11,3.3,3.6,3.3,1,1,1,1,3.1,3,1
1519,0,Latin America,HR,Legal & Compliance,Meets,Female,40,20,0,10,3.5,2.6,3.3,1,0,0,0,3.3,2.5,2.2
1520,0,Middle East & Africa,R&D,Market Access,Below,Male,29,5,1,5,,3.7,1.9,1,1,1,1,3.4,3.8,3.3
1521,0,Latin America,R&D,Regulatory Affairs,Meets,Male,39,8,1,7,,2.8,4.4,1,1,1,1,3.1,5,1.7
1522,0,Middle East & Africa,Manufacturing,Sales,Meets,Female,43,4,0,6,3.2,2.3,4.6,1,0,0,0,3.3,1,3.8
1523,0,Asia Pacific,Manufacturing,Clinical Operations,Far Exceeds,Male,48,19,0,7,3.2,3.7,3.9,1,1,1,1,3.6,1.9,4.2
1524,0,North America,HR,Pharmacovigilance,Exceeds,Male,38,4,0,8,3.5,4.1,1.6,1,1,1,1,3.4,4.8,2.9
1525,0,Asia Pacific,HR,Market Access,Meets,Female,49,21,0,7,1.8,3.5,3.4,1,1,1,1,2.8,3.9,1.9
1526,1,Asia Pacific,Commercial,Finance & Accounting,Meets,Male,42,13,1,9,,2.8,2.8,1,1,1,1,1.8,3.2,3.3
1527,0,Europe,Digital,Market Access,Meets,Male,41,29,0,9,3,3.7,2.7,0,0,0,0,3.4,1.3,1.1
1528,0,Europe,R&D,Pharmacovigilance,Meets,Male,45,4,0,9,3.1,4,2.9,1,1,1,1,2.7,3.2,2.5
1529,0,Europe,R&D,Marketing,Meets,Male,46,13,0,8,2.3,3.5,2.2,1,1,1,1,3.6,4.8,1.8
1530,0,Europe,HR,Human Resources,Meets,Male,43,2,0,8,3.4,2.8,2.1,1,1,1,1,3,2.5,1.6
1531,0,Middle East & Africa,HR,Pharmacovigilance,Meets,Male,37,2,0,9,3.1,2.3,3.4,1,1,1,1,4.2,2.4,1.8
1532,0,Latin America,Commercial,Legal & Compliance,Below,Male,35,14,0,11,2.1,2.8,1.8,1,1,1,1,2.1,3.2,1.6
1533,0,North America,Digital,Data Science,Below,Female,30,4,1,7,,3.3,3.6,1,1,0,0,1.7,2.9,3.1
1534,0,Asia Pacific,Commercial,Communications,Exceeds,Male,39,7,0,10,3.4,3.6,3,1,1,1,1,3.4,3.7,3.8
1535,0,Middle East & Africa,Digital,Medical Affairs,Far Below,Female,45,18,0,8,4.2,3.4,1,1,1,1,1,4.4,1.8,1.6
1536,0,North America,Finance,Finance & Accounting,Below,Male,32,17,0,9,4.6,2.5,2.6,1,1,1,1,4.1,4.1,3.4
1537,1,Middle East & Africa,R&D,Marketing,Meets,Female,32,10,0,12,3.2,3.8,2.8,1,1,1,1,5,4.3,3.1
1538,0,Middle East & Africa,Commercial,Medical Affairs,Exceeds,Non-Binary/Other,49,13,0,6,4.3,3.6,2.9,0,0,0,0,3.2,3.2,2.9
1539,0,Asia Pacific,HR,Clinical Operations,Meets,Female,36,30,0,7,4.1,3.9,1.7,1,1,1,1,4.4,2,2.8
1540,0,Latin America,Commercial,Supply Chain,Below,Female,28,12,1,10,,3.9,1.7,1,1,1,1,4.5,2.2,3.3
1541,0,Europe,Finance,Sales,Meets,Male,29,16,0,7,2.6,3.9,4.3,0,0,0,0,3.6,3.5,4.1
1542,0,Latin America,Commercial,Legal & Compliance,Meets,Male,41,12,0,6,3.8,4,1.8,1,1,1,1,3,3.9,1.9
1543,0,Asia Pacific,R&D,Communications,Meets,Female,35,5,1,7,,3,2,1,1,1,1,3.3,2.8,3.3
1544,0,Asia Pacific,Finance,Quality Assurance,Meets,Female,41,5,0,7,4,5,3.1,1,1,1,1,4,3,3.4
1545,0,Asia Pacific,HR,Pharmacovigilance,Meets,Female,37,8,1,10,,2.9,1,1,1,1,1,2.6,3.1,2.2
1546,0,North America,HR,Sales,Exceeds,Female,39,13,1,5,,4,2.2,1,1,1,1,2.4,4.8,1.6
1547,0,Latin America,Manufacturing,Quality Assurance,Meets,Male,49,28,0,9,3.8,4.7,3.1,1,1,1,0,4.2,3.8,1.7
1548,0,Latin America,Finance,Finance & Accounting,Meets,Female,37,16,0,11,4.7,3.3,2.3,1,1,1,1,4.6,2.4,2.5
1549,0,Middle East & Africa,Manufacturing,Clinical Operations,Meets,Male,45,4,0,5,3.7,3.2,1,1,1,1,0,3.5,2.8,1.3
1550,0,Middle East & Africa,Manufacturing,Clinical Operations,Exceeds,Female,39,17,1,10,,4,3.2,1,1,1,1,4.6,5,3.5
1551,0,Middle East & Africa,R&D,Supply Chain,Meets,Male,31,14,0,7,2.6,1.2,2.1,0,0,0,0,3.8,2.8,2.9
1552,0,Asia Pacific,Commercial,Communications,Below,Female,50,7,0,5,2.9,3.1,2.6,1,1,1,1,5,2.8,3.6
1553,0,Latin America,HR,Marketing,Meets,Female,51,9,0,9,3.1,3.5,2.3,1,1,1,1,4,3.3,3.4
1554,0,Asia Pacific,HR,Sales,Meets,Male,37,2,0,10,2.9,4.1,1.7,1,1,1,1,3.5,4.1,3.2
1555,0,North America,Commercial,Legal & Compliance,Meets,Female,39,24,0,11,4,2.5,2.8,1,1,1,1,3,3.7,3.1
1556,0,Middle East & Africa,HR,Communications,Exceeds,Female,45,8,0,11,2.8,3.9,2.1,1,1,1,1,2.6,3.5,1.6
1557,0,Asia Pacific,Commercial,Sales,Meets,Male,37,7,0,12,2.8,3.1,3,1,1,1,1,2.2,2.7,4.3
1558,0,Asia Pacific,Finance,Legal & Compliance,Meets,Male,44,19,0,6,2.1,5,3.6,1,1,1,1,2.9,4.4,3.7
1559,0,North America,R&D,Pharmacovigilance,Meets,Male,33,6,1,12,,4,2.8,1,1,1,1,3,3.5,3.2
1560,1,Europe,R&D,Clinical Operations,Meets,Male,49,12,0,5,4.3,5,3,1,1,1,1,5,3.1,4.1
1561,0,Latin America,R&D,Quality Assurance,Far Exceeds,Female,40,12,0,6,3.8,2.7,1.5,1,1,1,1,3.9,2.9,1.1
1562,0,Europe,Commercial,Regulatory Affairs,Meets,Male,43,8,1,12,,2.2,2.2,1,1,1,1,5,1.9,2.1
1563,0,Middle East & Africa,Commercial,Supply Chain,Below,Male,46,6,1,6,,2.5,3.3,1,1,1,1,3.7,1.9,1.7
1564,0,Asia Pacific,Digital,Marketing,Below,Female,43,13,0,11,4.3,1.8,3.5,1,1,1,1,3.8,2.2,2.6
1565,0,North America,HR,Market Access,Meets,Non-Binary/Other,38,8,0,12,4.9,2.6,1.7,0,0,0,0,4.6,3.6,1.7
1566,0,North America,HR,Regulatory Affairs,Meets,Female,48,15,0,12,3.8,3.8,2.4,1,0,0,0,4.1,2.8,1.4
1567,1,Latin America,Digital,IT & Digital,Exceeds,Female,43,12,0,12,2.3,2.5,1,1,0,0,0,1,5,2.1
1568,0,Europe,Digital,Finance & Accounting,Meets,Male,37,7,0,10,3.8,3.2,4.1,1,0,0,0,2.4,4,5
1569,0,Latin America,R&D,Data Science,Meets,Male,29,20,0,11,3.7,3,2.3,1,1,0,0,3.8,1.6,1.8
1570,0,Asia Pacific,Digital,Medical Affairs,Meets,Male,38,2,0,10,3.1,2,1,1,1,1,1,2.9,1.5,2.7
1571,0,Latin America,Commercial,Supply Chain,Exceeds,Female,35,9,0,5,2.7,5,2.7,1,1,1,1,2,4.8,2.4
1572,0,North America,Manufacturing,Quality Assurance,Meets,Male,38,3,0,10,3.9,2.8,2.6,1,1,1,1,3.9,2.4,3.3
1573,0,North America,Commercial,Finance & Accounting,Meets,Male,34,20,0,6,3.1,4,4.5,1,1,1,1,3.5,2.7,3.5
1574,0,Middle East & Africa,Digital,Human Resources,Below,Female,40,14,1,6,,3.4,4.2,1,1,1,1,3.1,2.4,2.7
1575,0,Middle East & Africa,HR,Regulatory Affairs,Meets,Female,35,12,0,10,5,1.5,3.3,1,1,1,1,4.2,1.8,3.8
1576,1,Asia Pacific,Commercial,Quality Assurance,Exceeds,Female,47,8,0,8,4.4,2.1,3,1,1,1,1,3.8,2.7,2.9
1577,0,Europe,HR,Human Resources,Meets,Female,42,11,1,9,,3.2,2.1,1,1,1,1,2.6,3.4,2.4
1578,0,Latin America,Commercial,Pharmacovigilance,Meets,Male,35,8,0,5,5,2.6,3.4,1,1,1,1,4.9,2.5,3.4
1579,0,Asia Pacific,HR,Supply Chain,Meets,Female,38,18,0,11,3.5,4.3,2.6,1,1,0,0,2.9,2.5,1.7
1580,0,Middle East & Africa,Finance,Clinical Operations,Meets,Male,41,9,0,12,4,1.2,3,1,1,1,1,3.7,2.2,2.4
1581,0,Latin America,Commercial,Marketing,Below,Non-Binary/Other,29,4,1,6,,4.1,3.2,1,1,1,1,3.4,5,3.4
1582,0,Middle East & Africa,HR,Quality Assurance,Exceeds,Male,41,2,0,9,4.4,2.7,3.3,1,1,1,1,3.7,3.3,2.6
1583,0,Latin America,Manufacturing,Sales,Meets,Female,28,32,0,5,4.1,1.3,3,1,1,0,0,2.7,2.5,1.2
1584,0,Europe,R&D,IT & Digital,Meets,Female,47,11,0,12,2.7,2.6,2.3,1,1,1,1,3.2,2.1,3.7
1585,0,Asia Pacific,Commercial,Communications,Meets,Female,36,19,0,11,3.8,3.5,3.5,1,1,1,1,3.8,3.1,2.2
1586,0,Latin America,Manufacturing,Regulatory Affairs,Far Exceeds,Female,44,14,0,8,4.2,2.7,3.5,1,1,1,1,3,3.4,2.7
1587,0,North America,R&D,Communications,Meets,Female,31,17,0,6,4.4,3.5,3.1,1,1,1,1,3.7,3.5,3.5
1588,0,North America,Commercial,Sales,Meets,Female,41,13,0,8,2.4,4.7,3.2,1,1,1,1,2.9,4.8,4.8
1589,0,Latin America,Manufacturing,Quality Assurance,Meets,Female,31,15,0,8,4,5,3.9,1,1,1,1,4.2,4.9,1.9
1590,0,Latin America,Manufacturing,Regulatory Affairs,Meets,Female,36,8,1,10,,2.4,1.8,1,1,1,1,3.5,3.4,2.4
1591,0,Latin America,Finance,Clinical Operations,Meets,Male,44,24,0,5,2.7,4.2,2.7,1,1,1,1,2.6,2.3,3.1
1592,0,North America,Manufacturing,Communications,Far Exceeds,Female,42,12,1,6,,2.9,3.6,1,1,1,1,3.3,3.8,3.9
1593,0,North America,Finance,Medical Affairs,Exceeds,Female,41,14,0,7,3.1,1.7,1.1,1,1,1,1,3.7,2.8,1
1594,0,Latin America,Digital,Medical Affairs,Meets,Female,36,10,1,7,,1.7,4.2,1,1,1,1,2.9,3.6,3.2
1595,0,Middle East & Africa,HR,Pharmacovigilance,Meets,Female,32,6,0,5,2.6,3.1,3.2,0,0,0,0,2.6,4.2,4.1
1596,0,Middle East & Africa,R&D,Data Science,Below,Male,43,6,0,9,3.1,4.1,2.9,1,1,1,1,2.8,4,4.4
1597,0,Europe,HR,Medical Affairs,Exceeds,Male,32,19,0,7,4,2.5,3.7,1,1,1,1,4.9,2.3,3.1
1598,0,Asia Pacific,HR,Data Science,Meets,Male,34,2,1,8,,3,1.7,1,1,1,1,2.9,2.8,1.4
1599,0,Middle East & Africa,Finance,Regulatory Affairs,Meets,Female,47,14,0,10,2.3,3.3,4.6,1,1,1,1,2.9,3.8,4.3
1600,0,North America,HR,Medical Affairs,Exceeds,Male,41,9,1,10,,1,2.5,1,1,1,1,3.3,2.1,2
1601,0,Middle East & Africa,Manufacturing,Legal & Compliance,Meets,Female,30,9,0,6,4.3,3.6,2.3,1,1,1,1,4.3,3.1,1
1602,0,Europe,Finance,Quality Assurance,Exceeds,Male,38,16,0,11,3.2,3.9,2.1,1,1,1,1,1.6,3,3.6
1603,0,Europe,HR,Clinical Operations,Meets,Male,37,8,1,8,,4,5,1,1,1,1,3,3.3,3.8
1604,0,Asia Pacific,Finance,Quality Assurance,Meets,Male,36,10,0,9,2.9,3.5,4.7,1,1,1,1,2.8,4.4,3.9
1605,0,Middle East & Africa,Digital,Quality Assurance,Meets,Male,36,7,1,8,,3.2,3.7,1,1,1,1,2.7,2.9,4.1
1606,0,North America,Finance,Communications,Meets,Male,46,18,1,11,,3.3,2.9,1,1,1,1,1.9,3.1,3.3
1607,0,North America,Commercial,Data Science,Far Exceeds,Female,50,22,0,10,2.8,4.1,1.2,1,1,1,1,4,2.6,3.1
1608,0,Latin America,Manufacturing,Legal & Compliance,Meets,Male,38,13,0,8,1.9,3.2,3.6,1,1,1,0,3.6,3.3,3.4
1609,0,North America,R&D,Market Access,Meets,Male,39,5,1,5,,3.9,1,1,1,1,1,2.9,4.6,1.8
1610,0,Asia Pacific,Commercial,Market Access,Meets,Female,30,17,0,8,4.9,3.1,1.6,1,1,1,1,4.7,2.3,2.2
1611,0,Asia Pacific,Commercial,IT & Digital,Far Below,Male,48,5,0,9,2.2,4.3,3.2,1,1,1,1,3.5,4.3,3.9
1612,1,North America,Commercial,IT & Digital,Meets,Female,34,8,0,10,4,2.9,2.6,1,1,1,1,3.3,3.2,3.3
1613,0,North America,HR,Marketing,Meets,Non-Binary/Other,35,14,0,11,4.5,4.4,3,1,1,1,1,4.4,3.9,4.7
1614,0,Latin America,Finance,Finance & Accounting,Exceeds,Female,43,2,1,5,,1.8,1.9,0,0,0,0,5,4.2,3
1615,0,North America,Finance,Finance & Accounting,Meets,Female,40,11,0,12,3.1,3.4,3.5,1,1,1,1,4.1,3.7,4.2
1616,0,Latin America,HR,Medical Affairs,Meets,Male,41,17,0,5,2.2,4.3,1.9,1,1,1,1,3,3.6,3.1
1617,0,Latin America,Manufacturing,Finance & Accounting,Meets,Male,42,8,0,10,2.2,3.6,1,1,1,1,1,3.1,3.7,1.5
1618,1,North America,HR,Clinical Operations,Meets,Female,38,11,0,10,3.5,3.6,4.3,1,1,1,1,4,3.1,1.7
1619,0,Europe,HR,Legal & Compliance,Exceeds,Male,43,6,0,7,5,3.7,1.2,1,1,1,1,4.3,4.5,2.9
1620,0,Europe,HR,Clinical Operations,Meets,Male,28,12,1,10,,3.2,3.2,0,0,0,0,2.6,3,3.2
1621,0,Latin America,Manufacturing,Sales,Meets,Female,48,36,0,10,3.8,2.8,3,1,1,1,1,4.7,3.2,3.4
1622,0,North America,Manufacturing,IT & Digital,Meets,Male,37,11,0,12,2.5,3.6,2.2,1,1,1,1,3.3,3.8,2.4
1623,0,Europe,Digital,Quality Assurance,Far Below,Female,43,15,0,7,2.8,3.7,1.6,0,0,0,0,3.5,2.5,2
1624,0,North America,Digital,Clinical Operations,Meets,Female,41,10,0,7,2.4,2.4,3.5,1,1,1,1,2.4,2.7,1.3
1625,0,North America,Digital,Regulatory Affairs,Meets,Male,28,21,0,6,2.7,3.8,3.8,0,0,0,0,3.4,3.2,3
1626,0,North America,Digital,Supply Chain,Meets,Male,39,18,1,11,,3,3,1,1,1,1,4.3,4.3,2.8
1627,0,Middle East & Africa,Finance,Quality Assurance,Below,Male,28,22,0,7,1.9,2.3,3.3,1,1,1,1,1.8,2.6,2.5
1628,0,North America,Commercial,IT & Digital,Meets,Female,41,4,0,5,3.2,4.2,3,1,1,1,1,3.7,4.3,2.8
1629,0,Middle East & Africa,Commercial,Legal & Compliance,Meets,Male,39,12,0,5,1.5,3.5,2.1,1,1,1,1,2.1,3.9,2.9
1630,0,Latin America,Digital,Data Science,Far Below,Female,30,6,0,7,2.9,4.1,2.8,1,1,1,1,2.6,3,3.3
1631,0,Europe,Digital,Human Resources,Far Below,Female,39,28,0,11,2.2,2.6,2.2,1,1,1,1,2.9,2.7,2.6
1632,0,Europe,R&D,IT & Digital,Meets,Female,35,17,1,5,,4.5,3.7,1,1,1,1,3.1,3.4,2.2
1633,0,Europe,Commercial,Finance & Accounting,Meets,Male,37,11,0,8,3.5,3.1,3.2,1,1,1,1,3.1,3.1,2.2
1634,0,Europe,R&D,Quality Assurance,Below,Female,28,17,1,6,,3.8,4.4,0,0,0,0,3,4.2,4.4
1635,0,Europe,R&D,Clinical Operations,Below,Male,31,7,0,6,2.1,2.4,3.9,1,1,1,1,3.3,3.2,3.3
1636,0,Europe,HR,Pharmacovigilance,Exceeds,Male,33,9,1,6,,3.7,2.5,1,1,1,0,4.4,4.6,1.3
1637,0,Europe,Finance,IT & Digital,Meets,Male,31,15,0,11,3.1,3.7,2.4,1,1,1,1,4,2,3.5
1638,0,Latin America,Manufacturing,Regulatory Affairs,Meets,Female,35,15,1,8,,2.9,1,1,1,1,1,5,2.9,2.2
1639,0,North America,Commercial,Legal & Compliance,Exceeds,Non-Binary/Other,34,16,0,7,3.1,2.2,1.6,0,0,0,0,4.1,2.7,3.5
1640,0,Asia Pacific,Digital,Finance & Accounting,Far Below,Male,40,6,1,11,,3.7,3.4,1,1,1,0,2.9,4,5
1641,0,Middle East & Africa,Digital,Regulatory Affairs,Meets,Female,28,22,0,5,3.3,4.2,2.4,1,1,1,1,1.8,3.5,2.6
1642,0,Asia Pacific,Manufacturing,Medical Affairs,Exceeds,Male,50,5,1,5,,2,1.6,1,1,1,1,3.4,4.4,1.8
1643,0,Asia Pacific,Commercial,IT & Digital,Meets,Female,34,13,0,6,1,3.2,2.5,1,1,1,1,1.8,3.2,3.6
1644,1,North America,Digital,Market Access,Far Exceeds,Male,36,5,0,8,2.5,3.7,1.7,1,1,1,1,3.1,3.2,2.7
1645,0,North America,Digital,Data Science,Exceeds,Female,42,7,1,10,,2.2,2.7,0,0,0,0,2.2,3,2.5
1646,0,North America,HR,Medical Affairs,Below,Female,48,16,0,5,4.3,4.6,1.2,1,1,1,1,2.4,4.5,2.6
1647,1,Europe,R&D,Marketing,Far Exceeds,Female,34,8,0,5,4.4,4.1,1.9,1,1,1,1,4.6,3.7,2.3
1648,0,Latin America,Digital,Supply Chain,Exceeds,Male,42,14,1,7,,3.8,3.8,1,1,1,1,3.9,4.1,3.7
1649,0,Europe,Finance,Sales,Meets,Female,34,21,0,12,3.2,3.5,3.8,1,0,0,0,3.5,4,4.1
1650,0,Latin America,Commercial,Regulatory Affairs,Far Exceeds,Male,44,10,0,10,2.4,2.5,3.2,1,1,1,1,4,1.5,2.6
1651,0,Latin America,Finance,Data Science,Far Below,Male,42,18,0,9,3.3,2.9,2.6,1,1,1,1,1.6,3.9,1.6
1652,0,Asia Pacific,Manufacturing,Market Access,Meets,Male,32,14,0,7,2.5,1.7,1,1,1,1,1,4,2.1,1.4
1653,0,Asia Pacific,HR,Human Resources,Meets,Female,41,13,0,9,2.6,2.5,1.3,0,0,0,0,3.5,1.9,1.4
1654,0,Latin America,Commercial,Data Science,Below,Female,29,4,0,12,2.6,3.5,3.3,1,1,1,1,2.6,3,2.8
1655,0,Latin America,HR,Legal & Compliance,Meets,Male,34,3,1,10,,3.3,3.2,1,1,1,1,3.6,3.6,1.9
1656,0,Europe,R&D,Sales,Meets,Female,30,16,0,11,3,2.6,3.7,1,1,1,1,3.5,2,3.5
1657,0,Europe,Digital,IT & Digital,Meets,Female,38,5,0,10,1.1,3.3,1.6,1,1,1,1,2.7,2.1,3.8
1658,0,Asia Pacific,Commercial,Human Resources,Meets,Female,44,24,1,10,,3.7,2.4,1,1,1,1,2.4,4,3.1
1659,0,North America,Manufacturing,IT & Digital,Meets,Female,31,8,0,5,3.2,2.3,2.8,1,1,1,1,3.3,1.7,2.8
1660,0,Latin America,R&D,Sales,Below,Female,40,13,0,5,3.4,4.6,2.2,1,1,1,1,3,4.2,3.7
1661,0,Europe,R&D,Medical Affairs,Meets,Male,37,7,0,12,2,3.1,3.6,1,1,1,1,2.7,2.8,3.3
1662,0,Asia Pacific,HR,Quality Assurance,Exceeds,Male,32,5,0,7,3.8,3.3,1.9,1,1,1,1,3,4.7,3.2
1663,0,Europe,R&D,Marketing,Meets,Female,35,7,0,10,4.1,2.9,3.1,1,1,1,1,3.9,2.5,2.9
1664,0,Latin America,Commercial,Marketing,Meets,Female,41,30,0,12,3.6,3.3,3.4,0,0,0,0,3.1,4.7,4.4
1665,0,Latin America,HR,Clinical Operations,Meets,Male,44,29,0,8,3.3,1.3,2.7,1,1,1,1,3.7,1.3,3.2
1666,0,Middle East & Africa,R&D,Marketing,Meets,Female,40,5,1,7,,2.8,2.2,1,1,1,1,2.5,2.9,2.9
1667,0,North America,Manufacturing,Data Science,Meets,Female,38,25,0,8,3.6,2.3,2.6,1,1,1,1,2.8,2.9,4
1668,0,Middle East & Africa,Finance,Finance & Accounting,Far Exceeds,Male,38,10,0,7,2.5,3.4,3.9,1,1,1,1,3.6,3.7,3
1669,0,Asia Pacific,Commercial,Marketing,Meets,Female,34,9,0,9,4.1,3,3,0,0,0,0,4.4,2,2.2
1670,0,Europe,Manufacturing,Market Access,Meets,Male,39,5,0,10,4.2,2.2,1.7,1,1,1,1,5,3.1,2.6
1671,0,Asia Pacific,Manufacturing,Finance & Accounting,Meets,Female,29,36,0,8,1.8,2.5,1.5,1,1,1,1,2.1,3.3,2.3
1672,0,Latin America,HR,Human Resources,Meets,Female,37,8,0,9,2,2.7,3.7,1,1,1,1,1,4.1,4
1673,0,Middle East & Africa,Digital,Finance & Accounting,Meets,Non-Binary/Other,48,9,0,6,3.5,3.4,3.3,1,1,1,1,2.9,3.2,2.3
1674,0,Middle East & Africa,HR,Marketing,Meets,Female,35,8,1,7,,3.7,1.9,1,1,1,1,3.2,3.6,4.1
1675,0,Middle East & Africa,Commercial,Regulatory Affairs,Meets,Male,45,13,0,12,4.1,2,2.6,1,1,1,1,4.6,2.6,4.3
1676,0,Asia Pacific,Commercial,Clinical Operations,Meets,Male,42,7,0,5,4.1,4.1,2.2,1,1,0,0,4.1,3.6,2.8
1677,0,Latin America,HR,Human Resources,Meets,Female,47,22,0,5,3.7,3.5,4.3,1,1,1,1,4,3.3,4.6
1678,1,Europe,Digital,Communications,Exceeds,Female,28,20,0,6,3.2,2.8,2.5,0,0,0,0,2.2,2.7,2.6
1679,0,Europe,HR,Data Science,Meets,Female,39,14,0,6,2.5,2.7,3.1,1,1,1,1,3.5,3.9,3.2
1680,0,Asia Pacific,Commercial,Sales,Far Exceeds,Male,42,13,0,6,4.1,3.4,4.5,1,0,0,0,4.3,3.2,4
1681,0,Middle East & Africa,Digital,Communications,Below,Female,43,11,0,5,3.9,3.9,2.4,0,0,0,0,3.3,4.2,2.7
1682,0,North America,Commercial,Communications,Meets,Male,45,9,0,7,4.1,4.7,1.9,1,1,1,1,3,4.8,2
1683,0,Asia Pacific,Digital,Medical Affairs,Meets,Male,42,6,0,5,2.2,3.3,2,1,1,1,1,2.3,2.8,1.9
1684,0,Asia Pacific,Digital,Supply Chain,Meets,Male,39,16,0,8,4.3,4.4,1.9,1,1,1,1,3.8,3.9,1.6
1685,0,Latin America,HR,Medical Affairs,Meets,Female,32,17,0,7,4.2,4.2,3.3,1,1,1,1,4.4,3.8,3.5
1686,0,Europe,HR,Quality Assurance,Below,Female,28,28,0,11,2.5,4,2.4,1,0,0,0,3.1,3.9,2.5
1687,0,Asia Pacific,HR,Supply Chain,Meets,Non-Binary/Other,46,12,0,11,3.5,3.3,2.2,1,1,1,1,3.8,2.1,2.6
1688,0,Asia Pacific,Digital,Market Access,Meets,Female,34,8,1,9,,3.3,3,1,1,1,1,2.4,2.4,4.2
1689,0,Middle East & Africa,Digital,Pharmacovigilance,Meets,Male,36,13,0,11,4.1,3.9,2.9,1,1,1,1,4.9,3.3,2.4
1690,0,Middle East & Africa,Commercial,Clinical Operations,Meets,Female,43,10,0,10,3.2,2.8,3.9,1,1,1,1,3,2.8,2.7
1691,1,North America,Manufacturing,Communications,Meets,Male,38,12,0,12,3.1,4.7,2.6,1,1,1,1,3.5,3.3,1.9
1692,0,Latin America,HR,Sales,Meets,Female,31,5,0,10,3.3,3.9,2.4,1,1,1,1,3,2.6,2.9
1693,0,North America,Finance,Finance & Accounting,Meets,Male,28,12,1,8,,1.8,3.5,1,1,1,1,3.1,1.6,2.6
1694,0,Middle East & Africa,Commercial,Medical Affairs,Below,Female,36,3,0,10,3.3,2.5,5,1,1,1,1,4.2,2.7,3
1695,0,Europe,Commercial,Marketing,Meets,Female,39,24,0,6,3.8,3.8,2.9,1,1,1,1,3.4,4.6,2.5
1696,0,Middle East & Africa,R&D,Clinical Operations,Below,Male,43,8,0,8,3.8,4.5,2.5,1,1,1,1,3.5,5,2.7
1697,0,Latin America,HR,Marketing,Meets,Male,37,15,0,6,3.1,4.5,4.2,1,1,1,1,4,3.1,3.4
1698,0,Middle East & Africa,Commercial,Clinical Operations,Exceeds,Male,38,17,0,8,3.9,3.2,1.9,1,1,1,1,3.9,4.4,4
1699,0,Latin America,R&D,Legal & Compliance,Below,Non-Binary/Other,30,6,0,5,3.4,3.3,2.7,1,1,1,1,1.8,2.9,2.7
1700,0,Latin America,Finance,Legal & Compliance,Below,Male,44,3,0,6,3.3,3.4,1.8,1,1,1,1,2.9,3.3,1
1701,0,Latin America,Finance,Clinical Operations,Below,Female,55,26,0,5,5,4.3,2.7,1,1,1,1,4.9,5,3
1702,0,Latin America,HR,Quality Assurance,Exceeds,Male,46,7,0,10,3.5,2.2,3.5,1,1,1,1,4,2.7,3.3
1703,0,Latin America,Digital,Regulatory Affairs,Below,Male,45,11,0,5,3.2,3.9,1.6,1,1,1,1,3.6,2.8,3.1
1704,0,Europe,R&D,Market Access,Far Exceeds,Female,40,7,0,8,3.4,4.8,4.2,0,0,0,0,3.1,4,3.8
1705,0,North America,Digital,Finance & Accounting,Meets,Female,32,8,0,9,3.3,3.9,2.7,1,1,1,1,3.8,3.4,3
1706,0,Asia Pacific,Finance,Legal & Compliance,Meets,Female,33,8,0,7,3.1,2.8,1.8,1,1,1,1,2.5,2.1,1
1707,0,North America,Finance,Marketing,Below,Female,42,15,0,11,3.9,3.4,2.4,1,1,1,1,2.9,3.5,2.8
1708,0,Latin America,Manufacturing,Legal & Compliance,Meets,Female,43,9,0,11,3.4,4.1,2.2,1,1,1,1,2.7,3.8,2.1
1709,0,Europe,Manufacturing,Marketing,Meets,Male,32,3,1,11,,2.5,2.4,1,1,1,1,1.7,3.9,2.1
1710,0,Middle East & Africa,Manufacturing,Marketing,Meets,Male,41,18,0,8,3.2,2.5,1,1,0,0,0,3.9,3.4,2.2
1711,0,Europe,Manufacturing,Quality Assurance,Meets,Male,39,8,0,12,4.7,1,1,1,1,1,1,3.7,2.6,1.5
1712,0,Latin America,Commercial,Medical Affairs,Meets,Male,41,10,0,5,3.3,4.5,1.8,1,1,1,1,3.4,2.6,3
1713,0,Europe,Manufacturing,Data Science,Meets,Non-Binary/Other,40,35,0,7,3.3,3.8,2.3,1,0,0,0,2.8,2.8,2.3
1714,0,Europe,Commercial,Marketing,Meets,Female,40,11,0,12,2.9,3.8,4.5,1,1,1,1,4.1,3.3,4.5
1715,0,Latin America,Commercial,Medical Affairs,Meets,Male,28,11,0,9,3.6,2.7,2.4,1,1,1,1,3.1,3.3,3.7
1716,0,Europe,HR,Regulatory Affairs,Meets,Female,49,23,0,7,5,1.8,2.4,1,1,1,1,2.6,3.4,2.8
1717,0,Asia Pacific,Commercial,Marketing,Meets,Female,46,6,0,11,3.3,2.4,1.5,0,0,0,0,2.4,2.6,2.1
1718,0,Asia Pacific,Commercial,Market Access,Meets,Male,38,31,0,11,4,2.2,2.9,1,1,1,1,3.5,3.6,4.8
1719,0,Europe,Manufacturing,Sales,Meets,Female,31,3,0,5,3.1,4.4,2,1,1,1,1,3.7,4,3.1
1720,0,Middle East & Africa,Commercial,Human Resources,Far Below,Male,41,18,0,12,1.2,1.1,4.1,1,1,1,1,3.9,2.7,5
1721,0,Latin America,Digital,Pharmacovigilance,Meets,Female,29,18,0,10,4.7,3.2,2.4,0,0,0,0,5,2.2,2.4
1722,0,Asia Pacific,Manufacturing,Human Resources,Meets,Male,48,9,0,8,3.7,3.1,2.4,1,1,1,0,4,3.6,3.3
1723,0,Middle East & Africa,R&D,Marketing,Below,Female,37,7,1,5,,4.2,3.2,1,1,1,0,3.2,4.2,3.4
1724,0,Europe,Manufacturing,Legal & Compliance,Exceeds,Male,34,10,0,9,3.4,2,2.6,1,1,1,1,3.5,3.3,3.6
1725,0,Middle East & Africa,Commercial,Data Science,Meets,Non-Binary/Other,42,5,0,12,3.1,1.4,1,1,1,1,1,3,2,1.3
1726,0,North America,Digital,Human Resources,Meets,Male,35,6,1,8,,5,2.7,0,0,0,0,1.9,3.8,4.4
1727,0,Asia Pacific,Manufacturing,Sales,Exceeds,Male,36,6,0,10,3.9,3.5,3.2,1,1,1,1,4.4,3.4,3.1
1728,0,Europe,Digital,Communications,Below,Female,33,7,1,7,,2,2.7,1,1,1,1,3.2,2,2.7
1729,0,Latin America,R&D,Market Access,Exceeds,Female,42,8,0,9,2.9,3.7,3.1,1,1,0,0,3,3.3,2.7
1730,1,Europe,Finance,Quality Assurance,Meets,Female,40,18,0,9,2.7,1.6,3.5,1,1,1,1,3.3,3.7,3.9
1731,0,Latin America,R&D,Pharmacovigilance,Meets,Female,44,8,0,7,3.3,3.2,2.9,1,1,1,1,3.9,3.5,2.4
1732,0,Europe,Finance,Quality Assurance,Meets,Female,28,21,1,12,,4.8,4.3,0,0,0,0,3.5,3.9,3.4
1733,0,Middle East & Africa,HR,Communications,Exceeds,Male,31,12,0,9,3.6,2,3.6,1,1,1,1,2.7,4.3,2.2
1734,0,Middle East & Africa,Finance,Data Science,Meets,Male,35,10,0,7,3.5,3.5,1.8,1,1,1,1,4.4,2.8,2.4
1735,0,Middle East & Africa,HR,Pharmacovigilance,Meets,Male,45,3,1,5,,2.8,3.4,0,0,0,0,2.4,4,2.8
1736,0,North America,Manufacturing,Data Science,Meets,Female,29,11,0,8,2.4,2.1,2.5,1,1,1,1,3,2.2,2.3
1737,1,Latin America,HR,Quality Assurance,Meets,Male,33,6,1,6,,2.1,2.1,1,1,1,1,5,2.8,2.4
1738,0,Middle East & Africa,Digital,Market Access,Meets,Male,47,9,1,11,,2.9,3.5,1,1,1,1,2.9,3.8,3.6
1739,0,North America,HR,Pharmacovigilance,Below,Female,41,17,1,5,,3.8,2.6,1,1,1,1,2.4,2.8,2.8
1740,0,Latin America,Digital,Supply Chain,Meets,Male,44,8,1,11,,2.9,2.1,1,1,1,1,4.6,1,3.3
1741,0,Europe,Finance,Medical Affairs,Meets,Male,37,14,0,6,3.1,2.1,3.1,1,1,1,1,3.2,3.2,3.9
1742,0,North America,Finance,Market Access,Exceeds,Female,49,12,0,6,2.5,3,4,1,1,1,1,1,3.5,4.5
1743,0,Asia Pacific,Finance,Communications,Meets,Male,29,16,0,12,3.8,1.1,1.9,1,1,1,1,3.9,1,2.3
1744,0,North America,HR,Pharmacovigilance,Meets,Female,37,5,1,9,,1.6,4.7,1,1,1,1,3.6,2,4.6
1745,0,North America,Finance,Data Science,Below,Male,36,17,0,6,2.5,4.1,2,1,1,1,1,2.4,4.5,3.3
1746,0,Latin America,HR,Communications,Below,Male,36,9,0,12,2.5,2.1,2.5,1,1,1,1,4,1.3,3.4
1747,0,Europe,HR,Data Science,Meets,Female,30,36,0,7,3.6,4.1,3.3,1,1,1,1,2.9,3.6,3.9
1748,0,Asia Pacific,Commercial,Regulatory Affairs,Meets,Male,41,6,1,6,,5,2.2,1,1,1,1,4.3,2.7,3.1
1749,0,Middle East & Africa,Commercial,Market Access,Meets,Male,31,5,0,12,3.9,3.3,3.9,1,1,1,1,4.8,4.6,3.1
1750,0,Middle East & Africa,HR,Communications,Meets,Female,30,13,0,10,2.9,3.3,2.2,1,1,1,1,3.6,3,2.1
1751,0,North America,Digital,Data Science,Meets,Male,28,4,0,7,4.5,3.8,2.9,1,1,1,1,4.8,2,3.6
1752,0,Latin America,Manufacturing,Clinical Operations,Meets,Male,34,11,1,7,,3.2,3.4,1,1,0,0,5,4,4.2
1753,0,Latin America,R&D,Communications,Below,Male,39,19,0,9,4.3,4.2,2.8,1,1,1,1,3.8,5,2.5
1754,0,Middle East & Africa,Commercial,Medical Affairs,Meets,Female,40,14,0,9,4.4,3.6,2.6,1,1,1,1,3.6,5,2
1755,0,Asia Pacific,HR,Quality Assurance,Below,Male,37,4,0,11,3.9,3.3,1.8,1,1,1,1,2.3,1.9,3.4
1756,0,Europe,R&D,Sales,Meets,Female,34,15,0,9,2.7,2.9,2.1,1,1,1,1,3,1,3.1
1757,0,Asia Pacific,Commercial,Regulatory Affairs,Meets,Male,36,11,1,11,,5,1.2,1,1,1,1,3.8,2.2,2.9
1758,0,Europe,Manufacturing,Data Science,Meets,Male,34,11,0,9,5,1.7,1,1,1,1,1,3.9,2.5,2.5
1759,0,Middle East & Africa,Digital,Clinical Operations,Meets,Female,50,7,0,5,4.3,4.9,4.2,1,1,1,0,4.6,4.5,3.9
1760,0,Europe,HR,Regulatory Affairs,Meets,Male,31,6,1,11,,3.5,2.5,1,1,1,1,2.9,1.7,3.4
1761,0,Latin America,Manufacturing,Clinical Operations,Exceeds,Male,33,2,1,10,,2.6,2.5,1,1,1,0,2.7,4,2
1762,0,North America,Commercial,Regulatory Affairs,Meets,Female,38,11,1,11,,2.3,4.4,1,1,1,1,3,2.3,2
1763,0,North America,HR,Data Science,Far Below,Non-Binary/Other,31,5,1,12,,2.9,1.9,0,0,0,0,2.6,2.8,2.5
1764,0,Middle East & Africa,R&D,Clinical Operations,Far Exceeds,Male,38,27,0,10,3.5,4.1,1.9,1,1,1,1,3.8,3.9,2.5
1765,0,Latin America,Finance,Human Resources,Below,Male,28,13,0,6,3.3,3.8,2.9,1,1,1,1,2.4,4.5,3.4
1766,0,Asia Pacific,Digital,Pharmacovigilance,Meets,Male,39,9,1,5,,3,2.1,1,1,1,1,3.5,3.3,2.8
1767,0,Latin America,Commercial,Market Access,Meets,Female,35,17,0,9,4.1,2.2,1.1,1,0,0,0,5,3.4,1
1768,0,North America,Digital,Sales,Meets,Female,34,8,1,11,,1.6,2.1,1,1,1,1,2.6,1,3.3
1769,0,North America,HR,Quality Assurance,Meets,Female,36,9,0,6,3.9,3,1,1,1,1,1,3,3.7,1
1770,0,Latin America,Finance,Sales,Below,Male,35,7,0,7,3.2,3.2,3.9,1,1,1,1,3,2.7,3.7
1771,0,Latin America,Manufacturing,Quality Assurance,Exceeds,Male,36,12,1,6,,4.4,2.5,0,0,0,0,3.6,3.8,2.1
1772,0,North America,Digital,Supply Chain,Meets,Male,43,23,0,7,3.2,1.3,1,1,1,1,1,4,1.3,1.1
1773,0,Asia Pacific,R&D,IT & Digital,Meets,Male,49,15,1,11,,4,2.9,1,1,1,1,3.7,2.9,1
1774,0,Middle East & Africa,Commercial,Medical Affairs,Meets,Female,28,4,0,11,4.6,3.8,3.8,1,1,1,1,4.3,1.6,3.3
1775,0,Middle East & Africa,R&D,Communications,Far Below,Male,37,13,0,10,1.5,2.5,3.5,1,1,1,1,3.6,2.4,3.8
1776,0,Latin America,Digital,Supply Chain,Meets,Female,30,36,0,12,4.5,1.6,3.7,1,1,1,1,5,3.5,3.5
1777,0,Middle East & Africa,Finance,Marketing,Exceeds,Female,36,6,0,10,1.6,3.3,2.2,1,1,0,0,2.7,3.5,2
1778,0,North America,Manufacturing,Data Science,Meets,Male,40,9,0,9,4.2,4.6,3.3,1,1,1,1,4.1,3.3,1.8
1779,0,North America,Manufacturing,Pharmacovigilance,Meets,Female,52,9,0,12,3.2,1.1,2.5,1,1,1,1,3.3,2.4,3.2
1780,0,Latin America,R&D,IT & Digital,Meets,Male,36,11,0,5,3.8,5,3.6,1,1,1,1,5,3.7,2.1
1781,0,Latin America,HR,Market Access,Exceeds,Male,39,25,0,8,3.2,4.9,2.3,1,1,1,1,3.1,3.6,1
1782,0,Latin America,HR,Communications,Below,Male,33,17,0,8,3.2,3.3,3.3,1,1,1,1,1.5,4.6,4.6
1783,0,Asia Pacific,Finance,Finance & Accounting,Meets,Male,32,13,0,8,3.4,1.9,2.4,1,1,1,1,3.4,1.9,2.7
1784,0,Middle East & Africa,Manufacturing,Pharmacovigilance,Meets,Male,32,3,1,11,,3.9,2.7,1,1,1,1,3.9,3.4,3.6
1785,0,Latin America,R&D,Legal & Compliance,Exceeds,Female,34,25,0,12,2.7,1.3,2.5,1,1,1,1,3.3,1.5,1.8
1786,1,Europe,R&D,Sales,Meets,Female,35,4,1,7,,2,2.6,1,1,1,1,2.7,2.6,2.6
1787,0,Europe,R&D,Quality Assurance,Exceeds,Male,47,4,1,5,,3.8,2.1,1,1,1,1,1,2.5,3.7
1788,0,North America,Digital,Supply Chain,Exceeds,Female,36,13,1,9,,3.3,3.5,1,1,1,1,3.4,3.4,2.9
1789,0,Middle East & Africa,Finance,Pharmacovigilance,Meets,Female,41,9,0,6,5,2.2,2.5,0,0,0,0,4.1,2.7,5
1790,0,Latin America,HR,Supply Chain,Far Below,Female,40,22,0,5,1.9,3.8,2.1,1,1,1,1,1.9,3.7,2.6
1791,0,Europe,HR,Medical Affairs,Meets,Male,44,7,0,12,4.7,3.5,3.5,1,1,1,1,3.6,4.1,3.8
1792,0,Middle East & Africa,Digital,Medical Affairs,Meets,Male,28,3,1,9,,2.6,2.3,1,1,1,1,2.3,4.7,2.7
1793,0,North America,Commercial,Human Resources,Meets,Female,40,6,0,5,3.3,2.8,3.1,0,0,0,0,3,2.5,2.3
1794,0,Asia Pacific,Digital,Quality Assurance,Meets,Female,39,15,1,6,,2.9,1.6,1,1,1,1,3,3.8,1.5
1795,0,Middle East & Africa,Finance,Marketing,Meets,Male,37,17,0,8,3.1,1,3.7,1,1,1,0,2.8,1.4,2.3
1796,0,Middle East & Africa,R&D,Pharmacovigilance,Meets,Female,44,17,0,6,2.7,3.9,1.7,1,1,1,1,3.8,5,1.5
1797,0,Asia Pacific,Digital,Legal & Compliance,Meets,Male,37,7,0,7,2,3.7,3.1,1,1,1,1,4.3,3.3,2.8
1798,0,Middle East & Africa,R&D,Market Access,Meets,Female,43,16,0,7,3.3,2.7,3.4,1,0,0,0,3.3,3.3,4.2
1799,0,North America,Finance,Legal & Compliance,Meets,Male,39,3,0,11,3.1,3.2,2.8,1,1,1,1,2.2,1.6,1.5
1800,0,North America,Finance,Supply Chain,Meets,Female,39,4,0,9,3,2.8,1.8,1,1,1,1,3.1,3.1,2.9
1801,0,Asia Pacific,Manufacturing,Supply Chain,Meets,Female,40,23,0,11,4.1,4.2,1.5,0,0,0,0,3.1,3.4,1.8
1802,0,Latin America,R&D,Medical Affairs,Exceeds,Male,37,22,0,11,3,2.4,2.6,1,1,1,1,3.7,1.2,4
1803,0,Europe,HR,Data Science,Meets,Male,47,6,0,11,4,3.7,3.4,1,1,1,1,3.6,3.1,3.5
1804,0,Latin America,Digital,Quality Assurance,Meets,Female,44,6,1,6,,2.7,2.2,1,1,1,1,2.8,2.7,1
1805,0,Middle East & Africa,Finance,Supply Chain,Meets,Female,38,7,0,12,4.1,3.7,1.2,1,1,1,1,2.8,2.3,2.6
1806,0,Europe,R&D,Medical Affairs,Below,Female,39,17,0,10,4.4,2.7,3.9,1,1,1,1,4.1,3.2,3.1
1807,0,Asia Pacific,Commercial,Finance & Accounting,Below,Female,41,6,1,5,,2.9,2.1,1,1,1,1,3.2,2.7,2.4
1808,1,Asia Pacific,Manufacturing,Medical Affairs,Meets,Female,43,21,0,12,3.3,2,2,1,1,1,1,3.4,1.4,4.3
1809,0,Europe,Commercial,Clinical Operations,Below,Male,48,36,0,11,4,3.5,2.5,1,1,1,1,3.9,3.6,2.6
1810,0,North America,Finance,Human Resources,Meets,Female,43,5,0,8,3.8,2.7,3.6,1,1,1,1,4.1,4.6,1.7
1811,0,Europe,Commercial,Supply Chain,Meets,Male,37,9,1,9,,3.8,2.9,1,1,1,1,2.9,5,3.4
1812,0,Middle East & Africa,Commercial,Clinical Operations,Meets,Male,33,10,0,11,3.4,4.4,2.7,1,1,1,1,4.7,4.2,2.4
1813,0,North America,Manufacturing,Market Access,Meets,Female,44,22,0,9,5,3.2,3.6,1,1,1,1,3.6,2.6,3.4
1814,0,Asia Pacific,Manufacturing,Market Access,Below,Non-Binary/Other,40,11,0,8,2.8,1.8,2.7,1,1,1,1,3.1,1.1,2.6
1815,0,Europe,Manufacturing,Medical Affairs,Meets,Male,32,14,0,8,3.8,2.4,2.6,1,1,1,1,3.8,3.1,3.3
1816,0,Latin America,Manufacturing,Human Resources,Meets,Male,43,8,0,6,3.7,4.1,3.4,1,1,1,1,2.3,3.5,1.9
1817,0,Latin America,Commercial,Legal & Compliance,Exceeds,Female,47,7,0,10,3.4,3.5,2.6,1,1,1,1,3.1,5,2.7
1818,0,Middle East & Africa,HR,Data Science,Exceeds,Male,38,13,0,12,4.3,2.3,2,1,1,1,1,4.6,2.8,3.1
1819,0,Latin America,HR,Human Resources,Meets,Non-Binary/Other,47,10,0,8,4.7,4.5,3.5,1,1,1,1,4.1,3.8,3.5
1820,0,Europe,Manufacturing,Data Science,Meets,Female,43,5,0,6,4.6,4.1,3.8,1,0,0,0,4.1,5,4.3
1821,0,Europe,Digital,IT & Digital,Below,Female,31,12,0,6,4,4,3,0,0,0,0,2.7,3.5,1.4
1822,0,Latin America,R&D,Clinical Operations,Below,Male,41,9,1,5,,2.8,3.3,1,1,1,1,3.8,3.6,3.6
1823,0,Europe,Finance,Medical Affairs,Exceeds,Male,28,13,0,10,2.4,5,3.2,1,1,1,1,2.1,3.6,3.7
1824,0,Middle East & Africa,Digital,Legal & Compliance,Meets,Female,40,14,0,9,1.9,3.1,1,1,1,1,1,2.2,3.5,2.5
1825,0,North America,Finance,Clinical Operations,Meets,Male,32,13,0,10,1.1,3.7,2.5,1,1,1,1,1.8,2.9,3.4
1826,0,Middle East & Africa,Digital,Legal & Compliance,Exceeds,Female,39,32,0,10,2.9,3.3,2.6,1,1,1,1,4.5,5,3.4
1827,0,Middle East & Africa,Digital,Finance & Accounting,Meets,Male,42,8,1,11,,1.1,2.4,1,1,1,1,3.9,1.5,2.7
1828,0,Europe,HR,Finance & Accounting,Below,Male,34,11,1,8,,2.6,3.8,1,1,0,0,3.7,3.3,4.6
1829,0,North America,R&D,Quality Assurance,Meets,Female,48,16,0,11,2.6,3.5,2.3,1,1,1,1,2.8,3.7,3
1830,0,Europe,Digital,Communications,Far Below,Female,32,12,1,8,,4.1,2.9,1,1,1,1,4.6,4.2,1.9
1831,0,Asia Pacific,Manufacturing,Communications,Meets,Male,28,22,0,6,2.6,1.2,1.6,0,0,0,0,2.1,1,1.7
1832,0,Europe,Finance,Clinical Operations,Meets,Female,38,11,0,11,2.6,2.8,3.5,1,1,1,1,2.3,3.7,4.5
1833,0,Europe,HR,IT & Digital,Exceeds,Female,46,22,0,11,2.8,4.2,1.9,1,1,1,1,3.4,4.2,1.6
1834,0,Europe,Finance,Legal & Compliance,Meets,Female,38,17,0,11,4,2.1,4.2,1,1,1,1,3.3,1.5,2.7
1835,0,North America,Manufacturing,Marketing,Below,Male,34,10,0,9,2.2,3.2,4.2,1,1,1,1,3.4,1.6,4
1836,0,Europe,Manufacturing,Supply Chain,Below,Male,28,6,1,7,,3,2.9,1,1,1,1,1.9,2,2.5
1837,0,North America,Digital,Communications,Meets,Female,35,10,0,5,2.3,3,3.3,1,1,1,1,2.4,3.6,2.5
1838,0,Latin America,Manufacturing,Market Access,Exceeds,Male,31,7,0,6,3.7,2.1,2.4,1,1,1,1,4.8,4.4,3.1
1839,0,Asia Pacific,R&D,Legal & Compliance,Meets,Male,39,6,1,12,,3.7,2.4,1,1,1,1,5,4.1,1.7
1840,0,North America,Manufacturing,IT & Digital,Exceeds,Male,40,9,0,6,2.8,2.6,1.4,1,1,1,0,3.1,3.1,3.6
1841,0,Latin America,Digital,Regulatory Affairs,Meets,Male,32,11,1,6,,2.8,1.2,1,1,1,1,3,2.5,1.7
1842,0,North America,Finance,Medical Affairs,Meets,Female,36,8,0,11,1.5,4.4,1.7,1,1,1,1,3,3.7,1.8
1843,0,North America,Manufacturing,Human Resources,Exceeds,Male,47,15,0,7,3.6,2.7,3.9,1,1,1,1,3.7,3.9,3.1
1844,0,Asia Pacific,HR,Legal & Compliance,Far Below,Male,35,11,0,10,3.2,3.9,2.4,1,1,1,1,2.6,4.6,3
1845,0,Middle East & Africa,HR,Data Science,Meets,Female,35,14,0,7,2.4,2.1,3.7,1,1,1,1,3.3,3.7,3.8
1846,0,Middle East & Africa,HR,Finance & Accounting,Far Below,Female,39,9,0,11,4.6,4.4,2.7,1,1,1,1,3.7,3.6,2.1
1847,0,North America,Finance,Finance & Accounting,Exceeds,Male,30,3,0,7,3.4,2.4,2.7,1,1,1,1,3.8,4.2,2.5
1848,0,Europe,Commercial,Pharmacovigilance,Exceeds,Female,44,20,0,8,3.2,2.4,2.4,0,0,0,0,4.2,2.4,1.3
1849,0,Latin America,HR,Legal & Compliance,Exceeds,Male,36,20,1,11,,2.9,3,1,1,1,1,3.5,3.3,2.8
1850,0,Europe,HR,Supply Chain,Below,Male,31,9,1,10,,3,2.7,0,0,0,0,2,4.2,3.5
1851,0,Europe,Commercial,Regulatory Affairs,Below,Female,41,8,0,7,2.6,5,2.5,1,1,1,1,3.4,4,1.8
1852,0,North America,Finance,Human Resources,Meets,Female,35,16,0,10,3,2.6,3.3,1,1,1,1,4.2,2.9,3.5
1853,1,North America,HR,IT & Digital,Meets,Female,33,8,0,8,1.6,3.1,2.7,1,0,0,0,3.8,4.3,2.6
1854,0,North America,Digital,Marketing,Meets,Female,38,13,0,12,3,2.9,2.2,0,0,0,0,2,3.8,1.1
1855,0,North America,Finance,Pharmacovigilance,Meets,Female,44,36,0,10,1.6,3,2.1,1,1,1,1,1.9,4,3.3
1856,0,Middle East & Africa,HR,IT & Digital,Below,Non-Binary/Other,36,14,1,8,,4.7,3.3,1,1,1,1,3.1,4.8,2.9
1857,0,North America,HR,Data Science,Meets,Female,32,2,0,12,3.5,3.1,1,1,1,1,1,3.2,3.4,1.2
1858,0,Middle East & Africa,Commercial,Legal & Compliance,Exceeds,Female,28,10,1,8,,2.3,1.3,1,1,1,1,3.9,2.5,2.2
1859,1,Middle East & Africa,Digital,Communications,Far Exceeds,Female,29,22,0,12,3.5,1.9,3.6,1,1,1,1,3.6,3.3,4.6
1860,0,North America,Finance,Human Resources,Meets,Male,35,5,1,7,,5,3.4,0,0,0,0,3.9,2.8,2.3
1861,0,Asia Pacific,Manufacturing,Marketing,Meets,Male,30,10,0,12,3,3.3,2.2,1,1,1,1,2.7,4.3,2.7
1862,0,Latin America,R&D,Legal & Compliance,Below,Male,34,32,0,11,3,3.7,3.5,1,1,1,1,3.1,3.4,4.4
1863,0,Europe,Digital,Data Science,Below,Female,50,6,0,9,1.7,3.5,2.7,1,1,1,1,1.5,3.9,2.1
1864,0,Middle East & Africa,Manufacturing,Data Science,Meets,Female,45,15,0,12,3.9,2.8,2.3,1,1,1,1,2.2,2.5,3.6
1865,0,Latin America,Digital,Medical Affairs,Far Exceeds,Female,33,6,0,10,4.5,2.9,2.9,1,1,1,1,5,2.2,3.5
1866,0,Asia Pacific,Manufacturing,Pharmacovigilance,Below,Male,39,20,0,10,4.3,2.7,2.2,0,0,0,0,4.4,5,2.2
1867,1,Europe,Manufacturing,Human Resources,Meets,Male,32,5,0,8,1.8,2.3,2.2,0,0,0,0,4,2.8,2.2
1868,0,Europe,Digital,Finance & Accounting,Below,Male,47,6,0,8,4,2.9,2,0,0,0,0,2.6,3.4,2.4
1869,0,Middle East & Africa,Commercial,Quality Assurance,Meets,Female,38,12,0,10,2.9,3,3,1,1,1,1,3.5,2.2,3.6
1870,0,North America,Digital,Clinical Operations,Below,Female,44,6,0,6,4.8,1,2.8,1,1,1,1,5,3.8,3.5
1871,0,Asia Pacific,Digital,Finance & Accounting,Meets,Female,33,8,0,11,3.2,3.6,2.4,1,1,1,1,3.5,3.2,2.8
1872,0,Middle East & Africa,Manufacturing,IT & Digital,Meets,Male,48,10,0,5,4.2,2.4,2.8,1,1,1,1,4.7,3,3.5
1873,0,Asia Pacific,R&D,Human Resources,Below,Male,35,11,1,10,,4.5,2,0,0,0,0,4,3.7,2.3
1874,0,North America,Manufacturing,Clinical Operations,Below,Male,28,9,1,8,,4.3,2.3,1,1,1,1,3.1,4.3,1.6
1875,0,North America,HR,Supply Chain,Meets,Male,37,5,0,5,5,3.3,2.6,1,1,1,1,4.8,3.7,1.3
1876,0,Middle East & Africa,Digital,Data Science,Meets,Female,34,22,0,7,2.1,1,3.8,1,1,1,1,3.7,2.9,2.2
1877,0,North America,Finance,Legal & Compliance,Below,Male,44,21,1,7,,4.2,2.2,1,1,0,0,3.5,3.2,1.9
1878,0,Latin America,Digital,Human Resources,Exceeds,Female,34,13,0,6,3.9,3.3,2.6,1,1,1,1,2.1,3,1
1879,0,Europe,Commercial,Supply Chain,Meets,Female,41,8,0,5,2.9,2.1,3.1,1,1,1,1,3.7,1.4,3.6
1880,0,Middle East & Africa,Finance,Pharmacovigilance,Meets,Male,34,7,1,12,,4.2,3,1,1,1,1,2.5,5,3.4
1881,0,Asia Pacific,Manufacturing,Data Science,Exceeds,Male,33,8,0,11,4.4,1,2.3,0,0,0,0,3.9,1,3.5
1882,0,Latin America,Commercial,Data Science,Meets,Non-Binary/Other,38,12,0,10,3.6,2.8,1.9,0,0,0,0,3.5,1.8,1.8
1883,0,Middle East & Africa,Digital,Regulatory Affairs,Exceeds,Male,41,26,0,9,4.9,4.7,3,1,1,1,1,3.9,3,4.3
1884,0,North America,Manufacturing,Market Access,Exceeds,Female,29,5,0,9,3,3.8,3.9,1,1,1,1,3.9,2.9,2.3
1885,0,North America,Manufacturing,Clinical Operations,Below,Male,44,21,0,10,3.6,3.3,3.1,1,1,1,0,3.4,3.4,3
1886,0,North America,HR,Pharmacovigilance,Exceeds,Female,44,8,1,7,,3.1,1,1,1,1,1,3.7,4.4,2.3
1887,0,North America,HR,Marketing,Below,Male,36,13,0,7,4.1,3.2,3.3,1,1,1,1,3.1,3.7,1.9
1888,0,Asia Pacific,R&D,Marketing,Meets,Female,37,14,0,11,2.6,4.7,3.4,1,1,1,1,3.6,3.6,5
1889,0,Latin America,HR,Quality Assurance,Exceeds,Female,28,7,0,5,3.8,1,1.9,1,1,1,1,2.9,1.9,1.9
1890,1,Europe,Finance,Human Resources,Exceeds,Male,49,4,1,5,,3.6,3.9,1,1,1,1,3.5,5,4.1
1891,0,Asia Pacific,Manufacturing,Sales,Meets,Male,36,27,0,11,3.3,3,2.3,1,0,0,0,3.2,1.6,3
1892,0,Asia Pacific,HR,Pharmacovigilance,Below,Female,45,8,1,5,,3.3,3.5,1,1,1,1,4.7,2.1,3.6
1893,0,Europe,R&D,Communications,Meets,Male,34,13,0,5,3.4,1.3,3.5,1,1,1,1,2.5,1.7,3.3
1894,0,Europe,Digital,Human Resources,Meets,Female,38,8,0,11,3.4,3.4,3,1,1,1,1,3,2.3,3.1
1895,0,North America,Finance,Sales,Meets,Female,41,9,0,7,2.2,2.2,4.1,1,0,0,0,3.1,3.1,4.6
1896,0,Asia Pacific,HR,Regulatory Affairs,Far Exceeds,Male,35,2,1,12,,4.1,3.1,1,1,1,1,3.5,3.9,3.2
1897,0,Middle East & Africa,Manufacturing,Marketing,Meets,Male,29,29,0,9,2.9,2.5,3,1,1,1,1,3.8,3.5,2.6
1898,0,Europe,Digital,Communications,Meets,Male,37,8,0,9,3.7,1.3,1.7,1,1,1,1,2.8,3.2,1.4
1899,0,Europe,Manufacturing,Pharmacovigilance,Below,Female,30,11,0,9,3.8,1.7,1.9,0,0,0,0,4.6,1.8,3.5
1900,0,Latin America,Digital,Data Science,Meets,Female,33,7,0,8,2.6,2.4,4.9,1,1,1,1,2.7,3.4,5
1901,1,Middle East & Africa,Finance,Market Access,Meets,Female,34,2,1,12,,4.1,1,1,1,1,1,3.2,3.7,1.5
1902,0,Middle East & Africa,Manufacturing,Medical Affairs,Meets,Female,38,13,0,6,3.7,2.7,2.7,1,1,1,1,3.6,3.4,3.4
1903,0,Europe,HR,Market Access,Meets,Female,34,3,1,6,,3.8,2.3,1,1,1,1,5,2.8,3.9
1904,0,North America,HR,Human Resources,Below,Male,31,8,1,5,,2.1,3.3,1,1,1,1,3.2,1.7,3.6
1905,0,Latin America,R&D,Quality Assurance,Meets,Female,39,10,0,9,3,3.9,3.2,1,1,1,1,3.4,3.4,2.6
1906,0,Middle East & Africa,Digital,Marketing,Meets,Male,42,9,0,10,3,3.8,2.1,1,1,1,1,3,3,2.4
1907,0,Europe,R&D,Finance & Accounting,Below,Male,30,20,0,11,2.6,3.6,2.8,1,0,0,0,4.2,2.8,3
1908,0,Middle East & Africa,Commercial,Supply Chain,Meets,Female,38,14,0,11,3.4,2.8,1,1,1,1,1,3.8,4.6,1.8
1909,1,Latin America,HR,Supply Chain,Meets,Female,43,6,0,6,2.8,2.8,4.2,1,1,1,1,2.9,4.4,4.1
1910,0,Latin America,Digital,Medical Affairs,Meets,Male,39,2,0,5,1.7,2.4,2.4,1,1,1,1,2.4,5,2.4
1911,0,Asia Pacific,Finance,Communications,Meets,Female,31,11,0,9,3.3,3.6,3.8,1,1,1,1,3.9,2.5,2.2
1912,0,Europe,R&D,IT & Digital,Exceeds,Male,39,6,1,8,,3.3,1.8,1,1,1,1,3,3.4,3.3
1913,0,Latin America,Finance,Marketing,Far Exceeds,Female,38,5,1,8,,4.1,3.3,1,1,1,1,4.5,4,2.9
1914,0,Asia Pacific,Finance,IT & Digital,Below,Male,39,12,0,7,2.5,1.5,2.5,1,1,1,1,2,3.4,2.2
1915,0,Asia Pacific,Finance,Pharmacovigilance,Meets,Male,38,15,0,5,3.3,3.2,3.1,1,1,1,1,5,2.8,3.1
1916,0,Middle East & Africa,R&D,Data Science,Below,Female,28,5,0,12,4.2,3.8,2.1,1,1,1,1,4.8,1.8,2.3
1917,0,Middle East & Africa,Commercial,Quality Assurance,Far Below,Female,37,4,1,10,,3.1,2.2,1,1,1,0,4,2.4,2.5
1918,0,Asia Pacific,R&D,Supply Chain,Meets,Female,44,2,1,10,,2.5,3,1,0,0,0,4,4.2,3.1
1919,0,Middle East & Africa,Manufacturing,Medical Affairs,Far Exceeds,Female,47,4,1,12,,3.2,1.4,1,1,1,1,2.9,3,1.6
1920,0,Latin America,HR,Market Access,Meets,Female,44,2,1,7,,3.8,4.5,1,1,1,1,3.2,4.4,3.9
1921,0,North America,R&D,Finance & Accounting,Meets,Female,38,7,0,9,3.3,3.6,2.5,1,1,1,1,3.7,3,1.5
1922,0,Latin America,R&D,Data Science,Below,Female,42,25,0,12,3.6,3.9,2.8,1,1,1,1,3.3,3,2.2
1923,0,Asia Pacific,Commercial,Legal & Compliance,Exceeds,Female,41,7,1,9,,2.6,4.2,1,1,1,0,4,4.4,3.3
1924,0,Asia Pacific,Manufacturing,Supply Chain,Meets,Female,37,19,1,11,,3,4.1,1,1,1,1,2.1,2.9,3.3
1925,0,Latin America,R&D,Market Access,Meets,Male,45,9,0,6,2.1,4.4,3.2,0,0,0,0,4.1,5,3.7
1926,0,Middle East & Africa,HR,Pharmacovigilance,Exceeds,Female,34,8,0,8,2.6,1.4,2.6,1,1,1,1,3.4,2.3,2.6
1927,0,Middle East & Africa,HR,IT & Digital,Meets,Female,37,4,0,7,4.4,5,1.8,1,0,0,0,3.5,5,3
1928,0,Asia Pacific,R&D,Market Access,Below,Male,43,7,0,7,4.1,1.9,5,1,1,1,1,4.3,3,4
1929,0,Europe,Finance,Data Science,Meets,Female,32,20,0,6,3.4,2.9,3.4,1,1,1,1,3.7,4.5,3.8
1930,0,Middle East & Africa,Finance,Communications,Exceeds,Male,30,7,0,10,3.4,2.3,1,1,1,1,1,3.9,2.5,1
1931,0,Latin America,Manufacturing,Market Access,Exceeds,Male,32,21,0,7,3.7,3.4,3.3,1,1,1,1,2.7,3.6,3.4
1932,0,Middle East & Africa,HR,Pharmacovigilance,Below,Female,41,15,0,9,3.7,3.3,2.2,1,1,1,1,3.3,3.1,2.8
1933,0,Latin America,Finance,Finance & Accounting,Meets,Male,51,13,0,11,2.8,3.6,1,1,1,1,1,3,3.7,2.8
1934,0,Asia Pacific,HR,Quality Assurance,Below,Female,45,17,0,6,2.1,3.3,2.7,1,1,1,0,3,3.8,4.3
1935,0,Middle East & Africa,Manufacturing,IT & Digital,Meets,Male,43,2,0,9,2.6,2.6,2,1,1,1,1,3.3,3,2
1936,0,Latin America,Manufacturing,Data Science,Meets,Female,47,8,1,9,,3.3,3.1,1,1,1,1,2.2,4.3,4.8
1937,0,Asia Pacific,Finance,Communications,Meets,Male,40,10,0,10,3.3,3.9,1.7,1,1,1,1,4.6,3.6,1.4
1938,0,Europe,R&D,Quality Assurance,Meets,Male,34,12,0,11,2.8,2.7,2.5,1,1,1,1,2.6,3.1,2.7
1939,0,Latin America,Digital,IT & Digital,Meets,Female,38,28,0,6,4.9,3.1,4.6,1,1,1,1,3.3,3.4,4.3
1940,0,Europe,Commercial,Medical Affairs,Meets,Male,36,2,0,8,2.6,3.1,2.7,1,1,0,0,3.3,2.3,2.8
1941,0,Europe,Digital,Marketing,Exceeds,Male,32,9,0,11,2.5,3.5,3.6,1,1,1,0,3.5,2.6,3.1
1942,0,North America,Digital,IT & Digital,Meets,Male,37,9,0,10,3.2,3.1,2.6,1,1,0,0,2.7,2.1,3.9
1943,0,Middle East & Africa,HR,Market Access,Meets,Male,29,18,0,6,2.4,4,1.7,1,1,1,1,2.2,4.3,1.3
1944,0,Latin America,Manufacturing,Regulatory Affairs,Meets,Male,36,8,0,5,4.4,2.2,1,1,1,1,1,4.1,3.4,2.1
1945,0,Europe,HR,Quality Assurance,Exceeds,Male,37,14,0,9,3.3,2.9,3.3,1,1,1,1,4.2,2.1,2.1
1946,0,North America,Finance,Finance & Accounting,Below,Female,37,9,0,8,5,2.7,2.7,1,1,1,1,4.9,3.5,1.6
1947,0,Asia Pacific,Commercial,Pharmacovigilance,Exceeds,Female,48,13,0,8,4.6,4,3.6,0,0,0,0,3.9,3.8,2.3
1948,0,Latin America,Finance,Supply Chain,Below,Female,39,8,0,6,3.1,3.3,2.8,1,1,1,1,3.5,2.1,3.9
1949,0,Europe,R&D,Quality Assurance,Far Below,Female,49,10,0,8,2.7,3.1,4.7,1,1,1,1,2,3.1,3.1
1950,0,Middle East & Africa,Commercial,Supply Chain,Below,Male,30,7,1,7,,4.2,2.1,1,1,1,1,3.5,2.9,1.8
1951,1,North America,HR,Human Resources,Far Exceeds,Female,43,5,0,9,4.4,4,3,1,1,1,1,5,4,4.2
1952,1,Europe,HR,Market Access,Meets,Male,39,27,0,8,2.4,2.2,2.8,1,1,1,1,1.5,3.3,2.7
1953,0,Middle East & Africa,Finance,Medical Affairs,Far Below,Non-Binary/Other,37,12,0,5,1.6,2.3,3.3,1,1,1,1,3.1,2.2,2.7
1954,0,Europe,HR,Clinical Operations,Far Exceeds,Male,30,2,1,10,,3.8,1.6,1,1,1,1,2.2,3.2,4.2
1955,0,Latin America,HR,Data Science,Meets,Female,40,10,1,5,,1.6,1.9,1,1,1,1,2.2,2.8,1.8
1956,0,Latin America,Digital,Supply Chain,Exceeds,Female,52,18,0,10,4.1,3.3,1.8,1,1,1,1,4.2,2.6,1.9
1957,0,Latin America,R&D,Human Resources,Meets,Male,41,10,0,5,2.4,3.5,3.6,1,1,1,1,2.5,3.9,3.1
1958,0,North America,Digital,Human Resources,Below,Non-Binary/Other,38,3,1,10,,4,4.8,1,1,1,1,4.6,4.4,5
1959,0,Latin America,HR,Supply Chain,Meets,Male,39,4,0,9,2.8,1.8,1.8,1,1,1,1,1.6,2.7,1.9
1960,0,Middle East & Africa,Manufacturing,Human Resources,Meets,Female,42,6,0,5,2.6,2.9,2.9,1,1,1,1,3.3,2.7,1.4
1961,1,Europe,Digital,Finance & Accounting,Meets,Female,47,14,1,9,,2.1,2.9,1,1,1,1,5,1.8,4
1962,0,Asia Pacific,HR,Data Science,Meets,Male,36,7,0,8,2.2,2.8,1.5,1,0,0,0,3.7,3.2,1.2
1963,0,Middle East & Africa,HR,Clinical Operations,Meets,Male,39,8,1,12,,3.5,3.6,1,1,1,1,3.3,5,3.3
1964,0,Middle East & Africa,R&D,Market Access,Meets,Female,38,9,1,7,,2.4,2.9,1,1,1,1,2.6,2.6,1.9
1965,0,Latin America,Finance,Pharmacovigilance,Meets,Female,35,8,0,5,2.6,3.2,1.5,1,1,1,1,3.1,2.9,1.8
1966,0,North America,Commercial,IT & Digital,Meets,Female,39,18,0,8,5,2.9,2.5,1,1,1,1,3.7,3,2.4
1967,0,Europe,Digital,Marketing,Below,Female,47,9,0,10,4.7,1.7,3.7,1,1,1,1,3.6,1.8,4.3
1968,0,North America,Digital,Finance & Accounting,Meets,Male,34,16,0,8,1.7,2.9,3.4,1,1,1,1,1.9,1.8,1.7
1969,0,Europe,Digital,Finance & Accounting,Meets,Female,40,22,0,6,3,3.7,3.2,1,1,1,1,3.2,3.9,2.9
1970,0,Europe,HR,IT & Digital,Exceeds,Non-Binary/Other,40,8,1,11,,3.9,3.3,1,1,1,1,3.9,3.7,3.9
1971,0,North America,R&D,Supply Chain,Meets,Male,38,6,0,6,2.6,5,1.2,0,0,0,0,3.3,2.5,3.1
1972,0,Middle East & Africa,HR,Clinical Operations,Below,Male,41,16,1,12,,3,3.3,1,1,1,1,3,2.3,3
1973,0,Europe,HR,Clinical Operations,Far Below,Male,40,5,1,5,,2,4.6,1,1,1,1,3.7,2,2.8
1974,0,North America,Finance,Medical Affairs,Exceeds,Female,33,22,0,11,3.1,2.7,1.4,1,1,1,1,1.9,4.4,3.9
1975,0,Europe,Manufacturing,Supply Chain,Meets,Male,38,11,0,11,3.1,2.3,3.2,0,0,0,0,3.1,1,2.7
1976,0,Asia Pacific,R&D,Legal & Compliance,Far Exceeds,Female,38,12,1,9,,2.9,3.4,1,1,1,1,3.4,3.4,3.4
1977,0,Middle East & Africa,Digital,Human Resources,Exceeds,Non-Binary/Other,32,1,0,12,4,2.9,2.9,1,1,1,1,3.1,2.5,2.9
1978,0,Latin America,Commercial,Communications,Meets,Male,38,7,1,12,,4.4,3.8,1,1,1,1,3.1,3.2,3.6
1979,0,Europe,Digital,Human Resources,Below,Female,38,16,0,8,2.6,1.7,4,1,1,1,1,3.3,1.2,3.4
1980,0,Asia Pacific,HR,Quality Assurance,Meets,Male,50,6,0,8,3.7,3.4,5,1,1,1,1,3.4,3.3,3.6
1981,0,Latin America,R&D,Market Access,Far Below,Male,33,26,0,10,3.4,2.1,3.3,1,1,1,1,4.6,1.2,4.2
1982,0,Latin America,R&D,Pharmacovigilance,Below,Male,44,14,0,7,3.9,3.6,2,1,1,1,1,3.1,4.2,2.7
1983,0,Europe,R&D,Clinical Operations,Meets,Female,41,3,0,7,4.6,3.8,3.2,1,1,1,1,3.3,4.7,4
1984,0,North America,Manufacturing,Medical Affairs,Meets,Female,44,12,0,9,3.2,4.1,2,1,1,1,1,3.2,4.3,1.7
1985,1,Europe,Digital,Medical Affairs,Meets,Non-Binary/Other,33,8,0,11,2.2,2.2,3.2,1,1,1,1,3,1,3.7
1986,0,Asia Pacific,Manufacturing,Data Science,Meets,Male,28,2,1,12,,3.9,1.7,1,1,0,0,5,3.9,1.8
1987,0,Latin America,Finance,Supply Chain,Meets,Female,37,13,0,5,3.3,2.5,1.4,1,1,1,1,4.1,3.5,3.1
1988,0,Europe,Commercial,Clinical Operations,Below,Female,43,3,0,11,2.5,3.5,2.9,1,1,1,1,3.8,2.9,3.3
1989,0,North America,Finance,Pharmacovigilance,Meets,Male,36,25,0,10,3,2.4,1,1,1,1,1,3.3,3.4,1.5
1990,0,Europe,HR,Finance & Accounting,Meets,Male,37,7,0,12,3.2,3.2,4,1,1,1,1,3.4,4.9,3.5
1991,0,Middle East & Africa,Manufacturing,Quality Assurance,Meets,Female,50,36,0,12,2.4,3.3,2.9,1,1,1,0,2,3.5,2.9
1992,0,North America,Manufacturing,Regulatory Affairs,Meets,Female,34,5,0,7,2.5,4.6,3.8,1,1,1,1,2.7,2.5,3.9
1993,0,Asia Pacific,Finance,Regulatory Affairs,Meets,Male,44,14,1,12,,1.4,3.6,1,1,1,1,3.4,1.9,1.9
1994,0,Latin America,HR,Quality Assurance,Below,Female,32,7,1,8,,4.6,3.5,1,1,1,1,3.3,3.1,1.4
1995,0,Europe,R&D,Human Resources,Meets,Non-Binary/Other,45,14,0,8,4,2.4,3,1,1,1,1,2.9,4.1,1.7
1996,0,North America,HR,Legal & Compliance,Far Exceeds,Male,38,4,0,11,3.8,2.4,2.6,1,1,1,1,4.3,3.7,3.9
1997,0,Middle East & Africa,Digital,Communications,Below,Male,41,26,0,11,2.4,2.3,3.2,1,1,1,1,3.8,1.2,3.7
1998,0,North America,Finance,Clinical Operations,Meets,Female,34,7,0,8,3.3,5,1.8,1,1,1,1,4.1,4.8,1.3
1999,0,Middle East & Africa,HR,Finance & Accounting,Exceeds,Male,39,14,1,11,,3.2,2.6,1,1,1,1,5,2.6,4
2000,0,Asia Pacific,R&D,Supply Chain,Meets,Female,39,8,1,11,,2.7,2.4,0,0,0,0,3.9,4.5,2.6
2001,0,Latin America,HR,Pharmacovigilance,Meets,Male,30,29,0,8,4.1,2.4,3.1,1,1,1,1,3.4,3.6,3.1
2002,0,Asia Pacific,Manufacturing,IT & Digital,Exceeds,Female,35,6,1,6,,3,3,1,1,1,1,4.1,2.1,3.6
2003,0,Europe,Commercial,Communications,Meets,Female,40,25,1,8,,1.4,2.6,1,1,1,1,4.7,2.5,1.5
2004,0,North America,Manufacturing,Data Science,Meets,Male,33,18,1,7,,3,4.3,1,1,1,1,3.4,3.2,3.8
2005,0,Middle East & Africa,Commercial,Supply Chain,Meets,Male,39,8,0,5,4.5,3.5,4,1,1,1,1,5,2.8,3.6
2006,0,Middle East & Africa,HR,Marketing,Meets,Female,37,10,1,6,,2.8,4.5,1,1,1,1,4.3,4.6,2.8
2007,0,North America,Digital,Communications,Far Exceeds,Male,42,12,1,10,,4.1,1.4,1,1,1,1,4,3.3,2.6
2008,0,North America,HR,Supply Chain,Exceeds,Female,37,11,0,11,3.4,2.5,3.3,1,1,1,1,3.2,3.5,2.8
2009,0,Europe,R&D,Supply Chain,Meets,Male,52,14,0,6,3.3,2.8,2.3,1,1,1,1,3.1,2.1,2.5
2010,0,Asia Pacific,HR,Market Access,Exceeds,Male,28,8,0,6,3,2.1,1.7,1,1,1,1,4.6,3.5,1.6
2011,0,Middle East & Africa,Commercial,Clinical Operations,Exceeds,Male,33,13,0,5,2.4,4.1,3.5,0,0,0,0,2.2,3.1,2.6
2012,0,Europe,Manufacturing,Legal & Compliance,Far Exceeds,Male,42,14,1,8,,2.2,4.7,1,1,1,1,3.2,3.1,4.3
2013,0,Asia Pacific,Digital,Data Science,Meets,Male,39,12,0,12,2.4,4.4,1.6,1,1,1,1,2,4.6,2
2014,0,Europe,HR,Market Access,Below,Female,41,18,0,6,4.3,2.4,2.5,1,1,1,1,3,2.5,4.1
2015,0,Middle East & Africa,HR,Clinical Operations,Meets,Female,28,7,0,11,3.3,3.7,1.2,1,1,1,1,4.3,5,2.7
2016,0,North America,Manufacturing,Sales,Below,Female,37,12,0,9,4.3,2.4,3,1,1,1,1,4.6,3,2.5
2017,0,North America,Digital,Data Science,Meets,Male,38,12,0,11,1.5,2,2,1,0,0,0,2.2,2,2.6
2018,0,Asia Pacific,Finance,Clinical Operations,Below,Male,42,11,0,7,2.4,3.3,3.2,0,0,0,0,3.4,2.7,4.9
2019,0,Latin America,HR,Regulatory Affairs,Exceeds,Male,40,11,0,5,2.9,1.8,4.1,0,0,0,0,2.7,3,3.7
2020,0,Asia Pacific,HR,Market Access,Meets,Male,38,15,0,8,4.1,5,3.6,1,0,0,0,3.6,3.9,2.7
2021,0,Latin America,Finance,Sales,Meets,Female,37,8,1,8,,3.3,3.8,1,1,0,0,2.5,4.1,2.9
2022,0,Europe,Commercial,Human Resources,Meets,Female,30,1,0,6,3.3,3.1,2.7,1,1,1,0,2.8,4.1,1
2023,0,Europe,Commercial,Data Science,Below,Male,40,13,1,7,,1,3.5,1,1,1,1,3.8,1.4,2.5
2024,0,Middle East & Africa,R&D,Marketing,Meets,Female,37,5,1,6,,3.3,1,1,1,1,1,3.6,3.9,1.4
2025,0,Latin America,Manufacturing,Pharmacovigilance,Meets,Male,35,11,0,10,3.3,3.8,3.4,1,1,1,1,2.9,3.7,4.3
2026,0,Middle East & Africa,Digital,Marketing,Exceeds,Female,38,4,0,12,4.9,2.5,3.8,1,1,1,1,3.8,2.1,3.4
2027,0,North America,HR,Regulatory Affairs,Below,Female,36,7,1,11,,3,2.2,1,1,1,1,2.1,3.7,2.6
2028,0,Latin America,HR,Regulatory Affairs,Meets,Male,29,13,0,12,3.2,3.4,2.5,1,1,1,1,3,3.5,2.2
2029,0,Asia Pacific,R&D,Communications,Meets,Female,42,10,0,7,2.3,4.6,3.2,1,1,1,1,3,2.6,1.9
2030,0,North America,HR,Finance & Accounting,Far Below,Female,49,11,0,5,2.3,2,1,1,1,1,1,3.3,2.8,2.9
2031,0,North America,Manufacturing,Finance & Accounting,Meets,Male,40,14,0,8,2.7,4.2,1.7,1,0,0,0,3.6,3.1,3.7
2032,0,Asia Pacific,R&D,Quality Assurance,Meets,Female,40,2,1,9,,3.8,1,1,1,1,1,4.7,1.6,1.5
2033,0,North America,Manufacturing,Human Resources,Meets,Female,47,11,1,8,,1.8,3.2,1,1,1,1,4.1,1.7,4.4
2034,0,Latin America,R&D,Quality Assurance,Meets,Female,49,4,0,5,3.1,1.3,3.9,1,1,1,1,2.8,1,2.9
2035,0,Middle East & Africa,HR,Marketing,Meets,Female,37,12,1,12,,2.2,2.4,1,1,1,1,3,1,3.9
2036,0,North America,R&D,Market Access,Far Exceeds,Male,34,7,0,5,3.6,2.7,3.2,1,1,1,1,3.7,4.5,3.2
2037,0,Latin America,Commercial,Supply Chain,Meets,Male,41,9,0,10,2.9,1.8,3.1,1,1,1,1,3.5,2.8,3
2038,0,Europe,Digital,Clinical Operations,Meets,Male,39,8,0,12,3.5,3.4,3.3,1,1,1,1,2.4,2.2,4.5
2039,0,Latin America,HR,Communications,Meets,Male,44,6,0,7,3.5,2,4.1,1,0,0,0,3.4,3.4,3
2040,0,Middle East & Africa,Finance,IT & Digital,Meets,Female,38,3,1,7,,3.6,3.3,1,1,1,1,1.9,2.7,3.7
2041,0,Latin America,Digital,Pharmacovigilance,Far Below,Male,38,23,0,10,3.6,2.8,1.2,1,1,1,1,3.9,3,2
2042,0,Asia Pacific,HR,Sales,Meets,Female,32,2,1,5,,2.9,3.4,1,1,1,1,3.6,3,2.1
2043,0,Middle East & Africa,Digital,Pharmacovigilance,Meets,Female,44,13,0,12,3.1,4.2,4.5,1,1,1,1,2.8,3.8,3.5
2044,0,Europe,Commercial,Regulatory Affairs,Meets,Female,34,3,1,6,,4.1,1.4,0,0,0,0,3,3.6,2.7
2045,0,Asia Pacific,Digital,Legal & Compliance,Exceeds,Male,31,7,1,8,,3.8,2,1,1,1,0,2.4,4.3,2.2
2046,0,Latin America,R&D,Quality Assurance,Exceeds,Male,28,26,1,5,,1.9,1.5,1,1,1,1,4.1,2.9,1
2047,0,Middle East & Africa,Digital,Supply Chain,Below,Male,37,5,1,6,,2,2,1,1,1,1,3.5,1.6,3
2048,0,Europe,HR,Human Resources,Meets,Non-Binary/Other,34,9,1,12,,2.5,5,1,1,1,1,5,4.1,5
2049,0,Asia Pacific,Finance,Legal & Compliance,Far Below,Female,37,29,0,9,4.1,4.9,2.5,1,1,1,1,3.9,5,1.3
2050,0,Europe,Finance,Medical Affairs,Meets,Male,35,23,0,7,2.7,1.9,1.2,1,1,1,1,3.5,3,1.5
2051,0,Latin America,Manufacturing,Data Science,Below,Male,36,24,0,7,1.5,3.7,1.2,1,1,1,1,2.3,4.5,2.1
2052,0,Europe,Digital,Medical Affairs,Exceeds,Female,33,8,0,11,2.7,1.8,1.2,1,1,1,1,2.9,2.4,1
2053,0,North America,Finance,Medical Affairs,Exceeds,Male,34,16,0,11,3.7,3.7,3.2,1,1,1,1,4.1,2.2,3.7
2054,0,Asia Pacific,Digital,Market Access,Far Below,Female,32,4,0,8,3.4,2.3,3.3,1,1,1,1,3.1,2.6,3
2055,0,Europe,Finance,Market Access,Meets,Female,37,8,0,12,3.3,3.6,1.6,0,0,0,0,3.9,4.7,2.9
2056,0,Latin America,Digital,Quality Assurance,Meets,Female,31,14,0,9,3,2.2,2.7,1,1,1,1,3.3,1,3.5
2057,0,Latin America,HR,Finance & Accounting,Meets,Female,46,22,0,6,2.3,2.5,3.5,1,1,1,1,3.2,2.4,3
2058,0,Europe,Digital,Finance & Accounting,Meets,Female,38,6,0,6,4.7,3,4,1,1,1,1,3.8,3.5,4.8
2059,0,Latin America,HR,Medical Affairs,Meets,Male,29,14,0,7,3.8,2.4,2,1,1,1,1,3.7,2,2.3
2060,0,Middle East & Africa,HR,Legal & Compliance,Exceeds,Female,39,17,0,8,3.7,2.1,4,1,1,0,0,3,3.4,5
2061,0,Middle East & Africa,Manufacturing,Sales,Meets,Female,33,12,0,5,2,2.6,2.9,1,1,1,1,3.4,2.7,4.3
2062,0,Middle East & Africa,Finance,Regulatory Affairs,Meets,Male,44,6,0,8,3.1,3.3,1.7,1,1,1,1,3,1.7,1
2063,0,North America,R&D,Finance & Accounting,Exceeds,Male,34,10,0,12,3.8,1,4.1,1,1,1,1,2.8,1.9,3.2
2064,1,Europe,HR,Medical Affairs,Far Exceeds,Male,46,5,1,6,,3.3,2.5,1,1,1,1,4,3.5,3.9
2065,0,North America,Finance,Supply Chain,Meets,Female,44,12,0,12,4.2,1.5,2.3,1,1,1,1,3.5,1.7,2.6
2066,0,Latin America,Commercial,Data Science,Below,Male,55,13,1,9,,3.4,2.6,1,1,1,1,3.8,1.9,3
2067,0,North America,Digital,Legal & Compliance,Meets,Female,39,8,0,7,3.9,5,4,1,1,1,1,4.4,4.1,3.5
2068,0,Latin America,Commercial,Legal & Compliance,Far Exceeds,Male,42,19,0,7,3.6,2.9,3.3,1,1,1,1,3.5,3.1,1.9
2069,0,Latin America,Digital,Clinical Operations,Below,Female,38,13,0,7,4,3.3,3.6,1,1,1,1,2.3,3.8,5
2070,0,Asia Pacific,Manufacturing,Finance & Accounting,Meets,Female,39,24,0,6,3,2,2.1,1,1,1,1,2.8,4.1,2.8
2071,0,Middle East & Africa,HR,Quality Assurance,Below,Male,45,20,0,11,3.4,2.9,1,1,1,1,1,3.2,2,2.1
2072,0,Latin America,R&D,Quality Assurance,Meets,Male,43,9,0,9,2.6,1.5,3.5,1,1,1,1,1.7,1,3.4
2073,0,Asia Pacific,HR,Marketing,Exceeds,Male,37,13,0,9,3,4.2,3,1,1,1,1,2.3,3.8,3.8
2074,1,Middle East & Africa,Digital,Supply Chain,Meets,Female,46,9,0,11,4.3,1.9,1.7,1,1,1,1,4.6,2.2,2.5
2075,0,Latin America,R&D,Communications,Meets,Female,44,16,0,10,3.5,2.9,2.4,1,1,1,1,4.1,5,2.5
2076,0,Latin America,HR,Market Access,Exceeds,Male,47,20,1,7,,4.7,3.8,1,0,0,0,3.3,2.2,2.2
2077,0,North America,R&D,Human Resources,Below,Female,45,22,0,10,2.9,2.9,2.1,1,1,1,1,4.1,2.6,1.9
2078,0,North America,Digital,Regulatory Affairs,Exceeds,Male,36,19,1,7,,3,1.8,1,1,1,1,4.3,2.5,2.5
2079,0,Middle East & Africa,Manufacturing,Sales,Meets,Female,35,14,0,12,1.8,3.4,2.9,1,1,1,1,2.2,2.8,3
2080,0,Latin America,Manufacturing,IT & Digital,Meets,Male,35,13,0,11,3.9,4.5,2.1,1,1,1,1,3.2,3.8,3.1
2081,0,Europe,HR,Supply Chain,Meets,Female,43,15,0,10,4.2,2.8,2.6,1,1,1,1,4.1,2.8,2.7
2082,0,North America,Commercial,Communications,Meets,Female,46,4,1,10,,4.7,4,1,1,1,1,3.2,2.7,5
2083,1,Middle East & Africa,Digital,Pharmacovigilance,Exceeds,Female,44,4,0,12,2.8,3.5,1.7,1,1,1,1,3.6,4.1,3.6
2084,1,Latin America,HR,Clinical Operations,Far Exceeds,Male,29,15,0,9,1.9,3.8,1.3,1,1,1,1,4.2,3.6,2.3
2085,0,Latin America,HR,Communications,Exceeds,Male,34,6,1,5,,3.9,1.7,1,1,1,1,1.8,2.4,1.3
2086,0,Europe,Manufacturing,Data Science,Below,Female,42,18,0,7,4.6,3.3,3.6,1,1,1,1,2,1.6,3.5
2087,0,Middle East & Africa,R&D,Marketing,Meets,Male,45,23,0,12,3.2,2.8,2.2,1,1,1,1,4.9,3,3.3
2088,0,Latin America,Digital,Legal & Compliance,Meets,Male,40,15,0,7,4.4,2.9,3.3,1,1,1,1,3.8,2.9,2
2089,0,North America,R&D,Supply Chain,Exceeds,Female,47,7,0,8,3,2.3,1.9,1,1,1,1,3.1,1.7,3.1
2090,0,Europe,Finance,Marketing,Meets,Male,28,5,0,10,2.7,2.2,2.1,1,1,1,1,2,1.8,2
2091,0,Middle East & Africa,Finance,Clinical Operations,Far Exceeds,Male,37,8,1,12,,2.7,1.6,1,1,1,1,1.9,2.9,2
2092,0,Europe,Digital,Medical Affairs,Far Exceeds,Female,47,10,1,12,,2.8,3.2,1,1,1,1,3.5,1.9,3.1
2093,0,North America,Commercial,Marketing,Meets,Female,40,7,0,12,3.8,2.5,4.6,1,1,1,1,3.9,2.9,3.8
2094,0,Middle East & Africa,Finance,Quality Assurance,Exceeds,Male,33,9,0,7,2.4,2.1,3.3,1,1,1,1,2,1.9,2.9
2095,0,Europe,Manufacturing,Market Access,Far Exceeds,Female,43,9,1,9,,3.7,2.4,1,1,1,1,2.1,3.2,3.5
2096,0,Asia Pacific,Commercial,Communications,Exceeds,Female,39,4,1,11,,4.7,4.2,1,1,1,1,2,3.5,3.6
2097,0,North America,HR,Legal & Compliance,Meets,Non-Binary/Other,35,6,0,9,4.4,5,2.6,1,1,1,1,3.8,5,1.7
2098,0,North America,Finance,Medical Affairs,Exceeds,Male,29,6,1,5,,3.7,2.5,1,1,1,1,2.6,2.4,3.2
2099,0,North America,Manufacturing,Supply Chain,Below,Non-Binary/Other,42,12,0,12,3.5,1.6,3.8,1,1,1,1,4.7,1.1,4.1
2100,0,Asia Pacific,HR,Human Resources,Meets,Male,31,16,1,9,,4.8,3.3,1,1,1,1,2.9,2.9,4.4
2101,0,Asia Pacific,Commercial,Data Science,Meets,Male,51,11,1,12,,3.7,1,1,1,1,1,3.5,2.2,1.6
2102,0,Latin America,Digital,Quality Assurance,Below,Male,28,12,0,12,2.7,4,2.9,1,1,1,0,3.9,4.6,2.7
2103,0,Europe,HR,Clinical Operations,Exceeds,Male,38,10,0,5,1.6,4.4,2.1,0,0,0,0,3.6,3.2,2.5
2104,0,Latin America,R&D,Medical Affairs,Meets,Female,43,15,1,9,,4.5,2.3,1,1,0,0,2.5,2.7,2.5
2105,1,Europe,Digital,Quality Assurance,Meets,Female,32,10,0,12,5,3.2,3,1,1,1,1,2.8,3.7,3.7
2106,0,Asia Pacific,Digital,Market Access,Meets,Male,34,11,0,11,2.5,2.3,3.7,1,1,1,1,2.3,2.1,4.2
2107,0,Asia Pacific,Commercial,Medical Affairs,Far Exceeds,Male,43,30,0,12,1.8,4.3,1.9,1,1,0,0,1.8,4.6,1
2108,0,Latin America,Commercial,Regulatory Affairs,Exceeds,Male,32,3,0,12,3,1,3.7,1,1,1,1,1.8,2.1,2.8
2109,0,Middle East & Africa,Manufacturing,Regulatory Affairs,Far Below,Male,50,7,0,6,3.6,2.2,1.1,1,1,1,1,3.9,1.6,2.9
2110,0,Latin America,Manufacturing,Medical Affairs,Far Exceeds,Male,38,11,0,10,2.4,4.8,1.2,1,1,1,1,3.3,4.1,2.5
2111,0,Europe,R&D,Communications,Meets,Male,35,9,0,5,2.8,2.5,3.3,1,1,1,1,1.5,4.4,2.6
2112,0,Latin America,Digital,Finance & Accounting,Meets,Male,48,3,1,5,,4.7,2.7,1,1,1,0,2,5,3.7
2113,0,North America,R&D,Medical Affairs,Meets,Male,32,12,0,11,3.3,2.4,4.3,1,1,1,1,3.2,1,4.1
2114,0,Europe,R&D,Communications,Exceeds,Female,48,8,0,11,3.6,1.9,2.5,1,1,1,1,4.2,2.8,2.8
2115,0,Europe,Commercial,Regulatory Affairs,Exceeds,Male,32,10,1,11,,3.3,3.4,1,1,1,1,3.1,3.6,2
2116,0,Middle East & Africa,R&D,Supply Chain,Meets,Male,46,6,0,6,2.5,3.9,4.7,1,1,1,1,5,4.9,4.7
2117,0,Asia Pacific,R&D,Communications,Meets,Male,49,8,0,10,3.8,2.7,3.5,1,1,1,1,3.2,5,2.1
2118,0,Europe,HR,Marketing,Meets,Male,37,15,0,5,3.9,3.5,2.1,1,1,1,1,4.5,3.7,2.8
2119,0,Asia Pacific,Manufacturing,Human Resources,Meets,Female,37,10,0,5,3.1,3.4,4.3,1,1,1,1,3.2,3.4,3.1
2120,0,Latin America,Manufacturing,Data Science,Meets,Female,36,11,0,6,3.6,3.4,4.5,1,1,1,1,4.8,4.4,5
2121,0,North America,Digital,Quality Assurance,Meets,Female,33,9,0,6,4,5,2.6,1,1,1,1,3.4,4.4,2.5
2122,0,Middle East & Africa,Manufacturing,Quality Assurance,Meets,Female,39,13,0,5,2.6,2.5,3.9,1,1,1,1,3,3.6,2.2
2123,1,Asia Pacific,Finance,Clinical Operations,Meets,Male,43,4,0,6,2.1,3.5,4.2,1,1,1,1,4.5,3.4,3.8
2124,0,Europe,Digital,Data Science,Meets,Male,42,9,0,8,4,2.5,3.1,1,1,1,1,3.1,2.1,4.1
2125,0,Asia Pacific,HR,Sales,Meets,Female,41,27,0,9,5,2.1,2.6,1,1,1,1,5,4.6,3.9
2126,0,Europe,Manufacturing,Regulatory Affairs,Meets,Female,34,3,1,11,,3,2.6,1,1,1,1,3,3.1,2.4
2127,0,Asia Pacific,HR,IT & Digital,Far Exceeds,Female,32,6,1,6,,1.5,2.6,1,1,1,1,4.4,1.8,3.6
2128,0,Europe,Manufacturing,IT & Digital,Below,Male,49,14,0,9,3.2,3.5,1.7,1,1,1,1,2.4,3.1,2.8
2129,0,Latin America,Manufacturing,Sales,Meets,Male,30,31,0,5,4.1,3.5,1.9,1,1,1,1,3,2.9,1
2130,0,Europe,HR,Human Resources,Meets,Male,37,16,0,5,2.2,2.6,2.5,1,1,1,1,3.2,4.8,2
2131,0,Europe,R&D,Market Access,Far Below,Male,43,13,0,5,2.8,2.9,3.7,1,1,1,1,3.9,2.2,2.3
2132,0,North America,R&D,Data Science,Meets,Female,47,12,0,6,4.1,4.3,4.5,1,0,0,0,2.5,3.1,4.2
2133,0,Europe,R&D,Communications,Exceeds,Male,38,16,0,5,4.1,2.8,3.3,1,1,1,1,2.9,3.3,2.5
2134,0,North America,Finance,Pharmacovigilance,Meets,Male,40,11,0,5,3,2.1,2.7,1,1,1,1,3.1,2.3,3
2135,0,Middle East & Africa,R&D,Human Resources,Meets,Female,35,11,1,11,,2.5,2.1,1,1,1,1,4.5,3.7,3.6
2136,0,North America,Manufacturing,Clinical Operations,Meets,Male,48,9,1,8,,4.1,1.3,0,0,0,0,2.5,5,2.9
2137,0,Latin America,Commercial,Medical Affairs,Exceeds,Male,46,11,0,5,2.2,4.8,3.5,1,1,1,1,1.8,4.5,3.9
2138,0,North America,HR,Market Access,Meets,Male,32,8,0,6,3.4,3.3,3.2,1,1,1,1,3.6,3.2,3.5
2139,0,Middle East & Africa,Commercial,Marketing,Exceeds,Male,42,7,0,8,3.2,3.3,3.9,1,1,1,1,4.1,3.2,4.2
2140,0,Latin America,Finance,Communications,Meets,Male,37,22,0,5,3,2.9,2.8,1,1,1,1,1.2,1.3,2.3
2141,0,Asia Pacific,Commercial,Pharmacovigilance,Meets,Female,40,9,0,10,2.2,2.9,2.4,1,1,1,1,1.8,3.1,4.2
2142,0,Asia Pacific,Digital,Data Science,Below,Female,33,3,0,9,3.1,2.1,2.4,1,1,1,1,2.5,1.6,3.5
2143,0,North America,R&D,Communications,Exceeds,Female,28,10,0,10,3.5,3.1,2,1,1,1,1,3.6,3.1,3.3
2144,0,North America,Finance,Data Science,Meets,Female,31,6,1,8,,2.8,1.4,0,0,0,0,2.6,1,2.8
2145,0,Middle East & Africa,Manufacturing,Communications,Meets,Female,35,3,1,9,,1.7,3.6,1,1,1,1,4.8,1.1,3
2146,0,Middle East & Africa,R&D,IT & Digital,Far Below,Male,35,7,0,9,2,3.3,2.8,0,0,0,0,1.6,2.8,3.4
2147,0,Europe,R&D,Sales,Meets,Female,28,6,0,10,3.1,2,4.3,0,0,0,0,4.9,2.6,3.1
2148,0,Middle East & Africa,Commercial,Supply Chain,Meets,Male,40,5,1,6,,1,3.1,1,1,1,1,4,1.5,2.1
2149,0,Europe,Digital,Legal & Compliance,Meets,Male,30,3,0,7,2.8,3,1.1,1,1,1,1,4,4,2.5
2150,1,Latin America,R&D,Sales,Exceeds,Male,38,23,1,12,,2.5,2.6,1,1,1,1,2.8,1.8,2.2
2151,0,North America,HR,Human Resources,Meets,Male,31,6,0,11,2.9,2.5,2.2,1,1,1,1,3.5,4.1,2.7
2152,0,Latin America,HR,Quality Assurance,Meets,Female,28,10,0,10,2.8,3.8,1.9,1,1,1,1,2.8,4,2.1
2153,1,Middle East & Africa,R&D,Sales,Far Exceeds,Male,38,8,1,12,,1.5,1,0,0,0,0,5,2.8,2.7
2154,0,Latin America,Commercial,Supply Chain,Exceeds,Male,37,13,1,10,,4.5,1.4,1,1,1,1,4.3,3.3,1
2155,0,Latin America,Commercial,Marketing,Meets,Female,39,12,0,7,4.9,3.5,4.6,1,1,1,1,4.5,3.3,4.1
2156,0,Latin America,Manufacturing,Legal & Compliance,Meets,Male,48,1,1,12,,4.1,1.7,1,1,1,1,4.1,3,3.7
2157,0,Middle East & Africa,Finance,Market Access,Exceeds,Female,42,9,1,5,,2.1,2.8,1,1,1,1,4.2,4.3,5
2158,0,Latin America,Finance,Finance & Accounting,Meets,Female,50,10,0,12,5,5,2,1,1,1,1,4.6,4.3,1.6
2159,0,Europe,Finance,Regulatory Affairs,Meets,Male,36,3,1,10,,2.7,1,1,1,1,1,3.4,2.7,1.5
2160,0,Middle East & Africa,Digital,Data Science,Meets,Male,34,24,0,5,4.1,2.8,2.4,1,1,1,1,3.5,2,3.9
2161,0,Latin America,Commercial,Human Resources,Meets,Male,41,12,1,11,,3.4,3.4,1,1,1,1,1.8,4.2,3.5
2162,0,Middle East & Africa,Manufacturing,Human Resources,Exceeds,Male,49,21,0,10,3.9,3.2,2.2,1,1,1,1,2.7,3.4,3.2
2163,0,Asia Pacific,HR,Medical Affairs,Meets,Male,31,9,0,8,2.5,3.6,5,1,1,1,1,2.8,3.3,3.5
2164,0,Europe,Finance,Sales,Meets,Male,46,9,0,7,3.1,3.3,1.7,1,1,1,1,3.6,3.5,3.3
2165,0,Latin America,HR,Pharmacovigilance,Below,Female,41,14,0,12,3.1,1.4,2.9,1,1,1,1,4.8,1.4,2
2166,0,Asia Pacific,HR,Marketing,Meets,Male,35,6,0,10,4.2,3.8,1.1,1,1,1,1,4.5,2.7,2.8
2167,0,Asia Pacific,R&D,Clinical Operations,Meets,Male,47,5,0,12,3.8,3.6,3,1,1,1,1,2.9,2.6,5
2168,0,Middle East & Africa,Digital,Data Science,Meets,Male,31,8,0,10,3.5,2.1,4.1,1,1,1,1,4.2,2.6,5
2169,0,Asia Pacific,Manufacturing,Supply Chain,Meets,Female,42,14,0,5,2.3,1.9,3.3,1,1,1,1,2.1,2.5,5
2170,0,Europe,Digital,Quality Assurance,Meets,Male,37,14,0,8,2.9,3.5,1,1,1,1,1,4,2.5,1
2171,0,Europe,R&D,Supply Chain,Below,Male,45,3,0,10,2.8,3.4,3.3,1,1,1,1,2.7,3.2,2.8
2172,0,North America,Manufacturing,Sales,Meets,Male,40,27,0,9,5,4.2,2,1,1,1,1,3.8,4.1,1.4
2173,0,Europe,Manufacturing,Communications,Meets,Male,45,20,1,5,,4.2,1.8,1,1,1,1,3.7,3.4,2.5
2174,0,Asia Pacific,Commercial,Market Access,Below,Male,38,3,0,9,2.6,4.9,3.3,1,1,1,1,3,4,2.4
2175,0,Europe,Digital,Quality Assurance,Far Below,Non-Binary/Other,35,20,0,12,3.4,2.6,3.5,0,0,0,0,4.1,2.8,3.3
2176,0,Middle East & Africa,Digital,Pharmacovigilance,Exceeds,Female,38,8,0,10,3.5,2.1,2.8,1,1,1,1,2.2,2,2.2
2177,0,North America,Commercial,Supply Chain,Below,Female,39,17,0,5,3.2,1.7,2.9,1,1,1,1,3.2,3.7,2.2
2178,0,Asia Pacific,HR,Human Resources,Exceeds,Female,40,3,0,7,4.6,2.4,3.8,1,0,0,0,3.8,3.2,3.7
2179,0,North America,R&D,Pharmacovigilance,Meets,Female,42,18,0,12,4.3,4,4,1,1,1,1,2.2,4,3.3
2180,0,Asia Pacific,Digital,Clinical Operations,Meets,Female,38,12,0,5,2.7,1.6,2.8,1,1,1,1,3.3,3.4,3.4
2181,0,Middle East & Africa,Commercial,Legal & Compliance,Below,Male,42,4,1,5,,1.7,3.7,1,1,1,1,2.1,3.1,3
2182,0,North America,Manufacturing,Pharmacovigilance,Exceeds,Female,51,10,0,9,2.1,2.4,3.5,1,1,1,1,3.2,3.9,3.2
2183,0,Latin America,Finance,Data Science,Below,Male,34,13,0,12,5,3.3,5,1,1,1,1,5,3.4,4.9
2184,0,Asia Pacific,Commercial,Marketing,Meets,Male,44,21,0,6,2.8,3.8,1.8,1,1,1,1,3,1.3,2.2
2185,0,Latin America,Finance,Quality Assurance,Meets,Male,34,9,0,8,3.3,3.1,4.3,1,1,1,1,3.3,3.3,3
2186,0,North America,HR,Data Science,Exceeds,Female,32,5,0,12,2.9,2.3,2.5,1,1,1,1,3.1,3.3,4.5
2187,0,Latin America,R&D,Medical Affairs,Exceeds,Male,47,7,0,11,2.2,3.9,5,1,1,1,1,3.8,3.6,3.7
2188,0,Latin America,Finance,Supply Chain,Meets,Female,33,29,1,5,,2.7,2.6,1,1,1,1,3.6,2.2,1.7
2189,0,North America,HR,IT & Digital,Meets,Female,38,17,0,12,3.7,1,3.3,1,1,1,1,3.8,2.7,3
2190,0,Middle East & Africa,Finance,Supply Chain,Meets,Male,33,13,0,9,3.1,3.8,2.9,1,0,0,0,3.6,5,1.9
2191,0,Latin America,Manufacturing,Medical Affairs,Exceeds,Male,53,11,0,12,1.7,3.8,2.5,1,1,1,1,2.2,3.1,1.8
2192,0,Latin America,Manufacturing,Pharmacovigilance,Meets,Male,38,15,0,6,3.2,4.1,1.5,0,0,0,0,4.3,5,2.6
2193,1,Middle East & Africa,Manufacturing,Finance & Accounting,Exceeds,Male,31,15,0,8,3.7,2.2,2.7,1,1,1,1,4.9,2.1,4.4
2194,0,Latin America,Manufacturing,Data Science,Meets,Female,33,21,1,7,,3.4,2.6,1,1,1,1,2.9,3.2,1.4
2195,0,Latin America,Commercial,IT & Digital,Below,Female,51,5,1,11,,4.3,2.5,1,1,1,1,3.6,3.3,3.1
2196,0,Latin America,Manufacturing,Quality Assurance,Below,Male,37,4,1,10,,4.3,1.9,1,1,1,1,4.7,4.5,3.4
2197,0,Europe,Manufacturing,Quality Assurance,Meets,Female,38,20,0,8,3.7,2.6,3,0,0,0,0,3.1,1.6,1.8
2198,0,Middle East & Africa,Commercial,Finance & Accounting,Meets,Female,47,9,0,8,2.5,2,2.7,1,1,1,1,1.8,2.6,3.1
2199,0,Latin America,Manufacturing,Medical Affairs,Below,Male,46,20,0,5,2.8,1.9,3.2,1,1,1,1,2.6,1.8,2.9
2200,0,Middle East & Africa,HR,Supply Chain,Meets,Female,33,8,1,6,,1,3.3,1,1,1,1,4.2,1.5,2.9
2201,0,Asia Pacific,HR,Medical Affairs,Meets,Male,33,4,0,12,4.3,3.1,2.8,1,1,1,1,4.8,3.4,2.9
2202,0,Asia Pacific,Digital,Finance & Accounting,Below,Female,35,5,1,10,,1.7,4.6,1,1,1,1,3.8,4.1,4.9
2203,0,Latin America,HR,IT & Digital,Far Below,Male,36,25,0,7,3.2,4.2,2.4,1,1,1,1,3.7,3.8,1
2204,1,Middle East & Africa,R&D,Clinical Operations,Exceeds,Female,43,9,0,6,2.7,1.7,2,1,1,1,1,2.5,2.1,1.2
2205,0,Middle East & Africa,R&D,Clinical Operations,Meets,Male,37,9,1,9,,3.2,3.2,1,1,1,1,3.7,3.3,1.7
2206,0,Middle East & Africa,R&D,Legal & Compliance,Meets,Female,36,25,0,6,4.4,1.3,3,0,0,0,0,4.4,1,3.1
2207,0,Europe,Commercial,Clinical Operations,Meets,Male,38,11,0,6,3.3,3.8,3.9,1,1,1,1,4.1,3.6,3
2208,0,Asia Pacific,HR,Regulatory Affairs,Exceeds,Male,35,15,0,9,2.4,4.6,2.5,1,1,1,1,3.6,4.1,4.2
2209,0,Middle East & Africa,R&D,Marketing,Meets,Female,47,4,0,8,2.1,4,2.1,1,1,1,1,2.2,4.5,1
2210,0,Middle East & Africa,Digital,IT & Digital,Meets,Female,34,10,0,6,3.1,4,2,1,1,1,1,4.3,3.9,3.1
2211,0,Europe,Commercial,Market Access,Exceeds,Female,38,10,0,11,4.6,3.9,3.3,1,1,1,1,5,2.7,2.3
2212,0,Europe,Digital,Human Resources,Meets,Non-Binary/Other,42,12,0,7,2.4,4.2,3,1,1,1,1,2.1,3.2,3.4
2213,0,Middle East & Africa,HR,Sales,Meets,Female,42,5,0,11,3.8,2.7,3.9,1,1,1,1,4.4,3.1,4.2
2214,1,North America,Manufacturing,Human Resources,Meets,Female,36,31,0,6,3.9,1,3.5,1,1,0,0,4.4,3.8,2.9
2215,0,Middle East & Africa,Digital,Regulatory Affairs,Meets,Male,45,6,0,11,2.2,3.3,2.1,1,1,1,1,2.9,2.9,2
2216,0,Middle East & Africa,Manufacturing,Quality Assurance,Meets,Male,51,13,0,9,2.5,2.9,2.7,1,1,1,1,3.5,1.9,2.8
2217,0,Europe,Commercial,Pharmacovigilance,Exceeds,Non-Binary/Other,49,18,0,8,2.8,3.8,1.7,1,1,1,1,2.8,1.8,3.7
2218,1,Europe,Digital,Supply Chain,Meets,Female,28,15,0,6,3.8,4.1,2.4,0,0,0,0,3.9,3.6,3.8
2219,0,Middle East & Africa,Digital,IT & Digital,Exceeds,Male,38,24,0,7,1.6,3.5,1.5,1,1,1,1,3.2,3.2,2.1
2220,0,Middle East & Africa,Finance,Legal & Compliance,Meets,Female,34,11,1,11,,1,1.4,1,1,1,1,4.9,2.1,1.7
2221,0,Middle East & Africa,Commercial,Communications,Meets,Female,41,9,0,10,2.4,1.6,4.8,1,1,1,1,1.7,2.1,4.2
2222,0,Europe,Commercial,Communications,Meets,Female,44,27,0,8,2.8,3.1,2.3,0,0,0,0,2.4,2.5,2
2223,0,Middle East & Africa,R&D,IT & Digital,Below,Female,31,4,0,5,1.4,3.7,3.1,1,1,1,1,1.3,3.6,3
2224,0,Middle East & Africa,HR,Pharmacovigilance,Meets,Male,43,13,0,8,2.8,2.3,3.7,1,1,1,1,2.5,3.8,3.3
2225,0,Latin America,Digital,Medical Affairs,Meets,Female,38,15,0,9,4.7,2.7,3,1,1,1,1,3.6,4,3.9
2226,0,North America,Digital,Finance & Accounting,Meets,Male,36,5,0,10,2.5,4,1.6,1,1,1,1,3.7,5,2.5
2227,0,Asia Pacific,Commercial,Supply Chain,Below,Female,41,9,0,12,4.5,3,4.9,1,1,1,1,3.7,3.7,3.2
2228,0,North America,Commercial,Sales,Meets,Male,37,8,0,5,1.9,4.4,2.3,1,1,1,1,3.2,4.3,1.1
2229,0,Latin America,HR,Sales,Below,Female,45,5,0,8,2.5,3,2.9,0,0,0,0,2.7,2.9,1.8
2230,0,Asia Pacific,Commercial,Data Science,Exceeds,Female,36,4,1,6,,2.7,2.6,1,1,1,1,4.4,3,2.9
2231,0,Middle East & Africa,Manufacturing,Pharmacovigilance,Below,Female,46,21,0,10,3.5,1.8,2.9,0,0,0,0,2.6,1.8,3.6
2232,0,Latin America,Manufacturing,Finance & Accounting,Meets,Female,38,6,0,12,3.6,2,4,1,1,1,1,3.5,4,3.8
2233,0,Middle East & Africa,Finance,Market Access,Meets,Female,28,10,1,11,,2.4,2.4,1,1,1,1,1.2,2,1.9
2234,0,Europe,Manufacturing,Sales,Meets,Male,33,15,0,9,4.6,4.9,2.3,1,1,1,1,3.7,5,2.2
2235,0,Latin America,Manufacturing,Marketing,Meets,Female,37,23,0,11,3.2,5,3.5,1,1,1,1,3.6,4.6,2.8
2236,0,Europe,HR,Data Science,Meets,Male,40,15,0,8,4.1,2.8,2.7,1,1,1,1,5,3.3,2
2237,0,Latin America,Digital,Market Access,Exceeds,Female,37,6,1,8,,4.3,3.3,1,1,1,1,4.8,4.3,2.9
2238,0,Latin America,Manufacturing,Supply Chain,Meets,Male,34,8,0,5,3.6,3.8,3.3,1,1,1,0,4.7,3.1,3.1
2239,0,Europe,Finance,Pharmacovigilance,Meets,Male,49,11,0,12,3,2.6,2.2,1,1,1,1,3,3.2,2.8
2240,0,Asia Pacific,Commercial,Pharmacovigilance,Meets,Male,46,14,0,9,4.2,2.2,2.4,1,1,1,1,2.8,2.5,2.4
2241,0,North America,Manufacturing,Legal & Compliance,Below,Female,31,18,0,9,3.8,3.5,3.1,1,1,1,1,3.2,2.6,3.4
2242,0,Middle East & Africa,Finance,Communications,Below,Male,33,19,0,9,3.6,1.8,3.3,1,1,1,1,4.5,1.6,3.5
2243,0,Latin America,HR,Finance & Accounting,Exceeds,Male,40,25,0,5,3.3,5,2.9,1,1,1,1,2.6,3.8,3.3
2244,0,Middle East & Africa,Commercial,Market Access,Exceeds,Female,37,4,0,6,1.9,3.4,4.1,1,1,1,1,2.8,3.1,3.1
2245,0,Europe,Finance,Legal & Compliance,Meets,Male,28,5,1,6,,4.1,2.6,0,0,0,0,4.2,2.7,2.1
2246,0,Middle East & Africa,Manufacturing,Market Access,Meets,Female,34,23,0,7,5,2.9,2.9,0,0,0,0,4.8,4.3,3.2
2247,0,Europe,Digital,Sales,Meets,Female,42,6,0,10,3.5,4.5,2.4,1,1,1,1,2.6,3.6,2.3
2248,0,Middle East & Africa,Commercial,Supply Chain,Meets,Female,39,4,0,8,2.7,4.3,2.8,1,1,1,0,1.3,4.7,2.7
2249,0,North America,Commercial,Finance & Accounting,Meets,Male,32,6,1,7,,3.5,2,1,1,1,1,3.2,2.5,3.5
2250,0,North America,Digital,IT & Digital,Exceeds,Male,35,10,0,11,4.4,1.4,1.4,1,1,1,0,2.9,2,1.6
2251,0,North America,Commercial,IT & Digital,Meets,Male,37,6,1,5,,2,2.4,1,1,1,1,2.5,4,3
2252,0,North America,Manufacturing,Finance & Accounting,Meets,Male,53,16,0,7,4.6,3.6,4.4,0,0,0,0,3.6,2.9,3.1
2253,0,North America,Commercial,Data Science,Meets,Male,38,13,0,12,3.7,4.3,2.2,1,1,1,1,4.5,5,1.4
2254,0,North America,Manufacturing,Marketing,Far Below,Female,34,13,0,11,2.5,3.8,2.8,0,0,0,0,2.2,2.1,2.8
2255,0,Europe,Digital,IT & Digital,Meets,Female,49,18,0,11,4.2,3.8,2.8,1,1,1,1,3.8,2.7,2
2256,0,Latin America,R&D,Quality Assurance,Far Exceeds,Male,41,7,0,10,4,4.1,1.9,1,1,0,0,2.9,3.1,2.6
2257,0,Middle East & Africa,Digital,Finance & Accounting,Exceeds,Male,33,9,0,5,2.7,3.5,2.2,1,1,1,1,4,4.7,2.7
2258,0,North America,Manufacturing,Quality Assurance,Exceeds,Female,38,9,0,10,3.5,3.6,2.9,1,1,1,1,3.1,5,3.4
2259,0,Europe,HR,Regulatory Affairs,Meets,Male,37,20,1,6,,4.6,1.8,1,1,1,1,1.7,3.9,3.6
2260,0,Europe,Digital,Marketing,Meets,Female,41,6,1,10,,3.1,1.6,1,1,1,1,2.3,2.7,3
2261,1,Europe,HR,Supply Chain,Far Exceeds,Male,30,29,0,6,3.8,4.6,2.1,0,0,0,0,4.5,4.2,2
2262,0,Latin America,HR,IT & Digital,Meets,Female,31,17,0,10,2.8,1.1,2.1,1,1,1,1,3.1,2.6,2.7
2263,0,Middle East & Africa,Manufacturing,Supply Chain,Exceeds,Female,36,16,1,10,,2.9,1.5,1,1,1,1,3.1,5,1.2
2264,0,Latin America,Manufacturing,Data Science,Meets,Female,33,8,0,7,3.2,2.7,3.6,1,1,1,1,2.3,2.5,1.4
2265,0,Asia Pacific,R&D,Legal & Compliance,Meets,Male,44,5,1,12,,3.9,4.3,1,1,1,1,2.4,4.4,4
2266,0,Europe,Finance,Legal & Compliance,Meets,Male,32,4,0,10,4.9,2.3,2.1,1,1,1,1,5,3.4,2.9
2267,0,Asia Pacific,Commercial,Pharmacovigilance,Meets,Female,52,3,1,7,,2.4,3.7,1,1,1,1,2.8,3.6,3.5
2268,0,North America,Digital,Regulatory Affairs,Below,Female,37,17,0,5,1.2,2.1,3.4,1,1,0,0,2.5,2.4,3
2269,0,North America,Manufacturing,Human Resources,Meets,Female,39,28,0,5,4.4,3.7,3.1,0,0,0,0,3.8,3.8,2.5
2270,0,Latin America,Digital,Data Science,Exceeds,Female,40,10,1,7,,3.5,3.2,0,0,0,0,3.4,3.2,3.5
2271,0,Middle East & Africa,Finance,Communications,Meets,Male,38,11,0,12,3.6,3.8,3.7,0,0,0,0,1.9,4.4,1.5
2272,0,Asia Pacific,Finance,Human Resources,Meets,Male,45,17,0,12,2.9,2.7,1,1,1,1,1,4.7,1.7,1.3
2273,0,Middle East & Africa,HR,Regulatory Affairs,Meets,Male,39,8,0,8,2.5,3.4,2.5,1,1,1,1,3.7,3.3,2.6
2274,0,Latin America,Commercial,Human Resources,Meets,Female,35,15,0,8,4.6,2.4,1.6,1,1,1,1,4.2,2.5,2.4
2275,0,North America,R&D,Pharmacovigilance,Meets,Male,30,8,0,6,3.1,3.4,2.7,1,1,1,1,3,3.8,2.9
2276,0,Middle East & Africa,Digital,Medical Affairs,Meets,Male,40,10,0,11,2.9,4.4,2.7,1,1,1,1,2.4,2.5,1.4
2277,0,Middle East & Africa,Commercial,Regulatory Affairs,Meets,Female,43,24,0,12,2.1,3,1.8,1,1,1,1,3.6,3.4,3.1
2278,0,North America,R&D,Data Science,Meets,Female,30,12,0,5,3.8,2.7,4.7,1,1,1,1,3.8,3.9,5
2279,0,Asia Pacific,Digital,Finance & Accounting,Below,Female,36,17,1,10,,3,3.7,1,1,1,1,3.1,2.9,2.9
2280,1,North America,Commercial,Medical Affairs,Meets,Female,44,5,1,6,,3.4,1.2,1,1,1,1,3,3.4,1.8
2281,0,Middle East & Africa,Manufacturing,Communications,Meets,Non-Binary/Other,33,12,0,9,4.1,3.7,3.8,1,0,0,0,2.9,3.1,4.3
2282,0,Asia Pacific,Digital,Legal & Compliance,Meets,Male,33,32,0,12,1,3,2.7,1,1,1,1,1,2.6,3.3
2283,0,Asia Pacific,Commercial,Market Access,Meets,Male,37,6,0,5,2.2,3,1.5,1,1,1,1,3.1,4.1,2
2284,0,North America,Finance,Finance & Accounting,Meets,Female,46,12,1,12,,4,4.2,1,0,0,0,4.5,2.5,4.1
2285,0,Middle East & Africa,R&D,Marketing,Exceeds,Male,44,8,0,9,4.2,2.8,2.7,1,0,0,0,4.2,3.8,1.8
2286,0,Latin America,Commercial,Sales,Meets,Male,46,9,0,5,2.1,3.2,4.5,1,1,1,1,1.9,3,3.9
2287,0,Middle East & Africa,Manufacturing,Data Science,Meets,Male,32,16,0,6,4.5,2.9,2,1,1,1,1,3.7,3.6,2.9
2288,0,Europe,Digital,Market Access,Meets,Female,34,12,0,8,3.9,3,2.2,1,1,1,1,2.7,2.2,1.6
2289,0,Latin America,Digital,Quality Assurance,Far Below,Male,37,6,0,6,2.6,3.4,2.5,1,1,1,1,2.9,3.7,1.8
2290,0,Asia Pacific,Digital,Quality Assurance,Meets,Male,36,6,1,11,,3.4,4.3,1,1,1,1,3.3,2.9,2.4
2291,0,Latin America,Manufacturing,Supply Chain,Exceeds,Male,33,10,1,11,,2.7,2.4,1,1,1,1,2.1,3.9,3.6
2292,0,Asia Pacific,R&D,Data Science,Meets,Male,41,36,0,7,3.1,3.8,3.1,1,1,1,1,3.1,2.9,3.6
2293,0,Asia Pacific,Digital,Legal & Compliance,Meets,Female,28,14,0,6,3.8,2.8,4.9,1,1,1,1,2.9,4.6,4.5
2294,0,Latin America,R&D,Communications,Meets,Non-Binary/Other,39,12,0,9,2.8,2.9,2.7,1,1,1,1,3.3,1.6,3.6
2295,1,Asia Pacific,Commercial,Clinical Operations,Exceeds,Female,48,10,0,8,4,3.8,3.6,1,1,1,1,5,2.9,2.6
2296,0,Asia Pacific,Finance,Sales,Exceeds,Non-Binary/Other,38,7,0,6,2.8,3.7,1.5,1,1,1,1,2.9,2.7,2.7
2297,0,Europe,Finance,Clinical Operations,Below,Male,33,3,1,9,,3.2,1.1,1,1,1,1,3.8,3.6,2.4
2298,1,Middle East & Africa,R&D,Marketing,Meets,Female,30,7,0,8,2.7,3.2,1.8,1,1,1,1,3.3,4.9,2.1
2299,0,Middle East & Africa,R&D,Human Resources,Below,Male,40,23,0,6,3.1,3,3.9,1,1,1,1,4,2.3,4.5
2300,0,Europe,Finance,Supply Chain,Meets,Female,48,8,0,9,2.4,3,1.4,1,1,1,1,3.8,3.5,2.7
2301,0,Latin America,Digital,Communications,Below,Male,39,8,1,5,,2.5,4.3,1,1,1,1,1.5,2.4,3.5
2302,0,North America,HR,Communications,Below,Female,36,6,0,8,4.3,5,1.2,1,1,1,1,3.3,4.4,1.1
2303,0,North America,HR,IT & Digital,Far Below,Male,33,10,0,9,4.1,3.8,3.1,1,1,1,1,4.2,2.8,1.1
2304,0,North America,Manufacturing,Sales,Exceeds,Male,29,30,0,12,4.5,2.7,2.9,1,1,1,1,3.3,2.9,2.1
2305,0,Europe,Finance,Medical Affairs,Exceeds,Female,40,9,0,7,3.7,3.5,1.3,1,1,1,1,3.3,3.1,1.8
2306,0,Europe,Finance,Regulatory Affairs,Below,Female,28,20,0,9,5,1.5,2.2,0,0,0,0,4.8,3.8,2.5
2307,0,Asia Pacific,Manufacturing,Sales,Meets,Female,43,30,0,10,2.6,2.7,2.4,1,1,1,1,4,3.9,3.3
2308,0,North America,HR,Pharmacovigilance,Meets,Female,42,4,0,6,3.6,4.4,2,1,1,1,1,3.2,4.1,1.7
2309,0,Latin America,Commercial,Medical Affairs,Meets,Male,37,11,0,5,1.4,5,1.2,1,1,1,1,2.1,4.3,1.1
2310,0,Latin America,Digital,Legal & Compliance,Exceeds,Female,42,13,0,8,3.6,2.6,3.7,1,1,1,1,4.5,3.3,3.4
2311,0,North America,Digital,Regulatory Affairs,Below,Male,39,19,0,7,2.4,3.6,1.1,1,1,1,1,2.9,3,2.7
2312,0,North America,Commercial,Finance & Accounting,Meets,Female,42,10,0,11,3.1,2.6,1.6,0,0,0,0,4.4,3.6,1.5
2313,0,North America,Commercial,Communications,Meets,Female,43,4,1,12,,4.1,2.2,0,0,0,0,1.7,4.1,2.6
2314,0,Europe,HR,Marketing,Below,Female,36,18,0,6,2.6,1.7,2.9,1,1,1,1,3.2,3.1,3.7
2315,0,Europe,Manufacturing,Quality Assurance,Meets,Male,30,8,0,6,4.9,3.5,3.5,1,1,1,1,4.1,2.7,1.8
2316,0,Europe,Commercial,Regulatory Affairs,Exceeds,Male,52,3,1,9,,1.9,2,1,1,1,1,4,1,2.7
2317,0,Middle East & Africa,Manufacturing,Pharmacovigilance,Meets,Male,37,10,1,10,,3,1.6,1,1,1,1,3.2,3.4,1.3
2318,0,Latin America,R&D,Supply Chain,Below,Male,35,8,0,12,3.3,2.9,1.7,1,1,1,1,3.4,3.8,2.3
2319,0,Latin America,Digital,Legal & Compliance,Exceeds,Male,41,1,1,7,,3.2,2.9,1,1,1,1,3.7,3.4,1.8
2320,0,Asia Pacific,HR,Finance & Accounting,Exceeds,Female,37,24,0,9,1.5,4.5,1.5,0,0,0,0,2.9,2.6,1
2321,0,Europe,Digital,Regulatory Affairs,Meets,Male,30,21,0,7,4.2,3.7,2.3,1,1,1,1,3.2,2.5,2.2
2322,0,Middle East & Africa,HR,Human Resources,Meets,Female,31,9,1,11,,3.2,1.8,1,0,0,0,3.9,2.5,3.7
2323,0,Middle East & Africa,R&D,Sales,Below,Male,33,19,0,5,5,3.2,1,1,1,1,1,3.9,1.7,1.4
2324,0,Latin America,Digital,Sales,Meets,Male,40,5,0,11,2.6,3.3,2.3,1,1,1,1,2.9,1.9,1.8
2325,0,Europe,R&D,Supply Chain,Meets,Female,34,14,0,10,4,3.9,2.7,1,1,1,1,3.7,2.6,1.4
2326,0,Asia Pacific,HR,Finance & Accounting,Meets,Female,44,14,0,10,1.6,3.5,3.3,1,1,1,1,2.8,3.5,4.1
2327,0,Europe,Commercial,Communications,Far Below,Female,37,15,0,8,3.2,4.4,3,1,1,1,1,3.7,3.2,3.3
2328,0,North America,Digital,Sales,Meets,Male,38,8,0,5,3.1,2.2,2.1,0,0,0,0,2.9,4.4,1.6
2329,0,Europe,R&D,Human Resources,Meets,Male,38,30,1,9,,3,2.4,1,1,1,0,2.6,2,2.2
2330,0,North America,Finance,Legal & Compliance,Meets,Female,32,14,0,7,3.3,3.1,2.5,0,0,0,0,2.6,5,1.3
2331,0,North America,Digital,Marketing,Meets,Female,46,12,0,11,3.8,2.9,3.6,1,1,1,1,2.9,1.3,4.6
2332,0,Asia Pacific,Digital,Legal & Compliance,Below,Non-Binary/Other,40,7,0,10,4.7,3.1,3.6,1,1,1,1,4.1,2.2,3.2
2333,0,Latin America,Digital,Pharmacovigilance,Meets,Male,37,21,0,12,3.6,3.5,4.3,0,0,0,0,2.5,2.4,3.4
2334,0,Europe,Manufacturing,Data Science,Meets,Female,35,5,1,6,,2.2,2.7,1,1,1,1,3.1,2.1,3.8
2335,0,North America,R&D,Data Science,Exceeds,Female,35,8,0,8,3.5,1,3.9,1,0,0,0,2.7,2.2,3.8
2336,0,Europe,R&D,Quality Assurance,Meets,Female,31,8,1,11,,3.5,2.5,1,1,1,1,2.8,3.4,3.2
2337,0,Latin America,Digital,Market Access,Below,Male,30,9,1,10,,2.4,2.8,1,0,0,0,3.6,3.2,2.6
2338,0,Latin America,Commercial,IT & Digital,Far Below,Female,30,22,1,5,,2,2.1,1,1,1,1,3.2,3.2,2.5
2339,0,Middle East & Africa,Digital,Marketing,Meets,Female,44,14,0,8,3,2.9,3.1,1,1,1,1,3.4,3.1,3.1
2340,0,Latin America,Manufacturing,IT & Digital,Below,Female,33,11,0,8,2,4.7,1.2,1,1,1,1,1.7,5,1.9
2341,0,Asia Pacific,HR,Market Access,Meets,Male,32,5,0,6,3,4.6,3.8,1,1,1,1,3.7,3.7,4.8
2342,0,North America,Manufacturing,Data Science,Exceeds,Female,46,19,0,9,3.4,2.9,2.9,1,0,0,0,1.8,3.6,3.3
2343,0,Middle East & Africa,Commercial,Regulatory Affairs,Meets,Non-Binary/Other,38,9,0,8,3.6,1.9,3.2,1,1,1,1,3.5,2.7,4.8
2344,0,Asia Pacific,Digital,Finance & Accounting,Meets,Female,31,10,0,6,4.1,4.1,2.9,0,0,0,0,3.2,2.9,4.1
2345,0,Europe,R&D,Regulatory Affairs,Meets,Female,41,12,0,6,4.5,5,3.9,1,1,1,1,3.8,4.5,1.9
2346,0,North America,Finance,Regulatory Affairs,Meets,Female,47,5,1,11,,4.8,3.1,0,0,0,0,4.1,3.9,1.9
2347,0,Latin America,Digital,Communications,Below,Female,42,6,1,10,,3.1,1.6,1,1,1,1,2.9,3.8,1.8
2348,0,North America,Commercial,Sales,Meets,Male,39,5,1,9,,3.6,1.8,1,1,1,1,4.6,3.6,2.2
2349,0,Europe,R&D,Communications,Exceeds,Male,41,5,1,10,,3.6,2.6,1,1,1,1,3,5,3.4
2350,0,Middle East & Africa,Manufacturing,IT & Digital,Exceeds,Female,45,13,0,9,2.7,3.3,1.8,1,1,1,1,1.4,4.7,2
2351,0,Middle East & Africa,HR,Sales,Below,Male,48,13,0,7,3.6,2.5,1.7,1,1,1,1,2.5,2.6,1.6
2352,0,Middle East & Africa,HR,Clinical Operations,Meets,Female,32,4,1,11,,2.2,2,1,1,1,1,3.9,4.7,3.1
2353,0,Latin America,Digital,Regulatory Affairs,Meets,Female,38,30,0,12,2,4,2.8,1,1,1,1,2.3,4.5,3.4
2354,0,Asia Pacific,Manufacturing,Regulatory Affairs,Meets,Female,42,5,1,8,,3.3,3.9,1,1,1,1,4,4,4.9
2355,0,Asia Pacific,Finance,Communications,Meets,Female,39,2,0,5,3.9,3.6,3.9,1,1,1,1,3.7,3.2,3.7
2356,0,North America,Finance,Medical Affairs,Meets,Male,41,15,0,11,3.8,2.7,3.3,1,1,1,0,4.4,3.6,3.5
2357,0,Latin America,Commercial,Supply Chain,Far Exceeds,Male,51,12,0,12,3.6,2.5,2.4,1,1,1,1,4.8,3.1,3.4
2358,1,Middle East & Africa,HR,Data Science,Meets,Male,36,10,0,5,2.5,1.5,2.6,1,1,1,1,3.1,2.4,3.7
2359,0,Middle East & Africa,Manufacturing,Sales,Below,Female,30,8,0,8,3.2,1.4,2.8,1,1,1,1,2.9,1,4.7
2360,1,Europe,Digital,Human Resources,Meets,Non-Binary/Other,49,12,0,11,4.2,4.1,2,1,1,1,1,3.5,4.5,1.6
2361,0,Europe,R&D,Pharmacovigilance,Below,Male,49,17,0,10,1.9,4.9,3.1,1,1,1,1,3.9,4,4.9
2362,1,Middle East & Africa,Digital,Sales,Meets,Male,41,10,0,10,4.2,3.2,3.4,1,1,1,1,4,2.5,2.1
2363,0,Middle East & Africa,Digital,Pharmacovigilance,Meets,Male,35,11,0,11,2.1,3.2,2.2,1,1,1,1,4,2.1,3.4
2364,1,Latin America,Manufacturing,Clinical Operations,Meets,Female,43,12,0,12,4,2.4,1,0,0,0,0,4.4,3.1,1.7
2365,0,Asia Pacific,HR,Pharmacovigilance,Meets,Female,38,12,0,11,2.7,2.1,1.3,1,1,1,1,3.9,3.4,1.4
2366,0,Europe,Manufacturing,Legal & Compliance,Meets,Female,36,5,0,10,2.9,2.5,3.4,1,1,1,1,2.4,1.7,2.1
2367,0,Asia Pacific,R&D,Sales,Meets,Female,34,33,0,11,2.3,4.6,1.3,1,1,1,1,1.6,4.6,2.9
2368,0,Latin America,Manufacturing,Quality Assurance,Meets,Female,38,4,0,9,5,5,3,0,0,0,0,3.8,4.2,2.8
2369,0,Middle East & Africa,Commercial,Sales,Meets,Male,41,14,0,5,3.6,2,2.3,0,0,0,0,3.8,1,1.9
2370,0,Asia Pacific,Digital,Legal & Compliance,Below,Male,39,31,0,10,4.4,3.8,3.9,1,1,1,1,4.2,3.2,3.8
2371,0,Middle East & Africa,HR,IT & Digital,Meets,Female,43,11,0,5,1.8,4.4,2.8,0,0,0,0,2.4,3.4,4
2372,0,Middle East & Africa,Finance,Marketing,Meets,Female,37,19,0,9,4.1,2.7,1,0,0,0,0,4.2,4.2,1.1
2373,0,North America,R&D,Quality Assurance,Meets,Male,35,5,1,10,,3.3,2.6,1,1,1,1,3.9,3,2.5
2374,0,Asia Pacific,Finance,Regulatory Affairs,Meets,Male,40,5,1,10,,2.3,2.7,1,1,1,1,3.4,1.8,2.9
2375,0,Asia Pacific,Digital,Data Science,Meets,Female,39,12,0,9,3,4.2,2.5,1,1,1,1,3.8,3.2,1.8
2376,0,Middle East & Africa,Manufacturing,Human Resources,Far Exceeds,Male,47,10,0,10,2.5,3.8,1.8,1,1,1,1,3.5,3.2,2.1
2377,0,Latin America,Finance,Pharmacovigilance,Below,Female,36,11,0,9,3.8,1.8,3,1,1,1,1,4.4,1.5,3.2
2378,0,North America,Commercial,Sales,Meets,Female,35,18,0,10,2.5,2.9,2.4,1,1,1,1,2.5,3.2,2.6
2379,0,Middle East & Africa,Manufacturing,Sales,Meets,Male,37,8,0,8,3.5,2.7,3.4,1,1,1,1,4.1,2.8,3.9
2380,0,Europe,Digital,Pharmacovigilance,Meets,Female,36,5,0,7,4.2,4.5,2.6,1,1,1,1,4.7,3.6,4.4
2381,0,Europe,Finance,Market Access,Meets,Male,34,2,0,5,4.6,3.4,2.9,1,1,1,1,3.5,4.4,1.9
2382,0,North America,R&D,Data Science,Exceeds,Male,28,8,0,11,3.7,2.9,2.3,1,1,1,0,4.3,2.8,2.5
2383,0,Latin America,Finance,Legal & Compliance,Meets,Male,31,8,0,8,3,4.1,2.3,0,0,0,0,2.6,4,3.2
2384,0,Middle East & Africa,Finance,Medical Affairs,Exceeds,Female,37,1,0,5,3.8,1.5,3.2,1,1,1,1,4.3,3.4,3.5
2385,0,Asia Pacific,HR,Supply Chain,Below,Female,30,7,0,8,4,1.7,3.1,1,1,1,1,4.4,2.1,3.1
2386,0,North America,Finance,Regulatory Affairs,Meets,Male,41,25,0,5,2,4.6,2.4,1,1,1,1,1.7,3.8,2.1
2387,0,Latin America,Digital,Quality Assurance,Meets,Female,40,14,1,7,,2.7,2.2,1,1,1,1,3.1,2,3.2
2388,0,Asia Pacific,R&D,Sales,Meets,Male,34,24,0,6,2.7,2.5,3.3,1,1,0,0,1.8,2.6,2.4
2389,0,Europe,Digital,Communications,Meets,Female,38,11,0,8,3.9,2.8,1.6,1,1,1,1,3.7,2.6,2.1
2390,0,Europe,Commercial,Clinical Operations,Meets,Female,37,3,0,9,1.3,5,2.5,1,1,1,1,2.7,5,2.7
2391,0,Asia Pacific,Manufacturing,Data Science,Meets,Female,28,13,0,10,3.1,4.1,1.8,1,1,1,1,3.8,4.4,2.4
2392,0,North America,Finance,Communications,Meets,Male,41,25,0,6,3.7,1.7,3.2,1,1,1,1,2.9,3.3,2.6
2393,0,Europe,HR,Pharmacovigilance,Meets,Male,34,17,1,7,,3.3,1.7,1,1,1,1,3.7,2.3,2.3
2394,0,Middle East & Africa,R&D,Sales,Meets,Male,32,25,0,12,3.3,2.4,2.9,1,1,1,1,5,2.8,2.1
2395,0,Asia Pacific,HR,Quality Assurance,Meets,Male,42,15,1,11,,4.3,1.5,1,1,1,1,3.2,3.3,2.6
2396,0,Asia Pacific,HR,Clinical Operations,Meets,Female,39,14,0,8,1.3,2.1,2.7,1,1,1,1,3.5,1.3,3
2397,0,Europe,HR,Legal & Compliance,Meets,Male,43,9,0,6,3.3,3.5,2.5,1,1,1,1,3.2,3.6,3.1
2398,0,North America,Finance,Supply Chain,Meets,Male,37,24,0,6,2.7,2.9,2.1,1,1,1,1,4.4,4.7,2.1
2399,0,Middle East & Africa,R&D,Supply Chain,Meets,Male,39,18,0,10,2.5,3.1,2.5,1,1,1,1,4.2,2.8,2.5
2400,0,North America,R&D,Quality Assurance,Meets,Female,43,11,0,5,4.1,3.4,1.7,1,1,1,1,3.6,3.5,2.7
2401,0,Latin America,HR,Data Science,Meets,Female,48,6,0,11,5,4.2,2.3,1,1,0,0,4,4.3,3.2
2402,0,Latin America,Manufacturing,Clinical Operations,Exceeds,Male,36,15,0,10,3.9,2.5,2.3,1,1,1,1,3.9,3.7,3.7
2403,0,Europe,Finance,Human Resources,Meets,Male,39,6,0,8,3.9,2,3.6,1,1,1,0,3.5,3,3.8
2404,0,Europe,Finance,Communications,Below,Female,41,7,1,9,,3.5,2.4,1,1,1,1,3.3,3.3,2.2
2405,0,Europe,Digital,Pharmacovigilance,Exceeds,Male,41,27,1,10,,2.3,5,1,1,1,1,3.3,3.1,3.8
2406,0,Latin America,Finance,Clinical Operations,Far Below,Female,35,5,0,6,3.5,3.5,1.5,1,1,1,1,2.7,3.1,1.4
2407,0,North America,HR,Human Resources,Meets,Female,37,4,1,9,,3,3.1,1,1,1,1,2.3,5,2.1
2408,0,North America,Commercial,Marketing,Exceeds,Male,41,9,1,11,,2.2,1.1,1,1,1,1,3.8,2.8,2.3
2409,0,Europe,HR,Pharmacovigilance,Exceeds,Male,39,14,0,11,3.2,2.1,1.9,1,1,1,1,3.9,4.5,3.3
2410,0,Middle East & Africa,R&D,Legal & Compliance,Meets,Male,49,12,0,5,4.6,3.8,3.4,1,1,1,1,4,4.8,3
2411,0,North America,Finance,Regulatory Affairs,Meets,Female,36,7,0,11,3.7,2.9,3.4,1,1,1,1,3,5,2.3
2412,0,Latin America,Finance,Medical Affairs,Meets,Female,33,7,0,10,3.7,2.2,2.6,0,0,0,0,4.8,2.9,1.2
2413,0,Asia Pacific,Digital,Regulatory Affairs,Exceeds,Male,41,4,1,9,,3,1.8,1,1,1,1,4.2,3.3,2.2
2414,0,Asia Pacific,Commercial,Medical Affairs,Meets,Male,32,9,0,5,4.9,2.3,3.5,1,1,1,1,4.2,2.9,3.3
2415,0,Asia Pacific,Finance,Regulatory Affairs,Meets,Female,35,10,0,11,3.2,3.3,3.9,1,1,1,1,2.5,2.7,4
2416,0,Middle East & Africa,Digital,IT & Digital,Meets,Male,38,8,0,11,2.4,3.5,1.8,1,1,1,1,2.5,2.4,2.8
2417,0,Europe,Digital,Clinical Operations,Exceeds,Male,38,11,0,5,3.2,3.2,2.7,1,1,1,1,1.8,2.5,3.1
2418,0,Latin America,Commercial,Human Resources,Exceeds,Female,38,8,1,10,,2.7,3.3,1,1,1,1,3.2,3.6,2.8
2419,0,Middle East & Africa,HR,Data Science,Meets,Female,35,11,0,6,2.5,2,2.7,1,1,1,1,2.7,3.4,4
2420,0,Latin America,HR,Quality Assurance,Meets,Male,40,11,0,8,2.9,3.3,2.3,1,1,1,1,3.6,2.9,2.6
2421,0,Latin America,HR,Sales,Far Below,Male,51,12,0,7,2.7,2.2,2.6,1,1,1,1,4.8,1.7,2
2422,0,Europe,Manufacturing,Medical Affairs,Meets,Female,43,15,0,10,1,2.5,1.9,1,1,1,1,1.9,3.6,2.2
2423,0,Asia Pacific,HR,Sales,Meets,Male,28,15,0,9,3.3,3.1,1,0,0,0,0,3.1,3.4,1.9
2424,0,Europe,Commercial,Marketing,Far Below,Female,36,19,0,8,3.9,3.5,1.8,1,1,1,1,4.2,4.1,2.7
2425,1,Middle East & Africa,Manufacturing,Marketing,Exceeds,Female,41,13,1,12,,4.6,3.5,1,1,1,1,3.3,3.1,3.5
2426,0,Middle East & Africa,HR,Sales,Exceeds,Male,29,2,0,9,4.8,2.4,1.5,1,1,1,1,3.1,3,2.2
2427,0,Middle East & Africa,Manufacturing,IT & Digital,Meets,Female,28,7,0,9,3.8,2.6,3,1,1,1,1,2.5,2,2
2428,0,Europe,Commercial,Human Resources,Exceeds,Male,34,10,0,12,3.9,1.3,3.1,1,1,1,1,3,2.1,2.8
2429,0,Latin America,HR,IT & Digital,Meets,Female,33,23,0,6,2,3.2,5,1,1,1,0,2.5,2.8,3.7
2430,0,Latin America,R&D,Marketing,Meets,Female,48,7,0,5,3.3,2,2.6,1,1,1,1,3.6,3.3,4
2431,0,North America,Finance,Pharmacovigilance,Exceeds,Female,40,10,0,8,4,3.9,3.8,1,1,1,1,4.6,5,3.1
2432,0,Middle East & Africa,Commercial,Sales,Meets,Female,37,12,0,6,2.7,3.4,3,1,1,1,1,3.1,3.9,2.9
2433,0,Latin America,Digital,Finance & Accounting,Meets,Male,36,10,0,12,5,2,1,1,1,1,1,4.4,3.6,1
2434,0,North America,Digital,Marketing,Meets,Male,41,19,0,6,4.2,3.1,1.8,1,1,1,1,4.6,2.6,3.3
2435,0,Latin America,Commercial,Medical Affairs,Meets,Male,39,5,0,8,3.9,3.1,2.8,1,1,1,1,4.2,1.9,1.3
2436,0,Middle East & Africa,Digital,Finance & Accounting,Meets,Female,41,28,0,9,3.2,4.2,4.5,1,1,1,1,3.2,4.6,2.3
2437,0,Asia Pacific,Commercial,Data Science,Below,Female,40,1,1,11,,3.5,3.3,1,1,1,1,3.4,4,4
2438,0,Middle East & Africa,R&D,Finance & Accounting,Meets,Male,44,7,0,10,4,2.3,2.5,1,1,1,1,3,2.7,2.4
2439,0,Europe,Commercial,IT & Digital,Meets,Female,38,14,0,5,2.8,4.8,3,1,1,1,1,2.9,4.9,3.5
2440,0,Latin America,HR,Marketing,Below,Male,43,14,0,6,2.7,2,2,1,1,1,1,3.6,1,2.2
2441,0,Latin America,HR,Human Resources,Below,Female,40,14,0,12,3,4.7,2.6,1,1,1,1,4.3,2.6,2.1
2442,0,Europe,Manufacturing,Human Resources,Meets,Male,39,18,0,11,2.1,3.2,1.6,1,1,1,1,2.8,3.6,2
2443,0,Europe,Digital,Sales,Exceeds,Female,36,9,0,6,2.4,1.9,2.8,1,1,1,1,1.9,2.5,1
2444,0,Asia Pacific,Finance,Medical Affairs,Exceeds,Male,38,21,0,5,3.9,2.4,3.6,1,1,1,1,4.5,2.5,3.1
2445,0,Latin America,Digital,Sales,Exceeds,Male,38,11,0,7,3.8,3.6,4.2,1,1,1,1,3.8,3.9,3.9
2446,0,Latin America,Commercial,Supply Chain,Exceeds,Male,44,7,0,10,3.5,4.3,5,1,1,1,1,3,3.8,3.6
2447,0,Asia Pacific,Finance,Clinical Operations,Below,Male,39,12,0,6,1.9,2.3,4.9,1,1,1,1,2.7,1.6,3.6
2448,0,North America,Finance,Legal & Compliance,Meets,Male,33,18,0,6,4.4,2.6,1.6,1,1,1,1,3.9,1.9,1
2449,1,Asia Pacific,Digital,Communications,Meets,Male,29,7,0,8,3.8,2.1,4.8,1,1,1,1,4.1,2.1,4.6
2450,0,Middle East & Africa,Finance,Clinical Operations,Below,Male,31,36,0,10,1.9,2.5,3.6,0,0,0,0,2.2,4.9,4.1
2451,0,Latin America,Finance,Human Resources,Meets,Female,34,3,1,6,,2.4,3.7,1,1,1,1,3.4,4.1,2.1
2452,0,Europe,HR,Finance & Accounting,Meets,Female,41,17,0,12,2.9,2.5,4,1,1,1,1,4,3.8,3.8
2453,1,Middle East & Africa,R&D,Clinical Operations,Exceeds,Female,34,5,0,10,3.8,3.3,1.8,1,1,1,1,3.6,3.8,2.7
2454,0,Latin America,Commercial,Regulatory Affairs,Meets,Female,45,3,0,6,1.9,2.3,3.7,1,1,1,1,3.3,2.2,3
2455,0,Asia Pacific,Digital,Pharmacovigilance,Far Exceeds,Male,31,4,0,10,2.8,3.1,1,1,1,1,1,2.9,3.1,1.1
2456,0,Middle East & Africa,HR,Finance & Accounting,Below,Female,42,8,0,5,1.2,4.6,2,1,1,1,1,1.8,5,3.6
2457,0,Latin America,Manufacturing,Sales,Far Below,Male,28,9,0,11,3.2,1.9,1.7,1,1,1,1,3,2.7,3
2458,1,North America,Finance,Legal & Compliance,Far Exceeds,Male,31,4,1,8,,3.8,4.3,1,1,1,1,3.9,3.7,3.5
2459,0,North America,Finance,Pharmacovigilance,Below,Male,32,11,0,5,2.7,1.9,3.7,1,1,1,1,2.5,2.4,3.5
2460,0,Europe,Digital,Finance & Accounting,Meets,Male,32,11,0,5,3.5,2.9,2.4,1,1,1,1,3.2,3.3,2.7
2461,0,Latin America,R&D,Sales,Meets,Male,34,11,0,6,2.2,3.4,2.8,1,0,0,0,3.3,3.2,2.8
2462,0,North America,R&D,Communications,Exceeds,Male,43,14,0,12,3.2,3.2,3.6,0,0,0,0,3.4,3.2,3
2463,1,Asia Pacific,Digital,Legal & Compliance,Meets,Male,42,5,0,5,4.5,3.7,3.4,1,1,1,1,3.9,3.1,2.1
2464,0,Latin America,Digital,Supply Chain,Far Below,Male,32,16,0,7,3.1,2.2,3.7,1,1,1,1,2.2,2.8,2.5
2465,0,Asia Pacific,HR,Legal & Compliance,Meets,Female,37,7,1,11,,3.1,1,1,1,1,1,4.2,1.9,3.3
2466,0,Asia Pacific,Digital,Legal & Compliance,Meets,Female,41,12,0,11,3.9,2.2,2.1,1,0,0,0,3.5,3.9,2.1
2467,0,North America,Manufacturing,Communications,Meets,Female,37,7,0,12,4.1,3.2,1.9,1,1,1,1,3.8,4.7,1.3
2468,0,Latin America,HR,Marketing,Exceeds,Male,47,4,1,9,,4.1,1.4,1,1,1,1,3.9,3.8,1.7
2469,0,Middle East & Africa,Finance,Regulatory Affairs,Meets,Male,40,30,0,7,4,4.3,2.2,1,1,1,1,3.9,3.8,2.2
2470,0,North America,Finance,Data Science,Exceeds,Female,33,15,0,11,4.5,3.8,3.1,1,1,0,0,3.6,3.1,4.5
2471,0,North America,Finance,Sales,Below,Male,33,4,0,8,4.7,3.5,1.1,1,1,1,1,4.2,3.1,2.3
2472,0,Latin America,Finance,Medical Affairs,Meets,Female,32,10,0,9,2.6,3.4,1.3,1,1,1,1,2.6,3.9,3.2
2473,0,Latin America,Commercial,Legal & Compliance,Far Exceeds,Female,34,7,0,6,3.4,3.3,3.7,1,1,1,1,4.2,3.4,1.3
2474,0,Asia Pacific,Manufacturing,Human Resources,Meets,Male,38,5,0,12,2.2,4.1,2.7,1,1,1,1,3.2,3.7,3.3
2475,0,Latin America,HR,Marketing,Below,Male,37,7,0,5,2.9,1.2,1.9,1,1,1,1,2.9,2.4,2.9
2476,0,Asia Pacific,HR,Quality Assurance,Far Exceeds,Female,35,10,0,8,2.3,3.1,3.3,1,1,1,1,3.5,3.4,3.3
2477,0,North America,Finance,Quality Assurance,Meets,Male,41,12,0,5,4.2,3.3,2.2,1,1,1,1,4.1,4.1,2.6
2478,0,Europe,R&D,Data Science,Exceeds,Male,40,15,1,8,,2.1,3.3,1,1,1,1,4,3.2,5
2479,0,Middle East & Africa,HR,Medical Affairs,Below,Female,29,6,0,5,3.8,1,2.3,1,1,1,1,3.6,2.3,3.3
2480,0,North America,Manufacturing,Clinical Operations,Meets,Female,30,7,0,5,3.5,2.4,2.9,1,1,1,1,3.6,3.8,2.4
2481,0,Latin America,Digital,Regulatory Affairs,Exceeds,Female,32,13,0,11,3.5,4.4,3.5,1,1,1,1,3.9,2.6,1.4
2482,0,Middle East & Africa,Manufacturing,Finance & Accounting,Meets,Male,33,14,0,12,3.2,5,2.8,0,0,0,0,2.7,4.8,3.1
2483,0,Europe,Finance,Pharmacovigilance,Meets,Female,34,12,0,8,3.8,1,2.8,0,0,0,0,4.7,1.7,2.6
2484,0,Europe,Finance,Communications,Below,Male,36,7,1,10,,3.7,4,1,1,1,1,3.7,2.5,4.9
2485,0,Asia Pacific,Commercial,IT & Digital,Meets,Male,40,7,1,8,,2.9,1.4,1,1,1,1,3.4,2.9,1.6
2486,0,Middle East & Africa,HR,Market Access,Meets,Female,31,8,0,9,4.4,2.7,1.4,1,1,1,1,3.5,2.9,2.4
2487,0,Asia Pacific,HR,Market Access,Meets,Male,33,9,0,6,5,2,4.6,1,1,1,1,3.9,4,5
2488,0,North America,HR,Regulatory Affairs,Below,Female,28,8,0,9,3.9,3.2,2.5,1,1,1,1,4.3,3.8,2.9
2489,0,Middle East & Africa,Finance,IT & Digital,Below,Non-Binary/Other,32,11,0,6,2.4,1,4.3,1,1,1,1,2.9,3,4.1
2490,0,North America,HR,Marketing,Meets,Female,37,11,1,7,,3.9,1.8,1,1,1,1,2.7,2.1,3
2491,0,Asia Pacific,R&D,Legal & Compliance,Meets,Female,33,14,0,9,2.4,5,1.7,1,1,1,1,3.4,3.5,2.4
2492,0,Middle East & Africa,R&D,Supply Chain,Meets,Female,32,22,0,9,3.1,2.6,3.1,1,1,1,1,3.1,3.8,2.8
2493,0,Asia Pacific,Digital,Marketing,Meets,Female,35,12,0,5,3.2,1.6,2,1,1,1,1,3.1,3.7,3
2494,0,Middle East & Africa,HR,Quality Assurance,Exceeds,Female,39,17,0,12,3.3,1.7,2.4,1,1,1,1,2.5,3.2,3.7
2495,0,Asia Pacific,Commercial,Pharmacovigilance,Meets,Male,32,20,1,10,,2.7,2.3,1,1,1,1,2.9,3.2,2.8
2496,0,Europe,Digital,Quality Assurance,Meets,Female,44,23,0,12,3.6,1.8,1,1,1,1,1,3.3,2.8,2
2497,0,Asia Pacific,Finance,Sales,Meets,Male,33,11,1,12,,3,2.4,1,1,1,1,2.6,3.5,4.1
2498,0,Europe,HR,Quality Assurance,Far Below,Female,36,5,0,11,4.5,3.5,2.4,1,1,0,0,5,2.9,2.5
2499,0,Asia Pacific,R&D,Market Access,Meets,Female,45,4,1,9,,2.7,2.9,1,1,1,1,4.3,2.8,3.5
2500,0,Middle East & Africa,Commercial,Communications,Exceeds,Female,41,18,1,5,,2.9,1.6,1,1,1,1,3.1,3,2.4
2501,0,Middle East & Africa,Digital,Communications,Far Below,Female,37,15,0,6,3.5,3.7,2.7,1,1,1,1,4.1,4.7,4
2502,0,Middle East & Africa,Commercial,Market Access,Far Below,Female,40,36,0,11,4.8,2.7,3.3,1,1,1,1,3.8,2.2,3.1
2503,0,Latin America,HR,Pharmacovigilance,Meets,Female,30,18,0,9,2.8,4.4,2,1,1,1,1,4.9,4.9,2.7
2504,0,North America,Manufacturing,Legal & Compliance,Meets,Female,49,10,0,6,2.5,3.8,2.8,1,1,1,0,3.8,3.4,1.8
2505,0,Middle East & Africa,Commercial,Quality Assurance,Meets,Male,31,10,1,9,,3.3,3.6,1,1,1,1,3.8,2.9,3.4
2506,0,Europe,Commercial,Regulatory Affairs,Meets,Male,39,23,0,6,2.1,3.1,1.9,1,1,1,1,3.4,3.4,2.1
2507,1,Middle East & Africa,Finance,Regulatory Affairs,Far Exceeds,Male,45,2,1,10,,3.4,2.1,1,1,1,1,2.4,2.7,2.2
2508,0,Latin America,R&D,IT & Digital,Meets,Female,40,25,0,9,1.9,4.1,4.3,1,1,1,0,2.6,5,3.6
2509,0,Europe,HR,Data Science,Meets,Male,38,12,0,7,2.6,3,4,1,1,1,1,1.7,2.9,4.7
2510,0,Latin America,Commercial,Supply Chain,Below,Male,45,30,0,10,4.6,3.8,3.4,1,1,1,1,4.4,4.7,2.7
2511,0,Europe,HR,Pharmacovigilance,Meets,Male,42,4,1,5,,3.7,4,1,1,1,1,2.8,2.8,4.1
2512,0,Asia Pacific,R&D,Quality Assurance,Meets,Male,35,26,0,10,3.2,1.7,3.7,1,1,1,1,4.4,1.8,2.8
2513,0,North America,Finance,Pharmacovigilance,Far Exceeds,Male,47,6,1,7,,4.4,3.7,1,1,1,1,3.8,2.3,2.3
2514,0,North America,HR,Marketing,Meets,Male,34,8,0,10,3.4,2.9,2.8,1,0,0,0,2.8,2.2,3.3
2515,0,Latin America,R&D,Clinical Operations,Meets,Male,48,23,0,5,3.2,2,2.5,0,0,0,0,1.9,2.3,3.4
2516,0,North America,R&D,Legal & Compliance,Below,Female,42,7,1,9,,4,2.7,1,1,1,1,3.4,4.4,3.6
2517,0,Latin America,Digital,IT & Digital,Meets,Male,36,2,0,10,3.5,3,1.5,1,1,1,1,2.8,1.4,3.3
2518,0,Latin America,Finance,Medical Affairs,Meets,Female,32,14,0,12,2.1,2.2,3.5,1,1,1,1,2.6,3.4,3.7
2519,0,Latin America,Finance,Finance & Accounting,Exceeds,Female,39,11,1,10,,3.9,1.6,1,1,1,1,2.9,2.6,1.9
2520,0,North America,HR,Marketing,Meets,Male,34,9,0,9,1.6,3,3.2,1,1,1,1,3.3,3,1.6
2521,0,Latin America,Manufacturing,Communications,Meets,Male,39,14,1,9,,3,2.4,1,1,1,1,3.4,2.2,2.4
2522,0,North America,Digital,IT & Digital,Meets,Female,43,7,1,8,,3.5,2.7,1,1,1,1,3.3,3.6,4.2
2523,0,Latin America,Finance,Marketing,Below,Male,43,16,0,8,3.7,1.4,2.1,1,1,1,1,5,1.6,1.8
2524,0,Middle East & Africa,R&D,Communications,Meets,Female,46,11,1,9,,3.5,1.4,1,1,1,1,2.9,4.6,1.6
2525,0,Latin America,Finance,Quality Assurance,Below,Male,32,11,0,11,3.2,3.9,2.4,1,1,1,1,2.7,3.5,1.7
2526,0,Europe,Manufacturing,Communications,Meets,Female,39,18,0,12,4.1,3.2,2.5,1,1,1,1,4.9,4.2,2.7
2527,0,Latin America,Commercial,Clinical Operations,Meets,Non-Binary/Other,30,7,1,10,,3.2,2.4,1,1,1,1,4.5,1.1,3.5
2528,0,Asia Pacific,Commercial,Finance & Accounting,Meets,Female,38,4,0,6,2.6,4.5,3.1,1,1,1,1,3.1,3.9,5
2529,0,Latin America,Finance,Human Resources,Meets,Female,29,7,1,5,,1.7,3.4,1,0,0,0,3.9,3.3,1.5
2530,0,Europe,Finance,Regulatory Affairs,Far Below,Female,51,11,0,5,1.9,3.7,2.4,0,0,0,0,2.2,2.8,1.5
2531,0,Europe,Digital,Regulatory Affairs,Meets,Female,46,10,0,11,2.7,3.4,3.2,1,1,1,1,2.8,3.1,4.5
2532,0,North America,Finance,Finance & Accounting,Meets,Female,29,9,0,7,2.2,1.8,2.8,0,0,0,0,3.2,1.9,2.8
2533,0,Middle East & Africa,Manufacturing,Marketing,Meets,Male,34,11,0,8,3.9,3.1,2.5,1,1,1,1,3.7,3,2.4
2534,0,Latin America,Finance,Legal & Compliance,Far Exceeds,Male,42,9,0,5,3.6,3.9,1,1,1,1,1,2.9,5,1
2535,0,North America,HR,Legal & Compliance,Below,Male,39,9,0,12,2.3,3.7,3.9,1,1,1,1,3,4.9,4.1
2536,0,Middle East & Africa,Manufacturing,Human Resources,Meets,Non-Binary/Other,38,16,0,7,2.5,3,4.4,1,0,0,0,3.1,4,3.4
2537,0,Latin America,Digital,Supply Chain,Meets,Male,40,29,0,8,3,2.5,3.7,1,1,1,1,3.1,3.9,3.8
2538,0,Asia Pacific,HR,Regulatory Affairs,Meets,Male,43,5,0,7,2.8,3.2,2.4,1,1,1,1,3.8,3.6,2.1
2539,0,Latin America,HR,Sales,Meets,Female,50,23,0,9,4.3,3,1.3,1,1,1,1,5,3.3,1.6
2540,0,Europe,Commercial,Marketing,Below,Male,31,5,0,5,5,3.5,2.4,1,1,1,1,3.5,3.6,2.7
2541,0,Europe,Manufacturing,Medical Affairs,Meets,Female,37,25,0,9,2.4,2.5,3.2,1,1,1,1,3.6,2.7,3.1
2542,0,Asia Pacific,HR,Clinical Operations,Below,Female,28,36,1,7,,3,2.3,1,1,1,1,5,3,2.3
2543,0,North America,Digital,Data Science,Meets,Female,38,5,1,6,,4,3.4,1,1,1,1,2,4.6,3.2
2544,0,Middle East & Africa,Commercial,Legal & Compliance,Meets,Female,48,12,1,5,,4.2,2.9,0,0,0,0,4,3.7,3.7
2545,0,Latin America,HR,Market Access,Below,Female,41,12,1,9,,2.2,3.8,1,1,1,0,3.8,4.8,1.9
2546,0,Europe,Manufacturing,Pharmacovigilance,Meets,Female,43,7,0,5,2.8,1.9,1.9,1,1,0,0,3.1,3.2,1.6
2547,0,North America,Commercial,Finance & Accounting,Below,Male,39,10,0,10,2.6,1.1,3.9,1,1,1,1,2.2,2.8,3.4
2548,0,Asia Pacific,Manufacturing,Marketing,Meets,Male,34,32,0,11,2.8,2.7,2.3,1,1,1,1,3.6,2.8,2.9
2549,0,Europe,Manufacturing,Regulatory Affairs,Meets,Male,29,9,0,7,3.5,4.8,2.2,1,1,1,1,4.1,3.5,2.7
2550,0,Asia Pacific,Manufacturing,Pharmacovigilance,Meets,Female,47,10,0,12,3.6,3.6,2.7,1,1,1,1,3.4,2.3,2.6
2551,0,Latin America,Commercial,Medical Affairs,Exceeds,Female,35,11,0,7,5,3.9,3.7,1,1,1,1,4.3,1.5,3.3
2552,0,Middle East & Africa,HR,Human Resources,Meets,Male,37,6,0,12,3.2,3.2,3.3,1,1,1,1,1.8,3.2,2.7
2553,0,Europe,Finance,Finance & Accounting,Meets,Female,28,9,1,11,,3.7,1.4,1,1,1,1,3.6,3.2,3.6
2554,1,Europe,R&D,Quality Assurance,Exceeds,Female,34,13,0,9,2.9,2.6,1.9,0,0,0,0,3.1,2.6,3.3
2555,0,Latin America,HR,Market Access,Below,Male,39,15,0,11,3,3.3,5,1,1,1,1,3.1,3.2,2.8
2556,0,North America,Commercial,Supply Chain,Meets,Male,40,15,0,10,3.2,3.7,3.6,1,1,1,1,2.6,4.1,3.3
2557,1,Middle East & Africa,R&D,IT & Digital,Exceeds,Female,48,12,1,8,,4.3,2.9,1,1,1,1,3.7,2.8,5
2558,0,Europe,R&D,Human Resources,Meets,Female,36,6,0,11,5,3.6,2,1,1,1,1,4.9,4.4,1.9
2559,0,Middle East & Africa,R&D,Data Science,Below,Male,37,8,0,8,3.2,3.1,3.3,1,1,1,1,2.4,2.7,3.7
2560,0,Europe,Finance,Communications,Below,Female,47,15,0,8,2.1,2.1,1.7,1,1,1,1,2.7,2.8,3.3
2561,0,Middle East & Africa,Digital,Quality Assurance,Meets,Male,45,22,1,6,,2.8,3.5,0,0,0,0,3.7,1.7,2
2562,0,Asia Pacific,Commercial,Medical Affairs,Meets,Female,30,8,0,6,3.7,3.5,3.5,1,1,0,0,4.6,3.3,2.5
2563,0,Europe,Finance,Regulatory Affairs,Below,Male,47,12,1,6,,2.9,3.5,1,1,1,1,2.6,4.3,3.1
2564,0,Middle East & Africa,Finance,Human Resources,Meets,Female,28,13,0,11,3.5,2.1,5,1,1,1,0,2.5,3.3,4.2
2565,0,North America,Digital,Sales,Meets,Female,41,10,0,5,3.4,3.7,3.1,1,1,1,1,3.5,2.7,2.6
2566,0,Asia Pacific,R&D,Clinical Operations,Exceeds,Female,43,4,0,11,4,3.1,2.1,1,1,1,0,2.6,4.7,3.2
2567,0,Asia Pacific,Digital,Finance & Accounting,Exceeds,Female,39,9,1,8,,2.4,1.1,0,0,0,0,4.7,4.1,2.5
2568,0,North America,Digital,Quality Assurance,Exceeds,Male,36,6,1,11,,1,4.4,1,1,1,1,2,1.1,3.3
2569,0,Middle East & Africa,Finance,Legal & Compliance,Meets,Female,35,10,0,6,3,3.1,2.4,1,1,1,1,3.3,2.5,2
2570,0,Latin America,Commercial,Quality Assurance,Meets,Male,28,10,0,10,3.4,2.7,2.7,1,1,1,1,4.1,2.5,2.2
2571,0,North America,Manufacturing,Data Science,Meets,Male,39,8,0,8,3,5,1,1,1,1,1,2.7,3.9,2.7
2572,1,Middle East & Africa,Digital,Clinical Operations,Meets,Female,38,16,0,9,2.1,4.4,2.3,1,1,1,1,4.4,2.6,3
2573,0,North America,Digital,Medical Affairs,Meets,Male,47,3,1,6,,2,2.2,1,1,1,1,3.7,2.4,1
2574,0,North America,R&D,Pharmacovigilance,Exceeds,Male,36,8,1,6,,4.2,4.5,1,1,1,1,1.1,3.1,3.5
2575,0,Europe,R&D,Pharmacovigilance,Below,Female,35,8,0,11,2.1,3.2,2.7,1,1,1,1,2.3,4.4,2.5
2576,0,Middle East & Africa,Finance,Communications,Meets,Female,35,11,0,8,2.1,4.1,2.8,1,1,1,1,3.8,5,2
2577,0,Latin America,R&D,Clinical Operations,Meets,Female,33,5,0,10,3.3,5,2.3,1,1,1,1,3.5,4.4,3.8
2578,0,Europe,HR,Human Resources,Meets,Female,35,12,0,5,2.8,2.6,3.8,1,1,1,1,1,1.9,2.4
2579,0,North America,Digital,Communications,Exceeds,Non-Binary/Other,32,10,0,11,4,2.7,1,1,1,1,1,4.6,2.1,1.6
2580,0,North America,R&D,Supply Chain,Below,Female,42,12,0,12,4.3,2.2,2.4,1,1,1,1,3.8,4.8,2.6
2581,0,North America,Commercial,Marketing,Meets,Female,40,15,0,6,2.2,3.9,2.8,1,1,1,1,3,5,2.5
2582,0,Middle East & Africa,HR,Legal & Compliance,Exceeds,Male,29,2,1,9,,3.9,3.4,1,1,1,1,2,2.2,5
2583,0,Middle East & Africa,Finance,Supply Chain,Meets,Female,39,7,0,10,2,4.8,2.8,1,1,1,0,2.6,3.1,2.3
2584,0,Europe,Manufacturing,Supply Chain,Meets,Male,45,29,0,9,4.4,3.7,3.5,0,0,0,0,3.5,4,3.9
2585,0,Latin America,Digital,Quality Assurance,Below,Female,44,9,0,9,3.4,1.8,2.5,1,1,1,1,3.6,2,3
2586,0,Europe,Digital,Quality Assurance,Meets,Female,32,32,0,10,2.6,4.5,2.8,1,1,1,1,3.2,4.4,3.5
2587,0,Asia Pacific,Commercial,Market Access,Meets,Male,46,5,1,10,,3.4,3,1,1,1,1,4.7,2.5,3.1
2588,0,North America,Manufacturing,Legal & Compliance,Meets,Female,35,8,0,12,2.7,2.9,4.3,1,1,1,1,3.6,3.2,2.8
2589,0,North America,Manufacturing,Human Resources,Meets,Female,38,21,0,10,3.6,2.2,2.8,1,1,1,1,4,3,3.3
2590,0,North America,Finance,Regulatory Affairs,Meets,Female,36,7,0,8,2.9,4,3.2,1,1,1,1,3.4,4.1,1.5
2591,0,Europe,Finance,IT & Digital,Meets,Male,31,6,0,5,2.2,1.8,4,1,1,0,0,3,3.2,3.6
2592,0,Europe,HR,IT & Digital,Meets,Female,33,21,0,9,4,4.8,3.5,1,1,1,1,4.9,3,2
2593,0,North America,Digital,IT & Digital,Exceeds,Male,45,5,1,9,,3.1,2.3,1,1,1,1,3.1,2.9,3.7
2594,0,Europe,R&D,Medical Affairs,Exceeds,Female,46,5,1,5,,1,1.8,1,1,0,0,2.9,2.1,2.3
2595,0,Middle East & Africa,Finance,Medical Affairs,Below,Male,42,17,0,6,4.8,3.5,3,1,1,1,1,2.8,2.8,3.8
2596,0,Middle East & Africa,Commercial,Finance & Accounting,Exceeds,Male,37,15,1,6,,3.3,4.4,1,1,1,1,2.8,2.3,4.9
2597,0,Europe,Commercial,Communications,Below,Male,49,16,0,8,4.2,2.9,4.1,1,1,1,1,4.8,3.5,2.4
2598,0,North America,Commercial,Human Resources,Meets,Male,44,6,0,6,3.9,4.8,1,1,1,1,1,3.6,4.3,2.4
2599,0,Europe,Finance,Market Access,Meets,Female,37,11,0,8,2.9,4.1,4.3,0,0,0,0,3.5,2.8,3.8
2600,0,Europe,Finance,IT & Digital,Below,Male,28,15,1,10,,1.8,3.3,1,1,1,1,3.3,3.6,3.7
2601,0,Europe,Commercial,Finance & Accounting,Far Below,Female,43,13,1,12,,3.7,1.4,1,1,1,1,3.4,4.3,2.2
2602,0,Asia Pacific,Finance,Quality Assurance,Meets,Non-Binary/Other,45,1,1,11,,4,1.5,0,0,0,0,2.3,3.5,2.1
2603,0,Middle East & Africa,R&D,Legal & Compliance,Meets,Female,41,14,1,8,,2.7,2.3,1,1,1,1,3.5,3.6,4.2
2604,0,Latin America,R&D,Finance & Accounting,Meets,Male,28,26,0,7,3.9,2.8,2,1,1,1,1,3.8,4.2,1.4
2605,0,Latin America,HR,Finance & Accounting,Meets,Female,39,9,0,11,2.8,3.1,4.7,1,1,1,1,3.3,2.6,3.9
2606,0,Asia Pacific,Digital,Data Science,Exceeds,Male,51,17,0,6,1.9,1.7,3.8,1,1,1,1,1.6,1.8,3.2
2607,0,Europe,R&D,IT & Digital,Meets,Male,37,11,0,10,4.7,2.8,3,0,0,0,0,4.1,4.3,3.6
2608,0,Asia Pacific,HR,Finance & Accounting,Meets,Female,50,7,0,9,3.6,3.1,4,1,1,1,1,2.8,3.3,4.4
2609,0,Asia Pacific,Manufacturing,Communications,Meets,Male,42,13,0,10,4.2,4.2,5,1,1,1,1,3,3.3,5
2610,0,North America,Digital,Finance & Accounting,Far Below,Female,38,6,1,7,,2.5,2.6,0,0,0,0,3.3,3.8,1.7
2611,0,Middle East & Africa,R&D,IT & Digital,Below,Male,46,13,0,10,3.2,3.2,1.6,1,1,1,1,2.4,3.5,1.3
2612,0,Latin America,Manufacturing,Data Science,Meets,Male,34,2,1,11,,2.2,4.1,1,1,1,1,2,3.3,3.2
2613,0,Europe,HR,Finance & Accounting,Meets,Male,31,6,0,11,4.7,2.4,3.6,1,1,1,1,3.5,2.7,1.8
2614,0,Latin America,R&D,Regulatory Affairs,Far Exceeds,Female,31,36,0,5,5,2.4,2.9,1,1,1,1,3.4,1.6,1.6
2615,0,Latin America,R&D,Clinical Operations,Below,Male,39,21,1,11,,2.6,2.2,1,1,1,1,1.4,3.3,2.6
2616,0,Middle East & Africa,Finance,Quality Assurance,Below,Male,41,30,0,6,3.5,3.2,3.3,1,1,1,1,3.5,2.1,2.8
2617,0,Latin America,Manufacturing,Legal & Compliance,Below,Female,34,16,0,5,4.6,3.6,1.6,1,1,1,1,4.3,3,2.3
2618,0,Latin America,R&D,Pharmacovigilance,Below,Female,45,23,1,9,,4,3.4,0,0,0,0,3.6,2,3.4
2619,0,Asia Pacific,Commercial,Pharmacovigilance,Meets,Female,39,7,1,11,,1.9,1.1,1,1,1,1,4.1,1,2.1
2620,0,Middle East & Africa,Finance,Human Resources,Far Exceeds,Male,43,18,0,8,4.9,3.5,1.7,1,1,1,1,4,4,2.4
2621,1,North America,Finance,Quality Assurance,Meets,Male,34,9,0,7,2.3,1.7,3.6,1,1,1,1,3.6,3.3,3.6
2622,0,Europe,R&D,Sales,Meets,Female,37,9,0,11,2.4,1,1,1,1,1,1,3.7,3.4,1.5
2623,0,Latin America,Finance,Clinical Operations,Meets,Female,28,4,0,5,2,3.5,3.3,1,1,1,1,3.8,5,2.2
2624,0,Europe,Digital,Pharmacovigilance,Below,Female,36,14,0,5,2.1,3.3,3.2,0,0,0,0,3,2.5,1.8
2625,0,North America,Manufacturing,Marketing,Exceeds,Female,39,8,0,12,3.8,4.1,1.5,1,1,1,1,4.9,4.1,2
2626,0,Europe,Digital,IT & Digital,Meets,Male,35,4,1,8,,2.1,3.2,0,0,0,0,4.1,3.5,2.7
2627,0,North America,HR,Communications,Below,Male,38,13,0,5,3.6,2.7,2.4,0,0,0,0,3.1,3.2,5
2628,0,Asia Pacific,Digital,Supply Chain,Meets,Female,39,11,0,12,4.4,3.5,2.2,1,1,1,1,1.8,3.9,3.8
2629,0,Latin America,Commercial,Quality Assurance,Meets,Male,35,26,0,7,4.1,2.8,2.4,1,1,1,0,3,3.4,3.1
2630,0,North America,Finance,Finance & Accounting,Below,Non-Binary/Other,36,9,0,6,4.2,2.8,1.4,1,1,1,1,3.5,2.3,1
2631,0,Europe,Finance,Sales,Meets,Male,34,9,1,8,,3.4,3.5,1,1,1,1,3.2,1.9,2.5
2632,0,Latin America,Commercial,Marketing,Meets,Female,32,20,0,12,4.3,4.1,2.3,1,1,1,1,3.6,3.9,3.3
2633,0,Asia Pacific,Finance,IT & Digital,Meets,Male,45,12,0,9,3.3,4.4,1.1,1,1,1,1,2.6,4.2,2
2634,0,Latin America,Digital,Finance & Accounting,Meets,Male,29,10,0,12,2.8,3.8,2.9,1,1,0,0,3.6,2.5,3.8
2635,0,North America,HR,Supply Chain,Meets,Female,43,10,0,8,2.2,2.3,3.9,1,1,1,1,2.3,5,3.4
2636,0,Asia Pacific,R&D,Supply Chain,Meets,Female,30,20,0,9,4,2.1,1,1,1,1,1,3.6,1.4,2.2
2637,0,Europe,Commercial,Regulatory Affairs,Meets,Male,47,15,1,6,,5,3.2,1,1,1,1,3.8,4.4,2.7
2638,0,Asia Pacific,Digital,Legal & Compliance,Far Exceeds,Male,41,3,1,9,,2.7,3.5,1,1,1,1,3.4,2.4,2.4
2639,0,Asia Pacific,Digital,Human Resources,Meets,Female,36,18,1,8,,2.8,1.9,1,1,1,1,3.7,3.4,1.6
2640,0,Middle East & Africa,Digital,IT & Digital,Meets,Female,44,15,0,12,3.3,3.1,2,1,1,1,1,3.9,2.6,1.6
2641,0,Asia Pacific,R&D,Legal & Compliance,Exceeds,Male,45,13,0,5,3.1,1.6,3.8,1,1,1,1,3.8,3.2,2.5
2642,0,Asia Pacific,Manufacturing,Clinical Operations,Meets,Female,41,8,1,6,,2.2,2.2,1,1,1,1,4.5,3.3,2.5
2643,0,Latin America,Finance,Quality Assurance,Below,Male,41,26,1,9,,3.6,3.7,1,1,1,1,4.1,4,2.9
2644,0,Europe,Finance,Sales,Meets,Female,39,14,0,11,2.9,1.6,1.5,1,1,1,1,3.3,1.8,2.6
2645,0,Latin America,HR,Market Access,Meets,Female,47,16,0,5,3.7,2.5,1.6,1,1,1,1,3.6,2.5,1.9
2646,0,Latin America,Manufacturing,Communications,Meets,Male,38,7,1,6,,2,3.9,1,1,1,1,3.2,1.4,3.3
2647,1,North America,Finance,Regulatory Affairs,Far Exceeds,Female,39,5,0,9,2.7,2.5,2.3,1,1,1,1,3.4,2.2,2.3
2648,0,Latin America,HR,Data Science,Meets,Male,43,9,1,11,,2.8,3.4,0,0,0,0,2.7,3.6,4.3
2649,0,Middle East & Africa,HR,Marketing,Exceeds,Male,36,4,0,11,2.5,3.9,1.3,1,1,1,1,2.3,3.6,2.9
2650,0,Middle East & Africa,Digital,Market Access,Below,Female,45,14,0,6,2,3.9,3.3,1,1,1,1,3,4.4,3.4
2651,0,North America,Commercial,Marketing,Meets,Male,43,9,1,9,,3.1,2.2,1,1,1,1,2.4,3.1,2.7
2652,0,Europe,Digital,Quality Assurance,Exceeds,Female,55,12,0,9,3.6,2.9,2.4,1,1,1,1,3.2,2.5,2.8
2653,0,Europe,R&D,Sales,Meets,Male,37,26,0,11,3.8,1.7,1.2,0,0,0,0,4.4,3.6,2.3
2654,0,Latin America,Finance,Sales,Below,Female,42,6,1,10,,1.6,3.6,0,0,0,0,3.3,1.5,3.6
2655,0,Latin America,HR,Supply Chain,Meets,Male,41,14,0,12,2.9,3.3,1.8,1,1,1,1,2.9,4.2,4.1
2656,0,Latin America,Commercial,Market Access,Meets,Male,43,20,0,8,3.6,4.3,1.9,1,1,1,1,3.8,4.7,2.8
2657,0,Europe,Finance,Finance & Accounting,Below,Female,38,11,0,5,2.5,3.3,3,1,1,1,1,3.7,2.3,2.9
2658,0,Asia Pacific,HR,Legal & Compliance,Meets,Male,41,9,1,6,,3.2,3.2,1,1,1,1,3.1,3.1,4
2659,0,Middle East & Africa,HR,Communications,Below,Non-Binary/Other,39,10,0,7,3.3,5,4.1,1,1,1,1,3.5,4.1,4.9
2660,0,Asia Pacific,Digital,Sales,Meets,Female,43,20,0,12,4.1,3.8,3.2,1,1,1,1,2.3,4.7,2.3
2661,1,Asia Pacific,Commercial,Communications,Far Exceeds,Male,28,18,0,12,3.8,1.9,2.3,1,1,1,1,4.7,3.9,1.5
2662,0,Europe,Commercial,Pharmacovigilance,Below,Female,37,11,1,12,,1.9,1,1,1,1,1,3.2,3.5,1.9
2663,0,Asia Pacific,Finance,Marketing,Far Below,Male,51,10,0,7,3.4,2.6,1.1,1,1,1,1,4.4,3.1,1
2664,0,North America,HR,Supply Chain,Meets,Male,47,23,0,8,2.3,2,2.5,1,1,1,1,3.8,2.5,3.5
2665,0,Latin America,Commercial,IT & Digital,Meets,Female,40,15,0,6,3.5,2.5,2.8,1,1,1,1,3.4,4.2,2.6
2666,0,North America,Commercial,Quality Assurance,Meets,Female,42,7,0,8,2.6,3.1,3.2,1,1,1,1,2.4,4.9,3.3
2667,0,Middle East & Africa,Finance,Finance & Accounting,Meets,Female,41,8,1,7,,1.9,4.6,1,1,1,1,3.2,3.1,3.7
2668,0,Latin America,Digital,Sales,Far Exceeds,Female,42,6,0,8,4.3,3.1,2.4,1,0,0,0,4,2.6,2.2
2669,1,Asia Pacific,Manufacturing,Legal & Compliance,Meets,Female,33,3,1,12,,3.3,1,1,1,1,1,3.5,3.9,2.7
2670,1,Middle East & Africa,R&D,Human Resources,Meets,Female,34,10,0,11,4.3,5,2.6,1,1,1,0,5,5,1.6
2671,0,Latin America,Manufacturing,Medical Affairs,Meets,Female,34,19,0,7,2.6,2.9,2,1,1,1,1,4.3,2.2,2.2
2672,0,Asia Pacific,Commercial,Communications,Meets,Male,35,13,0,8,4.1,2.7,4.8,1,1,1,1,4.2,4.4,3.8
2673,0,North America,HR,IT & Digital,Far Below,Male,47,23,0,12,2.6,4.9,3.4,1,1,1,1,3.3,2.1,1.6
2674,1,Latin America,R&D,Communications,Meets,Male,31,12,1,9,,1.7,1.7,1,0,0,0,5,2.3,2.1
2675,0,Asia Pacific,R&D,Quality Assurance,Far Exceeds,Female,50,20,0,6,3.5,5,1.3,1,1,1,1,3.9,4.2,2.2
2676,1,North America,HR,IT & Digital,Meets,Female,40,22,0,8,3.7,3.4,1.7,1,1,1,1,4.1,3.8,1.6
2677,0,Middle East & Africa,R&D,Market Access,Meets,Female,31,26,0,11,3.3,4.2,2.8,1,1,1,1,3.2,3.5,4.3
2678,0,Middle East & Africa,HR,Pharmacovigilance,Far Below,Male,35,13,1,8,,2.7,2.4,1,1,1,1,1.8,1,2.5
2679,0,Middle East & Africa,R&D,Clinical Operations,Meets,Male,41,13,1,9,,1.8,2.7,0,0,0,0,3.3,1.3,2.4
2680,0,Middle East & Africa,Finance,Data Science,Meets,Female,30,15,1,7,,1.9,1.6,0,0,0,0,4.1,3.3,3.2
2681,0,Europe,Finance,IT & Digital,Meets,Male,36,13,0,10,4.9,3.5,2,0,0,0,0,3.5,3.5,3.9
2682,0,Latin America,Manufacturing,Medical Affairs,Meets,Female,31,13,0,12,2.9,4.9,1.3,1,1,1,1,2.7,3.6,3.9
2683,0,Latin America,R&D,Finance & Accounting,Below,Male,42,11,0,5,4.5,2,3.2,1,1,1,1,2.7,1.5,3.1
2684,0,Europe,Digital,Supply Chain,Meets,Female,31,4,1,9,,3.3,3.1,1,1,1,1,3.5,3.7,2.7
2685,0,Asia Pacific,HR,Marketing,Meets,Female,29,17,0,11,3.9,1.7,2.5,1,1,1,1,4.3,3.5,3.2
2686,0,Asia Pacific,R&D,Market Access,Meets,Female,47,4,0,8,2.3,4.3,3.9,1,1,1,1,3.1,3.8,5
2687,0,Middle East & Africa,Finance,Market Access,Exceeds,Male,36,4,1,8,,3.4,3.3,1,1,1,1,4.1,2.3,3.3
2688,0,North America,Finance,Human Resources,Far Below,Female,36,8,1,7,,1.5,1.7,1,1,1,1,3.2,1.6,3.2
2689,0,Asia Pacific,HR,Clinical Operations,Meets,Female,41,5,0,9,3.3,3.3,2.8,1,1,1,1,2.9,3.1,3.9
2690,1,North America,Digital,Medical Affairs,Meets,Female,38,18,0,10,3.6,3.5,1.3,1,1,1,1,4.6,2.9,2.9
2691,0,Latin America,R&D,Marketing,Meets,Female,33,5,0,7,2.8,4.2,2.4,1,1,1,1,3,3.7,4
2692,0,North America,R&D,Data Science,Meets,Male,34,7,1,6,,3.5,3.4,1,1,1,1,3.3,4,3.1
2693,0,Latin America,Digital,Communications,Meets,Female,42,6,0,6,4.2,1,2.2,1,1,1,1,3.9,2.3,1.8
2694,0,Europe,Digital,Regulatory Affairs,Far Below,Female,32,19,0,9,1.6,1,2.5,1,1,1,1,1.7,1.1,2.5
2695,0,Europe,Digital,Regulatory Affairs,Meets,Female,38,2,0,7,3.4,3.5,3,1,1,1,1,3.9,2.4,2.2
2696,0,Middle East & Africa,Finance,Market Access,Meets,Male,48,6,1,11,,1.3,3.2,1,1,1,1,2.5,1.9,2.7
2697,0,Asia Pacific,HR,IT & Digital,Meets,Male,36,28,0,5,2.7,5,2.6,1,1,1,1,2.4,4.5,1.5
2698,0,Middle East & Africa,Digital,IT & Digital,Exceeds,Female,45,7,1,6,,3.3,3.9,1,1,1,1,1.9,3.7,1.7
2699,0,Latin America,HR,Medical Affairs,Exceeds,Female,32,9,1,5,,3.6,3.1,1,1,1,1,3.3,3.3,1.5
2700,0,Middle East & Africa,Manufacturing,Finance & Accounting,Meets,Male,39,14,0,8,2.9,2.6,1.8,1,1,1,1,3,4.1,1
2701,0,North America,R&D,Clinical Operations,Meets,Male,45,14,0,11,5,3.3,5,1,1,1,1,4,4.3,3.1
2702,0,Latin America,R&D,Communications,Far Below,Male,35,5,1,7,,5,1.8,0,0,0,0,2.3,3.4,1.8
2703,0,Europe,Commercial,Market Access,Exceeds,Male,50,5,0,5,2.8,2.9,3.9,1,1,1,1,3.3,3.2,4.1
2704,0,Asia Pacific,Manufacturing,Regulatory Affairs,Exceeds,Male,38,10,0,9,3.6,3.6,3,1,1,1,1,4,4.3,3.3
2705,0,Latin America,Digital,Finance & Accounting,Far Below,Male,31,11,0,6,1.9,3.8,4.9,1,1,1,1,1.6,4.1,3.8
2706,0,Latin America,Digital,Market Access,Meets,Female,44,13,1,9,,2.2,2,1,1,1,1,3.3,2.3,3.4
2707,0,North America,Finance,Communications,Exceeds,Male,48,7,1,11,,3.2,3.1,1,1,1,1,2.4,3.5,4
2708,0,Asia Pacific,Manufacturing,Regulatory Affairs,Below,Female,31,22,0,9,4.4,3.4,3.8,1,1,1,1,3.6,2.3,3.1
2709,1,Europe,Digital,Medical Affairs,Meets,Female,41,9,1,11,,4.4,4.1,1,1,1,1,2.3,3.9,3.7
2710,0,Latin America,Commercial,Medical Affairs,Meets,Female,34,11,1,7,,2.7,2.5,1,1,1,1,4.4,1.9,3.2
2711,0,Latin America,HR,Clinical Operations,Meets,Female,32,26,0,9,3.3,1.5,3.5,1,1,1,1,2.3,2.5,3.3
2712,0,North America,R&D,Supply Chain,Far Below,Female,33,21,0,5,4,4.4,2.2,1,1,1,1,3.1,3.5,1.4
2713,0,Middle East & Africa,Manufacturing,Supply Chain,Meets,Female,39,8,1,9,,3.2,2.4,1,1,1,1,3.3,1.2,2.2
2714,0,Europe,R&D,Market Access,Meets,Female,46,20,0,9,3.7,3.8,1.9,1,1,1,1,4,1.8,1.8
2715,0,Asia Pacific,HR,Human Resources,Exceeds,Male,38,10,0,12,4.1,3.7,1.5,1,1,1,1,4.4,5,3.2
2716,0,Latin America,Manufacturing,Market Access,Meets,Male,41,9,0,9,3.6,4.9,2.1,1,1,1,1,3.9,4,1.4
2717,0,Latin America,HR,Market Access,Meets,Female,35,27,0,9,2.7,3.4,2.9,1,1,1,1,2.6,2,1.7
2718,1,Europe,Digital,Clinical Operations,Meets,Female,37,16,0,10,4.8,4.2,3.4,1,1,1,1,3.1,4.2,4.3
2719,0,Middle East & Africa,Digital,Human Resources,Below,Female,33,19,1,6,,3.6,1.8,1,1,1,1,2.2,3.8,3
2720,0,Latin America,Digital,Quality Assurance,Far Exceeds,Male,28,8,0,10,2.3,3.1,3.4,1,1,1,1,1.8,2,2.2
2721,0,Europe,HR,Market Access,Exceeds,Male,35,19,0,12,3,4.9,4.5,1,1,1,1,3.2,3.4,3.5
2722,0,North America,HR,Legal & Compliance,Meets,Male,45,29,0,5,2.7,4.3,3.7,1,1,1,1,3.2,3.3,1.9
2723,0,Middle East & Africa,HR,Legal & Compliance,Meets,Male,28,2,0,12,3.3,2.4,3.7,0,0,0,0,2.3,2.5,2.6
2724,0,Asia Pacific,R&D,Supply Chain,Meets,Female,45,1,1,8,,3.4,2.9,1,1,1,1,4.1,4.4,2.3
2725,0,Latin America,HR,Supply Chain,Meets,Female,40,3,1,8,,3.2,1.2,1,1,1,1,3.6,2.9,3.1
2726,0,Europe,Digital,Human Resources,Below,Female,37,12,0,5,3.7,3,3.7,1,1,1,1,3.5,3.6,4.1
2727,0,North America,Commercial,Marketing,Meets,Male,35,10,1,6,,3.6,3.9,1,1,1,1,3.1,3.7,2.7
2728,1,Asia Pacific,HR,IT & Digital,Far Exceeds,Female,41,20,0,10,3.7,3.4,1,1,1,1,1,5,3.9,3
2729,0,Europe,Commercial,Medical Affairs,Below,Female,46,2,0,12,2.8,1.8,1.6,1,1,1,1,2.8,2.3,2.4
2730,0,Europe,Digital,Human Resources,Meets,Female,40,8,1,5,,2.8,2,1,1,1,1,4.1,3.1,1.2
2731,0,Asia Pacific,HR,Quality Assurance,Far Below,Female,37,23,0,5,2.3,2.9,1.3,1,1,1,1,2.8,5,1
2732,0,North America,R&D,Regulatory Affairs,Below,Female,54,16,0,6,5,2.5,1.6,1,1,1,1,3.2,3.5,1.8
2733,0,North America,R&D,Supply Chain,Meets,Male,39,14,0,10,2.8,2.1,4.4,1,1,1,1,2.9,4.3,3.8
2734,0,Middle East & Africa,Commercial,Data Science,Meets,Female,28,3,0,8,4.7,2.7,3.3,1,1,1,1,4.4,2.6,3.5
2735,0,Latin America,Finance,Legal & Compliance,Exceeds,Female,40,19,0,9,2.4,2.8,2.8,1,1,1,1,2.6,3.5,2.6
2736,0,Asia Pacific,R&D,Data Science,Meets,Male,34,17,1,9,,3,2.7,1,1,1,1,5,4.6,2.4
2737,0,Asia Pacific,R&D,Legal & Compliance,Meets,Female,36,9,0,6,3.6,2.5,4.5,1,1,1,0,4.3,2.4,4.7
2738,0,Asia Pacific,R&D,Supply Chain,Meets,Male,46,10,1,11,,3.1,2.3,1,1,1,1,4.3,2.4,1.2
2739,0,North America,Digital,IT & Digital,Meets,Male,43,11,0,11,2.9,1.1,1.7,1,0,0,0,5,3.1,1
2740,0,Latin America,R&D,Data Science,Far Below,Female,28,13,1,12,,2.7,3.8,1,1,0,0,3.3,1.6,4
2741,0,Middle East & Africa,Manufacturing,Communications,Meets,Male,28,9,1,8,,4.4,1.7,1,1,1,1,3.6,3.5,3.6
2742,0,Europe,HR,Communications,Meets,Male,39,7,1,5,,3,1,1,1,1,1,3.5,3.3,1
2743,0,Europe,R&D,Sales,Below,Male,44,5,1,10,,2.8,2.7,0,0,0,0,3.9,3.1,2.2
2744,0,Asia Pacific,Finance,Quality Assurance,Exceeds,Male,28,8,0,7,3.6,3.1,1.4,1,1,1,1,3,5,1.6
2745,0,Latin America,Finance,Legal & Compliance,Meets,Female,44,9,0,6,3.7,5,3.5,1,1,1,1,3.3,3.5,3.5
2746,0,North America,R&D,Finance & Accounting,Below,Female,53,9,0,6,1.9,4.3,2.9,1,1,1,1,1.2,4.3,2.2
2747,0,Latin America,R&D,Medical Affairs,Meets,Male,45,6,0,9,3.9,3.2,2.8,1,1,1,1,4,3.4,2.4
2748,0,Latin America,Manufacturing,Supply Chain,Below,Female,33,7,0,8,1.9,2.6,2.6,1,1,1,1,3.3,3.1,2.3
2749,0,North America,R&D,Supply Chain,Meets,Male,42,3,0,7,2.9,2.4,2.6,1,1,1,0,4.5,3.7,2.1
2750,0,Asia Pacific,R&D,Regulatory Affairs,Meets,Female,39,12,0,12,2.8,3.7,2.5,1,1,1,1,4.2,5,3.4
2751,0,Latin America,HR,Legal & Compliance,Below,Female,49,14,0,5,3.2,3.6,3.3,1,1,1,1,4.8,2.3,3.1
2752,0,Europe,Finance,Quality Assurance,Exceeds,Female,45,8,0,9,3.1,2.9,1.5,1,1,1,1,3.4,3.6,1
2753,1,North America,Manufacturing,Market Access,Meets,Non-Binary/Other,33,10,0,10,3.1,4.3,4,1,1,0,0,4,3.2,4.2
2754,0,Middle East & Africa,Finance,IT & Digital,Meets,Female,42,25,0,9,3.2,2.8,2.7,1,1,1,1,3,3.5,2.2
2755,0,Asia Pacific,Manufacturing,Market Access,Meets,Female,33,13,1,9,,2.3,4,1,1,1,1,3.8,1.8,2.5
2756,0,North America,Finance,Communications,Below,Male,44,6,0,11,5,3.2,3.6,1,1,1,1,4.5,3.9,2.8
2757,0,Middle East & Africa,R&D,Legal & Compliance,Meets,Female,36,4,0,7,1.7,1.4,2.1,1,1,1,0,3,2.6,1.9
2758,0,Middle East & Africa,Finance,Pharmacovigilance,Exceeds,Female,38,6,0,8,2.6,3.5,3.6,1,1,1,1,2.5,3.8,3.7
2759,0,Latin America,Finance,Marketing,Below,Female,39,2,0,8,3.3,2.1,1.8,1,1,1,1,3.6,3.4,3.3
2760,0,Latin America,Manufacturing,Legal & Compliance,Meets,Female,35,16,0,6,2.9,3.3,2.1,1,1,1,1,2.3,4,2.2
2761,0,Latin America,Commercial,Sales,Meets,Female,39,17,0,6,3.1,4.7,1,1,1,1,1,3.7,4.1,1.3
2762,0,North America,Manufacturing,Clinical Operations,Meets,Female,41,16,0,6,3.1,3,4.2,1,1,1,1,3.8,4.4,2.4
2763,0,North America,Manufacturing,Clinical Operations,Meets,Male,36,5,1,12,,3.6,3.9,1,1,1,1,4.4,3.5,3.6
2764,0,Asia Pacific,Manufacturing,Pharmacovigilance,Below,Male,39,9,0,5,4.6,2.5,1.5,1,1,1,1,3.7,3,2.7
2765,0,Latin America,Digital,Legal & Compliance,Meets,Male,34,10,0,8,4.6,4,2.6,0,0,0,0,5,2.6,1.6
2766,0,Middle East & Africa,Digital,Medical Affairs,Far Below,Male,31,3,1,11,,3.3,3.2,1,1,1,1,1.9,1.2,3.5
2767,0,Europe,Digital,Clinical Operations,Meets,Male,38,21,0,6,2.5,2.7,3,1,1,1,0,2.4,2.3,3.4
2768,0,Asia Pacific,Manufacturing,Human Resources,Meets,Male,44,19,0,9,2.3,1.4,1.8,1,1,1,1,4,2,1
2769,0,North America,Commercial,Market Access,Exceeds,Male,44,7,0,8,2.1,3.3,3.4,0,0,0,0,2.5,2.9,3.5
2770,0,Asia Pacific,Manufacturing,IT & Digital,Meets,Female,44,20,0,10,1.8,2.7,4.3,0,0,0,0,3.3,3.1,3.8
2771,0,Asia Pacific,R&D,Data Science,Below,Male,44,9,0,7,4.5,4.6,4.3,1,1,1,1,4.2,4.8,3.9
2772,0,Asia Pacific,Commercial,Marketing,Meets,Male,39,26,0,9,4,1.2,3,1,1,1,1,3.8,2.2,4.1
2773,0,Asia Pacific,Digital,Legal & Compliance,Meets,Female,35,10,0,10,2.8,4,3,1,1,1,1,4.4,3.2,4.5
2774,0,Europe,Finance,Human Resources,Meets,Female,36,10,0,11,3.2,3.3,1.1,1,1,1,0,2.3,3.6,1.7
2775,0,Latin America,Finance,Finance & Accounting,Far Below,Male,37,27,0,11,2.6,2.8,1.7,1,1,1,1,3.5,1.6,2.8
2776,0,Middle East & Africa,HR,Finance & Accounting,Below,Male,34,10,1,5,,4.7,2.2,1,1,1,1,2.6,3.1,2.3
2777,0,Asia Pacific,Commercial,Human Resources,Meets,Male,42,4,0,7,4,4,4.3,1,1,1,1,3.9,2.9,2.6
2778,0,Asia Pacific,Digital,Quality Assurance,Exceeds,Male,34,15,0,12,3.6,2.3,2.8,1,1,1,1,2.9,2,2.8
2779,0,Asia Pacific,Commercial,Finance & Accounting,Meets,Male,28,3,0,8,2.5,2.1,1.3,1,1,1,1,3,2.6,1.3
2780,0,Latin America,Commercial,Market Access,Exceeds,Female,44,20,0,7,4.7,4,1.7,0,0,0,0,4.6,4.6,1.9
2781,0,North America,Finance,Regulatory Affairs,Meets,Female,41,9,0,6,4.5,4.1,3.9,1,0,0,0,4.8,3,2.2
2782,0,North America,Manufacturing,Quality Assurance,Meets,Female,28,23,0,12,2.4,2.6,2.5,1,1,1,1,2.8,3.9,2.5
2783,0,Europe,R&D,Legal & Compliance,Exceeds,Male,34,15,0,6,2.1,4.1,1.5,1,1,1,1,2.3,3.4,2.2
2784,0,North America,HR,Finance & Accounting,Below,Male,37,19,0,7,3.6,4.6,2.4,1,1,1,1,3,3.5,3
2785,0,Asia Pacific,Digital,Clinical Operations,Far Below,Male,38,12,1,6,,3.7,2.2,0,0,0,0,5,1.9,3.1
2786,0,Asia Pacific,Commercial,Human Resources,Meets,Male,51,20,0,6,2.5,3.7,2,1,1,1,1,3,4.3,2.4
2787,0,Asia Pacific,HR,Regulatory Affairs,Meets,Female,32,4,1,5,,4.7,4.3,1,1,1,1,3.4,1.9,1.4
2788,0,Europe,Commercial,Quality Assurance,Meets,Female,32,12,0,7,2.9,3.1,4.7,1,1,1,1,3.8,3.7,4.3
2789,0,Asia Pacific,Finance,Supply Chain,Meets,Male,46,9,1,9,,3.7,1.7,1,1,0,0,3.7,2.7,3.3
2790,0,North America,R&D,Sales,Exceeds,Female,37,15,0,11,1.5,2.9,1.7,1,1,1,1,1.9,2.7,2.4
2791,0,Latin America,Finance,Communications,Meets,Female,45,16,0,7,2.6,2.9,1,0,0,0,0,2.9,4.3,2.7
2792,0,Latin America,HR,Finance & Accounting,Meets,Male,36,10,0,8,3.5,3.4,2.9,0,0,0,0,3.5,2.9,4
2793,0,Middle East & Africa,Digital,Market Access,Meets,Male,45,5,1,5,,2,4.3,1,1,1,1,1.8,4.1,3.9
2794,0,North America,Commercial,Regulatory Affairs,Meets,Male,36,23,0,6,1.6,4.2,3.2,1,1,1,1,2.2,4.5,2.5
2795,0,Asia Pacific,R&D,Pharmacovigilance,Meets,Female,37,8,1,9,,3.8,3.7,1,1,1,1,2.1,4.1,2.8
2796,0,Latin America,Finance,Sales,Exceeds,Male,32,6,1,11,,2.2,3.6,1,1,1,1,3.6,1.9,3.2
2797,0,North America,HR,Quality Assurance,Meets,Male,48,6,1,11,,1.7,2.6,1,1,1,1,3.8,3.8,2.7
2798,0,Latin America,Finance,Finance & Accounting,Meets,Female,33,16,0,8,3.2,2.7,3.2,1,1,1,1,3.3,2.9,2.6
2799,0,Asia Pacific,Commercial,Medical Affairs,Exceeds,Male,30,12,1,6,,3.4,2.6,1,1,1,1,4.8,2.7,4.1
2800,0,Latin America,Commercial,Legal & Compliance,Exceeds,Male,48,12,0,6,4.5,2.7,2.4,1,1,1,1,4.5,3.9,1
2801,0,Middle East & Africa,Digital,Pharmacovigilance,Below,Female,42,10,1,7,,3.8,3.4,1,1,1,1,2.1,3,1.9
2802,0,Middle East & Africa,R&D,Market Access,Below,Female,48,22,1,11,,1.7,3.6,1,1,1,1,3.5,2.1,1.1
2803,0,Latin America,Manufacturing,Supply Chain,Meets,Male,34,9,0,11,4.1,2.9,2.6,1,1,1,1,3.8,3.9,2.8
2804,1,North America,Finance,Regulatory Affairs,Far Exceeds,Male,42,8,0,5,3,3.5,2.7,1,1,1,1,4.5,1.4,3.7
2805,0,North America,Commercial,Data Science,Meets,Female,46,8,0,5,2.9,2.5,3.1,1,1,1,1,3.5,2.9,3.6
2806,0,North America,HR,Legal & Compliance,Meets,Female,31,6,1,8,,2.5,3.1,1,1,1,1,3.9,3,3
2807,0,Latin America,Finance,Regulatory Affairs,Meets,Non-Binary/Other,40,24,0,10,3.7,4.1,2.1,1,1,1,1,4.1,4,2.8
2808,0,North America,Digital,Sales,Meets,Male,35,36,0,11,4.3,3.4,1.4,1,1,1,1,2.1,3.4,2.3
2809,1,Asia Pacific,Digital,Regulatory Affairs,Far Exceeds,Female,36,16,0,7,3.7,3.7,1.5,1,1,1,1,3.2,4.5,2.2
2810,0,Middle East & Africa,Commercial,Sales,Meets,Male,33,9,0,7,3.1,4.2,2.4,1,1,1,1,4.1,3.1,2.4
2811,0,Asia Pacific,Commercial,Finance & Accounting,Exceeds,Female,41,18,1,11,,3.2,3.3,1,1,1,1,3.4,2.2,3.2
2812,0,North America,Commercial,Pharmacovigilance,Meets,Male,37,14,1,7,,3.3,2.7,1,1,1,1,2.5,1.3,1.8
2813,0,Asia Pacific,Manufacturing,Regulatory Affairs,Exceeds,Male,32,1,0,12,1.6,4,2,1,1,1,1,2.6,5,2.6
2814,0,North America,Commercial,Pharmacovigilance,Meets,Male,47,8,0,12,4,4.7,2.7,0,0,0,0,4.8,4.9,1.9
2815,0,Latin America,Finance,Supply Chain,Meets,Male,38,10,0,7,2.3,3.8,1.4,0,0,0,0,2.8,4,1.4
2816,0,Asia Pacific,Finance,Supply Chain,Far Exceeds,Male,29,10,1,10,,4.9,2.1,0,0,0,0,4.2,4.7,2.3
2817,0,Latin America,R&D,Legal & Compliance,Meets,Male,34,9,1,9,,4.7,4,1,1,1,1,2.6,4.3,3.4
2818,1,Latin America,HR,Sales,Meets,Male,29,5,0,9,3.5,1.5,4.1,1,1,1,1,4.5,2.6,3.6
2819,0,Europe,Commercial,Quality Assurance,Below,Male,34,10,1,7,,4,4.9,1,1,1,1,1.9,3.2,5
2820,0,North America,Finance,Supply Chain,Meets,Female,40,6,0,7,2,2.4,3.1,1,1,1,1,1,2.3,2.5
2821,0,Middle East & Africa,Finance,Marketing,Exceeds,Male,42,17,0,12,3.3,4.3,2.6,1,1,1,1,4.8,5,1.9
2822,1,North America,Finance,Regulatory Affairs,Meets,Female,43,4,1,11,,4.3,2.5,1,1,1,1,3.7,5,3
2823,0,Middle East & Africa,Manufacturing,Marketing,Meets,Female,34,36,0,9,3.6,3.9,2.6,1,1,1,1,5,1.7,2.4
2824,0,North America,HR,Legal & Compliance,Meets,Male,36,15,0,8,2.7,1.7,1.9,1,1,1,1,3.4,2.9,2.4
2825,0,Latin America,Digital,Regulatory Affairs,Meets,Male,41,11,1,7,,3.4,2.7,1,1,1,1,3.1,4.4,3.6
2826,0,Asia Pacific,Finance,Clinical Operations,Meets,Female,43,12,1,8,,4.3,2.8,1,1,1,1,2.3,3.2,1
2827,0,Asia Pacific,Commercial,Pharmacovigilance,Meets,Male,37,21,0,8,4.9,3.4,1.9,1,1,1,1,4.4,2.5,1.9
2828,0,Europe,Finance,Finance & Accounting,Below,Male,42,6,0,11,3.7,3.3,2.5,1,1,1,1,5,2.9,3.5
2829,0,Middle East & Africa,HR,Sales,Exceeds,Male,35,13,1,9,,2.5,2.5,1,1,1,1,4.2,1.5,2.3
2830,0,Middle East & Africa,Digital,Market Access,Meets,Male,28,13,0,12,1.8,3.4,2,1,1,1,1,4.1,3.1,3
2831,0,Middle East & Africa,Manufacturing,Market Access,Meets,Male,43,10,0,7,4,2.4,3.4,1,1,1,1,4.5,4.5,2.2
2832,0,Latin America,R&D,Medical Affairs,Meets,Non-Binary/Other,41,12,0,5,2.8,3.6,1.2,0,0,0,0,3.4,3.2,1.8
2833,0,Middle East & Africa,Commercial,IT & Digital,Meets,Female,37,11,0,8,3.1,2.8,1.3,1,1,1,1,1.4,3.2,2.1
2834,0,Asia Pacific,R&D,Human Resources,Meets,Female,39,2,0,10,4.4,1.6,1,1,1,1,1,2.7,3.4,2.8
2835,0,Latin America,Manufacturing,Quality Assurance,Meets,Male,45,9,0,11,2.9,1.7,1.2,1,1,1,1,3.1,2.1,2.4
2836,0,North America,HR,Communications,Meets,Non-Binary/Other,38,22,0,9,3.8,3.1,5,1,1,1,1,4.5,4.4,2.8
2837,0,Middle East & Africa,HR,Sales,Exceeds,Female,28,17,0,8,3,2.6,4.6,1,1,1,1,3.2,4,3.5
2838,0,Middle East & Africa,Manufacturing,Legal & Compliance,Below,Female,28,9,1,10,,3.8,2.2,1,1,1,1,3.6,3.8,2
2839,0,North America,Finance,Supply Chain,Meets,Female,46,9,1,10,,3.2,2.3,1,1,1,1,2.6,2.3,2.6
2840,0,Middle East & Africa,Manufacturing,Data Science,Far Exceeds,Male,42,6,1,9,,4.5,2.2,1,1,1,1,4.1,3.7,3.6
2841,0,North America,Commercial,Communications,Far Below,Female,45,31,0,6,3.4,4.8,2.1,1,1,1,1,3.1,5,4
2842,0,Latin America,Digital,Quality Assurance,Exceeds,Female,47,16,0,5,3.6,3.9,4.1,1,1,1,1,3.2,3.6,4.6
2843,0,Asia Pacific,R&D,Quality Assurance,Meets,Non-Binary/Other,47,3,0,7,4.5,3.7,3.2,1,1,1,1,4.3,3,2.7
2844,0,North America,R&D,Data Science,Below,Male,30,13,0,5,3.3,1.9,1.9,1,1,1,1,1.4,2.4,2.8
2845,0,Europe,HR,Pharmacovigilance,Far Below,Non-Binary/Other,37,6,1,12,,3,2.7,1,1,1,1,1.5,4.6,3.1
2846,0,North America,Finance,Legal & Compliance,Below,Male,33,12,1,11,,2.9,5,1,1,1,1,5,4.1,4.2
2847,0,Middle East & Africa,HR,Quality Assurance,Below,Male,39,4,0,11,3.5,3.3,2.9,1,1,1,1,3.5,2.8,4.1
2848,0,Latin America,Commercial,Clinical Operations,Far Below,Female,30,7,0,8,2.5,3.1,4.4,1,1,1,1,4.2,3.2,2.8
2849,0,Latin America,Manufacturing,Quality Assurance,Meets,Female,38,13,0,8,4.1,3.2,3.2,1,1,1,1,3,3.9,3.1
2850,0,North America,R&D,IT & Digital,Far Below,Female,28,28,0,5,2.2,3.2,3.6,1,1,1,1,1.9,4.5,2.9
2851,0,Asia Pacific,Commercial,Human Resources,Meets,Male,36,15,0,10,1.4,3.3,1.6,1,1,1,1,2.5,4.3,1
2852,0,Europe,HR,Communications,Exceeds,Male,47,11,0,11,4.2,4.2,3.9,1,1,1,1,3.3,2.1,4.1
2853,0,Latin America,HR,Medical Affairs,Exceeds,Female,34,17,0,10,4.3,3.7,1.7,1,1,1,1,4,2,1.7
2854,0,Middle East & Africa,R&D,Marketing,Meets,Male,34,33,0,10,4.3,2.6,4.2,1,1,1,1,4.5,1.3,3.7
2855,0,Middle East & Africa,HR,Legal & Compliance,Exceeds,Female,39,20,0,12,2.9,1.9,2.6,1,1,1,1,4.7,2.9,1.9
2856,0,Asia Pacific,Finance,Finance & Accounting,Far Below,Male,39,4,0,10,3,2,1,1,1,1,1,3.1,3.2,2.9
2857,0,Latin America,HR,Market Access,Below,Male,40,6,0,5,2.9,2.8,2.7,1,1,1,0,3.9,2.2,3.6
2858,1,North America,Digital,Pharmacovigilance,Meets,Non-Binary/Other,33,13,0,6,2.1,4.6,4.1,1,1,1,1,3.4,4.6,3.2
2859,0,Middle East & Africa,Manufacturing,Sales,Meets,Male,34,26,0,5,3,3.5,2.2,1,1,1,1,3,3.4,4.6
2860,0,Asia Pacific,HR,Supply Chain,Exceeds,Female,38,18,1,11,,3.9,4.7,1,0,0,0,2.7,3.2,3.2
2861,0,Latin America,Digital,Finance & Accounting,Meets,Male,44,20,0,5,2.3,2.2,2.9,1,0,0,0,3.1,1.6,2.2
2862,0,Latin America,Commercial,Communications,Meets,Male,34,6,1,5,,2.7,5,1,1,1,1,3.5,2.6,3.8
2863,0,Latin America,HR,Clinical Operations,Meets,Female,37,13,0,5,2.7,3.6,2.4,1,1,1,1,3,3.2,2
2864,0,Latin America,Finance,Pharmacovigilance,Below,Male,28,14,0,7,4.6,3.1,3,1,1,1,1,4.2,3.2,3.3
2865,0,Latin America,Commercial,Legal & Compliance,Meets,Female,35,3,1,9,,4,2.7,1,1,1,1,2,3.5,4.2
2866,1,Middle East & Africa,HR,Marketing,Meets,Female,39,7,1,6,,2.7,2.9,1,1,1,1,3.1,3,2.6
2867,0,Asia Pacific,R&D,Human Resources,Below,Female,43,11,1,7,,3.8,2.5,0,0,0,0,3.6,3.8,3.5
2868,0,Latin America,Digital,Medical Affairs,Far Below,Female,33,10,0,11,3.9,1.5,2.3,1,1,1,1,3.7,1.7,3.6
2869,0,Europe,Digital,Marketing,Meets,Female,39,9,1,10,,3.7,2.7,1,1,1,1,4.9,4.1,3.5
2870,0,Europe,R&D,Sales,Meets,Female,40,4,0,5,2.7,5,2.5,1,1,1,1,2.3,3.6,2.2
2871,0,Asia Pacific,Manufacturing,Data Science,Meets,Male,28,13,1,11,,3.5,2,1,1,1,1,3.5,1.8,4.2
2872,0,North America,Finance,Supply Chain,Meets,Female,30,22,0,10,3,4.2,2.7,1,1,1,1,2,2.8,3.2
2873,0,North America,Digital,Data Science,Far Exceeds,Female,41,9,1,10,,2.4,3.8,1,1,1,1,3.7,2.1,2.9
2874,0,North America,Commercial,Finance & Accounting,Meets,Male,38,8,0,9,3.4,4.2,2.9,1,1,1,1,4.5,4,3.6
2875,0,Europe,Finance,Legal & Compliance,Below,Male,39,6,1,11,,2.2,3.4,1,1,1,1,3,1.3,3.8
2876,0,North America,Digital,Communications,Meets,Male,32,6,0,6,2.2,3.6,2.5,1,1,1,1,1.1,4.6,2.5
2877,0,Middle East & Africa,Manufacturing,Finance & Accounting,Meets,Male,29,12,0,12,4.1,4.3,4,1,1,1,1,5,2.9,4
2878,0,Latin America,Commercial,Regulatory Affairs,Far Below,Male,41,10,0,12,2.6,2,2.5,1,1,1,0,3.8,1.3,3.5
2879,0,Europe,Finance,Legal & Compliance,Meets,Female,39,9,0,8,2.8,2.3,2.5,0,0,0,0,3.6,1.6,1.1
2880,0,Asia Pacific,Commercial,Medical Affairs,Meets,Male,28,13,1,10,,1.9,3,1,1,1,1,4.4,2.4,2.1
2881,0,Asia Pacific,R&D,Supply Chain,Meets,Female,37,10,0,11,2.3,1.1,2.3,1,1,1,1,3.2,3,3.5
2882,0,Latin America,HR,Sales,Meets,Female,49,19,0,10,3.9,4.7,3.9,1,1,1,1,3.4,4.3,3.2
2883,0,Europe,R&D,Legal & Compliance,Meets,Male,42,17,0,7,3.5,4,1.8,1,1,1,1,2.6,4,1.6
2884,0,North America,Finance,Pharmacovigilance,Exceeds,Male,33,7,1,7,,2.2,4,1,1,1,1,4.4,1.9,4.8
2885,0,North America,HR,Market Access,Exceeds,Male,39,21,1,7,,2.8,2.4,1,1,1,1,3.5,4.1,2.3
2886,0,Middle East & Africa,R&D,Communications,Meets,Female,37,12,0,9,2.9,1.2,3,1,1,1,1,2.2,1.8,3
2887,0,Middle East & Africa,HR,Supply Chain,Meets,Female,48,8,0,6,2.5,2.3,1,1,1,1,1,2.6,2.9,1.4
2888,0,North America,Digital,IT & Digital,Exceeds,Male,31,6,0,10,1.1,4.4,2.2,0,0,0,0,2.1,5,3
2889,0,Asia Pacific,Commercial,Legal & Compliance,Exceeds,Male,46,20,0,7,2.6,1.1,3.7,1,1,1,1,3.4,2.3,3.6
2890,0,Asia Pacific,HR,Pharmacovigilance,Exceeds,Male,31,9,0,6,3.1,1.7,4.1,1,0,0,0,3.5,1.7,2.8
2891,0,Middle East & Africa,Digital,Legal & Compliance,Below,Female,40,8,1,9,,3.3,4,1,1,1,1,3.7,5,4.8
2892,0,Latin America,Manufacturing,Pharmacovigilance,Far Below,Male,42,5,0,12,3.6,3.8,4,1,1,1,1,2.5,3.7,2.3
2893,0,North America,R&D,IT & Digital,Far Exceeds,Female,45,11,0,10,2.2,2.2,1.9,1,1,1,1,3.6,2.8,2.6
2894,0,Middle East & Africa,Manufacturing,Regulatory Affairs,Far Exceeds,Female,43,11,1,6,,2.1,5,1,1,1,1,3.4,1.3,3.2
2895,0,Middle East & Africa,Finance,Communications,Meets,Male,29,6,0,11,3.8,2.6,3.4,1,1,1,1,3.9,2.1,3.3
2896,0,North America,Digital,Clinical Operations,Far Exceeds,Female,38,4,0,9,4.1,2.7,1.9,1,1,1,1,4.8,3.5,1.6
2897,0,North America,Manufacturing,Human Resources,Meets,Male,41,1,0,9,4.6,1,2.5,1,1,1,1,3.7,2.1,2.1
2898,0,Asia Pacific,Manufacturing,Medical Affairs,Meets,Male,45,2,0,5,2.8,3,1.7,1,0,0,0,3.5,3.3,2.9
2899,0,Latin America,Digital,Medical Affairs,Meets,Male,31,15,0,8,2.2,1.8,4,1,1,1,1,3.4,2.1,3.5
2900,0,Latin America,Commercial,Finance & Accounting,Meets,Male,32,7,0,9,4,2.4,3.5,1,1,1,1,1.7,2.9,2.4
2901,0,North America,HR,Regulatory Affairs,Meets,Male,29,6,1,5,,3.6,2.9,0,0,0,0,2.8,4.4,2.7
2902,0,Europe,Finance,Data Science,Far Exceeds,Female,38,6,1,8,,2.4,3.1,1,1,1,1,3.8,1.6,3.7
2903,0,Middle East & Africa,Finance,Data Science,Meets,Female,40,26,0,5,2.4,2.8,3.8,0,0,0,0,2.9,1.9,3.6
2904,0,Middle East & Africa,R&D,Sales,Exceeds,Female,40,10,0,10,2.4,2.8,2.8,1,1,1,1,1.6,3.1,2.1
2905,0,North America,HR,Clinical Operations,Exceeds,Male,36,6,0,9,3,1.7,1.1,1,1,1,1,2.9,1.9,2.1
2906,0,Europe,R&D,Pharmacovigilance,Below,Non-Binary/Other,37,18,0,5,5,3.1,4,1,1,1,1,4.9,3.7,3.2
2907,0,Asia Pacific,Finance,Quality Assurance,Below,Male,37,14,0,10,3.3,3.8,1,1,1,1,1,3.6,4.2,2
2908,0,North America,HR,Quality Assurance,Meets,Male,37,12,0,12,4,3.8,3.6,1,1,1,1,3.1,4.3,3.5
2909,0,North America,Manufacturing,Data Science,Meets,Male,28,4,1,5,,2.6,3.6,1,1,1,1,2.7,2.7,2.7
2910,0,Middle East & Africa,Commercial,Regulatory Affairs,Meets,Female,32,11,1,5,,2.3,2.5,1,1,1,1,1.2,3.1,3
2911,0,North America,Manufacturing,Clinical Operations,Below,Male,41,13,0,6,3.9,3.3,2.2,1,1,0,0,3,3.1,3.6
2912,0,North America,Commercial,IT & Digital,Meets,Female,35,14,0,5,2.4,5,1.5,1,1,1,1,2.4,4.3,1.9
2913,0,North America,Digital,Marketing,Below,Male,35,12,1,7,,3.6,2.3,1,1,1,1,4.3,3.7,2.6
2914,0,Middle East & Africa,R&D,Finance & Accounting,Meets,Female,46,8,1,10,,3.1,1,1,1,1,0,4.5,3.2,2.6
2915,0,Asia Pacific,R&D,Market Access,Below,Female,44,14,0,10,4.6,2.8,2.6,1,1,1,1,4.7,2.7,3.4
2916,0,Asia Pacific,Digital,Clinical Operations,Far Exceeds,Female,34,19,0,6,4.1,2.5,3.6,1,1,1,1,4.2,1,3.6
2917,0,North America,HR,Legal & Compliance,Meets,Female,47,7,1,6,,1.1,1,1,1,1,1,1.9,3.7,3.3
2918,1,Middle East & Africa,Digital,Human Resources,Exceeds,Female,37,6,1,6,,3.1,2.5,1,1,1,1,2.6,2.3,3.2
2919,0,Asia Pacific,Finance,Sales,Far Exceeds,Male,43,10,0,9,3.7,2.2,3.8,1,1,1,1,4.3,3.2,3.4
2920,1,Asia Pacific,Digital,Pharmacovigilance,Exceeds,Female,38,9,0,11,3.8,2.9,4.1,1,1,1,1,2.5,1.7,3.5
2921,0,Asia Pacific,Commercial,Human Resources,Meets,Male,34,18,0,10,3,3.4,2.9,1,1,1,1,3.3,4.5,2.7
2922,0,Middle East & Africa,Finance,Pharmacovigilance,Meets,Non-Binary/Other,43,6,0,12,3.7,4.6,1,1,1,1,1,2.6,4.6,1.8
2923,0,Middle East & Africa,Digital,Finance & Accounting,Below,Female,33,11,1,7,,1.9,1.5,1,1,1,1,3.9,2.7,3.7
2924,0,North America,R&D,IT & Digital,Below,Male,37,18,0,12,3.6,2.3,1.5,0,0,0,0,3.6,1.6,3
2925,0,Latin America,Manufacturing,Communications,Exceeds,Female,38,13,0,12,2.3,4.1,3.6,0,0,0,0,3.3,3.4,3.8
2926,0,Asia Pacific,Commercial,Medical Affairs,Far Below,Male,36,33,0,8,3.3,2.3,3.5,1,1,0,0,2.5,2.2,3.9
2927,0,Latin America,Commercial,Supply Chain,Far Exceeds,Male,30,19,0,12,4.1,2.8,2.1,1,1,1,1,3.6,3.5,2.2
2928,0,Middle East & Africa,HR,Legal & Compliance,Meets,Female,41,6,1,11,,2,3.2,1,1,1,1,1.7,3.5,3.4
2929,0,Middle East & Africa,Manufacturing,Human Resources,Meets,Male,44,9,0,8,4.3,4.4,1.4,1,1,1,1,4.1,2.4,3.3
2930,0,Middle East & Africa,Commercial,Supply Chain,Below,Female,39,17,0,9,4,3.4,2.3,1,1,1,1,4.5,2.8,1.6
2931,0,Latin America,Digital,Medical Affairs,Meets,Male,33,7,0,6,3.6,2.2,2.5,1,1,1,1,4.7,1,3.6
2932,0,Middle East & Africa,Commercial,Sales,Meets,Female,51,16,0,7,3.7,4.3,2.7,1,1,1,1,1.9,3.7,2.2
2933,0,North America,Commercial,Human Resources,Meets,Female,37,4,1,6,,4.6,1.4,1,1,1,1,4.2,3.3,2.5
2934,0,Middle East & Africa,Commercial,Pharmacovigilance,Meets,Female,37,6,1,12,,1.8,3.1,0,0,0,0,4.3,3.9,3.3
2935,0,Europe,HR,Supply Chain,Below,Male,28,5,0,6,3.1,4.1,1,1,1,1,1,1.3,3.7,1
2936,0,Latin America,Commercial,Supply Chain,Meets,Male,31,11,1,9,,3.3,1.4,1,1,1,1,2.8,1.9,1.8
2937,0,Europe,Commercial,Market Access,Meets,Female,45,13,0,7,3.1,1.6,1.9,1,1,1,1,2.5,2,1.1
2938,0,Middle East & Africa,HR,Supply Chain,Far Below,Female,55,13,0,5,3.6,3,3.6,1,1,1,1,3.2,3,4.9
2939,0,North America,Finance,Communications,Far Below,Male,46,10,0,12,3.6,3.3,3.2,1,1,1,1,4.5,3.8,3.5
2940,0,Asia Pacific,Manufacturing,Pharmacovigilance,Meets,Female,32,16,0,8,3.3,1.4,1.7,1,1,1,1,2.1,2.5,2.4
2941,0,Middle East & Africa,Finance,Sales,Meets,Non-Binary/Other,41,8,1,11,,5,2.9,1,1,1,1,2.6,4,3.9
2942,0,North America,R&D,Marketing,Meets,Female,36,15,0,8,3.9,2.5,3.7,1,1,1,1,3,2.9,4.7
2943,0,Latin America,HR,Data Science,Meets,Female,36,21,0,8,2.4,3.5,4.7,1,1,1,1,4.7,2.4,4
2944,0,Europe,HR,Clinical Operations,Meets,Female,30,12,1,6,,3,3.3,1,1,1,1,3.1,3.4,3.2
2945,0,Europe,Commercial,Human Resources,Meets,Male,41,25,0,11,2.8,2.8,3.3,0,0,0,0,3,3.4,2.2
2946,0,Europe,Commercial,IT & Digital,Meets,Female,30,9,0,5,3.6,2.5,1.6,1,1,1,1,2.6,3.5,2.4
2947,0,Latin America,R&D,Regulatory Affairs,Meets,Female,28,14,0,5,3.1,3.2,3,1,1,1,1,3.2,4.9,1
2948,0,North America,Commercial,Quality Assurance,Meets,Male,36,18,0,6,3.3,2.1,2.8,1,0,0,0,3.1,1.4,3.2
2949,0,Latin America,Digital,Finance & Accounting,Below,Male,28,13,0,10,4.3,3.1,2.2,1,1,1,1,3.6,3.3,2.2
2950,0,Europe,Commercial,Clinical Operations,Meets,Male,33,15,1,6,,1.6,1.2,1,1,1,1,2.4,3,1.5
2951,0,Middle East & Africa,Commercial,Market Access,Meets,Female,42,15,0,7,3.6,4,1.8,1,1,1,1,4,3.9,1.6
2952,1,Asia Pacific,Digital,Supply Chain,Meets,Female,45,9,1,8,,2.5,1.9,1,1,1,1,5,2.5,3.3
2953,0,Latin America,R&D,Sales,Exceeds,Female,42,9,0,8,4,2.9,3.7,1,1,1,1,2.1,2.9,2.9
2954,0,Latin America,Digital,Finance & Accounting,Meets,Female,37,18,0,5,3.7,3.6,2.3,1,1,0,0,2.9,3.8,2.9
2955,0,North America,HR,Marketing,Meets,Male,35,17,0,10,5,4.4,2.1,1,1,1,1,4.7,5,2.2
2956,0,North America,Digital,Quality Assurance,Exceeds,Female,32,8,0,8,3.4,4.8,1,1,1,1,1,3.9,3.9,2
2957,0,Latin America,Manufacturing,Medical Affairs,Meets,Female,47,12,0,11,4.2,4,3,1,1,1,1,3.9,4.8,3.6
2958,0,Europe,HR,Marketing,Exceeds,Male,30,7,1,8,,1.9,3.6,1,1,1,1,5,2.7,2.7
2959,0,Asia Pacific,Commercial,Legal & Compliance,Below,Female,39,19,0,7,2.8,4.4,1,1,1,1,1,2.4,4.6,1.7
2960,0,North America,HR,Human Resources,Exceeds,Male,42,6,0,6,4.7,2.2,2.3,0,0,0,0,4.1,3.1,2.7
2961,0,Europe,R&D,Data Science,Below,Male,28,9,1,6,,2.1,2.9,1,1,1,1,3.8,3.1,2.4
2962,0,Middle East & Africa,R&D,Supply Chain,Meets,Male,28,18,0,9,4.8,2.7,4.3,1,1,1,0,5,3.8,3.1
2963,0,North America,Digital,Regulatory Affairs,Meets,Female,42,12,0,5,3.5,3.5,2,1,0,0,0,3.3,2,3.1
2964,0,Europe,HR,IT & Digital,Exceeds,Female,29,16,0,9,4,5,3.9,1,1,1,1,2.9,4.6,3.6
2965,0,Europe,Commercial,Quality Assurance,Meets,Female,40,23,0,12,2.1,2.9,1.9,0,0,0,0,2.4,1.5,2.4
2966,0,Asia Pacific,R&D,Finance & Accounting,Meets,Female,33,11,0,7,2.3,5,3.9,1,1,1,1,3.1,5,3.3
2967,0,Asia Pacific,Finance,Supply Chain,Meets,Male,40,4,0,11,3.8,3.9,2,1,1,1,1,3.3,4.2,1
2968,0,Middle East & Africa,Commercial,IT & Digital,Below,Male,40,4,0,11,3.9,2.7,2.7,1,1,1,1,2.1,3.3,4
2969,0,Europe,Finance,IT & Digital,Meets,Male,44,4,1,6,,4,3.3,1,1,1,1,3,3.7,3.9
2970,0,Europe,Manufacturing,Quality Assurance,Meets,Male,41,21,0,7,3.9,2.1,1,1,1,1,1,4.6,1.9,1
2971,0,Asia Pacific,Finance,Regulatory Affairs,Meets,Female,39,10,0,11,3.7,2.7,1,1,1,1,1,3.9,1.3,1.7
2972,0,North America,R&D,Data Science,Meets,Female,48,8,0,11,3.8,2.4,3.6,0,0,0,0,2.7,4.8,2.8
2973,0,North America,Digital,IT & Digital,Exceeds,Male,32,22,0,12,4.2,3.7,3.8,1,1,1,1,3.5,4.4,4.5
2974,0,Latin America,Manufacturing,Medical Affairs,Meets,Male,38,7,1,6,,4.2,4.1,1,1,1,1,3.2,2,3.3
2975,1,Asia Pacific,HR,IT & Digital,Far Exceeds,Female,43,36,0,9,4,3.2,3.5,1,1,1,1,3.8,3.3,4.1
2976,0,Latin America,Commercial,Pharmacovigilance,Below,Female,28,23,0,10,3.7,2.8,3.2,1,1,1,1,2.6,3.7,4.3
2977,0,Asia Pacific,R&D,IT & Digital,Far Below,Female,47,7,1,9,,2.9,2.5,1,1,1,1,2.3,2.1,2.2
2978,0,Middle East & Africa,Manufacturing,IT & Digital,Exceeds,Male,37,6,0,12,2.3,1.4,2.5,1,1,1,1,4.7,1.2,3.7
2979,1,Europe,Manufacturing,Sales,Exceeds,Female,41,17,0,5,2.9,2.7,3,1,1,1,1,4.7,3.5,2.2
2980,0,Middle East & Africa,R&D,Marketing,Below,Male,35,10,0,12,3,3.2,1,1,1,1,1,3.6,3.2,1.4
2981,0,Asia Pacific,HR,Clinical Operations,Meets,Female,41,16,1,9,,5,2.9,1,1,1,1,3,4.6,4
2982,0,Europe,HR,Medical Affairs,Exceeds,Male,40,5,0,12,3.4,2,2.9,1,1,1,1,2.6,2.9,3.2
2983,0,North America,Digital,Legal & Compliance,Below,Male,31,11,0,5,4.3,3.4,2.8,1,0,0,0,5,2.8,2.3
2984,0,North America,Finance,Medical Affairs,Meets,Female,35,26,0,7,3.6,1.8,1,1,1,1,1,3.3,4.2,2.7
2985,0,Latin America,HR,Market Access,Meets,Male,41,9,0,8,2.4,3.5,3.1,0,0,0,0,2,3.9,3.6
2986,1,Asia Pacific,Digital,Quality Assurance,Far Exceeds,Female,47,14,0,5,3.6,3.4,1.8,1,1,1,1,4.1,3.1,1.8
2987,0,Asia Pacific,Finance,Quality Assurance,Meets,Male,36,19,0,9,3,4.2,3.1,1,1,1,1,4.6,2.9,2.3
2988,0,North America,Manufacturing,Market Access,Meets,Male,30,8,0,8,3,3.2,4.3,1,1,1,1,1.8,3.8,4.6
2989,0,Middle East & Africa,R&D,Marketing,Meets,Female,40,13,1,7,,3.2,2.8,0,0,0,0,2.1,3.4,2.6
2990,0,Europe,HR,Quality Assurance,Meets,Male,36,3,0,9,3.5,3.5,2,0,0,0,0,2,2.7,3.9
2991,0,Middle East & Africa,Digital,Pharmacovigilance,Below,Male,43,3,1,7,,2.9,1.2,1,0,0,0,2.9,4.6,1.1
2992,0,Middle East & Africa,Manufacturing,Sales,Far Exceeds,Male,34,14,0,10,2.8,3.3,3,1,1,1,1,3.7,3.2,3.7
2993,0,North America,HR,Clinical Operations,Meets,Female,30,13,0,12,3.6,3.1,2.8,1,1,1,1,2.7,3.3,1.2
2994,0,North America,Commercial,Clinical Operations,Meets,Female,47,13,0,9,3.2,2.2,2.4,1,1,1,1,3.7,3,2.6
2995,0,North America,Manufacturing,Regulatory Affairs,Exceeds,Female,35,2,0,10,3,3.7,2.3,1,1,0,0,3.8,3,2.3
2996,0,Latin America,HR,Regulatory Affairs,Far Below,Female,33,8,0,5,3.4,4.7,2.5,1,1,1,1,2.8,4,2.8
2997,0,Middle East & Africa,Manufacturing,Sales,Far Exceeds,Female,34,8,0,8,3.2,2.1,2.2,1,1,1,1,4.2,3.3,1.5
2998,0,Asia Pacific,R&D,Supply Chain,Meets,Female,46,15,0,10,2.9,3.4,1.8,1,1,1,1,2.8,1.9,1.5
2999,0,Europe,R&D,Supply Chain,Meets,Female,52,14,0,11,4.2,4.4,2.1,0,0,0,0,4.3,3.6,3.3
3000,0,Latin America,R&D,Communications,Below,Male,33,10,0,9,4.2,3,3.5,1,1,1,1,3.1,2.4,1.9
3001,0,Asia Pacific,Finance,Medical Affairs,Exceeds,Female,37,5,1,9,,4.7,1.4,1,1,0,0,3.7,3.6,2.5
3002,0,Middle East & Africa,Commercial,Finance & Accounting,Exceeds,Female,40,17,0,9,3.6,4,3.2,1,1,1,1,2.4,4.8,4
3003,0,North America,R&D,Medical Affairs,Far Below,Female,28,15,0,5,3,2.1,2.9,1,1,1,1,4.5,2.4,3.7
3004,0,Middle East & Africa,Commercial,Legal & Compliance,Below,Male,35,6,0,6,3.1,2.6,2.5,1,1,1,1,2.1,1.1,2
3005,0,Europe,R&D,Legal & Compliance,Exceeds,Female,49,13,0,9,2.8,4,2.6,1,1,1,1,3.6,3.1,1.8
3006,0,Latin America,Finance,Human Resources,Below,Female,36,18,0,8,2.4,1.3,2.7,1,1,1,1,3.3,2.3,1.9
3007,0,Latin America,Manufacturing,Communications,Meets,Male,46,11,0,12,3.3,2.3,2,1,1,1,1,4.7,1.3,1.7
3008,0,Europe,HR,Market Access,Meets,Non-Binary/Other,38,9,1,8,,3.5,1.4,1,1,1,1,3.8,2.7,2.3
3009,0,Asia Pacific,HR,Data Science,Exceeds,Female,28,11,1,9,,2.6,3.4,1,1,1,1,4,3.1,3.7
3010,0,Asia Pacific,R&D,Human Resources,Meets,Male,44,11,0,12,4.4,1.9,1.7,0,0,0,0,3.2,1.9,1.8
3011,0,Latin America,HR,Regulatory Affairs,Meets,Female,36,20,0,8,3.6,3.1,3.3,1,1,1,1,3.2,3.2,3.4
3012,0,Latin America,R&D,Data Science,Far Exceeds,Female,47,28,0,11,3.6,4.3,3.4,1,1,1,1,5,3.7,3.9
3013,0,North America,R&D,Quality Assurance,Meets,Female,39,36,0,10,4.7,2.3,1.6,1,1,1,0,3.7,1,2.9
3014,0,Asia Pacific,Digital,Communications,Meets,Female,38,22,0,11,3.7,2.5,3.5,1,1,1,1,4.7,2.3,2.3
3015,0,Europe,Digital,Clinical Operations,Below,Male,41,1,0,9,5,2.9,1,1,1,1,1,4,3,2.4
3016,0,Asia Pacific,Digital,Medical Affairs,Far Exceeds,Male,40,26,0,12,3,4.9,3.7,1,1,1,0,2.6,3.1,2.8
3017,0,North America,Commercial,Supply Chain,Meets,Male,28,9,0,10,3.3,2.1,2.2,1,1,1,1,2.2,1.5,3.9
3018,0,Latin America,Digital,Sales,Far Below,Male,44,27,0,7,4.2,2.1,3.5,1,1,1,1,3.8,4.2,2.9
3019,1,Latin America,R&D,Regulatory Affairs,Meets,Female,38,5,1,10,,3.5,3.1,1,1,1,1,3.2,3.3,4
3020,0,North America,Finance,Clinical Operations,Meets,Male,38,2,0,9,3.5,4.6,3.3,0,0,0,0,3.2,3.9,2.6
3021,0,Europe,Finance,Marketing,Far Exceeds,Male,41,12,0,9,5,2.4,1.5,1,1,1,1,4,2.4,1
3022,0,Latin America,Manufacturing,Finance & Accounting,Meets,Female,43,3,0,9,2.5,4.9,5,1,1,1,1,4.1,3.3,3.5
3023,0,Middle East & Africa,Digital,Finance & Accounting,Meets,Male,44,8,1,6,,1.6,3.6,1,1,1,1,2.2,3.6,2.8
3024,0,Latin America,Finance,Sales,Meets,Male,42,18,0,6,3.2,1.8,3.7,1,1,1,1,3.1,3.2,5
3025,0,Middle East & Africa,Digital,Data Science,Far Below,Female,28,4,1,11,,2.4,3.7,1,1,1,1,4.4,1,2.1
3026,0,North America,Manufacturing,Human Resources,Exceeds,Male,38,5,0,9,2.7,3.1,3.1,0,0,0,0,4.2,1.1,4.4
3027,0,North America,Finance,Human Resources,Below,Female,32,21,0,8,2.7,2.8,3,1,1,1,1,3.3,3.1,3
3028,0,Latin America,R&D,Communications,Meets,Female,39,12,0,6,2.5,2.3,3.5,0,0,0,0,1.8,2.6,3
3029,0,Asia Pacific,Commercial,Human Resources,Meets,Female,37,5,0,12,3.5,1,2.5,1,1,1,1,3.9,2.4,1.3
3030,0,Middle East & Africa,Digital,Pharmacovigilance,Meets,Male,50,21,0,9,3,3.1,1.9,1,1,1,0,2.3,2.4,1.4
3031,0,Europe,Finance,Data Science,Below,Male,30,11,1,7,,2.9,3.7,1,1,1,1,4.2,3.1,2.8
3032,0,Latin America,Finance,Regulatory Affairs,Far Exceeds,Female,38,19,0,8,3.6,3.1,2.3,1,1,1,1,3.9,3.3,1.8
3033,0,Europe,Manufacturing,Sales,Meets,Male,39,3,0,8,3.9,2.1,2.3,1,1,1,1,3.8,2.8,1.7
3034,0,Latin America,R&D,Pharmacovigilance,Meets,Male,35,24,0,5,1.6,2.8,1,1,1,1,1,3.2,2.8,1.1
3035,0,Asia Pacific,HR,Quality Assurance,Meets,Male,38,26,0,9,4.1,3,3.3,1,1,1,1,2.9,3.3,3.6
3036,1,Asia Pacific,Finance,Marketing,Exceeds,Female,51,7,0,10,2.3,2.6,2.6,1,1,1,1,1.7,3.5,2.4
3037,0,Asia Pacific,Commercial,Data Science,Meets,Female,40,21,0,8,3,2.4,3.2,1,1,1,1,4.1,3.3,2.9
3038,0,Asia Pacific,Manufacturing,Marketing,Meets,Non-Binary/Other,47,7,0,6,3,3.6,2.7,0,0,0,0,3.6,4.3,1.6
3039,0,North America,Finance,Sales,Exceeds,Female,35,3,1,9,,1.8,3.6,1,1,1,1,5,2.7,4.7
3040,0,North America,Finance,Clinical Operations,Below,Male,43,3,1,7,,3,3,1,1,1,1,3,3.2,3.5
3041,0,Middle East & Africa,Manufacturing,Sales,Far Below,Female,33,16,0,10,4,2.6,3.6,0,0,0,0,2.8,2.4,2.3
3042,0,Europe,Manufacturing,Legal & Compliance,Exceeds,Female,33,36,0,8,2.6,2.5,3.4,1,1,1,1,1.9,3.5,3.8
3043,0,Latin America,Digital,Supply Chain,Meets,Female,28,13,0,10,4.2,3.9,3,1,1,1,1,3.5,4,2
3044,0,Latin America,Finance,Pharmacovigilance,Below,Female,32,13,0,10,3.2,3.8,2.2,1,1,1,1,3.7,3.3,2.8
3045,0,North America,HR,IT & Digital,Meets,Non-Binary/Other,38,4,0,7,3.5,3.3,3.9,1,1,1,1,4.3,2.7,3.4
3046,0,Latin America,Commercial,Communications,Below,Female,47,10,0,11,4.2,3.6,2,1,1,1,1,4.6,3.6,3.6
3047,0,North America,R&D,Clinical Operations,Far Below,Female,37,4,1,8,,3.5,2.2,0,0,0,0,4.2,2.8,1.7
3048,0,Middle East & Africa,R&D,Data Science,Below,Female,39,15,0,7,5,2.3,2.1,1,1,1,1,4.5,3.3,1
3049,0,Europe,HR,Quality Assurance,Meets,Non-Binary/Other,45,11,0,9,3.1,3,4,0,0,0,0,3,3,2.7
3050,0,Middle East & Africa,Manufacturing,Marketing,Meets,Female,36,13,0,7,3.5,2.3,1.7,1,1,1,1,3.4,3,2.1
3051,0,Asia Pacific,Manufacturing,Finance & Accounting,Meets,Female,32,10,0,11,4.7,3.1,2.6,1,1,1,1,5,1.5,2.7
3052,0,Asia Pacific,Manufacturing,Sales,Meets,Female,33,7,1,11,,1,2.4,1,1,0,0,3.3,1.9,3.2
3053,0,Asia Pacific,Finance,Finance & Accounting,Meets,Female,45,14,0,11,4.1,1,1.9,1,1,1,1,4.7,1.4,1.4
3054,0,Middle East & Africa,Manufacturing,Market Access,Meets,Male,39,14,1,10,,3.3,1.7,1,1,1,1,3.9,3.6,1.5
3055,0,Latin America,Manufacturing,Regulatory Affairs,Meets,Male,39,9,1,6,,4.4,3.6,1,1,1,1,3.4,3.3,3.7
3056,0,Europe,Finance,Data Science,Exceeds,Male,33,14,0,5,2.8,3,3.4,1,1,1,1,3.2,1.9,4.2
3057,0,Asia Pacific,Finance,IT & Digital,Meets,Male,46,1,1,5,,2.2,2.6,1,1,1,1,4.2,2,3.3
3058,1,Asia Pacific,HR,Regulatory Affairs,Meets,Female,49,13,0,11,2.7,2.6,2.5,1,1,1,1,3.1,2.7,1.6
3059,0,Asia Pacific,Digital,Clinical Operations,Far Exceeds,Female,39,23,0,11,3.4,3.4,2.2,0,0,0,0,2.8,4.2,3
3060,0,Europe,Finance,Supply Chain,Meets,Female,44,13,0,10,2,4.7,1.4,1,1,1,1,1,5,2.3
3061,1,Asia Pacific,Commercial,Legal & Compliance,Meets,Non-Binary/Other,34,12,0,12,3.4,1,3.2,1,1,1,1,2.3,1.6,4.9
3062,0,Europe,Manufacturing,Data Science,Meets,Male,46,18,1,11,,3.8,1.9,1,1,1,1,3,5,2.2
3063,0,Asia Pacific,Digital,Supply Chain,Meets,Female,41,2,1,6,,2.5,1,1,1,1,0,2.7,3.5,1.7
3064,0,Middle East & Africa,R&D,IT & Digital,Meets,Male,31,5,0,9,3.4,3.1,1.6,1,1,1,1,5,3.2,2.7
3065,0,Middle East & Africa,HR,Supply Chain,Meets,Female,41,2,1,7,,1,3.4,0,0,0,0,3,1.9,2.4
3066,0,Europe,Digital,Quality Assurance,Meets,Female,41,13,0,7,3,2.4,3.1,1,1,1,1,4.3,3.7,2.3
3067,0,Middle East & Africa,Finance,Clinical Operations,Far Below,Female,39,14,0,12,2.5,2.9,2.6,1,1,1,1,3.6,4.5,1.3
3068,0,Europe,Manufacturing,Sales,Far Exceeds,Female,41,8,0,6,2.4,3.4,3.6,1,1,1,1,3.8,3.2,2.8
3069,0,Middle East & Africa,Manufacturing,Market Access,Meets,Male,38,3,0,5,4.6,1.4,1.8,1,1,1,1,4.7,1.7,2.6
3070,0,Middle East & Africa,Manufacturing,Pharmacovigilance,Below,Male,37,1,0,5,3.9,3.8,3.1,1,1,1,1,2.7,4.1,3.9
3071,0,Europe,Digital,IT & Digital,Meets,Male,39,15,1,9,,3.8,3.5,1,1,1,1,3,2.3,3.3
3072,0,Latin America,Manufacturing,Human Resources,Meets,Male,36,4,1,7,,4.3,1.5,1,0,0,0,3.9,4,1.8
3073,0,Middle East & Africa,Finance,Supply Chain,Below,Female,34,10,0,11,2.4,3.1,1.9,1,1,1,0,2.9,1.2,3.3
3074,0,Asia Pacific,Digital,Clinical Operations,Far Below,Female,45,7,0,10,3.2,2.6,4.8,0,0,0,0,3.1,2.7,3.7
3075,0,Latin America,Manufacturing,Quality Assurance,Meets,Female,35,8,1,6,,5,2,1,1,1,1,3.7,5,1
3076,0,Europe,R&D,Data Science,Meets,Female,37,21,0,7,3.7,1.7,2.5,1,1,1,1,4.5,3.3,4.4
3077,0,Latin America,R&D,Finance & Accounting,Meets,Male,35,16,0,6,4.1,3.1,2.5,1,1,1,1,2.8,3.6,3.6
3078,0,North America,Commercial,Medical Affairs,Below,Male,33,30,0,5,2.3,3.1,2.8,1,1,1,1,1.7,3,3.1
3079,0,North America,Manufacturing,Medical Affairs,Meets,Female,47,11,1,10,,4.3,2.2,1,1,1,1,3.7,2.5,1.6
3080,0,Middle East & Africa,Manufacturing,Communications,Meets,Male,29,9,0,9,3.5,2.7,2,1,1,1,1,3.5,4.1,2.1
3081,0,Middle East & Africa,Digital,Market Access,Meets,Female,40,18,0,10,1.4,2.8,5,0,0,0,0,2.5,4.5,3.9
3082,0,Asia Pacific,Digital,Legal & Compliance,Meets,Female,37,10,0,9,2.8,5,2.1,1,1,1,0,5,2.7,2.9
3083,0,Latin America,Manufacturing,IT & Digital,Below,Female,41,21,0,5,2.6,4.3,3,1,0,0,0,3.5,3.2,1.4
3084,0,North America,Commercial,Quality Assurance,Meets,Female,37,10,0,5,4.4,3.4,2.2,0,0,0,0,3.8,3.3,2.1
3085,0,Middle East & Africa,Manufacturing,Clinical Operations,Far Exceeds,Female,41,15,0,12,4,2.6,2.8,1,1,0,0,4,2.3,3.5
3086,0,Latin America,Finance,Quality Assurance,Meets,Female,40,10,0,12,3.7,3.7,4,1,1,1,1,3.6,4.2,3.5
3087,0,Middle East & Africa,Digital,Pharmacovigilance,Meets,Female,42,13,0,7,3.3,4.2,2.3,1,1,1,1,3.9,3.6,2.3
3088,0,Middle East & Africa,Manufacturing,Pharmacovigilance,Meets,Female,48,4,0,8,3.8,2.3,1.8,1,1,1,1,3.7,3.4,2.2
3089,0,North America,Digital,Sales,Meets,Male,28,26,0,9,3.1,1.9,2.8,1,1,1,1,2.3,2,1.9
3090,0,North America,Manufacturing,Medical Affairs,Exceeds,Female,38,13,0,9,4.1,3.6,5,1,1,1,1,3.4,3.9,3.8
3091,0,Middle East & Africa,HR,Medical Affairs,Meets,Male,32,5,1,8,,3.9,1,1,1,1,1,3.9,3,1
3092,0,Europe,Digital,Pharmacovigilance,Exceeds,Female,34,36,0,8,2.4,3.9,4.4,1,1,1,1,3.3,3.2,3.9
3093,0,Middle East & Africa,Commercial,Communications,Below,Male,32,13,0,8,3.2,2.8,1.5,0,0,0,0,4.5,2.7,2.3
3094,0,Middle East & Africa,HR,Quality Assurance,Exceeds,Male,36,4,1,5,,3.1,1.9,1,1,1,1,1.7,4,2.4
3095,0,Asia Pacific,Finance,Market Access,Below,Male,45,11,0,5,4.3,3.5,2.7,1,1,1,1,4.5,3.8,1.4
3096,0,Asia Pacific,Manufacturing,Communications,Far Below,Male,36,14,0,10,2.6,3.5,2.8,1,1,1,1,2.2,3.5,2.3
3097,0,Asia Pacific,Finance,Market Access,Below,Male,40,8,0,8,3.3,2.9,4.1,1,1,1,1,4.5,2.9,3.1
3098,0,Europe,Digital,IT & Digital,Below,Male,43,7,0,6,3.4,2.3,1.1,1,1,1,1,2.7,3.8,1.9
3099,0,Europe,HR,Supply Chain,Meets,Female,33,22,0,9,2.7,2.7,3.8,1,1,1,1,3,2.8,3.3
3100,0,Middle East & Africa,Finance,IT & Digital,Meets,Female,33,8,0,8,3.8,4.7,3,1,1,1,1,4.1,3.9,3
3101,0,Asia Pacific,Commercial,Data Science,Meets,Female,38,12,0,7,2.4,3.7,3.3,1,1,1,1,4,4,2.8
3102,0,Europe,Digital,Medical Affairs,Below,Female,28,5,0,9,3.2,3.3,2.7,1,1,1,1,4,2.2,3
3103,0,North America,HR,Communications,Meets,Female,50,28,0,6,3.6,2.4,1,1,1,1,1,2.8,2.9,3.4
3104,0,Middle East & Africa,Finance,Pharmacovigilance,Meets,Female,38,8,1,8,,2.2,3.7,1,1,1,1,2.7,3.3,4.1
3105,0,Latin America,HR,Legal & Compliance,Meets,Female,41,21,0,6,3.5,2.8,1.3,1,1,1,1,3,2.6,2.6
3106,0,Middle East & Africa,HR,Finance & Accounting,Far Below,Female,37,8,1,11,,1.8,2.2,1,1,1,1,3.3,4,1
3107,0,Latin America,Finance,Quality Assurance,Far Below,Female,42,9,0,9,4.2,3.9,3.8,1,1,1,1,3.9,3.3,1.9
3108,0,Asia Pacific,R&D,IT & Digital,Meets,Male,37,4,1,12,,4.7,1.3,0,0,0,0,5,4.6,2.5
3109,0,Latin America,Manufacturing,IT & Digital,Exceeds,Male,41,7,0,9,2,1.8,2.2,1,1,1,1,2.7,2.6,1.7
3110,0,Asia Pacific,Digital,Clinical Operations,Meets,Female,46,13,1,8,,2.2,4.2,1,1,1,1,2.2,3.9,4
3111,0,North America,Digital,Data Science,Far Below,Male,28,7,0,6,2.1,3.4,2.6,1,1,1,1,2.2,2.9,1.7
3112,0,Latin America,Digital,Legal & Compliance,Below,Male,42,10,0,9,2.4,3.2,2.8,1,1,1,1,3,4.7,2.6
3113,0,Middle East & Africa,HR,IT & Digital,Meets,Male,35,19,0,5,3.1,3.2,2.3,1,1,1,1,4.1,2.7,3.8
3114,0,Asia Pacific,Finance,Market Access,Meets,Female,31,13,0,12,1.3,3.5,2.2,1,1,1,1,1.7,4,1.4
3115,0,Middle East & Africa,Manufacturing,Regulatory Affairs,Meets,Female,29,5,0,12,4,4.8,3.5,1,1,1,1,3.6,4.2,3.6
3116,0,Europe,Commercial,Regulatory Affairs,Meets,Male,39,16,0,8,4.4,1.5,2,1,0,0,0,3.7,2.8,2.7
3117,0,Asia Pacific,Digital,Finance & Accounting,Meets,Male,40,14,0,8,4.2,5,2.8,1,1,1,1,4.1,5,3.7
3118,0,Latin America,Finance,Finance & Accounting,Meets,Male,34,22,0,12,2.2,2.6,4.3,1,1,1,1,1.1,2.2,5
3119,0,Asia Pacific,Manufacturing,Quality Assurance,Meets,Female,30,7,1,11,,2.6,2.3,1,1,1,1,3.6,2.7,4.3
3120,0,Middle East & Africa,Manufacturing,Marketing,Below,Male,39,9,0,12,4.2,3.1,1.5,1,1,1,1,4.2,1.8,3.7
3121,0,North America,R&D,IT & Digital,Meets,Male,38,6,1,5,,2.4,3.8,1,1,1,1,5,4.3,4.4
3122,0,Asia Pacific,Finance,IT & Digital,Meets,Male,42,15,0,10,2.2,5,3.8,1,1,1,1,1.6,4.6,4.7
3123,0,Latin America,Digital,IT & Digital,Exceeds,Male,42,15,0,6,3.9,3.3,1.4,1,1,1,1,3.7,2.3,3
3124,0,Europe,HR,Finance & Accounting,Meets,Male,45,16,0,9,3,3.9,3.7,1,1,1,1,4.6,2,2.5
3125,0,North America,Manufacturing,Marketing,Below,Female,42,8,0,7,3.7,4.2,3.7,1,1,1,1,4.4,2.5,3.9
3126,0,Europe,Manufacturing,Medical Affairs,Below,Male,28,8,1,5,,3.4,1,0,0,0,0,3.3,3.7,2.4
3127,0,Asia Pacific,Commercial,Clinical Operations,Meets,Female,38,17,0,5,3.6,2.3,2.8,1,1,1,1,4,3,3.4
3128,0,Middle East & Africa,R&D,Human Resources,Meets,Male,44,22,0,5,5,3.6,3,1,1,1,1,4,3.1,2.8
3129,0,Middle East & Africa,Manufacturing,Supply Chain,Exceeds,Male,43,11,0,11,2.6,2.5,3.1,1,1,1,1,3.9,3.1,2.1
3130,0,Latin America,Manufacturing,Quality Assurance,Meets,Male,53,16,0,5,2.2,3.6,4.5,1,1,1,1,3.5,3,3.2
3131,0,Middle East & Africa,HR,Regulatory Affairs,Exceeds,Female,43,10,0,7,2.7,2.2,3.7,1,1,1,1,3.2,3.4,3.4
3132,0,North America,HR,Regulatory Affairs,Meets,Female,30,17,0,6,3.8,2.9,3.3,1,1,0,0,3.8,3.5,2.8
3133,0,Middle East & Africa,Commercial,Clinical Operations,Exceeds,Female,29,10,1,11,,2.6,2.6,1,1,1,1,3.8,1.2,3.2
3134,1,Latin America,Finance,Medical Affairs,Meets,Male,38,13,1,12,,1.7,5,1,1,1,1,2.8,2.5,5
3135,1,Asia Pacific,Commercial,Marketing,Meets,Male,39,12,0,11,3.1,2.1,3.2,1,1,1,1,3.4,3.1,2.6
3136,1,Asia Pacific,Commercial,Legal & Compliance,Meets,Male,35,10,0,9,3.8,3.4,3,1,1,1,1,4.7,3.8,2.7
3137,0,Middle East & Africa,HR,Sales,Exceeds,Male,43,21,0,8,3.6,1.3,1.3,1,1,1,1,3.2,1.7,1
3138,0,Europe,Finance,Medical Affairs,Meets,Male,28,14,0,5,3.5,3.3,2.3,1,1,1,1,3.3,3,3.1
3139,1,Asia Pacific,HR,Legal & Compliance,Exceeds,Male,35,12,1,9,,3.2,2.4,1,1,1,1,4.4,2.2,3.5
3140,0,Middle East & Africa,R&D,Medical Affairs,Meets,Male,28,8,0,10,3.1,4.2,3.9,1,1,1,1,2.8,2.8,5
3141,1,Latin America,Digital,Market Access,Meets,Female,33,26,0,11,3.6,2,2.8,1,1,1,1,3.8,1.7,3.1
3142,1,Middle East & Africa,Digital,Communications,Far Exceeds,Female,36,7,0,5,2.4,2.5,2.1,1,1,1,1,2.8,3.2,2.6
3143,0,Asia Pacific,R&D,Supply Chain,Exceeds,Male,44,5,1,9,,1,3,0,0,0,0,4.9,2,3.3
3144,0,Latin America,Digital,Supply Chain,Meets,Male,31,9,0,6,2.3,3.7,4.1,1,1,1,1,2,3.4,5
3145,0,Middle East & Africa,Finance,Regulatory Affairs,Meets,Female,37,18,0,7,2.8,4.2,4.3,1,1,1,1,4.3,4,4.4
3146,0,North America,HR,Finance & Accounting,Far Exceeds,Male,35,16,1,7,,4.6,3,1,1,1,1,4.7,4.8,3.1
3147,0,Latin America,Digital,Supply Chain,Meets,Female,37,5,0,10,2.9,4.8,2.1,1,1,1,1,4.6,4.5,2.4
3148,0,North America,Finance,Regulatory Affairs,Meets,Non-Binary/Other,36,11,0,10,3.7,2.9,2,0,0,0,0,2.5,3.9,4.1
3149,0,Europe,HR,Medical Affairs,Exceeds,Female,36,8,1,8,,3,2.6,1,1,1,1,3.2,4.2,3.7
3150,0,Latin America,Finance,Communications,Below,Male,34,15,0,11,1.8,4.2,2.4,1,1,1,1,1.8,4,1.4
3151,0,North America,R&D,Clinical Operations,Below,Female,40,17,0,7,2.5,2.4,2.4,1,1,1,1,2.5,1.5,3.1
3152,0,Asia Pacific,Commercial,Sales,Meets,Female,45,15,0,6,4.3,3.4,3.5,1,1,1,1,3.9,3.5,4.2
3153,0,Asia Pacific,R&D,Clinical Operations,Below,Male,38,18,0,12,1.7,3.5,3.4,1,1,0,0,2.5,2.7,3.1
3154,0,Europe,Digital,Medical Affairs,Meets,Female,50,12,0,8,3.7,4.2,2.7,1,1,1,1,3.8,4.7,3.3
3155,0,Latin America,HR,Finance & Accounting,Meets,Male,38,19,1,5,,2.8,1.8,1,1,1,1,5,3.6,1.9
3156,0,Latin America,Finance,Pharmacovigilance,Below,Female,43,6,0,7,3.4,4.3,3.8,1,1,1,1,4,2.6,4.6
3157,0,Latin America,Digital,Finance & Accounting,Meets,Male,33,16,1,9,,3.6,3.9,1,1,1,1,1.8,3.5,3.9
3158,0,Europe,Digital,IT & Digital,Meets,Male,37,6,0,10,2.7,3,1.9,1,1,1,1,3.3,3.6,2
3159,0,Latin America,Commercial,Quality Assurance,Below,Female,36,26,0,12,4.2,2.7,4.5,1,1,0,0,4,2.9,3.6
3160,0,Asia Pacific,Digital,Marketing,Far Below,Male,31,15,0,5,3.2,1.6,3.5,0,0,0,0,3.8,3.7,2.6
3161,0,North America,Commercial,Communications,Meets,Male,33,15,1,12,,4.4,2.5,1,1,1,1,2.7,3.5,1.8
3162,0,Asia Pacific,HR,Quality Assurance,Meets,Female,40,6,0,12,3.2,3.7,2.5,1,1,1,1,4.8,3.4,1.5
3163,1,Asia Pacific,HR,Sales,Exceeds,Male,46,3,1,10,,3.9,2.9,1,1,1,1,5,3.1,4.7
3164,0,North America,Finance,Supply Chain,Below,Female,41,9,0,5,3.4,2,3.6,1,1,1,1,3.3,3.3,3.9
3165,0,Asia Pacific,Commercial,Quality Assurance,Meets,Male,40,19,0,12,4.1,1.1,4.8,1,1,1,1,3.1,2.5,5
3166,0,Europe,R&D,Supply Chain,Meets,Male,33,13,0,8,2.8,5,2.7,1,1,0,0,2.2,5,2.7
3167,0,North America,HR,Legal & Compliance,Meets,Male,41,15,0,6,2.5,2.6,2.8,1,1,1,1,3.4,2.3,1.9
3168,0,Asia Pacific,Finance,Medical Affairs,Exceeds,Male,34,9,0,7,3.3,2.1,4.1,1,1,1,1,3.8,3.9,4.3
3169,0,Middle East & Africa,R&D,Sales,Meets,Female,31,11,1,8,,2.4,3.5,0,0,0,0,2.3,2.7,1
3170,0,Asia Pacific,HR,Finance & Accounting,Meets,Male,33,25,0,9,3.3,5,3.5,1,1,1,1,2.6,4,2.8
3171,0,Europe,HR,Legal & Compliance,Meets,Female,37,15,0,9,5,2.7,4.1,1,1,1,0,4.8,2.7,4.1
3172,0,Latin America,Finance,Market Access,Far Exceeds,Male,35,24,0,7,2.7,2.6,3.4,1,1,1,1,2,2.8,1.2
3173,0,Asia Pacific,Finance,Marketing,Meets,Male,40,10,0,11,4,5,3.6,1,1,1,1,5,5,3.8
3174,0,Latin America,Manufacturing,Legal & Compliance,Meets,Female,36,7,0,7,3,3.5,1.8,1,1,1,1,2.7,3.5,2.1
3175,0,Middle East & Africa,Digital,Legal & Compliance,Meets,Male,40,8,0,7,3.9,3.2,2.4,1,1,1,1,4.5,2.4,3
3176,0,Asia Pacific,Digital,IT & Digital,Meets,Male,36,28,0,12,3.4,3.5,2.9,1,1,1,1,3.7,2,2.7
3177,0,North America,R&D,Human Resources,Exceeds,Male,38,21,0,5,3.7,3,1.3,1,0,0,0,2.9,2.3,1
3178,0,Latin America,Digital,Marketing,Far Below,Male,32,17,0,5,3.8,2.2,2.1,1,1,1,1,3.4,2.6,3.5
3179,0,Middle East & Africa,R&D,Finance & Accounting,Meets,Female,47,5,1,9,,4.3,3.3,1,1,1,1,3,4.7,2.5
3180,0,North America,HR,Pharmacovigilance,Meets,Female,28,25,0,5,1.3,2.8,1.4,0,0,0,0,2.5,3,2.2
3181,0,North America,Manufacturing,Market Access,Below,Male,53,14,0,11,4.1,2.7,4.2,1,1,1,1,4.1,3,4.6
3182,0,North America,Manufacturing,Legal & Compliance,Below,Female,41,15,0,9,1.2,2.1,2.2,1,1,1,1,2.5,2.9,3.5
3183,0,North America,HR,Legal & Compliance,Meets,Non-Binary/Other,29,23,0,8,2.7,4.2,2.9,1,1,1,1,3.1,4,1.7
3184,0,Asia Pacific,Finance,Regulatory Affairs,Meets,Female,39,5,0,9,2.4,3.1,2.6,1,1,1,1,3.6,1.3,4.4
3185,0,Asia Pacific,Commercial,Marketing,Meets,Male,39,13,0,9,4,3.7,2.8,1,1,1,1,3.5,4,1.7
3186,0,Asia Pacific,Commercial,Finance & Accounting,Below,Male,47,10,0,10,4.7,4.4,2.3,1,1,1,1,3.3,5,3.5
3187,0,Middle East & Africa,Digital,Data Science,Meets,Female,30,12,0,12,3.4,3.2,4,1,1,1,1,4.1,4.4,4.1
3188,1,Middle East & Africa,Finance,Legal & Compliance,Exceeds,Male,30,8,0,6,2.9,3.7,3.1,1,1,1,1,4.1,3.1,4.5
3189,0,Middle East & Africa,R&D,Regulatory Affairs,Exceeds,Male,40,17,0,10,2.7,4.1,1.3,1,1,1,1,3.8,1.8,3.4
3190,0,Europe,Manufacturing,Marketing,Meets,Male,39,5,1,10,,3.2,3.6,1,1,1,1,3.6,3.4,1.7
3191,0,Middle East & Africa,Digital,Medical Affairs,Meets,Male,47,11,0,5,2.1,3.6,2.6,0,0,0,0,1.7,3.7,2.6
3192,0,Asia Pacific,HR,Sales,Meets,Female,32,6,0,6,1.8,3,3.8,1,1,1,1,2.8,3.9,3.4
3193,0,Asia Pacific,Finance,Sales,Below,Female,32,8,0,5,2.6,4,3.2,1,1,1,1,2.9,4,2.8
3194,0,Europe,Manufacturing,Data Science,Exceeds,Male,49,16,0,12,2.9,2.4,2.7,1,1,1,1,2.4,3.7,1.7
3195,0,Europe,R&D,IT & Digital,Meets,Female,38,27,0,5,1.5,3.8,2.1,1,1,1,1,3,4.4,3.4
3196,0,Middle East & Africa,R&D,Medical Affairs,Meets,Female,34,8,0,9,4.7,2.7,1.8,1,1,1,1,4.2,1.1,1.9
3197,0,Latin America,Commercial,Data Science,Meets,Female,42,17,0,9,2.7,4,2.2,1,1,1,1,3.7,2.5,2.5
3198,0,Europe,Digital,Supply Chain,Exceeds,Non-Binary/Other,28,8,1,6,,2.2,2.1,1,1,1,1,2.9,2.9,1.4
3199,0,North America,HR,Communications,Exceeds,Non-Binary/Other,40,18,0,12,3.9,4.2,1,1,1,1,1,4.4,3.6,1.9
3200,0,Asia Pacific,Manufacturing,Clinical Operations,Meets,Female,34,10,1,8,,1,2.4,1,1,1,1,3.2,3.6,1.8
3201,0,North America,R&D,Communications,Meets,Female,35,15,0,5,3,3.7,2.7,1,1,1,1,3.6,4.1,3.1
3202,0,Asia Pacific,Manufacturing,Marketing,Meets,Male,46,12,0,9,3.5,1.6,3.4,0,0,0,0,2.9,3.1,4.2
3203,0,Asia Pacific,HR,Medical Affairs,Below,Female,41,17,0,5,2.5,3.3,3.3,0,0,0,0,4.4,2.3,3
3204,0,Europe,Manufacturing,Clinical Operations,Exceeds,Female,31,12,0,11,3.2,2,1.9,1,1,1,1,3.1,2.1,3.3
3205,0,Europe,Digital,Clinical Operations,Meets,Female,38,14,0,7,3.7,3.1,4.1,1,1,1,1,2.4,2.1,4.8
3206,0,North America,Commercial,Sales,Meets,Male,39,8,1,8,,3.8,3.3,1,1,1,1,3.7,3.3,3.7
3207,0,Asia Pacific,Manufacturing,Legal & Compliance,Meets,Male,36,4,0,9,4.9,2,2.6,1,1,1,1,4,2.4,3.3
3208,0,North America,Finance,Sales,Meets,Male,32,4,0,10,3.1,2.8,3.6,1,1,1,1,4.1,2.4,4.5
3209,0,Latin America,Commercial,Market Access,Below,Female,39,17,1,8,,1,2.6,1,1,1,1,3.6,4.5,3.4
3210,1,North America,HR,Supply Chain,Far Exceeds,Non-Binary/Other,42,7,0,8,3.1,4.5,4.4,1,1,1,1,3.9,4.4,4.7
3211,0,Middle East & Africa,Commercial,Finance & Accounting,Below,Male,41,8,1,8,,5,4,1,1,1,1,3,5,2.5
3212,0,North America,Manufacturing,IT & Digital,Meets,Female,34,7,0,12,2.8,4.3,2.1,1,1,1,1,2.2,4.2,2.5
3213,0,Middle East & Africa,Manufacturing,Medical Affairs,Meets,Male,37,8,1,12,,2.9,3.6,0,0,0,0,4,4.1,2.3
3214,0,Middle East & Africa,Finance,Legal & Compliance,Below,Female,28,7,0,11,4.5,4.3,1.8,1,1,1,1,3.6,4.1,2.2
3215,0,Middle East & Africa,R&D,Pharmacovigilance,Exceeds,Female,48,12,0,6,3.8,3.4,2.8,1,1,1,1,3.3,2.7,3.8
3216,1,Latin America,Finance,Medical Affairs,Meets,Male,34,5,0,5,3.3,4.4,3.5,1,1,1,1,4.4,3.4,4.1
3217,0,North America,Manufacturing,Supply Chain,Meets,Male,35,13,0,12,2.9,3,2.8,0,0,0,0,4.9,2.1,1.5
3218,0,North America,Commercial,Sales,Meets,Male,30,10,0,12,2.9,3.7,2.8,1,1,1,1,4.9,3.6,2.4
3219,0,Latin America,Finance,Communications,Meets,Non-Binary/Other,43,13,0,7,5,2.6,4,1,1,1,1,5,3.7,2.9
3220,0,Asia Pacific,Finance,Sales,Below,Male,44,11,1,6,,1.3,4.1,1,1,1,1,3.9,2.3,2.9
3221,0,Europe,R&D,Marketing,Meets,Female,35,5,1,11,,4.9,3.5,1,1,1,1,3.1,4.8,2
3222,0,North America,Manufacturing,Quality Assurance,Meets,Male,31,5,1,12,,4.7,1.5,0,0,0,0,3.7,2.1,3.3
3223,0,Europe,Manufacturing,Communications,Below,Female,38,10,0,12,2,3.6,1.6,0,0,0,0,1.9,4.5,2
3224,0,Latin America,HR,Sales,Meets,Male,36,18,0,12,2.4,2.6,2.3,1,1,1,1,3.6,3.7,2.9
3225,0,Asia Pacific,R&D,Communications,Meets,Male,42,8,0,8,3.2,2.8,3.2,1,1,1,1,2.9,3,1.5
3226,0,Asia Pacific,HR,Data Science,Meets,Male,37,5,0,11,3.3,3.3,3.2,1,0,0,0,4.3,3.7,2.3
3227,0,Asia Pacific,HR,Marketing,Below,Male,37,13,0,10,3.2,5,1.3,0,0,0,0,3.1,3.5,1.4
3228,0,Latin America,HR,Legal & Compliance,Meets,Male,42,17,0,10,3.4,3,1.7,1,1,1,0,3.1,1.2,2.1
3229,0,Middle East & Africa,Digital,IT & Digital,Below,Female,29,21,1,7,,2.5,2.4,1,1,0,0,4.5,1.4,2.6
3230,0,Middle East & Africa,HR,Legal & Compliance,Meets,Male,36,11,1,11,,2,2.7,1,1,1,1,3.5,2.3,1.7
3231,0,Europe,Finance,Regulatory Affairs,Exceeds,Female,39,10,0,5,3,1.6,3.1,1,1,1,1,3.8,2.9,2.3
3232,0,Middle East & Africa,Commercial,IT & Digital,Far Below,Male,35,7,0,10,2.3,2.3,3.4,1,1,1,1,2.2,2.1,3.7
3233,0,Middle East & Africa,Finance,IT & Digital,Meets,Male,40,8,0,8,4,4.4,3.7,0,0,0,0,3.6,3.7,2.8
3234,0,Asia Pacific,Finance,Quality Assurance,Meets,Male,39,10,0,12,2.8,1.4,2.1,1,1,1,1,3.5,1.5,3
3235,0,Asia Pacific,Manufacturing,Quality Assurance,Far Below,Female,43,7,0,7,3.1,3.4,2.5,0,0,0,0,1.3,3.9,2.1
3236,0,Europe,Digital,Communications,Far Below,Male,36,3,0,10,4.5,3.1,2.2,1,1,1,1,3.8,2,3.8
3237,0,North America,HR,Data Science,Meets,Male,28,14,0,8,3.5,2.9,2.9,0,0,0,0,2.9,4.8,3.5
3238,0,Europe,Manufacturing,IT & Digital,Meets,Female,29,14,0,6,2.6,2.2,2,1,1,1,1,3.9,2.8,2.7
3239,0,Europe,R&D,Quality Assurance,Meets,Male,41,3,0,12,3,3.6,2.4,1,1,1,1,3.6,4.3,2.5
3240,0,Latin America,R&D,Pharmacovigilance,Meets,Female,39,13,0,10,3.3,3.2,4.4,1,1,1,1,2.8,3.3,3.6
3241,0,Latin America,Manufacturing,Sales,Meets,Male,37,18,0,12,3.8,3.8,3.4,1,1,1,1,4.1,3.1,3.1
3242,0,Europe,Commercial,Sales,Exceeds,Male,37,16,0,12,3.3,3.5,3.3,1,1,1,1,4.5,2.8,3.3
3243,0,Europe,Manufacturing,Marketing,Far Below,Female,34,13,0,11,2.5,2,2.6,1,1,1,1,1.4,1.2,3.1
3244,0,Europe,Manufacturing,Supply Chain,Meets,Male,34,20,0,12,4.3,2.8,3.8,1,1,1,1,3.6,4,4.6
3245,0,Middle East & Africa,Digital,Data Science,Meets,Male,35,15,0,10,2.3,3.3,3,1,1,1,1,2.4,5,3.5
3246,0,Latin America,R&D,Sales,Below,Female,36,20,0,10,3.8,1.6,3.2,1,1,1,1,4.4,4.4,3.1
3247,0,Europe,R&D,Clinical Operations,Meets,Male,39,19,0,9,3.5,4,4.2,1,1,1,1,3.9,2.5,3
3248,0,Asia Pacific,HR,Human Resources,Meets,Female,38,3,0,6,3.2,4.5,2.4,0,0,0,0,5,3.9,2.3
3249,0,Asia Pacific,Finance,Market Access,Meets,Female,36,3,1,8,,3.3,1.5,1,1,1,1,3.5,2.2,1
3250,0,Middle East & Africa,Manufacturing,Sales,Meets,Female,42,9,0,9,1,2.7,3.5,1,1,1,1,3,3.4,4.3
3251,0,Middle East & Africa,Manufacturing,Medical Affairs,Meets,Male,43,20,0,9,1.9,1.7,2.2,1,1,1,1,3.7,3.7,2.4
3252,0,North America,Commercial,Clinical Operations,Meets,Female,46,11,0,11,3.6,2.6,3.1,1,1,1,1,3.2,2.1,2
3253,0,North America,R&D,Supply Chain,Meets,Male,37,12,0,9,3.7,3.7,3,1,1,1,1,4.7,3.2,3.3
3254,0,North America,Commercial,Communications,Meets,Male,35,12,0,9,4.6,4,4,1,1,1,1,3.1,3.9,3.3
3255,0,Middle East & Africa,Digital,Clinical Operations,Meets,Female,38,8,1,10,,3.8,2.1,1,0,0,0,3.5,3.8,2.8
3256,0,Middle East & Africa,HR,Finance & Accounting,Below,Male,35,5,0,5,3.3,1,3.2,1,1,1,1,2.6,3.9,1.4
3257,0,Middle East & Africa,Commercial,Quality Assurance,Meets,Male,38,10,0,8,2.7,2.1,3.1,1,1,1,1,3.9,1.3,2.3
3258,0,Asia Pacific,R&D,Legal & Compliance,Far Below,Male,40,5,1,6,,3.7,3.8,1,1,1,1,3,2.6,4.4
3259,0,Middle East & Africa,Digital,Market Access,Below,Non-Binary/Other,39,18,0,5,3.3,1.9,1.5,1,1,1,1,3.3,2.8,1.9
3260,0,Asia Pacific,Manufacturing,IT & Digital,Below,Male,37,6,1,9,,2.5,3.6,1,1,1,1,3.7,2.2,3.9
3261,0,North America,Digital,Regulatory Affairs,Exceeds,Male,42,4,1,10,,2.3,4.5,1,1,1,0,4.7,3.9,3.5
3262,0,North America,Finance,Market Access,Far Below,Female,48,8,0,12,2.9,1.6,2.6,1,1,1,1,3.4,4.2,2.6
3263,0,North America,Commercial,Finance & Accounting,Meets,Female,34,4,1,7,,3.7,3.2,1,1,1,1,2.1,1.9,2.5
3264,0,Europe,R&D,IT & Digital,Far Below,Male,40,6,1,7,,3.7,2,1,1,1,1,3.7,3.5,3.4
3265,0,Europe,Commercial,Sales,Meets,Female,37,24,0,10,2.2,3.1,2.5,1,1,1,1,3.5,3.5,1.9
3266,1,Latin America,Manufacturing,Finance & Accounting,Exceeds,Male,33,14,1,12,,4.5,4.3,1,1,1,1,3.3,4.5,1.9
3267,0,Latin America,Manufacturing,Marketing,Meets,Male,34,36,0,9,3.3,3.6,4.3,1,1,1,1,4.1,1.9,3.2
3268,0,Latin America,R&D,Pharmacovigilance,Exceeds,Male,36,7,0,6,2.6,3.3,3.4,1,1,1,1,2.5,4.6,2.8
3269,0,Europe,Finance,Communications,Meets,Female,47,19,0,5,4.3,3.2,2.4,1,1,1,1,4.1,3.4,2.7
3270,0,Europe,HR,Legal & Compliance,Meets,Male,44,13,0,6,4,3.9,2.6,1,1,1,1,4,3.1,2.1
3271,0,Latin America,Digital,Supply Chain,Meets,Female,33,22,0,11,3.7,3.5,1.5,0,0,0,0,3.2,3.9,3.2
3272,0,Latin America,Digital,Marketing,Meets,Non-Binary/Other,41,26,0,11,4.2,2.5,1.4,1,1,1,1,4.1,3.2,2.8
3273,0,Middle East & Africa,Manufacturing,Sales,Meets,Male,32,13,1,8,,3.5,3.1,1,1,1,1,1.5,2.9,3
3274,0,Latin America,Commercial,Marketing,Far Exceeds,Non-Binary/Other,34,15,0,5,2.9,4.1,2.5,1,1,1,1,2.9,5,2.8
3275,0,Middle East & Africa,Commercial,Communications,Meets,Male,46,10,1,9,,4.5,4,1,1,1,1,2.3,4.1,3.6
3276,0,Asia Pacific,Finance,Legal & Compliance,Far Exceeds,Male,50,5,0,5,3.2,5,1,1,1,1,1,4.1,4.4,4.3
3277,0,Europe,HR,Human Resources,Meets,Female,28,6,1,5,,4.4,3.3,0,0,0,0,1.7,2.6,2.9
3278,0,Latin America,Commercial,Medical Affairs,Meets,Female,38,5,0,11,1.9,2,3.9,1,0,0,0,1.3,1.8,3.8
3279,0,Europe,Digital,Clinical Operations,Meets,Female,40,16,1,5,,3.5,3.1,0,0,0,0,3.2,3.2,2.4
3280,0,Europe,Commercial,Communications,Exceeds,Male,36,9,0,6,3.3,4.1,1.4,1,1,0,0,3.3,4.8,2.3
3281,0,Europe,HR,IT & Digital,Meets,Female,39,12,1,6,,1.6,1.6,1,1,1,1,4,2.6,3.4
3282,0,Asia Pacific,Digital,Pharmacovigilance,Far Below,Female,36,2,0,9,2.1,3.3,2,1,1,1,1,4.8,3.4,3
3283,0,North America,Commercial,Human Resources,Meets,Male,42,8,0,10,4,2.7,2,1,1,1,1,3.3,3.3,4.4
3284,0,Latin America,Digital,Sales,Far Exceeds,Female,36,12,0,12,5,2.5,2.2,1,1,1,1,4.4,2.9,3.1
3285,0,North America,Manufacturing,Quality Assurance,Meets,Non-Binary/Other,41,16,0,6,2.6,3.5,1.9,0,0,0,0,2.2,4.2,2.8
3286,0,North America,Manufacturing,Supply Chain,Below,Male,44,6,0,8,2.8,2.2,2.5,0,0,0,0,3.2,2.6,2.7
3287,0,North America,Finance,Quality Assurance,Meets,Female,43,12,0,6,3.5,2.4,2.7,0,0,0,0,3.2,2.7,2.4
3288,0,Europe,Manufacturing,Clinical Operations,Exceeds,Female,37,6,0,9,3.7,2.6,3.3,1,1,1,1,1.7,3.9,4.1
3289,0,Middle East & Africa,Commercial,Pharmacovigilance,Far Below,Female,28,15,0,11,1.5,1.9,2.3,1,1,1,1,3.2,1.1,2.4
3290,0,Europe,HR,Clinical Operations,Meets,Male,41,10,0,7,4,2.6,1.1,0,0,0,0,3.7,4.6,1.7
3291,0,Europe,Digital,Data Science,Below,Female,29,24,0,8,1.8,4.5,3.1,1,1,1,0,3.3,5,3.5
3292,1,North America,R&D,Quality Assurance,Meets,Non-Binary/Other,41,11,0,9,4,2.1,1.4,1,0,0,0,3.4,1.7,2
3293,1,Europe,Manufacturing,IT & Digital,Meets,Male,40,30,0,9,1.7,3.2,2.5,0,0,0,0,2.6,2.8,3.3
3294,0,North America,Manufacturing,Human Resources,Meets,Female,37,14,0,7,2.7,3,1.9,1,1,1,1,2.3,2.8,4.5
3295,0,Middle East & Africa,R&D,Clinical Operations,Meets,Female,38,15,0,6,4.1,4.8,2.9,1,1,1,1,3.3,4.3,3.1
3296,1,Latin America,R&D,Legal & Compliance,Meets,Male,47,14,1,11,,3.9,2.2,1,1,1,1,3.4,3.4,1
3297,0,North America,Commercial,Clinical Operations,Meets,Male,46,14,0,11,4.2,3,5,1,1,1,1,2.9,4.2,5
3298,0,Middle East & Africa,Digital,Marketing,Meets,Female,36,35,0,5,3.3,4.6,3.3,1,1,1,1,3.5,3.8,2.8
3299,0,Latin America,Manufacturing,Sales,Exceeds,Male,28,15,0,7,3.4,2.5,2.2,1,1,1,1,3,2.5,2.1
3300,0,Asia Pacific,HR,Human Resources,Meets,Male,47,12,0,11,2.9,4.6,1.3,1,1,1,1,2.1,2.8,1.4
3301,0,North America,Commercial,Marketing,Below,Female,29,11,0,6,2.5,4.4,3.5,1,0,0,0,2.9,4.2,3.7
3302,0,North America,Commercial,Data Science,Far Below,Female,39,18,0,12,4.8,3.3,1.9,1,1,1,1,4.2,3.5,1.6
3303,0,Asia Pacific,HR,Market Access,Meets,Male,38,12,0,11,3.4,2.5,1,1,1,1,1,3.4,5,2
3304,0,Asia Pacific,HR,IT & Digital,Exceeds,Female,41,6,0,10,2,4.3,2.1,1,1,0,0,5,2,4.1
3305,0,North America,Finance,Market Access,Meets,Female,46,10,1,7,,3.8,2.4,1,1,1,1,2.8,4.2,2.3
3306,0,Asia Pacific,HR,Marketing,Meets,Male,38,20,0,8,2,3.8,2.6,1,1,1,1,2.7,5,2.2
3307,0,Europe,R&D,Regulatory Affairs,Meets,Female,35,18,1,12,,3.4,4.6,1,1,1,1,3.9,2.6,3.5
3308,0,Latin America,Manufacturing,Quality Assurance,Meets,Female,40,7,1,11,,2.8,3,1,1,1,1,3.1,3.6,1.6
3309,0,Latin America,Finance,Communications,Meets,Male,30,3,1,6,,3.7,2.9,0,0,0,0,2.8,3.2,3.1
3310,0,Latin America,R&D,IT & Digital,Below,Female,34,16,0,11,3.4,2.3,3,1,1,1,1,2.8,4.9,3.9
3311,0,Europe,Finance,Marketing,Below,Female,37,23,0,8,3.5,2.4,2.5,1,1,1,1,2.6,4.4,2.1
3312,0,Asia Pacific,Manufacturing,Finance & Accounting,Meets,Male,41,5,0,10,2.2,4.5,2.7,1,1,1,1,3.6,4.8,1.9
3313,0,Middle East & Africa,Finance,Finance & Accounting,Meets,Male,46,11,1,9,,5,2.8,1,1,1,1,3,1.5,2.9
3314,0,Asia Pacific,R&D,Medical Affairs,Far Exceeds,Male,44,13,0,9,1.8,2.9,2.3,1,1,1,1,2.9,2.9,2.4
3315,0,North America,Digital,Medical Affairs,Far Below,Male,44,13,0,7,4.2,4.2,3.4,1,1,1,1,3.5,3.2,2.8
3316,0,Latin America,Manufacturing,Legal & Compliance,Meets,Male,45,12,1,8,,3.4,2.8,1,1,1,1,5,4.9,3.5
3317,0,Asia Pacific,Commercial,Human Resources,Meets,Male,42,8,0,6,3.3,3,3.2,1,1,1,1,3.8,3.7,3.2
3318,0,Middle East & Africa,Manufacturing,Supply Chain,Meets,Female,38,5,0,5,2.6,2.9,1.8,1,1,1,1,1.7,3.2,1.7
3319,0,North America,Manufacturing,Legal & Compliance,Exceeds,Male,32,10,0,10,2.6,4.5,2.8,1,1,1,1,2.8,5,3.5
3320,0,Europe,Manufacturing,Data Science,Meets,Female,38,7,1,12,,2.8,3.9,1,1,1,1,5,3.5,2.6
3321,1,Europe,Digital,Human Resources,Far Exceeds,Female,28,8,0,6,3.6,2.6,2.8,1,1,1,1,3.3,1.3,3.3
3322,0,Middle East & Africa,R&D,Data Science,Below,Female,35,15,0,8,4.1,4.2,4.6,1,1,1,1,5,2.5,5
3323,0,North America,Commercial,Marketing,Below,Female,38,6,0,8,2.7,4.6,3.7,1,1,1,1,2.5,5,3
3324,0,Latin America,R&D,Pharmacovigilance,Below,Female,38,17,0,11,3.1,3.9,3,1,1,1,1,3.3,3.7,4.3
3325,0,Asia Pacific,Finance,Clinical Operations,Meets,Female,34,9,0,9,3.6,1.5,2.9,1,1,1,0,3,2,3.6
3326,0,North America,Finance,Sales,Meets,Female,28,6,0,12,3.1,2.9,2.1,1,1,1,1,3.7,3,1
3327,1,Europe,Finance,Clinical Operations,Exceeds,Male,35,15,0,10,3.7,4.4,4.5,0,0,0,0,5,4.2,3.9
3328,0,Middle East & Africa,R&D,Clinical Operations,Meets,Male,36,7,0,6,2.8,3.3,4,1,1,1,1,2.2,3.8,2.3
3329,0,Middle East & Africa,HR,Data Science,Exceeds,Female,39,7,0,7,2.3,1.7,3.3,1,1,1,1,2.4,2.6,4
3330,0,Asia Pacific,Digital,Data Science,Meets,Female,42,33,0,7,3.6,3.8,1.7,1,1,1,1,3.1,4.2,2.7
3331,0,Middle East & Africa,HR,Medical Affairs,Meets,Male,36,8,0,12,2.1,2.8,2.8,1,1,0,0,2.9,2.5,3.7
3332,0,Middle East & Africa,Finance,Data Science,Meets,Male,36,10,1,11,,2.1,3.9,1,1,1,1,4.4,3.4,4.9
3333,0,North America,Digital,Marketing,Below,Female,34,15,0,11,3,1.8,4.7,1,1,1,1,3.1,2.2,3.6
3334,0,Latin America,R&D,IT & Digital,Exceeds,Male,38,2,0,8,3,3.3,5,1,1,1,1,2.5,2.8,3.6
3335,0,Asia Pacific,Finance,Communications,Below,Female,44,4,1,5,,3.8,2.7,1,1,1,1,3.7,3,2.9
3336,0,North America,R&D,Medical Affairs,Meets,Female,32,6,1,10,,2.1,3.8,1,1,1,1,1.9,3.1,2.3
3337,0,Latin America,Digital,Quality Assurance,Meets,Male,28,7,1,9,,1.1,2.1,1,1,1,1,3.1,1,2.7
3338,0,North America,R&D,Clinical Operations,Exceeds,Male,39,15,1,11,,4.2,2.3,1,1,1,1,2.7,3.9,2.5
3339,0,North America,R&D,Quality Assurance,Meets,Male,45,9,0,12,2.9,4.4,1.2,1,1,1,1,3.2,4.5,3.7
3340,0,Middle East & Africa,Commercial,Human Resources,Meets,Male,40,2,1,9,,2.3,3.2,0,0,0,0,4,3.5,3.3
3341,0,Latin America,HR,Clinical Operations,Meets,Female,32,18,0,11,4,2.8,4.4,1,1,1,1,4.5,3,3.5
3342,0,Asia Pacific,HR,Human Resources,Far Below,Female,37,13,0,10,2.9,4.8,2.7,0,0,0,0,2.2,3.2,3.8
3343,0,Asia Pacific,HR,Clinical Operations,Meets,Non-Binary/Other,38,3,0,10,2.9,2.3,1.6,1,1,1,1,3.3,2.6,1.8
3344,0,Latin America,Manufacturing,Supply Chain,Below,Female,42,9,0,7,2.8,3.6,2.5,0,0,0,0,3.4,3.6,2.3
3345,1,Middle East & Africa,Commercial,Clinical Operations,Meets,Female,33,12,0,11,3.2,2.8,2.8,1,1,1,1,3.8,3.6,3.9
3346,0,Europe,Finance,Pharmacovigilance,Below,Female,47,22,1,6,,2,2.7,1,1,1,1,3.9,2.7,2.1
3347,0,North America,Finance,Legal & Compliance,Far Exceeds,Female,36,7,0,6,3.9,2.5,3.9,1,1,1,1,3.2,2.8,4
3348,1,Middle East & Africa,Finance,Communications,Meets,Female,34,6,0,8,3.4,1.7,5,1,1,1,1,4.9,2.9,3.2
3349,0,Latin America,HR,Quality Assurance,Exceeds,Female,40,12,0,9,3.5,2.7,3.8,1,1,1,1,3.1,1,4.1
3350,0,North America,HR,Finance & Accounting,Far Below,Female,30,2,0,6,3.2,2.3,2.1,1,0,0,0,4.1,3.3,3.7
3351,0,Asia Pacific,Commercial,Communications,Meets,Male,50,5,1,5,,3,1.3,1,1,1,1,3.8,2.6,2.3
3352,0,Europe,R&D,Clinical Operations,Meets,Male,41,14,0,6,3,4.6,1.7,1,1,1,1,3.1,4.5,4.1
3353,0,Asia Pacific,HR,Regulatory Affairs,Meets,Female,36,18,0,12,4.9,2.7,4.3,1,1,1,1,3.6,1.8,2.5
3354,0,Latin America,Finance,Regulatory Affairs,Exceeds,Female,32,5,0,12,4.5,2.6,2.2,1,1,1,1,4.6,3.1,1.4
3355,0,North America,R&D,Regulatory Affairs,Far Exceeds,Female,37,8,0,12,3.1,2.1,2.2,1,1,1,1,3,1.9,1
3356,0,Latin America,HR,Marketing,Meets,Female,44,10,0,10,3.2,4.3,4.3,1,1,1,1,5,2.9,3.8
3357,0,North America,Digital,Medical Affairs,Exceeds,Female,36,9,0,11,1,3.1,1,1,1,1,1,1,3,1.9
3358,0,Middle East & Africa,Manufacturing,Quality Assurance,Meets,Male,33,11,0,10,2.2,4.6,2.4,1,1,1,1,4.8,5,1.6
3359,0,Europe,HR,Clinical Operations,Far Exceeds,Male,42,17,0,9,2.9,2.7,2.9,1,1,1,1,2.9,3.4,4.5
3360,0,Middle East & Africa,Digital,Communications,Meets,Male,32,16,0,10,2.9,3.5,4.8,1,1,1,1,3.4,2.4,3.5
3361,1,Middle East & Africa,Commercial,Market Access,Far Exceeds,Male,39,17,0,6,3.7,1.9,4.2,1,1,1,1,4.5,3.5,3.8
3362,0,Latin America,Digital,Legal & Compliance,Exceeds,Female,40,29,0,10,4,3.4,3.5,1,1,1,1,5,4.4,2.4
3363,0,Europe,Commercial,Medical Affairs,Below,Male,40,12,0,10,1.9,4.4,3.8,1,1,1,1,2.2,3.9,3.1
3364,0,North America,HR,Market Access,Meets,Male,41,9,1,9,,3.3,2.4,1,1,1,1,3.7,4.9,1
3365,0,North America,Commercial,Human Resources,Meets,Male,32,5,1,11,,2.6,2.8,1,0,0,0,3.4,2.7,2.6
3366,0,Asia Pacific,Digital,Sales,Meets,Female,37,7,0,9,2.1,1.3,1.8,1,1,1,1,3.1,1.4,2.8
3367,0,North America,Manufacturing,Pharmacovigilance,Exceeds,Male,36,15,0,9,3.3,3.6,2.4,1,1,1,1,3.6,2.7,2.8
3368,0,Latin America,R&D,Sales,Meets,Female,39,12,0,8,4.1,4.3,2.5,1,1,1,1,4.3,3.2,2.9
3369,0,Middle East & Africa,R&D,Finance & Accounting,Meets,Male,28,3,0,9,4.4,3.1,3.4,1,1,1,1,4.3,3.9,3
3370,0,Middle East & Africa,Manufacturing,Human Resources,Meets,Male,30,12,0,10,4.3,2.4,2.3,1,1,1,1,3.8,3.9,3
3371,0,Middle East & Africa,Finance,Data Science,Below,Female,51,8,0,7,1.7,1.7,3.5,1,0,0,0,2.6,2.3,2.5
3372,0,Europe,R&D,Human Resources,Meets,Female,42,14,0,8,2.9,3.1,3.8,1,1,1,1,3.7,4.6,2.5
3373,0,North America,HR,Medical Affairs,Meets,Female,37,36,0,12,3.5,3.3,3.8,1,1,1,1,3.5,4.7,3.3
3374,0,Latin America,Finance,Market Access,Below,Female,38,20,0,9,3.9,2.6,2.5,1,1,1,1,3.6,2.8,2.6
3375,0,Europe,HR,Supply Chain,Meets,Female,50,13,0,12,1.1,3.7,1.6,1,1,1,1,1.9,3.1,2.3
3376,0,Asia Pacific,Digital,Clinical Operations,Meets,Female,28,26,0,9,2.6,3.3,3,1,1,1,1,4.8,3.1,4.5
3377,0,Latin America,Digital,Human Resources,Below,Male,39,4,0,10,4.5,3.5,4.7,1,1,1,0,4.5,1.3,3.6
3378,0,Latin America,Finance,Marketing,Meets,Female,36,29,0,8,3.2,4.2,2.7,1,1,1,1,4.3,3.2,3.5
3379,0,Latin America,Finance,Quality Assurance,Below,Female,45,14,0,10,4.5,2.4,3.2,0,0,0,0,3.7,3,3.1
3380,0,Middle East & Africa,Finance,Clinical Operations,Far Exceeds,Female,41,18,1,8,,2.8,2.8,1,1,1,1,4.1,3.3,3.1
3381,0,Latin America,Finance,Quality Assurance,Below,Female,51,14,0,11,2.8,3.9,2.8,1,1,1,1,3.7,4.6,1.3
3382,0,North America,Commercial,Supply Chain,Exceeds,Female,43,11,1,5,,2.9,4.3,1,1,1,1,3.7,4.3,3.6
3383,0,Latin America,Finance,Clinical Operations,Below,Male,35,9,1,11,,4.3,2.9,1,0,0,0,3.7,4.4,4.4
3384,0,Middle East & Africa,Finance,Pharmacovigilance,Exceeds,Female,37,33,0,5,3,2.3,2.1,1,1,1,1,1.8,2.3,2.4
3385,0,Latin America,Digital,Human Resources,Meets,Female,42,27,0,5,2.7,4.1,3.1,1,1,1,1,3.2,3.9,2
3386,0,Asia Pacific,HR,Data Science,Exceeds,Female,47,14,0,9,2.4,3.8,3.6,0,0,0,0,1.9,2.2,3.2
3387,0,Asia Pacific,Digital,Regulatory Affairs,Exceeds,Non-Binary/Other,34,13,0,12,4,3.5,3.6,1,1,1,1,3.4,3.6,1
3388,0,Middle East & Africa,R&D,Supply Chain,Meets,Female,40,12,0,5,4.1,4.5,1.5,1,1,1,1,3.7,4.6,2.1
3389,0,North America,Commercial,Human Resources,Exceeds,Non-Binary/Other,28,5,0,6,2.6,3,2.5,1,1,1,1,3.7,2.3,2.5
3390,0,North America,Commercial,Data Science,Meets,Male,36,29,0,11,2.2,4.2,4.3,1,1,1,1,2.7,2.8,2.7
3391,0,Europe,HR,Clinical Operations,Meets,Female,48,11,0,10,2.8,3.3,2.4,1,1,1,1,3.5,3.1,3.4
3392,0,Middle East & Africa,Finance,Market Access,Meets,Male,47,26,0,11,3.1,4.2,2.4,1,1,1,1,4,3.7,2.1
3393,0,Latin America,Digital,Finance & Accounting,Exceeds,Male,42,15,0,8,3.9,3.8,3.6,1,0,0,0,3.6,2.9,1.9
3394,1,Middle East & Africa,R&D,Data Science,Exceeds,Female,49,2,1,12,,3.3,1.6,1,1,0,0,4.7,2.1,3.6
3395,0,Europe,Digital,Marketing,Below,Male,36,36,0,8,2.7,2.5,2.1,1,1,1,1,2.7,1.7,3.2
3396,0,Middle East & Africa,Finance,Data Science,Meets,Female,38,10,0,5,4.7,2.6,1.4,1,1,1,1,5,2.3,3.8
3397,0,Middle East & Africa,Finance,Sales,Exceeds,Female,36,5,1,10,,3.5,2,1,1,1,1,2.4,3.1,1.3
3398,0,Europe,Manufacturing,Pharmacovigilance,Meets,Female,42,6,1,8,,4.5,3.2,1,1,1,1,4.7,3.9,3.5
3399,1,North America,Digital,Supply Chain,Far Exceeds,Male,55,11,1,6,,3,1,1,1,1,1,3.8,3.6,2.6
3400,0,Latin America,HR,Regulatory Affairs,Meets,Female,40,10,0,8,2.4,3.5,4.3,1,1,1,1,3.5,3.5,4.1
3401,0,Europe,Digital,Clinical Operations,Meets,Female,31,11,0,7,2.4,3.1,3.1,1,1,1,1,3.7,4,3.5
3402,0,Asia Pacific,Commercial,Supply Chain,Meets,Female,31,5,0,12,3.5,4,2.2,1,1,1,1,2.9,2.8,3.5
3403,0,North America,R&D,Medical Affairs,Meets,Male,33,16,0,12,4.2,2.9,1.3,1,1,1,1,4.1,2.7,2.1
3404,0,Asia Pacific,HR,Human Resources,Meets,Female,33,4,0,6,3.1,3.2,2.5,1,1,1,1,3.3,3.7,3.1
3405,0,North America,Manufacturing,Supply Chain,Meets,Female,33,10,0,10,4,2.3,3.7,1,1,1,1,4,4.4,4.1
3406,0,Latin America,R&D,Marketing,Below,Female,39,22,0,10,3.9,3.5,3.5,1,1,1,1,4.7,3.8,3.4
3407,0,Latin America,R&D,Supply Chain,Meets,Female,29,4,0,12,2.1,2.2,3.9,1,1,1,1,3.6,4,3.4
3408,0,Middle East & Africa,Commercial,Medical Affairs,Below,Male,41,8,0,9,3.3,4.7,3.4,1,1,1,1,3.6,3.4,3.1
3409,0,Asia Pacific,Commercial,Data Science,Meets,Male,44,6,0,5,4.1,2.5,3.4,1,1,1,1,3.3,3.6,3
3410,0,North America,Commercial,IT & Digital,Meets,Male,34,2,0,11,2.5,3,3.5,1,1,1,1,3.2,3.5,2.8
3411,0,Latin America,HR,Sales,Meets,Female,40,14,0,11,2.7,1,2.8,1,1,1,1,3.3,1.2,3
3412,0,Europe,Digital,Data Science,Meets,Female,42,13,1,8,,2.6,3.2,1,1,1,1,4.9,4.3,4.3
3413,0,Latin America,R&D,Legal & Compliance,Below,Female,43,11,0,5,3.2,2.7,1.4,0,0,0,0,4.1,3.7,1.4
3414,0,Europe,Digital,Data Science,Exceeds,Female,39,32,0,12,3.7,4,2.2,1,1,1,1,2,4.9,1.4
3415,0,North America,Digital,Medical Affairs,Meets,Female,32,13,0,5,1.8,2.4,2.8,1,1,1,0,1.7,2.1,2.7
3416,0,Latin America,Commercial,Quality Assurance,Exceeds,Male,39,8,1,5,,3.3,3.4,1,1,1,1,2.9,2.8,2.5
3417,0,Latin America,Digital,Regulatory Affairs,Meets,Male,37,8,0,8,2.7,4.5,3.3,1,0,0,0,2.6,5,3.1
3418,0,North America,R&D,Medical Affairs,Exceeds,Female,39,1,1,8,,3.6,2,1,1,1,1,2.4,3.7,1.7
3419,1,Latin America,R&D,Human Resources,Meets,Female,32,10,1,5,,2.6,3.1,1,1,1,1,3.9,3.8,3.5
3420,0,Europe,Finance,Data Science,Below,Female,29,14,0,11,4,4.3,1.9,0,0,0,0,3.7,3.8,3.1
3421,0,Latin America,Manufacturing,Supply Chain,Exceeds,Male,28,9,0,12,4.1,1,3.2,0,0,0,0,3.9,3.9,2.9
3422,0,Asia Pacific,HR,Regulatory Affairs,Meets,Male,28,14,0,9,3.2,3.6,3,1,1,1,1,3.4,3.8,2.6
3423,0,Middle East & Africa,Digital,Clinical Operations,Meets,Female,28,10,0,12,2.9,4.2,3.7,1,1,1,1,2.3,3.6,3.2
3424,0,Europe,HR,Market Access,Meets,Female,44,16,0,5,2,2.2,3.8,1,1,1,1,1.9,1.9,4.7
3425,0,Asia Pacific,HR,Clinical Operations,Meets,Female,40,26,0,5,3.8,1,5,1,1,1,1,4.3,2,4.1
3426,0,North America,HR,Marketing,Exceeds,Male,38,36,0,12,3.2,2.1,1,1,0,0,0,4.1,3.1,1.3
3427,0,Europe,Finance,Data Science,Far Exceeds,Female,36,6,1,5,,2.9,1.9,1,1,0,0,3.3,3,1.1
3428,1,Middle East & Africa,HR,Supply Chain,Meets,Male,28,10,0,8,3,2.3,2.7,1,1,1,1,3.2,3,3.1
3429,0,Middle East & Africa,Finance,Quality Assurance,Meets,Female,40,6,1,10,,3.5,5,1,1,1,1,3.6,4.7,4.2
3430,0,North America,R&D,Sales,Far Exceeds,Female,39,5,0,7,3.9,2.2,1.9,0,0,0,0,4.4,3.9,2.4
3431,1,North America,Digital,Sales,Exceeds,Male,38,13,0,12,4.1,2.9,2.2,1,1,1,1,3.2,2.6,2.5
3432,0,Europe,Finance,IT & Digital,Far Below,Male,33,5,0,12,3.9,3.9,2.5,1,1,1,1,2.1,3.3,2.8
3433,0,Latin America,Manufacturing,Regulatory Affairs,Meets,Male,34,12,1,9,,3.3,2.3,1,1,1,1,3.8,2,2.3
3434,0,North America,HR,Quality Assurance,Below,Non-Binary/Other,41,13,1,10,,1.6,3,1,1,1,1,3.3,2.2,2.5
3435,0,Latin America,Manufacturing,Market Access,Far Exceeds,Female,33,7,0,8,3.2,4.6,2.9,1,1,1,0,3.4,4.8,3
3436,0,Asia Pacific,R&D,Finance & Accounting,Below,Male,44,11,1,8,,3,2.9,1,1,1,1,4.2,2.8,3.1
3437,0,Middle East & Africa,R&D,Clinical Operations,Meets,Male,48,8,0,11,3.9,3.4,2.9,1,1,1,1,4.7,4.9,3
3438,0,Latin America,Commercial,Market Access,Meets,Non-Binary/Other,45,8,0,5,3.2,3.9,4.1,1,1,1,1,2.3,3.5,3.6
3439,0,Middle East & Africa,HR,Pharmacovigilance,Exceeds,Female,39,7,0,9,3.2,2.2,2.9,1,1,1,1,3.5,1.8,3.9
3440,0,Latin America,Commercial,Clinical Operations,Exceeds,Male,37,11,0,9,3.6,1.7,1.3,0,0,0,0,4.5,2.1,2.8
3441,0,Asia Pacific,Manufacturing,Clinical Operations,Meets,Male,39,12,0,7,3.7,2.4,2.6,1,1,0,0,5,1.8,2.5
3442,0,North America,Digital,Clinical Operations,Meets,Female,42,11,1,11,,4.7,2.7,0,0,0,0,2.6,3.9,3.3
3443,0,Asia Pacific,Commercial,Supply Chain,Far Exceeds,Male,47,11,1,10,,2.9,3.9,1,1,1,1,4.1,1.2,3.4
3444,0,North America,R&D,Medical Affairs,Meets,Male,41,25,0,6,2.5,3.8,3.5,1,1,1,1,3.5,4.2,2.7
3445,0,North America,HR,IT & Digital,Meets,Non-Binary/Other,28,16,0,12,2.8,2.6,3.7,1,1,1,1,1.6,4.1,4.5
3446,0,Middle East & Africa,Manufacturing,Supply Chain,Meets,Female,32,4,0,6,4.3,2.8,3.5,1,1,1,1,4.8,3.4,2.4
3447,0,Asia Pacific,Finance,Sales,Meets,Female,37,14,1,7,,5,2.9,1,1,1,1,2.6,4.2,4.3
3448,0,Latin America,R&D,IT & Digital,Meets,Male,44,10,0,10,3.8,2.9,1.9,0,0,0,0,4.2,3,1.7
3449,0,Asia Pacific,Finance,Legal & Compliance,Meets,Male,52,23,0,5,3.9,2.3,2.7,1,1,1,1,4.5,2.7,1
3450,1,Middle East & Africa,Digital,Supply Chain,Meets,Male,38,8,0,9,1.2,3.2,1.7,1,1,1,1,1.4,2.9,2.8
3451,0,North America,HR,Market Access,Exceeds,Female,42,2,0,5,3.1,1.6,1,0,0,0,0,3.8,1.7,2.4
3452,0,Middle East & Africa,Digital,Legal & Compliance,Far Below,Female,29,12,0,10,3.4,1.9,2.9,1,1,1,1,4.6,1.7,2.6
3453,0,Europe,Digital,Supply Chain,Meets,Female,34,9,0,6,2.5,4.2,3.7,1,1,1,1,3.3,3.9,2.8
3454,0,Europe,HR,Medical Affairs,Meets,Female,40,16,0,5,2,3.4,1.8,1,1,1,1,2.6,3.6,1.8
3455,0,Latin America,HR,Regulatory Affairs,Below,Female,28,20,0,7,3.1,3.3,1.3,1,1,1,1,2.4,2.5,1
3456,0,Middle East & Africa,Finance,Quality Assurance,Exceeds,Male,39,17,0,10,3.8,2.9,3.6,1,1,1,1,3.7,2.4,4.2
3457,0,Latin America,Digital,Regulatory Affairs,Meets,Male,36,7,0,11,4.1,1.9,3.9,1,1,0,0,4.6,1.8,4.1
3458,0,Latin America,Manufacturing,Pharmacovigilance,Below,Male,38,11,0,9,2.1,4,2.3,1,1,1,1,2.8,2.7,3.1
3459,0,Europe,Finance,Sales,Meets,Male,34,7,0,5,3.6,4.7,1.4,1,1,1,1,2.2,3.2,2.1
3460,0,Latin America,HR,Pharmacovigilance,Meets,Male,41,14,0,6,2.1,1.7,3.9,1,1,0,0,3,1.7,2.1
3461,0,Europe,R&D,Communications,Below,Female,44,15,0,6,3.6,3.5,2,1,1,1,1,2.5,3.6,4.1
3462,0,North America,Finance,Pharmacovigilance,Meets,Male,42,9,0,7,2.7,1.4,4,1,1,1,1,3.7,2.8,5
3463,0,Middle East & Africa,Commercial,Legal & Compliance,Meets,Female,42,12,1,8,,2.5,2,1,1,1,1,3.6,1,2.6
3464,0,Latin America,Manufacturing,Quality Assurance,Meets,Female,41,1,0,9,3.5,5,3.4,1,1,1,1,3.8,4.9,1.1
3465,0,Europe,Finance,Quality Assurance,Below,Male,38,5,0,8,4.7,4.1,2.8,1,1,1,0,4.9,2.9,1.9
3466,0,Asia Pacific,HR,Medical Affairs,Meets,Male,35,2,1,8,,3.5,2.8,1,1,0,0,2.9,1.2,2.2
3467,0,Latin America,HR,Legal & Compliance,Below,Male,44,11,0,10,3.7,1.4,2.9,1,1,1,1,3,3.2,2.2
3468,0,North America,Manufacturing,Medical Affairs,Below,Male,33,3,1,9,,4,2.9,1,1,1,1,4.2,3.6,4.9
3469,0,North America,Commercial,Legal & Compliance,Exceeds,Female,41,19,0,8,2.9,3.4,3.1,1,1,1,1,4.6,3.5,2.9
3470,0,Asia Pacific,Finance,Regulatory Affairs,Below,Female,41,14,0,9,4.2,2.8,2.3,1,0,0,0,2.4,3.3,2.2
3471,0,Europe,Finance,Medical Affairs,Below,Female,32,28,0,10,5,2.1,4.7,1,1,1,1,3.8,3.3,2.6
3472,0,Latin America,Digital,Medical Affairs,Exceeds,Male,32,13,1,8,,2,1,0,0,0,0,3.7,2.6,3
3473,0,Europe,R&D,Marketing,Meets,Female,41,28,0,7,2.6,2.3,3.8,1,1,1,1,3.5,3.3,2.8
3474,0,North America,HR,Data Science,Below,Female,39,6,0,10,1.3,3.7,2.9,1,1,1,1,2.6,4.4,2.2
3475,0,Europe,Finance,Regulatory Affairs,Far Exceeds,Male,40,10,1,11,,3,1.2,0,0,0,0,4.5,3.5,2.2
3476,0,North America,Finance,Communications,Below,Male,37,12,0,9,4.2,3.2,3.5,1,1,1,1,2.3,3,3.4
3477,0,Europe,Finance,Quality Assurance,Meets,Female,47,6,0,8,3.5,4.3,3.3,1,1,1,1,3.6,3.5,3.1
3478,0,Asia Pacific,Commercial,Regulatory Affairs,Far Below,Male,42,7,0,5,4,1.8,4.1,1,1,1,1,4.3,1.7,3.1
3479,0,Middle East & Africa,R&D,Quality Assurance,Meets,Female,46,11,0,11,2.3,1.2,1.5,1,1,1,1,2.8,2.1,1.2
3480,0,Asia Pacific,Finance,Supply Chain,Meets,Male,36,7,0,10,4.4,3.8,4,1,1,1,1,2.7,4.2,4.1
3481,0,Asia Pacific,Manufacturing,Data Science,Meets,Male,44,8,1,10,,1.9,2.5,1,1,1,1,3.3,1.6,1.7
3482,0,Middle East & Africa,HR,Marketing,Meets,Female,36,23,1,6,,2.6,2.3,1,1,1,1,1.9,3.4,3.4
3483,0,Middle East & Africa,Digital,Marketing,Meets,Female,36,14,0,11,3.4,2.8,2.8,1,1,1,1,4.1,2.2,2
3484,0,Latin America,Manufacturing,Market Access,Meets,Female,31,17,0,7,2.6,3,4.2,1,1,1,1,1.2,3.3,2.3
3485,1,Latin America,HR,Legal & Compliance,Exceeds,Male,41,11,0,6,2.6,1.2,3.5,1,1,1,1,3.3,2.3,3.2
3486,0,Asia Pacific,Commercial,Sales,Meets,Female,32,13,1,12,,3,2.7,1,1,1,1,3.6,3.5,3.1
3487,0,Asia Pacific,R&D,Finance & Accounting,Meets,Male,34,4,1,8,,4.8,5,1,1,1,1,3.9,4.4,5
3488,0,North America,R&D,Quality Assurance,Meets,Male,30,5,0,5,3.4,2.8,4,1,1,1,1,3,3.9,1.5
3489,0,North America,HR,Communications,Meets,Male,28,8,0,9,1.7,3.3,3.4,1,1,1,1,3.2,2.7,2.3
3490,0,Latin America,Manufacturing,Human Resources,Meets,Female,38,12,0,12,2,4,2.8,1,1,1,1,3.1,4.8,2.5
3491,0,Latin America,Digital,IT & Digital,Meets,Female,34,2,1,10,,4.3,1.6,0,0,0,0,4.1,2,3.1
3492,0,North America,Commercial,Sales,Meets,Male,40,7,0,12,3.9,4.3,4.7,1,1,1,1,2.1,5,5
3493,0,North America,HR,Supply Chain,Far Exceeds,Female,38,9,1,11,,2.7,5,1,1,1,1,3.5,2.8,3.8
3494,0,Europe,Commercial,Marketing,Meets,Female,44,9,0,10,4,3.6,3.8,1,1,1,1,3.7,5,2.8
3495,0,Europe,R&D,Human Resources,Meets,Female,50,8,0,6,1.9,4.7,2.4,1,1,1,1,3,4.6,1.8
3496,0,North America,Finance,Communications,Meets,Female,45,10,0,8,4.1,2.7,2.5,0,0,0,0,4.1,3.9,1.3
3497,0,Europe,Finance,Supply Chain,Exceeds,Female,38,10,0,7,1.1,4.5,2.1,1,1,1,1,1.8,4,2.5
3498,0,Middle East & Africa,Digital,Finance & Accounting,Exceeds,Male,42,8,1,7,,2.7,3.5,1,1,1,1,4.2,2.9,3.4
3499,0,Latin America,Commercial,Pharmacovigilance,Exceeds,Female,46,5,0,10,4.1,3.2,2.9,0,0,0,0,1.7,3.8,4
3500,1,Latin America,HR,Data Science,Exceeds,Non-Binary/Other,35,15,1,10,,5,1.8,1,1,1,1,3.9,2.9,1.6
3501,0,North America,Digital,Market Access,Meets,Female,43,27,0,7,4.3,2.1,3,1,1,1,1,3.8,2.8,1.7
3502,0,Asia Pacific,Manufacturing,Supply Chain,Meets,Male,46,20,1,8,,1,1.6,1,1,1,0,3,3.2,1.5
3503,0,North America,Finance,Finance & Accounting,Meets,Male,38,11,0,7,3.2,3.7,4,1,1,1,1,2.3,2.8,5
3504,0,Europe,HR,Market Access,Meets,Non-Binary/Other,41,15,0,12,4.4,4,4.2,1,1,1,1,3.9,4.7,2.5
3505,0,Asia Pacific,Commercial,Data Science,Meets,Male,50,12,0,12,4.2,2.7,4.6,1,1,1,1,3.7,4.5,2.7
3506,0,Europe,Digital,Finance & Accounting,Exceeds,Female,34,7,0,9,3,2.9,3.1,0,0,0,0,2.8,1,2
3507,0,Middle East & Africa,HR,Regulatory Affairs,Meets,Male,36,9,0,5,3.6,3.8,2.3,1,1,1,0,2.9,2.7,1
3508,0,Europe,Digital,IT & Digital,Far Exceeds,Male,41,19,0,6,2.7,2.5,1,1,1,1,1,3.6,3.1,1
3509,0,Middle East & Africa,Digital,Supply Chain,Far Exceeds,Female,33,10,0,5,4.4,2.7,3.5,1,1,1,1,3.9,2.9,2.8
3510,0,Middle East & Africa,Digital,Medical Affairs,Meets,Male,38,6,1,11,,3.9,2.9,1,1,1,1,3.9,2.5,3.4
3511,0,Europe,Commercial,Clinical Operations,Exceeds,Male,31,24,0,6,3.6,4,5,1,1,1,1,3.5,3.3,4.2
3512,0,Europe,HR,Marketing,Below,Male,28,19,1,10,,3.1,3.7,1,1,1,1,2.8,4.1,4.7
3513,0,Middle East & Africa,R&D,Human Resources,Meets,Female,39,5,0,9,1,2.3,2.6,1,1,1,1,2.2,4,2.6
3514,0,Asia Pacific,R&D,Marketing,Meets,Male,30,36,0,11,2.5,3.9,3.3,1,1,1,1,2.6,4.6,1.4
3515,0,Middle East & Africa,Commercial,Marketing,Meets,Male,32,16,0,7,2,3.4,3.7,1,1,1,1,1.8,2.5,2.4
3516,0,Latin America,Commercial,Regulatory Affairs,Exceeds,Female,44,22,0,9,3.6,2.2,4.8,1,1,1,1,3.9,3.3,4.9
3517,0,Middle East & Africa,Finance,Clinical Operations,Meets,Male,39,9,0,8,1.2,2.2,3,1,1,1,1,2.4,3.6,2.2
3518,0,Asia Pacific,Digital,Data Science,Meets,Male,38,6,0,12,3.5,2.7,2.7,1,1,1,1,4.4,3.5,2.1
3519,0,Latin America,HR,IT & Digital,Below,Female,36,18,1,5,,4.4,1.1,1,1,1,1,2.7,4.6,1.7
3520,0,North America,HR,Legal & Compliance,Below,Female,47,12,0,11,3.6,2.2,3,1,1,1,1,2.7,3.2,3.1
3521,0,North America,Manufacturing,Regulatory Affairs,Meets,Male,51,12,0,9,3.3,4.9,2.8,1,1,1,1,2.9,3.6,2.9
3522,0,Asia Pacific,Manufacturing,Marketing,Meets,Female,42,7,1,10,,4.3,2,0,0,0,0,4.1,3.1,3.5
3523,0,Middle East & Africa,R&D,Finance & Accounting,Meets,Female,28,16,0,7,4.2,3.7,1.9,1,1,1,1,2.7,4.4,2.9
3524,0,Europe,Manufacturing,IT & Digital,Meets,Male,38,9,0,11,4.2,2.6,1,1,1,1,1,2.9,2.5,3.2
3525,0,Asia Pacific,Manufacturing,Marketing,Meets,Female,32,27,0,9,4.4,5,1.5,1,0,0,0,5,4,3.4
3526,0,Latin America,R&D,Finance & Accounting,Below,Male,35,10,0,6,2.7,3.1,1.6,1,1,1,1,2.3,3.9,1.4
3527,0,Latin America,Finance,Sales,Meets,Male,41,13,0,7,2.3,2.5,1.7,1,1,1,1,3.5,2.5,3
3528,1,North America,R&D,Market Access,Exceeds,Female,39,9,0,11,4.2,2.7,2.7,1,1,1,1,4.6,3.7,4.7
3529,0,Latin America,Manufacturing,Market Access,Meets,Male,30,15,0,11,2.7,1.6,3.8,1,1,1,1,2.5,2.5,3.9
3530,0,Asia Pacific,HR,Sales,Meets,Female,34,4,1,11,,2.2,2.7,1,1,1,1,2.8,3.9,1.7
3531,0,Latin America,Manufacturing,Pharmacovigilance,Meets,Male,45,4,1,9,,2.4,1.2,1,1,1,0,2,4.2,2
3532,1,Asia Pacific,Digital,Legal & Compliance,Meets,Male,48,4,0,10,3.4,3,2.3,1,1,1,1,3.7,2.2,2.7
3533,0,Europe,Digital,Sales,Meets,Male,46,14,0,11,3.1,2.9,2.2,1,1,1,1,3.2,2.5,1.9
3534,0,North America,Digital,Finance & Accounting,Far Exceeds,Male,30,7,0,10,4.2,1.7,4.3,1,1,1,1,4.7,4,3.6
3535,0,Latin America,Finance,Market Access,Below,Female,36,10,0,12,2.1,2.7,2.5,1,1,0,0,2.7,2.8,4.5
3536,0,Asia Pacific,Commercial,Marketing,Far Exceeds,Female,34,6,0,8,2,2.8,3.2,1,1,1,1,3,4,4.6
3537,0,Middle East & Africa,Digital,Human Resources,Far Exceeds,Female,42,9,1,11,,2.7,4,1,1,1,1,3.8,2.7,2.8
3538,0,North America,HR,Medical Affairs,Exceeds,Female,36,13,0,7,1.6,3.3,2.9,1,1,1,1,1,2.6,2.4
3539,0,Europe,Finance,Market Access,Meets,Female,32,17,0,11,2.9,3.4,3.4,1,1,1,1,3,3.8,2.2
3540,0,Asia Pacific,Commercial,Legal & Compliance,Exceeds,Female,47,13,0,5,4,3.6,2.7,0,0,0,0,3.9,3.1,3
3541,0,Europe,Commercial,Legal & Compliance,Meets,Male,35,16,0,11,5,1.8,2.3,1,1,1,1,4.9,2.5,2.7
3542,0,Europe,Digital,Communications,Meets,Female,44,7,1,11,,2.2,2.8,1,1,1,1,3.2,2.5,2.6
3543,0,Latin America,Manufacturing,Clinical Operations,Below,Female,34,6,1,7,,2.5,2.9,1,1,1,1,2.2,1,3.3
3544,0,Latin America,R&D,Medical Affairs,Exceeds,Female,43,10,1,10,,3.8,2,1,1,1,1,4.6,3.2,2.2
3545,0,Asia Pacific,Manufacturing,Regulatory Affairs,Meets,Female,36,19,1,6,,3.3,3,1,1,1,1,4,4.3,3.5
3546,0,Middle East & Africa,Manufacturing,Market Access,Below,Male,32,10,0,7,4.2,2.9,3.7,1,1,1,1,3.5,1.8,4.2
3547,0,Asia Pacific,Commercial,Data Science,Exceeds,Female,45,9,0,5,2.8,3,2.3,1,1,1,1,3.3,4.3,1.8
3548,0,Middle East & Africa,Commercial,Supply Chain,Meets,Non-Binary/Other,34,17,0,8,4.2,4.3,1,1,1,1,1,2.2,2.9,1
3549,0,Europe,Finance,Supply Chain,Meets,Female,39,6,0,8,2.9,4.6,4,0,0,0,0,2.2,4.3,5
3550,0,North America,Finance,Clinical Operations,Meets,Female,30,18,0,10,4.7,2.9,2.7,1,1,1,1,4.1,3.5,1
3551,0,Asia Pacific,Commercial,Quality Assurance,Exceeds,Male,30,6,0,5,4.1,2.5,2.9,1,1,1,1,3.8,2.6,1.8
3552,0,Asia Pacific,HR,Supply Chain,Meets,Female,47,12,1,11,,1.1,4.5,1,1,1,1,2.8,1.2,3.4
3553,0,Middle East & Africa,HR,Clinical Operations,Meets,Female,39,11,0,10,3.4,3.5,2.3,1,1,1,1,3.9,2.7,1
3554,0,Europe,R&D,Quality Assurance,Meets,Male,37,17,0,12,2.9,3.1,2.4,1,1,1,1,3.1,2,1.7
3555,0,Europe,Commercial,Legal & Compliance,Meets,Female,35,15,0,9,3.8,4,2.3,1,1,1,1,4.3,3.5,2
3556,0,Middle East & Africa,Digital,Legal & Compliance,Meets,Male,33,9,0,10,3,4,4.4,1,1,1,1,3.4,3.8,4.4
3557,0,Europe,Finance,Regulatory Affairs,Meets,Male,41,12,0,6,2.7,3,2.2,1,1,1,1,3.7,3.4,2.9
3558,0,Latin America,Commercial,Quality Assurance,Meets,Male,47,18,0,6,3.8,1.8,1.1,1,1,1,1,3.7,1.8,1.3
3559,0,North America,HR,Data Science,Meets,Female,43,28,0,10,3.6,4.4,2.7,0,0,0,0,4.1,3.1,2.4
3560,0,Asia Pacific,Commercial,Market Access,Exceeds,Female,42,15,0,5,2.2,2.4,3.7,1,1,1,1,3.3,1.3,2.5
3561,0,North America,HR,Supply Chain,Meets,Female,36,28,0,12,4.5,4.4,1.9,1,1,1,1,5,2.8,1.7
3562,0,Asia Pacific,Commercial,Finance & Accounting,Meets,Female,42,7,0,7,4.1,3.8,2.4,1,1,1,1,5,3.9,2.1
3563,0,Latin America,Digital,Marketing,Meets,Female,50,11,0,8,4,1.3,4,1,1,1,1,4.2,1,3.1
3564,0,Europe,R&D,Sales,Meets,Female,36,11,0,8,3.1,2.7,3,1,1,1,1,2.5,3.2,3.7
3565,0,Middle East & Africa,Digital,Communications,Exceeds,Female,40,7,0,8,2.4,2.5,1.4,1,1,1,1,3.7,3,2.4
3566,0,Latin America,HR,Human Resources,Far Below,Female,46,13,0,10,4.3,1,4.4,1,1,1,1,3.3,1,4.2
3567,0,North America,Finance,Market Access,Meets,Male,50,22,0,11,2.7,1.8,1.5,0,0,0,0,3.8,3.2,3.7
3568,0,Middle East & Africa,Finance,Legal & Compliance,Meets,Male,39,11,0,11,2.6,1.6,2.8,1,1,1,1,3,1.7,2.7
3569,0,Europe,Manufacturing,Human Resources,Meets,Female,43,17,0,9,3.5,4,4,1,1,1,1,3.7,4,2.3
3570,0,Latin America,Digital,Regulatory Affairs,Far Below,Male,36,8,0,8,1.8,2.5,2.4,1,1,1,1,2,4.4,1.6
3571,0,Middle East & Africa,Commercial,Regulatory Affairs,Exceeds,Male,40,10,1,9,,2.9,3.5,0,0,0,0,3.3,3.6,2.8
3572,0,Latin America,R&D,Finance & Accounting,Exceeds,Female,37,5,0,10,2.6,3.1,5,1,1,1,1,2.1,4.1,3.7
3573,0,Latin America,Commercial,IT & Digital,Below,Non-Binary/Other,45,2,1,11,,5,2,1,1,1,1,2.8,4.9,1.1
3574,0,Europe,Commercial,Communications,Meets,Female,48,8,1,5,,3.1,2.9,1,1,1,1,3.9,4.2,2.2
3575,0,Asia Pacific,Digital,Clinical Operations,Below,Male,31,13,1,7,,2.5,4.5,1,1,1,1,4.3,2.5,3.9
3576,0,Middle East & Africa,R&D,Legal & Compliance,Meets,Female,37,17,0,12,4.2,2.5,3.3,1,1,1,1,3.3,1.3,3.4
3577,0,Europe,Manufacturing,Pharmacovigilance,Meets,Female,35,19,0,8,4.5,2.7,3.6,1,1,1,1,3.8,2.7,1.3
3578,0,Latin America,Commercial,Human Resources,Meets,Female,36,6,1,5,,3.5,4,1,1,1,1,4.7,3.2,1.9
3579,0,Europe,R&D,Quality Assurance,Below,Male,37,16,0,10,1.3,2.8,1.3,1,1,1,1,2.4,3.9,2.4
3580,0,Asia Pacific,Manufacturing,Quality Assurance,Exceeds,Female,33,21,0,10,3.1,2.2,3.8,1,1,1,1,3.4,2.8,2.1
3581,0,Middle East & Africa,Commercial,Clinical Operations,Meets,Male,40,32,0,9,3.9,3.2,1.7,1,0,0,0,4.7,2.8,3.1
3582,0,Asia Pacific,R&D,Sales,Far Below,Female,31,9,1,6,,4.2,1.7,1,1,1,1,3.1,2.5,2.6
3583,0,North America,Digital,IT & Digital,Meets,Female,43,11,0,6,3,3.2,3.2,0,0,0,0,3.4,2.8,3
3584,0,Middle East & Africa,Finance,Marketing,Exceeds,Female,40,18,0,9,2.3,2.5,2,1,1,1,1,2.7,2.2,2.2
3585,0,Asia Pacific,Finance,Communications,Meets,Female,32,5,0,8,3.9,3.3,3.1,1,1,1,1,3.3,3,2.1
3586,0,Latin America,Commercial,Regulatory Affairs,Meets,Non-Binary/Other,31,11,1,9,,1,3,1,0,0,0,4,1,3.6
3587,0,Middle East & Africa,Commercial,Market Access,Meets,Male,43,5,0,11,3.1,2.9,2,1,1,1,1,4.5,4.6,4.7
3588,0,Middle East & Africa,R&D,Communications,Meets,Male,34,20,0,10,3.8,2.2,1.8,1,1,1,1,4.2,2.5,2.6
3589,0,Europe,Finance,Sales,Meets,Male,47,14,1,9,,1.3,2.2,1,1,1,1,3.1,2.2,2.4
3590,0,Latin America,Commercial,Marketing,Far Exceeds,Female,28,14,1,8,,4.4,3.2,1,1,1,1,3.4,5,4.1
3591,0,North America,Manufacturing,Pharmacovigilance,Below,Female,32,8,1,5,,2.6,5,1,1,1,1,2.5,2.5,4
3592,0,Asia Pacific,Commercial,Communications,Meets,Female,36,23,0,10,1.8,2.3,1.3,1,1,1,0,1,2.6,1.6
3593,0,Europe,Finance,Market Access,Below,Female,38,3,0,7,3.9,3.2,1.6,1,1,1,1,4.2,4.1,3.5
3594,0,Asia Pacific,HR,Clinical Operations,Meets,Male,42,7,1,6,,1.7,3.6,1,1,1,1,5,2.5,2.6
3595,0,North America,Finance,Finance & Accounting,Meets,Male,37,10,1,5,,2.4,1.8,1,1,1,1,3.5,2.9,2.6
3596,0,North America,Manufacturing,Market Access,Exceeds,Male,36,12,0,8,2.9,2.4,2.7,1,1,1,1,3.3,2.6,2.9
3597,0,Middle East & Africa,R&D,Data Science,Below,Female,34,16,0,6,3.6,2.9,3.3,1,1,1,1,3.9,4,3.5
3598,0,North America,Manufacturing,IT & Digital,Far Exceeds,Female,33,12,0,5,3.1,5,3.7,1,1,1,1,3,5,2.9
3599,0,Asia Pacific,HR,Pharmacovigilance,Meets,Female,34,11,0,6,2,4.7,2.3,0,0,0,0,3.5,4.1,3.7
3600,0,Latin America,HR,Communications,Meets,Male,38,7,1,12,,1.6,1.6,1,1,1,1,2.8,1.8,1.9
3601,0,Latin America,Commercial,Legal & Compliance,Below,Male,28,7,0,8,3.8,3.1,3.5,1,1,1,1,3.5,2.7,2.3
3602,0,Middle East & Africa,Commercial,Clinical Operations,Meets,Female,41,9,1,11,,2.4,3.7,1,1,1,1,1.9,3.7,4.1
3603,0,Asia Pacific,Finance,Clinical Operations,Meets,Male,38,4,1,12,,3.3,2.8,1,1,1,1,2,3.3,3.1
3604,0,Asia Pacific,Digital,Clinical Operations,Meets,Male,37,11,1,10,,1.7,1.5,1,1,1,1,3,2,1.6
3605,0,North America,Manufacturing,Supply Chain,Meets,Male,45,20,0,9,2.9,5,4.2,0,0,0,0,3.8,2.9,2.3
3606,0,Asia Pacific,Finance,Finance & Accounting,Meets,Female,42,23,0,5,4.1,3,3.6,1,1,1,1,3,3.5,1.1
3607,0,Europe,Digital,Sales,Meets,Male,39,13,0,11,3.4,2.5,2.5,1,1,1,1,4,4.5,3.2
3608,0,North America,Finance,Marketing,Meets,Male,42,27,1,9,,2.4,2.8,1,1,1,1,2.6,2.4,3.6
3609,0,Europe,HR,Finance & Accounting,Exceeds,Female,34,20,1,7,,3.3,4.6,1,1,1,1,2.6,2.5,4.2
3610,0,Middle East & Africa,Commercial,Communications,Meets,Male,42,14,0,5,5,2.2,3.9,1,1,1,1,5,2.4,3.9
3611,0,Latin America,Commercial,Legal & Compliance,Meets,Male,43,14,0,6,4.6,2.5,3.8,1,1,1,1,3.3,3.2,2.6
3612,0,Middle East & Africa,Finance,Quality Assurance,Meets,Female,28,4,0,7,3.6,3.5,4.7,1,0,0,0,2.6,3.1,4.4
3613,0,Latin America,Commercial,Legal & Compliance,Meets,Female,49,9,0,6,2.9,1.9,3.7,1,1,1,1,3.6,2.7,4
3614,0,Middle East & Africa,R&D,Finance & Accounting,Below,Male,40,9,1,9,,3.3,1.4,1,1,1,1,3.6,4.3,2.6
3615,0,Asia Pacific,Finance,Regulatory Affairs,Meets,Male,42,18,0,12,4.5,3.5,1.4,1,1,1,1,5,3.1,2.3
3616,0,Europe,HR,Finance & Accounting,Meets,Male,44,8,1,7,,1.7,2.4,1,1,1,1,3.7,2,2
3617,0,Latin America,Finance,Regulatory Affairs,Meets,Female,37,8,1,5,,3.2,2.6,1,0,0,0,3.5,2.5,4.2
3618,0,North America,Finance,Data Science,Meets,Female,36,22,0,12,2.3,3.2,2.4,1,1,1,1,3.8,3.6,2.6
3619,0,Europe,Commercial,Finance & Accounting,Far Exceeds,Male,40,16,0,11,2.3,3.9,3,1,0,0,0,2.8,3.6,2.4
3620,0,North America,HR,Data Science,Exceeds,Male,55,23,0,6,3.3,2.8,2.5,0,0,0,0,2.7,3.3,1.4
3621,0,Europe,Finance,Finance & Accounting,Exceeds,Male,37,11,0,5,3.8,2.1,1.8,1,1,1,1,2.4,2.5,1.6
3622,0,Europe,Commercial,Data Science,Below,Male,34,4,0,9,1.6,2,1,1,0,0,0,4.4,2.2,2.6
3623,0,Middle East & Africa,Manufacturing,Medical Affairs,Exceeds,Male,46,5,0,8,4.2,1.8,2.6,1,0,0,0,4.9,3.8,2
3624,0,Latin America,HR,Data Science,Meets,Female,28,9,1,6,,3,4.6,1,1,1,1,2.5,1.4,3.1
3625,0,Latin America,Digital,Regulatory Affairs,Meets,Female,37,16,1,5,,2.2,4,1,1,1,1,2.7,3.6,2.4
3626,0,Europe,R&D,Pharmacovigilance,Meets,Male,34,25,0,9,4.4,4.1,3.8,1,1,1,1,4,3.2,3.5
3627,0,Asia Pacific,Digital,Marketing,Meets,Female,42,5,1,9,,3.2,3.3,1,0,0,0,3.5,2.9,4.4
3628,0,Asia Pacific,HR,Data Science,Exceeds,Male,39,7,1,7,,3.4,2.3,0,0,0,0,3,2.4,2.9
3629,0,North America,Finance,Pharmacovigilance,Meets,Male,31,8,0,12,3.2,3.2,3.4,1,1,1,1,3.5,3.7,3.5
3630,0,North America,Commercial,Communications,Meets,Female,42,17,1,9,,2.9,2.7,0,0,0,0,3.3,3.4,2.9
3631,0,Middle East & Africa,HR,Medical Affairs,Below,Male,33,7,0,7,3.2,4.3,2.9,1,1,1,1,3,4.6,2.3
3632,0,Europe,R&D,Medical Affairs,Meets,Female,38,9,0,6,4,1.4,3.4,1,1,1,1,2.4,3.3,2.7
3633,0,North America,HR,Quality Assurance,Meets,Female,35,15,0,5,2.8,3.1,3.2,1,1,1,1,2.8,4.6,2.7
3634,0,North America,Commercial,Supply Chain,Exceeds,Non-Binary/Other,43,14,0,12,2.8,1.7,2.4,1,1,1,1,3.8,3.3,4.1
3635,0,Europe,Digital,Communications,Meets,Female,35,5,0,11,2.7,1.3,2,1,1,1,0,2,2.6,2.2
3636,0,Middle East & Africa,Manufacturing,Supply Chain,Meets,Male,28,23,1,7,,1.8,4.2,1,1,1,1,2.9,3.7,2.7
3637,0,North America,Digital,Market Access,Meets,Female,31,3,0,7,3.7,4.9,2.4,1,1,1,1,3.7,3.1,2.2
3638,0,Middle East & Africa,Commercial,Supply Chain,Meets,Male,38,13,0,12,3.6,2.7,4.9,1,1,1,1,2.8,3.4,5
3639,0,Latin America,Commercial,Market Access,Meets,Female,34,5,0,5,4.9,3.2,3.2,1,1,1,1,4,2.3,1.9
3640,0,Middle East & Africa,R&D,Human Resources,Below,Female,45,6,0,9,3.8,4.5,3.6,1,1,1,1,3.9,4.8,1.6
3641,0,Asia Pacific,HR,Sales,Meets,Female,32,12,0,8,5,2,2.4,1,1,1,1,3.8,2.4,2.9
3642,0,Asia Pacific,HR,Communications,Below,Female,41,5,1,9,,2.9,2.3,1,1,0,0,3.8,3.9,3.2
3643,0,Middle East & Africa,Digital,Supply Chain,Meets,Female,43,1,0,12,2.4,2.8,1,1,1,1,1,3.7,2.7,1.5
3644,0,Asia Pacific,Manufacturing,Medical Affairs,Below,Female,39,8,1,6,,3.9,4.1,1,1,1,1,3.7,4.4,5
3645,0,Latin America,Manufacturing,Quality Assurance,Far Exceeds,Female,40,6,0,6,4.5,4.3,2.4,1,1,1,1,4.2,3.7,2
3646,0,Europe,R&D,Pharmacovigilance,Exceeds,Male,37,8,0,5,2.2,2.1,2.9,1,1,1,1,2.5,3.2,3.6
3647,0,Asia Pacific,Commercial,Finance & Accounting,Meets,Female,40,6,1,10,,2.3,2.6,1,1,0,0,3.3,2.8,2.4
3648,0,Asia Pacific,R&D,IT & Digital,Meets,Female,35,4,1,10,,4.3,3.4,1,1,1,1,2.5,3.2,3.3
3649,0,Middle East & Africa,HR,Data Science,Meets,Female,39,20,0,9,3.6,2.4,2.3,1,1,1,1,3.7,2.7,2.9
3650,0,Latin America,Finance,Supply Chain,Meets,Non-Binary/Other,36,16,0,6,4.3,2.8,2.6,1,1,1,1,4.1,3.7,3.1
3651,0,Europe,Finance,IT & Digital,Meets,Male,36,8,0,8,2.6,2.6,3.8,1,1,1,1,3.7,1.5,3.1
3652,0,Middle East & Africa,Finance,Market Access,Meets,Male,34,8,1,8,,4.1,3.3,1,1,1,1,2.8,4.4,4.4
3653,0,Middle East & Africa,Commercial,Pharmacovigilance,Far Below,Female,37,16,1,12,,3.4,3.5,1,1,1,1,1.8,3.3,3.5
3654,0,Latin America,R&D,Clinical Operations,Below,Male,47,15,0,11,3.6,1.2,2,1,1,1,1,2.8,2,2.1
3655,0,Europe,Digital,Regulatory Affairs,Meets,Female,37,7,0,9,3.6,2.1,4.3,1,1,1,1,2.8,1.4,3.3
3656,0,Latin America,HR,Supply Chain,Below,Female,44,16,0,6,3.4,2.7,3,1,1,1,0,4,3.2,2.8
3657,0,Europe,Finance,Communications,Meets,Male,41,15,0,9,2.7,3,1.1,1,1,1,1,2.2,2.5,2.7
3658,0,Latin America,Manufacturing,Finance & Accounting,Below,Female,39,13,0,7,3.9,4.4,3.5,1,1,1,1,4.1,3.5,5
3659,1,Middle East & Africa,R&D,Regulatory Affairs,Exceeds,Non-Binary/Other,40,26,0,6,4,3.4,1.8,1,1,0,0,4.5,4,2
3660,0,Middle East & Africa,HR,Supply Chain,Meets,Male,38,10,0,7,4.9,2.8,3,0,0,0,0,2.6,2.7,2.2
3661,0,North America,HR,Clinical Operations,Meets,Female,35,17,0,5,5,3.4,1.5,1,1,1,1,5,3.6,3.8
3662,0,Asia Pacific,Manufacturing,Communications,Meets,Male,48,18,0,7,2.4,3,3,1,1,1,1,2,1.6,3.3
3663,0,Latin America,Manufacturing,Data Science,Meets,Female,44,10,0,6,2.7,2.4,2.8,1,1,0,0,3.7,2.7,3.5
3664,0,North America,Manufacturing,Communications,Meets,Female,38,15,0,6,3,2.2,2.3,1,1,1,1,3.5,3.9,2.5
3665,0,Asia Pacific,Finance,Sales,Meets,Female,38,6,1,5,,2.8,5,1,1,1,1,4.2,4,3.5
3666,0,Latin America,Finance,Legal & Compliance,Far Below,Male,41,21,0,8,3.2,2,1.8,0,0,0,0,2.3,1.2,2.1
3667,0,Europe,R&D,IT & Digital,Meets,Female,32,5,1,5,,3.2,2.5,1,1,1,1,3.5,2.4,2.2
3668,0,Asia Pacific,Manufacturing,Legal & Compliance,Meets,Female,33,21,0,6,2.6,4.1,1.8,1,1,1,1,2.8,3.9,2.4
3669,0,Middle East & Africa,Digital,Human Resources,Far Exceeds,Male,28,6,0,6,2.9,3.7,3.5,1,1,1,1,4.3,4.8,4
3670,0,North America,HR,Marketing,Exceeds,Female,37,5,0,6,1.2,3.8,3.9,1,1,1,1,1.9,4.8,1.9
3671,0,Asia Pacific,Manufacturing,Communications,Below,Female,45,8,0,10,3.5,2.3,3.4,1,1,1,1,4.1,3,3.9
3672,0,Asia Pacific,HR,Finance & Accounting,Meets,Female,36,6,1,7,,1.9,3.3,1,1,1,1,2.8,1.7,2.7
3673,0,Middle East & Africa,Commercial,Pharmacovigilance,Exceeds,Female,51,7,0,10,3,3.9,3.5,1,1,1,1,2.9,3.9,3.8
3674,0,Latin America,Commercial,Pharmacovigilance,Far Below,Female,35,10,1,11,,3.4,2.5,0,0,0,0,4.4,3.1,2.3
3675,0,Europe,Manufacturing,Data Science,Meets,Female,39,6,0,6,2.8,2.9,1.7,1,1,1,1,4.2,2.7,3.1
3676,0,Middle East & Africa,HR,Legal & Compliance,Meets,Male,36,7,0,11,3.6,3.7,1.8,1,1,1,1,3.7,2.2,2.6
3677,0,Europe,Commercial,Quality Assurance,Meets,Female,28,8,0,5,4.5,2.8,2.2,1,1,0,0,4.9,2.4,1.8
3678,0,Latin America,Manufacturing,Finance & Accounting,Meets,Female,36,11,0,12,3.8,4.6,3.8,1,0,0,0,2.5,3.5,4.7
3679,0,Asia Pacific,HR,Medical Affairs,Far Exceeds,Female,33,7,0,7,4.5,3.7,2.5,1,1,1,0,5,3.5,2.7
3680,0,Europe,Manufacturing,Supply Chain,Meets,Male,39,23,0,5,4.8,3.1,3,0,0,0,0,3.4,2.2,3.9
3681,0,North America,Finance,Marketing,Meets,Male,46,11,1,8,,1.7,4,1,1,1,1,4.5,2.6,4.5
3682,0,North America,HR,Quality Assurance,Meets,Female,36,6,0,6,3.5,2.6,4.7,1,1,1,1,2.9,2.7,5
3683,0,Middle East & Africa,Commercial,Marketing,Meets,Male,40,3,0,5,3.8,4.3,3.5,1,1,1,1,3.6,4.6,2.3
3684,0,Latin America,Manufacturing,Medical Affairs,Far Exceeds,Male,37,13,0,8,2.2,3.7,2.5,1,1,1,1,2.2,2.8,2
3685,0,Middle East & Africa,Commercial,Regulatory Affairs,Meets,Male,43,17,0,8,3.9,4.7,1.2,1,1,1,1,3.4,4.6,1
3686,0,Middle East & Africa,Manufacturing,Supply Chain,Meets,Female,52,11,0,6,4.1,2.2,3.4,1,1,1,1,3.2,2.8,2.9
3687,0,Middle East & Africa,R&D,Human Resources,Meets,Non-Binary/Other,47,34,0,9,1.9,1.4,3.2,0,0,0,0,2.7,2.6,2.8
3688,0,North America,Commercial,Communications,Far Below,Female,34,17,0,10,2.7,3.9,2.9,1,1,1,1,2.9,4.1,2.1
3689,0,North America,Commercial,Finance & Accounting,Meets,Male,46,15,0,8,2.2,3.9,2.2,1,1,1,1,1.1,3.8,2.2
3690,0,Middle East & Africa,Digital,Human Resources,Meets,Male,40,9,0,7,3.7,3.2,3.1,1,1,1,1,2.4,2.6,4.5
3691,0,North America,Finance,Medical Affairs,Meets,Female,45,27,0,6,2.7,4,3.2,1,1,1,1,3.3,2.2,2.7
3692,0,Latin America,Commercial,Finance & Accounting,Meets,Female,32,8,0,10,4.5,4.5,2.2,0,0,0,0,4,3,3.5
3693,0,Middle East & Africa,HR,Pharmacovigilance,Meets,Male,37,17,0,11,4,2.8,1.1,1,1,1,1,2.6,3.5,1.8
3694,0,North America,Manufacturing,Pharmacovigilance,Meets,Female,39,18,0,7,4.7,4.4,2.8,1,1,1,1,5,4.6,1.2
3695,0,Europe,R&D,Supply Chain,Far Below,Male,38,11,0,9,3,1.5,3.7,1,1,1,1,2.1,3,4.3
3696,0,Middle East & Africa,HR,Sales,Meets,Female,40,30,0,10,5,3.2,2.5,1,1,1,1,4.7,1.8,2.8
3697,0,Middle East & Africa,HR,Data Science,Exceeds,Male,37,10,0,6,1.4,3.2,2.7,1,1,1,1,1,4.1,1.2
3698,0,Latin America,HR,Data Science,Exceeds,Non-Binary/Other,36,5,1,12,,3.4,3,1,1,1,1,3.6,4.1,2.8
3699,0,Asia Pacific,HR,Pharmacovigilance,Meets,Female,35,12,1,7,,3.8,3.9,1,1,1,1,4.4,3.8,3
3700,0,Asia Pacific,R&D,Pharmacovigilance,Far Below,Male,33,18,0,11,4.2,4,1.6,1,1,1,1,5,4.1,3.6
3701,0,Latin America,Digital,IT & Digital,Meets,Female,40,6,0,6,3,2.6,2.3,1,1,1,1,3.9,2.6,2.9
3702,0,Latin America,Finance,Finance & Accounting,Meets,Male,37,29,0,9,4.1,2,1.2,1,1,1,1,4.6,2.3,2.4
3703,0,Latin America,Commercial,Human Resources,Meets,Male,35,11,1,8,,4,2.2,1,1,1,1,2.3,5,1.4
3704,0,Asia Pacific,HR,Medical Affairs,Meets,Male,29,16,0,8,2.9,2.2,1,1,1,1,1,2.7,4.4,1
3705,0,Latin America,Commercial,Human Resources,Far Exceeds,Female,41,6,0,12,3.4,1.5,2.2,1,1,1,1,3.8,2,1.7
3706,0,North America,Commercial,Clinical Operations,Meets,Male,42,23,0,9,3.9,3.4,4,1,1,1,1,2.4,2.3,2.8
3707,0,Middle East & Africa,HR,Finance & Accounting,Meets,Female,32,29,1,5,,2.8,2.5,1,1,1,1,4.4,2.6,2.9
3708,0,Middle East & Africa,Digital,Market Access,Meets,Female,39,8,0,11,3.7,1.7,3,1,1,1,1,3.3,1.7,2.5
3709,0,Europe,Commercial,Sales,Below,Female,35,20,1,10,,1.7,1.8,1,1,1,1,1.4,2,1.6
3710,0,Europe,Manufacturing,Legal & Compliance,Below,Male,42,15,0,12,2.5,3,3.3,1,1,1,1,4.1,3.6,1.9
3711,0,Middle East & Africa,Commercial,Quality Assurance,Exceeds,Male,35,9,1,9,,2.7,2.7,1,0,0,0,3.4,2.1,1.7
3712,0,North America,Finance,Market Access,Meets,Male,35,18,0,8,4.2,3.5,2.3,1,1,1,1,5,3.4,2.7
3713,0,Asia Pacific,HR,Communications,Meets,Male,39,8,0,7,4.5,3.4,4,1,1,1,1,5,2.3,4.2
3714,0,Asia Pacific,R&D,Communications,Meets,Female,35,30,0,6,2.5,3.4,2.3,1,1,1,1,2.4,3,2
3715,0,North America,Commercial,Medical Affairs,Exceeds,Female,35,6,0,7,2.6,2.3,4,1,1,1,1,2.7,1,4.5
3716,0,Asia Pacific,Digital,Market Access,Meets,Male,34,10,0,10,2.7,2.9,1.9,1,1,1,1,3.7,2.2,1
3717,0,Latin America,Manufacturing,Market Access,Far Below,Female,35,18,0,9,3.6,3.5,3.7,0,0,0,0,2.8,3.9,2
3718,0,Middle East & Africa,Manufacturing,Medical Affairs,Meets,Male,36,11,0,11,4.6,2.9,4,1,1,0,0,4.7,3.1,3.3
3719,0,Middle East & Africa,R&D,Finance & Accounting,Meets,Male,38,5,0,7,3.4,4.1,1.1,1,1,1,1,5,3.1,1
3720,0,North America,Finance,IT & Digital,Meets,Female,37,5,0,11,1.7,2.6,1,1,1,1,1,2.8,2.6,1.8
3721,0,Asia Pacific,R&D,Legal & Compliance,Meets,Female,41,1,1,8,,3.6,3.6,1,0,0,0,2.1,3.4,3
3722,0,Europe,Finance,Pharmacovigilance,Below,Female,31,3,0,6,3.3,3.2,2.7,1,1,1,1,3.4,2.1,4.4
3723,1,Europe,Commercial,Communications,Far Exceeds,Female,51,11,0,10,4.4,2.4,3.4,1,1,1,1,4.2,1,3
3724,0,Asia Pacific,HR,Pharmacovigilance,Meets,Male,38,15,0,12,3.6,3.9,2.1,1,1,1,1,5,4,1.9
3725,1,Europe,Digital,Supply Chain,Meets,Female,44,15,0,5,3.6,2.5,4.3,1,1,1,1,3.6,4.3,3.2
3726,0,North America,Manufacturing,Market Access,Meets,Female,41,25,1,10,,3.6,3.6,1,1,1,1,2.9,4.7,4
3727,0,North America,R&D,Quality Assurance,Meets,Female,39,6,1,5,,3.9,3.4,1,1,1,1,3.4,1.7,1.3
3728,0,Asia Pacific,Digital,IT & Digital,Meets,Non-Binary/Other,41,5,0,8,3.3,3.9,2.2,1,1,1,1,3.2,3.3,3
3729,0,Europe,Finance,IT & Digital,Far Below,Male,40,7,0,9,3.6,3.1,2.8,1,1,1,1,2.5,2.9,4
3730,0,North America,HR,Medical Affairs,Meets,Female,37,3,1,10,,1.9,3.7,1,1,1,1,2.9,4.4,2.7
3731,0,North America,Manufacturing,Quality Assurance,Meets,Male,52,7,0,10,1.7,3.4,2.7,0,0,0,0,3,4.7,1.4
3732,1,Latin America,Manufacturing,Legal & Compliance,Exceeds,Female,45,33,0,8,4.1,4.7,2.9,1,1,1,1,5,3.9,2.4
3733,0,Latin America,Finance,Marketing,Meets,Female,28,17,0,12,3.5,4.8,1.9,1,1,1,1,1.9,3,5
3734,0,North America,HR,Finance & Accounting,Meets,Male,44,14,1,9,,2.4,2.7,1,1,1,1,4.7,2.6,2.4
3735,0,Asia Pacific,Manufacturing,Data Science,Meets,Non-Binary/Other,38,28,0,7,3.1,3.4,2.2,1,1,1,1,3.4,3.5,2
3736,0,Middle East & Africa,HR,Supply Chain,Meets,Male,48,10,0,9,3.6,2.3,1.8,1,1,1,1,2.7,3,2.6
3737,0,Middle East & Africa,Manufacturing,Data Science,Meets,Male,36,16,0,5,1.9,4.7,4.2,1,1,1,1,2.3,3.1,4.4
3738,0,North America,Commercial,Human Resources,Meets,Female,28,14,1,7,,3.8,3.3,1,1,1,1,3.7,3.7,2.8
3739,0,North America,Finance,Supply Chain,Meets,Male,36,16,0,12,4.5,3.3,2,1,1,1,1,3.6,1.7,3.3
3740,0,North America,HR,Sales,Exceeds,Male,28,14,1,9,,3.7,3.8,1,1,1,1,1.7,3.6,2.9
3741,0,Asia Pacific,Digital,Medical Affairs,Meets,Female,34,8,1,5,,1.2,1.1,1,1,1,1,3.1,1.8,2.1
3742,0,Latin America,Commercial,Data Science,Exceeds,Female,35,18,0,11,2.8,2.7,1.1,1,1,1,1,2.9,3.5,2.9
3743,0,North America,Digital,Quality Assurance,Meets,Female,40,3,1,8,,3.4,2.4,1,1,0,0,5,3.4,2.5
3744,0,North America,Finance,Medical Affairs,Exceeds,Female,40,4,1,9,,2.2,4,1,1,1,1,3.5,2.1,3
3745,0,Europe,Manufacturing,Quality Assurance,Below,Female,42,19,0,10,3.8,2.8,3.6,1,1,0,0,3.4,3.5,2.8
3746,0,Asia Pacific,Digital,Market Access,Meets,Female,41,9,0,6,4.6,3.5,1.5,1,1,1,1,4.3,3.4,2.1
3747,0,North America,Commercial,Data Science,Meets,Female,50,9,0,12,2.3,3.7,2.8,1,1,1,1,2.9,4.3,4
3748,0,Europe,HR,Market Access,Meets,Male,38,6,1,5,,2.8,4.3,1,1,1,1,4.6,5,3.8
3749,0,Middle East & Africa,R&D,Finance & Accounting,Below,Female,41,14,0,9,3.6,3.1,2.7,1,1,1,1,2.8,3.1,2.5
3750,0,North America,Digital,Pharmacovigilance,Far Below,Male,43,8,1,6,,2.2,3.4,1,1,0,0,5,2.2,4.4
3751,0,North America,R&D,Marketing,Meets,Male,34,9,0,6,3.5,2.5,3.6,1,1,1,1,3.4,2.4,3.1
3752,1,Europe,Finance,Communications,Meets,Female,30,5,0,10,4.4,3.8,3.7,1,1,1,1,5,4.8,4.1
3753,0,Asia Pacific,Digital,Sales,Meets,Female,40,11,1,7,,2.1,3,1,1,1,1,2.8,3.1,2.7
3754,0,North America,Digital,Sales,Meets,Male,36,9,1,5,,4.1,3.4,1,1,1,1,2.8,3.9,3
3755,0,Middle East & Africa,HR,Finance & Accounting,Meets,Male,43,22,0,9,1.9,4.1,4.6,1,1,1,1,1.8,3.2,5
3756,0,North America,Manufacturing,Data Science,Exceeds,Female,42,11,0,8,3.2,3.6,4,1,1,1,1,3.6,3.1,3.4
3757,0,Middle East & Africa,Commercial,Regulatory Affairs,Meets,Male,44,5,0,7,4.2,3.6,2.3,1,1,1,1,3.8,2.3,3
3758,0,Latin America,Commercial,Marketing,Meets,Male,33,14,0,7,3.4,1.9,1.9,1,1,1,1,4.7,2.8,2
3759,0,Latin America,Commercial,Human Resources,Meets,Female,35,24,0,7,4.1,3.7,1.8,1,1,1,1,5,2.9,3
3760,0,Middle East & Africa,Finance,Clinical Operations,Exceeds,Male,39,15,0,7,3.2,2.1,3,1,1,1,1,3.2,2.6,3.3
3761,0,Asia Pacific,Manufacturing,Communications,Exceeds,Male,37,8,0,12,1.8,1.4,1,0,0,0,0,1.6,3.5,2.9
3762,0,North America,R&D,Communications,Far Below,Female,41,12,1,5,,3.4,2,0,0,0,0,3.3,3.7,1.2
3763,0,North America,Commercial,Legal & Compliance,Exceeds,Female,46,7,1,8,,4.8,3,1,1,1,1,3,4.7,4
3764,0,Latin America,R&D,Supply Chain,Meets,Male,37,20,0,7,2.9,2.4,3.9,1,0,0,0,4.1,2.2,1.6
3765,0,Middle East & Africa,Manufacturing,Communications,Meets,Female,30,13,0,11,2,3.6,4.2,1,1,1,1,2.6,4.6,3.5
3766,0,North America,Finance,Sales,Meets,Male,28,8,0,11,4,3.5,2.2,1,1,1,1,3.4,2.6,1
3767,0,North America,Manufacturing,Medical Affairs,Meets,Female,30,9,0,9,4,3.2,3.5,1,1,1,1,1.7,2.9,2.5
3768,0,Asia Pacific,HR,Pharmacovigilance,Meets,Male,30,5,0,12,3.7,1.7,1.8,1,1,1,1,3.5,2.8,1.2
3769,0,Europe,Commercial,Market Access,Meets,Female,42,17,0,5,2.5,3.3,3.7,1,1,1,1,2.6,3.3,3.1
3770,0,Latin America,Finance,Clinical Operations,Meets,Female,38,7,1,5,,4.6,3.3,1,1,1,1,3.9,5,3.9
3771,0,Latin America,HR,Human Resources,Meets,Female,38,27,1,6,,4,4.1,1,1,1,1,1.4,5,4.8
3772,0,Europe,Commercial,Communications,Meets,Male,42,17,0,9,1.9,1.3,4.5,1,1,1,1,3.2,1.2,3.4
3773,0,North America,Manufacturing,Medical Affairs,Far Below,Female,46,11,0,9,3.5,4.2,1.6,1,1,1,1,3.9,3.1,1
3774,0,Asia Pacific,Manufacturing,Data Science,Far Below,Male,37,12,0,6,4,3.1,2.3,1,1,1,0,3.4,3.1,1.3
3775,0,Asia Pacific,Digital,Marketing,Meets,Male,42,19,0,8,3.7,4.3,3.2,1,1,1,1,3.6,4.1,1.7
3776,0,Latin America,Digital,Sales,Exceeds,Male,40,2,0,7,2.4,1.7,2.1,1,1,1,1,3.8,2.2,1.6
3777,0,Asia Pacific,Manufacturing,Supply Chain,Meets,Female,29,13,0,7,4.1,2.5,3.7,1,1,1,1,3.8,2.2,2.2
3778,0,Europe,Manufacturing,Finance & Accounting,Meets,Male,29,2,1,11,,3.2,2.7,1,1,1,1,4.3,3.1,3.3
3779,0,North America,R&D,Clinical Operations,Meets,Non-Binary/Other,36,7,1,9,,4.3,4.2,1,1,1,1,3.3,2.3,3.3
3780,0,Europe,R&D,Finance & Accounting,Meets,Male,39,12,1,10,,2.9,2.5,1,1,1,1,2.9,2.1,4.3
3781,0,Middle East & Africa,HR,Sales,Far Exceeds,Female,41,11,0,9,2.8,2.6,2.9,1,1,1,1,3.3,1.9,1.5
3782,0,Latin America,Digital,Legal & Compliance,Meets,Male,37,13,0,8,2.5,3,3.3,1,1,1,0,1.1,3.3,2.9
3783,0,Asia Pacific,Digital,Regulatory Affairs,Meets,Male,28,4,1,8,,4.9,1,1,1,1,1,2.3,3.3,1.4
3784,0,Middle East & Africa,Manufacturing,Regulatory Affairs,Meets,Male,36,12,0,7,3.7,2.2,3.3,0,0,0,0,4.1,2,3.7
3785,0,Asia Pacific,Manufacturing,Human Resources,Exceeds,Non-Binary/Other,28,7,0,12,3.6,2.7,1.7,0,0,0,0,4.8,2.4,2.9
3786,0,North America,HR,Communications,Below,Male,37,19,0,6,2.9,2.1,2.8,1,1,1,1,4,2.6,2.9
3787,0,North America,Finance,Human Resources,Meets,Female,41,13,0,6,3.3,3.6,1.9,1,1,1,1,5,2.5,3.5
3788,0,North America,Finance,Regulatory Affairs,Meets,Male,41,7,1,7,,2.1,1.4,1,1,1,1,2.1,4,1
3789,0,Asia Pacific,Finance,Pharmacovigilance,Meets,Female,35,23,0,5,3.1,3.2,2.3,1,1,1,1,3.9,2.8,3
3790,0,Middle East & Africa,Digital,Market Access,Below,Male,40,16,0,10,3.1,2.4,3.2,1,1,1,1,2.2,3.4,1.9
3791,0,North America,R&D,Data Science,Meets,Male,31,15,0,6,2.7,3.5,3.4,1,1,1,1,3.6,3.3,1.8
3792,0,Middle East & Africa,Finance,Medical Affairs,Meets,Female,34,15,0,7,3.5,3.3,1.8,1,1,1,1,3.6,4,3.4
3793,0,Asia Pacific,Commercial,Communications,Exceeds,Male,28,10,0,5,3.3,3.9,1.2,1,1,1,1,3.2,1,2.2
3794,0,Middle East & Africa,HR,Sales,Meets,Female,35,7,1,12,,3.6,1.9,1,1,1,1,3.5,2.4,2.5
3795,0,Asia Pacific,Finance,Legal & Compliance,Below,Male,33,4,1,10,,4.3,2,1,1,1,0,3.3,3.3,3.4
3796,0,Asia Pacific,Commercial,Medical Affairs,Meets,Female,36,7,1,9,,5,2.2,1,0,0,0,3.2,5,3.4
3797,0,Latin America,Finance,Medical Affairs,Meets,Male,36,8,0,11,4,5,2.4,1,1,1,1,4.7,4.2,3.1
3798,0,Asia Pacific,R&D,Sales,Meets,Male,39,6,1,12,,3.5,4,1,1,1,1,2.1,2.1,3.8
3799,0,Asia Pacific,R&D,Market Access,Meets,Female,28,3,1,8,,3.3,1.6,1,1,1,1,3.1,2,3.3
3800,0,Europe,Finance,Communications,Below,Male,33,19,0,9,3.8,2.8,3.6,1,1,1,1,3.1,3.7,3.3
3801,0,North America,Commercial,Pharmacovigilance,Meets,Female,44,30,0,6,5,2.9,1.7,0,0,0,0,5,3.6,1.9
3802,0,Latin America,HR,IT & Digital,Meets,Female,44,5,0,7,2.6,3.4,2,1,1,0,0,2.6,3,2.4
3803,0,Latin America,Commercial,Pharmacovigilance,Exceeds,Female,38,17,1,8,,2.2,3.9,1,1,1,1,2.9,1,3
3804,0,Latin America,HR,Legal & Compliance,Meets,Male,38,23,0,11,3.1,3.7,2.8,1,1,1,1,3.6,4.2,2.7
3805,0,Europe,Finance,Legal & Compliance,Below,Female,31,17,0,9,3.2,1.4,2.5,1,1,1,1,3.1,2.9,2.1
3806,0,Asia Pacific,HR,Marketing,Meets,Male,36,8,0,7,3.2,3.2,2.3,1,1,0,0,3.1,3.6,3.1
3807,0,North America,Manufacturing,Human Resources,Exceeds,Male,43,16,0,7,3.6,2.3,2,1,1,1,1,4.5,1.3,2.2
3808,0,Middle East & Africa,Digital,IT & Digital,Exceeds,Female,31,11,1,6,,2.8,3.5,1,1,1,1,3.8,4,2.8
3809,0,Asia Pacific,Digital,Legal & Compliance,Exceeds,Male,39,10,0,10,4,3.7,2.9,1,1,1,1,3.8,3.6,3.5
3810,0,Europe,R&D,Data Science,Meets,Male,41,3,1,11,,2.1,1.9,1,1,1,1,2.6,2.9,1.1
3811,0,Asia Pacific,Manufacturing,Marketing,Meets,Female,38,6,0,8,1.6,2.5,3.6,1,1,1,1,1.9,2.4,3.8
3812,0,Asia Pacific,Digital,Market Access,Meets,Male,37,27,0,6,4.6,2,2.3,1,1,1,1,3.6,3.7,2.1
3813,0,Europe,Finance,Medical Affairs,Below,Male,37,6,1,12,,4.3,4,1,1,1,1,2.8,3.1,3.2
3814,0,Latin America,HR,Data Science,Far Below,Male,41,5,1,10,,1.2,2.3,1,1,1,1,4.5,2.8,1.7
3815,0,Latin America,HR,Marketing,Meets,Male,39,3,1,7,,2.7,1.9,1,1,1,1,5,2.3,1.6
3816,0,North America,Commercial,Communications,Meets,Male,41,8,0,5,4.7,3.9,2.2,1,1,1,1,3.8,3,1.1
3817,0,North America,Commercial,Human Resources,Exceeds,Male,36,9,0,5,4.7,4.2,3.8,1,1,1,1,5,3.9,3.5
3818,0,Latin America,HR,Marketing,Below,Male,36,9,0,6,4.2,4.2,3,1,1,0,0,5,1.7,1.7
3819,0,Middle East & Africa,Finance,Regulatory Affairs,Exceeds,Female,41,8,0,9,4.7,3.8,2.6,1,1,1,1,3.1,5,2
3820,0,Asia Pacific,HR,Pharmacovigilance,Meets,Male,33,7,1,10,,2.3,2,1,1,1,1,3.8,3.1,2.1
3821,0,Middle East & Africa,Commercial,Quality Assurance,Meets,Female,31,3,0,7,5,3.3,5,1,1,1,0,5,4.1,3.2
3822,0,Asia Pacific,Digital,Marketing,Meets,Female,52,3,0,8,3.1,1.4,3.1,1,1,1,1,3.6,1,3.4
3823,1,Latin America,R&D,Clinical Operations,Meets,Male,41,11,1,8,,2.4,4.3,1,1,1,1,2.6,1.9,4.3
3824,0,North America,Commercial,IT & Digital,Meets,Male,37,9,0,9,2.1,2.1,3.5,1,1,1,1,2,1.5,2.4
3825,0,North America,Finance,Regulatory Affairs,Meets,Female,34,16,0,8,3,2.6,1.8,1,1,1,1,1.2,4,1.9
3826,0,Middle East & Africa,Digital,Communications,Meets,Male,32,10,0,6,1.3,3,3.6,1,1,1,1,3.1,2.4,2.6
3827,0,North America,Digital,Medical Affairs,Exceeds,Female,38,11,0,8,3.1,1.9,2.7,1,1,1,1,3.1,3.2,3.5
3828,0,Latin America,Digital,Supply Chain,Meets,Male,37,2,0,12,3.3,4.4,2.9,1,1,1,1,3.1,3.9,4.5
3829,0,Middle East & Africa,Manufacturing,Pharmacovigilance,Meets,Male,41,12,0,7,3.8,1.9,3.7,1,1,1,1,2.9,2.6,2.6
3830,0,Asia Pacific,Manufacturing,Market Access,Meets,Male,30,3,0,6,2.9,3.4,3.7,1,1,1,1,3.5,4.4,2.6
3831,0,North America,Digital,Sales,Far Exceeds,Male,30,5,0,10,2.4,1.5,1.5,1,1,1,1,3.4,1.9,1.5
3832,0,Europe,Finance,Market Access,Meets,Male,40,25,0,12,3.4,3.2,2.3,1,1,1,1,2.9,3.2,2.6
3833,0,North America,HR,Regulatory Affairs,Far Exceeds,Male,40,5,1,11,,1.9,4,1,1,1,1,3.5,2.1,5
3834,0,Asia Pacific,Finance,Communications,Meets,Male,43,24,0,10,3.5,4.3,1.5,1,1,1,1,2.3,3.1,1.3
3835,0,Middle East & Africa,Manufacturing,Finance & Accounting,Meets,Female,48,10,0,5,1.6,3,3.2,1,1,1,1,2.8,3.1,3.8
3836,0,Asia Pacific,Commercial,Human Resources,Far Below,Male,36,20,0,11,3.9,2.6,2.7,1,1,1,1,3.5,2.1,2.1
3837,0,Europe,Manufacturing,Human Resources,Meets,Female,42,9,1,5,,3.6,1.5,1,1,0,0,4,4.5,2.5
3838,0,Latin America,HR,Human Resources,Meets,Male,32,3,1,8,,3,2,1,1,1,1,3.1,2.5,1
3839,0,North America,R&D,Clinical Operations,Far Below,Male,28,19,0,9,4.4,3.7,3.3,1,1,1,1,3.5,4.2,3.6
3840,0,Middle East & Africa,Manufacturing,Market Access,Meets,Male,32,8,0,11,4.2,4,2.2,1,1,1,1,4.6,3,2
3841,0,Latin America,Finance,Legal & Compliance,Far Exceeds,Female,35,4,0,5,3.3,2.9,3.8,1,1,1,1,4.1,2.8,2.7
3842,0,Asia Pacific,Finance,Finance & Accounting,Meets,Female,51,13,0,5,3.1,3,2.2,1,1,1,1,4.1,4.2,3.1
3843,0,Middle East & Africa,Digital,Legal & Compliance,Below,Male,28,14,0,7,3.8,1.9,3.4,1,1,1,1,3.9,3.1,2.1
3844,0,Latin America,Digital,Clinical Operations,Meets,Male,42,10,0,11,3.5,4,1,1,1,1,1,2.2,3.6,1
3845,0,Middle East & Africa,Digital,Sales,Far Below,Non-Binary/Other,34,9,1,9,,3.2,2.5,1,1,1,1,4.9,2.4,2.9
3846,0,Europe,R&D,Legal & Compliance,Meets,Female,41,15,0,10,2.8,3.7,2.3,1,1,1,1,2.9,3.9,1.2
3847,0,Europe,HR,Supply Chain,Meets,Male,38,11,1,5,,2.7,2.9,1,1,1,1,4.5,2.1,3.5
3848,0,North America,Commercial,Pharmacovigilance,Meets,Female,33,7,0,6,3.7,1.4,4.3,1,1,1,1,3.9,3.5,2.5
3849,0,North America,Finance,Pharmacovigilance,Meets,Male,44,13,0,12,3.6,2.3,3.2,1,1,1,1,3.6,2.9,2.8
3850,0,Europe,Finance,Quality Assurance,Below,Male,41,29,0,12,1.8,1,2.1,0,0,0,0,2,4.2,3.2
3851,0,Middle East & Africa,HR,Clinical Operations,Exceeds,Female,38,10,0,7,4.6,2.8,2,1,1,1,1,3.8,2.1,2.1
3852,0,Europe,R&D,Sales,Far Exceeds,Female,40,12,1,6,,4.2,2.1,1,1,1,1,3.8,3.1,3.4
3853,0,North America,Digital,Marketing,Far Below,Male,35,8,1,11,,2.1,4.3,1,1,1,1,3,2.9,3.1
3854,0,Europe,HR,Marketing,Exceeds,Female,28,11,0,7,2.8,4.8,1.6,0,0,0,0,4.2,3.9,1.9
3855,0,Europe,Commercial,Medical Affairs,Meets,Female,39,11,0,7,2.8,2.1,4.6,1,1,1,0,2.3,3.7,3.3
3856,0,Middle East & Africa,Digital,Clinical Operations,Meets,Male,51,13,0,7,3.1,1.4,1,1,1,1,1,3.6,1.9,1.2
3857,0,Latin America,Commercial,Data Science,Meets,Male,43,24,0,7,3.2,2,2,1,1,1,1,4.4,4.4,2.6
3858,0,North America,Manufacturing,Market Access,Meets,Male,40,11,0,12,2.8,3.7,4.5,1,1,1,1,3.1,2.5,5
3859,0,Middle East & Africa,Commercial,Communications,Far Exceeds,Male,40,7,0,12,5,2.9,4.2,1,1,1,1,4.3,5,3.1
3860,0,Europe,Digital,Communications,Meets,Female,38,5,0,8,3.5,3.8,2.7,1,1,1,1,3.1,2.8,2.6
3861,0,Europe,Manufacturing,Medical Affairs,Below,Male,28,7,0,7,4,4.2,4.4,1,1,1,1,2.8,4,3.8
3862,0,Latin America,Digital,Medical Affairs,Meets,Male,32,23,0,9,4.2,2.1,3.9,1,1,1,1,3.5,3.8,4.7
3863,0,North America,Finance,Finance & Accounting,Meets,Female,38,19,1,8,,3.6,2.9,1,1,1,1,4.5,4,4.1
3864,0,North America,Digital,Medical Affairs,Exceeds,Non-Binary/Other,44,3,0,9,3.9,1.7,2.7,1,1,1,1,4.3,2.7,2.6
3865,0,Asia Pacific,Manufacturing,Legal & Compliance,Meets,Female,49,9,0,12,3.2,2.2,2.1,1,1,1,1,3.9,2.2,3.5
3866,0,North America,Commercial,Sales,Meets,Female,32,18,0,8,3.3,3.5,3.1,1,1,1,1,3.5,3.2,3.2
3867,0,Latin America,Finance,Finance & Accounting,Meets,Female,42,8,0,7,4,4,1.9,1,1,1,1,3.8,3.3,2.3
3868,0,Asia Pacific,R&D,Communications,Meets,Female,28,9,0,6,4.2,2.7,2.5,1,1,1,1,2.9,3.3,2.8
3869,0,Asia Pacific,R&D,Communications,Far Below,Male,36,15,0,7,2,3.5,3.6,1,1,1,1,3.3,3.2,2.9
3870,0,Europe,R&D,Human Resources,Meets,Male,38,12,1,8,,2.7,1.3,1,1,1,1,3.6,2.4,1.5
3871,0,Europe,R&D,Pharmacovigilance,Below,Female,48,9,0,12,5,5,4.1,1,1,1,1,4.3,3.3,3.8
3872,0,North America,HR,Medical Affairs,Exceeds,Male,33,3,1,7,,3.2,3.2,1,1,1,1,3.6,2.5,2.4
3873,0,Asia Pacific,R&D,Pharmacovigilance,Meets,Male,36,8,0,11,3.3,3.1,4.2,1,1,0,0,3.5,3.1,3.1
3874,0,Europe,Manufacturing,Pharmacovigilance,Exceeds,Female,44,5,0,11,4.2,2.2,1.5,1,1,1,1,4.8,4,2.5
3875,0,Latin America,R&D,Clinical Operations,Far Exceeds,Male,34,5,1,6,,3,3.1,0,0,0,0,4,1.6,2.9
3876,0,Europe,Digital,Sales,Exceeds,Male,35,6,0,8,3.7,3.4,2.4,1,1,1,1,5,2.3,4.6
3877,0,Europe,R&D,Pharmacovigilance,Below,Male,29,6,1,7,,2.9,1.6,1,1,1,1,4.3,2,1.2
3878,0,Asia Pacific,Commercial,Medical Affairs,Exceeds,Male,42,8,1,10,,2.5,1.7,1,1,1,1,3,1.4,1.6
3879,0,Asia Pacific,Manufacturing,Sales,Meets,Female,29,7,1,5,,3.7,3.3,1,1,1,1,2.7,3.1,4
3880,0,Middle East & Africa,Manufacturing,Medical Affairs,Meets,Female,44,14,1,12,,2.6,2.1,1,1,1,1,4.9,2.1,4.4
3881,0,Latin America,Finance,Finance & Accounting,Below,Female,31,23,0,9,3.7,4,3.6,1,1,1,1,4.3,4.9,3.8
3882,0,Asia Pacific,HR,Regulatory Affairs,Below,Female,33,4,0,5,3.5,2.5,2.6,1,1,1,1,4.2,2.5,2.1
3883,0,North America,Digital,Market Access,Far Exceeds,Female,31,5,1,6,,2.5,4.1,1,1,1,1,4.5,2.7,3.1
3884,0,Latin America,Manufacturing,Regulatory Affairs,Meets,Female,36,30,0,8,4.7,3.9,1,1,1,1,1,4,3.9,1
3885,0,Latin America,Commercial,Regulatory Affairs,Below,Male,44,8,1,9,,3.7,2.3,1,1,1,1,3.2,5,3.1
3886,0,Asia Pacific,R&D,Finance & Accounting,Meets,Female,34,11,0,9,2.9,4.5,3.5,1,1,1,1,3.4,4.2,3.1
3887,0,Latin America,Manufacturing,Clinical Operations,Exceeds,Female,32,18,0,12,3.1,2.2,1.6,1,0,0,0,2.6,2.5,1
3888,0,Asia Pacific,Commercial,Data Science,Meets,Female,38,12,0,8,3.7,3.2,2.4,0,0,0,0,3.7,4.6,2.6
3889,1,Europe,R&D,Communications,Exceeds,Female,38,15,1,9,,4,2.7,1,1,1,1,2.2,4,3.1
3890,1,Middle East & Africa,HR,Legal & Compliance,Meets,Male,42,5,0,12,5,4.3,3.8,1,1,1,1,4.2,3.3,2.5
3891,0,Europe,Manufacturing,Human Resources,Meets,Male,30,9,0,5,1.6,4.1,2,1,1,1,1,3,4.8,2
3892,0,Asia Pacific,Manufacturing,Market Access,Meets,Female,39,16,1,12,,3,3.7,1,1,1,0,1.7,3.6,3.1
3893,0,Asia Pacific,Commercial,Clinical Operations,Meets,Male,45,12,0,6,2.9,3.6,1.6,0,0,0,0,4.2,3.6,2.5
3894,1,Europe,Finance,Medical Affairs,Meets,Male,32,4,1,5,,1.8,3.3,1,1,1,1,4.8,1.3,3
3895,0,North America,Digital,Clinical Operations,Meets,Male,39,12,0,5,5,5,2,1,1,1,1,3.8,3.5,2.9
3896,0,North America,HR,Medical Affairs,Meets,Male,32,7,1,7,,3.5,2.6,0,0,0,0,3.3,5,4.8
3897,0,North America,Digital,Data Science,Meets,Male,45,29,0,5,3.6,3,2.7,1,1,1,1,3.7,4.1,3.6
3898,1,Asia Pacific,Manufacturing,Pharmacovigilance,Meets,Female,48,5,0,6,4.1,3.8,3.6,1,1,1,1,4.7,2.8,3.1
3899,0,Latin America,Digital,Clinical Operations,Meets,Non-Binary/Other,31,14,0,9,3.4,3.1,4.6,1,1,1,1,3.1,1.8,4
3900,0,Asia Pacific,R&D,Legal & Compliance,Below,Male,40,16,0,6,3.2,5,3.3,1,1,1,1,4.5,5,4.5
3901,0,Latin America,HR,Quality Assurance,Below,Male,40,9,1,5,,5,2.8,1,1,1,1,2.6,4.2,3.8
3902,0,Europe,Digital,Human Resources,Meets,Female,39,2,1,6,,2.5,3.5,0,0,0,0,2.5,3.2,3
3903,1,Middle East & Africa,R&D,Pharmacovigilance,Exceeds,Male,37,17,0,8,4.5,3.2,2.4,1,1,1,1,3.5,4,3.3
3904,0,Latin America,Commercial,IT & Digital,Meets,Female,35,11,0,8,3.1,3.1,3.2,1,1,1,1,2.2,4.8,4.1
3905,0,North America,Digital,Supply Chain,Below,Male,29,8,0,11,3.2,1.3,5,1,1,1,1,3.8,4.2,4.4
3906,0,Asia Pacific,HR,Clinical Operations,Meets,Non-Binary/Other,37,2,0,10,2.9,3.7,3,0,0,0,0,4.6,2.8,2.5
3907,0,Europe,R&D,Medical Affairs,Meets,Male,43,6,0,7,3.2,3.1,3.5,1,1,1,1,3.2,2.3,3.9
3908,0,North America,Digital,Market Access,Meets,Female,45,11,1,12,,3.8,1,1,1,1,1,5,3.5,2.9
3909,0,Europe,Commercial,Clinical Operations,Meets,Female,39,17,0,11,2.4,1.9,3.1,1,1,1,1,2.7,3.4,2.4
3910,1,Middle East & Africa,Digital,Medical Affairs,Meets,Female,32,7,0,5,3.9,4.3,2.3,1,1,1,1,3.7,3.3,2.1
3911,0,Asia Pacific,R&D,Communications,Meets,Female,30,14,0,12,3.5,3.1,2.9,1,1,1,1,3.8,2.4,3
3912,0,Asia Pacific,Digital,Data Science,Below,Female,34,26,0,8,3.9,1.6,2.3,0,0,0,0,3.4,2,3.4
3913,0,Middle East & Africa,HR,Regulatory Affairs,Below,Female,28,21,0,11,3.9,1.7,2.4,0,0,0,0,4.5,1,1.5
3914,0,Asia Pacific,Manufacturing,Clinical Operations,Meets,Female,28,6,0,5,2.6,3.1,1.8,1,1,1,1,2.6,4.4,3.7
3915,0,Latin America,R&D,Marketing,Meets,Female,30,15,0,7,3,2.6,2.7,1,1,1,1,4.2,3.3,1.6
3916,0,Europe,R&D,IT & Digital,Far Exceeds,Male,40,7,0,7,2.3,2.2,2.1,1,1,0,0,3.2,2,2.1
3917,0,North America,R&D,Supply Chain,Meets,Male,28,11,0,9,2.8,3.4,3.6,1,1,1,1,3.9,2.2,3
3918,0,Middle East & Africa,R&D,Marketing,Meets,Male,40,4,0,8,3,3.5,1.2,1,0,0,0,3.4,3.7,1.1
3919,0,Latin America,Digital,Pharmacovigilance,Below,Male,33,14,1,12,,3.3,3.8,1,1,1,1,3.8,4.6,3
3920,0,North America,HR,IT & Digital,Exceeds,Female,45,17,0,8,3.9,1.8,1.7,0,0,0,0,3.4,3.4,1.9
3921,0,North America,Commercial,Pharmacovigilance,Meets,Male,34,5,1,7,,3,4.1,1,1,1,1,3.9,4.2,4
3922,0,Middle East & Africa,HR,Regulatory Affairs,Meets,Female,35,7,0,8,2.3,3.2,2.3,0,0,0,0,2.3,3.5,4.4
3923,0,Latin America,R&D,Communications,Below,Female,33,22,0,11,5,1.9,1,1,1,1,1,3.7,1.5,1.4
3924,0,North America,Finance,Communications,Far Below,Female,34,15,0,11,3.6,3.5,1.7,1,1,1,1,4.4,3.2,3.2
3925,0,North America,Digital,Regulatory Affairs,Meets,Female,39,8,1,7,,3.3,2.2,1,1,1,1,2,2.9,2.2
3926,0,Latin America,Finance,Pharmacovigilance,Below,Male,40,6,0,12,2.6,1.5,4.6,1,1,1,1,2.7,2,2.2
3927,0,Asia Pacific,Digital,Clinical Operations,Below,Non-Binary/Other,38,10,0,10,2,2.2,2,1,1,1,1,2.5,4.6,3.3
3928,0,North America,R&D,Sales,Below,Male,30,12,0,12,3.2,3,3.7,1,1,1,1,3.6,2.4,3
3929,0,Europe,Digital,Clinical Operations,Below,Female,40,12,0,8,3.4,3.8,2.1,0,0,0,0,2.5,3.6,2.8
3930,0,Latin America,R&D,Supply Chain,Meets,Male,31,12,0,8,4.4,1,2.2,1,1,1,1,4.6,1.1,3.1
3931,0,North America,HR,Pharmacovigilance,Meets,Male,31,8,0,5,2.2,4.2,3.3,1,1,1,1,3,3.4,3.4
3932,0,Middle East & Africa,Manufacturing,Marketing,Meets,Female,35,6,1,7,,2.8,3.4,1,1,1,1,3.9,2.4,3.2
3933,0,Europe,Digital,Legal & Compliance,Meets,Female,43,12,0,11,3.6,4.2,2.5,1,1,1,1,3.3,5,3.1
3934,1,North America,R&D,Regulatory Affairs,Exceeds,Male,31,19,0,5,3.9,1,3.1,1,1,1,1,4.5,1.5,3.6
3935,0,Europe,Finance,Marketing,Exceeds,Female,40,4,0,8,4.3,2.2,1.3,1,1,1,1,3.7,3.1,2
3936,0,Europe,R&D,Pharmacovigilance,Meets,Male,28,13,0,5,1.7,3.7,4,1,1,1,1,3.4,3.7,3.6
3937,0,Asia Pacific,Finance,Data Science,Meets,Male,41,18,0,9,3.5,4.1,1.2,1,1,1,1,3.2,2.8,2.1
3938,0,Europe,Digital,Pharmacovigilance,Meets,Female,44,2,1,6,,4.4,2.3,1,1,1,1,4.5,4.1,3
3939,0,Asia Pacific,Commercial,Quality Assurance,Meets,Female,42,36,0,10,4,4,2.9,1,1,1,1,3.1,4,2.7
3940,0,Latin America,Finance,Communications,Meets,Female,38,10,0,11,3.3,3.1,3.7,1,1,1,1,3.7,2.7,2
3941,0,Asia Pacific,R&D,Finance & Accounting,Meets,Female,34,7,1,12,,3.7,1.8,1,1,1,1,3.2,4,2.2
3942,0,Middle East & Africa,Digital,IT & Digital,Meets,Female,32,20,0,11,4.5,4.4,1.3,1,0,0,0,3.3,4.7,1.7
3943,0,North America,R&D,Supply Chain,Meets,Male,33,10,0,6,3.2,4.1,3.7,1,0,0,0,3.8,3.7,3.6
3944,0,Latin America,Commercial,Quality Assurance,Exceeds,Male,34,5,0,10,3.4,2.7,3.1,1,1,1,1,2.2,2.7,2.5
3945,0,Latin America,Manufacturing,Market Access,Exceeds,Male,44,10,0,12,3.2,3.8,3.4,1,1,1,1,3.3,3.2,3.7
3946,0,Middle East & Africa,Commercial,Marketing,Meets,Female,37,9,1,10,,3.1,3.5,1,1,1,1,3.2,1.4,5
3947,0,Asia Pacific,HR,Data Science,Meets,Male,43,9,0,12,2.2,4.4,3.3,0,0,0,0,2.2,3.5,3.4
3948,0,North America,Digital,Supply Chain,Meets,Male,55,14,1,5,,2.6,2.5,1,1,1,1,3.3,2.8,1.8
3949,0,Asia Pacific,Commercial,Medical Affairs,Exceeds,Female,48,6,0,7,3.9,3.8,3.1,1,1,1,1,1.9,3,3.9
3950,0,Europe,Manufacturing,Human Resources,Below,Male,38,33,0,7,3.8,4.1,1.6,1,1,1,1,3.1,3.6,1.5
3951,0,Asia Pacific,R&D,Market Access,Meets,Female,35,12,1,6,,2.2,4.5,1,1,1,1,4,3.6,2.4
3952,0,Latin America,Digital,Legal & Compliance,Meets,Male,43,13,0,12,3.3,2.6,2,1,1,1,1,4.3,2.2,2.2
3953,0,North America,Finance,Sales,Meets,Female,43,17,0,11,1.8,4.9,2.1,1,1,1,1,1.2,4.7,2.8
3954,0,Asia Pacific,Commercial,Quality Assurance,Meets,Male,41,23,0,9,4.2,3.8,2.7,1,1,1,1,3.7,4.4,1.9
3955,1,North America,Manufacturing,Communications,Exceeds,Male,47,7,1,5,,4.5,3.2,1,1,1,1,3.9,3.8,3.4
3956,0,North America,Commercial,Supply Chain,Below,Female,32,6,0,8,2.2,2.5,2.4,1,1,1,0,1.9,1.8,2.5
3957,0,Europe,HR,Supply Chain,Meets,Female,40,5,0,9,3.3,2.3,4.4,1,1,1,1,4.8,1.7,4.8
3958,1,Europe,Digital,Quality Assurance,Exceeds,Male,38,4,1,11,,3.3,3.4,1,1,1,1,3.9,2.7,3.2
3959,1,Latin America,R&D,Market Access,Exceeds,Male,42,25,0,7,4.6,2.6,1.9,1,1,1,1,4.7,1.5,3.2
3960,1,Middle East & Africa,Manufacturing,Data Science,Meets,Male,35,11,0,6,4.1,1,3.8,1,1,1,1,5,4.1,4.4
3961,0,North America,Commercial,Data Science,Meets,Male,40,7,0,9,3.9,4.4,2.5,1,0,0,0,3.2,1.7,2.9
3962,0,Middle East & Africa,Digital,Regulatory Affairs,Far Exceeds,Female,28,12,0,8,3.7,4.7,2.6,1,1,1,1,3.6,5,1.9
3963,0,Latin America,Commercial,Communications,Meets,Female,38,9,0,5,1,4.4,4.6,1,1,1,1,2.5,4.9,3.9
3964,0,North America,Digital,Clinical Operations,Meets,Male,48,17,0,12,3.7,4.7,1,1,1,1,1,3.8,2.8,2.3
3965,0,North America,HR,Market Access,Meets,Male,35,7,0,8,4.2,3.7,3.6,1,1,1,1,3.6,3.9,2
3966,0,Middle East & Africa,Commercial,Marketing,Far Below,Female,37,22,0,12,2,2.8,2,1,1,1,1,2.2,3.8,1.6
3967,0,Asia Pacific,HR,Marketing,Meets,Male,44,9,0,9,3.5,5,3,1,1,1,1,3,1.8,1.8
3968,0,Europe,Finance,Finance & Accounting,Meets,Female,41,13,0,5,2,4.5,1.1,1,1,1,1,2.6,3.2,1
3969,0,Asia Pacific,Finance,Market Access,Meets,Female,28,8,0,12,4,3.9,3.5,1,1,1,1,2.9,3.6,1.4
3970,0,Middle East & Africa,Manufacturing,IT & Digital,Far Below,Male,37,27,0,5,2.5,1,3.2,1,1,1,1,2.5,1.7,3.7
3971,0,Europe,HR,Quality Assurance,Exceeds,Male,40,7,0,7,5,3.3,3.8,1,1,1,1,4.6,3.4,2.6
3972,0,Asia Pacific,Digital,Legal & Compliance,Meets,Male,46,11,0,7,4,2.8,4.1,1,1,1,0,2.5,3.1,2.1
3973,0,Europe,Manufacturing,Marketing,Meets,Female,45,11,1,12,,3.4,3.3,1,1,1,1,3.1,2.6,2.3
3974,0,North America,Commercial,Marketing,Far Exceeds,Female,38,6,0,6,3.3,2.3,2.3,1,1,1,1,3,3.3,3.1
3975,0,Asia Pacific,Commercial,Clinical Operations,Meets,Female,42,11,0,10,4,3.5,2,1,1,1,1,3.7,5,2.9
3976,0,Europe,Digital,IT & Digital,Meets,Non-Binary/Other,38,2,1,8,,2.4,1,0,0,0,0,3.2,3.7,3
3977,0,Europe,R&D,Supply Chain,Meets,Female,35,15,0,5,3.6,3.8,2.8,1,1,1,1,3.4,3.8,2.8
3978,0,Europe,R&D,Supply Chain,Meets,Female,45,15,0,8,2.3,2.1,2.4,1,1,1,1,2.2,5,2.6
3979,0,Asia Pacific,Commercial,Market Access,Meets,Male,44,9,0,11,4,3.4,2,1,1,1,1,3.5,2.4,2.7
3980,0,Latin America,Digital,Pharmacovigilance,Meets,Male,40,3,0,9,2.9,3.3,1.5,1,1,0,0,2.6,2.3,2.7
3981,0,Asia Pacific,R&D,Legal & Compliance,Meets,Male,34,6,1,12,,3.4,2.6,0,0,0,0,3.1,3.5,2.1
3982,0,Middle East & Africa,HR,Communications,Meets,Female,38,4,0,12,3.2,2.8,2.1,1,1,1,1,4.3,2.4,3.2
3983,0,Asia Pacific,Commercial,IT & Digital,Meets,Male,38,15,0,12,3,2.6,2.9,1,1,1,1,4.5,2.3,3.7
3984,0,Europe,Finance,Supply Chain,Exceeds,Female,44,15,0,8,3.5,4.3,2.4,1,1,1,1,2.3,2.7,3.1
3985,0,North America,HR,Quality Assurance,Meets,Female,36,1,1,9,,3.2,3.5,1,1,1,1,3.7,2.6,1.9
3986,0,Asia Pacific,Digital,Medical Affairs,Exceeds,Male,38,5,1,5,,2.7,1.5,1,1,1,1,3.1,4.2,2.8
3987,0,Asia Pacific,Finance,Pharmacovigilance,Meets,Female,39,9,0,5,3.7,2.8,2.1,1,1,1,1,3.7,2,2.2
3988,0,Europe,HR,Communications,Meets,Male,36,11,0,5,3.8,3.6,4,1,1,1,1,4.7,3.3,3.8
3989,0,North America,R&D,Legal & Compliance,Far Exceeds,Male,40,17,0,6,1.9,2.4,2.6,1,1,1,1,2.1,1.2,1.8
3990,0,North America,R&D,Clinical Operations,Far Exceeds,Female,39,17,0,8,3.1,2.8,4,1,1,1,1,3.7,2.9,3.5
3991,0,Middle East & Africa,Finance,Quality Assurance,Meets,Female,33,17,0,8,3.4,2.6,3.1,1,1,1,1,2.4,3.8,4
3992,0,Asia Pacific,Manufacturing,Data Science,Exceeds,Male,35,6,1,7,,4.6,2.8,1,1,1,1,3.4,2.9,2.3
3993,0,North America,Commercial,Legal & Compliance,Meets,Male,30,6,0,9,3.7,2.8,3,1,1,1,1,5,4,1.4
3994,0,North America,Finance,Clinical Operations,Below,Male,34,15,0,9,3.3,2.1,2.2,1,1,1,1,4.2,2.4,1.7
3995,0,Latin America,Digital,Regulatory Affairs,Meets,Male,47,19,0,11,3.2,1.9,1.8,1,1,1,1,2.8,3.1,3.4
3996,0,Latin America,Commercial,Communications,Far Exceeds,Non-Binary/Other,42,5,1,6,,2.6,3.8,1,1,1,1,2.9,4,2
3997,0,North America,HR,Marketing,Far Exceeds,Male,33,15,1,10,,2.8,3.4,1,1,1,1,3,3.1,3.4
3998,0,Middle East & Africa,Digital,Sales,Below,Female,37,16,0,10,4.2,3.2,3.6,1,1,1,1,3.4,2.8,4.6
3999,0,North America,Digital,Legal & Compliance,Meets,Female,33,8,0,10,4.5,2.4,4.5,1,1,1,1,2.3,3.8,4.1
4000,0,Europe,R&D,Data Science,Exceeds,Male,42,21,0,6,2.6,3.1,2.7,1,1,1,1,2.2,4.2,4
4001,0,Asia Pacific,HR,Pharmacovigilance,Meets,Male,40,7,0,9,3.2,4.6,3.5,1,1,1,1,2.6,4.5,3.6
4002,0,Middle East & Africa,R&D,Quality Assurance,Meets,Female,42,19,0,8,2.5,3,1.5,1,1,1,1,3.3,4.9,1.5
4003,0,Europe,R&D,Finance & Accounting,Meets,Male,36,11,0,11,3.2,4.2,3.8,1,1,1,1,3,4.2,4.2
4004,0,Middle East & Africa,Manufacturing,Data Science,Meets,Female,44,23,0,9,3.5,3.3,1.3,1,1,1,1,3.8,4.4,2
4005,0,Europe,R&D,Regulatory Affairs,Meets,Male,31,29,0,6,3.4,2.4,2.1,1,1,1,1,4.2,2.8,2.4
4006,0,Asia Pacific,Commercial,Quality Assurance,Meets,Male,34,11,0,11,1.1,2.5,2.1,1,1,1,1,3.3,2.5,2.8
4007,0,Asia Pacific,Digital,Legal & Compliance,Meets,Male,36,11,0,9,4.3,3.5,3.3,0,0,0,0,3.3,3.1,4.3
4008,0,Latin America,R&D,Communications,Below,Male,43,12,0,11,2.9,1.3,2.3,1,1,1,1,4.1,2.1,2.2
4009,0,Europe,Finance,Sales,Meets,Female,35,8,0,8,2.3,3.3,2.4,1,1,1,1,1.5,3.4,3.6
4010,0,Latin America,Commercial,Communications,Meets,Non-Binary/Other,32,10,0,7,2.6,2,2.4,1,1,0,0,2.4,1.2,2.6
4011,0,Europe,HR,Pharmacovigilance,Meets,Male,38,20,0,8,4.2,4.1,2.9,1,1,1,1,5,2.3,3.5
4012,0,Latin America,Digital,Clinical Operations,Meets,Male,53,12,0,12,3.9,4.3,2.9,1,1,1,1,3.9,2.3,2.6
4013,0,Asia Pacific,Finance,Market Access,Below,Male,32,24,1,10,,2.8,2.1,0,0,0,0,3.7,3.5,2.8
4014,0,Middle East & Africa,Finance,Data Science,Exceeds,Male,45,15,0,6,3.2,5,3.4,1,1,1,1,4.1,5,2.5
4015,0,Latin America,HR,Sales,Meets,Female,38,25,0,9,2.2,2.4,2.5,1,1,1,1,3.4,2.2,3.3
4016,0,Europe,Finance,Regulatory Affairs,Meets,Female,38,11,0,9,4.2,2.2,2.7,1,1,1,1,3.4,2.4,2.8
4017,0,Europe,Commercial,Data Science,Below,Male,34,18,0,7,4.1,2.8,3.8,1,1,1,1,4.2,1.9,3.3
4018,0,Asia Pacific,HR,Medical Affairs,Below,Female,42,8,0,10,4.4,1,2.8,1,1,1,1,4.1,2.6,3.7
4019,0,Europe,Finance,Medical Affairs,Exceeds,Female,44,16,0,8,3.5,3,1.9,0,0,0,0,2.4,3.7,2.8
4020,0,North America,HR,Human Resources,Meets,Male,47,12,0,5,4.3,2.6,2.3,1,1,1,1,4.6,1.7,2.4
4021,0,Middle East & Africa,HR,Pharmacovigilance,Meets,Female,40,5,1,9,,5,4,1,1,1,1,1.7,5,3.5
4022,0,Latin America,R&D,Clinical Operations,Below,Male,34,11,0,12,3.4,2,1.8,1,1,1,1,2.1,3.3,2.5
4023,0,Middle East & Africa,R&D,IT & Digital,Meets,Female,49,13,1,6,,5,2.3,1,1,1,1,3.6,5,1.5
4024,0,Asia Pacific,R&D,Pharmacovigilance,Exceeds,Female,35,26,0,11,3.9,4.2,3.8,1,1,1,1,3.4,3.5,3
4025,0,Latin America,Finance,Communications,Meets,Male,33,30,0,11,4.7,1.6,2.5,1,1,1,1,5,3.8,1.3
4026,0,Latin America,Digital,Pharmacovigilance,Meets,Female,40,3,0,6,2.8,3.3,3.1,1,1,1,0,2.1,2,3.1
4027,1,North America,Commercial,Human Resources,Exceeds,Female,32,11,0,9,4,3.7,2.1,1,1,1,1,3.9,4.5,2.6
4028,0,Asia Pacific,Finance,Marketing,Meets,Female,35,7,0,11,2.3,3,2.7,1,1,1,1,3.5,1,3.6
4029,0,Europe,R&D,Human Resources,Below,Male,42,28,0,7,1.8,1.8,1.7,1,1,1,1,1.9,2.5,2.6
4030,0,North America,HR,Clinical Operations,Meets,Female,55,15,0,11,3.6,2.1,3,1,1,1,1,3,3.1,3.7
4031,0,North America,Finance,Human Resources,Below,Male,41,22,0,6,4.8,2.5,3.2,0,0,0,0,4.8,2.5,3.1
4032,0,Middle East & Africa,HR,Finance & Accounting,Exceeds,Female,45,13,0,6,4.6,2.7,2.8,1,1,1,1,5,2.7,2.1
4033,0,Middle East & Africa,HR,IT & Digital,Meets,Female,35,6,1,7,,2.9,1.7,0,0,0,0,4.5,1.8,2.4
4034,1,Middle East & Africa,HR,Marketing,Far Exceeds,Male,40,10,1,7,,1.6,3.5,1,1,1,1,2.9,1.4,5
4035,0,North America,Manufacturing,Quality Assurance,Far Below,Male,28,12,1,10,,3.5,3.1,1,1,1,1,2.1,3.3,2.8
4036,0,Europe,Digital,Sales,Meets,Female,30,15,0,5,3.4,3.5,4.1,1,1,1,0,2.1,3.9,4.3
4037,0,Latin America,Commercial,Sales,Below,Female,39,22,0,9,3.8,1.6,1.8,1,1,1,1,4.5,3,2.1
4038,0,Middle East & Africa,Commercial,Clinical Operations,Meets,Non-Binary/Other,40,12,0,5,3,3.6,1.5,1,1,1,1,4.1,3.4,2.1
4039,0,Europe,R&D,Clinical Operations,Below,Male,43,11,0,11,3.5,1,2.2,1,1,1,1,2.8,2.8,1.9
4040,0,Asia Pacific,Manufacturing,Quality Assurance,Meets,Female,37,11,0,8,2.7,2,4,1,1,1,1,3.8,1.2,5
4041,0,Middle East & Africa,Finance,Finance & Accounting,Exceeds,Female,47,5,1,6,,2,5,1,1,1,1,4,1.6,2.7
4042,0,Latin America,Finance,Sales,Below,Female,41,12,0,11,2.5,3.8,2.2,0,0,0,0,3,5,3.2
4043,0,Asia Pacific,Commercial,Quality Assurance,Meets,Female,28,11,0,11,2.6,2.2,4.4,1,1,1,1,4,2.9,3.3
4044,0,Asia Pacific,Digital,Market Access,Exceeds,Male,28,14,0,6,4.8,2.4,2.2,1,1,0,0,4.6,4.2,2.5
4045,0,Latin America,HR,Regulatory Affairs,Far Exceeds,Female,39,3,0,11,3.8,3.8,2.2,1,1,1,1,3.3,3.2,2.4
4046,0,Middle East & Africa,R&D,Communications,Meets,Female,37,10,1,11,,2.8,3.4,1,1,1,1,2.4,4.4,2.9
4047,0,North America,Digital,Medical Affairs,Exceeds,Male,39,10,0,5,3.7,2.5,2.1,1,1,1,1,2.5,1.8,1
4048,0,Latin America,Commercial,Finance & Accounting,Meets,Male,36,10,1,5,,1,2,1,1,1,1,4.8,1,1.7
4049,0,Latin America,Manufacturing,Human Resources,Meets,Female,34,12,0,6,4.9,3.6,2.9,1,1,1,1,3.8,5,1.9
4050,0,Latin America,R&D,Legal & Compliance,Exceeds,Male,34,8,0,10,2.3,4.1,2.9,1,1,1,1,3.7,4.1,2.8
4051,0,Asia Pacific,Commercial,Market Access,Meets,Male,38,18,0,10,3.8,3.1,4.6,1,1,1,1,4.2,3.8,3
4052,0,Europe,Finance,Pharmacovigilance,Exceeds,Female,43,16,0,11,3.2,4.1,1,0,0,0,0,2.7,2.2,2.2
4053,0,North America,R&D,Finance & Accounting,Exceeds,Male,32,14,0,9,3.5,3.3,3.4,1,1,1,1,3.6,3.4,3.8
4054,0,Middle East & Africa,Commercial,Data Science,Meets,Male,37,11,0,10,3.9,2.4,2.7,1,1,1,1,2.5,2.6,3.5
4055,0,Middle East & Africa,Finance,Marketing,Meets,Female,47,11,0,11,1.5,4.2,2.3,1,1,1,1,3,5,2.5
4056,0,Europe,Finance,Human Resources,Meets,Male,28,3,1,7,,4.1,4.4,1,1,1,1,2.9,5,4.4
4057,0,Latin America,HR,Supply Chain,Meets,Female,42,3,1,7,,2.9,3.8,0,0,0,0,3.5,4.1,3.1
4058,0,North America,Manufacturing,Data Science,Below,Male,37,13,0,7,3.5,3.6,4.6,1,1,1,1,3.3,3.4,4.7
4059,0,Middle East & Africa,HR,Clinical Operations,Meets,Female,33,7,0,8,2.4,4.8,1,1,1,1,1,1.9,3,2
4060,1,Middle East & Africa,Commercial,Regulatory Affairs,Exceeds,Male,35,5,0,12,3.2,2.7,1,1,1,1,1,3,2.8,3
4061,0,Latin America,Digital,Human Resources,Exceeds,Male,44,24,0,11,4.5,3.9,3.4,0,0,0,0,5,2.7,4.2
4062,0,Europe,HR,Legal & Compliance,Meets,Female,37,14,0,11,3.3,3.7,2.4,1,1,1,1,4.7,4.5,1.5
4063,0,North America,Digital,Market Access,Meets,Male,32,7,0,10,4,3.3,4,1,1,1,1,2.8,4.3,3.1
4064,0,Europe,Finance,Supply Chain,Meets,Female,33,10,0,12,3.7,3,2.1,1,1,1,1,3.4,4.3,3.2
4065,1,Europe,Commercial,Supply Chain,Meets,Female,35,15,0,10,4.3,1,2.4,1,1,1,1,4.2,2.2,1.6
4066,0,North America,Manufacturing,IT & Digital,Far Exceeds,Female,43,10,0,9,4.7,4.2,1,1,1,1,1,3.8,5,1.6
4067,0,North America,Digital,Clinical Operations,Below,Male,35,16,0,7,1.5,2.1,2.7,1,1,1,1,3.1,4,3.3
4068,0,Middle East & Africa,Commercial,Market Access,Meets,Female,38,30,0,12,2.7,3.5,2.1,0,0,0,0,4,3.3,1.8
4069,0,Middle East & Africa,Digital,Supply Chain,Exceeds,Female,34,9,0,10,3.3,2.6,2.3,1,1,1,1,3,1.8,2.6
4070,0,North America,HR,Communications,Exceeds,Male,36,8,0,9,5,4.6,3.1,1,1,1,0,4.7,3.4,2.9
4071,1,Asia Pacific,Commercial,Market Access,Meets,Male,37,7,1,7,,2.3,3.1,1,1,1,1,3.9,1.8,5
4072,0,Middle East & Africa,HR,Human Resources,Below,Female,32,13,0,6,3.8,2.6,4,1,1,1,1,4.6,1.6,2.2
4073,0,Asia Pacific,R&D,Marketing,Exceeds,Female,33,17,0,5,3.8,5,2.8,1,1,1,1,4.2,3.9,3.8
4074,0,North America,Commercial,Human Resources,Meets,Male,35,7,0,12,2.5,3.8,1,0,0,0,0,2.4,3.4,3
4075,0,Middle East & Africa,Digital,Marketing,Meets,Female,47,20,0,5,3.8,2.5,3.1,1,1,1,1,3.7,2.5,2
4076,0,Europe,R&D,Supply Chain,Meets,Female,38,5,0,9,2,2.8,2,1,1,1,1,2.1,2.8,3.4
4077,0,North America,HR,Supply Chain,Meets,Male,33,7,0,5,3.4,3.5,2,0,0,0,0,4.3,4.5,2.1
4078,0,Latin America,HR,Clinical Operations,Far Below,Female,43,2,1,9,,2.3,4.8,1,1,1,1,3,2.4,4.9
4079,0,Asia Pacific,Digital,Market Access,Meets,Male,43,25,0,6,4.1,2.6,2,1,1,1,1,4,2.8,4
4080,0,North America,R&D,Sales,Below,Female,33,12,0,5,2.1,3,1,1,1,1,1,2.1,4.2,1.1
4081,0,North America,Finance,Communications,Below,Female,48,4,0,6,3,3.4,2.4,1,1,1,1,3.6,1.5,1.8
4082,0,Middle East & Africa,Manufacturing,Legal & Compliance,Meets,Male,40,11,1,6,,3.7,3,1,1,1,1,2.5,4.1,2.8
4083,0,Middle East & Africa,Digital,Legal & Compliance,Meets,Female,41,14,0,6,4.4,1.6,2.6,1,1,1,1,3.1,1,4.6
4084,0,Middle East & Africa,HR,Quality Assurance,Meets,Male,40,7,0,11,4.8,2.6,2.8,1,1,1,1,4,1.8,4.4
4085,0,Latin America,Commercial,Quality Assurance,Below,Female,40,13,0,5,4.1,3.2,3.1,1,1,1,1,4.2,3.5,3.6
4086,0,Middle East & Africa,R&D,Data Science,Exceeds,Male,37,7,0,8,2.3,4.3,1.8,1,1,1,1,2,3.3,1
4087,0,North America,Finance,Data Science,Below,Female,42,19,0,6,3.3,3.2,2.5,1,1,1,1,2.7,2.2,2.2
4088,0,Middle East & Africa,Manufacturing,Supply Chain,Meets,Female,36,12,0,6,3.8,4,3.9,1,1,1,1,4.1,4.4,4.7
4089,0,Europe,Commercial,Communications,Meets,Female,47,17,0,9,3.5,2.6,2.9,1,1,1,1,3.7,3.8,4.8
4090,0,Middle East & Africa,R&D,Medical Affairs,Exceeds,Male,28,23,0,9,3.8,4.2,2.8,1,1,1,1,4.9,4.3,2.8
4091,0,Latin America,Finance,Marketing,Meets,Female,33,4,0,11,3.5,2.9,1,0,0,0,0,2.1,1.9,1.8
4092,0,Europe,Digital,Pharmacovigilance,Below,Male,40,15,1,8,,4,4.3,1,1,1,1,3.6,2.7,4.1
4093,0,North America,Finance,Market Access,Far Below,Male,38,9,0,12,2.4,3,1.9,1,1,1,1,4,2.5,3.6
4094,0,North America,Digital,Regulatory Affairs,Meets,Male,35,7,0,8,4,3.9,3.5,1,1,1,1,4.7,2.4,2.6
4095,0,Asia Pacific,R&D,Regulatory Affairs,Meets,Female,39,6,0,11,1.8,2.9,5,1,1,1,1,3.3,2.3,4.6
4096,0,Europe,Finance,Marketing,Meets,Female,31,6,1,9,,3.4,3.2,1,1,1,1,3.6,3.1,2.2
4097,0,Asia Pacific,Manufacturing,Data Science,Below,Female,32,14,1,11,,3.1,1.3,1,1,1,1,2.8,2.9,2.1
4098,1,Europe,Finance,Clinical Operations,Meets,Female,37,12,1,8,,3.2,4.6,1,1,1,1,4.2,3.3,3.9
4099,0,Europe,R&D,Regulatory Affairs,Meets,Female,40,22,0,5,3.3,3.8,2.7,1,1,1,1,1.9,2.7,2.7
4100,0,Latin America,Commercial,Legal & Compliance,Meets,Male,34,12,1,11,,3.8,1.3,1,1,1,1,2.7,3.8,1.4
4101,0,Asia Pacific,Commercial,Finance & Accounting,Below,Female,28,8,0,12,4.3,1.9,3.6,1,1,1,1,4.3,3.8,3.3
4102,0,Latin America,Finance,Supply Chain,Meets,Male,39,8,0,11,3.9,4.2,4,1,1,1,1,4.3,4.5,3.2
4103,0,Europe,Finance,Medical Affairs,Meets,Female,41,23,0,9,2.9,1.8,3.3,1,1,1,1,3.5,2.2,3.8
4104,0,North America,Digital,IT & Digital,Meets,Female,31,9,1,11,,3.4,2.7,0,0,0,0,3.3,3.6,2.8
4105,0,Europe,R&D,Regulatory Affairs,Meets,Female,36,16,0,9,3.3,2,4.9,1,1,1,0,3.5,2.4,4.9
4106,0,Latin America,Digital,Human Resources,Exceeds,Female,43,9,0,12,3.3,4.2,2.4,1,1,1,1,3.8,2.6,2.2
4107,1,Asia Pacific,Manufacturing,IT & Digital,Meets,Male,31,16,0,7,3.6,4,4.8,1,1,1,1,2.9,4.1,3.4
4108,0,Asia Pacific,Commercial,IT & Digital,Meets,Male,38,19,0,8,3.6,3.3,3.9,1,1,1,1,4.5,3.6,2.5
4109,0,Latin America,HR,Quality Assurance,Meets,Male,34,5,0,6,3.4,2.4,1.2,1,0,0,0,4,3.3,2.2
4110,0,Asia Pacific,HR,Medical Affairs,Meets,Male,51,9,0,6,4,5,2.7,1,1,1,1,3.7,4.1,3
4111,0,Middle East & Africa,R&D,Medical Affairs,Far Below,Female,31,5,1,11,,2.8,1,1,1,1,1,3.1,2.5,1
4112,0,North America,R&D,Regulatory Affairs,Meets,Male,28,13,0,12,4.1,2.5,2.4,1,1,1,1,2.8,2.2,2.6
4113,0,North America,HR,Legal & Compliance,Below,Female,42,11,0,12,2.5,1,2.7,1,1,1,1,3.4,1,2.8
4114,0,North America,R&D,Clinical Operations,Far Exceeds,Female,36,9,1,9,,1.7,1.9,1,1,1,1,3,3.9,3.6
4115,0,Asia Pacific,Commercial,Clinical Operations,Meets,Female,32,11,1,11,,4.3,3,1,1,1,0,3.3,3.6,3.9
4116,0,Asia Pacific,Manufacturing,Data Science,Below,Female,35,15,0,6,2.7,2.9,2.7,1,1,1,1,3.1,3.9,2.7
4117,0,Europe,Manufacturing,Marketing,Below,Male,47,21,0,8,3.1,2.6,3.7,1,1,1,1,1,3.6,2.1
4118,0,Europe,Digital,Supply Chain,Meets,Male,38,14,0,6,3.8,3.7,2.1,0,0,0,0,4.1,3.2,1.6
4119,0,North America,Commercial,Finance & Accounting,Meets,Female,47,17,1,9,,2.5,2,1,1,1,1,4.6,3.7,1
4120,0,Middle East & Africa,R&D,Pharmacovigilance,Meets,Male,31,5,1,9,,1.9,1.9,1,1,1,1,4.2,3.7,3.5
4121,0,Europe,R&D,Sales,Meets,Male,45,18,0,9,3.8,3.5,3,1,1,1,1,3.4,2.6,2.6
4122,0,Europe,Digital,Pharmacovigilance,Exceeds,Female,32,17,0,12,3.2,3.6,3.9,1,1,1,1,4.3,3.2,4.6
4123,0,Asia Pacific,Digital,Quality Assurance,Meets,Female,45,7,1,9,,3.7,2.7,1,1,1,1,2.4,2.7,2.8
4124,0,Middle East & Africa,R&D,Clinical Operations,Meets,Female,45,14,0,8,2.6,1.4,2.6,0,0,0,0,2.6,2.7,4.1
4125,0,North America,R&D,Human Resources,Exceeds,Male,32,9,1,5,,3.8,3.3,1,0,0,0,4.4,3.5,2.6
4126,0,Europe,Commercial,IT & Digital,Far Below,Female,41,11,0,12,3,3.6,1.7,1,1,1,1,1.4,3.9,3.8
4127,0,Middle East & Africa,Digital,Data Science,Below,Female,39,16,1,8,,3.4,1.3,0,0,0,0,3.5,3.7,2.2
4128,0,Middle East & Africa,Commercial,Quality Assurance,Meets,Female,44,10,1,7,,3.5,3.1,1,1,1,1,2.7,2.9,3
4129,0,North America,Finance,Pharmacovigilance,Meets,Male,31,34,0,5,3.5,3.5,2.6,1,1,1,1,4.2,4.1,4.5
4130,0,Middle East & Africa,R&D,Legal & Compliance,Meets,Female,36,27,0,7,2.8,2.3,2.1,1,1,1,1,3.4,2.9,2.6
4131,0,Middle East & Africa,HR,Medical Affairs,Below,Female,38,7,0,11,2.1,2,2.7,1,1,1,1,3.2,2.1,2.1
4132,0,Middle East & Africa,HR,Legal & Compliance,Exceeds,Female,47,35,0,8,2.5,3.8,2.2,1,1,1,1,4,4.6,2.1
4133,0,Europe,Finance,Legal & Compliance,Meets,Male,38,18,0,6,4.2,2.9,1.4,1,1,1,1,4.1,2.3,1.6
4134,0,North America,R&D,Legal & Compliance,Meets,Female,32,11,1,11,,4.8,3.8,1,1,1,1,4.2,4.7,3.5
4135,0,Middle East & Africa,Digital,IT & Digital,Exceeds,Female,40,22,0,12,2.1,2.7,2.2,1,1,1,1,2.1,2.3,2.3
4136,0,Middle East & Africa,HR,Marketing,Meets,Female,32,24,0,10,1.4,3.1,2.3,1,1,1,1,2.8,3.8,1.3
4137,0,Europe,Digital,Medical Affairs,Exceeds,Male,28,22,0,5,4.6,1.9,3,1,1,1,0,3.6,1,3.7
4138,0,North America,HR,Finance & Accounting,Meets,Male,37,22,0,5,2.2,2,2.8,1,1,1,1,3.2,3.3,1.3
4139,0,Asia Pacific,Digital,Communications,Exceeds,Male,40,10,0,8,2.9,2.5,2.4,1,1,1,1,2.7,4.1,2
4140,0,Europe,HR,Pharmacovigilance,Meets,Female,39,11,0,12,3.3,2,1.5,1,1,1,1,3.6,3.4,1
4141,0,North America,Digital,Regulatory Affairs,Exceeds,Female,38,7,0,6,1.9,4,2.4,0,0,0,0,2.4,5,4
4142,0,Middle East & Africa,Finance,Marketing,Below,Male,49,22,0,12,3.6,4,2.3,1,1,1,0,3.4,3.4,3.3
4143,0,North America,Commercial,Human Resources,Meets,Female,47,19,0,10,2.2,1,2.7,0,0,0,0,1.9,2.6,2.5
4144,0,North America,Digital,Finance & Accounting,Meets,Female,33,9,0,12,2.8,2.2,2.7,1,1,1,1,3.5,3.6,2.8
4145,0,North America,Commercial,Data Science,Below,Male,44,13,1,9,,2.6,3.6,1,1,1,1,4.7,2.4,2.4
4146,0,Asia Pacific,Commercial,Market Access,Below,Male,52,12,1,11,,3.6,2.5,1,1,0,0,3.6,3.3,2.6
4147,0,North America,R&D,Medical Affairs,Meets,Male,49,11,0,8,3.2,2.7,3.2,1,1,1,1,4.1,2.7,1.6
4148,0,Asia Pacific,Finance,Regulatory Affairs,Meets,Female,44,24,0,8,2.2,1,4.2,1,1,1,1,1.6,2,4.5
4149,0,Middle East & Africa,Commercial,Human Resources,Meets,Male,37,16,0,10,1.2,1.6,2.1,1,1,1,1,1.4,3.1,2.9
4150,0,Asia Pacific,Manufacturing,Quality Assurance,Meets,Female,30,18,0,11,4.2,4.5,3.1,1,1,1,1,3.7,3.1,3.4
4151,0,Middle East & Africa,Commercial,Market Access,Meets,Female,32,36,0,9,4.1,2.4,2.6,1,1,1,1,2.9,4.2,3.5
4152,0,Middle East & Africa,Digital,Quality Assurance,Meets,Male,41,14,0,9,3.6,3.6,3.2,1,1,1,1,3.7,2.9,1
4153,0,Asia Pacific,Commercial,Clinical Operations,Meets,Male,40,6,0,6,3.3,3.9,2.5,1,1,1,1,3.7,3.4,2.8
4154,0,Europe,Digital,Market Access,Exceeds,Female,38,14,0,11,3.5,1.7,2.3,1,1,1,1,2.6,3.5,2.4
4155,0,Latin America,Digital,Marketing,Meets,Male,43,12,0,11,4.6,3,5,1,0,0,0,4.6,5,2.8
4156,0,North America,Manufacturing,Clinical Operations,Far Below,Female,45,8,0,12,4,4.7,2.8,0,0,0,0,4.3,5,3.3
4157,0,Latin America,Commercial,Marketing,Meets,Female,45,10,0,5,4,3.4,1,1,1,1,1,3.6,3.9,2.9
4158,0,North America,Commercial,Supply Chain,Meets,Male,42,20,0,8,3.4,3.2,4,1,1,1,1,3.3,3.3,2.7
4159,0,North America,HR,Communications,Below,Female,41,11,0,7,2.2,3.1,3.7,1,1,1,1,3.1,1.3,1.7
4160,0,Middle East & Africa,HR,Regulatory Affairs,Meets,Female,35,8,1,12,,4.3,2.9,1,1,1,1,4.4,3.3,3
4161,0,North America,R&D,Pharmacovigilance,Meets,Male,39,8,0,9,1,5,2.1,1,1,1,1,2.8,4,2.5
4162,0,North America,Digital,Quality Assurance,Far Exceeds,Male,40,12,0,5,3,1.1,2.5,1,0,0,0,3.2,2.8,2.1
4163,0,Asia Pacific,Manufacturing,Pharmacovigilance,Meets,Female,38,12,0,6,2.3,5,3.6,1,1,1,1,2.9,3.7,3.8
4164,0,Latin America,HR,Communications,Meets,Male,28,16,0,12,5,3.6,3.5,1,0,0,0,4.5,5,3.9
4165,0,Asia Pacific,Commercial,Market Access,Meets,Male,40,20,0,12,3.5,3.8,1.7,0,0,0,0,3.4,3.8,1.6
4166,0,North America,R&D,Finance & Accounting,Meets,Female,38,22,0,10,4.9,2.8,4.8,1,1,0,0,4.5,3.7,3.1
4167,0,Middle East & Africa,Manufacturing,Medical Affairs,Meets,Female,37,14,0,6,2.5,4.9,2.9,1,1,1,1,3.6,4.3,3.3
4168,0,Asia Pacific,Finance,Medical Affairs,Meets,Female,41,21,0,5,4.3,3.1,1.8,1,1,1,1,5,4,1.7
4169,0,Asia Pacific,Commercial,IT & Digital,Meets,Male,41,13,0,7,3.7,3.2,1,1,1,1,1,3.2,3.1,2.5
4170,1,Europe,Commercial,Quality Assurance,Exceeds,Male,45,12,0,9,4.2,2.3,2.9,1,1,1,1,4.3,3.4,3
4171,0,North America,Finance,Clinical Operations,Below,Female,42,15,0,5,3.1,2,2.7,1,1,1,1,4.6,5,2.7
4172,0,Middle East & Africa,Digital,Quality Assurance,Below,Female,36,20,0,6,3.2,2.2,3.1,1,1,1,1,1.8,3.2,1.3
4173,0,Asia Pacific,Digital,Supply Chain,Meets,Female,46,9,0,8,3.8,4.1,2.9,1,1,1,1,3.9,3.7,4.4
4174,0,Asia Pacific,HR,IT & Digital,Meets,Male,47,21,0,12,3.4,4.3,4.3,1,1,1,1,2.9,4.5,3.9
4175,0,Middle East & Africa,HR,Supply Chain,Meets,Male,38,14,0,9,2.9,4,2.6,1,1,1,1,4.1,3.4,2.4
4176,0,North America,Commercial,Pharmacovigilance,Meets,Female,45,4,0,9,2.1,3,2.6,1,1,1,1,3.1,3.1,3.6
4177,0,Europe,Commercial,Communications,Meets,Female,39,16,0,6,4.6,4,3.4,1,1,1,1,4.4,2.4,2.4
4178,0,Asia Pacific,HR,Finance & Accounting,Meets,Male,45,12,0,6,1.8,2.4,2.5,1,1,1,1,4.7,4,3
4179,0,Europe,Finance,Market Access,Exceeds,Male,46,14,0,12,3.6,3.1,4,1,1,1,0,3,2.3,3.9
4180,0,Latin America,HR,Supply Chain,Far Below,Female,34,22,1,8,,2.6,2.6,1,1,1,1,3.4,3,2.2
4181,0,North America,Commercial,Communications,Exceeds,Non-Binary/Other,46,8,1,9,,2.4,1.6,1,1,1,1,2.8,2.4,1.4
4182,0,Latin America,Manufacturing,Regulatory Affairs,Meets,Male,38,19,0,9,3.5,3.3,3.8,1,1,1,1,3,5,2.1
4183,0,Latin America,Commercial,Clinical Operations,Meets,Male,40,7,0,6,3.3,3.7,1,1,0,0,0,3.8,4.4,1.2
4184,0,Latin America,Manufacturing,Clinical Operations,Meets,Male,45,7,1,7,,2.8,2.9,1,1,1,1,2.9,2.8,4.5
4185,0,North America,Manufacturing,Supply Chain,Meets,Male,36,20,0,6,3.7,3.7,3.3,1,1,1,1,3.3,2.8,1.2
4186,0,North America,Commercial,Sales,Far Below,Male,44,19,0,8,2,3.1,2.6,1,1,1,1,3.3,2.6,3.5
4187,0,Middle East & Africa,R&D,Medical Affairs,Meets,Male,39,18,0,12,3.9,1.1,1.9,1,1,1,1,3.6,2,2.2
4188,0,Europe,HR,Sales,Meets,Female,35,24,0,7,2.6,2.2,4,1,0,0,0,3.1,2,4.8
4189,0,Europe,Digital,Market Access,Below,Female,42,10,0,11,2.9,3.5,2.5,1,0,0,0,4.1,3.8,3.2
4190,0,Middle East & Africa,Commercial,Market Access,Below,Female,46,7,0,7,3.2,3.5,1,1,1,0,0,3.7,3.6,1.7
4191,0,Middle East & Africa,Manufacturing,Marketing,Meets,Female,39,5,0,8,4.4,2.6,3.4,1,1,1,1,4.1,3.5,5
4192,0,Latin America,Commercial,IT & Digital,Meets,Male,32,6,0,5,3.2,2.2,3,1,1,1,1,3.9,3.5,2.7
4193,0,Middle East & Africa,HR,Communications,Meets,Male,36,16,0,12,2.5,4.4,2.2,0,0,0,0,3.2,3.8,2.4
4194,0,Asia Pacific,Finance,Market Access,Meets,Female,34,8,0,12,4.4,3.8,2,1,1,1,1,1.7,4.3,2.9
4195,0,Europe,Manufacturing,Marketing,Meets,Female,52,22,0,7,2.4,1.2,3.3,1,1,1,1,1.8,3.3,3.4
4196,0,Middle East & Africa,Digital,Clinical Operations,Meets,Male,33,3,0,12,2.9,3.2,2.1,1,1,1,1,3.5,2.3,3.4
4197,0,Asia Pacific,Digital,Regulatory Affairs,Meets,Male,28,12,0,11,4.4,3.2,2.9,1,1,1,1,4.2,2.8,2.2
4198,0,Asia Pacific,Digital,Data Science,Meets,Female,36,16,0,10,3.8,2.4,4,0,0,0,0,4.9,4.1,3
4199,0,Asia Pacific,Finance,Medical Affairs,Exceeds,Male,39,11,0,8,2.7,2.9,5,1,1,1,1,2.9,3,3.2
4200,1,Asia Pacific,R&D,Marketing,Meets,Male,38,8,1,6,,1.9,3.1,1,1,1,1,1.9,1.7,2.6
4201,0,Latin America,Manufacturing,IT & Digital,Meets,Female,39,25,0,8,3.8,3.9,1.9,1,1,0,0,3.7,3.8,2.2
4202,0,Asia Pacific,Finance,IT & Digital,Meets,Female,30,12,0,5,2.2,4.5,2.5,0,0,0,0,4.2,4.4,3.1
4203,1,Latin America,Manufacturing,Human Resources,Meets,Female,38,10,0,12,4.4,2.3,1.6,0,0,0,0,3.9,2.4,3.9
4204,0,Latin America,Finance,Finance & Accounting,Meets,Male,32,5,0,12,3.5,2.9,3.3,1,1,1,1,2.9,1.9,4.3
4205,0,Asia Pacific,Finance,Pharmacovigilance,Meets,Female,43,10,1,8,,2,3.5,0,0,0,0,2.7,2.7,3.6
4206,0,Europe,R&D,IT & Digital,Meets,Female,31,11,0,6,3.8,2.7,3.3,1,1,1,1,4,2.1,1.9
4207,1,Asia Pacific,Manufacturing,Regulatory Affairs,Far Exceeds,Female,37,12,0,11,5,3.7,2.4,1,1,1,1,4.5,2.9,2.7
4208,0,Asia Pacific,Finance,Quality Assurance,Meets,Male,33,6,1,11,,2.9,2.9,1,1,1,1,2.5,3.6,3.1
4209,0,Asia Pacific,R&D,Pharmacovigilance,Below,Female,44,8,0,5,3.1,3.8,3.1,0,0,0,0,4.1,2.7,4.4
4210,1,Europe,Commercial,Regulatory Affairs,Meets,Male,35,21,0,10,3.8,5,2.4,1,1,1,1,4.9,4.3,3
4211,0,North America,HR,Pharmacovigilance,Far Below,Male,32,9,0,9,4.9,2.5,3,1,1,1,1,4.5,1.5,3.8
4212,0,North America,Finance,Supply Chain,Meets,Male,44,5,0,5,4.3,3.3,3.2,1,1,1,1,2.9,3.1,3.3
4213,1,Latin America,Digital,Pharmacovigilance,Meets,Female,28,8,0,8,3.2,2.7,2.6,1,1,1,1,3.5,2.1,3.2
4214,0,Latin America,R&D,Marketing,Meets,Female,42,17,0,11,3.4,3.8,2.5,1,1,1,1,4.1,3.5,3.5
4215,1,Europe,R&D,Regulatory Affairs,Far Exceeds,Female,40,13,0,6,3.8,3.2,1.8,1,1,1,1,3.6,3.9,3.5
4216,1,Middle East & Africa,Finance,Quality Assurance,Far Exceeds,Male,53,4,0,12,3.3,3.3,2.8,1,1,1,1,3.3,2.7,2.9
4217,0,North America,R&D,Market Access,Below,Female,42,8,0,9,2.8,3.1,3.2,1,1,1,1,2.3,3.2,1.7
4218,0,Latin America,Commercial,Communications,Meets,Male,41,12,0,7,4.2,3,2.5,0,0,0,0,4,3.4,2.4
4219,1,North America,R&D,Pharmacovigilance,Exceeds,Male,33,11,0,12,3.7,3.5,2.6,1,1,1,1,4.8,3.5,2.7
4220,0,Europe,HR,IT & Digital,Meets,Female,37,15,0,6,4.2,3.3,3.2,1,1,1,1,4,3.1,2.4
4221,0,Europe,HR,Quality Assurance,Meets,Male,40,13,0,12,2.3,4.2,3.4,0,0,0,0,2.7,2.4,2.4
4222,0,Middle East & Africa,Digital,Regulatory Affairs,Exceeds,Female,47,16,0,7,3.2,2.9,1,1,1,1,1,3.3,4.6,1.9
4223,0,Middle East & Africa,Commercial,Communications,Meets,Male,33,9,1,10,,4.7,3.2,1,1,1,1,2,4.7,2.3
4224,0,Europe,HR,Quality Assurance,Meets,Male,28,9,0,11,2.9,3.3,3.2,1,1,0,0,4.2,5,2.8
4225,0,Latin America,Finance,Data Science,Exceeds,Male,38,8,0,7,3.1,5,4.1,0,0,0,0,3.8,5,4.3
4226,0,North America,Manufacturing,Data Science,Exceeds,Male,28,9,0,10,2.5,4.4,3.2,0,0,0,0,2.8,3.2,2.9
4227,0,Asia Pacific,Manufacturing,Pharmacovigilance,Meets,Male,43,5,1,12,,3,2.4,1,1,1,1,3.3,2.7,3.5
4228,1,Middle East & Africa,Manufacturing,Finance & Accounting,Meets,Male,47,24,0,10,2.9,2.8,3.8,1,1,1,1,3.1,2.5,4.5
4229,0,Asia Pacific,Finance,Pharmacovigilance,Meets,Female,44,8,1,6,,1.9,2.8,1,1,1,1,3,1.8,3.3
4230,0,Latin America,R&D,Communications,Meets,Male,35,13,0,5,3.4,4.5,2.6,1,1,1,1,4.4,3.3,2.7
4231,0,Middle East & Africa,Finance,Pharmacovigilance,Meets,Female,48,10,0,6,4.2,5,2.6,1,1,1,1,2.8,3,3.9
4232,0,Asia Pacific,R&D,Medical Affairs,Meets,Female,33,10,0,12,1.7,2.5,3.6,1,1,1,1,2.1,4.2,3.3
4233,0,Latin America,Manufacturing,IT & Digital,Far Exceeds,Female,32,7,1,9,,3.1,2.2,1,1,1,1,3,4,1.7
4234,0,North America,Digital,Legal & Compliance,Exceeds,Female,47,7,0,12,2.5,3.4,3,1,1,1,1,3.3,2.1,4.5
4235,1,Latin America,Digital,Supply Chain,Meets,Male,36,17,0,6,2.3,3.2,3.2,1,1,1,1,3.2,3.2,2.3
4236,0,Middle East & Africa,R&D,Finance & Accounting,Meets,Male,39,10,0,7,2.7,2.2,1.5,1,1,1,1,2.8,3.6,1.9
4237,0,Europe,Manufacturing,Quality Assurance,Meets,Female,44,6,1,5,,4.2,5,1,1,1,1,3.3,4,3.9
4238,0,North America,Finance,Communications,Exceeds,Female,31,8,0,10,3.6,3.2,3,1,1,1,1,2.4,2.9,1.5
4239,1,Asia Pacific,Digital,Communications,Meets,Male,35,17,0,12,1.3,5,2,1,1,1,1,2.5,4.3,2.7
4240,0,Middle East & Africa,R&D,Finance & Accounting,Exceeds,Female,34,8,0,9,2.5,2.9,2.9,1,1,1,1,2.9,3.3,2
4241,0,Europe,Finance,Communications,Meets,Female,37,7,0,12,4.2,3.1,2.9,1,1,1,1,2.2,2.2,2.3
4242,0,Latin America,Manufacturing,Finance & Accounting,Meets,Female,34,10,0,9,4.3,2.6,3.2,1,1,1,1,4.5,1.9,3
4243,0,Europe,Commercial,Sales,Exceeds,Female,40,17,0,7,2.8,1.6,1.2,1,1,1,1,3.4,3.4,2.8
4244,0,Middle East & Africa,Manufacturing,Finance & Accounting,Meets,Male,40,6,0,7,2.4,3,2.4,1,1,1,1,2.8,2.7,2.2
4245,0,Middle East & Africa,Manufacturing,Communications,Far Below,Male,38,14,0,11,2.7,2.4,1.6,1,1,1,1,2.6,1.7,2.5
4246,0,Europe,Finance,Communications,Meets,Male,39,13,1,7,,4.1,4.3,1,1,1,1,4.9,3.7,4.3
4247,0,Latin America,Finance,Clinical Operations,Exceeds,Male,34,24,0,10,3.9,3,3.5,1,1,1,1,4.5,1.9,3.4
4248,0,Europe,HR,Communications,Meets,Female,38,13,1,5,,2.4,3.2,1,0,0,0,2.3,2.2,1.7
4249,0,Middle East & Africa,HR,Pharmacovigilance,Meets,Male,28,7,0,9,3.6,1.6,1.9,0,0,0,0,2.7,3.1,1.2
4250,0,Middle East & Africa,Finance,Marketing,Meets,Male,44,8,0,5,3.7,3.8,1.5,0,0,0,0,1.9,2.9,2.5
4251,0,Asia Pacific,Finance,Data Science,Meets,Male,35,7,1,11,,2.5,4,1,1,1,1,3,4.3,3.6
4252,0,Asia Pacific,Commercial,Data Science,Meets,Female,35,14,0,8,3.6,3.5,1.8,1,0,0,0,2.8,1.3,2.6
4253,0,North America,Commercial,Legal & Compliance,Below,Female,32,11,0,8,5,3.5,3.2,1,1,1,1,4.5,3,4.1
4254,0,Middle East & Africa,Manufacturing,Legal & Compliance,Far Exceeds,Female,39,8,0,5,2.8,3.8,4,1,1,1,1,3.8,3.7,3.7
4255,0,Asia Pacific,Digital,Market Access,Meets,Female,35,16,0,10,2.1,2.1,1.1,1,1,1,1,2,3.3,1.8
4256,0,Europe,Commercial,Clinical Operations,Meets,Male,42,14,0,8,4.9,3.8,2.4,0,0,0,0,4.3,4.5,3.1
4257,0,Latin America,Manufacturing,Finance & Accounting,Meets,Male,32,36,0,5,4.8,2.7,3.1,1,1,1,1,3.7,2.4,3.2
4258,0,Europe,R&D,Quality Assurance,Below,Female,39,6,1,11,,3.4,2.9,1,1,1,1,5,2.8,3.6
4259,0,Latin America,HR,Regulatory Affairs,Meets,Female,41,23,1,8,,2.9,3,0,0,0,0,2.9,2.9,3.3
4260,0,Asia Pacific,Digital,IT & Digital,Meets,Male,43,5,1,10,,4.3,3.6,1,1,1,1,4.2,3.5,2.8
4261,0,North America,Manufacturing,Clinical Operations,Exceeds,Male,42,17,0,12,3.8,3.4,3.1,1,1,1,1,3.6,3.3,3.5
4262,0,Europe,Finance,Supply Chain,Meets,Female,33,4,0,5,1.7,3.3,3.1,1,1,1,1,3.2,3.5,2.8
4263,0,Europe,R&D,Legal & Compliance,Meets,Male,38,4,0,12,2.9,5,2.5,1,1,1,1,2.8,4,1.7
4264,0,Europe,HR,Human Resources,Meets,Male,37,14,0,11,2.7,4.7,3,1,1,1,1,2.9,4,2.3
4265,0,Latin America,R&D,Pharmacovigilance,Meets,Female,32,8,0,6,2.9,2.6,1.4,1,1,1,1,2.8,3,1.5
4266,0,Asia Pacific,Manufacturing,Marketing,Meets,Male,38,8,0,9,4,2.6,4.3,1,1,1,1,3.8,3.5,2.6
4267,1,Europe,Commercial,Quality Assurance,Far Exceeds,Female,30,34,0,5,2.6,2.9,2.5,1,1,1,1,4.1,2.6,3.5
4268,0,Europe,HR,Quality Assurance,Meets,Male,39,6,0,6,3.1,3.2,3.3,1,1,1,1,3.5,2.2,1.9
4269,0,North America,R&D,Pharmacovigilance,Far Below,Male,45,12,1,6,,1.9,2.5,0,0,0,0,3.7,3,3.8
4270,0,North America,Commercial,Supply Chain,Meets,Female,44,13,0,6,2.5,4,2.9,1,1,1,1,2.1,2.4,3
4271,0,Asia Pacific,Digital,Pharmacovigilance,Meets,Male,40,9,0,5,2.4,2.6,1.9,1,1,1,1,2.4,3.8,2.3
4272,0,Asia Pacific,Manufacturing,Communications,Exceeds,Female,40,12,0,8,2.8,4.5,3.3,1,1,1,1,2.7,3.5,2.1
4273,1,Middle East & Africa,Manufacturing,Pharmacovigilance,Meets,Male,37,16,0,12,3.3,3.8,2,1,1,1,1,4.5,2.7,2.5
4274,0,North America,HR,IT & Digital,Meets,Male,51,16,1,5,,2.2,3,1,1,1,1,3.8,3,2.7
4275,0,Middle East & Africa,R&D,Human Resources,Below,Male,37,11,0,8,3.4,3,4.9,1,1,1,1,3.1,3.8,3.2
4276,0,Latin America,Digital,Clinical Operations,Meets,Female,30,4,0,7,1.2,1.6,3.2,1,1,1,1,2.2,4,3.3
4277,0,Middle East & Africa,Finance,Marketing,Meets,Male,43,5,0,5,3.1,3.5,1.5,1,1,1,1,3.2,3.8,2.7
4278,0,Europe,HR,IT & Digital,Meets,Male,41,8,1,12,,2.1,2.9,1,1,1,1,2.7,4.3,3.1
4279,0,Middle East & Africa,Finance,Quality Assurance,Below,Female,31,14,0,5,2.8,3.2,2.8,1,1,0,0,3,1.6,4.1
4280,0,Asia Pacific,HR,Market Access,Below,Female,36,14,0,11,3.2,2.6,1.8,1,1,1,1,3.3,2.8,1.7
4281,0,Latin America,R&D,Pharmacovigilance,Meets,Male,39,11,0,12,2.4,4.4,1.3,1,1,1,1,2.2,2.3,1.5
4282,0,Europe,Digital,Communications,Meets,Female,35,3,1,12,,3,4.6,1,1,1,1,3,3.8,3.4
4283,1,Middle East & Africa,R&D,Medical Affairs,Exceeds,Female,44,18,0,12,2.6,5,2.2,1,1,1,1,2.8,4.9,3.3
4284,0,Latin America,Manufacturing,Finance & Accounting,Far Below,Male,33,8,1,9,,1,2.2,1,1,1,1,2.5,2.6,2.8
4285,0,Latin America,Finance,Regulatory Affairs,Meets,Male,36,3,0,12,2.7,2.5,3.4,1,1,1,1,3.7,4.1,1.8
4286,0,Europe,Commercial,Human Resources,Meets,Female,35,25,0,12,4,5,1.1,0,0,0,0,3.1,5,2.2
4287,0,Middle East & Africa,Manufacturing,Pharmacovigilance,Exceeds,Male,41,15,0,7,3.8,2.8,3,1,1,1,1,4.2,4.4,1.7
4288,0,Latin America,Manufacturing,Pharmacovigilance,Meets,Female,42,25,0,7,4.1,3.8,3.4,1,1,1,1,3.5,2.7,3.8
4289,0,Latin America,Finance,IT & Digital,Meets,Male,41,15,0,6,3.4,2.2,2.6,1,1,1,1,4,3.7,3.5
4290,0,North America,HR,Quality Assurance,Meets,Female,28,11,1,9,,5,2.6,1,1,1,1,2.2,3.7,1.9
4291,0,Latin America,Manufacturing,Data Science,Meets,Female,39,12,0,9,3.1,2.8,3.7,0,0,0,0,3.8,3.2,2.7
4292,0,North America,Digital,Sales,Meets,Male,41,12,1,10,,1.9,3.4,1,1,1,1,2.7,3.9,2.4
4293,0,Middle East & Africa,Manufacturing,Regulatory Affairs,Far Below,Male,42,6,1,8,,3,1,1,1,1,1,2.4,2.2,3.1
4294,0,Middle East & Africa,Digital,Legal & Compliance,Meets,Female,37,9,0,5,3,2,2.1,1,1,1,1,2.6,2.8,1.8
4295,0,Middle East & Africa,R&D,Data Science,Meets,Female,38,4,1,11,,1.9,3,1,1,1,1,3.2,2.7,3.6
4296,0,Asia Pacific,HR,Clinical Operations,Meets,Male,35,7,1,9,,1.5,2.3,1,1,1,1,2.3,4.3,3
4297,0,Middle East & Africa,Digital,Medical Affairs,Meets,Female,46,5,0,8,3.8,2.3,2.4,1,1,1,1,3.8,2.7,3.1
4298,0,Latin America,Manufacturing,Sales,Meets,Female,30,24,0,12,5,3.6,4,1,1,1,1,3.8,3.7,3
4299,0,Europe,HR,IT & Digital,Meets,Non-Binary/Other,41,10,0,5,4,4.6,2.1,1,1,1,1,3.6,4.1,1.1
4300,0,North America,HR,Regulatory Affairs,Below,Female,32,7,1,6,,3.9,4.7,1,1,1,1,3.1,4.9,2.2
4301,0,Asia Pacific,Digital,Communications,Exceeds,Female,35,5,1,7,,3.6,2.7,1,1,1,1,2.8,3.8,2.5
4302,0,Middle East & Africa,Digital,Communications,Below,Female,38,18,0,8,1.7,3.1,1,1,1,1,1,4.1,3.1,1
4303,0,Middle East & Africa,Commercial,Data Science,Below,Male,28,35,0,11,3.3,3.1,2.1,1,1,1,1,4.1,3.3,1.6
4304,0,Europe,Commercial,IT & Digital,Exceeds,Female,30,2,0,7,3.1,2.1,3,1,1,1,1,2.4,3.7,2.4
4305,0,Europe,HR,Marketing,Exceeds,Male,28,12,0,12,3.3,3.5,3.5,1,1,1,1,3.7,5,3
4306,0,Asia Pacific,Finance,Marketing,Below,Male,41,3,0,5,4,2.7,2.9,1,1,1,1,4.8,2.9,1.9
4307,0,North America,Finance,Communications,Exceeds,Female,44,30,0,9,2.5,3.2,1.7,1,1,1,1,2,4.4,2.6
4308,0,Middle East & Africa,Commercial,Supply Chain,Meets,Male,28,8,1,5,,3.3,2.9,1,1,1,1,5,4.4,2.5
4309,0,Asia Pacific,Manufacturing,IT & Digital,Meets,Female,37,34,0,7,3.9,3.5,1.6,1,1,1,1,3.1,3.7,3
4310,0,Latin America,R&D,Pharmacovigilance,Below,Female,40,6,0,9,4,3.1,1.6,1,1,1,1,2.9,2.3,2.5
4311,0,Latin America,HR,Medical Affairs,Meets,Male,40,22,0,7,3.3,3.9,3.3,1,1,1,1,4.3,2.9,3.7
4312,0,Asia Pacific,R&D,Sales,Meets,Male,50,14,0,9,3.1,2.3,2.3,1,1,1,1,3.1,3.9,1
4313,0,Middle East & Africa,Commercial,Human Resources,Meets,Female,39,20,0,5,3.2,1.9,2.3,1,1,1,1,2,3.5,3.5
4314,0,Asia Pacific,Digital,Regulatory Affairs,Meets,Female,32,13,0,8,3.1,1.7,2.3,1,1,1,0,4,2.5,3.4
4315,0,Middle East & Africa,HR,Marketing,Meets,Female,42,13,0,12,3.3,3.4,3,1,1,1,1,3.3,3.9,4.5
4316,0,Europe,Commercial,Medical Affairs,Far Exceeds,Male,48,17,0,9,3.6,3.3,2.2,1,1,1,1,3.4,4,2.2
4317,0,Asia Pacific,Manufacturing,Sales,Below,Non-Binary/Other,30,8,0,12,4.4,3,3.4,1,1,1,1,4.2,3.5,3
4318,0,Middle East & Africa,HR,Supply Chain,Below,Male,41,5,1,11,,3.5,3.2,1,1,1,1,3.3,5,2.8
4319,0,Asia Pacific,HR,Marketing,Meets,Male,38,8,0,10,3.4,4.4,1.5,1,1,1,1,3.1,2.6,2.1
4320,0,Asia Pacific,Finance,Quality Assurance,Below,Male,32,4,0,8,2.2,1.1,3.1,1,1,1,1,2.8,2.5,4.4
4321,0,Middle East & Africa,Digital,Marketing,Meets,Male,34,21,0,10,3.6,2.6,3.4,1,0,0,0,3.2,1.7,2.7
4322,0,Middle East & Africa,HR,Market Access,Meets,Female,48,7,1,8,,2.4,1.2,1,1,1,1,1.8,2.1,1.1
4323,0,North America,Digital,Legal & Compliance,Meets,Female,43,2,1,11,,2.3,3.1,1,1,1,1,3.3,3.1,2.2
4324,0,Asia Pacific,Commercial,Quality Assurance,Exceeds,Female,41,19,0,8,3,3.8,3.8,1,0,0,0,3,2.3,4.5
4325,0,Latin America,Manufacturing,Finance & Accounting,Meets,Female,29,5,1,5,,3.1,2.4,1,1,1,1,2.5,3.4,4.1
4326,0,Asia Pacific,Manufacturing,Legal & Compliance,Meets,Male,42,5,1,7,,2.7,2.1,1,1,1,1,4,3.4,3.1
4327,0,Asia Pacific,HR,Legal & Compliance,Meets,Female,45,8,0,6,3.9,3.9,3.4,1,1,1,1,3.3,3.8,2.6
4328,0,Middle East & Africa,HR,Medical Affairs,Below,Male,30,7,0,7,1.4,4.9,2.4,1,1,1,1,3.7,5,4.4
4329,0,Asia Pacific,Commercial,IT & Digital,Meets,Female,38,8,1,10,,3.5,3.2,1,0,0,0,3.5,4.7,2.4
4330,0,Asia Pacific,Finance,Supply Chain,Meets,Male,44,17,0,8,4,2.4,3.4,1,1,1,1,4.1,3.1,2.8
4331,0,Latin America,Finance,Data Science,Meets,Male,43,23,0,9,4.9,2.8,4.4,1,1,1,1,2.5,4,3.2
4332,0,Middle East & Africa,Finance,Clinical Operations,Exceeds,Male,42,9,1,8,,4,3.5,1,1,0,0,4,3.9,3.3
4333,0,Asia Pacific,Digital,Finance & Accounting,Below,Female,38,13,1,9,,2.7,2,0,0,0,0,3.4,2.4,3.9
4334,0,Europe,Finance,Pharmacovigilance,Far Below,Female,45,14,0,10,4.4,3.3,2.3,1,1,1,1,5,3.3,3.8
4335,1,North America,Manufacturing,Pharmacovigilance,Far Exceeds,Female,39,17,1,12,,3.1,1.6,1,1,1,1,2,4,2.1
4336,0,Latin America,Digital,Marketing,Far Below,Male,41,8,0,6,3.6,4.6,2.4,1,1,1,1,4.5,4.5,2.3
4337,0,Asia Pacific,Commercial,Communications,Far Exceeds,Non-Binary/Other,40,19,0,9,4.3,2.4,3.2,0,0,0,0,5,3.4,3.8
4338,0,Europe,Manufacturing,Regulatory Affairs,Exceeds,Male,32,12,0,11,4.3,1.7,1,1,1,1,1,4.4,4.6,1.2
4339,1,Asia Pacific,Manufacturing,Quality Assurance,Exceeds,Female,32,18,0,10,3.2,2.6,1.1,1,1,1,1,3.9,4.4,1.2
4340,0,Asia Pacific,R&D,Market Access,Meets,Male,29,2,1,5,,2.7,3.9,1,0,0,0,3.4,3.5,3.1
4341,0,Middle East & Africa,Commercial,Marketing,Below,Male,36,15,0,9,3,2.7,3,1,1,1,0,2.8,1.9,2
4342,0,Middle East & Africa,Commercial,Supply Chain,Meets,Female,43,5,0,12,3.3,2.5,3.4,1,1,1,1,3.7,2.3,3.5
4343,0,Middle East & Africa,R&D,Finance & Accounting,Meets,Female,40,6,0,11,4.8,3.3,2.8,1,1,1,1,4.1,4.1,3.7
4344,0,Europe,Digital,Clinical Operations,Below,Female,38,14,0,9,3.6,2,3,1,0,0,0,2.9,3.7,2.5
4345,0,Asia Pacific,Finance,Data Science,Meets,Male,46,1,0,12,1.7,4.8,3.6,1,1,1,1,2,3.6,3.4
4346,1,North America,Finance,Communications,Meets,Female,36,36,0,7,3.1,2.9,1,0,0,0,0,2.8,4.7,2.2
4347,0,Latin America,Finance,Clinical Operations,Meets,Male,41,11,0,7,5,2.8,2,1,1,1,1,3.1,3.6,3.4
4348,0,Middle East & Africa,Finance,Market Access,Exceeds,Male,36,11,0,5,3.6,3.3,3.9,1,0,0,0,4.2,4.4,2.9
4349,0,Middle East & Africa,Finance,Clinical Operations,Below,Female,29,4,0,7,2.9,2.9,3.1,1,1,1,1,2.2,2.9,1.8
4350,0,Asia Pacific,R&D,IT & Digital,Meets,Female,33,8,0,9,1.6,2.8,3.7,1,1,1,1,1.4,4,4.5
4351,0,Asia Pacific,Commercial,IT & Digital,Below,Non-Binary/Other,33,24,0,9,4.4,4.2,2.7,1,1,1,1,2.7,3,2.2
4352,0,Europe,Digital,Human Resources,Below,Male,29,5,0,11,5,3.4,3.4,1,1,1,1,3.2,2.8,3.9
4353,0,Europe,Manufacturing,Finance & Accounting,Below,Female,37,19,0,11,4.1,3.2,2.3,1,0,0,0,3.9,3.9,3
4354,0,Middle East & Africa,Finance,Clinical Operations,Meets,Female,34,6,0,12,3.3,2.3,1.4,0,0,0,0,3.4,2,2.9
4355,0,Asia Pacific,R&D,Medical Affairs,Meets,Female,47,9,0,8,2.7,3,3.7,1,1,1,1,3.1,2.1,3.2
4356,0,North America,Digital,Finance & Accounting,Exceeds,Male,37,11,0,10,3.3,1.7,2.2,1,1,1,1,5,1.1,3.2
4357,0,Latin America,Digital,Supply Chain,Exceeds,Female,33,6,0,9,3.1,3.7,2.6,1,1,1,1,4.1,2.5,3.2
4358,0,Asia Pacific,Digital,Supply Chain,Meets,Female,31,9,1,11,,4.2,2.8,1,0,0,0,3.7,2.7,2.2
4359,0,Asia Pacific,R&D,IT & Digital,Below,Male,31,14,0,12,3.9,3.8,2.9,1,1,1,1,3.4,2.2,3.8
4360,0,Europe,Manufacturing,Finance & Accounting,Meets,Female,43,16,0,6,3.6,2.6,3.1,1,1,1,1,3.3,4.2,4.2
4361,0,Latin America,Finance,Sales,Meets,Male,44,11,1,8,,1.4,2.8,1,0,0,0,2.1,1.6,1.5
4362,0,Middle East & Africa,Digital,IT & Digital,Meets,Female,28,6,1,9,,2.9,1.7,1,1,0,0,2.2,2.8,2.4
4363,0,Asia Pacific,R&D,Marketing,Far Exceeds,Non-Binary/Other,51,8,0,9,4.7,4.2,2,1,1,1,1,4.3,3.2,2.2
4364,0,Middle East & Africa,Commercial,Regulatory Affairs,Far Below,Male,38,11,0,7,2.5,3.4,1.9,0,0,0,0,2.8,4.2,3.8
4365,1,Asia Pacific,R&D,Sales,Meets,Female,44,16,0,8,2.8,3.1,3.9,1,1,1,1,3,2.1,3.4
4366,0,Middle East & Africa,R&D,Supply Chain,Meets,Male,33,18,1,10,,3.6,1.8,1,1,1,1,4.7,2.8,3
4367,0,Latin America,R&D,Legal & Compliance,Exceeds,Female,32,11,0,8,3,2.8,1.8,1,1,1,1,1.8,3.1,2
4368,0,Europe,Digital,Pharmacovigilance,Meets,Female,37,8,0,10,3.4,3,2.9,1,1,1,1,3.2,1.9,2.3
4369,0,Latin America,R&D,Marketing,Meets,Male,40,14,0,5,3.2,3.8,2.4,0,0,0,0,3.1,3.6,4.4
4370,0,North America,Commercial,IT & Digital,Meets,Male,39,5,1,12,,2.5,2.7,1,1,1,1,4.7,4.4,1.8
4371,1,Europe,Digital,Legal & Compliance,Exceeds,Female,45,5,0,8,2.4,2.7,2.5,1,1,1,1,5,4.8,2.7
4372,0,Latin America,Commercial,Market Access,Meets,Female,28,26,0,11,3.9,4.2,3.6,1,1,1,1,3.1,4.1,3.7
4373,0,North America,HR,Medical Affairs,Below,Male,43,8,1,5,,2.4,1.5,1,1,1,1,3.5,3,2.2
4374,0,Asia Pacific,R&D,Data Science,Meets,Male,41,22,0,12,5,1.6,2.8,1,1,1,0,5,1,1.6
4375,0,Asia Pacific,Finance,Pharmacovigilance,Meets,Male,40,17,0,7,2.7,1.9,3,1,1,1,1,3.2,3.2,1
4376,0,Middle East & Africa,Finance,Supply Chain,Meets,Male,30,16,0,11,3.2,3.4,1.6,1,1,1,1,1.8,3.3,1.6
4377,0,Europe,Digital,Human Resources,Far Exceeds,Female,33,28,0,6,2.3,4.2,2.3,1,1,1,1,2.1,3.2,3.9
4378,1,Asia Pacific,Finance,Legal & Compliance,Meets,Male,42,14,0,10,2.7,5,2.2,1,1,1,1,3.9,3.6,2.8
4379,1,Europe,Digital,Finance & Accounting,Meets,Female,28,17,0,10,1.7,2.5,1,1,1,1,1,3.5,3.5,1.7
4380,1,Asia Pacific,R&D,Marketing,Meets,Male,28,8,0,9,2.6,1.4,2.7,1,1,1,1,2.7,2.2,3.2
4381,0,Middle East & Africa,Manufacturing,Supply Chain,Exceeds,Male,41,14,0,6,2.9,5,3.5,1,1,1,1,2.5,4.9,5
4382,0,Latin America,Manufacturing,Communications,Exceeds,Male,41,15,0,12,4.3,4,1,1,1,1,1,2.8,5,2.4
4383,0,Middle East & Africa,Commercial,Quality Assurance,Meets,Female,34,30,0,12,4.3,2.9,2.5,0,0,0,0,4.5,2.3,2.5
4384,0,North America,R&D,Sales,Meets,Male,34,11,0,5,3.7,2.7,3.4,0,0,0,0,3.3,2,3.2
4385,0,Asia Pacific,Finance,Data Science,Meets,Non-Binary/Other,44,28,0,11,1.9,2.8,2.5,0,0,0,0,1,4.3,3.7
4386,0,North America,R&D,Data Science,Meets,Male,43,14,0,9,3.3,2.8,3.7,0,0,0,0,5,3,2.1
4387,0,North America,HR,Finance & Accounting,Meets,Male,36,15,1,12,,3.3,1,1,1,1,1,4.3,3.3,1.5
4388,0,Europe,Manufacturing,Regulatory Affairs,Meets,Male,31,8,0,11,2.3,3.5,2.4,1,1,1,1,1.8,2.9,2.7
4389,0,Asia Pacific,Finance,Quality Assurance,Meets,Male,47,11,0,10,2.4,4,1.9,1,1,1,1,1.7,3.5,2.2
4390,0,North America,Manufacturing,Clinical Operations,Meets,Female,30,6,0,8,3.3,2.7,1.4,1,1,1,1,2.4,2.8,2.7
4391,0,Latin America,R&D,IT & Digital,Meets,Female,42,15,0,12,4.4,4.3,4.9,1,1,1,1,2.6,3.3,4.8
4392,0,North America,Finance,Quality Assurance,Far Exceeds,Male,45,24,0,9,3.9,2.6,3,1,1,1,1,4.1,3.1,3.9
4393,0,Latin America,Commercial,Data Science,Meets,Female,38,16,0,5,2.1,3.5,3.7,1,1,1,1,1.3,3.1,3.8
4394,0,Europe,R&D,Pharmacovigilance,Meets,Female,34,20,0,8,3.6,1.3,3,1,1,1,1,4.9,3.3,1.9
4395,0,North America,Commercial,IT & Digital,Meets,Non-Binary/Other,28,5,0,12,3.9,2.5,4.7,0,0,0,0,4.4,2.9,3.1
4396,0,Middle East & Africa,Finance,Legal & Compliance,Meets,Male,38,21,0,5,3.1,3.4,3.5,1,1,1,1,4.4,2.5,3.8
4397,0,Europe,Manufacturing,IT & Digital,Meets,Male,29,3,1,9,,2,1,1,1,1,1,3.5,3.3,1.6
4398,0,Latin America,HR,Human Resources,Meets,Female,40,25,0,12,3,2.3,3.7,1,1,1,1,3.4,3.4,3.6
4399,0,Europe,Digital,Regulatory Affairs,Below,Male,28,26,0,5,4.4,3.8,3.7,1,1,1,1,4,2.8,2.6
4400,0,North America,Manufacturing,Market Access,Meets,Female,28,8,1,8,,1.8,2.4,1,0,0,0,4.2,3.8,3.3
4401,1,Asia Pacific,Commercial,Pharmacovigilance,Meets,Female,39,3,0,11,4.1,3.3,4.2,1,1,1,1,3.1,1.3,2.9
4402,0,Asia Pacific,R&D,Marketing,Meets,Male,43,9,0,6,3.2,4.3,2.1,1,1,1,1,3.2,3.1,4.6
4403,1,Latin America,Finance,Clinical Operations,Meets,Female,36,9,0,9,3.9,4.1,1.2,0,0,0,0,3.5,4.2,1.2
4404,0,Latin America,Manufacturing,Sales,Meets,Female,44,14,0,6,5,5,2.8,1,1,1,1,4.4,4.3,4
4405,0,Asia Pacific,HR,Market Access,Meets,Female,35,6,1,10,,3.1,2.8,1,1,1,1,1.8,4.4,3.8
4406,0,Latin America,Finance,Pharmacovigilance,Exceeds,Female,51,3,0,12,2.9,3.6,2.1,1,1,1,1,3.5,3.7,3.3
4407,0,Europe,Commercial,Finance & Accounting,Exceeds,Female,30,4,0,6,3.9,3.3,4.5,1,1,1,1,4.2,1.4,3
4408,0,Middle East & Africa,Finance,Marketing,Meets,Male,34,17,0,10,2.1,3.5,1.8,1,1,1,1,3.1,3.1,2.1
4409,0,Middle East & Africa,Finance,Supply Chain,Meets,Female,46,21,0,9,3.9,3.5,4.6,1,1,1,1,4.2,3.3,4.3
4410,0,Europe,R&D,Medical Affairs,Meets,Male,36,14,0,7,4.3,1.9,2.1,1,1,1,1,3.5,4.4,1.9
4411,0,Middle East & Africa,Digital,Clinical Operations,Below,Male,44,9,0,5,1.9,3.3,1.6,1,1,1,1,1.6,4.4,2.1
4412,0,North America,Commercial,Sales,Below,Male,30,6,0,5,4.4,4.8,1.9,1,1,1,1,4.6,3.8,1.7
4413,0,Europe,R&D,Regulatory Affairs,Below,Female,32,6,0,8,2.5,3.7,2.9,1,1,1,1,4.3,3.4,4
4414,0,Latin America,Digital,Quality Assurance,Meets,Male,42,3,1,12,,2.6,1.8,1,1,1,1,2.9,3.4,1
4415,0,Europe,R&D,Medical Affairs,Below,Female,29,9,1,11,,3.9,4.4,1,1,1,1,3.7,3.4,4.7
4416,0,Asia Pacific,Digital,Clinical Operations,Meets,Female,31,13,1,12,,1.4,5,1,1,1,1,1,2.1,5
4417,0,Latin America,Digital,Market Access,Meets,Male,37,8,1,12,,3.6,2.9,1,1,1,1,2.9,4,3
4418,0,Asia Pacific,Digital,Supply Chain,Far Below,Male,46,6,0,10,2.4,1,2.7,1,1,1,1,3.2,1.6,1.3
4419,0,Latin America,R&D,IT & Digital,Below,Male,40,13,0,10,2.1,2,3,1,1,1,1,1.8,1.9,4
4420,1,Middle East & Africa,Finance,Human Resources,Exceeds,Male,37,13,0,8,3.1,2.4,3,1,1,1,1,4.9,3.6,4
4421,0,Europe,Digital,Regulatory Affairs,Meets,Male,39,10,0,9,3.1,2.2,1.9,1,1,1,1,3.3,3.2,2.6
4422,0,North America,Finance,Data Science,Meets,Male,28,15,1,7,,3.8,1.1,1,1,1,1,4.9,3.2,3.5
4423,0,Latin America,Commercial,Legal & Compliance,Far Below,Female,35,4,1,6,,2.5,3.8,1,1,1,1,5,3.6,3.5
4424,0,Latin America,HR,Pharmacovigilance,Meets,Female,41,20,1,6,,1.8,3.3,1,1,1,1,2.8,2,2.7
4425,0,Asia Pacific,Finance,Communications,Meets,Female,39,30,0,12,3.6,2.6,2.9,1,1,1,1,2.9,3.4,3.7
4426,0,Middle East & Africa,HR,Finance & Accounting,Far Exceeds,Male,42,10,0,6,4,2.8,3.1,1,1,0,0,4.7,3.6,4.1
4427,0,Asia Pacific,Digital,Pharmacovigilance,Meets,Male,42,4,1,12,,3.3,2,1,1,1,0,3.2,4.9,2.1
4428,1,Asia Pacific,HR,Regulatory Affairs,Far Exceeds,Female,39,3,0,9,4.3,2.6,2,1,1,1,1,2.8,3.3,1
4429,0,Middle East & Africa,HR,Data Science,Exceeds,Female,28,15,1,7,,4,3,1,1,1,1,2.4,3.4,2.3
4430,0,North America,Digital,Human Resources,Meets,Male,40,20,0,5,2.7,3.4,3,1,1,0,0,3.8,4.9,3.3
4431,0,Asia Pacific,Finance,IT & Digital,Meets,Male,35,6,1,8,,2.8,5,1,1,1,1,4.3,3.9,4.3
4432,0,Asia Pacific,Digital,Pharmacovigilance,Exceeds,Female,36,6,0,10,1.5,4,1.4,1,1,1,1,2.8,2.9,2.6
4433,0,Latin America,Commercial,Clinical Operations,Meets,Male,36,10,0,6,3.8,5,2.8,1,1,1,1,4,3.8,3.7
4434,0,Middle East & Africa,Manufacturing,Regulatory Affairs,Below,Male,40,12,0,9,3.7,3.1,4.2,1,1,1,1,2.6,5,3.5
4435,0,Europe,R&D,Human Resources,Meets,Male,29,17,1,9,,1.3,1,1,1,1,1,3,4,1.7
4436,0,North America,Digital,Regulatory Affairs,Below,Female,28,9,0,10,3.4,3,1,0,0,0,0,3.7,1.7,1
4437,0,North America,Digital,Market Access,Meets,Female,31,12,0,10,4.5,4.5,2.3,1,1,1,1,4.5,3.8,3
4438,0,Middle East & Africa,HR,Legal & Compliance,Meets,Male,44,7,1,11,,2.7,1.8,1,1,1,1,4.3,4,1.5
4439,0,Latin America,Commercial,Data Science,Far Exceeds,Male,35,20,0,7,4,3.2,1.3,1,1,1,1,3.9,4.4,1.9
4440,0,Latin America,HR,Market Access,Meets,Female,41,2,0,7,4.6,1.8,2.8,1,1,1,1,3.5,2.3,2.9
4441,0,Middle East & Africa,Finance,Data Science,Exceeds,Male,41,13,1,5,,3.6,2.8,1,1,1,0,2.9,5,2.4
4442,0,Latin America,Digital,Market Access,Meets,Male,40,17,0,11,4.4,2.3,2.2,1,1,1,1,4.7,2.5,2.8
4443,1,North America,Digital,Finance & Accounting,Meets,Male,41,26,0,12,2.8,4.2,4.4,1,1,1,1,4.7,2.6,5
4444,0,North America,HR,Regulatory Affairs,Exceeds,Male,35,16,0,6,4.1,2.4,4.3,1,1,1,1,2.5,3,3.9
4445,0,Europe,Digital,Quality Assurance,Meets,Female,42,4,0,7,3.6,1.5,1.6,1,1,1,1,4.9,3.8,2.1
4446,0,Middle East & Africa,Finance,Quality Assurance,Meets,Female,40,19,0,5,3.1,3.4,3.4,1,1,1,1,3.1,2.3,3.2
4447,0,Asia Pacific,Manufacturing,Quality Assurance,Meets,Female,28,13,0,9,4,2.6,1,1,1,1,1,4.5,1,1
4448,0,Asia Pacific,R&D,Regulatory Affairs,Meets,Female,38,19,0,10,2.4,1.7,1.9,1,1,1,1,2.5,2.8,3
4449,0,Europe,R&D,Communications,Exceeds,Non-Binary/Other,37,12,0,7,2.5,3.9,2.8,1,1,1,1,3,4.2,2.9
4450,1,Europe,R&D,Finance & Accounting,Meets,Non-Binary/Other,41,3,0,8,3,2.9,1.6,1,1,1,1,4,2.3,3.1
4451,0,Latin America,Manufacturing,Pharmacovigilance,Meets,Male,38,10,0,9,3.2,4.1,3.7,1,1,1,1,2.8,3.2,4.3
4452,0,Europe,Digital,Human Resources,Meets,Male,37,8,1,11,,2.6,1,1,1,1,1,4.7,3.6,2.5
4453,0,Europe,HR,Supply Chain,Below,Female,47,4,0,7,4.2,2.8,1.5,0,0,0,0,3.8,4,2.6
4454,0,Asia Pacific,Commercial,IT & Digital,Meets,Female,42,7,1,9,,3.6,2.2,1,1,1,0,3.8,5,3.5
4455,0,Latin America,Digital,Sales,Below,Female,38,4,0,6,4.3,3.7,2.7,1,1,1,1,3.4,3.3,1.9
4456,0,Europe,Manufacturing,Supply Chain,Meets,Female,31,3,0,10,3.7,2.1,2.3,1,1,1,1,4.5,1.8,2.8
4457,0,Europe,Finance,Quality Assurance,Meets,Male,39,7,1,8,,3,2.3,1,1,1,1,3.3,2.5,2.3
4458,0,Latin America,Manufacturing,Pharmacovigilance,Meets,Male,33,10,0,10,2.5,5,3,1,1,1,1,3,3.7,3.1
4459,0,Middle East & Africa,R&D,Regulatory Affairs,Meets,Male,28,12,0,9,1.8,4.8,4.1,1,1,1,1,1.8,3.4,4
4460,0,Latin America,Digital,Marketing,Exceeds,Female,36,36,0,6,3.4,3.5,3.5,1,1,1,1,2.9,3.3,2.8
4461,0,Asia Pacific,R&D,Pharmacovigilance,Meets,Non-Binary/Other,36,25,0,9,1.7,5,3.7,1,1,1,1,2.3,2.9,2.7
4462,0,Middle East & Africa,Commercial,Finance & Accounting,Far Exceeds,Male,44,7,0,5,4.7,3.4,2.8,1,1,1,1,3.3,3.3,4
4463,0,North America,Finance,Marketing,Meets,Female,44,6,0,10,4.2,2.4,1,1,1,1,1,3.3,3.2,1.9
4464,1,Latin America,R&D,Regulatory Affairs,Meets,Female,42,11,0,8,2.9,4.4,3.1,1,1,1,1,5,3,3.7
4465,0,Asia Pacific,Commercial,Clinical Operations,Below,Male,37,11,0,6,2.5,1.7,2.2,1,1,1,1,2.3,2.4,3
4466,0,Middle East & Africa,Manufacturing,IT & Digital,Meets,Female,38,12,0,10,2.2,2.3,4.1,1,1,1,1,3.1,4.4,4.5
4467,0,Latin America,R&D,Data Science,Below,Female,41,18,0,6,2.8,3.2,2.2,1,0,0,0,3.2,2.8,2.4
4468,0,Europe,R&D,Human Resources,Meets,Male,42,18,0,6,3.1,4.5,2.6,1,1,1,1,3.4,4.7,3.6
4469,0,Latin America,HR,Sales,Meets,Male,40,20,0,5,1.8,4.3,3.9,1,1,1,1,3,2.3,2.9
4470,0,North America,Finance,Supply Chain,Meets,Male,41,8,0,5,2.8,1.8,1,1,1,1,1,3.5,2.4,2
4471,0,Latin America,Finance,Market Access,Meets,Male,38,6,0,7,3,2.1,3.8,1,1,1,1,1.7,2.8,4
4472,0,Middle East & Africa,Manufacturing,Market Access,Meets,Male,36,7,1,11,,2,3.5,1,1,1,1,3.7,3.4,3.2
4473,0,Middle East & Africa,HR,Data Science,Meets,Male,28,7,0,5,3.5,3.1,3.9,0,0,0,0,3.7,4.6,2.7
4474,0,Latin America,Commercial,Pharmacovigilance,Below,Female,36,6,0,11,2.8,3.3,4.2,1,1,1,1,3.1,2.9,3.9
4475,0,Middle East & Africa,Commercial,Market Access,Meets,Female,34,9,0,9,2.8,2.8,2.5,1,1,1,1,3.7,2.8,1.3
4476,0,Europe,Manufacturing,IT & Digital,Meets,Female,39,15,0,12,2.3,2.6,3.2,0,0,0,0,3.2,1.3,1.5
4477,0,Latin America,Finance,Medical Affairs,Meets,Female,34,11,0,5,4.2,2.4,3.8,1,1,1,1,3.6,4.2,4.9
4478,0,Europe,Commercial,Market Access,Below,Female,39,9,0,5,3.3,4.5,2.7,1,1,1,1,4.4,4.3,2.7
4479,0,Europe,Manufacturing,Regulatory Affairs,Meets,Female,28,5,1,10,,2.3,2.4,1,1,1,1,3.1,2.8,4.3
4480,0,Asia Pacific,Commercial,Data Science,Below,Male,32,4,0,7,2.8,1.7,3.6,0,0,0,0,4.8,1.8,2.9
4481,0,Latin America,Digital,Sales,Below,Male,34,10,0,7,2.4,5,2.5,1,1,1,1,1.7,3.5,3
4482,0,Middle East & Africa,R&D,Data Science,Below,Male,32,13,0,8,3.8,3.1,1,1,1,1,1,3.9,4.1,2.3
4483,0,Europe,Finance,Sales,Meets,Female,55,16,0,11,4.2,3.4,2.9,1,1,0,0,5,4,4.2
4484,1,Asia Pacific,Digital,Medical Affairs,Meets,Female,28,9,0,5,2.7,2.4,3.6,1,1,1,1,4.1,1.5,3.3
4485,0,Latin America,Manufacturing,Finance & Accounting,Exceeds,Female,42,14,0,7,1.9,3.3,1,1,1,1,1,5,4.4,1.7
4486,0,Latin America,Manufacturing,Human Resources,Meets,Female,44,12,0,11,3.5,2.2,1.3,1,1,1,0,4.2,3,2.3
4487,0,North America,Digital,Market Access,Meets,Female,35,9,0,6,2.1,2.1,3.3,1,1,1,1,2.6,2,2.9
4488,0,North America,R&D,Finance & Accounting,Far Exceeds,Female,40,5,0,10,4.1,2.4,3.2,1,1,1,1,4,4,2.4
4489,0,Europe,R&D,Data Science,Meets,Non-Binary/Other,42,14,0,11,2.4,2.2,2.4,1,1,1,0,4.1,3.9,3.7
4490,0,North America,HR,IT & Digital,Meets,Female,39,7,1,11,,4.2,3.7,1,1,1,1,3.2,4.5,3.4
4491,0,Europe,Commercial,Marketing,Far Exceeds,Female,28,7,1,9,,3,1.8,1,1,1,1,2.8,3.1,2.5
4492,1,Middle East & Africa,HR,Quality Assurance,Far Exceeds,Female,40,34,0,5,4.2,4.2,4.2,1,1,1,1,4,2.2,3.8
4493,0,Europe,R&D,Finance & Accounting,Meets,Male,44,17,0,11,2.3,3.6,1.9,1,1,1,1,3,2.6,3
4494,0,North America,Digital,IT & Digital,Meets,Male,50,19,1,6,,5,4.1,1,1,1,1,1.4,5,3.8
4495,0,Middle East & Africa,Commercial,Medical Affairs,Meets,Male,30,7,0,12,3.4,2.6,3.6,1,1,1,1,3.1,2.4,5
4496,0,North America,Digital,Pharmacovigilance,Meets,Male,37,9,0,10,4.3,2.5,1.2,1,1,1,1,3,1.4,1
4497,0,Europe,HR,Marketing,Exceeds,Non-Binary/Other,38,12,0,11,3.7,3.7,1.4,1,1,1,1,2.9,4.3,1.9
4498,0,Asia Pacific,Manufacturing,Sales,Meets,Male,37,12,0,11,3.2,3.6,3.3,0,0,0,0,2.9,1.2,2.6
4499,0,Latin America,Digital,Data Science,Exceeds,Male,28,9,0,7,3.6,2.8,2.3,1,0,0,0,2.2,3.4,2.9
4500,0,North America,HR,Sales,Meets,Female,45,6,1,7,,3.7,4.7,1,1,1,1,3.8,3.5,4.6
4501,0,Europe,HR,Sales,Meets,Female,44,8,1,10,,2,3.8,1,1,1,1,5,3.1,4.4
4502,0,Middle East & Africa,HR,Legal & Compliance,Meets,Female,40,8,1,5,,3.5,3,1,1,1,1,4.4,3.2,1.9
4503,0,North America,Manufacturing,Communications,Meets,Male,35,11,1,10,,2.4,1,1,1,1,1,2.3,1.9,2.3
4504,0,North America,Manufacturing,IT & Digital,Below,Female,37,17,0,9,2,2.8,1.6,1,1,1,1,4.1,2.6,2.4
4505,0,Latin America,Manufacturing,IT & Digital,Far Exceeds,Male,36,17,0,10,3.8,2.1,2.3,1,1,1,1,2.4,1.4,4.4
4506,0,Europe,Commercial,Medical Affairs,Meets,Non-Binary/Other,30,6,0,7,2.6,2.5,1.3,1,1,0,0,3.4,2.4,3.2
4507,0,Asia Pacific,Manufacturing,IT & Digital,Meets,Female,42,5,0,5,2.5,2.3,1.4,1,1,1,1,3.8,1.8,1
4508,0,Middle East & Africa,Manufacturing,Marketing,Exceeds,Female,38,18,0,12,5,3.6,1.4,1,1,1,1,4.6,3.1,3.5
4509,0,Europe,Manufacturing,Data Science,Far Exceeds,Male,42,5,1,6,,4.8,1.9,1,1,1,1,3,4.4,2.8
4510,0,Middle East & Africa,Digital,Market Access,Exceeds,Female,40,4,0,9,2.5,1.6,3.2,1,1,1,1,2.5,2.1,3.1
4511,0,North America,Manufacturing,Clinical Operations,Meets,Female,32,8,1,12,,3.8,2.7,1,1,1,1,3.2,5,1.5
4512,0,Latin America,Commercial,Supply Chain,Meets,Male,32,24,0,8,3.3,4,2.8,1,1,1,1,2.3,4.4,2.5
4513,0,Latin America,HR,Supply Chain,Meets,Male,46,16,0,6,4.3,2.9,2.1,1,1,1,1,2.7,1,4.1
4514,0,Asia Pacific,Digital,IT & Digital,Meets,Non-Binary/Other,41,5,0,9,2,2,2.6,0,0,0,0,3.2,2.8,2.8
4515,0,Latin America,R&D,Medical Affairs,Exceeds,Male,36,10,1,8,,2.2,3.2,0,0,0,0,2.8,2.8,3
4516,0,North America,Manufacturing,Pharmacovigilance,Meets,Female,41,10,0,11,2.8,3.7,1.7,1,1,1,1,3.9,3.2,3.3
4517,0,Asia Pacific,HR,IT & Digital,Far Below,Female,33,10,1,6,,2.5,2.8,1,1,1,1,1.8,3.4,1.4
4518,0,Europe,HR,Regulatory Affairs,Below,Male,45,17,0,5,4.6,2.9,1,1,1,1,1,5,3.5,1.5
4519,0,Latin America,Digital,Communications,Exceeds,Male,30,17,0,11,3.7,1.5,4.1,1,1,1,1,4.1,2.1,3.9
4520,0,Asia Pacific,R&D,Finance & Accounting,Exceeds,Non-Binary/Other,39,14,1,6,,3.5,2.7,1,1,1,1,3.1,3.1,5
4521,0,North America,Finance,Clinical Operations,Meets,Female,37,15,0,7,3.7,4.1,4.5,1,1,1,1,3.4,4,4.5
4522,0,Middle East & Africa,Commercial,Communications,Meets,Male,38,3,1,8,,2.2,2.9,1,1,1,1,3.6,2.3,2.1
4523,0,Middle East & Africa,Finance,Data Science,Meets,Female,42,21,0,10,2.8,2.5,3.6,1,1,1,1,3.7,4.8,3.5
4524,0,North America,HR,Supply Chain,Meets,Male,44,6,1,6,,1.7,2.5,1,1,1,1,3.1,4.7,2.6
4525,0,North America,Finance,Pharmacovigilance,Meets,Female,36,3,0,8,3.5,2.8,2.3,0,0,0,0,3.3,3.6,2.4
4526,0,Middle East & Africa,HR,Regulatory Affairs,Meets,Male,28,11,1,10,,3.2,3.2,1,1,1,1,2.8,3,2.9
4527,0,Asia Pacific,Finance,Marketing,Meets,Male,28,8,1,9,,3.3,4.2,1,1,1,1,2.6,5,3.6
4528,0,Middle East & Africa,HR,Data Science,Meets,Male,36,24,0,5,3.1,4.2,2.3,1,1,1,1,2.9,4.2,1.5
4529,0,North America,HR,Sales,Meets,Male,38,9,0,6,4.7,4.2,3.4,1,1,1,1,4.9,4.2,3.8
4530,0,Latin America,Digital,IT & Digital,Exceeds,Female,40,22,0,12,3.3,3.6,2.5,1,1,1,1,2.4,2.9,2.5
4531,0,Europe,R&D,Pharmacovigilance,Exceeds,Female,39,12,0,12,1.8,1.6,3.7,1,1,1,1,3,3.4,2.6
4532,0,Latin America,HR,Data Science,Exceeds,Female,43,24,0,10,2.2,3.6,3.5,1,1,1,1,2.6,4.9,1.7
4533,1,Latin America,Commercial,Clinical Operations,Exceeds,Female,49,16,0,8,2.4,1.8,3.3,1,1,1,1,2.5,1.5,3.1
4534,0,North America,Commercial,Sales,Meets,Male,39,5,0,11,5,3,1,1,1,1,1,4.6,3.3,1.8
4535,0,Middle East & Africa,Manufacturing,Clinical Operations,Meets,Female,40,9,0,6,2.5,3.4,3.8,1,1,1,1,2.6,4.5,4.5
4536,0,Asia Pacific,HR,Quality Assurance,Meets,Female,33,3,0,12,2.5,2.7,1.2,1,1,1,1,2.3,3.5,2.5
4537,0,Latin America,HR,Supply Chain,Meets,Male,38,5,0,5,3.5,4.6,1,1,1,1,1,3.7,4.3,1.8
4538,0,Middle East & Africa,HR,Communications,Meets,Male,39,2,0,9,4.6,2.8,4.7,1,1,1,1,3.4,3.2,3.1
4539,0,Asia Pacific,Finance,Human Resources,Meets,Female,39,13,0,12,3,3.2,2.8,1,1,1,1,3.6,4,2.2
4540,0,Latin America,HR,Regulatory Affairs,Meets,Male,33,3,1,7,,4.4,4.1,1,1,1,1,2.5,5,3.6
4541,0,Asia Pacific,HR,Legal & Compliance,Meets,Male,39,11,1,12,,2.3,1.6,1,1,1,1,3.4,2,1.5
4542,0,Middle East & Africa,Commercial,Human Resources,Below,Female,39,12,0,10,3.4,2.8,3.5,1,1,1,1,2.6,2.9,1.7
4543,0,Europe,R&D,Pharmacovigilance,Below,Female,40,11,0,11,3.5,4.2,1,0,0,0,0,3.9,3.9,2.1
4544,0,Middle East & Africa,R&D,Sales,Meets,Female,36,8,1,12,,3.6,1.6,1,1,1,1,2.4,1.9,2.4
4545,0,North America,Manufacturing,Supply Chain,Meets,Female,38,8,0,7,3.4,3.2,4.3,1,1,1,1,3.9,3.9,4.2
4546,0,Asia Pacific,Commercial,Medical Affairs,Meets,Male,51,3,0,7,3.9,1.6,2.4,1,1,1,1,4.2,3.9,2.7
4547,0,Europe,HR,IT & Digital,Below,Female,38,13,0,8,2.9,2.8,2.7,1,1,1,1,2.5,4.1,2.8
4548,0,Asia Pacific,R&D,Finance & Accounting,Meets,Female,44,7,0,8,2.8,2,4,1,1,1,1,1.9,2.6,3.2
4549,0,Asia Pacific,Digital,Clinical Operations,Meets,Female,47,6,1,12,,3.9,2.6,1,1,0,0,2.5,4.3,4.1
4550,0,Latin America,Digital,Legal & Compliance,Meets,Male,29,4,0,9,4.1,3.1,1.6,1,1,1,1,4,3.6,1
4551,0,North America,Digital,Quality Assurance,Below,Female,37,11,0,7,3.1,1.4,1.8,1,1,1,1,3.4,2.4,3.3
4552,0,Asia Pacific,HR,Finance & Accounting,Far Exceeds,Female,37,18,0,5,2.8,1.4,2,1,1,1,1,3,1.7,1.7
4553,0,Middle East & Africa,HR,Clinical Operations,Meets,Female,50,13,0,9,4.8,2.4,3.8,1,1,1,1,5,3.9,3.4
4554,0,Middle East & Africa,Manufacturing,Data Science,Meets,Male,49,27,0,7,3.8,1.8,3.9,1,1,1,1,2.8,1,3.1
4555,0,Latin America,Manufacturing,Marketing,Meets,Male,29,5,1,7,,2.6,2.3,1,1,1,1,3.5,3.2,2.5
4556,0,North America,Manufacturing,Quality Assurance,Meets,Male,32,9,0,9,2.1,3.6,2.1,1,1,1,1,2.2,4.7,2.9
4557,0,North America,Finance,Quality Assurance,Far Exceeds,Male,45,4,0,8,3.7,2.2,2.1,1,1,1,1,3.3,3.1,3.6
4558,0,Middle East & Africa,Digital,Regulatory Affairs,Below,Female,35,5,0,7,2.3,3.8,2.3,1,1,1,1,2.7,2.8,2.5
4559,0,Europe,HR,Pharmacovigilance,Meets,Female,42,16,0,10,4,2.6,3,1,1,1,1,2.2,2.2,2.4
4560,0,Latin America,Digital,Medical Affairs,Meets,Female,37,11,0,10,4.6,3.4,3.8,1,1,1,1,2.1,2.9,3.6
4561,0,Latin America,Manufacturing,Medical Affairs,Meets,Female,32,9,1,6,,1.6,3,1,1,1,1,4.4,2.2,3.9
4562,0,Middle East & Africa,HR,Communications,Far Below,Male,46,12,0,12,4.4,4,2.3,1,1,1,1,4,3.8,1.6
4563,0,Middle East & Africa,Commercial,Legal & Compliance,Below,Female,34,5,1,5,,4.3,1.5,1,1,1,1,2.8,2.8,4.2
4564,0,Europe,R&D,Regulatory Affairs,Meets,Male,37,2,0,7,4.1,2.8,1.5,1,1,1,1,3.4,3.3,3
4565,0,Europe,R&D,Clinical Operations,Meets,Male,31,4,0,6,3,2.6,3.8,1,1,1,1,1.5,2.3,3.3
4566,0,North America,Manufacturing,Market Access,Meets,Male,31,11,1,7,,3.1,3.1,1,1,1,1,4,3.6,3.7
4567,0,Latin America,Digital,Supply Chain,Meets,Female,38,7,1,8,,2.9,2.9,1,1,1,1,2.9,4.6,3.1
4568,0,Latin America,Commercial,Human Resources,Meets,Male,32,21,0,7,3.1,2.6,2.1,0,0,0,0,2.6,3.4,3.1
4569,0,Middle East & Africa,HR,Market Access,Meets,Male,47,16,0,7,3,5,3.9,1,1,1,1,2.3,3.4,4
4570,0,North America,Digital,Data Science,Exceeds,Female,42,9,0,10,3.7,4,2.7,1,1,1,0,3.6,3.7,3
4571,0,Latin America,Manufacturing,Medical Affairs,Meets,Male,43,8,1,8,,3.5,2.3,1,1,1,1,2.7,3.7,2.8
4572,0,North America,Digital,Human Resources,Meets,Male,36,12,0,5,2,3.3,2.8,1,1,1,1,1.6,1.7,2.7
4573,0,North America,Manufacturing,Pharmacovigilance,Meets,Female,36,6,0,5,4.2,1.5,1,1,1,1,1,5,2.1,1.8
4574,0,Middle East & Africa,Finance,Marketing,Meets,Male,41,12,0,7,3,2.7,2.7,1,1,1,0,3.4,4,1.8
4575,0,North America,R&D,Legal & Compliance,Meets,Female,28,18,0,5,4.5,2.6,2.4,1,1,1,1,4.8,3.8,1
4576,0,Europe,R&D,Clinical Operations,Far Below,Female,35,35,0,12,4.2,4.1,4.4,1,1,1,1,3,2.2,3.5
4577,0,Europe,Digital,Pharmacovigilance,Below,Male,28,14,0,11,3.6,2.1,1.9,1,1,1,1,4.6,3.1,1.9
4578,0,Asia Pacific,Commercial,Pharmacovigilance,Exceeds,Male,39,3,1,12,,3.5,3.5,1,1,1,1,3.4,3.9,4
4579,0,Middle East & Africa,HR,Sales,Below,Female,31,5,0,5,2.9,2.3,2.1,1,1,1,1,2,1.6,2.6
4580,0,Asia Pacific,Manufacturing,Quality Assurance,Meets,Male,37,7,0,7,4,3.4,4,1,1,1,1,4.5,5,4.4
4581,0,Europe,HR,Supply Chain,Below,Female,33,10,0,11,3.4,2.5,4.1,1,1,1,1,4,4,2.8
4582,0,Asia Pacific,R&D,Human Resources,Meets,Female,47,14,0,5,1.7,3.3,1.9,1,1,1,1,1.9,2.9,2.1
4583,0,Middle East & Africa,Commercial,Quality Assurance,Meets,Female,52,4,0,5,3,3.2,2.4,1,1,1,0,3.4,3.4,3.2
4584,0,Middle East & Africa,Commercial,Pharmacovigilance,Far Below,Female,44,9,0,12,2.6,3.5,2.2,1,1,1,1,2.6,4.5,4.3
4585,0,North America,HR,Legal & Compliance,Below,Female,44,10,0,8,2.8,4.1,4.7,1,1,0,0,4,4.4,4.2
4586,0,Latin America,R&D,Regulatory Affairs,Meets,Male,38,6,0,5,2.5,3.8,2.6,1,0,0,0,2.8,4,1.3
4587,0,North America,HR,Market Access,Meets,Male,34,18,1,10,,4,3.3,1,1,1,1,1.8,4.5,3.4
4588,0,Middle East & Africa,Digital,Sales,Meets,Female,28,10,1,5,,4.5,2.1,1,1,1,1,4.4,5,2.2
4589,0,Europe,Commercial,Quality Assurance,Below,Male,39,11,0,7,2.8,3,3.1,1,1,1,1,3.3,2.5,3
4590,0,Europe,Commercial,Data Science,Exceeds,Female,36,5,0,6,3.2,3.1,2.4,1,1,1,1,4.3,2.8,2.6
4591,0,North America,Digital,Human Resources,Far Exceeds,Female,39,23,0,11,3.9,2,2.8,1,1,1,1,4.5,2.5,3.7
4592,0,Middle East & Africa,R&D,Communications,Far Below,Male,34,14,0,12,3.2,2.6,1.2,1,1,1,1,2.3,1,2.6
4593,1,Europe,Commercial,Human Resources,Far Exceeds,Male,29,2,1,10,,1.2,2.2,1,1,1,1,4.9,1.9,3
4594,0,Middle East & Africa,Finance,Marketing,Meets,Female,31,14,1,5,,4,3.8,1,1,1,1,3.6,4.7,3.1
4595,0,Europe,Finance,Marketing,Meets,Female,47,9,0,10,3,2.7,1.2,0,0,0,0,3.2,4.4,3.2
4596,0,Middle East & Africa,Finance,Supply Chain,Meets,Male,50,14,0,8,3.5,4.5,1.4,1,1,1,1,2.4,4,2.4
4597,0,Asia Pacific,Manufacturing,Finance & Accounting,Meets,Female,29,8,0,7,3.9,3.3,2,1,1,1,1,3.4,2.8,1.3
4598,0,Middle East & Africa,Manufacturing,Human Resources,Meets,Male,34,14,0,11,3.1,2.3,3,1,1,1,1,3.2,3.8,2.7
4599,0,Middle East & Africa,R&D,Data Science,Meets,Male,28,8,1,11,,1.6,4.5,1,1,1,1,4,1.7,5
4600,0,North America,Digital,Quality Assurance,Meets,Male,38,19,0,10,4,1.1,1.3,1,1,1,1,3.3,4.5,3.1
4601,0,Asia Pacific,HR,Quality Assurance,Meets,Male,39,3,1,9,,1.9,4.2,1,1,1,1,3.6,2.2,3
4602,0,Latin America,R&D,Pharmacovigilance,Meets,Female,37,7,0,6,3.9,3.6,1.8,1,1,1,1,5,2,1.8
4603,0,North America,HR,Quality Assurance,Far Exceeds,Female,35,6,0,10,3,3.7,1.9,1,1,1,1,2,4.8,2.6
4604,0,Latin America,R&D,Data Science,Exceeds,Non-Binary/Other,39,23,1,10,,3.2,3,1,1,1,1,3.7,5,2.1
4605,0,Europe,Manufacturing,Marketing,Far Exceeds,Male,42,5,0,6,2.4,3.3,1.9,1,1,1,1,2.4,5,2.7
4606,0,Latin America,Finance,Pharmacovigilance,Exceeds,Female,42,8,0,10,3.5,1.8,2.4,1,1,1,1,3.4,2.1,2
4607,0,Middle East & Africa,Digital,Clinical Operations,Meets,Female,45,13,0,9,3.5,2.1,2.1,1,1,1,1,3.1,4.1,3.4
4608,0,Latin America,Manufacturing,Data Science,Meets,Male,36,6,1,7,,2.4,2.9,0,0,0,0,4.1,4.2,2.3
4609,0,North America,Digital,Regulatory Affairs,Meets,Male,34,15,1,9,,3.5,3.8,1,1,1,1,2.5,5,3.1
4610,0,North America,HR,IT & Digital,Far Exceeds,Female,44,29,0,12,3.1,1.9,1.1,1,1,1,1,3.6,2.4,2.1
4611,0,Latin America,R&D,Quality Assurance,Below,Female,35,22,0,6,2.3,3.7,2.4,1,1,1,1,3.9,2.8,2.1
4612,0,North America,Commercial,Marketing,Meets,Female,37,10,1,10,,1.9,3.2,1,1,1,1,3.4,2.8,2.8
4613,0,North America,Commercial,Market Access,Below,Female,35,2,0,7,2.8,4.1,3.9,1,1,1,1,4.3,4,4
4614,0,Latin America,Digital,Human Resources,Meets,Male,48,11,0,9,4.1,2.2,1,1,1,1,1,4.6,1.9,1
4615,0,Asia Pacific,Finance,Human Resources,Meets,Male,42,10,0,8,3.8,2.2,2.9,0,0,0,0,3.3,2.5,3.1
4616,0,Asia Pacific,Finance,Quality Assurance,Meets,Male,31,8,0,5,1.7,3.8,1.6,1,1,1,1,2.2,4.9,2.6
4617,0,Europe,Digital,Regulatory Affairs,Below,Male,38,5,1,6,,3.1,1.9,1,1,1,1,5,3.9,2.5
4618,0,North America,Manufacturing,Human Resources,Meets,Female,40,7,1,12,,3.2,4,1,1,1,1,3.1,3.4,3.8
4619,0,Latin America,Commercial,Marketing,Exceeds,Female,31,5,1,9,,3.7,4.3,1,1,1,1,1.4,2.8,1.8
4620,0,North America,Manufacturing,Supply Chain,Meets,Male,40,8,0,7,3.8,3.1,2.2,1,1,1,1,3.9,2.5,2.1
4621,0,Middle East & Africa,HR,Quality Assurance,Below,Female,37,12,0,11,2.4,4.1,1.7,1,1,1,1,2.5,2.6,1
4622,0,North America,Commercial,Pharmacovigilance,Exceeds,Male,31,18,0,6,2.6,2.6,1,1,1,1,1,2,2.6,3.4
4623,0,North America,HR,Sales,Meets,Male,30,11,0,7,2.1,3.1,3.2,1,1,1,1,1.9,2.3,2.6
4624,0,Asia Pacific,R&D,Human Resources,Far Below,Male,46,14,0,11,3.2,3.8,1.1,1,1,1,1,4.2,4.2,2.3
4625,0,Latin America,Manufacturing,Data Science,Meets,Male,33,6,0,10,4.2,4.4,4.5,1,1,1,1,4.5,3.3,4
4626,0,North America,Digital,Regulatory Affairs,Meets,Male,44,20,0,8,3.7,2.2,3,1,1,1,1,3.7,2.6,2.3
4627,0,Asia Pacific,Commercial,Quality Assurance,Meets,Male,42,4,0,6,3.4,2.7,2,1,1,1,1,5,2,1.7
4628,0,Europe,Manufacturing,Clinical Operations,Far Below,Male,34,5,0,5,3.4,3.1,2.7,1,1,1,1,2.6,2.2,3.1
4629,0,Asia Pacific,Digital,Market Access,Meets,Male,41,17,0,11,4.9,3.1,2.8,1,1,1,1,3.7,2.7,2.8
4630,0,Asia Pacific,R&D,Communications,Meets,Female,40,8,0,5,4.4,3.4,3.2,1,1,1,1,2.9,4.3,3.2
4631,0,Asia Pacific,Commercial,Marketing,Meets,Male,43,7,1,11,,4,2.3,1,1,1,1,3.4,2.8,2.5
4632,0,North America,HR,Regulatory Affairs,Meets,Non-Binary/Other,39,9,0,9,2.2,3.4,1.9,1,1,1,1,3.8,2.9,1
4633,0,North America,R&D,Data Science,Meets,Female,36,12,1,10,,2.7,1.3,1,1,1,1,1.8,4,1
4634,0,Europe,Finance,Quality Assurance,Meets,Female,46,8,0,10,3,3.8,3.3,1,1,1,1,3.8,4.9,3.3
4635,0,Middle East & Africa,Digital,Clinical Operations,Meets,Female,42,2,0,6,4.1,5,1.4,1,1,1,1,3.9,3,3.1
4636,0,Middle East & Africa,Commercial,Marketing,Meets,Female,34,10,0,8,2.7,2.7,1,0,0,0,0,3,2.7,2.4
4637,0,Middle East & Africa,Commercial,Data Science,Exceeds,Male,37,4,0,11,4.3,2.5,1.9,0,0,0,0,2.9,5,1
4638,1,Europe,R&D,Marketing,Meets,Female,46,9,0,8,3.6,2.1,2.5,1,1,1,1,3.8,2.8,1.4
4639,0,Middle East & Africa,Commercial,Data Science,Meets,Male,47,13,0,10,2.6,4.4,2.3,1,1,1,1,3.6,3.8,4.1
4640,0,Middle East & Africa,Digital,Human Resources,Meets,Male,37,7,1,6,,2.1,3.8,1,1,1,1,4.8,2.6,4.3
4641,0,Asia Pacific,R&D,Human Resources,Meets,Male,41,3,0,10,3.4,2.6,2.2,0,0,0,0,3.8,2.9,1.4
4642,0,North America,HR,Quality Assurance,Exceeds,Male,40,12,0,9,2.9,3.7,2.1,1,1,1,1,4,2.1,2.9
4643,0,North America,R&D,Sales,Meets,Male,31,17,0,6,4,2.1,3.6,1,1,1,1,4.9,1.9,4.2
4644,0,Asia Pacific,R&D,Medical Affairs,Meets,Non-Binary/Other,41,12,0,10,3.2,3.7,2.6,1,1,1,1,2.1,4.5,3.8
4645,0,Asia Pacific,HR,Pharmacovigilance,Far Exceeds,Male,28,9,0,12,1,3.1,4.1,1,1,1,1,2.3,3.7,3.6
4646,0,Asia Pacific,Finance,Communications,Meets,Female,43,14,0,9,3.3,1,2.3,1,1,1,1,2.5,1.8,1
4647,0,North America,Digital,Sales,Below,Male,41,16,0,5,1.9,4.2,2.7,1,1,1,1,3.7,3.5,1.6
4648,0,Middle East & Africa,Finance,IT & Digital,Meets,Female,28,9,0,9,2.6,4,1,1,1,1,1,3.1,3.4,1
4649,0,Asia Pacific,Finance,Legal & Compliance,Meets,Female,32,11,0,6,2.2,2.3,2.5,1,1,1,0,2.9,1,4
4650,0,Europe,Finance,Medical Affairs,Meets,Female,28,25,0,9,3.1,2.4,2.4,1,1,1,1,5,2.1,3.2
4651,0,Asia Pacific,Manufacturing,Quality Assurance,Far Below,Male,32,1,0,11,1.9,2.7,1,1,1,1,1,3.5,1.9,1.8
4652,0,Latin America,Finance,Quality Assurance,Meets,Female,39,5,0,8,2.2,3.8,2.2,1,1,1,1,3.2,5,2.7
4653,0,Asia Pacific,Manufacturing,Quality Assurance,Meets,Male,48,11,0,8,4.4,3.6,2.9,0,0,0,0,3.4,3.8,2.4
4654,0,North America,HR,Medical Affairs,Below,Female,41,16,0,11,3.4,3.4,1.1,0,0,0,0,2,1.4,3.2
4655,0,Asia Pacific,Digital,Finance & Accounting,Meets,Female,36,9,0,11,3,4,3.5,1,1,1,1,3,4.7,3.7
4656,0,Latin America,Finance,Clinical Operations,Meets,Male,42,8,0,7,2.7,2,1.5,1,1,1,1,3.8,3,1
4657,0,Europe,Commercial,Regulatory Affairs,Meets,Male,42,17,0,12,2.5,2.1,2.9,1,1,1,1,3.8,3.3,3.5
4658,0,Middle East & Africa,HR,Medical Affairs,Meets,Male,47,17,0,6,4.9,4.5,4.5,1,1,1,1,3.6,4.2,1.9
4659,0,Asia Pacific,Manufacturing,Market Access,Meets,Female,43,2,0,10,3,2.5,3,1,1,1,1,2.3,3.6,1.7
4660,0,Latin America,Digital,Regulatory Affairs,Meets,Female,38,6,0,11,1.6,2.8,2.3,1,1,1,1,3.4,3.2,2.1
4661,0,Latin America,R&D,Human Resources,Meets,Male,29,14,0,11,2.5,2.8,2.7,1,0,0,0,2.8,1.1,3.3
4662,0,Europe,Digital,Market Access,Below,Male,46,11,0,11,4.2,2.7,3.9,1,1,1,1,4.4,3.4,2.2
4663,0,North America,Digital,Legal & Compliance,Meets,Male,37,20,0,10,4.5,3.1,2.5,1,1,1,1,4.3,3.5,2.1
4664,0,Asia Pacific,Finance,Legal & Compliance,Exceeds,Male,33,17,0,11,1.7,2.8,1.3,1,1,1,0,2,4.6,1.1
4665,0,Latin America,Finance,Data Science,Meets,Female,28,22,0,11,2.6,3.7,2,1,1,1,1,3.3,4.4,2.5
4666,0,Europe,Manufacturing,Pharmacovigilance,Meets,Female,31,19,0,9,2.2,4.8,2.1,0,0,0,0,4.4,3.7,3.2
4667,0,Middle East & Africa,Manufacturing,Communications,Meets,Female,40,12,0,8,1.9,2.9,2.4,1,1,1,1,2.1,4.1,2.3
4668,0,Latin America,Finance,Pharmacovigilance,Far Below,Female,36,10,0,6,3.8,4.1,4,1,1,1,1,2.8,4.3,3.9
4669,0,Europe,Finance,Legal & Compliance,Meets,Female,44,11,0,11,3.5,3.1,2.2,1,1,1,1,3.4,3.1,2.3
4670,0,North America,Commercial,Communications,Below,Female,48,11,0,10,3.1,2.7,4.7,1,1,1,1,3.2,3.2,5
4671,0,North America,Commercial,Human Resources,Exceeds,Female,28,14,0,6,2.9,2,2.1,1,1,1,1,2.8,3.7,1.7
4672,0,Latin America,HR,Pharmacovigilance,Meets,Female,32,13,0,7,3.7,2.6,1.3,1,1,1,1,4,1.5,1.2
4673,0,Latin America,Finance,Supply Chain,Meets,Female,39,7,0,7,3.7,1,1.9,1,1,1,1,4.1,3.1,2.1
4674,0,Asia Pacific,R&D,Communications,Below,Female,47,25,1,7,,3.6,2.6,1,1,1,1,3.6,3.2,3.2
4675,0,Europe,Commercial,Medical Affairs,Exceeds,Male,33,6,0,11,3.5,3.4,1.8,1,1,1,1,4.1,2.3,2.1
4676,0,Latin America,Manufacturing,Clinical Operations,Far Exceeds,Female,39,8,0,7,5,3,4.3,1,1,1,1,5,2.6,2.2
4677,0,Asia Pacific,Digital,Data Science,Below,Female,31,3,1,5,,2.1,1,1,1,1,1,2.6,3.8,1
4678,0,Asia Pacific,HR,Communications,Meets,Male,37,24,0,6,2.4,3.1,1.5,1,1,1,1,1.8,4.1,2.5
4679,0,Latin America,Commercial,Legal & Compliance,Far Below,Female,39,10,0,10,4,3.3,1,1,1,0,0,3.8,2.3,2.1
4680,0,North America,Digital,Quality Assurance,Meets,Male,36,12,1,12,,3.1,2.3,1,1,1,1,3,4.7,1.8
4681,0,Europe,Digital,Medical Affairs,Meets,Female,48,10,0,11,5,2.4,3,1,1,1,1,5,4,3.2
4682,0,Europe,Commercial,Market Access,Meets,Female,45,8,0,7,2.7,3.1,1.6,0,0,0,0,3.4,3.1,3.2
4683,0,North America,R&D,Market Access,Far Below,Male,36,15,0,8,3.9,1.8,2.4,1,1,1,1,3.5,2.1,2.4
4684,0,Latin America,R&D,Regulatory Affairs,Meets,Female,36,10,0,9,3.1,3.7,1.8,1,1,1,1,4.1,3.8,2.4
4685,0,Europe,HR,Legal & Compliance,Meets,Female,43,15,0,7,3.9,3.5,2.6,1,1,1,1,4.1,2.8,2.7
4686,0,Latin America,R&D,Quality Assurance,Meets,Female,38,2,0,8,1.5,4.7,3.3,1,1,1,1,3.6,3,4.6
4687,0,Latin America,HR,Supply Chain,Meets,Male,38,10,0,11,3.2,2,2.6,1,1,1,1,3.3,1.2,1.9
4688,0,Asia Pacific,Manufacturing,Human Resources,Below,Male,34,5,0,5,3.2,2.7,4,1,1,1,1,2.2,2,4.2
4689,0,North America,Commercial,Market Access,Meets,Female,42,12,0,7,2.5,2.9,1.5,1,1,1,1,2.5,3.3,3.9
4690,0,Latin America,Digital,Pharmacovigilance,Meets,Male,34,5,0,7,3.6,2.1,3.9,1,1,1,1,2.9,2.6,4.9
4691,0,Middle East & Africa,HR,Regulatory Affairs,Meets,Female,34,10,1,12,,2.1,1,1,1,1,1,3.5,2.6,1
4692,0,North America,R&D,Communications,Below,Female,40,13,0,6,3.3,2.8,3.3,1,1,1,1,3.2,2.5,4.3
4693,1,Europe,HR,Sales,Meets,Non-Binary/Other,39,6,0,8,3,1.8,1.4,1,1,1,1,3.6,2.6,2.3
4694,0,Asia Pacific,Finance,Marketing,Far Exceeds,Male,38,4,1,5,,3.9,1,1,1,1,1,2.3,3.9,2.7
4695,1,Europe,HR,Finance & Accounting,Far Exceeds,Male,28,29,0,9,3.5,2.8,2.8,1,1,1,1,5,3.7,3.5
4696,0,Europe,R&D,Regulatory Affairs,Meets,Female,39,9,0,8,3.7,3.4,2.7,0,0,0,0,3.8,1.9,3.4
4697,0,North America,Finance,Communications,Meets,Male,28,15,0,7,2.8,3.3,1,1,1,1,1,2.7,3.3,1.1
4698,0,Europe,Finance,Regulatory Affairs,Meets,Female,44,18,0,5,2.6,3.3,2,0,0,0,0,2.9,2.8,3.1
4699,0,Latin America,R&D,Finance & Accounting,Below,Female,35,10,0,11,3.2,3.6,2.6,1,1,1,1,2.3,3.4,2.6
4700,0,Europe,Finance,Communications,Meets,Female,39,6,0,8,3.7,2.6,3.3,1,1,1,1,3.1,1.5,2.3
4701,0,Asia Pacific,Commercial,Legal & Compliance,Below,Male,35,18,0,7,3.8,5,3.8,1,1,1,1,3.6,4.4,2.9
4702,0,Asia Pacific,Digital,Legal & Compliance,Meets,Male,40,5,0,12,2.9,3,2.4,1,1,1,1,3.4,4.2,3
4703,0,Middle East & Africa,Commercial,Market Access,Exceeds,Male,31,24,0,5,2.4,2.3,2.8,1,1,1,1,3.6,3.5,2.9
4704,0,Asia Pacific,Commercial,Legal & Compliance,Far Exceeds,Male,49,6,1,5,,1.8,3.4,1,1,1,1,3.6,2.6,3.9
4705,0,Europe,R&D,Medical Affairs,Exceeds,Female,34,16,0,8,3.3,1.7,3.4,1,1,1,1,3.4,3.6,3.1
4706,0,Asia Pacific,R&D,Communications,Below,Male,43,10,0,5,1.5,5,3.2,0,0,0,0,2.4,4.9,2.5
4707,0,North America,Digital,Quality Assurance,Exceeds,Female,31,15,0,12,3.2,3.3,4,1,1,1,1,3.2,1.7,3
4708,0,Asia Pacific,HR,Communications,Below,Female,36,12,0,11,2.3,2.4,3.8,1,1,0,0,2.6,3.2,1.7
4709,0,Latin America,Commercial,Legal & Compliance,Meets,Male,33,16,0,9,3,2.3,2.7,1,1,1,1,3.5,1.5,1.4
4710,0,North America,Finance,Communications,Meets,Female,34,7,0,8,3,3.7,1.9,0,0,0,0,3.4,5,3.7
4711,0,Middle East & Africa,Digital,Finance & Accounting,Meets,Female,41,12,0,9,2.7,2.3,2.9,1,1,1,1,2.2,4.2,2.5
4712,0,Latin America,Commercial,Human Resources,Far Exceeds,Male,41,29,0,5,2.9,3.5,4,1,1,0,0,2.9,3.2,4.1
4713,0,Europe,HR,Sales,Meets,Male,40,4,0,6,4.3,3.7,1.8,1,1,1,1,4.8,3.1,3.9
4714,0,Europe,Finance,Pharmacovigilance,Meets,Female,33,16,0,6,3,3.3,4,1,1,1,1,3.7,3.7,2.2
4715,0,Europe,Commercial,Medical Affairs,Below,Female,39,36,0,5,5,1.3,2.3,1,1,1,1,4.3,2.6,2.3
4716,0,Latin America,Manufacturing,Data Science,Exceeds,Female,33,29,0,9,2.8,4.4,1,0,0,0,0,2.5,4.4,1.1
4717,0,Latin America,Digital,Market Access,Meets,Male,47,14,0,12,2.3,3.6,2,1,1,1,1,2,1.3,1.9
4718,0,Latin America,R&D,Communications,Meets,Male,32,18,0,10,4.2,5,1.4,1,1,1,1,3.8,3.9,2.1
4719,0,North America,Commercial,Quality Assurance,Meets,Male,35,31,0,11,2.4,3.7,1.6,1,1,1,1,1.7,3.6,1
4720,0,North America,Finance,Clinical Operations,Meets,Male,38,19,0,9,2.9,2.4,5,1,0,0,0,2.7,2.9,2.5
4721,0,Europe,Finance,Pharmacovigilance,Meets,Female,32,10,1,9,,2.8,2.2,1,1,1,1,1.8,3.9,2.9
4722,0,Asia Pacific,Digital,Medical Affairs,Meets,Female,42,10,0,6,3.1,3,2.9,1,1,1,1,3.1,3.8,3
4723,0,Europe,Digital,Human Resources,Meets,Female,45,5,0,11,5,2.8,3,1,1,1,1,5,2.4,3.3
4724,0,Middle East & Africa,Finance,Pharmacovigilance,Far Exceeds,Male,33,18,1,6,,2.5,2.5,0,0,0,0,2.9,3.8,3
4725,0,North America,Finance,Quality Assurance,Exceeds,Male,34,36,0,9,3.2,3.3,1.3,1,1,1,1,2.7,3,1.4
4726,0,Latin America,Finance,Data Science,Below,Female,45,13,0,7,2.8,2.5,1.6,1,1,1,1,2.9,2.3,1.8
4727,0,North America,Commercial,Data Science,Far Below,Female,39,9,0,7,2.1,4.5,1.9,1,1,1,1,1.7,3.1,1.2
4728,0,Latin America,Finance,Legal & Compliance,Meets,Female,37,11,0,8,5,1.7,1.9,1,1,1,1,3.9,1.6,1.3
4729,0,Middle East & Africa,R&D,Pharmacovigilance,Meets,Male,33,9,0,11,1.5,2.9,3,1,1,1,0,1,4.2,3.5
4730,1,Middle East & Africa,Finance,Data Science,Meets,Female,36,4,1,6,,2.2,2.6,1,1,1,1,4,2.3,4
4731,0,North America,R&D,Medical Affairs,Meets,Female,37,5,0,8,3.2,2.9,2.3,1,1,1,1,3.4,4.6,2.6
4732,0,Latin America,Commercial,Pharmacovigilance,Exceeds,Non-Binary/Other,42,6,1,6,,3.9,2.7,1,1,0,0,4,1,2.4
4733,0,Middle East & Africa,Digital,IT & Digital,Meets,Non-Binary/Other,38,8,0,11,4.7,3.6,1.6,1,1,1,1,4.7,3.9,2.6
4734,0,Europe,R&D,Medical Affairs,Meets,Non-Binary/Other,33,18,0,11,2.3,4.6,1.5,1,1,1,1,2.1,3.9,2.6
4735,0,Europe,Commercial,Human Resources,Exceeds,Female,35,11,0,5,3.7,1.9,2.9,1,1,1,1,2.4,4.4,2.2
4736,0,Latin America,Finance,Data Science,Meets,Female,31,3,1,12,,1.6,2,1,1,1,1,2.7,2.9,1.8
4737,0,North America,Commercial,Legal & Compliance,Meets,Male,37,18,0,11,5,2.1,3,1,1,1,1,4.9,3.9,3.1
4738,0,Middle East & Africa,Finance,Supply Chain,Meets,Female,52,8,0,9,3.2,1.8,4.2,1,1,1,1,3.4,2.9,2
4739,0,North America,Commercial,Marketing,Meets,Male,53,14,0,7,2.2,3.5,3.9,1,1,1,1,1.3,4.5,3.8
4740,1,Europe,Digital,Clinical Operations,Meets,Male,40,25,0,9,3.1,3.9,2.9,1,1,1,1,3.4,1.7,2.5
4741,0,Middle East & Africa,R&D,Legal & Compliance,Meets,Female,28,10,0,6,3.6,4.4,2.8,1,1,1,1,3.4,4,3.5
4742,0,North America,Digital,Market Access,Meets,Female,44,20,0,5,4.8,1.6,3.8,1,1,1,1,5,4,2.7
4743,0,Asia Pacific,Manufacturing,Quality Assurance,Meets,Female,42,18,0,11,3,2.4,4.2,0,0,0,0,4.9,4.2,4.7
4744,0,Latin America,Finance,Clinical Operations,Meets,Male,54,11,0,11,2.7,1.8,3,1,1,1,1,3.2,2.4,4.3
4745,0,Latin America,R&D,Medical Affairs,Meets,Female,38,9,0,9,4.2,2.1,4.7,1,1,1,1,3.9,1.8,3.5
4746,0,Asia Pacific,Digital,Marketing,Meets,Female,35,6,0,12,3.3,3.6,3.5,1,0,0,0,3.6,2.2,3
4747,0,Europe,R&D,Marketing,Exceeds,Female,32,12,0,11,3.3,1.2,2.9,1,1,1,1,4,1.6,2.5
4748,0,Middle East & Africa,Manufacturing,Supply Chain,Meets,Female,43,20,0,6,3.5,2,1.6,1,1,1,1,2.8,3.2,2.7
4749,0,Latin America,HR,Legal & Compliance,Below,Female,37,8,0,6,1.6,3,3.8,1,1,1,1,2.2,3,4.5
4750,0,Asia Pacific,Finance,Human Resources,Meets,Female,36,19,0,9,3.2,1.3,2.2,1,1,1,1,3.2,3,1.7
4751,0,Asia Pacific,Finance,IT & Digital,Meets,Male,35,17,0,12,2.8,4.2,3,1,0,0,0,3.3,3.2,1.9
4752,0,Europe,Commercial,Legal & Compliance,Meets,Male,51,7,1,5,,2.4,1,1,1,1,1,3.2,5,2.6
4753,0,Europe,Finance,Sales,Below,Male,36,6,0,10,3.5,4.9,1.7,1,1,1,1,3.3,4.9,3.2
4754,0,North America,Finance,Sales,Below,Male,42,21,0,8,1.1,3.2,3.8,1,1,1,1,2.6,4.7,3.2
4755,0,Latin America,Digital,Medical Affairs,Meets,Male,41,18,0,7,2.4,2.7,1.2,1,1,1,1,2.7,2.6,3.6
4756,0,North America,Finance,Marketing,Meets,Female,28,15,0,8,3.3,2,3.6,1,1,1,1,3.5,1.3,3.7
4757,0,Asia Pacific,Finance,Supply Chain,Exceeds,Male,51,2,0,11,3.7,2,1.6,1,1,1,1,4.3,3.5,1.8
4758,0,Middle East & Africa,Manufacturing,Market Access,Meets,Male,28,7,0,6,3.2,1.9,1.3,1,1,1,1,2.9,2.1,2
4759,0,Middle East & Africa,Manufacturing,Communications,Meets,Male,33,12,0,9,2.1,3.5,2.4,1,1,1,1,3.1,4.1,2.5
4760,1,Europe,R&D,Market Access,Exceeds,Female,35,6,0,7,2.9,4.2,1,1,1,1,1,3.8,4.3,1.8
4761,0,Middle East & Africa,R&D,Clinical Operations,Below,Female,34,5,1,5,,3.6,1.7,1,1,1,1,5,3.5,2.4
4762,0,Middle East & Africa,Finance,Pharmacovigilance,Meets,Male,37,13,0,9,4.2,1.7,3.4,1,0,0,0,4.2,2.7,1.3
4763,0,Middle East & Africa,Finance,Communications,Below,Male,33,14,0,5,2.8,3.1,3.9,1,1,1,1,2.9,4.5,3
4764,0,Asia Pacific,Commercial,Legal & Compliance,Meets,Female,46,14,0,12,2.2,2.9,2.4,1,1,1,1,3,2.6,2.8
4765,0,Middle East & Africa,R&D,Quality Assurance,Below,Female,42,7,0,7,4.8,2.8,3.9,1,1,1,1,4.3,4.6,3.7
4766,0,Middle East & Africa,Digital,Supply Chain,Below,Female,34,17,1,12,,1.1,1.9,1,1,1,1,4.9,3.4,2
4767,0,Middle East & Africa,Finance,Pharmacovigilance,Exceeds,Female,33,7,1,12,,1,2,1,1,1,1,5,2,2.9
4768,0,North America,Digital,Data Science,Meets,Female,35,10,0,7,3.2,2.5,1.4,1,1,1,1,2.6,2.3,2.4
4769,0,Asia Pacific,Finance,Market Access,Exceeds,Female,33,19,0,11,2.2,2.3,1.4,1,1,1,1,3,3.6,3.9
4770,0,Europe,Digital,Medical Affairs,Meets,Male,31,12,0,11,3.5,4.1,3,1,1,1,1,3,5,3.8
4771,0,North America,HR,Supply Chain,Meets,Female,44,9,0,8,3.3,3.8,1.6,1,1,1,1,3.8,2.7,2.6
4772,0,Latin America,Digital,Marketing,Far Below,Female,36,7,1,8,,3.4,2.7,1,1,1,1,3.4,1.9,3
4773,0,Asia Pacific,R&D,Legal & Compliance,Meets,Male,40,10,0,12,2.6,2.4,1.9,1,1,1,1,3.7,2.7,1.2
4774,0,Asia Pacific,Finance,Finance & Accounting,Meets,Male,38,10,0,9,2.7,4.4,3.9,1,0,0,0,3.6,1.9,3.7
4775,0,Latin America,R&D,Regulatory Affairs,Far Below,Female,47,7,1,5,,4.8,2.3,1,1,1,1,3.9,3.8,3.3
4776,0,Latin America,Digital,Regulatory Affairs,Meets,Male,43,9,0,8,3.7,3.7,3,1,0,0,0,2.7,4.5,2.6
4777,0,Latin America,Manufacturing,Market Access,Meets,Female,40,8,1,10,,2.6,1.2,0,0,0,0,4.5,3.8,1.5
4778,0,Europe,Manufacturing,Supply Chain,Meets,Female,52,23,0,5,3.1,2.9,3.1,1,1,1,1,2.7,2.3,3.1
4779,0,Middle East & Africa,Manufacturing,Pharmacovigilance,Meets,Male,34,4,0,11,3.5,5,2.1,1,1,1,1,3.1,3.7,1.3
4780,0,Asia Pacific,Finance,Human Resources,Far Exceeds,Male,37,4,0,8,3.1,3.4,2.9,1,1,0,0,3,2.5,1.9
4781,0,Middle East & Africa,Commercial,Communications,Below,Non-Binary/Other,42,7,0,11,2.2,4.3,2.6,1,1,1,1,3.3,3.9,2.1
4782,0,Middle East & Africa,HR,IT & Digital,Meets,Male,43,9,1,12,,2.8,2.7,1,1,1,1,3.6,1.9,1
4783,0,Latin America,Digital,Pharmacovigilance,Meets,Male,33,7,1,12,,2.2,3.6,1,0,0,0,3.6,2.2,3.9
4784,0,Europe,Commercial,Supply Chain,Below,Male,38,36,0,12,3.6,2.3,2.4,1,1,1,1,3.4,5,1.9
4785,0,North America,Manufacturing,Human Resources,Meets,Non-Binary/Other,38,11,0,10,1.9,1,4.2,1,1,1,0,3.6,3.2,3
4786,0,Europe,Digital,Quality Assurance,Meets,Female,52,12,0,11,4,2.5,2.4,1,1,1,1,4.3,2.3,1.9
4787,0,Middle East & Africa,Commercial,Market Access,Below,Female,42,8,1,10,,4.9,2.2,1,1,1,1,3.8,5,1.2
4788,0,Europe,R&D,Data Science,Below,Male,44,7,0,7,2.5,3.3,3.8,1,1,1,1,2.9,3.4,3.5
4789,0,Latin America,Manufacturing,Clinical Operations,Exceeds,Male,36,9,1,10,,2.7,1.7,0,0,0,0,2.8,1,1.2
4790,0,North America,Commercial,Supply Chain,Below,Male,33,9,0,8,3.3,2,2.9,1,0,0,0,4.3,3.1,1.6
4791,0,Latin America,Finance,Quality Assurance,Meets,Female,35,12,0,6,5,3.6,4.2,1,1,1,1,4.1,3.3,4.1
4792,0,North America,R&D,Regulatory Affairs,Below,Male,41,10,1,8,,3.6,1.8,0,0,0,0,4.5,3.5,2.2
4793,0,Middle East & Africa,Manufacturing,Communications,Below,Female,47,6,0,9,3.4,3.6,1,0,0,0,0,5,4.1,1
4794,0,North America,HR,Pharmacovigilance,Meets,Female,29,20,0,7,2.2,2.5,4.2,1,1,1,1,3.1,1.8,2.6
4795,0,North America,Manufacturing,Medical Affairs,Meets,Male,50,19,0,12,3.5,2.7,4.1,1,1,1,1,2.1,1,3.3
4796,0,North America,Finance,Market Access,Meets,Non-Binary/Other,43,20,0,6,4.2,3.1,2.7,1,1,1,0,4.5,5,2.6
4797,0,Europe,HR,Human Resources,Below,Male,44,24,0,9,4.2,1.8,1.4,1,1,1,1,4.7,1.4,2.7
4798,0,Europe,HR,Pharmacovigilance,Exceeds,Male,44,18,1,8,,4.2,4.3,1,1,1,1,4.5,3.5,2.6
4799,0,Middle East & Africa,HR,Finance & Accounting,Meets,Female,36,33,0,9,3.5,2,3.1,1,1,1,1,3.2,2,3.4
4800,0,North America,Digital,Data Science,Below,Male,37,3,1,5,,5,3.4,1,1,1,1,4.3,4.4,2.2
4801,0,Asia Pacific,Digital,Quality Assurance,Meets,Male,42,5,1,5,,3.3,2.6,1,1,1,1,3.2,1.9,2.4
4802,0,Middle East & Africa,HR,Human Resources,Below,Female,37,7,1,10,,3.5,3.9,1,1,1,1,3.4,3.1,3.6
4803,0,North America,R&D,Regulatory Affairs,Meets,Male,39,2,1,10,,1.8,3.6,1,1,1,1,2.8,1,4.2
4804,0,North America,HR,Communications,Meets,Non-Binary/Other,34,23,0,12,3.9,3.3,3.8,1,1,1,1,4.1,1.6,2.4
4805,0,Europe,Commercial,Legal & Compliance,Below,Male,43,5,1,12,,4,3,0,0,0,0,3.7,3.7,2.8
4806,0,Middle East & Africa,HR,Data Science,Below,Male,37,15,0,10,3.1,3.4,2.4,1,1,1,1,4.4,3,2.9
4807,0,North America,Digital,Clinical Operations,Meets,Female,36,7,0,9,2.1,3.2,2.6,1,1,1,1,2.9,3.5,2.3
4808,0,North America,Digital,Sales,Exceeds,Male,33,6,0,10,4,2.8,2.5,0,0,0,0,4.5,2.8,1.2
4809,0,Middle East & Africa,Commercial,Medical Affairs,Below,Female,34,11,0,5,5,3.5,1.7,1,1,1,1,4.5,2.9,1.9
4810,0,Asia Pacific,Commercial,Finance & Accounting,Below,Male,30,12,1,7,,2.7,1.6,1,1,1,1,4.2,2.9,2.3
4811,0,Middle East & Africa,Manufacturing,Clinical Operations,Meets,Male,41,16,0,7,2.8,3.4,1,1,1,1,1,3.8,2.5,1.5
4812,0,Middle East & Africa,R&D,Market Access,Meets,Male,34,3,1,12,,4.6,1,1,1,1,1,3.2,4,1
4813,0,Asia Pacific,R&D,Pharmacovigilance,Below,Male,38,11,0,11,2.1,4.2,3.7,1,1,1,1,1.7,2.2,3.9
4814,0,Middle East & Africa,R&D,Marketing,Meets,Male,45,12,1,7,,3.3,2.8,1,1,1,1,3.4,3.6,2
4815,0,North America,Finance,Marketing,Meets,Male,37,12,0,6,3.7,2,3.4,1,1,1,1,3.7,2.8,2.8
4816,0,Middle East & Africa,Digital,Legal & Compliance,Below,Female,37,34,0,9,4.1,2.9,1.7,1,1,1,1,5,2.9,2.3
4817,0,Asia Pacific,R&D,Human Resources,Meets,Male,38,7,1,9,,3.5,2.6,1,1,1,1,2.1,5,2.5
4818,0,Latin America,Manufacturing,Regulatory Affairs,Far Below,Male,40,20,1,5,,3.6,2.5,1,1,1,1,3.7,4.2,2.8
4819,0,Middle East & Africa,Manufacturing,Communications,Meets,Male,35,16,0,5,3.3,4.2,3.3,0,0,0,0,4,4.1,3.3
4820,0,Europe,R&D,Legal & Compliance,Far Exceeds,Female,43,6,0,10,2.8,2,2,1,0,0,0,4.2,2.2,2.6
4821,0,North America,Commercial,Supply Chain,Meets,Male,39,10,0,5,3.7,4.1,3.3,1,1,1,1,3.8,4.2,2.2
4822,0,North America,Manufacturing,IT & Digital,Meets,Male,35,12,0,8,4.1,3.8,3,1,1,1,1,4.2,3.8,2.9
4823,0,Europe,Commercial,IT & Digital,Meets,Female,36,20,0,12,2.9,4.3,3.2,1,1,1,1,2.9,4.2,1
4824,0,Europe,Digital,Communications,Meets,Male,45,25,0,12,3.5,1.9,3.8,1,1,1,1,3.8,1.9,2.5
4825,0,Middle East & Africa,Finance,Pharmacovigilance,Exceeds,Male,34,10,0,5,3.2,5,1.9,1,1,1,1,2.7,3.7,3.1
4826,0,Europe,Manufacturing,Marketing,Meets,Male,41,21,1,9,,2.2,1.7,1,1,1,1,3.8,2.4,1.6
4827,0,Latin America,Commercial,Human Resources,Meets,Male,41,6,1,8,,2.5,2,1,1,1,1,3.3,2.7,2.4
4828,0,Asia Pacific,R&D,Quality Assurance,Meets,Female,32,14,0,8,3.8,2.4,2.1,1,1,1,1,3.7,2.9,1
4829,0,Europe,Digital,IT & Digital,Meets,Male,29,14,0,8,4.2,3.7,4.4,1,1,1,1,3.9,2.3,3.3
4830,0,Europe,HR,Sales,Meets,Male,36,7,0,5,3.7,3.4,1,1,1,1,1,1.7,3.3,1
4831,0,Latin America,HR,Regulatory Affairs,Far Below,Male,43,4,0,12,3.6,2.9,3,1,1,1,1,4.4,1.5,2.6
4832,0,North America,R&D,Finance & Accounting,Meets,Non-Binary/Other,29,17,1,7,,4.5,2.9,1,1,1,1,3.1,5,2.2
4833,0,North America,Digital,Communications,Meets,Male,33,10,0,7,2.5,3.9,3.1,0,0,0,0,3.2,2.6,1.4
4834,0,Middle East & Africa,Digital,Medical Affairs,Meets,Female,42,3,1,5,,2.6,1.6,1,1,1,1,4.3,2.4,1
4835,0,Latin America,Digital,IT & Digital,Exceeds,Male,32,9,0,7,3.2,2.1,3.5,1,1,0,0,2.1,2.5,3.8
4836,0,Asia Pacific,Digital,Clinical Operations,Meets,Female,44,3,1,6,,4.2,4.6,1,1,1,1,3.1,4.3,4.3
4837,0,Asia Pacific,HR,Clinical Operations,Below,Female,54,11,0,9,4,2.2,2.1,1,1,1,1,1.8,3.5,1.5
4838,0,Latin America,Commercial,Marketing,Exceeds,Male,33,12,1,8,,3.7,1,1,1,0,0,3.1,2.7,1.6
4839,0,Asia Pacific,Digital,Communications,Exceeds,Male,47,11,0,6,3.2,1,1.3,0,0,0,0,3.7,2,2
4840,0,North America,Commercial,Regulatory Affairs,Meets,Male,40,12,0,8,2.4,3.1,1.4,1,0,0,0,2.9,4.1,3.1
4841,0,Asia Pacific,Digital,Marketing,Below,Male,33,5,1,6,,4.6,2.4,1,1,1,1,2.3,3.3,3.2
4842,0,Asia Pacific,Manufacturing,Clinical Operations,Meets,Male,48,13,0,6,3.1,3.6,1.8,1,1,1,1,2.9,2,1.7
4843,0,Latin America,Finance,Human Resources,Below,Male,40,7,0,12,4.4,4.7,1.6,0,0,0,0,5,4.5,1.9
4844,0,Latin America,Manufacturing,Market Access,Exceeds,Male,45,20,0,10,2.4,2.6,2.7,1,1,1,1,2.2,2.5,2.4
4845,0,Asia Pacific,Finance,Data Science,Meets,Male,52,2,0,5,2.4,3.3,3.3,1,1,1,1,3.5,1.9,4.9
4846,0,Europe,Manufacturing,Legal & Compliance,Meets,Female,37,28,0,11,2.6,2.9,2,0,0,0,0,3.8,4.3,1
4847,0,Latin America,Digital,Pharmacovigilance,Exceeds,Male,41,21,0,7,3.9,3.1,3.5,0,0,0,0,2.7,1.6,3.5
4848,0,Middle East & Africa,Commercial,Regulatory Affairs,Meets,Male,31,13,1,11,,2.2,4.4,1,1,1,1,4.2,3.8,3.6
4849,1,Middle East & Africa,Finance,Quality Assurance,Far Exceeds,Female,35,5,0,8,2.6,3.1,1.4,1,1,1,1,4.1,3,2.9
4850,0,North America,HR,Marketing,Far Exceeds,Female,38,18,0,5,3.9,2.9,2.1,1,1,1,1,2.9,4.3,1.1
4851,0,Asia Pacific,R&D,IT & Digital,Far Below,Female,39,17,0,5,2.5,2.6,1.3,1,1,1,1,3.2,2.1,2
4852,0,Europe,Finance,Marketing,Below,Female,28,6,0,12,3.4,2.6,3.9,1,1,1,1,1.9,2.2,4
4853,0,North America,Finance,Supply Chain,Meets,Female,47,7,0,5,2.2,2.7,2.6,1,1,1,1,2.1,3.2,2.4
4854,1,Asia Pacific,HR,Sales,Far Exceeds,Male,42,28,0,6,4.5,4,3.2,1,1,1,1,4.6,4.3,3.2
4855,0,Latin America,Digital,IT & Digital,Far Exceeds,Female,41,21,0,6,4.3,3.3,2.9,1,1,1,1,3.8,3.1,2.8
4856,0,Middle East & Africa,Manufacturing,Human Resources,Meets,Female,50,9,0,7,3.3,2.9,2.7,1,1,1,1,2.1,2.4,1.7
4857,0,Europe,Manufacturing,Medical Affairs,Below,Female,48,16,0,9,4.7,3.5,3.2,1,1,1,1,5,2.1,3
4858,0,Middle East & Africa,Commercial,Marketing,Below,Male,37,9,0,10,2.8,3.5,4.2,1,1,1,1,3.4,2.6,3.9
4859,0,Latin America,Digital,Quality Assurance,Meets,Female,35,23,1,6,,2.9,1,1,1,1,1,2,1.6,2.6
4860,0,Asia Pacific,HR,Medical Affairs,Meets,Female,42,6,0,7,4.6,2,3.3,1,1,1,1,4.1,3.6,3.7
4861,0,Latin America,Digital,Sales,Meets,Male,47,17,0,12,2.5,1,2.2,1,0,0,0,2.2,3,3.4
4862,0,Latin America,Digital,Supply Chain,Meets,Female,37,2,1,12,,4.8,4,1,1,1,1,3.9,3.6,2.7
4863,0,Middle East & Africa,Manufacturing,Marketing,Meets,Male,43,18,0,10,5,3,2.8,1,1,1,1,2.9,2.5,4.4
4864,0,Europe,HR,Finance & Accounting,Exceeds,Female,48,7,1,9,,2.3,3.8,1,1,1,1,3.4,2.2,5
4865,0,Latin America,R&D,Medical Affairs,Meets,Female,44,19,0,12,3.3,2.3,3.2,1,1,1,1,3.5,1,2
4866,0,Middle East & Africa,Finance,Finance & Accounting,Meets,Male,28,7,1,9,,4,2.5,1,1,1,1,2.6,3.4,2.4
4867,0,Europe,Manufacturing,Medical Affairs,Meets,Female,31,4,0,12,3.8,5,2.7,1,1,1,0,4.5,3.7,2.5
4868,0,Asia Pacific,HR,Market Access,Exceeds,Female,50,27,0,8,2.2,4.1,2.7,1,1,1,1,3.2,4.6,2.4
4869,0,Asia Pacific,Commercial,Medical Affairs,Meets,Male,39,8,0,5,4.1,2.3,4.8,1,1,1,1,4.5,2.3,3.2
4870,0,North America,Finance,Clinical Operations,Meets,Male,40,8,0,5,3,4.7,1.2,1,1,1,1,2.8,4.7,2.2
4871,0,Middle East & Africa,Finance,Sales,Meets,Female,41,8,1,8,,4.8,3.6,1,1,1,1,3.7,2.5,1.9
4872,0,Europe,Manufacturing,Quality Assurance,Meets,Male,47,14,0,5,2,1.2,1.9,1,1,1,1,3.2,4.7,2.7
4873,0,Latin America,Commercial,Supply Chain,Below,Male,33,9,0,8,5,4.7,2.7,1,1,0,0,4.9,2.8,2.4
4874,1,Asia Pacific,Manufacturing,Sales,Meets,Female,36,13,0,6,3,2.2,1.8,1,1,1,1,5,2.9,3.1
4875,0,Europe,Digital,Data Science,Meets,Non-Binary/Other,32,3,1,11,,3.4,2.7,0,0,0,0,2.6,1.8,3.8
4876,0,Middle East & Africa,HR,Communications,Meets,Male,28,20,0,12,2.5,4.8,1,1,0,0,0,2.9,4.9,1
4877,0,North America,Commercial,Communications,Below,Male,40,15,0,11,1.8,2.3,3.3,1,1,1,1,3.9,2.6,2.7
4878,0,Asia Pacific,Finance,Human Resources,Below,Female,33,12,0,8,2.9,3.8,1.8,1,1,1,1,3,3.6,2.6
4879,0,Europe,Manufacturing,Clinical Operations,Meets,Female,44,9,1,7,,4,3.1,1,1,1,1,5,5,1.9
4880,0,Europe,Finance,Finance & Accounting,Meets,Female,34,10,0,5,4.1,3.5,2.4,1,1,1,1,4,3.1,2.2
4881,0,Europe,Commercial,Supply Chain,Meets,Male,30,36,0,9,2.7,2,4.9,1,1,1,1,4.9,2.2,4.2
4882,0,Middle East & Africa,Finance,Finance & Accounting,Exceeds,Female,44,8,0,8,4.6,3.3,3.9,1,1,1,1,4.6,1.9,5
4883,0,Middle East & Africa,Manufacturing,Communications,Below,Male,41,7,1,7,,2.3,2.3,1,1,1,1,1.9,2.6,2.9
4884,0,Middle East & Africa,Manufacturing,Human Resources,Meets,Female,37,17,0,11,3,3.8,1.8,1,1,1,1,1.9,1.5,3
4885,0,Latin America,R&D,Data Science,Meets,Male,37,7,0,10,3.7,4.4,3,1,1,1,1,3.5,3.3,2.8
4886,0,Europe,Finance,Medical Affairs,Exceeds,Female,42,10,0,12,2.4,4.5,5,0,0,0,0,2.7,5,3
4887,0,Asia Pacific,R&D,Legal & Compliance,Meets,Female,48,12,0,11,1,4.3,3.9,1,1,1,1,2.9,5,1.7
4888,0,Middle East & Africa,R&D,Sales,Meets,Female,40,9,0,5,4,1.4,3.2,1,1,1,1,3.5,2.9,3.7
4889,0,Middle East & Africa,Finance,Finance & Accounting,Meets,Male,41,27,0,7,3.4,1.9,3.7,1,1,1,1,3.4,1,3
4890,0,Europe,Commercial,Communications,Meets,Female,35,4,0,10,3.4,1.7,3,1,1,1,1,3.2,2.7,2.4
4891,0,Middle East & Africa,Digital,IT & Digital,Meets,Female,37,30,0,12,2.4,2.8,3.8,1,1,1,1,2.1,3.4,2.5
4892,0,Latin America,Manufacturing,Quality Assurance,Meets,Female,28,18,0,9,3.3,4,3.1,1,1,1,1,2.8,3.6,2.5
4893,0,Latin America,HR,Finance & Accounting,Exceeds,Female,32,7,0,6,2.8,3,2.1,1,1,1,1,3.2,2.5,3.6
4894,0,Middle East & Africa,R&D,Supply Chain,Meets,Male,32,11,0,5,2.6,2.6,1.3,1,1,1,1,4.2,1.9,2.9
4895,0,Europe,Commercial,Pharmacovigilance,Far Exceeds,Male,31,10,1,9,,1.5,4,1,1,1,1,5,1.5,3.2
4896,0,Europe,Finance,Human Resources,Meets,Male,36,5,0,5,2.5,4.3,2.8,1,1,1,1,3.1,2.9,4
4897,0,Europe,Commercial,Data Science,Exceeds,Male,36,23,0,6,3.2,3.7,2.8,1,1,1,1,3,2.7,2.3
4898,0,North America,Commercial,Legal & Compliance,Meets,Male,32,10,0,12,3.4,3.5,2.6,1,1,1,1,4,3.7,3.5
4899,0,Middle East & Africa,Finance,Human Resources,Meets,Female,46,12,0,5,2.7,2.5,4.4,1,1,1,1,3.8,2.9,4.4
4900,0,Europe,HR,Market Access,Meets,Female,42,4,0,8,2.9,3.5,1.7,1,1,1,1,2.9,5,1.6
4901,0,Latin America,Finance,Clinical Operations,Exceeds,Female,39,6,0,7,3.8,2.5,2,0,0,0,0,3.5,2.8,1
4902,0,Asia Pacific,HR,Clinical Operations,Meets,Female,42,8,1,11,,3,3.2,0,0,0,0,5,4,2.6
4903,0,Asia Pacific,Finance,IT & Digital,Meets,Male,28,2,0,10,3.2,3.9,3.7,1,1,1,1,3.9,3.6,3.6
4904,0,Europe,R&D,Market Access,Below,Female,28,15,0,12,3.7,2,1.5,1,1,1,1,2.5,2.5,2.5
4905,0,Asia Pacific,HR,Finance & Accounting,Far Exceeds,Male,45,29,0,11,2.8,3.2,3.2,1,1,1,1,2.8,3.1,1.4
4906,0,Asia Pacific,R&D,Legal & Compliance,Meets,Male,52,6,1,11,,4.4,3,1,0,0,0,3.3,5,3.2
4907,0,North America,HR,Clinical Operations,Meets,Male,38,11,1,11,,5,2.7,1,1,1,1,2.9,2.7,1.7
4908,0,Latin America,HR,Regulatory Affairs,Exceeds,Female,52,7,0,12,3.6,2,4.6,1,1,1,1,2.8,3.1,4.5
4909,0,Latin America,Finance,Regulatory Affairs,Exceeds,Non-Binary/Other,38,12,0,7,2.6,3.3,1,1,0,0,0,4.5,2.4,1.8
4910,0,North America,HR,Supply Chain,Meets,Male,34,7,1,11,,2.5,1.4,1,1,1,1,3.3,2.6,3.2
4911,1,North America,R&D,Pharmacovigilance,Exceeds,Male,44,3,0,5,3,4.4,4,1,1,1,1,2.9,3.6,3.5
4912,0,Asia Pacific,Finance,Quality Assurance,Meets,Female,28,20,0,7,2.1,2,2.6,1,1,1,1,2.3,3.5,2.7
4913,0,Middle East & Africa,Manufacturing,Communications,Below,Female,34,18,0,6,2.6,3.8,4.3,1,1,1,1,2.5,1.8,2.3
4914,0,Asia Pacific,R&D,Medical Affairs,Exceeds,Female,33,22,0,10,3.5,1.2,4.8,1,1,1,1,2.3,2.1,4
4915,0,North America,Manufacturing,Regulatory Affairs,Meets,Male,31,16,0,5,2.8,3.6,3.4,1,1,1,1,3,2.2,4.2
4916,0,Latin America,Commercial,Data Science,Meets,Female,35,15,0,5,4.9,4,2.6,1,1,1,1,3.8,4.9,4.4
4917,0,Asia Pacific,Finance,Market Access,Below,Male,40,10,0,7,4.1,2.5,4.1,0,0,0,0,3.8,1.4,4.3
4918,0,Middle East & Africa,Commercial,Sales,Meets,Male,46,22,0,7,4.2,1,3.4,1,1,1,1,4.5,1,2.9
4919,0,Asia Pacific,Finance,Pharmacovigilance,Meets,Male,44,25,0,5,2.3,4.1,1.3,1,1,1,1,2.1,3.9,1.1
4920,1,Europe,Finance,Quality Assurance,Far Exceeds,Female,28,5,0,6,2.7,1.3,3.4,1,1,1,1,3.9,2.4,2.8
4921,0,Asia Pacific,R&D,Finance & Accounting,Meets,Male,52,9,0,6,2.9,1.3,5,1,1,1,1,2.4,2,4.2
4922,0,North America,Manufacturing,IT & Digital,Exceeds,Female,45,9,1,10,,3.5,3.1,1,1,1,1,2.3,3.5,1.8
4923,0,Latin America,Finance,Legal & Compliance,Meets,Male,38,18,0,7,4.7,3.9,2.5,1,1,1,1,4.8,3.6,3.3
4924,0,Latin America,Manufacturing,Data Science,Meets,Male,46,5,1,11,,3.2,2.2,1,1,1,1,2.1,3.2,2.9
4925,0,North America,Finance,Pharmacovigilance,Below,Non-Binary/Other,32,4,0,8,3.2,1.3,2.4,1,1,1,1,3.8,2.7,1.4
4926,0,Europe,Manufacturing,Market Access,Meets,Male,43,18,0,5,2.8,1.3,2.4,1,1,1,1,3.8,2.3,3.1
4927,0,North America,Commercial,Data Science,Meets,Female,28,16,0,12,3.3,3,2.5,1,1,1,1,3.2,3.6,3.3
4928,0,Asia Pacific,R&D,Market Access,Exceeds,Female,36,2,0,12,3.3,4.5,2.4,1,1,1,1,3.8,3.8,3.8
4929,0,North America,Finance,IT & Digital,Meets,Female,46,11,0,11,2.8,4.4,3.8,0,0,0,0,3.5,4,3.3
4930,0,North America,Digital,Legal & Compliance,Meets,Male,35,21,0,12,3.2,3.2,3.1,1,1,1,1,3.5,2.5,2.4
4931,0,Europe,Manufacturing,Quality Assurance,Exceeds,Female,36,1,1,10,,2.7,3.8,1,1,1,1,3.4,3.3,2.6
4932,0,Asia Pacific,Manufacturing,Clinical Operations,Meets,Female,34,7,1,5,,1.2,1.7,1,1,1,1,3.1,2.2,2.3
4933,0,Middle East & Africa,Digital,Medical Affairs,Meets,Non-Binary/Other,37,36,1,5,,2.7,2.6,1,1,1,1,3.9,2,1.1
4934,0,Middle East & Africa,R&D,Medical Affairs,Meets,Female,32,24,0,6,3.2,2.3,2.8,0,0,0,0,2.2,2,3.3
4935,0,Latin America,Manufacturing,Marketing,Exceeds,Male,47,5,0,8,4.8,4.3,2.2,0,0,0,0,4.2,3.5,2.7
4936,0,North America,R&D,IT & Digital,Meets,Female,31,11,0,12,3.9,3.1,2.4,1,1,1,1,4,3.4,1.4
4937,0,Latin America,Manufacturing,IT & Digital,Below,Female,40,7,1,11,,2.6,1.3,1,1,1,1,4.4,2.8,3
4938,0,Europe,HR,Regulatory Affairs,Meets,Male,43,16,0,11,2.9,2.8,1.7,1,1,1,1,2.8,1.7,2.7
4939,0,Middle East & Africa,Manufacturing,Supply Chain,Far Exceeds,Female,34,18,1,12,,3,3.4,1,1,1,1,3.1,1.4,2.7
4940,0,North America,HR,Sales,Below,Female,29,8,0,8,1.6,3.5,3.4,1,1,1,1,1.3,2.5,1.5
4941,0,Europe,Finance,Market Access,Meets,Female,35,24,0,11,2,4.5,1.4,1,1,0,0,1.8,3.1,3.1
4942,0,Europe,R&D,Marketing,Meets,Female,36,17,0,11,2.6,2.2,2.4,1,1,1,1,1.7,3.8,1
4943,0,North America,Manufacturing,Human Resources,Below,Male,44,23,0,5,2.1,1.4,1.7,1,1,1,1,1.6,2,2.2
4944,0,Europe,Commercial,Legal & Compliance,Meets,Male,37,7,0,9,3.3,2,1.9,1,1,1,1,2.9,3.2,2.9
4945,0,North America,Commercial,Marketing,Exceeds,Male,38,14,0,5,3.3,2.9,1,1,1,1,1,3.9,3.3,2.8
4946,0,North America,Digital,Legal & Compliance,Far Below,Male,30,10,0,10,4.8,2.6,1.5,0,0,0,0,4.4,4.2,2.5
4947,0,Asia Pacific,Commercial,Legal & Compliance,Meets,Male,37,8,0,12,3.6,2,1.8,1,1,1,1,4.7,2.7,2
4948,0,Latin America,HR,IT & Digital,Exceeds,Female,47,14,0,10,3.4,5,2.9,1,1,1,1,3.8,4.7,5
4949,0,Europe,Commercial,Legal & Compliance,Meets,Female,45,14,0,5,3.4,4.2,2.9,1,1,1,1,2,3.2,3.6
4950,0,Europe,Commercial,Human Resources,Meets,Male,35,11,0,12,3.5,2.3,2.6,1,1,1,1,3.6,4,2.7
4951,0,Asia Pacific,Commercial,Marketing,Exceeds,Male,43,9,1,6,,3.1,3.5,1,1,1,1,4.5,2.9,2.2
4952,0,Asia Pacific,Manufacturing,Market Access,Meets,Female,37,25,0,11,3.1,3.9,3.6,1,1,1,1,2.4,2.9,4.8
4953,0,Asia Pacific,Digital,IT & Digital,Below,Male,41,5,0,10,2.6,3.6,3.1,1,1,1,1,3.3,3.6,2.2
4954,0,Middle East & Africa,R&D,Quality Assurance,Meets,Female,36,5,0,6,1.8,3.3,3,1,1,1,1,2.4,3.6,2.1
4955,1,Middle East & Africa,Digital,Market Access,Meets,Male,32,6,0,9,2.9,2.3,1.3,1,1,1,1,3.5,2.8,2.5
4956,0,Middle East & Africa,HR,Medical Affairs,Meets,Male,32,14,0,10,3.5,3.8,3.4,0,0,0,0,4.3,2.8,2.1
4957,0,North America,Manufacturing,Market Access,Meets,Female,41,8,0,12,4.2,3.7,3.4,1,1,1,1,3.9,3.1,4.5
4958,0,Europe,Finance,Quality Assurance,Far Exceeds,Female,28,3,1,9,,3.1,2.8,1,1,1,1,3.3,2.3,1.7
4959,0,Latin America,Manufacturing,Pharmacovigilance,Meets,Male,44,3,0,10,2.5,2.6,3.7,1,1,1,1,2.8,4.2,4
4960,0,North America,Commercial,Finance & Accounting,Exceeds,Non-Binary/Other,37,11,1,8,,3.1,1.9,1,1,1,1,4.5,4.1,1.3
4961,1,Europe,Commercial,Finance & Accounting,Meets,Male,34,21,1,10,,3.1,2.8,1,1,1,0,3.3,3.4,2.9
4962,0,Europe,HR,Medical Affairs,Below,Male,44,16,0,7,2.1,1,2.6,1,1,1,1,2.8,2.3,4.9
4963,0,Asia Pacific,Finance,Clinical Operations,Meets,Female,28,9,0,9,2.4,2.1,4.3,1,1,0,0,2.6,1.6,4.9
4964,0,Asia Pacific,Manufacturing,Data Science,Meets,Female,41,13,0,11,3.5,2.5,2.3,1,1,1,1,2.8,3,1.5
4965,0,North America,Finance,Clinical Operations,Meets,Male,48,9,1,7,,2.6,2.4,1,1,1,1,4.2,2.1,2
4966,0,Asia Pacific,R&D,Supply Chain,Meets,Female,30,30,0,6,3.8,1.8,2.9,1,1,1,1,4.4,3,3.7
4967,1,Europe,Digital,IT & Digital,Meets,Male,35,8,0,12,3.5,1.6,3.6,1,1,1,1,4.1,3.3,3
4968,0,Asia Pacific,Manufacturing,Clinical Operations,Meets,Non-Binary/Other,41,8,0,9,4.3,3.1,1.3,1,1,1,1,4.3,3.7,1
4969,0,Middle East & Africa,Finance,Human Resources,Far Exceeds,Female,29,12,1,9,,4,3.3,1,1,1,1,4.9,2.7,3.7
4970,0,Asia Pacific,R&D,Medical Affairs,Exceeds,Male,39,17,0,9,3.8,2.3,1.5,1,1,1,1,3.4,1,1.9
4971,0,Europe,R&D,Finance & Accounting,Meets,Male,54,16,0,7,2.8,3.8,2.9,1,1,1,1,3,3,3.5
4972,0,North America,Digital,Legal & Compliance,Meets,Female,40,13,0,10,3.6,2.8,1.2,1,1,1,1,2.9,2.5,3.1
4973,0,Latin America,R&D,Clinical Operations,Far Below,Female,40,10,0,6,3,4.1,2.2,1,1,1,1,3.8,2.8,3.5
4974,0,Asia Pacific,HR,Finance & Accounting,Below,Female,31,7,0,10,3.5,3.4,3.1,1,1,1,1,3.3,3.9,3.7
4975,0,Europe,R&D,Finance & Accounting,Below,Female,46,8,1,12,,2.7,2.2,1,1,1,1,3.4,2.8,2.6
4976,0,Latin America,Finance,Regulatory Affairs,Meets,Male,28,22,0,7,3.2,5,3.8,0,0,0,0,3.7,4.2,3.7
4977,0,Latin America,HR,Human Resources,Below,Female,38,24,0,12,3.5,2.7,3.3,1,1,1,1,3.9,3.3,3.2
4978,0,Middle East & Africa,R&D,Communications,Meets,Female,43,15,0,5,4.9,3.2,2.3,1,1,1,1,3.3,4.2,2.6
4979,0,Latin America,Commercial,Legal & Compliance,Meets,Male,28,12,0,10,3.8,3.9,3.8,1,1,1,1,4.1,3.8,3.1
4980,0,Europe,R&D,Clinical Operations,Meets,Female,28,27,0,11,3.5,2.3,3.5,1,1,1,1,5,3,2.6
4981,0,Europe,HR,Finance & Accounting,Exceeds,Male,29,26,0,12,3.3,1.9,3.6,1,1,1,1,3.4,2,3.4
4982,0,Asia Pacific,R&D,Sales,Far Exceeds,Male,46,8,0,8,4.4,3.4,3.5,1,1,1,1,5,2.7,3.8
4983,0,Asia Pacific,R&D,Supply Chain,Meets,Female,34,2,1,7,,3.4,1.6,1,1,1,1,1.8,4,1
4984,0,Asia Pacific,R&D,Data Science,Meets,Female,43,3,1,7,,2.5,2.9,1,1,1,1,3.8,3.6,1.7
4985,0,Latin America,HR,Legal & Compliance,Meets,Female,42,12,1,9,,3.5,3.2,1,1,1,1,2.7,3.7,3
4986,0,Latin America,R&D,Quality Assurance,Meets,Male,28,13,0,11,3.7,3.7,3.9,1,1,1,1,4.4,4.7,3.4
4987,0,Middle East & Africa,Digital,Legal & Compliance,Meets,Male,36,7,1,8,,2.2,1.7,1,1,1,1,2.4,1.6,1.6
4988,0,Asia Pacific,Finance,Communications,Below,Male,37,7,0,10,2.5,4,4,1,1,1,1,2.7,4.4,5
4989,1,North America,Digital,Sales,Meets,Male,41,14,1,5,,2.1,3,1,1,1,1,3,2.6,3.7
4990,0,Middle East & Africa,HR,Sales,Meets,Non-Binary/Other,39,20,0,12,4.2,3.8,2,1,1,1,0,4.7,2.8,1
4991,0,North America,Commercial,Finance & Accounting,Meets,Male,38,5,0,12,4,4.7,2.2,1,1,1,1,4.6,3.1,2
4992,0,Latin America,Digital,Sales,Meets,Female,45,5,1,8,,3.4,4.7,1,0,0,0,2.6,2.5,3.6
4993,0,Middle East & Africa,Finance,Quality Assurance,Meets,Female,45,10,1,6,,2.5,1.6,1,1,1,1,3.8,2,3.1
4994,0,Middle East & Africa,Manufacturing,Regulatory Affairs,Meets,Female,29,7,1,6,,4.2,2.4,1,1,1,1,3.1,3.8,2.4
4995,0,Europe,Finance,Regulatory Affairs,Far Below,Female,35,8,0,8,3.4,3.1,2.3,1,1,1,1,3.4,4.9,1.7
4996,0,Latin America,Digital,Communications,Meets,Female,38,23,0,7,2.8,3.3,3.2,1,1,1,1,2.1,3.2,2.8
4997,0,Latin America,Manufacturing,Legal & Compliance,Meets,Female,39,4,1,11,,4.2,2.1,1,1,1,1,3.6,3.1,3.2
4998,0,Middle East & Africa,HR,IT & Digital,Below,Male,41,36,0,8,2.1,5,3.6,1,1,1,1,2.7,4.5,3.6
4999,0,Latin America,Finance,Quality Assurance,Below,Non-Binary/Other,40,28,0,7,3.5,3.9,4.2,1,1,1,1,4.2,4.6,3.8
5000,0,Middle East & Africa,Commercial,Pharmacovigilance,Exceeds,Female,42,22,0,10,3,3.6,1,0,0,0,0,3,2.5,1.8
5001,0,Europe,Manufacturing,Human Resources,Meets,Male,42,5,1,8,,2.4,1.1,1,1,1,1,4.8,2.5,1.4
5002,0,Middle East & Africa,Manufacturing,IT & Digital,Exceeds,Female,36,3,0,8,3.7,3.2,4,1,0,0,0,3.1,2.5,3
5003,0,Latin America,Finance,Market Access,Exceeds,Female,36,14,0,7,2.7,4,2.8,0,0,0,0,1.7,3.9,1.1
5004,0,Latin America,Digital,Market Access,Exceeds,Female,46,10,0,8,2.7,3.3,4.2,1,1,1,1,2,2.9,4.2
5005,0,Middle East & Africa,Manufacturing,Regulatory Affairs,Far Below,Male,35,3,0,12,3.3,4.7,3.3,1,1,1,1,2.9,4.5,3.1
5006,0,Middle East & Africa,HR,Medical Affairs,Below,Female,42,4,0,11,4.2,5,2.5,1,1,1,1,5,4.5,2.3
5007,0,Middle East & Africa,Finance,Quality Assurance,Meets,Male,33,11,0,6,2.8,4.6,1,0,0,0,0,2.9,4,1.6
5008,0,Asia Pacific,HR,Regulatory Affairs,Below,Male,40,17,0,5,3,3.9,1.2,1,1,1,1,2.7,4.1,2.2
5009,0,Latin America,Finance,Medical Affairs,Meets,Female,40,20,0,12,3.7,2.4,3.7,1,1,1,1,3.9,3.8,1.2
5010,0,Latin America,HR,Market Access,Meets,Female,42,9,1,8,,2.5,3.9,1,1,1,1,5,3.1,2.9
5011,1,Asia Pacific,Digital,Finance & Accounting,Far Exceeds,Female,48,14,0,7,3.5,3,2.8,1,1,1,1,4.3,4.6,3.6
5012,0,Middle East & Africa,Finance,Finance & Accounting,Exceeds,Female,32,13,0,6,1.6,2.1,1.2,1,1,1,1,2.4,2.5,1
5013,0,Europe,Commercial,Clinical Operations,Meets,Female,39,11,1,10,,3.1,4.4,1,1,1,1,4.4,3.2,3.2
5014,0,Middle East & Africa,Digital,Regulatory Affairs,Meets,Female,42,13,1,6,,2.6,4.8,1,0,0,0,3.6,3.2,3.4
5015,0,Middle East & Africa,HR,Supply Chain,Meets,Male,42,6,1,11,,3.5,3.9,1,1,1,1,3.1,2.6,4
5016,0,Asia Pacific,Finance,Clinical Operations,Meets,Male,36,14,0,11,4.5,2.8,3.3,1,1,1,1,5,4.8,2.2
5017,0,Latin America,Digital,IT & Digital,Exceeds,Female,40,15,0,11,3.4,3.8,3.3,1,1,1,1,3.5,4.7,1.2
5018,0,Middle East & Africa,HR,Clinical Operations,Far Below,Male,38,8,1,8,,2.1,1,1,1,1,0,3.7,3.4,1
5019,0,Latin America,R&D,Regulatory Affairs,Meets,Male,42,12,0,11,3.1,1.8,4.4,1,1,1,1,2.8,2.6,2.9
5020,0,North America,R&D,Medical Affairs,Exceeds,Female,38,12,0,11,3.1,2.8,4.6,0,0,0,0,2.6,1.9,4.8
5021,0,Latin America,Manufacturing,Supply Chain,Below,Female,38,6,0,9,2.8,4,4.1,1,1,1,0,3.1,2.7,4.7
5022,0,Europe,Commercial,Medical Affairs,Far Exceeds,Male,40,12,1,11,,3.5,1.1,1,1,1,1,2.6,2.3,1.7
5023,0,Europe,R&D,Sales,Far Below,Female,35,16,0,6,3,3.2,3.9,1,1,1,1,4.3,2.8,4.9
5024,0,Middle East & Africa,HR,Medical Affairs,Exceeds,Male,33,6,0,12,3.7,4,2.4,1,1,1,1,3.8,2.8,2.4
5025,0,Latin America,Digital,Medical Affairs,Meets,Male,30,10,0,7,3.1,3.7,2.7,1,1,1,0,3.1,4.6,3.6
5026,0,Middle East & Africa,Finance,Pharmacovigilance,Below,Male,37,10,1,10,,4.6,1.2,0,0,0,0,3.5,3.6,4.2
5027,0,Asia Pacific,Digital,Communications,Below,Male,34,5,0,6,3.6,2.9,1,1,1,1,1,4.5,3.3,2.8
5028,0,Europe,Manufacturing,Marketing,Meets,Female,36,12,0,9,3.3,3.7,1,1,0,0,0,3.4,3,2.6
5029,0,Middle East & Africa,Digital,IT & Digital,Exceeds,Male,45,9,0,7,5,4.1,2.3,1,1,1,1,4.2,2.5,2.4
5030,0,Asia Pacific,R&D,Data Science,Meets,Female,36,12,0,10,2.8,2.6,1,1,0,0,0,5,2.5,1.7
5031,0,Middle East & Africa,Digital,Marketing,Exceeds,Female,46,5,0,9,2.9,3.6,1.8,1,1,1,1,2.6,2.9,1.3
5032,0,Latin America,R&D,Finance & Accounting,Exceeds,Male,40,3,0,6,2.4,4.2,2.6,1,1,1,1,2.8,1.6,2.2
5033,0,Latin America,R&D,Supply Chain,Far Below,Male,36,8,1,12,,3.5,2.5,1,1,1,1,2.3,2.6,1.4
5034,0,Latin America,Commercial,Supply Chain,Meets,Male,32,1,1,9,,1.9,2.5,1,1,1,1,4.6,2.1,1.9
5035,0,Latin America,Manufacturing,Quality Assurance,Meets,Female,37,6,1,12,,3.9,2.4,1,1,1,1,3.5,4.3,1.5
5036,0,North America,HR,Finance & Accounting,Meets,Male,36,16,0,5,5,3.9,2.4,1,1,1,1,5,3.3,2.6
5037,0,Asia Pacific,R&D,Medical Affairs,Below,Female,45,15,0,8,2.9,1.6,2.1,1,1,1,1,3.8,2.1,1.9
5038,0,Asia Pacific,Finance,Clinical Operations,Meets,Male,50,6,0,12,2.2,3.4,2.5,1,1,1,1,1.8,4.1,3.6
5039,0,Latin America,Manufacturing,Marketing,Meets,Female,44,18,0,10,3.1,3.8,3.1,0,0,0,0,2.8,2,2.5
5040,0,North America,HR,Quality Assurance,Meets,Female,34,22,0,8,2,4.1,1.4,1,1,1,1,1.5,2.5,4.4
5041,0,Latin America,Finance,Sales,Meets,Female,38,7,0,10,3.7,2.9,3.8,1,1,1,1,2.9,2.6,3.5
5042,1,North America,Digital,Finance & Accounting,Exceeds,Female,37,3,0,5,2.1,3.3,2.2,1,1,1,1,1.3,3.5,3.4
5043,0,Latin America,Manufacturing,Data Science,Far Below,Female,34,10,0,12,3,1.3,1.2,1,1,1,1,3.2,1.6,2.6
5044,1,Europe,Finance,Medical Affairs,Meets,Female,37,27,0,9,2.6,4.1,3,1,1,0,0,3.8,2.1,3.9
5045,0,Europe,Manufacturing,Quality Assurance,Meets,Female,37,12,0,11,3.1,2.5,3.9,1,1,1,1,3.1,4,3.7
5046,0,Middle East & Africa,Manufacturing,Marketing,Far Below,Female,49,36,0,12,2.5,3.6,1,1,0,0,0,3.5,3.9,3
5047,1,Latin America,Digital,Finance & Accounting,Meets,Female,40,18,0,5,2.6,2,1,1,1,1,1,2.9,3,1.3
5048,0,Asia Pacific,Digital,Communications,Meets,Male,43,5,0,11,3.4,3.6,4.1,1,1,1,1,3.6,1.8,3.9
5049,0,Middle East & Africa,Manufacturing,Finance & Accounting,Meets,Male,44,10,0,7,3.8,3.3,1.3,0,0,0,0,2.7,3.9,1.1
5050,0,Europe,Finance,Sales,Below,Male,43,13,0,12,2.1,2.9,1.3,1,1,1,1,2.9,2.7,2
5051,0,Latin America,Commercial,Finance & Accounting,Meets,Female,46,4,0,11,4.3,1,3.3,1,1,1,1,4.2,1.7,3.2
5052,0,Middle East & Africa,R&D,Pharmacovigilance,Meets,Male,36,7,0,5,3,2.2,1.1,1,1,1,1,3.3,3.9,1.8
5053,0,Latin America,Digital,Market Access,Meets,Female,44,25,0,6,3.2,3.3,3.2,1,1,1,1,3.1,3.3,2.2
5054,0,Europe,Commercial,Data Science,Below,Male,50,15,0,7,3.5,2,3.1,1,1,1,1,4.3,2.7,4.7
5055,0,Middle East & Africa,Digital,Supply Chain,Exceeds,Male,34,2,1,11,,3,1,0,0,0,0,3.2,4,1
5056,0,Europe,Manufacturing,Pharmacovigilance,Exceeds,Male,36,19,0,5,4.5,2.5,1,1,1,1,1,4.3,2.8,3.3
5057,0,North America,Commercial,Human Resources,Meets,Male,36,10,1,5,,4.1,1.4,1,1,1,1,3.9,2.5,2
5058,0,Europe,Finance,Finance & Accounting,Meets,Female,51,15,0,11,2.2,1.5,4.1,1,1,1,1,3.6,1.5,3.2
5059,0,Latin America,Finance,Human Resources,Below,Male,32,16,0,10,4.8,2.6,2.1,1,1,1,1,3.8,1.7,1.8
5060,0,Asia Pacific,HR,IT & Digital,Exceeds,Male,39,13,0,5,5,2.9,1.7,1,1,1,1,5,3.8,1.8
5061,0,Europe,R&D,Medical Affairs,Below,Female,41,7,1,10,,4.3,1.6,1,1,1,1,3,3.8,1
5062,0,Asia Pacific,R&D,Market Access,Far Below,Male,35,9,0,9,3.9,3.6,3.2,1,1,1,1,4.6,1,2
5063,0,North America,Digital,Market Access,Meets,Male,32,11,0,6,5,4,2.8,1,1,1,0,4.6,3.2,2.7
5064,0,Middle East & Africa,R&D,Data Science,Meets,Female,33,7,0,11,3.5,2.7,2,0,0,0,0,3.4,2.2,2.2
5065,0,Middle East & Africa,HR,Clinical Operations,Meets,Male,36,11,0,12,3.6,3,1,1,1,1,1,3.3,3.5,2.8
5066,0,Asia Pacific,Finance,Pharmacovigilance,Below,Male,35,8,0,5,4.3,3,3,1,1,1,1,3,4.8,2.7
5067,0,Middle East & Africa,Commercial,Finance & Accounting,Meets,Male,47,6,0,10,4.4,3.2,1.8,0,0,0,0,4,3.1,3.6
5068,0,Europe,Commercial,Clinical Operations,Meets,Female,35,13,0,9,3.9,3.9,2.9,1,1,1,1,2.5,4.9,2.8
5069,0,Asia Pacific,Finance,Regulatory Affairs,Meets,Male,35,26,0,8,2.1,3.7,1,0,0,0,0,2.4,4,1.7
5070,0,Latin America,Manufacturing,Pharmacovigilance,Meets,Male,40,9,0,6,2.3,4.8,4.1,1,1,1,1,2.8,3.8,1.7
5071,0,Europe,Finance,Sales,Meets,Male,40,8,0,9,3.1,4,2.3,1,1,1,1,2.3,4.5,2.3
5072,0,Europe,Commercial,Medical Affairs,Meets,Male,28,16,0,6,4.5,3.2,3.2,1,1,1,1,2.8,2.7,4.1
5073,0,Europe,Digital,Pharmacovigilance,Meets,Male,33,10,0,9,2.3,2.4,3.4,1,1,1,1,2.8,4.3,5
5074,0,Latin America,HR,Pharmacovigilance,Meets,Male,35,9,1,12,,3.7,1,1,1,1,1,2.2,3.3,1.8
5075,0,North America,Finance,Regulatory Affairs,Meets,Female,32,13,0,10,4.2,1.4,1.4,1,1,1,1,2.2,3.4,2.6
5076,0,Middle East & Africa,Manufacturing,Data Science,Meets,Male,44,17,0,10,2.6,2.4,2.7,1,1,1,1,3.4,3.9,3.5
5077,0,Asia Pacific,Digital,IT & Digital,Far Below,Female,29,13,0,7,2.9,3.3,1,0,0,0,0,3.4,1.3,1
5078,0,North America,Finance,Data Science,Meets,Female,44,17,0,11,2,4.2,1.2,1,1,1,1,2.9,2.7,1.9
5079,0,Asia Pacific,Digital,Sales,Meets,Female,28,9,0,11,2.7,2.9,3.7,1,1,1,1,3.1,3.5,3.3
5080,0,Middle East & Africa,Finance,Finance & Accounting,Meets,Female,38,33,0,5,2.5,3.4,3.1,1,1,1,1,3.3,4.5,4
5081,0,Latin America,Digital,Data Science,Below,Female,47,15,0,6,3.2,2.6,3,1,1,1,1,2.9,3.6,4.3
5082,1,Europe,R&D,Market Access,Exceeds,Female,34,11,0,7,2.4,5,3.8,1,1,1,1,2.9,3.3,3.2
5083,1,Europe,Digital,Marketing,Meets,Male,38,9,0,12,4.2,4,4.1,1,1,1,1,5,2.4,2.9
5084,0,Latin America,R&D,Regulatory Affairs,Meets,Male,44,9,1,5,,3.3,4,1,1,1,1,3.3,3.2,3.6
5085,0,North America,Commercial,Marketing,Far Below,Male,44,13,0,12,2.9,3.9,2.5,1,1,1,1,2.6,3.7,3.7
5086,0,North America,R&D,Marketing,Meets,Male,40,2,0,7,2.7,2.7,1,1,1,1,1,3.7,4.3,2.8
5087,0,Asia Pacific,Digital,Regulatory Affairs,Meets,Female,37,6,1,12,,2.7,1.6,1,1,1,1,3.3,2.3,2.9
5088,0,Latin America,HR,Marketing,Exceeds,Female,37,11,1,8,,4,2.2,1,1,1,1,4,3.6,3.1
5089,0,North America,HR,Marketing,Meets,Male,30,10,1,10,,3.8,3.3,1,1,1,1,2.9,2.3,4.4
5090,0,Latin America,Commercial,Marketing,Meets,Female,32,4,0,7,3.8,3.7,1,1,1,1,1,2.8,3.5,2.5
5091,0,Middle East & Africa,Digital,IT & Digital,Meets,Male,38,3,0,10,2.4,1.9,3.3,1,1,1,1,2.7,2.7,3.3
5092,0,Europe,R&D,Finance & Accounting,Meets,Female,40,14,0,10,4.3,3.8,2.7,1,1,1,1,4,3.9,4.3
5093,0,Europe,HR,Legal & Compliance,Exceeds,Female,53,17,0,11,3.5,4,2.4,1,1,0,0,4.2,2.2,1.8
5094,0,Europe,Finance,Sales,Meets,Male,43,10,0,9,3.5,3.9,5,1,1,1,1,2.8,4.2,3.8
5095,0,Latin America,Manufacturing,Supply Chain,Meets,Female,36,10,0,10,3.8,4,1.6,1,1,1,1,4.1,3.1,2.6
5096,0,Latin America,Digital,Finance & Accounting,Below,Female,41,19,1,12,,3.4,3.4,1,1,1,1,4.2,3.6,2.4
5097,0,Asia Pacific,Finance,Communications,Meets,Female,28,12,0,7,4.7,4.6,2,0,0,0,0,5,5,2.1
5098,0,Europe,Finance,IT & Digital,Below,Male,39,3,1,10,,4.3,3.6,1,1,1,1,4,4.1,2.4
5099,0,Asia Pacific,Digital,Sales,Meets,Female,42,15,0,9,2.4,3.3,1,1,1,1,1,3.4,2.5,1.8
5100,0,Europe,Manufacturing,Human Resources,Meets,Female,42,4,1,5,,2.1,2.3,1,1,1,1,4.4,2.6,3.8
5101,0,Asia Pacific,HR,Clinical Operations,Far Below,Female,38,23,0,6,3.2,3.4,2.5,1,1,1,1,2.8,2.7,3
5102,1,Asia Pacific,Manufacturing,IT & Digital,Meets,Male,41,9,0,12,4.4,3,3.4,1,1,1,1,3.9,4,1.4
5103,0,Middle East & Africa,Commercial,Pharmacovigilance,Meets,Male,36,27,0,7,1.5,4.2,2.2,1,1,1,1,1.7,2.6,3.1
5104,0,Asia Pacific,R&D,Data Science,Meets,Female,40,5,0,6,3.5,2.4,3.3,1,1,1,1,2.8,3.9,2.2
5105,0,Latin America,R&D,Regulatory Affairs,Far Below,Male,32,7,0,11,2.2,1.8,1,1,1,1,1,2.7,3.3,2.3
5106,0,Asia Pacific,Finance,Market Access,Meets,Male,31,9,1,11,,1.2,2.7,1,0,0,0,3.8,1.7,2.2
5107,0,Europe,HR,Marketing,Meets,Male,46,4,1,6,,4.3,2.4,1,1,1,1,4.3,4.4,3.1
5108,0,Asia Pacific,Manufacturing,Quality Assurance,Meets,Male,37,25,0,10,2.4,4.4,3.3,1,1,1,1,2.8,2.7,2.6
5109,1,North America,Finance,Regulatory Affairs,Meets,Male,41,4,0,5,1.7,5,4.3,1,1,1,1,1.8,4.6,3.8
5110,0,Europe,Digital,Medical Affairs,Exceeds,Male,33,6,1,8,,5,2.5,1,1,1,1,3.9,3.3,2.3
5111,0,North America,Finance,Regulatory Affairs,Far Below,Male,31,9,0,10,3.5,4.7,3,1,1,1,1,4.3,5,2.9
5112,0,Europe,Digital,IT & Digital,Meets,Female,35,12,0,5,3.7,3.9,1.6,1,1,1,0,3.3,3,2.7
5113,0,Latin America,Digital,IT & Digital,Meets,Female,41,16,0,10,3.1,2.7,1.5,0,0,0,0,2.1,4,2.9
5114,0,Latin America,Commercial,Pharmacovigilance,Exceeds,Male,28,16,1,8,,2.5,3,1,1,1,1,3.2,2.8,2.8
5115,0,Latin America,Commercial,Market Access,Meets,Female,39,22,0,11,3.7,3.1,3.1,1,1,1,1,3.3,2.9,3.6
5116,0,North America,Digital,Finance & Accounting,Meets,Male,42,29,0,6,5,4.1,1.4,1,1,1,1,5,3.5,2.4
5117,0,Middle East & Africa,HR,Communications,Below,Male,33,16,0,9,3.6,2.2,2.1,1,1,1,1,5,3.9,2.8
5118,1,Europe,Commercial,Regulatory Affairs,Exceeds,Male,39,6,0,5,2.4,2.1,2.3,1,1,1,1,3.6,2.3,2.3
5119,0,Latin America,Commercial,Market Access,Meets,Female,39,5,1,9,,3.6,2.9,1,1,1,1,3.2,4.1,1.9
5120,1,Europe,R&D,Regulatory Affairs,Meets,Female,33,20,0,8,3.1,2.1,3.6,1,1,1,1,4.2,2,2.5
5121,0,North America,Finance,Legal & Compliance,Below,Male,37,17,0,12,3.9,1.6,2,1,1,1,1,3.9,1.7,2.9
5122,0,Middle East & Africa,R&D,Finance & Accounting,Exceeds,Female,38,5,0,9,2.6,3,1.8,1,1,1,1,2,3.4,2.2
5123,0,North America,HR,Sales,Meets,Female,33,11,0,12,2.6,3.9,3.1,1,1,1,1,2.4,5,4.1
5124,0,Europe,Commercial,IT & Digital,Below,Male,36,6,1,6,,2.4,1.4,1,1,1,1,2.9,2.1,2.4
5125,0,Middle East & Africa,Commercial,Sales,Below,Female,38,7,0,5,2.4,1.9,3,1,1,1,1,2.8,4,3.8
5126,0,Middle East & Africa,Manufacturing,IT & Digital,Meets,Male,40,15,0,10,3.9,1.9,2.2,1,1,1,1,3.9,1.5,3.5
5127,0,North America,HR,Supply Chain,Meets,Female,49,5,0,9,2.9,3.2,5,1,1,1,1,2.9,1,3.8
5128,0,Latin America,Finance,Clinical Operations,Meets,Female,32,10,0,9,3.9,3,2.4,1,1,1,1,2.5,1.5,1.6
5129,0,Europe,Finance,IT & Digital,Far Exceeds,Female,46,30,0,5,2.9,2.6,2.6,1,1,1,1,3.3,2.9,1.6
5130,0,Asia Pacific,Finance,Regulatory Affairs,Meets,Female,33,20,0,9,2,2.8,2.6,1,1,1,0,4,3.4,1.3
5131,0,Asia Pacific,HR,Human Resources,Exceeds,Female,38,17,0,10,5,3.4,4.2,1,1,1,1,3.8,5,2.8
5132,0,North America,Manufacturing,Human Resources,Meets,Male,44,18,0,12,2.9,3.1,3.5,1,1,1,0,3.5,2.5,4.1
5133,0,Europe,Manufacturing,Marketing,Meets,Male,41,30,0,6,4,2.5,3.1,1,1,1,1,5,3.2,3.8
5134,0,Europe,R&D,Regulatory Affairs,Meets,Female,28,14,0,11,3.2,4.2,3.2,1,1,1,1,5,3.5,2.6
5135,0,North America,HR,Medical Affairs,Meets,Male,45,10,1,11,,4.3,1.1,1,1,1,1,3.6,2.9,2.9
5136,0,Europe,HR,Market Access,Meets,Male,40,8,1,6,,2.3,2.9,1,1,1,1,4.3,1.5,3
5137,0,Latin America,Manufacturing,Marketing,Meets,Male,35,20,0,9,4.9,1.9,3.4,1,1,1,1,3.6,3.4,3.1
5138,0,North America,Digital,Finance & Accounting,Far Exceeds,Male,37,8,1,7,,3,2.5,1,1,1,1,3.6,3.5,4.2
5139,0,Latin America,Digital,IT & Digital,Meets,Male,41,15,0,8,2.7,3.5,3.7,1,1,1,1,2.4,2.9,3.6
5140,0,Europe,R&D,Supply Chain,Exceeds,Female,42,15,0,8,2.8,3.1,3,1,1,1,1,3,3.7,3.6
5141,0,North America,Digital,Market Access,Meets,Male,41,9,1,12,,5,3.5,1,0,0,0,5,5,3.8
5142,0,Europe,Digital,Sales,Meets,Female,34,9,0,8,2.2,3.3,3.1,1,1,1,1,4.1,4.1,4.4
5143,0,North America,Digital,Quality Assurance,Meets,Male,38,13,0,5,2.9,3.3,4,1,1,0,0,4.2,1.7,3.8
5144,0,Europe,Commercial,Marketing,Meets,Female,33,2,1,9,,3.6,3.3,1,1,1,1,3.1,4.3,3.1
5145,0,Latin America,R&D,Sales,Below,Male,43,16,0,6,2.4,3.3,1,0,0,0,0,3.6,2.8,1.9
5146,0,Latin America,Manufacturing,Medical Affairs,Meets,Female,37,6,1,7,,3.3,3.6,1,1,1,1,4.3,4.7,2.4
5147,0,Europe,Digital,Marketing,Exceeds,Male,41,7,0,6,4.7,1.7,3.9,1,0,0,0,4.4,2.2,4
5148,0,North America,Finance,Marketing,Meets,Female,35,16,0,10,3.6,2.8,2.3,1,1,1,1,2.3,3.3,2.3
5149,0,Asia Pacific,Commercial,Marketing,Exceeds,Male,39,10,0,11,3.5,2.9,2.7,1,1,1,1,3.2,3.2,3.2
5150,0,Latin America,Digital,Clinical Operations,Meets,Female,37,13,0,7,2.6,3.6,3.4,0,0,0,0,2.4,3.4,4
5151,0,Latin America,Commercial,Marketing,Meets,Male,31,26,0,5,4.5,4.4,2.8,1,1,1,1,3.6,4.6,3.8
5152,0,Asia Pacific,R&D,Clinical Operations,Meets,Male,45,22,0,11,1.8,3.3,2.9,1,1,1,0,1.3,4.9,4.2
5153,0,Europe,Finance,Sales,Below,Male,42,12,0,10,3.4,2.6,5,1,1,1,1,2.5,3.8,4.3
5154,0,North America,Finance,Supply Chain,Below,Female,30,14,0,6,3.5,1.7,2.7,1,1,0,0,2.2,2.5,4
5155,0,Europe,Finance,Clinical Operations,Meets,Male,33,18,1,9,,4.8,2.7,1,0,0,0,3.6,4.7,2.9
5156,0,Middle East & Africa,Digital,Finance & Accounting,Far Below,Female,34,6,0,12,4.1,2.7,2.5,1,1,1,1,5,5,3.9
5157,0,Latin America,Commercial,Clinical Operations,Below,Non-Binary/Other,46,27,0,12,3.6,4,2.9,1,1,1,1,2.4,2.8,1.3
5158,0,Middle East & Africa,Finance,Finance & Accounting,Below,Male,43,13,0,10,3.1,3.4,2.1,0,0,0,0,3.6,4.2,2.3
5159,0,Latin America,HR,Finance & Accounting,Far Below,Non-Binary/Other,39,6,0,12,3.4,4.3,3.5,1,1,1,1,2.9,4.6,3
5160,0,Latin America,HR,Communications,Below,Male,29,16,0,9,3,1.6,1,1,1,1,1,3.7,1.3,2.8
5161,0,Middle East & Africa,Commercial,Marketing,Meets,Female,41,1,1,9,,2,3.1,0,0,0,0,4.1,3.5,1.7
5162,0,Middle East & Africa,Digital,Communications,Exceeds,Non-Binary/Other,39,24,0,6,3.6,2.3,3.3,1,1,1,1,3.3,4.8,4.8
5163,0,Europe,Digital,Supply Chain,Below,Non-Binary/Other,36,12,1,7,,5,2.3,1,1,1,0,3.7,5,3.7
5164,0,Middle East & Africa,R&D,Marketing,Below,Male,46,16,0,12,2.6,2.1,1.7,1,1,1,1,2.4,2.1,3.1
5165,0,Europe,R&D,Sales,Meets,Female,37,21,0,7,3.2,2.6,3.4,1,0,0,0,3.8,3,2.9
5166,0,Europe,Finance,Marketing,Far Below,Male,45,8,1,7,,2.7,4.4,1,1,1,1,4.3,2.7,2
5167,0,Europe,Manufacturing,Finance & Accounting,Meets,Male,36,16,0,8,4,4,1,0,0,0,0,5,4.3,2.6
5168,0,Latin America,R&D,Legal & Compliance,Below,Male,33,8,0,8,2.5,5,3.6,1,1,1,1,3,5,3.2
5169,0,Latin America,Digital,Data Science,Meets,Male,31,13,0,10,3.8,4,3.9,1,1,1,1,4.3,4.9,1.9
5170,0,Middle East & Africa,Manufacturing,Pharmacovigilance,Below,Female,38,14,1,8,,3,1.6,0,0,0,0,3.4,2.6,2.8
5171,0,Latin America,R&D,Communications,Meets,Male,38,11,0,11,3.2,1.5,4.2,1,1,1,0,3.6,2.3,4.5
5172,0,Middle East & Africa,Commercial,Sales,Meets,Non-Binary/Other,32,4,0,6,2.5,3.9,2.7,1,1,1,1,3,3.5,3.3
5173,0,Latin America,HR,Regulatory Affairs,Below,Female,33,7,1,7,,3.4,1.1,1,1,1,1,3.4,3.4,1
5174,0,North America,R&D,Legal & Compliance,Far Exceeds,Female,45,18,0,9,2.7,3.4,3.1,1,1,1,1,3.4,4,4.2
5175,0,North America,R&D,Legal & Compliance,Meets,Female,42,7,0,10,1.5,3.3,3,1,1,1,1,2.9,2.4,1.8
5176,0,Middle East & Africa,Commercial,IT & Digital,Exceeds,Female,49,14,0,12,4.8,3.5,2,1,1,1,1,4.7,4.1,3
5177,0,Latin America,Digital,Market Access,Below,Male,28,18,0,10,3,4.7,4.2,1,1,1,1,2.9,3.4,3.6
5178,0,Latin America,Finance,Market Access,Below,Female,48,7,0,5,3.2,1.5,2.4,1,1,1,1,3.6,2.6,2
5179,0,Europe,Commercial,Supply Chain,Meets,Male,33,31,0,5,2.4,3.7,3.2,1,1,1,1,2.8,4.5,2.1
5180,0,Asia Pacific,Finance,Data Science,Below,Male,30,17,0,10,3,3.5,2.2,1,1,1,1,3.4,5,2
5181,0,Middle East & Africa,R&D,Clinical Operations,Exceeds,Male,40,8,1,5,,3.6,2.2,1,0,0,0,2.3,4.9,1.7
5182,0,Asia Pacific,Digital,Data Science,Meets,Female,28,14,1,6,,2,1.6,1,1,1,1,3.1,2.7,2.7
5183,0,Asia Pacific,Manufacturing,Pharmacovigilance,Meets,Male,44,5,1,8,,2,4.4,1,1,1,1,1.3,2.7,2.7
5184,0,Middle East & Africa,R&D,Sales,Below,Male,39,19,0,8,1.8,2.9,3.2,1,1,1,0,3.7,1.9,4.7
5185,0,Latin America,Commercial,Supply Chain,Meets,Male,34,3,0,8,3.7,3.5,2,1,1,1,1,3.3,2.9,3.3
5186,0,Middle East & Africa,Manufacturing,Data Science,Meets,Male,44,13,0,5,3.6,3.8,2.8,1,1,1,1,4.7,4,2.3
5187,0,Asia Pacific,HR,Medical Affairs,Meets,Female,37,8,0,8,2.4,3.7,3.8,0,0,0,0,3,4.7,3.8
5188,0,Latin America,Manufacturing,Clinical Operations,Meets,Female,38,6,0,8,3.6,4.5,2.6,1,1,1,1,3.7,1.3,2.7
5189,1,North America,Commercial,Data Science,Exceeds,Non-Binary/Other,42,23,0,5,3.6,3.4,3.2,1,1,1,1,5,2.7,3.7
5190,1,Middle East & Africa,Manufacturing,Supply Chain,Far Exceeds,Male,34,8,0,6,2.5,2.8,2,1,1,1,1,4.4,2.7,2.4
5191,0,Middle East & Africa,Commercial,Medical Affairs,Exceeds,Male,32,5,0,5,4.1,5,2.7,1,1,1,1,2.3,4.5,2.6
5192,0,Latin America,R&D,Communications,Meets,Male,37,13,0,11,2.5,3.4,1,0,0,0,0,4.2,4.8,1
5193,0,North America,Digital,Regulatory Affairs,Meets,Female,30,10,0,8,5,3.4,2.6,1,1,1,1,3.4,1.8,1.5
5194,0,North America,HR,Legal & Compliance,Below,Male,35,15,0,10,4.8,2.6,2,1,1,1,1,4.4,2.7,1
5195,0,Latin America,Digital,Sales,Exceeds,Male,32,7,1,8,,3,4,1,1,1,1,4.1,2,3.9
5196,0,Europe,Digital,Communications,Far Exceeds,Male,36,7,1,12,,3,2,1,1,1,1,3.8,2.6,2.1
5197,0,Middle East & Africa,Digital,Sales,Far Below,Male,33,10,0,10,3.3,4.1,1.8,1,1,1,1,2.6,5,2.8
5198,0,Middle East & Africa,Commercial,Communications,Meets,Male,36,7,0,11,3.2,3.4,3.5,1,1,1,1,3.9,3.5,1.9
5199,0,Asia Pacific,Commercial,Regulatory Affairs,Exceeds,Female,44,11,0,6,2.8,3.6,1.9,1,1,1,1,3.1,2.6,2.5
5200,0,Latin America,HR,Communications,Below,Female,34,3,0,10,3.2,2.1,2.7,1,1,1,1,4.6,2.3,4.1
5201,0,Asia Pacific,Commercial,Communications,Below,Male,40,21,0,8,3.3,2.9,2.6,1,1,1,1,3.8,2.3,3
5202,0,Asia Pacific,Finance,Human Resources,Far Exceeds,Male,28,9,0,5,2.8,4.8,2.5,1,1,1,0,3.6,4,2.7
5203,0,North America,Commercial,Marketing,Exceeds,Male,36,5,1,10,,3.6,1.7,1,1,1,1,3.7,2.8,4.3
5204,0,Middle East & Africa,Commercial,Market Access,Exceeds,Female,33,16,1,8,,2.9,3.7,1,1,1,1,3.9,4.4,3.7
5205,0,Asia Pacific,Commercial,Medical Affairs,Below,Female,38,7,0,11,4.8,3,2,1,1,1,1,4.1,2.8,2.2
5206,0,North America,R&D,Legal & Compliance,Meets,Female,35,8,0,9,4.5,1.4,3.2,1,1,1,1,4.8,2.6,3.9
5207,0,Latin America,HR,Clinical Operations,Meets,Male,43,15,1,8,,2.9,3.1,1,1,1,1,5,3.2,4.4
5208,0,Asia Pacific,Finance,Data Science,Meets,Female,36,13,0,6,3,4.2,3.3,1,1,1,1,4.4,3.3,3.1
5209,0,Middle East & Africa,Commercial,Legal & Compliance,Meets,Non-Binary/Other,45,26,0,11,3.2,1.9,2.2,1,1,1,1,3.8,2,2.4
5210,0,Asia Pacific,HR,Pharmacovigilance,Exceeds,Female,28,18,0,10,3.2,3.9,2.2,1,1,1,1,3.4,4,2.3
5211,0,Latin America,Manufacturing,Market Access,Exceeds,Male,38,23,0,7,1.8,4,3.3,1,1,1,1,2.5,3.7,2.9
5212,0,Asia Pacific,R&D,Supply Chain,Meets,Female,39,3,1,6,,3,2,1,1,1,1,2.4,3.7,1.4
5213,0,Middle East & Africa,Commercial,Finance & Accounting,Below,Female,32,12,0,6,2.4,3.3,2.2,1,1,1,1,3.7,1,3
5214,0,North America,Finance,Marketing,Below,Male,38,7,0,7,3,4.4,2.3,1,1,1,1,3.1,2.3,2.7
5215,1,Middle East & Africa,R&D,Legal & Compliance,Meets,Male,41,18,0,6,2.8,1.8,2.6,1,0,0,0,3.6,2,3
5216,0,North America,Finance,Clinical Operations,Below,Female,45,16,0,8,4.4,3.8,2.3,1,1,1,1,2.5,2.7,3.6
5217,0,Europe,R&D,Pharmacovigilance,Meets,Female,36,27,0,7,3.6,2.1,2.6,1,1,1,1,4.4,1.8,2.4
5218,0,Middle East & Africa,Manufacturing,Finance & Accounting,Meets,Non-Binary/Other,35,9,0,7,3.9,3.9,1.7,1,1,1,1,4.2,2.9,1.4
5219,0,Middle East & Africa,HR,Pharmacovigilance,Exceeds,Male,34,28,0,6,4.2,2.1,2.7,1,1,1,1,4.3,1,2.1
5220,0,Latin America,R&D,Clinical Operations,Meets,Female,38,5,0,5,4.1,4.3,3.6,0,0,0,0,4.2,3.9,4
5221,0,Asia Pacific,Digital,Legal & Compliance,Meets,Male,32,10,0,11,3.8,2.7,1.9,1,1,1,1,4.6,2.3,2
5222,0,North America,Manufacturing,Finance & Accounting,Meets,Non-Binary/Other,43,6,0,11,4,1.6,3.2,1,0,0,0,2.9,2.1,2.7
5223,0,North America,Digital,Finance & Accounting,Meets,Male,28,5,0,10,2.7,2.9,4.7,1,1,1,1,2.1,3.2,3.5
5224,0,Latin America,Manufacturing,Communications,Far Exceeds,Male,38,11,0,6,3.6,2.2,1.5,1,1,1,1,3.5,3.9,1.1
5225,0,Latin America,Digital,Marketing,Meets,Male,30,25,0,11,4.8,4.1,2.6,1,1,1,1,4.2,3,2.9
5226,1,Asia Pacific,Digital,Supply Chain,Exceeds,Female,38,17,0,9,4.8,4.5,2.9,1,1,1,1,5,4.4,2.4
5227,0,Asia Pacific,Finance,Regulatory Affairs,Meets,Male,43,8,0,10,3.7,2.5,2.5,1,1,0,0,3.4,2.6,1.7
5228,0,Middle East & Africa,R&D,Market Access,Meets,Female,39,10,1,8,,3.5,1.5,1,1,1,1,2.7,2.4,2.8
5229,0,Europe,R&D,Quality Assurance,Meets,Female,34,2,0,11,2.9,3.5,2.8,1,1,1,1,3.5,3.7,4.5
5230,0,Asia Pacific,Manufacturing,Quality Assurance,Far Exceeds,Male,42,17,0,9,2.3,2.6,2,1,1,1,1,3.3,3.2,1
5231,1,Latin America,HR,Marketing,Meets,Male,28,4,1,12,,3,3.3,1,1,1,1,4.1,3.2,3
5232,0,Asia Pacific,Finance,Pharmacovigilance,Below,Male,38,17,0,11,4.9,2.6,4.8,1,1,1,1,4,2.8,4
5233,0,North America,R&D,Data Science,Meets,Male,33,7,1,8,,2.6,2.8,1,1,1,1,3.2,2.4,3.2
5234,0,Europe,R&D,Regulatory Affairs,Meets,Female,41,20,1,12,,3.9,4.3,1,1,1,1,1.5,3.7,4.3
5235,0,Middle East & Africa,Finance,Regulatory Affairs,Meets,Female,28,9,0,7,1.6,3.1,1.7,1,1,1,1,2.6,3.1,1.6
5236,1,North America,Commercial,Marketing,Far Exceeds,Male,35,1,0,11,2.6,3.9,2.9,1,1,0,0,4.9,3.4,3.1
5237,0,North America,Finance,Supply Chain,Exceeds,Female,34,15,0,7,4.7,4.6,3.1,1,1,1,1,4.6,3.9,3
5238,0,Europe,R&D,Marketing,Meets,Male,43,8,0,10,3.8,3.3,1.6,1,1,1,1,3,1.6,2.9
5239,0,Middle East & Africa,HR,Human Resources,Below,Female,33,20,0,10,4.3,2.1,1.3,1,1,1,1,3.2,3.4,2
5240,0,Latin America,Commercial,Data Science,Meets,Non-Binary/Other,37,6,1,5,,3.5,2.5,1,1,0,0,4.4,2.8,1.4
5241,0,Middle East & Africa,Digital,Sales,Meets,Male,38,4,0,9,4.6,3.4,1,1,1,1,1,4.9,3.7,1
5242,0,Asia Pacific,Finance,Quality Assurance,Meets,Female,38,13,1,11,,2.7,3.6,1,1,1,1,2.5,2.4,2.1
5243,0,North America,Digital,Marketing,Meets,Female,38,17,0,7,2.7,3.8,2.1,1,1,1,1,2,4.8,2.1
5244,0,Asia Pacific,Commercial,Regulatory Affairs,Meets,Male,38,36,0,9,4.6,2.7,3.1,1,1,1,1,3.4,3,5
5245,0,Latin America,Commercial,Communications,Below,Female,38,30,0,7,4.9,2.8,3.3,1,1,1,1,5,3.3,3.1
5246,0,Asia Pacific,Commercial,Supply Chain,Meets,Male,52,6,0,9,3.4,2.5,2.7,1,1,1,1,4.3,1.8,3.3
5247,0,Middle East & Africa,Manufacturing,Quality Assurance,Below,Male,28,23,0,5,3.3,3.3,1.3,1,1,1,1,2.8,2.2,1.6
5248,0,Asia Pacific,Finance,Medical Affairs,Far Below,Female,33,10,0,10,2.5,3.3,1.3,1,1,0,0,4.1,4,2.5
5249,0,Latin America,HR,IT & Digital,Meets,Female,38,17,1,9,,3.4,2.7,1,1,1,1,3.1,3.8,3
5250,0,Latin America,HR,Clinical Operations,Meets,Female,45,13,0,7,2.3,3.8,1.3,1,1,1,1,4,4.2,1.7
5251,0,Latin America,Digital,Regulatory Affairs,Meets,Female,44,10,0,5,3.3,3.3,1.8,1,0,0,0,4.1,3.4,1.1
5252,0,Middle East & Africa,Digital,Medical Affairs,Meets,Male,44,17,0,7,2.8,2.5,2.1,1,1,1,1,4.7,1.3,1.8
5253,0,Latin America,Digital,Supply Chain,Far Below,Female,38,5,0,7,3.9,3.1,1.2,1,1,1,1,2.7,3.1,1.8
5254,0,North America,Finance,Regulatory Affairs,Meets,Female,45,7,1,11,,2.1,3.2,1,1,1,1,3.4,3.5,2.3
5255,0,Latin America,R&D,Marketing,Meets,Female,34,13,0,10,3,4.4,2.5,1,1,1,1,2.4,4.7,4.2
5256,1,Asia Pacific,Digital,Regulatory Affairs,Meets,Female,43,7,0,6,2.9,1.6,3.9,1,0,0,0,2.4,2,3.5
5257,0,Asia Pacific,Commercial,IT & Digital,Meets,Female,39,17,0,11,1.1,3.2,4.5,1,1,1,1,2.4,2.3,4.7
5258,0,Asia Pacific,Digital,Supply Chain,Meets,Male,39,8,0,5,2.7,3.3,1.5,1,1,0,0,2.6,2.1,2.8
5259,0,Middle East & Africa,Commercial,Regulatory Affairs,Meets,Male,30,10,0,12,2.5,4.1,1,1,1,1,1,2.1,3.1,2.3
5260,0,Asia Pacific,Manufacturing,Data Science,Exceeds,Female,28,10,0,10,2,2.5,2.4,1,1,1,1,3.3,2.9,2.7
5261,1,Middle East & Africa,R&D,Pharmacovigilance,Exceeds,Female,36,18,0,10,3.9,3.5,2.7,1,1,1,1,3.8,4.2,2.4
5262,0,Middle East & Africa,R&D,Finance & Accounting,Exceeds,Female,37,14,0,9,1.2,1.4,1.1,1,1,1,1,1.9,2.4,3.1
5263,0,Latin America,Finance,Communications,Meets,Male,31,9,0,6,1,3.7,3,1,1,1,1,1.7,4.4,4
5264,0,North America,Finance,Medical Affairs,Meets,Male,44,6,1,11,,3.3,2.3,1,1,1,1,3.3,1.4,1.9
5265,0,Latin America,HR,Legal & Compliance,Meets,Male,33,13,1,12,,2.4,4.2,1,1,1,1,3.9,2.6,4.3
5266,0,Latin America,Manufacturing,Sales,Meets,Female,41,7,1,10,,2.8,1.9,1,1,1,1,4.8,1.5,1.8
5267,0,Middle East & Africa,Finance,Pharmacovigilance,Meets,Male,36,6,0,7,3.7,3.4,1,1,1,1,1,2.9,3.2,2
5268,0,Middle East & Africa,Commercial,Supply Chain,Meets,Female,43,10,0,11,3.9,3.1,1,0,0,0,0,3.9,2.2,1.2
5269,0,Asia Pacific,Manufacturing,Quality Assurance,Meets,Non-Binary/Other,31,33,0,8,4.1,3.3,1.5,1,1,1,1,5,3.5,1.2
5270,0,Asia Pacific,R&D,Communications,Below,Male,28,12,0,8,2.2,3.1,3.6,1,1,1,1,2.6,2.8,3.5
5271,0,Latin America,Commercial,Human Resources,Meets,Male,41,23,0,9,3.5,3.2,3,1,1,1,1,4.3,3.7,3.7
5272,0,Europe,Manufacturing,Data Science,Below,Male,43,1,0,11,3,4.2,2.6,1,1,1,1,3.3,2.2,2.7
5273,0,Europe,R&D,Human Resources,Far Below,Male,40,2,1,12,,3.8,2.3,1,1,1,1,3.5,3.5,2.8
5274,0,Asia Pacific,Finance,Human Resources,Exceeds,Male,33,4,1,5,,3.4,3,1,1,1,1,3.8,3,1.8
5275,0,Europe,Commercial,Medical Affairs,Meets,Female,42,14,0,5,3.3,3.3,1.9,0,0,0,0,2.9,3.8,1.7
5276,0,Asia Pacific,Commercial,Supply Chain,Meets,Female,41,11,0,12,3.6,2.9,4,1,1,1,1,3.4,3.2,1.9
5277,0,Middle East & Africa,R&D,Medical Affairs,Meets,Male,31,1,0,10,3.5,4.6,1.3,1,1,1,1,4.5,2.8,1.8
5278,0,Latin America,Commercial,Regulatory Affairs,Meets,Female,41,25,0,7,2.5,2.5,3.2,1,1,1,1,2.9,2.1,2.7
5279,0,North America,Finance,Legal & Compliance,Below,Female,39,8,1,7,,1.7,2.3,0,0,0,0,2.1,2.8,3.3
5280,1,Latin America,Finance,Market Access,Meets,Male,39,7,0,9,3.5,2.1,4.2,1,1,1,1,4.2,3.2,3.8
5281,0,Asia Pacific,Finance,Marketing,Exceeds,Female,30,11,0,12,4.1,1.3,1.8,1,1,1,1,3.1,1.3,3.2
5282,0,Asia Pacific,R&D,Pharmacovigilance,Exceeds,Male,43,5,1,9,,3.9,2.4,1,1,1,1,5,4.1,3.4
5283,0,Latin America,Digital,Regulatory Affairs,Below,Male,35,10,0,5,4.9,1.7,1.4,1,1,1,1,3.6,1.9,1.9
5284,0,Asia Pacific,Digital,Clinical Operations,Meets,Female,34,11,0,12,3.2,4.2,2.6,1,1,1,1,2.8,3.8,4.5
5285,0,Europe,Commercial,Quality Assurance,Exceeds,Male,41,15,0,6,3.3,2.6,3.7,1,1,1,1,3.2,3.7,2.8
5286,0,Europe,Finance,Clinical Operations,Below,Male,37,15,0,6,2.8,1.7,2.5,1,1,1,1,3.3,3,1.2
5287,0,Asia Pacific,Commercial,Clinical Operations,Below,Male,29,9,1,6,,3,3.3,1,1,1,1,2.8,2.7,3.6
5288,0,Asia Pacific,R&D,Data Science,Exceeds,Female,47,5,0,11,3.1,4.7,1.4,1,1,1,1,4.2,1.9,1.6
5289,0,Europe,Commercial,Sales,Meets,Male,39,8,0,5,3.7,2.7,4.8,1,1,1,1,4.3,2.4,3.9
5290,0,Asia Pacific,HR,Finance & Accounting,Meets,Female,38,13,0,9,2.7,5,2.6,1,1,1,1,2.9,3.5,3.2
5291,0,Asia Pacific,Digital,IT & Digital,Below,Female,38,13,1,12,,1.7,1.6,1,1,1,1,2.6,3.3,1.7
5292,0,Latin America,Commercial,Pharmacovigilance,Meets,Male,38,13,0,10,1.8,3.3,1.5,1,1,1,1,3,3.1,1
5293,0,North America,Commercial,Human Resources,Meets,Male,39,21,0,8,2.4,3.6,2.2,1,1,1,1,2.2,3,1.7
5294,0,Europe,Manufacturing,Market Access,Meets,Male,45,6,1,9,,3.9,1,1,1,1,1,5,3.7,1.4
5295,0,Latin America,Commercial,Regulatory Affairs,Meets,Male,47,7,1,7,,4,2.1,1,1,1,1,3.7,3.8,2.7
5296,0,North America,HR,IT & Digital,Meets,Male,36,24,0,12,3.4,3.1,3.3,1,1,1,1,4.6,3.1,2.9
5297,0,Asia Pacific,Digital,IT & Digital,Meets,Male,42,7,0,6,3.4,4.3,2.3,1,1,1,1,4.1,4.9,1.7
5298,0,Asia Pacific,Manufacturing,Clinical Operations,Meets,Male,42,7,0,7,2.5,2.5,3.4,1,1,1,1,3.5,2.3,5
5299,0,Latin America,R&D,Clinical Operations,Meets,Male,42,12,1,8,,2.6,3.8,1,1,1,1,3.2,2.6,3.6
5300,0,Asia Pacific,R&D,Quality Assurance,Below,Female,46,10,0,10,3.1,2.9,1.4,1,1,1,1,4.2,2.9,1
5301,0,Middle East & Africa,Digital,Market Access,Meets,Male,43,10,0,5,2.5,2.8,2.1,1,1,1,0,3.8,2.3,3.2
5302,0,Latin America,R&D,Market Access,Below,Female,41,11,0,12,5,3.3,1.3,1,1,1,1,4.5,3.8,3.3
5303,0,North America,HR,Market Access,Meets,Male,34,34,0,8,4.6,3.7,3.5,1,1,1,0,4.8,3.7,2
5304,1,Latin America,Commercial,Regulatory Affairs,Far Exceeds,Female,40,25,0,10,4.8,3,2.6,1,1,1,1,4.3,4,2.7
5305,0,Europe,Digital,Finance & Accounting,Meets,Female,32,5,1,7,,2.5,4.4,1,1,1,1,1.9,2.6,3.5
5306,0,Latin America,Manufacturing,Pharmacovigilance,Below,Male,41,15,1,6,,3.8,3.3,1,1,1,1,3.7,3.9,3.5
5307,0,Asia Pacific,Commercial,Pharmacovigilance,Meets,Female,40,6,0,10,4.9,3.6,2.6,1,1,1,1,4.3,4.1,2.4
5308,0,Asia Pacific,R&D,Regulatory Affairs,Below,Male,29,5,0,8,2.1,2.4,3.8,1,1,1,1,1.6,2.4,4
5309,0,Middle East & Africa,R&D,Data Science,Below,Female,35,12,0,7,3.5,1.7,4.3,1,1,1,1,3.4,2.7,3.4
5310,0,Middle East & Africa,Manufacturing,Regulatory Affairs,Meets,Female,34,29,0,12,2.6,3.9,2.5,1,1,1,1,2.5,4.8,2.3
5311,0,Middle East & Africa,HR,Marketing,Meets,Male,42,7,0,7,3.4,3.4,2.3,1,1,1,1,2.1,3.3,3.4
5312,0,North America,Manufacturing,Communications,Meets,Female,36,15,0,8,4.9,1.7,2.5,1,1,1,1,3.8,2.4,2
5313,0,Middle East & Africa,Digital,Supply Chain,Below,Female,29,14,0,5,4.1,3.7,1.5,1,1,1,1,4,4.4,3.9
5314,0,North America,Manufacturing,IT & Digital,Meets,Male,41,19,0,8,3.3,3.2,3,1,1,1,1,2.4,4.2,1.3
5315,0,Middle East & Africa,R&D,Marketing,Meets,Female,39,17,0,11,3.6,3.7,2.7,1,0,0,0,2.9,3.7,2.8
5316,0,North America,HR,Data Science,Exceeds,Female,39,15,0,11,1,2.9,1.8,1,1,1,1,2.7,5,2.5
5317,0,Latin America,HR,IT & Digital,Below,Male,31,6,0,12,3.1,2.4,4.1,1,1,0,0,3.4,2.2,3.8
5318,0,Latin America,Finance,Communications,Exceeds,Female,42,16,0,6,2.9,5,2.6,0,0,0,0,4.2,4.4,3.3
5319,0,Asia Pacific,Manufacturing,Data Science,Meets,Male,37,11,0,11,3.1,4.1,4.2,1,1,1,1,3.1,4.1,3.9
5320,0,North America,Digital,IT & Digital,Meets,Female,37,14,0,11,2.8,3.4,2.8,1,1,1,1,3.4,4.3,1.2
5321,0,Europe,R&D,Regulatory Affairs,Meets,Male,30,18,1,11,,2.8,2.3,0,0,0,0,2.1,2.8,3.6
5322,0,Asia Pacific,Commercial,Regulatory Affairs,Meets,Female,31,15,1,6,,4.5,2.4,1,1,1,1,2.1,3.8,1
5323,0,Latin America,HR,Human Resources,Meets,Female,55,14,1,8,,5,2,1,1,1,1,3.6,4.3,2.8
5324,0,North America,Manufacturing,IT & Digital,Below,Female,31,14,0,8,3.4,2.4,3.6,1,1,1,1,4.9,3.1,3.4
5325,0,Middle East & Africa,Finance,Sales,Exceeds,Non-Binary/Other,28,6,1,12,,3.2,4,1,1,1,1,4.9,3.6,2.4
5326,0,Europe,Digital,Human Resources,Below,Male,36,26,0,7,2.7,2.9,1.3,1,1,1,1,1.7,3.8,1.7
5327,0,Latin America,Digital,Human Resources,Meets,Male,37,11,0,11,2.5,3.2,2.8,1,1,1,1,4.1,3.2,2
5328,0,Asia Pacific,R&D,Quality Assurance,Meets,Female,32,5,0,5,3.5,5,3,1,1,1,1,2.4,2.6,1.9
5329,0,North America,HR,Marketing,Meets,Male,33,18,0,12,1.6,2.2,2.2,1,1,1,1,3.5,2.1,3.2
5330,0,Europe,R&D,Pharmacovigilance,Exceeds,Male,37,10,1,11,,3,2.3,1,1,1,1,2.7,2.5,1.4
5331,0,North America,Finance,Human Resources,Far Exceeds,Female,40,16,0,10,3.5,1.7,3.5,1,1,1,0,3.4,2.9,2.3
5332,0,Middle East & Africa,Commercial,Sales,Far Below,Female,30,13,1,12,,4.1,1.7,1,1,1,1,3.8,2.9,2.3
5333,0,Asia Pacific,Commercial,Market Access,Meets,Male,36,5,0,9,3.5,2.1,1,1,1,1,1,4,2.9,2.3
5334,0,North America,Commercial,Medical Affairs,Exceeds,Female,38,3,0,10,3.3,2.3,3.4,1,1,1,1,3.9,2.9,2.2
5335,0,Latin America,Digital,Pharmacovigilance,Meets,Female,37,8,0,11,4,3.2,2.1,1,1,1,1,4.1,1.8,3.9
5336,0,Asia Pacific,HR,IT & Digital,Meets,Female,34,10,0,6,3.5,2.1,4,1,1,1,1,4.3,1,4.5
5337,0,Latin America,R&D,Market Access,Far Exceeds,Female,32,10,0,11,3.8,3.4,2.5,1,1,1,1,3.5,3.4,1.2
5338,0,North America,R&D,Human Resources,Meets,Male,48,6,1,12,,4.4,3.3,1,1,1,1,4.7,4.9,3.6
5339,0,Asia Pacific,Finance,Legal & Compliance,Below,Female,28,12,1,9,,4.5,3.3,1,1,1,1,2.5,3,4.2
5340,0,Latin America,Commercial,Sales,Exceeds,Male,44,8,0,5,3.4,3.9,2.5,1,1,1,1,3.3,3.6,1
5341,0,Middle East & Africa,HR,Clinical Operations,Far Exceeds,Female,31,15,0,10,2.7,3.3,2.2,1,0,0,0,4.1,3.9,2.2
5342,0,Middle East & Africa,HR,Sales,Meets,Female,39,20,0,5,3.9,3.6,1.8,1,1,1,1,3.9,3.8,2.6
5343,0,North America,Finance,Communications,Meets,Male,38,6,0,11,2.9,1.3,3.3,1,1,1,1,3.9,3.4,2.9
5344,0,Asia Pacific,Manufacturing,Sales,Exceeds,Female,32,6,0,10,3.5,1.6,5,0,0,0,0,3.8,2.5,3.3
5345,0,Europe,HR,Sales,Far Exceeds,Female,37,8,1,11,,3.5,3.3,1,1,1,1,3.1,4.3,2.2
5346,1,Asia Pacific,HR,Finance & Accounting,Exceeds,Female,36,7,1,12,,1.8,3.2,1,1,1,1,2.4,3.2,3.6
5347,0,Middle East & Africa,R&D,Regulatory Affairs,Meets,Male,38,12,0,7,2.1,1.9,1.8,1,1,1,1,2.9,3.1,2.4
5348,0,Latin America,Finance,Finance & Accounting,Meets,Female,46,6,0,6,2.3,2.7,3.5,1,1,1,1,3.6,3,3.7
5349,0,Europe,HR,Marketing,Meets,Female,47,29,0,5,4.9,4.1,4,1,1,1,1,4,3.7,3.6
5350,0,North America,HR,Sales,Below,Female,33,8,1,12,,1.7,2.5,0,0,0,0,2.7,3.7,3.5
5351,0,Europe,R&D,Regulatory Affairs,Meets,Female,40,24,0,5,4.4,4.5,2.2,0,0,0,0,4.5,4,4
5352,0,North America,HR,IT & Digital,Meets,Female,44,10,1,9,,2.2,2.4,1,1,1,1,1.4,2,4.2
5353,0,Europe,R&D,Market Access,Exceeds,Female,35,10,0,7,3.3,2.2,2,0,0,0,0,2.6,2.4,2.1
5354,0,North America,Manufacturing,Communications,Exceeds,Male,42,11,1,9,,4,4.5,1,1,1,1,3.5,3.2,1.8
5355,0,North America,Digital,Communications,Below,Female,52,9,1,10,,2.5,4.7,1,0,0,0,5,1.4,4.8
5356,0,Europe,R&D,Legal & Compliance,Meets,Female,31,10,0,6,3.7,3.9,3.4,0,0,0,0,4,3.9,2.6
5357,0,Europe,R&D,Quality Assurance,Meets,Female,41,10,0,12,3.2,1.8,3.2,1,1,1,1,3.3,3.6,3.5
5358,1,North America,HR,Marketing,Exceeds,Male,32,4,0,12,2,3.3,1.9,0,0,0,0,4,2.8,4.2
5359,0,Middle East & Africa,R&D,Human Resources,Far Below,Male,34,10,1,7,,1.5,3,1,1,1,1,1.5,1.8,2.3
5360,0,Europe,Finance,Market Access,Meets,Male,35,19,0,8,3.5,1.7,2,1,1,1,1,3.2,3.1,2.9
5361,0,Asia Pacific,Commercial,IT & Digital,Meets,Female,41,9,1,7,,3.5,2.8,1,1,1,1,3.4,4.4,3.4
5362,0,Latin America,Commercial,Human Resources,Exceeds,Male,50,16,0,9,4.1,4.1,4.6,1,1,1,1,3.6,4.1,4.1
5363,0,North America,Manufacturing,Data Science,Meets,Male,34,16,0,11,2.1,3.3,2.2,1,1,1,1,3.7,2.3,4
5364,1,North America,R&D,Pharmacovigilance,Meets,Female,44,9,0,8,2.2,3.6,2.7,1,1,1,1,3.3,3.6,3.8
5365,0,Latin America,Finance,Finance & Accounting,Far Exceeds,Male,33,14,1,11,,2.9,2,1,1,1,1,4.3,3.8,2.3
5366,0,Middle East & Africa,HR,Human Resources,Meets,Female,35,7,0,7,2.8,2.7,2.4,1,1,1,1,4,3.2,3.6
5367,0,Latin America,HR,Human Resources,Below,Female,46,6,0,8,3,2.8,2.8,1,1,1,1,4,2.7,2.9
5368,0,Europe,Digital,Legal & Compliance,Below,Non-Binary/Other,44,14,0,10,2.2,3.8,2.4,1,1,1,1,2.8,3.6,2
5369,0,Latin America,Manufacturing,Medical Affairs,Exceeds,Male,36,15,0,10,3.6,2.8,3.6,1,1,1,1,3.8,3.7,2.4
5370,0,North America,Finance,Data Science,Meets,Male,34,21,0,5,3.1,2.8,2,1,1,1,1,2.8,3.8,3.9
5371,0,Latin America,Finance,Supply Chain,Meets,Male,41,11,0,6,3.6,2,2.3,0,0,0,0,4.3,2.8,3.7
5372,0,Asia Pacific,HR,IT & Digital,Meets,Female,34,9,0,8,4,4.2,2.7,1,1,1,1,2.5,2.9,4.6
5373,0,Europe,Digital,Finance & Accounting,Far Exceeds,Male,35,4,0,7,2.2,3.5,3,1,1,1,1,3,2.2,2.6
5374,0,Latin America,HR,Communications,Meets,Male,36,18,0,5,3.5,4.1,4.5,1,1,1,1,2.2,2.5,5
5375,0,North America,Digital,Legal & Compliance,Meets,Female,37,6,0,9,2.5,2.8,4.1,1,1,1,1,3.7,2.2,4.7
5376,0,Europe,Commercial,Quality Assurance,Far Below,Male,35,13,1,5,,4.3,1,1,1,1,1,4.5,4,1.9
5377,0,North America,Finance,Supply Chain,Meets,Female,28,18,0,8,2.1,1.8,1.4,1,1,1,1,3.8,1.7,1.5
5378,0,Middle East & Africa,Commercial,Clinical Operations,Below,Female,47,20,0,6,2.9,2,1.5,1,1,1,1,3.2,1,3.6
5379,0,Asia Pacific,HR,Clinical Operations,Exceeds,Male,43,12,1,12,,2.8,2.9,1,1,1,1,4.5,2.6,2.2
5380,0,Middle East & Africa,Manufacturing,Finance & Accounting,Exceeds,Female,37,16,0,8,2.3,2.8,2.6,1,1,1,1,2.6,3.3,1.8
5381,0,Asia Pacific,R&D,Sales,Meets,Female,34,5,0,6,2.3,3.7,5,1,1,1,1,1.6,3.6,3
5382,0,Latin America,Manufacturing,Communications,Meets,Male,45,4,1,10,,3.5,3.1,1,1,1,1,4,2.5,2.8
5383,0,Europe,Manufacturing,Legal & Compliance,Meets,Male,41,24,0,9,2.8,1.6,2.2,0,0,0,0,3.6,1.9,1.3
5384,0,Latin America,R&D,Quality Assurance,Meets,Female,34,3,1,9,,3,2.6,1,0,0,0,4.5,4.3,3.2
5385,0,Asia Pacific,Finance,Legal & Compliance,Meets,Male,41,7,1,6,,4.3,2.6,1,1,1,1,3.3,2.5,3.6
5386,1,Asia Pacific,Commercial,Market Access,Far Exceeds,Female,38,6,1,5,,3,2.5,1,1,1,1,5,2.9,3.7
5387,0,Asia Pacific,Commercial,Human Resources,Exceeds,Female,39,11,0,12,4.7,2.2,1.4,1,1,1,1,4.2,2.4,2.1
5388,0,North America,Finance,Data Science,Meets,Male,43,10,0,8,1.4,2.2,1.7,1,1,1,1,3,2.2,2.4
5389,0,Europe,R&D,Quality Assurance,Meets,Female,41,18,0,10,2.6,2.9,3.5,1,1,1,1,2.9,4.1,4
5390,0,Latin America,Digital,Data Science,Meets,Male,43,7,0,7,3.5,3.6,2.9,0,0,0,0,3.8,1,3.4
5391,1,Latin America,Manufacturing,Medical Affairs,Exceeds,Male,49,12,1,12,,5,1.5,1,1,1,1,5,4.6,2.6
5392,0,Middle East & Africa,HR,Market Access,Meets,Female,42,16,0,5,3.5,2.2,3.1,1,1,1,1,3.2,2.7,2.6
5393,0,Asia Pacific,Commercial,Supply Chain,Meets,Male,52,9,0,6,1.7,2.7,2.8,1,1,1,1,1.8,1.6,2.2
5394,0,Asia Pacific,Finance,Data Science,Far Below,Female,45,10,0,5,3.8,4.5,3.9,0,0,0,0,4.4,3.7,3.8
5395,0,Asia Pacific,HR,Medical Affairs,Exceeds,Female,37,29,0,5,5,3.2,4.7,1,1,1,1,4.2,1.4,4
5396,0,Latin America,R&D,Quality Assurance,Meets,Male,29,22,0,12,2.6,5,1,1,1,1,1,3,3.9,2.1
5397,0,Middle East & Africa,HR,Medical Affairs,Meets,Male,45,2,0,9,4,3.1,2.5,1,1,1,1,4.9,2.3,2.8
5398,0,North America,HR,Pharmacovigilance,Meets,Male,30,14,0,11,4,3.8,2.8,1,1,1,1,3.7,3.9,3.9
5399,0,Europe,Manufacturing,Medical Affairs,Below,Female,39,6,1,5,,2.4,2.8,1,1,1,1,3.7,3.1,2.4
5400,0,North America,R&D,Finance & Accounting,Exceeds,Male,42,9,0,10,4.7,1,5,1,1,1,1,3.7,3,4.5
5401,0,Latin America,HR,Legal & Compliance,Meets,Male,32,6,0,6,4.4,3.1,1,1,1,1,1,4,3.6,1.9
5402,0,Asia Pacific,Commercial,Medical Affairs,Meets,Female,34,4,1,6,,2.1,2.7,1,1,1,1,2.9,2.9,3.2
5403,0,Europe,R&D,Finance & Accounting,Below,Male,32,9,0,12,2.4,2,3.3,1,1,1,1,3.7,2.1,3
5404,0,Latin America,Commercial,Sales,Meets,Male,50,4,0,5,2.7,3.5,2.7,1,1,1,1,3.8,3.2,3.5
5405,0,Latin America,Finance,Clinical Operations,Meets,Female,42,8,0,9,3.4,3,2.8,1,1,1,1,4.1,2.5,3.1
5406,0,Latin America,Finance,Supply Chain,Meets,Male,34,6,0,8,4,3.3,2.9,1,1,1,1,3.9,3.4,3.2
5407,0,Europe,Digital,Pharmacovigilance,Meets,Male,29,13,0,12,3.1,1.5,3.1,1,1,1,1,3.5,3.4,2.4
5408,0,Europe,Finance,IT & Digital,Meets,Male,33,11,0,5,4.6,2.6,3,1,1,1,1,4.6,1.5,3
5409,0,Middle East & Africa,HR,Pharmacovigilance,Meets,Female,34,21,0,7,2.6,4.5,1.8,1,1,1,1,2.8,4.1,1.1
5410,0,Middle East & Africa,R&D,Clinical Operations,Meets,Male,35,10,0,7,4.2,2,2.6,1,1,1,1,4.6,3.3,2
5411,0,North America,Finance,Communications,Exceeds,Male,43,4,1,8,,2.2,3.1,1,1,1,1,3.1,2.5,4.6
5412,0,Europe,Commercial,Marketing,Meets,Male,30,7,1,9,,4,1.9,1,0,0,0,2.8,2.8,1.4
5413,0,Europe,HR,Data Science,Meets,Non-Binary/Other,45,9,0,12,2.9,3.3,2.4,1,1,1,1,3.3,2.7,3.8
5414,0,Europe,Finance,Medical Affairs,Below,Male,28,15,0,9,3.8,3.1,1,1,1,1,1,3.9,2.4,2.9
5415,0,Middle East & Africa,Manufacturing,Quality Assurance,Meets,Male,38,14,0,9,3.5,3.3,2.8,1,1,1,1,4.6,2.2,3.6
5416,0,Latin America,Commercial,Communications,Exceeds,Female,34,7,0,5,4.8,2.1,2,1,1,1,1,5,3.2,2
5417,0,Asia Pacific,Commercial,Medical Affairs,Far Below,Male,44,12,0,9,1.5,1.9,3.3,1,1,0,0,4.3,2.9,2
5418,0,Middle East & Africa,Digital,Quality Assurance,Meets,Female,47,8,0,12,2.3,1.6,2.1,1,1,1,1,2.3,2.1,2.7
5419,0,Europe,Manufacturing,Medical Affairs,Below,Female,43,7,0,10,3.7,4.5,4.2,1,1,1,1,3.3,3.7,3.5
5420,0,Middle East & Africa,Digital,Pharmacovigilance,Meets,Male,41,6,0,10,2.9,1.6,2.8,1,1,1,0,3.9,2.9,2.5
5421,0,North America,Finance,Marketing,Meets,Female,36,11,0,11,2.8,3.2,3.4,1,1,1,1,2.7,3.2,3.6
5422,0,Europe,Manufacturing,Clinical Operations,Below,Male,46,5,0,5,3.1,2.6,2.4,1,1,1,0,3.5,3,3.2
5423,0,North America,Commercial,Finance & Accounting,Below,Male,32,11,0,6,1.2,4.2,3.2,1,1,1,1,1.9,3.3,2.6
5424,0,Europe,Digital,Market Access,Exceeds,Female,41,5,1,12,,3.1,3.3,1,1,1,1,3.1,2.3,3.8
5425,0,Middle East & Africa,HR,Regulatory Affairs,Meets,Male,45,8,0,9,3.2,1.9,1.6,1,1,1,1,2.4,1.9,2.5
5426,0,Latin America,Manufacturing,Supply Chain,Meets,Male,43,10,0,6,3,3.4,1.4,1,1,1,1,1.4,3.6,1
5427,0,Asia Pacific,Commercial,Market Access,Exceeds,Male,41,15,0,6,2.5,3.4,1,1,1,1,1,3.4,3.4,2
5428,0,North America,R&D,Supply Chain,Meets,Female,41,4,0,8,4.9,2.3,3.6,1,1,1,1,4.2,1.8,3.1
5429,0,Middle East & Africa,Manufacturing,Data Science,Exceeds,Female,43,5,1,12,,2.8,1.9,1,1,1,1,2.7,3.4,3.3
5430,0,Latin America,Manufacturing,Clinical Operations,Far Exceeds,Male,37,10,0,11,1.3,4,3.1,1,1,1,1,1,2.8,2.2
5431,0,Middle East & Africa,Finance,Quality Assurance,Meets,Male,47,4,1,9,,4.4,2.8,1,1,1,1,3.4,3.7,2.2
5432,0,North America,HR,Finance & Accounting,Meets,Non-Binary/Other,50,10,0,8,3.2,3.1,2.1,1,1,1,1,3.9,2.8,2.8
5433,0,Asia Pacific,Finance,Finance & Accounting,Meets,Female,28,17,0,12,3.2,4.4,1.7,1,1,1,1,2.9,2.7,3.1
5434,0,Middle East & Africa,Manufacturing,Market Access,Exceeds,Male,36,19,0,12,2.5,3.4,3,1,1,1,1,3.7,2.4,3.5
5435,0,Europe,Manufacturing,Legal & Compliance,Meets,Female,31,4,0,5,2.1,2.8,2.4,1,1,1,1,2,3.1,4
5436,0,Latin America,HR,Human Resources,Meets,Male,34,11,0,6,3.7,3.3,1.7,1,0,0,0,3.9,3.4,3.1
5437,0,Middle East & Africa,HR,Communications,Far Exceeds,Female,39,19,0,7,2,2.3,2.1,1,1,1,1,1.1,1.7,2.7
5438,0,Latin America,Digital,Human Resources,Exceeds,Female,41,13,0,5,2.9,2.6,1,1,1,1,1,3,3.4,2.2
5439,0,Europe,Commercial,Market Access,Exceeds,Male,37,16,0,8,3.4,4,4,1,1,1,1,3.6,4.1,3
5440,0,Asia Pacific,Commercial,Communications,Meets,Female,42,12,0,6,2.9,1,3.3,1,1,1,1,2.8,1.6,1.7
5441,0,Asia Pacific,Digital,Supply Chain,Exceeds,Female,34,21,0,10,5,2.7,3.4,1,1,1,1,4.1,2.8,4.7
5442,0,Europe,Commercial,Market Access,Below,Female,36,12,0,12,4.1,3.1,3.1,1,0,0,0,4.9,3.1,3.8
5443,0,Latin America,Manufacturing,Quality Assurance,Meets,Male,42,5,0,7,3.4,3.9,4.1,1,1,1,1,2.7,4.8,2
5444,0,Middle East & Africa,Digital,Clinical Operations,Meets,Female,36,7,0,11,3,2.9,2.7,1,1,1,1,1.7,3.3,3.6
5445,0,Europe,Digital,Legal & Compliance,Meets,Male,30,14,0,9,2.3,3.8,1.9,1,1,1,0,3.5,1.9,3.8
5446,0,North America,Commercial,Data Science,Below,Male,51,17,0,7,5,3.3,2,1,1,1,1,3.1,1.8,1.8
5447,0,Latin America,R&D,Finance & Accounting,Meets,Male,44,5,0,10,2.9,1.9,3.5,1,1,1,1,2.9,3.3,2.9
5448,0,Asia Pacific,Commercial,Regulatory Affairs,Below,Female,39,21,0,7,2.6,2.6,1.4,0,0,0,0,2.2,3.2,2.9
5449,0,Europe,Finance,Clinical Operations,Meets,Male,43,20,0,6,3.6,3,3.8,1,1,1,1,3.9,3.1,4.8
5450,0,Asia Pacific,R&D,Sales,Meets,Female,41,13,0,5,2.6,3.4,2.3,1,1,1,1,3.8,4.5,2.7
5451,0,Latin America,Digital,Data Science,Far Exceeds,Male,28,16,0,10,3.9,2.7,3.6,1,0,0,0,2.9,3.3,4.8
5452,0,Asia Pacific,R&D,Market Access,Meets,Female,39,7,0,6,3.6,2.4,2.8,1,1,1,1,4.4,3.4,2.7
5453,0,Europe,Manufacturing,Communications,Exceeds,Male,34,12,1,11,,3.6,2.1,1,1,1,1,2.1,1.9,1
5454,0,Latin America,HR,Quality Assurance,Below,Male,39,7,1,12,,2.8,4.2,1,1,1,0,4.1,2.4,3.3
5455,0,North America,R&D,Marketing,Meets,Female,40,22,0,9,4.1,3.4,2.7,1,1,1,1,3.2,4,3.5
5456,0,Europe,Finance,Market Access,Meets,Female,44,12,1,8,,3.6,1.5,1,1,1,1,4.5,4.1,3.2
5457,0,Middle East & Africa,HR,Legal & Compliance,Meets,Male,32,16,0,9,3.1,4.4,1.7,1,1,1,1,1,4.6,1.9
5458,0,Europe,Manufacturing,Pharmacovigilance,Exceeds,Female,32,16,0,10,1.6,3.5,2.9,1,1,1,1,1.2,3,1.7
5459,0,Latin America,Finance,Pharmacovigilance,Meets,Male,35,8,0,11,3.3,3.7,1.8,1,1,1,1,3.2,2.4,1.4
5460,0,Europe,HR,Human Resources,Meets,Female,47,6,0,7,2.4,3.5,2.4,0,0,0,0,1.9,3.9,3.3
5461,1,North America,Manufacturing,Marketing,Meets,Male,36,16,0,6,4,3.2,2.7,1,1,1,1,5,4.4,2.1
5462,0,North America,HR,Regulatory Affairs,Meets,Male,41,13,0,11,4.3,2,2.3,1,1,1,1,2.6,1,2.9
5463,0,Middle East & Africa,HR,Pharmacovigilance,Meets,Female,38,11,0,12,4.6,2.7,4.5,1,0,0,0,3.7,3.2,4.1
5464,0,Asia Pacific,Commercial,Regulatory Affairs,Below,Male,36,6,0,5,4,1.9,3.7,1,0,0,0,5,2.2,2.1
5465,0,Latin America,Finance,Data Science,Exceeds,Female,39,5,0,9,5,2.3,1.7,1,1,1,1,4.9,1,3.2
5466,0,Latin America,Finance,Marketing,Exceeds,Male,43,9,0,12,2.6,2.7,3.1,1,1,1,1,1.5,1.8,3
5467,0,Asia Pacific,R&D,Regulatory Affairs,Meets,Male,42,5,1,9,,3.8,3.9,1,1,1,1,5,3.1,1.9
5468,0,North America,Finance,Sales,Exceeds,Female,31,6,0,9,3.6,2.7,1.9,1,0,0,0,5,3.4,2.3
5469,0,North America,Finance,Regulatory Affairs,Meets,Male,40,16,1,5,,2.3,1.3,1,1,1,1,2.7,2.8,1.3
5470,0,Europe,HR,IT & Digital,Meets,Male,48,8,0,10,2.9,2.7,3.5,0,0,0,0,3.5,1.7,4.1
5471,0,Middle East & Africa,Digital,Medical Affairs,Meets,Male,40,14,1,8,,4.3,2.4,0,0,0,0,2.9,2.7,2.9
5472,0,Middle East & Africa,Commercial,Communications,Far Exceeds,Male,45,5,0,12,2.3,1.9,2.1,0,0,0,0,3,2.9,1.4
5473,0,Middle East & Africa,R&D,Human Resources,Meets,Male,48,11,0,8,4.1,3.6,3.3,1,1,1,1,4,3.3,2.6
5474,0,Europe,Commercial,Human Resources,Meets,Female,39,8,0,6,3.6,3.6,2.6,1,1,1,1,3.4,3.8,1
5475,0,Middle East & Africa,R&D,Data Science,Meets,Male,38,14,0,9,2.1,4,3.1,1,1,1,1,3.1,2.9,5
5476,0,Asia Pacific,Manufacturing,Sales,Meets,Female,41,10,1,10,,2.4,4.6,1,1,1,1,4.4,2.7,2.9
5477,1,Europe,HR,Marketing,Meets,Male,46,19,1,11,,2.2,4.2,1,1,1,1,3,3.7,3.6
5478,0,Asia Pacific,Finance,Finance & Accounting,Meets,Female,37,11,0,7,3.2,2.2,3.9,1,1,1,1,2,4.3,2.7
5479,0,Europe,Finance,Supply Chain,Meets,Male,31,15,0,9,3.3,3.5,4.2,1,1,1,1,2.8,2.9,4.4
5480,0,Middle East & Africa,Digital,Market Access,Meets,Male,40,3,1,6,,3.1,3.8,0,0,0,0,3.2,4,2.2
5481,0,Asia Pacific,Commercial,Quality Assurance,Exceeds,Male,44,11,0,9,3.8,2.1,3.6,1,1,1,1,3.3,2.7,3.3
5482,1,Asia Pacific,Commercial,Pharmacovigilance,Far Exceeds,Male,40,11,1,11,,2.1,2.8,1,1,1,1,3.8,2.1,2.9
5483,0,Asia Pacific,Commercial,Legal & Compliance,Meets,Female,41,5,1,5,,2.4,2.4,1,1,1,1,3.2,4.1,4.1
5484,0,Europe,Finance,Medical Affairs,Exceeds,Male,38,11,0,11,3.1,2.6,3.5,1,1,1,1,2.6,3.2,1.8
5485,0,Latin America,Commercial,Medical Affairs,Exceeds,Female,37,15,0,9,2.1,2.4,1.3,1,1,1,1,2.1,1,3.4
5486,0,Middle East & Africa,HR,Supply Chain,Meets,Female,46,10,1,11,,3.1,2.3,1,1,1,1,5,4.5,2.4
5487,0,Asia Pacific,R&D,IT & Digital,Exceeds,Male,28,19,0,11,3,3,2.4,1,1,1,1,3.2,4.1,1.6
5488,0,Latin America,Finance,Communications,Below,Male,39,9,1,5,,1.8,3.5,1,1,1,1,4.3,3.3,2.7
5489,0,Middle East & Africa,HR,Market Access,Meets,Female,32,28,0,11,3,2.6,2.6,1,1,1,0,1.6,2.9,3.3
5490,0,Middle East & Africa,Manufacturing,Market Access,Meets,Male,38,23,0,7,3.2,4,3.7,1,1,1,1,5,4.1,2.2
5491,0,Asia Pacific,HR,Human Resources,Meets,Female,40,11,1,8,,3.5,2.7,1,1,1,1,3.6,3,3.3
5492,0,Asia Pacific,HR,Pharmacovigilance,Meets,Female,41,9,0,6,3.9,2.3,1,1,1,1,1,2.5,3.6,1.5
5493,0,Europe,Manufacturing,Human Resources,Meets,Female,39,13,0,10,2.8,3.7,3.6,1,1,1,1,3.3,1.6,2.9
5494,0,Latin America,HR,Regulatory Affairs,Below,Female,46,14,0,11,3.8,4.1,2.1,1,1,1,1,5,4.1,1
5495,0,Latin America,R&D,Finance & Accounting,Far Exceeds,Female,39,9,0,7,4.5,3,1.4,1,1,1,1,5,3.4,2
5496,0,Asia Pacific,Finance,Human Resources,Meets,Female,32,5,0,5,4.1,4.3,3.4,1,1,1,1,3.8,4.7,2.8
5497,0,Middle East & Africa,Digital,Marketing,Exceeds,Male,44,26,0,8,2.6,3.9,1,1,1,1,1,3,4.2,1
5498,0,Asia Pacific,Manufacturing,Market Access,Meets,Male,40,16,0,9,3,3.6,2.7,1,1,1,1,2.1,2.1,2.5
5499,0,Middle East & Africa,Finance,Market Access,Meets,Female,32,9,0,5,3.7,2.5,2.9,1,1,1,1,5,2.5,2
5500,0,Middle East & Africa,Commercial,Quality Assurance,Meets,Female,42,11,1,12,,1.5,3.6,1,1,1,1,4.3,2,3.8
5501,0,Asia Pacific,R&D,Finance & Accounting,Meets,Female,35,14,0,6,5,1.9,1.2,0,0,0,0,5,4,2.3
5502,0,North America,Digital,Sales,Below,Female,44,4,0,9,4.8,1.7,3.1,1,1,1,1,3.6,1.5,2
5503,0,Latin America,R&D,Sales,Meets,Male,30,30,0,5,2.7,3.8,3.9,1,1,1,1,4,3.1,2.7
5504,0,Middle East & Africa,R&D,Quality Assurance,Below,Female,37,31,0,12,3.3,2.8,2.1,1,1,1,1,2.9,4.2,1.5
5505,0,Middle East & Africa,Commercial,Clinical Operations,Meets,Male,41,4,1,9,,2.9,2.1,1,1,1,1,4.7,3.7,1.1
5506,0,North America,Digital,Marketing,Far Exceeds,Female,32,18,0,9,4.6,4.6,3.5,1,1,1,1,3.2,3.3,1.2
5507,0,Europe,R&D,Market Access,Far Below,Female,41,8,0,9,3,1.7,3.2,1,1,1,1,2.9,1.7,2.5
5508,0,North America,Commercial,Finance & Accounting,Meets,Male,44,10,0,8,4,3.6,2.1,1,1,1,1,4.4,4.8,2.3
5509,0,North America,Manufacturing,Pharmacovigilance,Meets,Female,37,9,1,11,,2.8,3,1,1,1,1,2.2,2.4,3.5
5510,0,Middle East & Africa,Commercial,IT & Digital,Meets,Non-Binary/Other,40,6,0,10,3.9,1.3,3.9,1,1,1,1,3.6,2.6,4.9
5511,0,Latin America,HR,Marketing,Meets,Female,33,23,0,10,4.1,3.3,1.6,1,1,1,1,2.9,4.3,1.4
5512,0,North America,Finance,Communications,Meets,Male,55,2,0,6,4.5,2,2.4,1,0,0,0,3.7,3.5,3.6
5513,0,Europe,Commercial,Supply Chain,Meets,Male,38,5,0,10,3.6,1.1,4.5,0,0,0,0,2.8,1.2,4
5514,0,Asia Pacific,Commercial,Medical Affairs,Below,Female,40,13,0,8,3.7,1.1,2.1,1,1,1,1,3.9,2.5,1.8
5515,0,North America,Commercial,IT & Digital,Meets,Male,36,9,0,9,3.4,2.3,2.4,1,1,1,1,4.1,3,3.2
5516,0,North America,R&D,Market Access,Meets,Male,34,12,0,8,3.5,2.5,3.8,1,1,1,1,3.4,2.8,3.3
5517,0,Europe,Digital,Clinical Operations,Exceeds,Female,44,2,1,6,,2.9,1.1,0,0,0,0,5,3.5,3.1
5518,0,Latin America,Commercial,Pharmacovigilance,Exceeds,Female,28,16,1,7,,1,2.2,1,1,1,1,2.6,3.4,1.8
5519,0,North America,Commercial,IT & Digital,Meets,Male,28,35,0,10,3,2.4,3.3,1,1,1,1,2.7,3.2,1.6
5520,0,North America,HR,Marketing,Meets,Male,40,8,0,7,2.6,3.5,1.7,1,0,0,0,2.8,3.2,2
5521,0,Latin America,HR,Data Science,Meets,Female,36,17,0,12,2.7,3.4,3,1,1,1,1,2.6,2.8,2
5522,1,Europe,Manufacturing,Medical Affairs,Meets,Female,43,6,1,5,,2,2.2,1,1,1,1,2.8,2.2,2.5
5523,0,North America,Manufacturing,Market Access,Meets,Male,35,15,0,7,2.4,4.4,1.2,1,0,0,0,4,3.4,2.2
5524,0,Latin America,HR,IT & Digital,Meets,Male,28,19,0,12,3.4,1.7,1,1,1,1,1,2.5,1.5,1.7
5525,0,North America,Digital,Marketing,Exceeds,Female,38,23,0,9,2.4,1.4,1,1,1,1,1,2.8,1,1
5526,1,Asia Pacific,Manufacturing,Marketing,Meets,Male,36,6,1,11,,3.2,3,1,1,1,1,4.6,3.7,2.2
5527,0,Middle East & Africa,Finance,IT & Digital,Meets,Male,32,6,1,10,,2.2,2.7,1,1,1,1,3.3,3.6,4.9
5528,0,Asia Pacific,Finance,Pharmacovigilance,Meets,Female,43,8,0,8,2.7,3.6,1.7,1,1,1,1,3.2,4.1,2
5529,0,North America,Digital,Medical Affairs,Exceeds,Female,40,19,0,7,4.2,2.1,3.2,1,1,1,1,3.5,3.9,4
5530,0,Europe,HR,Sales,Meets,Female,32,17,0,6,2.6,3.6,2.8,1,1,1,1,4,2.4,3
5531,0,Middle East & Africa,Manufacturing,Sales,Meets,Female,29,13,0,9,2.7,4.5,3.4,1,1,1,1,3.5,4.5,5
5532,0,Asia Pacific,Commercial,Data Science,Exceeds,Female,40,13,0,11,1.9,3.9,3.2,1,1,1,1,1.5,4.1,2.6
5533,0,Latin America,HR,Regulatory Affairs,Below,Female,32,16,0,5,3,2.6,3.2,1,0,0,0,4.5,4.4,2
5534,0,Europe,Manufacturing,Quality Assurance,Meets,Female,32,5,0,6,2.2,2.5,4,1,1,1,1,2.4,2.4,3.4
5535,0,Asia Pacific,Digital,Market Access,Exceeds,Female,37,11,0,12,4,2.5,2.9,1,0,0,0,4.7,4.1,3.6
5536,0,Latin America,Finance,Communications,Exceeds,Male,38,6,0,8,4.9,3.5,2.8,1,1,1,1,4.4,2.6,3
5537,0,North America,Digital,Pharmacovigilance,Far Below,Female,41,2,1,9,,2.6,2.8,1,1,1,1,3,2.6,2
5538,0,Latin America,Manufacturing,Market Access,Meets,Female,44,13,0,9,4.5,2.2,3.9,1,1,1,1,4.1,1.1,5
5539,0,Asia Pacific,Digital,Human Resources,Meets,Male,35,6,0,8,2.5,3.2,4.5,1,1,1,1,3.5,3.9,2.8
5540,0,Asia Pacific,Manufacturing,Finance & Accounting,Meets,Female,42,3,0,10,3.2,4.1,1.9,1,1,1,1,3.7,4.4,2.5
5541,0,North America,Manufacturing,Pharmacovigilance,Meets,Male,37,17,0,10,2.9,3.4,2.6,1,1,1,1,3.8,3.8,3.3
5542,0,Latin America,Digital,Legal & Compliance,Far Exceeds,Male,45,4,1,7,,4.3,5,1,1,1,1,2.8,4.2,4
5543,0,Latin America,R&D,Sales,Meets,Male,33,5,0,9,3.1,2.9,2.3,0,0,0,0,1.6,4.3,3.8
5544,0,North America,Commercial,Human Resources,Meets,Male,41,9,0,11,3.3,3,1,1,1,1,1,2.6,3,3.2
5545,0,Latin America,HR,Pharmacovigilance,Meets,Male,33,2,0,10,3,3.3,1.4,1,1,1,1,4.1,2.3,2.2
5546,0,North America,Finance,Medical Affairs,Below,Female,33,8,1,8,,4,2,1,1,1,1,3.5,4,2.3
5547,0,Europe,Commercial,Regulatory Affairs,Meets,Female,35,11,0,10,3.1,3.2,1.4,1,1,1,1,4.2,4.2,1
5548,0,Asia Pacific,HR,Data Science,Meets,Female,28,6,0,10,2.9,2,3.6,1,0,0,0,3.2,3.9,3.6
5549,1,Europe,HR,Clinical Operations,Exceeds,Non-Binary/Other,44,4,1,8,,5,3.8,1,1,1,1,5,4.7,4
5550,0,Middle East & Africa,Finance,Sales,Meets,Female,33,18,0,7,4,4.5,1.9,0,0,0,0,3.7,4.2,3.4
5551,0,Middle East & Africa,Commercial,Clinical Operations,Meets,Female,35,5,0,9,3.6,3.7,2.7,0,0,0,0,3.9,2.7,4.5
5552,0,Middle East & Africa,Finance,IT & Digital,Meets,Female,32,14,0,5,3.2,2.4,1.2,1,1,1,1,4.8,3.4,1.4
5553,0,North America,Manufacturing,Human Resources,Meets,Female,44,21,0,12,3.5,2.7,3.5,1,1,1,0,2.6,1.6,2.4
5554,0,Latin America,Finance,Clinical Operations,Below,Male,40,12,0,8,5,3.7,3.4,1,1,1,1,4.5,2.4,4.1
5555,0,Europe,Digital,Legal & Compliance,Exceeds,Male,41,15,0,10,2.6,2.3,1.6,1,1,1,1,2.5,3.2,1.4
5556,0,Europe,R&D,Human Resources,Exceeds,Female,39,7,0,9,3.5,2.8,3.8,1,1,1,1,2.1,4.1,2.5
5557,0,Europe,R&D,Human Resources,Below,Male,39,11,0,11,3.8,2.4,2.2,1,1,1,1,3.9,3.8,3.3
5558,0,Europe,R&D,Finance & Accounting,Meets,Male,40,14,0,5,2.6,3.2,2.3,1,1,1,1,3.7,4.7,3.6
5559,0,Middle East & Africa,Commercial,Supply Chain,Meets,Male,44,12,1,6,,3.5,1.9,1,1,1,1,2.6,1.8,3.6
5560,0,Europe,Commercial,Regulatory Affairs,Meets,Female,31,13,0,11,3.4,3.8,2.2,1,1,1,1,5,4.4,3.4
5561,0,Latin America,Manufacturing,Communications,Meets,Male,35,6,0,10,2.3,2,1.4,0,0,0,0,3,2.4,1.8
5562,0,Middle East & Africa,R&D,Quality Assurance,Meets,Female,32,6,0,8,3,2.5,1,0,0,0,0,3.2,3.5,2.9
5563,0,Europe,Manufacturing,Marketing,Far Below,Male,42,15,1,7,,2.4,3.2,0,0,0,0,2.6,4.8,2.4
5564,0,North America,R&D,Medical Affairs,Meets,Female,41,10,0,9,4.5,2.5,3.8,1,1,1,1,4,2.2,4.3
5565,0,Asia Pacific,Commercial,Pharmacovigilance,Below,Female,42,10,1,11,,3.2,2.1,1,1,1,1,4.9,2.8,3.9
5566,0,Asia Pacific,Digital,Communications,Far Below,Male,28,4,0,6,2.9,2.5,2.8,1,1,1,1,3.7,3,2
5567,1,Asia Pacific,Digital,Market Access,Meets,Female,35,7,0,7,1.6,2,1.4,0,0,0,0,4,2.3,1.8
5568,0,Middle East & Africa,Digital,Quality Assurance,Meets,Female,28,21,0,12,4.8,3.3,1.6,1,1,1,1,3.4,3.8,1
5569,0,Europe,Finance,Finance & Accounting,Meets,Male,50,15,0,8,4.6,1,2.9,1,1,1,1,4.7,1.9,3.7
5570,0,Middle East & Africa,Digital,Market Access,Meets,Male,39,17,0,9,4.8,2.6,1.8,1,1,1,1,4.8,4.3,2.5
5571,0,Latin America,HR,Data Science,Below,Male,33,13,0,5,3.1,4.1,3.3,1,1,1,1,3.3,2.7,3.2
5572,0,North America,R&D,Data Science,Meets,Female,37,20,0,6,4.4,4.4,1.9,1,1,1,1,2.8,2,4
5573,0,North America,Digital,Medical Affairs,Exceeds,Male,38,4,0,10,2.9,3.7,4.3,1,1,1,1,3.2,4,2.4
5574,0,Asia Pacific,HR,Legal & Compliance,Meets,Male,50,26,0,11,3.7,2.7,4,0,0,0,0,2.7,2.3,4
5575,0,Asia Pacific,HR,Pharmacovigilance,Exceeds,Female,37,10,0,12,3.6,3.7,4.5,1,1,1,1,3.8,2.8,2.6
5576,0,Asia Pacific,HR,Pharmacovigilance,Meets,Male,39,11,0,6,3.4,5,3.3,1,1,1,1,3,3.6,3.1
5577,0,Europe,Manufacturing,Sales,Exceeds,Male,34,17,0,6,2.5,3.4,1.1,1,1,1,1,4.5,4.1,1
5578,0,Latin America,Manufacturing,IT & Digital,Meets,Female,51,4,0,11,3.8,3.9,3.1,1,1,1,1,2.8,4,3.1
5579,0,Latin America,HR,Pharmacovigilance,Below,Male,47,6,1,12,,5,3,1,1,1,1,2.9,4.2,4.2
5580,0,Latin America,Finance,Marketing,Meets,Female,28,11,0,12,3,3.7,2.4,1,1,1,1,2.3,3.6,3.5
5581,0,Latin America,Digital,Quality Assurance,Meets,Female,43,16,0,12,4.3,2.4,2.2,1,1,1,1,5,2.8,1.4
5582,0,Asia Pacific,R&D,Human Resources,Meets,Male,41,10,0,12,2.3,1.4,2.3,0,0,0,0,2.3,1.4,3.4
5583,0,North America,Finance,Quality Assurance,Meets,Female,33,2,0,11,2.4,3.8,1.6,1,1,1,1,2.8,4.1,2.8
5584,0,Asia Pacific,Commercial,IT & Digital,Far Below,Female,32,13,0,8,2.6,2.3,2.6,1,1,1,1,2.7,2.4,2.3
5585,0,Latin America,Manufacturing,Market Access,Meets,Female,28,9,1,12,,3.5,1.7,1,1,0,0,3.7,4.6,2.8
5586,0,Asia Pacific,Digital,Communications,Exceeds,Male,42,5,1,7,,2,1.4,1,1,1,1,4.6,3.5,1.6
5587,0,Latin America,Digital,Supply Chain,Far Exceeds,Male,30,7,0,8,3.6,2.6,2,1,1,1,1,4.6,3,1.9
5588,0,Middle East & Africa,Commercial,Medical Affairs,Meets,Female,40,36,0,6,2.6,3.9,2.1,1,1,1,1,2.8,4.1,2.6
5589,0,North America,Commercial,Medical Affairs,Far Below,Male,31,12,0,8,3.8,1.2,2.7,1,1,1,1,2.3,1,1.4
5590,0,Middle East & Africa,Digital,Marketing,Below,Female,31,17,0,9,4.4,5,3.3,1,1,1,1,2.8,3.7,4.1
5591,0,Europe,Commercial,Legal & Compliance,Exceeds,Female,38,20,0,8,4.7,1.8,1,1,1,1,1,4.3,1,2
5592,0,Asia Pacific,Digital,Pharmacovigilance,Exceeds,Male,46,8,0,10,1.9,2.6,3.7,1,1,1,1,1.8,3.6,2.4
5593,0,Europe,Finance,Supply Chain,Exceeds,Female,33,4,0,10,4,2.8,4.9,1,1,1,1,3.7,2,3.2
5594,0,Asia Pacific,Commercial,Sales,Meets,Female,38,15,0,12,3.6,2.8,5,1,1,1,1,2.6,4.5,3.6
5595,0,Middle East & Africa,Finance,Sales,Exceeds,Male,39,6,1,11,,2.3,1.5,0,0,0,0,4.2,2.7,2.1
5596,0,Latin America,Finance,Quality Assurance,Exceeds,Female,38,36,0,11,3.1,4.7,2.4,1,1,1,1,2.1,4.2,2.5
5597,0,Latin America,Commercial,Marketing,Meets,Male,40,13,0,8,3.2,2.5,2.1,1,1,1,1,2.9,3.8,2.1
5598,0,Asia Pacific,Digital,Clinical Operations,Meets,Female,38,10,0,8,4.1,4.1,2.7,1,1,1,1,2.4,3.4,3.2
5599,0,Latin America,HR,Clinical Operations,Below,Female,28,20,0,9,4,2.1,5,1,1,1,1,2.9,1.8,5
5600,1,Middle East & Africa,Digital,Pharmacovigilance,Meets,Female,46,5,0,7,4.3,1.7,2.1,1,1,1,1,5,2.8,3.3
5601,0,Latin America,R&D,Quality Assurance,Far Exceeds,Male,40,16,0,11,2.7,3.8,1.4,1,1,1,1,3.4,3.4,1.5
5602,0,Middle East & Africa,Commercial,Marketing,Below,Male,37,9,0,7,3.2,4.3,3.8,1,1,1,1,3.5,1.8,4.3
5603,0,Europe,Manufacturing,Finance & Accounting,Meets,Female,32,16,0,7,4.4,3.2,3.2,1,1,1,1,3.2,2.9,2.8
5604,0,Middle East & Africa,Commercial,Clinical Operations,Meets,Male,36,4,0,9,3.3,5,2.5,1,1,1,1,2.5,4,2.6
5605,0,North America,R&D,Legal & Compliance,Exceeds,Female,43,20,0,11,4.4,2.9,2.9,0,0,0,0,2.9,4,3
5606,0,North America,Finance,Regulatory Affairs,Meets,Female,30,8,0,5,3.1,3.3,4.5,0,0,0,0,3.8,2.8,3.9
5607,0,North America,Manufacturing,Market Access,Exceeds,Male,33,15,0,11,4.4,2.5,2.7,1,1,1,1,4,1.7,3.2
5608,0,Asia Pacific,Manufacturing,Data Science,Meets,Male,37,2,1,10,,2.6,2.6,1,1,1,1,3.2,2.1,3.2
5609,0,Asia Pacific,Digital,Market Access,Meets,Female,28,4,1,12,,4.2,1.6,1,1,1,1,4.5,4.8,1.5
5610,0,Asia Pacific,HR,IT & Digital,Far Below,Female,32,22,0,11,3.7,4.6,2.8,0,0,0,0,2.7,3.5,3
5611,0,Middle East & Africa,Digital,Data Science,Meets,Male,36,12,1,7,,4.1,1.9,1,1,1,1,3.9,3.7,3
5612,0,Asia Pacific,Manufacturing,Regulatory Affairs,Meets,Female,28,7,0,11,1.4,2.3,2.2,1,0,0,0,1.4,3.4,2.8
5613,0,Europe,Manufacturing,IT & Digital,Meets,Non-Binary/Other,37,18,0,7,2.9,2.7,2.9,1,1,1,1,3.6,2.6,3.1
5614,0,North America,HR,Regulatory Affairs,Below,Male,30,12,0,11,4,1.6,3.2,1,1,1,1,5,2.7,3.7
5615,0,Middle East & Africa,Commercial,Marketing,Exceeds,Male,45,22,0,6,3,4.6,2.7,0,0,0,0,3.3,3.1,2.9
5616,0,North America,HR,Supply Chain,Meets,Female,35,4,1,5,,4.4,4.5,1,1,1,1,5,3.5,3.3
5617,0,Asia Pacific,Finance,Medical Affairs,Exceeds,Male,42,19,0,11,2.9,3.5,3.1,1,1,1,1,2.3,2.1,3.4
5618,0,Middle East & Africa,Digital,Clinical Operations,Meets,Female,40,5,1,7,,3.7,2.2,1,1,1,1,3.4,3.1,1.4
5619,0,Latin America,Commercial,Marketing,Below,Female,33,4,0,11,2,3.7,3.6,1,1,1,1,3.6,5,3.8
5620,0,Europe,Digital,Supply Chain,Meets,Male,40,18,0,10,4.7,2.3,3.8,1,1,0,0,4.8,3.3,4.4
5621,0,Asia Pacific,HR,Medical Affairs,Exceeds,Female,48,12,0,5,4.9,2.1,2.1,1,1,0,0,4.7,2.7,1
5622,0,Asia Pacific,Commercial,Marketing,Meets,Male,38,6,0,9,4.6,3.3,3.7,0,0,0,0,2.1,3.7,2.3
5623,0,Europe,HR,Pharmacovigilance,Meets,Male,36,15,0,6,3.7,3.8,2.5,1,1,1,1,4.5,2.5,2.5
5624,1,Europe,Finance,Medical Affairs,Far Exceeds,Male,40,10,0,7,2.2,3,2.8,1,1,1,1,4.3,3.6,3.2
5625,0,Latin America,R&D,IT & Digital,Meets,Female,41,18,0,8,3.3,3.5,1.9,1,1,1,1,3.6,3,1.6
5626,0,Asia Pacific,Manufacturing,Communications,Meets,Male,36,3,1,9,,3.9,1,0,0,0,0,4,4.4,1
5627,0,Asia Pacific,Commercial,Legal & Compliance,Meets,Male,28,19,0,12,3.9,4,3.7,1,1,1,1,3,4.2,3.8
5628,0,North America,Manufacturing,Market Access,Meets,Non-Binary/Other,33,20,0,6,2.7,2.1,2,1,1,1,1,4.3,2,2.8
5629,0,Middle East & Africa,R&D,Medical Affairs,Meets,Non-Binary/Other,30,16,0,10,3,1,2.9,1,1,1,1,2.9,3.1,2.5
5630,0,Middle East & Africa,Commercial,Market Access,Meets,Male,38,7,0,7,2.5,2,3,1,1,1,1,3,2.4,3.4
5631,0,North America,Manufacturing,IT & Digital,Meets,Male,45,12,0,12,4.4,3.5,3.5,1,1,1,1,3.4,4.9,3.9
5632,0,Middle East & Africa,Manufacturing,Sales,Below,Female,41,5,1,9,,1.1,1.7,1,1,1,1,2.2,1,2.5
5633,1,Europe,Commercial,Data Science,Meets,Female,35,17,0,7,4.8,3.2,2.2,1,1,1,1,4.3,2.1,3.4
5634,0,Middle East & Africa,Manufacturing,Market Access,Meets,Female,40,7,0,8,3.6,4,3,1,1,1,1,3.2,4.1,1.7
5635,0,Middle East & Africa,Manufacturing,Regulatory Affairs,Meets,Male,38,3,1,10,,3.1,3.7,1,1,1,1,4.3,4.8,4
5636,0,North America,Commercial,Communications,Exceeds,Male,41,11,0,9,4,3.7,3.4,1,1,1,1,3.2,4.6,2.8
5637,0,Latin America,Manufacturing,Pharmacovigilance,Below,Female,41,6,1,8,,2.6,1.7,1,1,1,1,3.9,2.7,2.4
5638,0,Middle East & Africa,Manufacturing,Finance & Accounting,Meets,Female,46,18,0,10,2.6,3.4,3.2,0,0,0,0,3.2,2.8,1
5639,0,Middle East & Africa,Digital,Clinical Operations,Meets,Female,37,23,0,12,2,3,2.4,1,1,1,1,3.5,3.5,3.6
5640,0,Latin America,Finance,Sales,Meets,Female,28,2,1,11,,2.3,3.5,0,0,0,0,4,3.8,2.6
5641,0,North America,Digital,Sales,Meets,Female,30,11,0,5,3.3,2,3,1,1,1,1,3.7,2.1,2.3
5642,0,Latin America,R&D,Quality Assurance,Meets,Male,38,9,1,7,,1.6,2,1,1,0,0,3.2,1.7,3.8
5643,0,North America,Digital,Marketing,Meets,Female,36,36,0,8,3.8,4,4.2,1,1,1,1,4.4,5,4.1
5644,0,Europe,Digital,Marketing,Meets,Male,42,8,0,5,4,3.5,3.2,1,1,0,0,4.2,5,2.3
5645,0,North America,R&D,Marketing,Meets,Male,44,9,0,5,3.2,2.2,3.2,1,1,1,1,3.9,1.7,4.3
5646,0,Europe,Manufacturing,Medical Affairs,Meets,Female,38,15,1,11,,2,2.8,1,1,1,1,2.4,2.5,3
5647,0,Europe,Manufacturing,Communications,Meets,Female,31,4,0,7,4.6,3.1,3,1,0,0,0,3.2,3,2.8
5648,0,North America,Digital,Clinical Operations,Exceeds,Male,41,1,1,9,,3.4,2.5,1,1,1,0,4.2,2.4,3.3
5649,0,Asia Pacific,R&D,Data Science,Below,Male,40,8,0,8,4.2,2.6,4.7,1,1,1,1,3.4,3.5,4.5
5650,0,North America,Manufacturing,Finance & Accounting,Far Exceeds,Male,42,10,0,12,4.7,2.5,2.3,0,0,0,0,5,3.3,1
5651,0,Middle East & Africa,HR,Finance & Accounting,Below,Male,34,2,1,6,,3,2.5,1,1,1,1,3.1,2.6,1
5652,0,Middle East & Africa,Commercial,Communications,Meets,Female,55,9,0,5,2.4,3,2.5,1,1,1,1,1.3,1,2.3
5653,0,Asia Pacific,Commercial,Market Access,Meets,Female,28,10,1,6,,2.5,4.3,1,1,1,1,3.1,3.7,4.2
5654,0,Europe,Finance,IT & Digital,Below,Female,39,22,0,8,5,3.2,2.5,1,1,1,1,4,4.3,2.1
5655,0,Asia Pacific,Commercial,Human Resources,Exceeds,Male,42,7,0,11,3.8,1,3.9,1,1,1,1,3.9,1,4.8
5656,0,Middle East & Africa,Digital,Marketing,Meets,Male,43,2,1,8,,3.4,2.5,0,0,0,0,3.2,3,3.2
5657,0,Asia Pacific,Commercial,Sales,Below,Male,38,19,0,12,3.1,3.8,3.3,1,1,1,1,3.4,4.5,2.3
5658,0,North America,Commercial,Market Access,Meets,Male,42,6,0,10,3.3,2.7,4.6,1,1,0,0,3.9,2.1,5
5659,0,Asia Pacific,HR,Clinical Operations,Meets,Female,43,7,0,6,3.2,4.5,1.9,1,1,1,1,4.5,3.9,2.9
5660,0,Europe,Manufacturing,Sales,Far Exceeds,Female,39,6,0,6,3,2.4,3.7,1,1,0,0,2.8,2.9,3.3
5661,0,North America,HR,Regulatory Affairs,Meets,Non-Binary/Other,39,13,0,8,4,3.2,1.2,1,1,1,1,4.4,2.7,2.8
5662,0,Latin America,Digital,Clinical Operations,Meets,Female,42,5,1,11,,2.2,2.3,1,1,1,1,3.4,1.9,2.7
5663,0,Middle East & Africa,Commercial,Medical Affairs,Below,Female,38,18,0,8,2.4,3.1,2.4,1,1,1,1,3.7,3.2,2.8
5664,0,Middle East & Africa,Manufacturing,Marketing,Meets,Male,46,19,0,12,4.8,2.9,2.6,1,1,1,1,4.6,4.6,3.5
5665,0,Asia Pacific,Finance,Supply Chain,Meets,Male,44,11,0,9,4.6,1.9,2.2,1,1,1,1,3.9,3.5,2.9
5666,0,North America,Finance,Pharmacovigilance,Far Exceeds,Female,36,16,0,6,3.4,3.5,3.1,1,1,1,1,4.6,2.3,2.7
5667,0,Latin America,Commercial,Sales,Meets,Female,34,10,0,10,5,3.4,2.3,1,1,1,1,2.1,4.8,3.2
5668,0,North America,Commercial,Quality Assurance,Exceeds,Female,43,36,0,5,2.5,2.9,2.4,1,1,1,1,2.6,4.3,1.8
5669,0,Middle East & Africa,Finance,Quality Assurance,Far Exceeds,Male,39,15,0,10,3.4,2,2.4,1,1,1,1,1.8,1.4,3.1
5670,0,North America,Finance,Human Resources,Meets,Non-Binary/Other,34,10,0,11,4.6,3.8,2.3,1,1,1,1,2.6,4.6,3.6
5671,0,Latin America,Digital,Pharmacovigilance,Below,Male,35,11,0,12,3.2,3.4,2.9,1,1,1,1,3.6,1.8,3.6
5672,0,Asia Pacific,Commercial,Data Science,Below,Male,42,25,0,12,2.6,4.9,2.7,1,1,1,1,2.2,4.2,1.4
5673,0,Europe,Finance,Data Science,Meets,Female,35,17,0,12,3.5,2,3.1,1,1,1,1,4.2,3.4,2.8
5674,0,North America,R&D,Pharmacovigilance,Meets,Male,47,13,1,9,,3.1,3.3,1,1,1,1,4.6,4,2.1
5675,0,Europe,Finance,Supply Chain,Below,Female,32,17,0,10,3.4,5,2.7,1,1,1,1,4.1,4.6,2.2
5676,0,Middle East & Africa,Manufacturing,Communications,Meets,Male,35,15,0,12,4.4,3.9,2,1,1,1,1,2.7,2.2,2
5677,0,Asia Pacific,Manufacturing,Medical Affairs,Meets,Female,32,16,1,6,,3.3,2,1,1,1,1,3.7,1.5,2
5678,0,Asia Pacific,R&D,Communications,Far Below,Male,31,16,1,9,,2.1,2.4,1,1,1,1,2.5,3.1,2.5
5679,0,North America,Digital,Clinical Operations,Meets,Male,33,11,0,9,3,3.9,4.9,1,1,1,1,3.4,2.9,4.2
5680,0,Asia Pacific,Commercial,Supply Chain,Below,Female,35,17,0,12,3.7,2.7,1.4,0,0,0,0,4.5,4.7,1.4
5681,0,North America,Commercial,Market Access,Meets,Male,35,5,1,11,,2.7,2.3,1,1,1,1,3.6,1.6,1.2
5682,0,North America,Finance,Marketing,Below,Male,28,12,0,7,2.6,4.7,2.1,1,1,0,0,1.8,3,2
5683,0,Europe,Manufacturing,Data Science,Exceeds,Female,31,11,0,6,3.8,4.3,1.5,1,1,1,1,3.6,3.5,2.2
5684,0,Asia Pacific,Digital,Legal & Compliance,Below,Female,39,8,0,11,4.8,3.3,2.3,1,1,1,1,4.4,3.9,1.9
5685,1,North America,Digital,Sales,Exceeds,Male,34,6,0,11,3.7,2.8,2.8,1,1,1,1,4.3,3,3
5686,0,Europe,Digital,Data Science,Meets,Male,44,6,0,11,3.8,1.4,4.1,1,1,1,1,3.5,2.3,5
5687,0,Latin America,Finance,Quality Assurance,Meets,Female,37,2,0,10,3.4,3.5,2.1,1,1,1,1,4.2,2.9,1
5688,0,Europe,Commercial,Sales,Meets,Female,42,21,0,8,3.8,3.1,4.5,1,1,1,1,4,4,4.7
5689,0,Europe,Digital,Market Access,Meets,Non-Binary/Other,36,22,0,10,2.6,3.7,1.2,0,0,0,0,2.6,4.7,2.2
5690,0,North America,Finance,Market Access,Below,Male,43,4,0,6,3.9,1,3.1,1,1,1,1,2,1.6,3.3
5691,0,Middle East & Africa,Finance,Marketing,Meets,Female,28,8,0,6,3.5,2.1,1.8,1,1,0,0,3.6,1.9,1.8
5692,0,Middle East & Africa,R&D,Regulatory Affairs,Exceeds,Male,39,6,1,6,,2.5,3,1,1,1,1,3.7,3.2,3.1
5693,1,Middle East & Africa,HR,Quality Assurance,Far Exceeds,Male,47,3,0,8,4.1,3.2,5,1,1,1,1,5,3.3,4.2
5694,0,Europe,Digital,Pharmacovigilance,Meets,Male,29,20,0,6,2.3,3.1,2.4,1,1,1,1,1.8,3.3,1.8
5695,0,North America,HR,Data Science,Meets,Male,43,36,0,7,3.1,2.5,3,1,1,1,1,2.3,1.7,3
5696,0,Asia Pacific,Commercial,Finance & Accounting,Meets,Female,40,14,0,8,3.7,3.2,3.1,1,1,1,1,4.4,5,3
5697,0,Europe,Finance,Communications,Meets,Male,29,15,0,11,3.7,4.6,2.6,0,0,0,0,3.9,5,3
5698,0,Europe,Digital,Marketing,Exceeds,Female,40,9,0,5,2.2,3.3,5,1,1,1,1,2.9,2.6,3
5699,0,North America,Manufacturing,Marketing,Meets,Female,40,14,1,7,,3.7,2.8,0,0,0,0,2.4,4.1,4.2
5700,1,Latin America,Commercial,Regulatory Affairs,Exceeds,Male,37,6,1,12,,3.1,2.7,1,0,0,0,4.1,1.8,2.2
5701,0,Europe,R&D,Market Access,Meets,Female,45,20,0,11,3.9,2.9,2,1,1,1,1,4.9,3.3,3.8
5702,0,Latin America,R&D,Quality Assurance,Meets,Non-Binary/Other,44,8,1,6,,2.8,1.7,1,1,1,1,2.9,4.5,1.2
5703,1,Latin America,HR,Sales,Far Exceeds,Female,43,15,0,12,4.5,3.1,3.9,1,1,1,1,3.6,1,5
5704,0,Middle East & Africa,Finance,Human Resources,Exceeds,Male,46,7,1,7,,4.2,4.5,1,1,1,1,1.6,3.8,3.4
5705,0,North America,HR,Human Resources,Meets,Male,33,10,0,9,5,4.2,4.4,1,1,1,1,4.6,2.7,4.5
5706,0,Latin America,Manufacturing,Quality Assurance,Meets,Male,35,8,0,12,3.1,4,3.2,1,1,1,1,3.1,2.8,3.2
5707,0,North America,Manufacturing,Legal & Compliance,Meets,Female,34,19,0,10,4.4,3.3,2,1,1,1,1,3.4,4.5,2.3
5708,0,Middle East & Africa,R&D,Finance & Accounting,Below,Male,35,17,1,12,,3.8,1.7,1,1,1,1,3.7,3.6,1.6
5709,1,North America,Digital,Legal & Compliance,Meets,Female,35,9,0,8,3.7,2.7,2.8,1,1,1,1,4.2,3.4,3.8
5710,0,Europe,R&D,Quality Assurance,Meets,Male,37,10,0,5,3.4,4.2,3.3,1,1,1,1,2.6,4.4,3.6
5711,0,Latin America,R&D,Communications,Meets,Male,36,16,0,5,3.2,4.2,2.6,1,1,1,1,2.8,4.6,2.5
5712,0,North America,Manufacturing,IT & Digital,Meets,Male,31,30,0,10,3.2,3,1.7,0,0,0,0,2.8,3.1,2.1
5713,0,Asia Pacific,HR,Data Science,Meets,Male,43,12,0,11,3.2,2.3,2.2,1,1,1,1,2,4.1,5
5714,0,North America,Manufacturing,Sales,Meets,Male,33,5,0,6,3.6,2.6,3.4,1,1,1,1,4.4,1.6,3
5715,0,Latin America,Finance,Supply Chain,Exceeds,Male,47,13,0,10,3.2,1.8,3,1,1,1,1,3.6,3.1,3.8
5716,0,Middle East & Africa,Manufacturing,Sales,Far Below,Female,43,6,0,10,4.1,2.6,4,1,1,1,1,4.2,2.5,2.9
5717,0,Middle East & Africa,Manufacturing,Marketing,Exceeds,Female,31,10,0,11,2.2,1.7,4.2,1,1,1,1,2.3,2.7,3.6
5718,0,Latin America,R&D,Regulatory Affairs,Meets,Male,38,28,0,5,3.6,2.2,5,1,1,1,1,4.1,3,4.1
5719,0,Europe,Digital,Quality Assurance,Meets,Female,30,7,0,7,3.6,3.5,2.2,1,1,1,1,4.4,5,1.3
5720,0,Europe,R&D,Sales,Exceeds,Female,46,2,0,5,3.2,2.5,3.6,1,1,1,1,3.5,3.4,4.2
5721,0,Middle East & Africa,Commercial,Marketing,Meets,Male,38,9,0,11,3.7,2,1.7,1,1,1,1,4.1,4.4,1.6
5722,0,Middle East & Africa,Manufacturing,Clinical Operations,Below,Male,38,23,0,7,1.9,3.1,3.1,1,1,1,1,1.9,3.7,2
5723,1,Latin America,Manufacturing,Market Access,Meets,Male,39,4,1,9,,3.2,2.7,1,1,1,1,5,3.9,2.3
5724,0,Europe,Commercial,Regulatory Affairs,Meets,Male,37,16,0,10,3,1.5,2.7,1,1,1,1,3.8,2.2,1.3
5725,1,Middle East & Africa,Manufacturing,Human Resources,Meets,Male,34,20,0,5,4,3.5,3.1,1,1,1,1,5,4,4.2
5726,0,Europe,Manufacturing,Medical Affairs,Below,Female,37,6,0,7,3.8,3.5,1.6,1,1,1,1,4.1,3.2,2.5
5727,0,Middle East & Africa,Finance,Human Resources,Below,Female,46,5,1,9,,1.6,1,1,1,1,1,3.4,3.3,2.3
5728,0,North America,Manufacturing,Pharmacovigilance,Meets,Male,35,17,1,8,,4.9,2.2,1,1,1,1,3.4,3.9,2.6
5729,0,Asia Pacific,Commercial,Marketing,Meets,Male,46,15,1,6,,4.9,2.5,0,0,0,0,2.3,4.6,2.3
5730,0,North America,R&D,Quality Assurance,Meets,Male,35,12,1,11,,4.4,2.8,1,1,1,1,3.5,4.4,2.4
5731,0,Middle East & Africa,Manufacturing,Regulatory Affairs,Meets,Female,39,13,0,8,4.4,2.2,2.1,1,1,1,1,4.2,3.2,2
5732,0,Asia Pacific,Digital,Market Access,Meets,Male,50,5,1,6,,1.4,2,1,1,1,1,3.9,3.6,2
5733,0,Asia Pacific,Commercial,Communications,Below,Male,41,11,1,5,,2.1,2.8,0,0,0,0,3.4,1,2.9
5734,0,Middle East & Africa,HR,Sales,Meets,Male,40,17,0,9,3.3,4,3.4,1,1,1,1,2.2,3.1,3.4
5735,1,Middle East & Africa,Finance,IT & Digital,Exceeds,Female,42,16,0,8,3.2,3.1,2.5,1,1,1,1,2.7,3.3,2.7
5736,0,Europe,Commercial,IT & Digital,Meets,Male,44,4,0,6,3.4,3.9,1,1,1,1,1,3.5,2.4,1.1
5737,0,Middle East & Africa,R&D,Finance & Accounting,Meets,Female,33,11,0,11,3,3.7,1.8,1,1,1,1,2.7,3.3,1.3
5738,0,Latin America,Commercial,Clinical Operations,Exceeds,Male,41,27,0,11,5,5,1.5,1,1,1,1,5,4.6,2.1
5739,0,Middle East & Africa,HR,Medical Affairs,Exceeds,Male,40,6,0,11,3.2,4.8,3,1,1,1,1,4.1,4.1,3.9
5740,0,Latin America,Finance,Market Access,Meets,Male,28,9,0,9,4,3.1,4.3,1,0,0,0,3.9,2.3,4.1
5741,0,Middle East & Africa,Digital,Clinical Operations,Meets,Female,39,14,0,7,3.2,3.6,2.1,1,1,1,0,2.5,2,1.8
5742,0,Europe,HR,Human Resources,Meets,Male,32,3,0,11,3.2,2,2.6,1,1,1,1,3.3,3.1,2.4
5743,0,Latin America,Commercial,Human Resources,Meets,Female,39,9,1,12,,2,1,0,0,0,0,3.5,3.3,3.3
5744,0,North America,HR,Pharmacovigilance,Meets,Male,44,21,0,9,3.5,4.8,4.5,1,1,1,1,2.4,4.3,1.4
5745,0,Latin America,Commercial,Regulatory Affairs,Below,Male,32,13,0,9,3.4,2.5,3.1,1,1,1,1,4.5,3.6,2.1
5746,0,Europe,Digital,Supply Chain,Meets,Female,37,30,0,7,3.1,4,1.3,1,1,0,0,3,1.8,2.1
5747,1,Latin America,Digital,Data Science,Meets,Male,35,10,1,12,,1.9,5,1,1,1,1,4.2,2.7,4
5748,0,Middle East & Africa,R&D,Legal & Compliance,Meets,Male,45,10,0,12,3.4,2,2.2,1,1,1,1,2.8,2.8,1
5749,0,Middle East & Africa,Digital,Regulatory Affairs,Meets,Male,35,7,0,6,2.7,5,1.8,0,0,0,0,3.7,4.5,1.7
5750,1,Europe,Manufacturing,Finance & Accounting,Far Exceeds,Male,39,19,1,5,,3.1,3.5,1,1,1,1,3.9,4.8,3.3
5751,0,Asia Pacific,HR,Medical Affairs,Far Exceeds,Male,42,7,1,10,,3,2.5,1,1,1,1,3.4,1.8,1
5752,0,Middle East & Africa,HR,Supply Chain,Meets,Male,43,11,0,12,4.2,4.7,3.2,1,1,1,1,3.3,3.5,4.1
5753,0,North America,Commercial,Supply Chain,Far Exceeds,Male,32,22,0,11,3.6,3,4.7,1,1,1,0,3.4,3.7,2.7
5754,0,Europe,Digital,Pharmacovigilance,Far Exceeds,Male,36,18,0,11,3.2,3,4.9,1,1,1,1,2.7,3.4,4.4
5755,0,Latin America,R&D,IT & Digital,Exceeds,Female,48,24,0,7,2.4,3.3,2.8,1,1,1,1,3.1,4.6,2.6
5756,0,Latin America,R&D,Finance & Accounting,Below,Male,38,13,0,9,2.9,3.2,2.3,1,1,1,1,3.6,4.3,2
5757,0,North America,R&D,Data Science,Meets,Female,44,8,0,11,3.7,3.1,1.2,1,1,1,1,3.9,3.9,2.8
5758,0,Middle East & Africa,Finance,Supply Chain,Meets,Male,50,13,0,7,2.7,4.7,1,0,0,0,0,2.2,5,2.4
5759,0,Europe,Manufacturing,Marketing,Below,Female,38,10,0,10,1.4,4.7,3.7,1,1,1,1,1.8,2.5,4
5760,0,North America,Digital,Market Access,Exceeds,Female,43,35,0,5,4.1,2.6,2.6,1,1,1,1,4.2,3,3.7
5761,0,Middle East & Africa,R&D,Supply Chain,Below,Female,44,11,0,7,3.3,2.3,2.1,1,1,1,1,4,4.8,2.7
5762,0,Europe,Manufacturing,Supply Chain,Meets,Female,30,26,0,7,3.2,1.1,3.1,1,1,1,1,3,2.5,1.6
5763,0,Latin America,HR,Market Access,Below,Male,40,14,1,12,,2.6,2.2,1,1,1,1,3,2.5,2.7
5764,0,Europe,Commercial,Sales,Meets,Male,47,23,0,5,3.5,2.3,3.2,1,0,0,0,3.3,3.2,1.2
5765,1,Asia Pacific,Digital,Pharmacovigilance,Meets,Female,29,7,0,9,3.3,4.3,2.7,1,1,1,1,4.2,3.3,3.7
5766,0,Europe,Digital,Supply Chain,Meets,Male,37,5,0,10,2.9,3.5,1.3,1,1,1,1,2.6,3.9,1.7
5767,0,Asia Pacific,Finance,Supply Chain,Meets,Male,39,8,1,8,,3.9,1.9,1,1,1,1,4.2,3.9,2.3
5768,0,Europe,HR,IT & Digital,Meets,Male,37,25,0,6,2.2,3.2,3.4,1,1,1,1,3,1.8,2.2
5769,0,Asia Pacific,Digital,Legal & Compliance,Meets,Male,37,27,0,8,1.8,2.6,2,1,1,1,1,2.5,2.9,2.4
5770,0,Latin America,Finance,Data Science,Meets,Female,31,10,0,10,4.1,2.1,1.9,1,1,1,1,4,1,2.1
5771,0,Middle East & Africa,Finance,Clinical Operations,Meets,Male,40,13,1,10,,2.1,4.3,1,1,1,1,3.6,2.1,2.9
5772,0,Asia Pacific,Finance,Legal & Compliance,Below,Male,34,7,1,7,,2.8,2.8,1,1,1,1,2.7,2.3,2.8
5773,0,Asia Pacific,Digital,Legal & Compliance,Far Below,Female,34,6,0,8,2.6,3.1,3.5,1,1,1,1,2.5,3.4,3.3
5774,0,Latin America,Digital,Sales,Meets,Male,28,11,0,9,3.3,4,3.9,1,1,1,1,3.6,5,2.6
5775,0,Asia Pacific,Digital,Quality Assurance,Meets,Male,29,3,1,5,,2.4,3.2,0,0,0,0,3.5,3.5,3
5776,0,North America,Manufacturing,Sales,Below,Female,47,20,0,5,4.1,2.8,1.9,1,1,1,1,4,2.8,2.2
5777,0,Latin America,Finance,Market Access,Below,Male,38,30,0,8,3.8,4.1,3.2,1,1,1,1,3.3,3.6,3.3
5778,0,North America,Manufacturing,Data Science,Meets,Female,42,16,0,8,3,2.9,5,1,1,1,1,3.4,3.5,4
5779,0,Latin America,Commercial,Pharmacovigilance,Meets,Male,33,7,0,9,3.3,3.5,2.2,1,1,1,1,3.5,1.5,3.5
5780,0,Asia Pacific,Digital,Regulatory Affairs,Meets,Male,28,4,0,12,3.7,4.5,3.8,1,1,1,1,4.7,4,4.2
5781,0,North America,HR,Communications,Meets,Male,34,20,1,5,,3.8,3.7,1,1,1,1,3.2,3,4.5
5782,0,Asia Pacific,R&D,Data Science,Below,Female,28,14,0,5,3.5,2.7,2,1,1,1,1,3.7,2.4,2.6
5783,0,Latin America,Commercial,IT & Digital,Meets,Female,34,22,0,12,3.5,3.5,1,1,1,1,1,3.8,4.7,2.4
5784,0,Asia Pacific,R&D,Medical Affairs,Meets,Female,45,3,0,9,2.9,3.8,2.6,1,1,1,1,4.2,5,2
5785,0,North America,R&D,Market Access,Meets,Female,37,9,1,10,,3.2,1.4,1,1,1,1,3.9,4.7,1.6
5786,0,North America,Digital,Clinical Operations,Exceeds,Male,47,15,0,10,3.6,4.1,1,1,1,1,1,4.5,4.1,1.1
5787,0,Asia Pacific,HR,Human Resources,Meets,Female,41,2,0,7,3.3,4.3,2,1,1,1,1,2.7,4,1.5
5788,0,Europe,R&D,Medical Affairs,Meets,Female,44,12,1,8,,3.2,2.8,1,1,1,1,3.9,3.2,3.3
5789,0,Latin America,Finance,Medical Affairs,Meets,Male,37,12,1,6,,4.5,4.4,1,1,1,1,3.9,3.9,3.9
5790,0,Latin America,R&D,Pharmacovigilance,Meets,Female,30,7,0,6,3.4,2.1,1.6,1,1,1,1,2.9,2.6,3.4
5791,0,Asia Pacific,Commercial,Quality Assurance,Meets,Female,32,19,0,7,4.4,3.1,2.5,1,1,1,1,3.8,2.8,2.6
5792,0,Europe,HR,Regulatory Affairs,Meets,Female,45,7,0,6,4.5,2.1,3.4,1,1,1,1,4.7,2.4,2.5
5793,0,North America,HR,Finance & Accounting,Meets,Male,39,36,0,10,4.4,2.8,1.1,1,1,1,1,3.6,3.2,1.8
5794,0,Middle East & Africa,R&D,Supply Chain,Meets,Non-Binary/Other,30,13,0,9,2.2,4.6,2.6,1,1,1,1,3.2,5,2.5
5795,0,Middle East & Africa,HR,Marketing,Meets,Male,42,5,0,11,4.1,2.1,2.4,1,1,1,1,3.7,2.5,3.2
5796,0,Asia Pacific,Commercial,Supply Chain,Far Exceeds,Female,29,10,0,10,4,2.4,1,1,1,1,0,4.6,2.7,1
5797,0,Europe,Commercial,Human Resources,Below,Male,41,6,0,10,5,4.7,2,1,1,1,1,4.3,3.5,3.8
5798,0,Europe,Commercial,Medical Affairs,Below,Female,36,7,1,11,,2.6,1.3,1,1,1,1,3.3,1.8,1.4
5799,0,Latin America,Finance,Legal & Compliance,Below,Male,42,14,0,7,3.6,4.6,3,1,1,1,1,4,4.4,2.9
5800,1,North America,Digital,Legal & Compliance,Meets,Female,36,7,0,5,3.5,2.8,2.5,1,1,1,1,3.2,3.5,4.2
5801,0,Europe,R&D,Sales,Below,Male,42,11,0,9,5,3.7,2.7,1,0,0,0,3.8,2,2.1
5802,0,Middle East & Africa,HR,Marketing,Meets,Female,29,25,0,7,3.2,2.3,2.5,1,1,1,1,3,2.1,1.1
5803,0,North America,Commercial,Pharmacovigilance,Meets,Female,40,5,0,5,4.3,3.3,2.2,1,0,0,0,3.5,5,1.8
5804,0,North America,R&D,Regulatory Affairs,Meets,Female,35,5,1,7,,1,2.8,1,1,1,1,2.6,2.1,2.1
5805,0,Asia Pacific,R&D,Human Resources,Below,Male,40,13,1,6,,3.1,2.9,1,1,1,1,4,2.6,3.3
5806,0,Europe,Digital,Pharmacovigilance,Meets,Male,36,10,1,9,,2.3,2,0,0,0,0,2.9,1.6,2
5807,0,Asia Pacific,Finance,Market Access,Below,Male,33,14,0,8,2.7,2,3.2,1,1,1,1,3.1,3.8,4.4
5808,0,Europe,HR,Clinical Operations,Below,Female,37,11,0,12,4.2,2.9,1.2,1,1,1,1,3.2,3.8,2.6
5809,0,Latin America,Finance,Medical Affairs,Meets,Female,45,18,0,12,4.5,1.2,3.1,1,1,1,1,4.4,2,2.1
5810,0,Asia Pacific,HR,IT & Digital,Meets,Female,34,13,0,5,4.4,3.1,4.1,1,1,1,1,3.9,4.3,4.5
5811,0,Asia Pacific,Commercial,Sales,Below,Male,39,16,0,6,3.5,4.3,2.8,1,1,1,1,3.6,3.5,1.7
5812,0,Middle East & Africa,Commercial,Pharmacovigilance,Meets,Male,34,18,0,6,4.5,2.2,1.2,1,1,0,0,3.5,2.5,2.3
5813,0,Asia Pacific,R&D,Communications,Meets,Female,28,16,0,9,2.3,2.7,2.3,1,1,1,1,3.1,4.3,2.3
5814,0,Europe,HR,Marketing,Meets,Male,38,8,0,10,4.5,2.8,2.6,1,1,1,1,4.6,3.2,1.9
5815,0,Middle East & Africa,HR,Medical Affairs,Exceeds,Male,55,10,0,6,4.3,4.1,1,1,1,1,1,3,2.6,1
5816,0,Asia Pacific,Finance,Regulatory Affairs,Exceeds,Male,30,10,1,10,,3.3,3.2,1,1,1,1,4.7,2.3,2.1
5817,0,Asia Pacific,Commercial,Sales,Meets,Male,44,13,0,6,3.8,2.7,3.9,1,1,0,0,3.2,2.7,1.4
5818,0,Latin America,Manufacturing,Quality Assurance,Meets,Male,28,24,0,7,4.1,2.6,3.8,1,1,1,1,2.6,2.4,4.5
5819,0,Asia Pacific,R&D,Quality Assurance,Meets,Female,38,6,0,11,3.5,3.3,1.4,1,1,1,1,4,3.8,2.1
5820,0,North America,HR,Marketing,Below,Male,30,20,0,7,3.6,3.6,3.2,1,1,1,1,3.1,1.2,1.7
5821,1,Middle East & Africa,Digital,Human Resources,Meets,Female,41,12,0,11,3.2,3.6,4.5,1,1,1,1,2.5,3.6,1.9
5822,0,North America,Digital,Clinical Operations,Exceeds,Female,35,9,0,12,3.2,4,2.1,1,1,1,1,3.3,4,3.5
5823,0,Middle East & Africa,Manufacturing,Communications,Meets,Female,34,10,0,12,2.6,4,3.6,1,1,1,1,2.9,4.3,2.9
5824,0,Latin America,Commercial,Quality Assurance,Meets,Male,31,10,0,5,2.1,2.5,1.9,1,1,1,1,2.1,1.8,3
5825,0,Asia Pacific,Commercial,Medical Affairs,Meets,Male,28,10,0,5,5,4.8,3.5,1,1,1,1,4.3,5,4.8
5826,0,Asia Pacific,Commercial,Communications,Below,Male,36,12,0,11,2.7,4.5,1.7,1,1,1,1,3.7,2.9,3.1
5827,0,Asia Pacific,Finance,Legal & Compliance,Meets,Female,34,8,0,12,2.7,4.5,2.8,1,1,1,1,2.9,4.8,3.7
5828,0,Middle East & Africa,Digital,Regulatory Affairs,Meets,Female,35,7,1,6,,5,3.5,1,1,1,1,5,2.1,3.3
5829,0,Asia Pacific,Commercial,Clinical Operations,Far Below,Female,36,8,0,9,5,3.9,3.1,1,1,1,1,3.8,4,3
5830,0,North America,Digital,Supply Chain,Below,Male,33,6,1,5,,4.7,2.7,1,1,1,1,4.3,3.4,2.1
5831,0,Asia Pacific,Manufacturing,Regulatory Affairs,Meets,Male,39,4,0,7,3.8,2.2,3,1,1,1,1,3.3,2.4,3.1
5832,0,Latin America,R&D,Finance & Accounting,Below,Male,37,10,0,12,2.6,3.6,3.2,1,1,1,1,3.4,2.7,3
5833,0,North America,Finance,Medical Affairs,Meets,Male,43,19,0,11,4.6,2.7,1.9,1,1,1,1,4.1,3.4,1.7
5834,0,Asia Pacific,HR,Medical Affairs,Meets,Male,52,12,1,8,,3.1,1,0,0,0,0,3.9,3.5,1
5835,0,Asia Pacific,Manufacturing,Finance & Accounting,Far Below,Female,39,27,0,9,1.9,4.2,1.4,1,1,1,1,1.5,4.3,1.9
5836,0,Europe,Digital,Market Access,Meets,Male,45,7,1,6,,1,2.6,1,1,1,1,4,3.3,2.8
5837,0,Middle East & Africa,Manufacturing,Communications,Far Below,Female,39,8,0,9,4.2,3,4.3,1,1,1,1,4,3.8,4.3
5838,0,North America,HR,Clinical Operations,Meets,Male,41,9,0,6,2.7,2.4,1,1,1,1,1,2.5,2.7,3.1
5839,1,Europe,Finance,Regulatory Affairs,Meets,Male,36,8,1,7,,3.5,1.4,1,1,1,1,4.6,5,2
5840,0,Latin America,R&D,Clinical Operations,Meets,Female,37,9,1,5,,1.4,4.4,1,1,1,1,2.2,1.9,3.7
5841,0,Middle East & Africa,HR,Marketing,Meets,Male,33,10,0,6,2.6,2.1,2.7,1,1,1,1,5,2.1,2
5842,0,North America,Finance,Finance & Accounting,Meets,Female,47,10,0,12,4,3.2,1.8,1,1,1,1,3.3,4,3.2
5843,0,Asia Pacific,Digital,Data Science,Meets,Female,44,3,1,6,,1.7,2.6,1,1,1,1,3.2,1.8,1.7
5844,0,North America,HR,Clinical Operations,Meets,Female,40,3,0,7,4,4.3,2.1,1,1,1,1,3.2,3.1,1.2
5845,0,Asia Pacific,Manufacturing,IT & Digital,Meets,Non-Binary/Other,32,3,1,12,,2.5,2.3,1,1,1,1,2.9,2.1,1
5846,0,Middle East & Africa,Commercial,Quality Assurance,Exceeds,Male,37,18,0,7,2.9,2.8,3,0,0,0,0,3.5,2.5,3.1
5847,0,Asia Pacific,Manufacturing,Legal & Compliance,Meets,Male,44,14,1,5,,5,2.5,1,1,1,1,3.9,4.2,1.5
5848,0,Latin America,Digital,IT & Digital,Far Exceeds,Female,53,6,1,6,,1.5,3.2,1,1,1,1,4,3.2,3.6
5849,1,Asia Pacific,R&D,Legal & Compliance,Exceeds,Male,38,19,1,6,,4.9,1.9,1,1,1,1,5,5,2
5850,0,Latin America,HR,Medical Affairs,Meets,Male,45,17,0,9,3.2,3.6,3.3,1,1,1,1,4.2,2.9,1.2
5851,0,Middle East & Africa,R&D,Market Access,Exceeds,Male,39,16,0,11,4.2,3.5,2.4,1,1,1,1,4.8,3.3,3.1
5852,0,Middle East & Africa,Digital,Supply Chain,Meets,Male,46,13,0,8,3.3,2.7,4.2,1,1,1,1,4.5,2.3,2.8
5853,0,North America,HR,Market Access,Exceeds,Female,28,2,0,11,4.2,4.4,3.8,1,1,1,1,3.9,2.9,2.6
5854,0,Latin America,Finance,Regulatory Affairs,Meets,Male,33,4,1,6,,3,3.5,1,1,1,1,3.6,2.9,3.6
5855,0,Latin America,Finance,Communications,Meets,Male,40,17,0,7,5,4.1,2.7,1,1,1,1,4.8,2.9,3.4
5856,0,Europe,Manufacturing,Marketing,Far Below,Male,31,5,0,9,4,3.4,2.2,1,1,1,1,3.9,4.3,2.4
5857,0,Europe,Manufacturing,Marketing,Meets,Male,41,9,0,5,2.9,1.2,1.9,1,1,1,1,3.3,1.9,2.8
5858,0,Europe,Digital,Supply Chain,Meets,Female,38,9,1,7,,4,2,0,0,0,0,3.7,3,1.6
5859,0,Asia Pacific,Finance,IT & Digital,Meets,Female,28,8,0,8,2.7,4.6,3.4,1,1,1,1,3.5,3.9,2.8
5860,0,Europe,HR,Clinical Operations,Far Exceeds,Male,28,13,0,10,2.5,2.3,2.4,1,1,1,1,2.9,2.7,1.5
5861,0,Latin America,Finance,Legal & Compliance,Below,Male,40,10,0,10,3.2,3.3,3.6,1,1,1,1,2.9,3,3.4
5862,0,Asia Pacific,Manufacturing,IT & Digital,Meets,Male,31,4,0,8,3.4,4,2.8,1,1,1,1,3.9,4.2,3.3
5863,0,Middle East & Africa,Digital,Clinical Operations,Below,Male,35,6,0,5,3,4.1,2.2,1,1,1,1,2.7,5,2.5
5864,0,North America,Finance,Communications,Far Below,Female,42,17,0,10,1.9,1.6,2.6,0,0,0,0,2.9,2.6,3.5
5865,0,Europe,Digital,Regulatory Affairs,Meets,Male,38,11,0,11,2.1,4,2.7,1,1,1,1,1.4,2.4,2.5
5866,0,Middle East & Africa,Finance,Legal & Compliance,Below,Male,35,20,0,10,3.7,2.5,2.6,1,1,1,1,3.7,2.5,2.4
5867,1,Latin America,R&D,Human Resources,Far Exceeds,Female,29,6,1,5,,2.7,1.5,1,1,1,1,4.1,3.5,1.9
5868,0,North America,Finance,Regulatory Affairs,Meets,Female,47,12,1,10,,4.4,2.4,1,1,1,1,3.6,4.4,1.3
5869,0,Middle East & Africa,Manufacturing,Sales,Below,Female,43,3,1,6,,4.9,2.8,1,1,1,1,4,4.2,2.2
5870,0,North America,HR,Clinical Operations,Far Below,Female,34,5,0,5,2.9,3.3,2.1,1,1,0,0,2.1,4.1,2.7
5871,0,Europe,Manufacturing,Human Resources,Meets,Male,33,6,1,10,,3.7,2.7,0,0,0,0,4,3.6,1.5
5872,0,Latin America,Manufacturing,Regulatory Affairs,Far Below,Male,35,2,1,9,,4,3,1,1,1,1,5,3.3,2
5873,0,North America,Manufacturing,Marketing,Meets,Female,32,9,0,12,3.1,3,3.3,1,1,1,1,2.4,1.9,2.4
5874,0,Middle East & Africa,Digital,Data Science,Meets,Male,36,21,0,5,2.6,4.5,2.7,1,1,1,1,2.7,3,4.2
5875,0,Europe,Commercial,Medical Affairs,Below,Male,45,31,0,6,3,3.9,1.8,1,1,1,1,2.8,3.7,2.1
5876,0,Europe,Commercial,Clinical Operations,Meets,Female,44,10,0,5,3,2.1,1.8,1,1,1,1,3.4,2.5,3.1
5877,0,Middle East & Africa,R&D,Sales,Exceeds,Female,44,15,0,5,3.9,3.5,3.7,1,1,1,1,3.6,5,3.4
5878,0,Middle East & Africa,Manufacturing,Medical Affairs,Meets,Male,30,7,1,12,,3.4,3.3,1,1,1,1,4.4,4.7,2.5
5879,0,North America,Commercial,Quality Assurance,Meets,Male,32,22,0,8,4.1,2.2,1.7,1,1,1,1,4.3,3.1,2.7
5880,0,Asia Pacific,R&D,Data Science,Meets,Female,44,3,0,12,4,4.3,2.2,1,1,1,1,4.1,3.6,3.2
5881,0,Europe,Digital,Market Access,Meets,Male,41,5,1,10,,1.6,4.1,1,1,1,1,3.2,1.1,2.8
5882,0,North America,Manufacturing,Clinical Operations,Meets,Male,35,12,0,5,4.2,3.8,1.9,1,1,1,1,3.1,5,1.2
5883,0,Middle East & Africa,HR,Legal & Compliance,Exceeds,Female,42,19,0,7,1.5,5,5,1,1,1,1,1,4,3.6
5884,0,North America,Digital,Finance & Accounting,Meets,Male,41,11,0,12,2.6,2.4,3.2,1,1,1,1,2.5,3.7,2.9
5885,0,Middle East & Africa,R&D,Market Access,Below,Male,29,6,0,11,2.1,3.6,3,1,1,1,1,2,3.7,3.4
5886,0,Latin America,Digital,Sales,Meets,Female,28,6,1,10,,3.4,3.6,1,1,1,1,4.1,4,3.4
5887,0,Middle East & Africa,HR,Legal & Compliance,Exceeds,Female,38,12,0,7,3.7,3.5,2.1,1,1,1,1,2.8,2.9,4.1
5888,0,Middle East & Africa,Digital,Communications,Below,Female,28,18,0,9,3.1,5,3.8,1,1,1,1,1.2,3.3,4.6
5889,0,Middle East & Africa,R&D,Clinical Operations,Meets,Female,45,25,0,10,4,2.5,3.4,1,1,1,1,3,3.5,5
5890,0,Asia Pacific,HR,Human Resources,Meets,Male,41,6,0,5,3.3,1.7,3.1,1,1,1,1,5,1.6,3.9
5891,0,Middle East & Africa,HR,Sales,Meets,Female,36,2,1,12,,3.9,3.2,1,1,1,1,5,4.1,2
5892,0,Europe,Digital,Pharmacovigilance,Meets,Female,31,7,0,5,4.3,2.3,4.6,1,1,1,1,3.5,3.7,3.5
5893,0,Europe,HR,Sales,Meets,Male,32,4,0,7,4.6,2.6,3.8,1,0,0,0,5,1.9,5
5894,0,North America,Digital,Regulatory Affairs,Below,Male,28,18,0,11,2.4,1.9,2.1,1,1,1,1,2.5,2.5,3.2
5895,0,Asia Pacific,Manufacturing,Finance & Accounting,Meets,Female,46,9,1,8,,3.3,2.1,0,0,0,0,3.9,3.2,1.9
5896,0,North America,HR,Communications,Far Below,Female,39,20,0,10,2.8,5,3.7,1,1,1,1,3.4,5,4.4
5897,0,Europe,Digital,Regulatory Affairs,Meets,Non-Binary/Other,37,6,0,5,1.9,3.6,2.8,1,1,1,1,1.4,2.2,1
5898,0,Europe,Manufacturing,Market Access,Exceeds,Male,49,18,0,12,2.9,2.8,2.9,1,1,1,1,5,3.5,2.8
5899,0,Latin America,HR,Pharmacovigilance,Meets,Female,32,8,1,7,,2.7,2.5,1,1,1,1,4,2.5,3.4
5900,0,Middle East & Africa,Manufacturing,IT & Digital,Meets,Female,37,5,0,9,3.2,2.8,2.3,1,1,1,1,3.1,3.4,2.6
5901,0,Europe,Finance,Legal & Compliance,Meets,Male,34,15,1,9,,2.6,3.3,1,1,1,1,3.7,2.3,2.8
5902,0,North America,HR,Sales,Below,Non-Binary/Other,50,7,0,10,2.5,3.9,2.9,1,1,1,1,3.6,4.1,3
5903,0,North America,Finance,Human Resources,Far Below,Female,36,4,1,11,,3.4,1.5,1,1,1,1,3.5,1.6,2.7
5904,0,Middle East & Africa,R&D,Quality Assurance,Meets,Female,39,5,0,5,3.7,2.7,2.1,1,1,1,1,3.9,2,3.3
5905,0,Middle East & Africa,R&D,Market Access,Meets,Female,48,4,0,7,3.3,2.8,3.7,1,1,0,0,3,3.2,4.1
5906,0,Latin America,Digital,Medical Affairs,Far Exceeds,Female,45,8,0,12,3.2,2.6,2.4,1,1,1,1,3,3.4,2.5
5907,0,Asia Pacific,Commercial,Regulatory Affairs,Meets,Male,28,17,0,6,3.3,2.4,2.6,1,1,1,1,3.3,3.5,4.3
5908,0,North America,Finance,Medical Affairs,Meets,Female,36,8,0,9,3.3,1.7,3.9,1,1,1,1,3.2,1,4.3
5909,0,Middle East & Africa,Finance,IT & Digital,Meets,Non-Binary/Other,38,4,1,7,,2.7,3.1,1,1,1,1,4.4,3.2,2.6
5910,0,North America,R&D,Human Resources,Meets,Male,39,28,0,11,4.3,1.8,2.7,1,1,1,1,3.5,1,3.2
5911,0,Middle East & Africa,Finance,Medical Affairs,Meets,Male,40,18,0,9,4.5,2.2,1.2,1,1,1,1,3.8,2.4,1.4
5912,0,Europe,Commercial,Human Resources,Meets,Male,33,9,0,11,3,4.2,3.2,0,0,0,0,3.9,4.5,3.4
5913,0,North America,Manufacturing,Pharmacovigilance,Meets,Female,47,6,1,12,,3.2,1.7,1,1,1,1,2.2,4,4.1
5914,0,Europe,Manufacturing,Market Access,Meets,Female,41,6,0,10,2.8,3.4,3.3,1,1,1,1,2,4.5,2.6
5915,0,North America,Commercial,Human Resources,Meets,Non-Binary/Other,42,9,0,5,2.9,2.3,1,0,0,0,0,2.8,2.9,1
5916,0,Asia Pacific,Finance,Marketing,Far Exceeds,Male,46,6,0,11,2.1,3.1,1.5,1,1,1,1,1.6,3.3,3.2
5917,0,Latin America,Finance,Communications,Meets,Female,40,8,1,6,,3.1,3,1,1,1,1,2.5,3.6,3.6
5918,0,Europe,Finance,Market Access,Meets,Female,37,22,0,10,3.7,3.7,4,1,1,1,1,3.3,2.5,3.3
5919,0,Middle East & Africa,Digital,Communications,Meets,Male,36,20,0,8,2.3,3.3,1,1,0,0,0,2.7,2.7,1.4
5920,0,Asia Pacific,HR,Marketing,Exceeds,Female,37,19,0,12,2.2,3.1,3,1,1,1,1,3.3,3.3,3.3
5921,0,North America,Commercial,Sales,Meets,Female,37,18,0,9,2.9,2.3,3.1,1,1,1,1,4,2.9,2.2
5922,0,Europe,Commercial,Marketing,Meets,Female,28,12,1,8,,2.4,3.8,1,1,1,1,3.8,5,4.1
5923,0,North America,Commercial,Clinical Operations,Meets,Female,34,6,0,6,1.7,2.4,3.4,1,1,1,1,2.5,2.6,4.1
5924,0,North America,Commercial,Finance & Accounting,Exceeds,Female,31,14,0,9,4,2.1,2.1,1,1,1,1,3,2.6,2.4
5925,0,North America,Commercial,Sales,Meets,Male,28,9,0,9,3.5,3.5,1.6,1,1,1,1,4,2.1,1.5
5926,0,Latin America,Finance,IT & Digital,Meets,Male,39,16,1,9,,3.1,1.8,1,1,1,1,1.6,1.9,4.2
5927,0,Latin America,Digital,Marketing,Exceeds,Female,41,18,0,5,2.9,2.8,1,1,1,1,1,4.7,4.4,1.3
5928,0,Middle East & Africa,R&D,Quality Assurance,Exceeds,Male,33,7,0,7,2.7,3.2,1.6,1,1,1,1,2.3,2.2,1.9
5929,0,Europe,Finance,Medical Affairs,Exceeds,Male,36,6,0,10,3.8,2.2,4.6,1,1,1,1,3.1,3.1,5
5930,0,Asia Pacific,Finance,Legal & Compliance,Below,Male,41,13,0,6,2.8,2.2,5,1,1,1,1,2.9,4,4.9
5931,0,Asia Pacific,HR,Sales,Meets,Male,36,6,1,5,,2.2,1.8,1,1,1,1,3,2.8,2.1
5932,0,Asia Pacific,R&D,Medical Affairs,Meets,Female,37,11,1,9,,3.7,2.5,1,1,1,1,2.9,2.5,2.8
5933,0,North America,Commercial,Supply Chain,Meets,Female,37,7,0,6,3.9,4,4,1,1,1,1,4,4.4,3.3
5934,0,Latin America,R&D,Market Access,Exceeds,Female,42,12,0,7,2,2.8,2.1,1,1,1,1,2.7,5,3.7
5935,0,Europe,Digital,Marketing,Exceeds,Female,38,36,0,11,2.9,4.3,4.9,1,1,1,1,3.4,4.6,3.9
5936,0,North America,Manufacturing,Legal & Compliance,Meets,Male,36,12,0,7,2.8,3.4,4,1,1,1,1,3.2,2.4,2.9
5937,0,Latin America,Finance,Medical Affairs,Below,Male,35,17,1,5,,2.7,2.9,1,1,1,1,3.4,2.8,3.2
5938,0,Latin America,R&D,Marketing,Far Below,Female,33,16,0,11,2.2,3.3,3,1,1,1,1,2.7,3.6,2.2
5939,0,Europe,HR,Finance & Accounting,Meets,Male,42,16,1,11,,4.1,4,1,1,1,1,2.9,3.9,4.7
5940,0,Europe,Digital,Medical Affairs,Far Below,Male,41,3,1,5,,3.8,2.7,1,1,1,1,2.9,2.7,2.7
5941,0,Europe,Manufacturing,IT & Digital,Meets,Female,38,16,0,7,2.6,2.4,1.1,1,1,1,1,3.4,4.4,1.9
5942,0,North America,Digital,Quality Assurance,Meets,Male,44,15,0,7,3.2,3,2.5,1,1,1,1,4.3,3.3,3.1
5943,0,Middle East & Africa,Commercial,Human Resources,Exceeds,Male,38,8,1,8,,2.8,4.1,1,1,0,0,3.6,2.9,4.4
5944,0,Europe,Manufacturing,Communications,Below,Male,40,19,0,12,2.8,1.6,2.4,1,0,0,0,2.9,1.8,2.7
5945,0,Middle East & Africa,HR,Communications,Meets,Non-Binary/Other,35,9,0,10,2.4,2.1,3.3,1,1,1,1,3.5,2.3,3.9
5946,0,North America,Manufacturing,Data Science,Exceeds,Male,45,5,0,6,2.6,3.8,2.5,1,1,1,1,3,5,4.6
5947,0,Middle East & Africa,HR,Quality Assurance,Meets,Male,39,22,1,5,,3.1,3.9,1,1,1,1,3.3,2.3,4.2
5948,0,Asia Pacific,Commercial,Finance & Accounting,Below,Female,40,19,0,6,2.6,2.9,3,1,1,1,1,2.6,4.4,3.5
5949,0,Middle East & Africa,HR,Regulatory Affairs,Below,Female,38,12,0,10,2.9,3.3,3.9,1,1,1,1,3.7,5,3.2
5950,0,Europe,Digital,Marketing,Exceeds,Female,39,16,0,9,2.5,3.3,2.7,1,1,1,1,2.7,2.4,4
5951,0,North America,R&D,Quality Assurance,Meets,Male,40,14,0,5,2.7,3.7,3.6,1,1,1,1,2.2,3.6,2.2
5952,0,Europe,Digital,Clinical Operations,Exceeds,Male,28,14,1,7,,4,2.1,1,1,1,1,2.5,4,2.2
5953,0,Asia Pacific,Finance,Marketing,Below,Male,41,18,0,11,3.4,2.6,3.3,1,1,1,1,2.8,2.4,2.6
5954,0,Europe,Digital,Pharmacovigilance,Meets,Female,34,15,1,7,,3.5,3.5,1,1,1,1,3,4.2,3.8
5955,0,Europe,Manufacturing,Communications,Meets,Female,37,4,0,6,2.6,2.6,4,1,1,1,1,3.1,1.8,2.8
5956,1,Europe,Commercial,Finance & Accounting,Meets,Male,34,7,0,6,3.5,1.7,2.5,1,1,1,1,4.5,2.8,1
5957,0,Latin America,Finance,Market Access,Far Exceeds,Female,43,20,0,11,4.1,3.7,2.6,1,1,1,1,3.8,2.9,3.3
5958,0,Asia Pacific,Finance,Market Access,Meets,Female,33,10,0,12,1.8,2.6,1.3,1,1,1,1,2.5,2.5,1.5
5959,0,Europe,Finance,Regulatory Affairs,Exceeds,Female,36,8,1,8,,2.8,3.8,1,1,1,1,4.1,4.1,2.8
5960,0,Europe,R&D,Human Resources,Exceeds,Female,34,5,0,10,3.4,2.5,1.3,1,1,1,1,3.4,3.9,1.6
5961,0,Europe,HR,Finance & Accounting,Meets,Female,34,17,1,9,,3,1,1,1,1,1,3.4,2.6,4.2
5962,0,North America,Manufacturing,Clinical Operations,Meets,Female,34,16,0,12,3.6,2,2.7,1,1,1,1,4,3.6,2.5
5963,0,Latin America,Commercial,Regulatory Affairs,Meets,Male,31,11,1,11,,3.9,2.1,1,1,1,1,2.2,4.3,1.2
5964,0,North America,R&D,Sales,Meets,Male,35,5,1,7,,3.8,3.7,1,1,1,1,5,3.2,5
5965,0,Latin America,Digital,Marketing,Meets,Female,39,17,0,10,3.7,3.5,3.7,1,1,1,1,5,2.4,4.5
5966,0,Europe,Commercial,Clinical Operations,Meets,Male,33,10,1,7,,3.5,1,1,1,1,1,3.4,4.3,1.7
5967,0,Asia Pacific,Finance,Supply Chain,Far Below,Male,39,23,0,9,2.8,3.3,3.6,1,1,1,1,3.2,3.1,2.8
5968,0,Middle East & Africa,Commercial,Human Resources,Meets,Female,41,7,1,12,,2.3,1.6,1,1,1,1,1.3,2.5,1
5969,0,Middle East & Africa,Commercial,Medical Affairs,Meets,Female,37,21,0,6,4.1,2.7,3,1,1,0,0,3.5,2.1,2.7
5970,0,Europe,Digital,Pharmacovigilance,Meets,Female,31,5,0,6,2.7,4.1,4.7,1,1,1,1,2.4,3,3.4
5971,0,North America,HR,Communications,Exceeds,Female,28,2,0,9,3.3,1.5,2.5,1,1,1,1,4.2,2.4,2
5972,0,Asia Pacific,Manufacturing,Communications,Below,Male,43,32,0,11,2.8,3,3.4,1,1,1,1,2.5,3.6,2.6
5973,0,Latin America,Finance,Communications,Meets,Female,47,17,0,11,3.4,3.3,3,1,1,1,1,3.7,3.5,2.6
5974,0,Europe,HR,Marketing,Meets,Female,46,11,0,6,2.2,2.5,2.3,1,1,1,1,4.3,2.5,2.9
5975,0,Asia Pacific,R&D,Pharmacovigilance,Meets,Female,40,13,0,11,2.6,3.4,2.5,0,0,0,0,2.9,3.7,2.9
5976,0,Asia Pacific,Finance,Clinical Operations,Meets,Female,40,2,1,8,,2.4,1.8,1,1,1,1,3.9,2.9,3.7
5977,0,Latin America,Manufacturing,Medical Affairs,Meets,Female,37,9,0,9,3,2.6,2.4,1,1,1,1,3.7,1.5,3.1
5978,0,Asia Pacific,R&D,Regulatory Affairs,Meets,Male,37,13,0,8,4.7,3.8,3.9,1,1,1,1,3.9,3.7,2.3
5979,0,North America,Digital,Marketing,Meets,Male,34,7,0,7,4.1,3.1,3.3,1,1,1,1,3.1,2.3,3.8
5980,0,North America,HR,Communications,Meets,Male,33,17,0,9,4.7,3,3.2,1,1,1,1,4.5,2.1,2.9
5981,0,North America,Finance,Medical Affairs,Meets,Female,28,7,0,12,3.3,3.9,4.5,1,1,1,1,1.8,3.4,4.3
5982,0,Asia Pacific,Commercial,Pharmacovigilance,Meets,Female,42,9,1,6,,2.9,4.1,1,1,1,1,2.7,1.9,4.1
5983,0,North America,Manufacturing,Legal & Compliance,Meets,Female,41,8,0,8,1.6,4.2,2.8,1,1,1,1,1,2.2,2.4
5984,0,Latin America,Finance,Data Science,Below,Male,36,7,0,10,3.1,4,1.3,1,1,1,1,2.4,2.3,1
5985,0,Asia Pacific,Commercial,Clinical Operations,Below,Male,46,17,0,9,2.8,2.9,2.1,1,1,1,1,2.5,3.7,2.8
5986,0,Middle East & Africa,Finance,Human Resources,Meets,Female,51,3,1,7,,2.7,1.1,1,1,1,1,3.1,2.6,2.3
5987,0,Asia Pacific,R&D,Finance & Accounting,Meets,Non-Binary/Other,29,9,0,12,2.5,3.6,2.5,1,1,0,0,2.2,4.4,2.8
5988,0,Latin America,Commercial,Human Resources,Far Below,Female,41,19,0,11,1.8,4.1,4.3,1,1,1,1,2,3.4,1
5989,0,Middle East & Africa,Commercial,Clinical Operations,Meets,Female,38,7,1,6,,2.8,1.5,0,0,0,0,2.3,2.1,3.8
5990,0,Asia Pacific,Finance,IT & Digital,Below,Female,48,11,0,7,3,4.7,3.2,1,1,1,1,2.7,3.3,5
5991,1,North America,Digital,Pharmacovigilance,Far Exceeds,Female,35,15,1,12,,3.5,1.9,1,1,1,1,2.8,3.8,3.9
5992,0,Europe,Digital,Pharmacovigilance,Meets,Male,44,3,1,6,,3,2.5,1,1,1,1,2.8,2.2,3.6
5993,0,Europe,HR,Sales,Meets,Male,42,9,0,9,2.3,1.9,3.5,1,1,1,1,2.6,3.7,4.2
5994,0,North America,R&D,Communications,Meets,Male,45,8,1,8,,2.2,1,1,1,1,1,2.5,2.4,1.6
5995,0,Europe,Digital,Regulatory Affairs,Exceeds,Male,34,13,0,6,3.3,3.1,3.4,1,1,1,1,4.7,1.7,3
5996,0,Europe,Finance,Pharmacovigilance,Below,Male,36,17,0,6,3.1,4.2,2.7,1,1,1,1,2.7,1.8,3.9
5997,0,North America,Digital,Finance & Accounting,Far Exceeds,Female,41,12,1,12,,2.3,2.4,1,1,1,1,1.4,3.9,1.9
5998,0,North America,HR,IT & Digital,Meets,Male,45,9,0,12,3.7,3.5,2.3,1,1,1,1,3.2,2.8,3.1
5999,0,Asia Pacific,Manufacturing,Finance & Accounting,Below,Male,39,10,0,12,2.3,2,2.9,1,1,1,1,1.9,1.6,4.3
6000,0,Asia Pacific,HR,Quality Assurance,Meets,Female,28,12,0,12,4.9,4.3,3.6,1,1,1,1,2.9,2.9,2.8
6001,0,North America,Commercial,Finance & Accounting,Meets,Male,45,28,0,11,4.7,1.6,2.5,1,1,1,1,2.9,3.9,2
6002,0,Latin America,Commercial,Human Resources,Far Exceeds,Male,46,13,0,12,4.8,2,3.2,1,1,1,1,3.4,1.6,1.9
6003,0,Europe,Digital,Market Access,Exceeds,Non-Binary/Other,35,12,0,6,3.5,3.5,4.1,1,1,1,1,2.6,2.7,3.8
6004,0,Asia Pacific,Digital,Market Access,Meets,Male,43,6,0,5,3,3.1,2.6,1,1,1,1,5,1.3,2.3
6005,0,Europe,HR,Marketing,Meets,Male,41,18,0,12,3,3.8,1.3,0,0,0,0,4.2,3.2,2.2
6006,1,Middle East & Africa,HR,Supply Chain,Exceeds,Male,33,4,1,5,,2.2,3.5,1,1,1,1,2.6,3.5,2.7
6007,0,North America,Finance,IT & Digital,Meets,Female,43,7,0,6,3.6,2.8,4.6,1,1,1,1,3.7,4.1,2.4
6008,0,Latin America,R&D,Marketing,Meets,Female,38,9,1,6,,4,3,0,0,0,0,2,3.3,2.1
6009,0,Middle East & Africa,Finance,Communications,Meets,Male,30,15,1,11,,3.2,2.4,1,0,0,0,3.2,4.6,2.2
6010,0,Middle East & Africa,Commercial,Communications,Meets,Female,43,7,1,5,,2.1,2.3,1,1,1,1,3,2.6,2.9
6011,0,Middle East & Africa,Finance,Sales,Exceeds,Male,51,23,0,5,3.9,3.1,2.1,1,1,1,1,3.5,4.5,1.8
6012,0,North America,HR,Medical Affairs,Meets,Female,28,7,0,5,3.8,3.3,2.2,1,1,1,1,2.5,4.4,1.7
6013,0,Asia Pacific,Finance,Supply Chain,Meets,Female,40,24,0,5,3.1,3.1,2.1,1,1,1,1,4.5,4.2,2.5
6014,0,North America,Manufacturing,Medical Affairs,Exceeds,Male,40,10,0,8,2.5,4.8,3.7,1,1,1,1,3.2,3.7,1.9
6015,0,Asia Pacific,R&D,Market Access,Far Below,Female,31,15,0,7,2,3.5,3.1,1,1,1,1,3.4,5,4
6016,0,Middle East & Africa,HR,Market Access,Meets,Male,44,19,0,12,3.5,4.1,1,1,1,1,1,3.8,4.8,2.4
6017,1,Middle East & Africa,Digital,Market Access,Exceeds,Female,31,1,0,6,2.5,4.3,3.2,1,1,1,1,3.4,4.2,3
6018,0,Latin America,Finance,Pharmacovigilance,Meets,Non-Binary/Other,39,25,0,10,2.6,2.2,1.4,1,1,1,1,2.9,2,3.7
6019,0,Asia Pacific,HR,Sales,Meets,Female,34,8,0,6,3.1,2.6,2.9,1,1,1,1,4.1,2.9,4.2
6020,0,Middle East & Africa,Digital,Quality Assurance,Meets,Female,32,32,0,8,2.3,3.8,3.1,1,1,0,0,3.4,2.3,2.7
6021,0,Europe,Digital,IT & Digital,Meets,Female,40,11,1,11,,3.3,3.6,1,1,1,1,4.3,2,3.4
6022,0,Latin America,Commercial,Finance & Accounting,Meets,Female,34,7,0,12,2.9,3.8,3.5,1,1,1,1,5,3.6,1.8
6023,0,North America,Commercial,Communications,Far Below,Male,46,4,1,6,,2.5,3.3,0,0,0,0,3,3.1,3.1
6024,0,Latin America,HR,IT & Digital,Below,Female,38,16,0,9,4.5,2.9,3.7,1,1,1,1,2.8,2.2,2.7
6025,0,Europe,HR,IT & Digital,Meets,Female,43,19,0,7,3.2,2.8,3.2,1,1,1,1,3.6,5,2.1
6026,0,Asia Pacific,Manufacturing,Marketing,Meets,Female,43,16,0,9,2.9,3,2.7,1,1,1,1,3.6,4,2.2
6027,0,North America,R&D,Medical Affairs,Meets,Male,45,8,1,5,,2.6,2,1,1,1,1,2.9,2.7,2.3
6028,0,North America,R&D,IT & Digital,Meets,Male,36,14,0,9,3.9,3.1,2.2,1,1,1,1,3.4,1.7,3
6029,0,Asia Pacific,HR,Data Science,Meets,Female,37,8,0,5,2.4,4.9,2.1,1,1,1,1,2.8,3.5,3.4
6030,0,Latin America,Commercial,Human Resources,Exceeds,Female,33,13,0,7,4.3,5,2.6,1,1,1,1,3.3,3.4,2.7
6031,0,Middle East & Africa,Finance,Marketing,Far Below,Non-Binary/Other,39,16,0,8,2.6,4.2,3.9,1,1,1,1,3.8,3,4
6032,0,Latin America,Manufacturing,Clinical Operations,Below,Female,33,14,1,5,,2.5,3.3,1,1,1,1,1.9,2.6,3.9
6033,0,Europe,R&D,Regulatory Affairs,Meets,Female,45,6,0,7,4.2,2,2,1,1,1,1,4,2.4,2.7
6034,0,Middle East & Africa,HR,Supply Chain,Below,Male,33,14,0,6,4.2,5,3,1,1,1,1,2.4,4.9,2.5
6035,0,Latin America,Commercial,Communications,Meets,Male,35,7,0,8,3,1.8,3.4,1,1,1,1,2.4,2.1,2.6
6036,1,Asia Pacific,Commercial,Medical Affairs,Far Exceeds,Female,41,8,1,10,,3,2.5,1,1,1,1,5,4.3,2.2
6037,0,Europe,Commercial,Sales,Exceeds,Female,41,3,0,8,2.6,4.2,3.1,0,0,0,0,2.4,3.9,2
6038,0,Europe,Finance,Communications,Meets,Female,31,7,0,5,3.6,2.7,1.8,1,1,1,1,5,2.2,2.1
6039,1,Europe,Digital,Human Resources,Exceeds,Male,34,6,0,12,2,3.4,2.5,1,1,1,1,2.8,2.4,2.6
6040,0,Middle East & Africa,Finance,Market Access,Below,Female,36,11,0,11,4.1,2.7,2.5,1,1,1,1,3.6,3.7,1.9
6041,0,North America,Commercial,Clinical Operations,Meets,Female,37,15,0,8,3.1,2.4,2,1,1,1,1,2.2,4.9,2
6042,1,Middle East & Africa,HR,Regulatory Affairs,Meets,Female,39,19,0,10,2.3,4.1,3.8,1,1,1,1,3.4,2.5,3.9
6043,0,Latin America,Manufacturing,Medical Affairs,Meets,Male,43,8,0,5,3.3,1.7,3.5,1,1,1,1,2.8,3.2,2.9
6044,0,North America,Finance,Quality Assurance,Far Below,Male,37,16,0,9,2.1,2.6,3,1,1,1,1,4.2,1.5,1.3
6045,0,Latin America,HR,Market Access,Exceeds,Male,39,6,0,11,3.6,2.7,1.6,1,1,1,1,2.8,2,2.5
6046,1,North America,Commercial,Medical Affairs,Meets,Male,33,6,0,8,3.4,4.2,4.1,1,1,1,0,3.4,3.6,3.9
6047,0,Middle East & Africa,Manufacturing,Legal & Compliance,Meets,Non-Binary/Other,47,32,0,8,3.6,2.7,2.8,1,1,1,1,2.9,3.6,2.6
6048,0,Europe,R&D,Data Science,Below,Male,40,17,0,8,2.9,2.4,2.7,1,1,1,1,2.4,3.1,3.3
6049,0,Asia Pacific,R&D,Data Science,Meets,Female,36,3,1,9,,3.3,4.5,1,1,1,1,3.8,3.8,2.8
6050,1,Europe,HR,IT & Digital,Exceeds,Female,45,9,0,9,2.8,2.1,3.2,1,1,1,1,3,2.6,2.8
6051,0,Middle East & Africa,Manufacturing,Sales,Meets,Male,40,7,1,7,,4.5,2.4,1,0,0,0,3,4.2,1
6052,0,North America,HR,Data Science,Meets,Female,39,5,1,10,,2.7,2.2,0,0,0,0,3.1,2.5,1.9
6053,0,Europe,Manufacturing,Quality Assurance,Exceeds,Male,38,6,0,11,2.4,3.1,2,1,1,1,1,2.7,4,3.3
6054,0,Middle East & Africa,Manufacturing,Sales,Meets,Female,44,16,0,7,1.8,3.4,3,1,1,1,1,4.2,3,2.4
6055,0,Latin America,HR,IT & Digital,Meets,Male,48,5,1,5,,3.2,4.7,1,1,1,1,3.3,2.1,3.9
6056,0,Asia Pacific,Manufacturing,Legal & Compliance,Meets,Female,44,4,1,5,,2.7,2.7,1,1,1,1,4.9,2,1.5
6057,0,Europe,Finance,IT & Digital,Meets,Female,38,16,0,6,3,1.8,1.7,1,1,1,1,2.2,2.6,1
6058,0,North America,Commercial,Legal & Compliance,Meets,Female,46,14,0,6,3.5,3.5,2,1,1,1,1,2.6,2.3,1
6059,0,Latin America,Manufacturing,Supply Chain,Meets,Female,36,9,1,8,,2.9,2.2,1,1,1,1,2.1,4.7,2.6
6060,0,Middle East & Africa,Finance,Human Resources,Meets,Female,33,2,0,5,3.3,3,3.5,1,1,1,1,3.2,2.7,3.1
6061,0,Asia Pacific,Manufacturing,Quality Assurance,Meets,Male,43,10,0,10,1.7,3.2,3.2,1,1,1,1,1.3,2.3,2.3
6062,0,North America,Finance,Sales,Below,Male,47,4,1,5,,4.1,2.8,1,1,1,1,2.6,3.7,2.7
6063,0,Middle East & Africa,HR,Quality Assurance,Meets,Male,38,6,0,8,4.3,1,3.6,1,1,1,1,4.5,3.1,2.8
6064,0,Middle East & Africa,R&D,IT & Digital,Meets,Female,48,9,0,9,3,2.3,3.7,1,1,1,1,2.8,3.3,1.9
6065,0,Europe,Digital,Communications,Exceeds,Male,29,16,0,7,3.7,3.8,2.4,1,1,1,1,4.8,3.3,1.9
6066,0,Europe,Manufacturing,Data Science,Meets,Non-Binary/Other,37,19,0,11,4.9,3.6,2.4,1,1,1,1,3.2,3.1,1
6067,0,North America,Digital,Communications,Meets,Female,33,7,1,10,,2.7,3.7,1,1,1,1,3.6,3.5,3.3
6068,0,Middle East & Africa,Manufacturing,Legal & Compliance,Meets,Male,33,9,1,8,,2.8,3.7,1,1,1,1,3,4.5,2.7
6069,0,Europe,HR,IT & Digital,Meets,Male,38,6,0,8,2.3,1.7,2.5,1,1,1,1,3.1,2.4,1.5
6070,0,Asia Pacific,HR,Supply Chain,Meets,Female,48,10,0,6,2.6,3.3,1,0,0,0,0,3.3,3.3,1.9
6071,0,Asia Pacific,Finance,Quality Assurance,Exceeds,Male,46,8,1,12,,4.9,3.7,1,1,1,1,2.9,3.1,5
6072,0,Middle East & Africa,Manufacturing,Supply Chain,Meets,Male,46,7,0,6,2.9,3.1,2.5,1,1,1,1,4.1,3.8,2.9
6073,0,Europe,HR,Legal & Compliance,Exceeds,Male,41,11,0,8,3,3.9,1.5,1,1,1,0,3.4,1.7,2.7
6074,0,North America,HR,Regulatory Affairs,Below,Female,36,10,0,5,2.4,3.6,3.6,1,1,0,0,3.5,2.1,1.9
6075,0,North America,Manufacturing,Quality Assurance,Far Below,Female,40,7,0,10,2.8,2.7,3.8,1,0,0,0,2.1,3,2.3
6076,0,North America,Finance,Marketing,Meets,Male,30,8,0,7,2.9,2.5,3.4,1,1,1,1,3,2.4,3
6077,0,Asia Pacific,Finance,Market Access,Meets,Male,47,7,0,10,3.6,3.7,3.5,1,0,0,0,2,3.7,2.5
6078,0,Europe,Finance,Data Science,Meets,Male,28,14,0,9,3.3,2.4,3.7,1,1,1,0,3.3,2,3.2
6079,0,Europe,Finance,Medical Affairs,Meets,Male,37,6,1,5,,4.1,2.3,1,1,1,1,3.6,2.8,3.2
6080,0,Asia Pacific,R&D,Supply Chain,Below,Female,38,12,1,10,,3.5,3.8,1,1,0,0,5,3.7,3.2
6081,0,North America,Manufacturing,Data Science,Meets,Female,43,2,0,8,4.3,3.2,2.4,1,1,1,1,4.9,2.1,4.2
6082,0,North America,R&D,Clinical Operations,Exceeds,Female,41,16,1,5,,2.6,1.7,1,1,1,1,1.8,2.6,1.1
6083,0,Middle East & Africa,HR,Marketing,Below,Male,41,7,0,10,4.8,3.2,3.2,1,1,1,1,4.3,3.7,2.9
6084,0,Latin America,R&D,Data Science,Exceeds,Female,28,9,0,10,3.2,3.3,2,0,0,0,0,3.4,3.3,2.2
6085,0,Europe,Finance,Human Resources,Meets,Male,37,5,0,8,5,2.3,2.6,1,1,1,1,4.3,3.5,2.9
6086,0,Europe,HR,Communications,Meets,Female,34,6,0,10,3.7,3.3,1.6,1,1,1,1,4.1,1.3,2.3
6087,0,Europe,R&D,Market Access,Below,Female,39,8,0,5,3.6,4.2,2.1,1,1,1,0,4.2,4.3,1.6
6088,0,Latin America,R&D,Marketing,Meets,Male,37,6,1,8,,2.8,3.3,1,1,1,1,3.5,3.5,2
6089,0,Middle East & Africa,Manufacturing,Market Access,Below,Male,39,15,0,8,2.8,2.9,3.5,1,1,1,1,2.6,4.2,2.4
6090,0,Latin America,R&D,IT & Digital,Far Below,Female,31,4,1,8,,2.4,2.8,1,1,1,1,4.2,1.9,1.9
6091,0,North America,HR,Data Science,Far Exceeds,Male,39,4,0,10,3.3,3.8,2,1,1,1,1,2.5,3.5,2.9
6092,0,North America,Finance,Marketing,Meets,Female,48,18,0,7,4.2,2.2,3.5,0,0,0,0,4.2,4,3
6093,0,Europe,Manufacturing,Human Resources,Meets,Female,51,19,1,11,,1.3,4.1,1,1,1,1,2.5,3.8,2.9
6094,0,Asia Pacific,R&D,Medical Affairs,Below,Male,46,4,1,11,,2.8,1.7,1,1,1,1,3.4,1.7,3.9
6095,0,Europe,Manufacturing,Finance & Accounting,Exceeds,Female,28,9,0,6,1,2.6,2.4,1,1,1,1,2.5,2.9,2.3
6096,0,Asia Pacific,Digital,Medical Affairs,Meets,Female,36,7,1,5,,3.9,2.4,1,1,1,1,3.4,2.7,1.5
6097,0,Latin America,Manufacturing,Market Access,Exceeds,Female,35,5,0,12,3.5,3.8,1.7,1,1,1,1,2.8,2.7,3.7
6098,0,North America,Finance,Market Access,Far Below,Male,39,14,0,12,2,2.6,1.9,1,1,0,0,2.9,1.9,1.6
6099,0,Asia Pacific,Digital,Human Resources,Meets,Female,46,15,0,10,3.9,2.2,2.7,1,1,1,1,2.9,1.2,4.3
6100,0,Latin America,Digital,Regulatory Affairs,Far Exceeds,Male,38,6,0,11,3.1,1.9,3,1,1,1,1,2.3,2.8,1.9
6101,0,North America,Manufacturing,Legal & Compliance,Meets,Male,32,13,0,5,2.9,3.1,4.4,1,1,1,1,2.9,2,3.5
6102,0,Asia Pacific,HR,Medical Affairs,Exceeds,Male,45,36,0,11,2.9,2.7,1.9,1,1,1,1,3.6,2.3,2.3
6103,0,Europe,Finance,Human Resources,Meets,Female,40,11,1,12,,3.8,1.5,1,1,1,1,3.3,4.1,1.4
6104,0,Europe,HR,IT & Digital,Meets,Male,43,11,0,5,4.3,3.5,1,1,1,1,1,3.6,4.2,2.3
6105,0,Europe,Finance,Medical Affairs,Exceeds,Female,44,10,0,5,1.4,2.8,3.1,0,0,0,0,1.5,4.1,3.7
6106,0,Latin America,Finance,Human Resources,Meets,Female,36,3,0,8,3.6,3.2,3.5,1,1,1,1,5,2.3,2.7
6107,0,Europe,HR,Supply Chain,Meets,Female,31,5,1,12,,5,2.3,1,1,1,1,3.5,4.1,3.3
6108,0,Middle East & Africa,Commercial,Sales,Meets,Female,39,4,0,11,3.4,2.4,2.7,1,1,1,1,2.9,2.1,2.1
6109,0,North America,Digital,Quality Assurance,Below,Female,36,7,0,9,3.3,2.5,1.8,1,1,1,1,3.1,1.9,3.5
6110,0,Latin America,Manufacturing,Supply Chain,Meets,Female,38,8,1,12,,1.8,2.4,1,0,0,0,4.1,3,1.4
6111,0,Europe,HR,Market Access,Meets,Female,47,7,1,7,,2.7,3,0,0,0,0,5,1.7,1.6
6112,1,North America,HR,Pharmacovigilance,Exceeds,Female,39,5,0,5,3.3,3.2,5,0,0,0,0,3.3,1.9,4.2
6113,0,Asia Pacific,Manufacturing,Quality Assurance,Meets,Male,49,24,0,11,2,3.5,1.6,0,0,0,0,2.8,3.2,1.9
6114,0,Europe,Digital,Communications,Meets,Female,40,14,0,11,3.3,2.5,1.5,1,1,1,1,2.3,4,1.2
6115,0,North America,Manufacturing,Pharmacovigilance,Exceeds,Female,36,8,0,8,2.5,3.3,1.6,1,1,1,1,3.2,3.6,1.3
6116,0,Middle East & Africa,Finance,Clinical Operations,Meets,Female,30,7,0,7,2.4,1,2.4,1,1,1,1,1.6,2.1,1.9
6117,0,Asia Pacific,Commercial,Market Access,Exceeds,Female,39,12,0,7,3.1,1.8,4.2,1,1,1,1,2.5,3.6,3.4
6118,0,Middle East & Africa,Finance,Finance & Accounting,Far Exceeds,Female,33,1,0,10,3.2,3.5,2.5,1,1,1,1,1.8,3.1,2.2
6119,0,North America,Commercial,IT & Digital,Far Below,Non-Binary/Other,41,20,0,5,2.7,3.6,3,1,1,1,1,3.8,1,2.8
6120,0,Middle East & Africa,Manufacturing,Data Science,Below,Male,37,15,0,7,4.5,4.6,1.2,1,1,1,1,4.8,2.5,1.3
6121,0,North America,Finance,Sales,Below,Male,37,30,0,9,3.2,2.5,1.4,1,1,1,1,3.4,2.5,2.4
6122,0,North America,Digital,Pharmacovigilance,Meets,Male,39,3,1,7,,2.9,2.4,1,1,1,1,4.2,2.7,3
6123,0,Middle East & Africa,Finance,Quality Assurance,Below,Non-Binary/Other,39,6,0,12,2.8,2.8,5,1,1,1,1,3.3,3.3,4
6124,0,North America,HR,Legal & Compliance,Meets,Male,38,17,0,6,4.7,3.6,1.1,1,1,1,1,3.8,4.9,1
6125,0,Europe,Commercial,Market Access,Meets,Female,51,13,1,12,,2.4,3.9,1,1,1,1,4.1,4.3,3.9
6126,0,North America,Commercial,Supply Chain,Exceeds,Male,33,7,1,7,,3.4,2.4,1,1,1,1,5,2.8,2.2
6127,0,Latin America,Digital,Regulatory Affairs,Exceeds,Male,44,19,0,12,4.6,4,1.3,1,1,1,1,4.9,3.1,2
6128,0,North America,Commercial,Communications,Far Exceeds,Female,46,15,0,6,3.2,4,1.4,1,1,1,1,4.6,4.1,2
6129,0,Latin America,Commercial,Human Resources,Meets,Female,31,6,1,8,,4.7,4.3,1,1,1,1,4.2,4.6,5
6130,0,North America,Digital,Marketing,Meets,Male,38,15,0,8,3.5,1.8,2.3,1,1,1,1,4.6,1,1.6
6131,0,North America,Finance,Medical Affairs,Far Below,Male,40,8,1,11,,3.5,2.7,1,1,1,1,4.3,2.8,2.6
6132,0,Middle East & Africa,Manufacturing,Sales,Meets,Male,39,6,0,12,2.7,2.2,3.9,1,1,1,0,3.7,3.2,3.4
6133,0,Europe,Finance,Legal & Compliance,Meets,Female,39,14,0,5,2.9,1.5,2.8,1,1,1,1,4.5,2.8,3.3
6134,0,Europe,HR,Sales,Far Exceeds,Male,42,4,0,7,4.3,1.5,3.6,1,1,1,1,4,1.8,3.8
6135,0,Asia Pacific,HR,Finance & Accounting,Exceeds,Female,28,8,1,5,,3.7,2.6,1,1,1,1,1.6,3.8,1
6136,0,Middle East & Africa,Commercial,Medical Affairs,Below,Male,37,7,1,12,,2.6,2.1,1,0,0,0,5,2.3,2.9
6137,0,Middle East & Africa,HR,Medical Affairs,Meets,Female,35,16,0,10,2.4,2.3,2.1,1,1,1,1,2.8,2.6,3.8
6138,0,Europe,Manufacturing,Communications,Below,Male,34,2,0,12,4,4.1,3.9,1,1,1,1,3.6,3.1,2.5
6139,0,Middle East & Africa,Commercial,Medical Affairs,Below,Male,43,9,0,9,4.6,2.7,3.1,0,0,0,0,2.8,4.3,2.4
6140,1,Europe,HR,Human Resources,Exceeds,Male,44,7,0,11,2.7,3.3,2.8,1,1,1,1,3.8,3.6,3.2
6141,0,Middle East & Africa,R&D,Regulatory Affairs,Far Exceeds,Female,45,10,0,7,3.9,1.5,1,1,1,1,1,4.5,2.1,1
6142,0,North America,R&D,Clinical Operations,Below,Female,43,14,0,7,3.2,3.4,3.5,1,1,1,1,4.2,5,2.5
6143,0,Europe,R&D,IT & Digital,Exceeds,Female,31,13,1,11,,3.2,4.9,1,1,1,1,3.4,2.9,4.2
6144,0,Europe,R&D,Regulatory Affairs,Exceeds,Female,39,10,0,8,3.5,3.7,3.2,1,1,1,1,3.4,3.4,2.8
6145,0,Latin America,Finance,Supply Chain,Below,Female,45,13,0,6,2.9,2.6,2.3,1,1,1,1,2.6,2.4,4.7
6146,0,Middle East & Africa,R&D,IT & Digital,Meets,Female,28,4,0,9,3.9,3.5,3.3,1,1,1,1,4,3.6,1.6
6147,0,Middle East & Africa,Commercial,Clinical Operations,Meets,Female,48,4,1,6,,2.3,4,1,1,1,1,3.5,1.6,2.9
6148,1,Europe,Digital,Marketing,Exceeds,Female,30,17,0,10,4.7,3.2,1.2,1,1,1,1,4.4,2.9,3.6
6149,0,North America,Finance,Medical Affairs,Meets,Female,33,14,1,11,,4.7,1.6,1,1,1,1,4.9,5,3.2
6150,0,North America,Digital,Regulatory Affairs,Below,Male,43,3,1,6,,2.2,2.1,1,1,1,1,3.5,1.5,2.7
6151,0,North America,Commercial,Communications,Meets,Male,50,8,0,6,3.8,2.7,3.1,1,1,1,1,3.7,3.8,1
6152,0,Middle East & Africa,Commercial,Communications,Meets,Female,32,9,1,12,,3.4,1.8,1,1,1,1,4.4,4.4,3
6153,0,Latin America,Manufacturing,Data Science,Meets,Female,33,11,1,12,,2.7,2.8,1,1,1,1,3.8,3.7,4.9
6154,0,Europe,Finance,Supply Chain,Below,Male,46,8,0,6,3,3.2,1,1,1,1,1,2.2,1.8,3.1
6155,0,Asia Pacific,Digital,Marketing,Exceeds,Male,39,9,1,9,,2.5,2.7,1,1,1,1,3.5,3.5,2.6
6156,0,Latin America,R&D,Communications,Meets,Male,37,8,0,8,2.1,3.1,3.6,1,1,1,1,3.5,3,3.7
6157,0,Asia Pacific,Commercial,Communications,Exceeds,Non-Binary/Other,39,22,0,9,2.8,2.7,2.9,1,1,1,1,1.2,3.2,2.1
6158,0,Latin America,R&D,Marketing,Exceeds,Male,51,8,0,6,1.6,3.5,4,1,1,1,0,2.5,4.1,3.8
6159,0,North America,Digital,Quality Assurance,Exceeds,Female,43,11,0,9,3.8,2.2,2.6,1,1,0,0,4.6,3.1,3.2
6160,0,Middle East & Africa,Finance,Quality Assurance,Far Exceeds,Non-Binary/Other,40,3,1,7,,2.4,3.3,1,1,1,1,3.2,4.3,2.1
6161,0,Asia Pacific,HR,Marketing,Far Exceeds,Male,41,2,0,6,3.1,1.9,2.7,1,1,1,1,3.4,2.7,3.6
6162,0,Latin America,HR,Clinical Operations,Meets,Female,40,10,0,11,2.7,3.6,4.5,1,1,1,1,3.2,2.4,3.9
6163,0,Middle East & Africa,Commercial,Market Access,Meets,Female,43,4,1,5,,4.4,2.5,1,1,1,1,4.5,4.4,2.1
6164,0,Asia Pacific,Manufacturing,Finance & Accounting,Meets,Male,34,18,0,9,4.1,4,1,1,1,1,1,5,2.1,1
6165,0,Europe,R&D,Supply Chain,Meets,Male,38,10,1,9,,4.1,1.7,1,1,1,1,2.6,4.2,2.3
6166,0,Latin America,Commercial,Quality Assurance,Far Below,Male,38,14,0,7,2.6,3.3,3.5,0,0,0,0,2.6,3.1,2.6
6167,0,Europe,Manufacturing,Sales,Meets,Male,32,10,0,6,1,3.4,3.6,1,1,1,1,1.8,3,2.4
6168,0,North America,R&D,Finance & Accounting,Below,Female,31,16,0,11,3.2,2.9,2.3,1,1,1,1,3.1,2.9,3.2
6169,0,Europe,Digital,Human Resources,Meets,Male,46,9,0,7,3.6,3.2,1.3,1,1,1,1,4,2.3,2.5
6170,0,Europe,HR,Medical Affairs,Below,Female,42,11,0,5,2.7,3.2,3.1,1,1,1,1,3.2,3.9,4.6
6171,0,Latin America,Manufacturing,Supply Chain,Exceeds,Male,49,8,0,10,3.9,2.1,2.1,1,1,1,1,3.4,3.2,2.5
6172,0,North America,R&D,IT & Digital,Meets,Non-Binary/Other,41,8,0,8,3.3,3.2,2.9,1,1,1,1,4.9,2.4,2.4
6173,0,Europe,Commercial,IT & Digital,Below,Male,40,18,0,8,4.3,1.1,2.6,1,1,1,1,4,2.6,1.5
6174,0,Middle East & Africa,R&D,Human Resources,Meets,Female,37,10,0,11,3.9,2.2,2.6,1,1,1,1,4,2.8,2.9
6175,0,Asia Pacific,Commercial,Finance & Accounting,Below,Male,44,20,0,10,3.3,4.2,3.3,1,1,1,0,2.4,2.8,4.5
6176,0,Europe,HR,Marketing,Exceeds,Male,30,11,0,6,3.2,2.9,1,1,1,1,1,4.2,2.8,3.3
6177,0,North America,HR,IT & Digital,Meets,Male,40,20,0,5,1.7,4.1,3,1,0,0,0,2.4,3.8,2.2
6178,0,Europe,R&D,Marketing,Meets,Male,44,14,0,9,1.9,3.2,2.7,1,1,1,1,1,2.8,4
6179,0,Asia Pacific,R&D,Legal & Compliance,Exceeds,Male,37,3,1,6,,1.1,3.6,1,0,0,0,3,1.1,3.6
6180,0,North America,Commercial,Data Science,Meets,Female,41,16,0,11,3.6,4.2,2.6,0,0,0,0,2.3,5,2.1
6181,0,Latin America,Commercial,Human Resources,Exceeds,Male,48,8,0,6,3.8,3.1,3.1,1,1,1,1,3.8,3.8,4.2
6182,1,North America,Manufacturing,Market Access,Meets,Female,37,16,0,6,2.9,3.2,2.9,1,1,1,1,4.2,1.1,3.3
6183,0,Latin America,Manufacturing,Communications,Meets,Female,41,11,1,12,,1.8,2.1,1,1,1,1,1.9,3.4,2.5
6184,0,North America,Manufacturing,Medical Affairs,Meets,Female,44,12,0,10,4.7,3.6,2.4,1,1,1,1,3.4,2.7,2.8
6185,0,Asia Pacific,R&D,Sales,Below,Female,36,14,0,5,3.9,4.1,3.6,1,1,1,1,4.1,3.4,3
6186,0,Asia Pacific,Finance,Pharmacovigilance,Below,Female,32,21,1,10,,4.2,1.8,1,1,1,1,3.4,5,1.8
6187,0,North America,Finance,Quality Assurance,Meets,Male,42,9,1,8,,3.3,3,1,1,1,1,3.3,2.6,3
6188,0,Europe,Finance,Data Science,Exceeds,Male,39,16,0,5,2.2,4.8,2.3,1,1,1,1,5,3.7,2.8
6189,0,Asia Pacific,Finance,Marketing,Meets,Female,38,4,0,9,2.5,2.7,2.7,1,1,1,1,2.3,4.7,2.6
6190,0,Latin America,Manufacturing,Market Access,Below,Female,39,28,0,11,4.6,1.8,2.9,1,1,1,1,2.3,2.8,2.8
6191,1,Latin America,R&D,Clinical Operations,Meets,Male,31,16,0,8,3.2,4.2,1.5,1,1,1,1,3.6,2.8,4
6192,0,Middle East & Africa,Finance,Data Science,Exceeds,Female,37,3,0,7,4.3,3.4,4.2,1,1,1,1,2.5,2.9,4.6
6193,0,Latin America,HR,Market Access,Below,Male,42,4,0,10,1.4,1,3.1,1,1,1,1,2.4,1.6,4
6194,0,Middle East & Africa,Digital,Legal & Compliance,Meets,Male,38,14,0,8,2.6,4.6,2.6,1,1,1,0,2.6,3.6,2.5
6195,0,North America,HR,IT & Digital,Meets,Female,35,4,0,8,2.4,2.7,2.2,1,1,1,1,2.2,2,3.2
6196,0,North America,R&D,Supply Chain,Meets,Male,34,21,0,6,3.1,4.5,4.1,1,1,1,1,4.5,5,4.5
6197,0,North America,R&D,Supply Chain,Meets,Male,40,8,0,12,4.1,3.1,5,1,1,1,1,3.1,2.4,3.8
6198,0,Europe,Digital,Regulatory Affairs,Exceeds,Male,43,19,0,10,4.4,2.6,1.8,1,1,1,1,2.5,2.7,3.1
6199,0,Europe,Commercial,Data Science,Meets,Male,44,12,0,11,2.9,3,2.7,1,1,1,1,3.6,2.5,3.9
6200,0,Middle East & Africa,Commercial,Communications,Meets,Male,35,8,1,10,,3.5,2.9,1,1,1,1,3.7,3.8,3.3
6201,0,Latin America,Commercial,Supply Chain,Meets,Male,48,14,0,7,3.3,3.7,2.6,1,1,1,1,2.8,3.7,2.6
6202,0,Latin America,Manufacturing,IT & Digital,Meets,Male,39,7,1,12,,2.6,3.2,1,1,1,1,3.6,3.9,3
6203,0,North America,Commercial,Marketing,Below,Male,28,16,0,12,3.9,2.1,2.1,1,1,1,1,4.1,3,3.5
6204,0,Asia Pacific,Manufacturing,Finance & Accounting,Exceeds,Male,39,14,0,12,2.8,3.1,3.1,1,1,1,1,1.9,2.4,4.1
6205,0,Europe,Manufacturing,Supply Chain,Below,Male,32,12,0,7,3.4,2.4,2,1,1,1,1,5,2.7,4.2
6206,0,Europe,Commercial,Market Access,Exceeds,Male,40,10,0,9,2.4,1.9,2.2,1,1,1,1,3.9,3.7,1.7
6207,0,North America,Commercial,Pharmacovigilance,Meets,Female,40,19,0,7,2,2.9,2,1,0,0,0,3.3,3.9,2.4
6208,1,Europe,Digital,Quality Assurance,Meets,Female,29,18,1,11,,2.6,2.9,1,1,1,1,4.4,2.2,2.8
6209,0,North America,Finance,Marketing,Below,Female,47,17,0,6,2.6,2.4,3.9,1,1,1,0,3.8,1.2,3.8
6210,0,Middle East & Africa,Digital,IT & Digital,Meets,Female,34,21,1,12,,2.2,1.8,1,1,1,1,3.8,4.1,1.7
6211,0,Latin America,Manufacturing,Legal & Compliance,Meets,Male,28,18,0,9,4.4,4.2,2.3,1,1,1,0,3.9,2.8,2.8
6212,0,Asia Pacific,Digital,Medical Affairs,Exceeds,Non-Binary/Other,46,24,0,9,2.4,1.7,1.9,1,1,1,1,2,1.9,1
6213,1,Latin America,Manufacturing,Legal & Compliance,Meets,Male,42,9,0,5,3.2,3.5,5,1,1,1,1,3.8,4.2,3.2
6214,1,Latin America,R&D,Finance & Accounting,Meets,Male,36,13,1,10,,3.5,3.4,1,1,1,1,3.2,2.6,3.2
6215,0,Middle East & Africa,Manufacturing,Market Access,Far Below,Male,38,26,0,10,3.6,3.8,1.4,1,1,1,1,1.8,3.2,2
6216,0,Europe,Manufacturing,Pharmacovigilance,Exceeds,Female,37,17,0,6,3.2,3.5,3.3,1,1,1,1,3.9,2.8,3.6
6217,0,Asia Pacific,Digital,Supply Chain,Exceeds,Female,28,8,1,11,,2.4,4.6,1,1,1,1,3.2,1.8,3.9
6218,0,Europe,Finance,Sales,Meets,Female,30,12,1,8,,3.8,1.5,1,1,1,1,3.2,2.9,1.7
6219,0,Latin America,R&D,Regulatory Affairs,Far Below,Male,44,16,0,7,3.8,1.6,3.5,1,0,0,0,3.7,2.5,3
6220,1,North America,HR,Pharmacovigilance,Meets,Female,40,16,0,9,3.2,4.3,2.2,1,1,1,1,4.5,3.7,1.4
6221,0,Latin America,HR,Legal & Compliance,Meets,Male,43,10,0,12,4.6,3.8,2.1,1,1,1,1,4.9,3.7,3.6
6222,0,Europe,Finance,Supply Chain,Meets,Female,45,24,0,5,4,1,2.7,1,1,1,1,3.3,2.6,4.2
6223,0,Latin America,HR,Pharmacovigilance,Meets,Female,28,21,0,12,4.3,3.2,3.5,0,0,0,0,4.9,3,3.3
6224,0,North America,R&D,Human Resources,Exceeds,Female,36,8,0,10,3.7,2.9,1.7,1,1,1,1,3.8,1.5,3
6225,0,Middle East & Africa,Commercial,Pharmacovigilance,Below,Male,31,8,0,10,3.4,3.5,3.7,1,0,0,0,3.9,3.6,2.6
6226,0,Europe,R&D,Market Access,Meets,Female,37,9,1,10,,2.1,3.4,1,1,1,0,4.1,3.1,2.4
6227,0,Latin America,Digital,Sales,Far Below,Male,28,14,0,11,4,2,3.1,1,1,1,1,3.1,2.7,1.6
6228,0,Europe,Manufacturing,Supply Chain,Below,Male,42,17,0,5,2.8,3.5,3.5,1,1,1,1,1.7,3,2.4
6229,0,Middle East & Africa,Manufacturing,Sales,Exceeds,Female,42,21,1,7,,4.1,2.9,1,1,1,1,2.2,4.1,2.2
6230,0,Latin America,Digital,Communications,Meets,Male,52,16,0,12,2.9,2.6,4.3,1,1,1,1,3.4,3.2,3.3
6231,0,Latin America,Digital,Data Science,Exceeds,Male,37,28,0,12,4.6,2.6,1.3,1,1,1,1,3.6,2.1,2.8
6232,0,Europe,Manufacturing,Market Access,Meets,Female,42,9,0,11,4.5,2.9,2,1,1,1,1,4.6,1.9,1.9
6233,1,Europe,Finance,Quality Assurance,Exceeds,Female,44,21,0,11,3.8,2.2,2.2,1,1,1,1,2.6,3.5,2.4
6234,0,North America,Commercial,Quality Assurance,Meets,Male,48,11,0,9,5,1,2.5,1,0,0,0,4,3.5,2.1
6235,0,Middle East & Africa,Commercial,Pharmacovigilance,Far Below,Male,31,2,1,11,,2.8,1.5,1,1,1,1,3.8,5,2.7
6236,0,North America,Commercial,Human Resources,Exceeds,Female,43,15,0,7,3.8,4.6,2.5,1,1,1,1,3.8,4.4,2.3
6237,0,Latin America,Digital,Legal & Compliance,Below,Male,40,10,0,9,2.5,1.7,3,1,1,1,1,1.9,2.8,4.6
6238,0,Europe,Manufacturing,IT & Digital,Meets,Female,28,9,0,8,2.4,1,2.6,1,0,0,0,2.9,2.4,3.4
6239,0,Latin America,Finance,Marketing,Meets,Female,41,6,0,11,2.3,4.7,1.8,1,1,1,1,3,3,2.1
6240,0,Latin America,Manufacturing,Regulatory Affairs,Far Below,Female,42,3,1,10,,4.5,2.3,1,1,1,1,2.4,3.9,3.2
6241,0,Asia Pacific,Manufacturing,Data Science,Below,Male,28,18,1,9,,3.1,2.3,1,1,1,1,3.3,5,3.4
6242,0,Asia Pacific,Finance,Finance & Accounting,Meets,Male,38,8,1,10,,3.7,2.9,1,1,1,1,3.4,4.3,2.8
6243,0,Latin America,R&D,Human Resources,Meets,Female,38,4,0,5,4.4,3.1,3.4,1,1,1,1,3.9,4,2.6
6244,0,Europe,Finance,IT & Digital,Meets,Female,38,10,0,11,3.3,1.3,1.2,0,0,0,0,2.8,2,2.4
6245,0,Latin America,R&D,Market Access,Meets,Female,42,15,0,9,3.3,3.7,2.8,1,1,1,1,3.3,3.7,3.1
6246,0,Asia Pacific,HR,Human Resources,Meets,Male,34,4,1,5,,3.9,1.6,1,1,1,1,4.5,3.4,2.2
6247,0,Europe,R&D,Communications,Meets,Male,31,2,0,12,4.2,3.4,2.8,1,1,1,1,4.1,3.2,2.5
6248,0,Latin America,Commercial,Marketing,Exceeds,Male,41,14,0,9,3.3,1.5,5,1,1,1,1,2.6,1.4,2.9
6249,0,Middle East & Africa,Commercial,Clinical Operations,Below,Female,47,4,1,6,,1,1.9,1,1,1,0,3.8,1,4.2
6250,0,Middle East & Africa,Finance,Legal & Compliance,Meets,Female,47,17,1,7,,2.1,2.1,1,1,1,1,3.7,2.6,2.1
6251,0,Latin America,Commercial,Regulatory Affairs,Meets,Male,52,3,0,7,3.1,1.5,3,1,1,0,0,2.1,1,4.9
6252,0,Europe,Commercial,Quality Assurance,Meets,Female,36,5,0,6,4.8,1.9,3.7,1,1,1,1,4.9,1.9,4.2
6253,1,Latin America,HR,Human Resources,Meets,Female,37,12,1,12,,2.9,3.4,1,1,1,1,4.1,3.8,2.5
6254,0,Latin America,Commercial,Quality Assurance,Meets,Female,28,21,1,11,,5,4.1,1,1,1,1,2.8,5,3.2
6255,0,Asia Pacific,Digital,Marketing,Below,Male,34,5,0,12,2,2.8,1.6,1,1,1,1,3.4,4.3,1.4
6256,0,Middle East & Africa,Digital,Data Science,Meets,Female,29,13,0,10,3.1,2.2,2.3,1,1,0,0,2.3,2.5,1.5
6257,0,Asia Pacific,Digital,Legal & Compliance,Below,Male,36,14,0,8,3.6,3.2,2.4,1,1,1,1,5,3.4,2.8
6258,0,Asia Pacific,R&D,Regulatory Affairs,Below,Female,46,11,1,10,,3.1,3.1,1,1,1,1,3.7,4.1,4.1
6259,1,Latin America,Finance,Finance & Accounting,Far Exceeds,Female,44,18,1,12,,4.3,1.9,1,1,1,1,5,3.5,3.9
6260,0,Asia Pacific,Finance,Marketing,Meets,Female,36,7,0,8,2.7,1.3,3.7,1,1,1,1,3.7,3.2,3.5
6261,0,Middle East & Africa,Manufacturing,Clinical Operations,Meets,Male,35,17,0,5,3.1,1.9,2.7,1,0,0,0,2.9,3.4,3.9
6262,0,Asia Pacific,HR,Legal & Compliance,Meets,Female,33,6,0,10,4,4,2.7,1,1,1,1,4.4,3.7,2.1
6263,0,Middle East & Africa,Digital,Market Access,Exceeds,Male,43,17,1,9,,4.4,1.8,1,1,1,1,3.1,3.4,2.7
6264,0,Asia Pacific,Digital,Marketing,Meets,Female,36,19,0,7,2.5,3.7,3.7,1,1,1,1,3.4,2.9,2.5
6265,0,Middle East & Africa,Commercial,Pharmacovigilance,Meets,Male,40,6,0,7,2.7,3,3,1,1,1,1,3.3,2.6,3.3
6266,0,Asia Pacific,Digital,Supply Chain,Meets,Male,42,3,0,8,4.6,5,1.4,1,1,1,1,3.9,4.3,3.4
6267,0,Asia Pacific,Commercial,Pharmacovigilance,Exceeds,Male,42,7,1,5,,4.2,2.9,1,1,1,1,2.9,2.9,2.4
6268,0,Europe,Commercial,Regulatory Affairs,Exceeds,Male,28,7,0,7,2.4,3.7,2.9,1,1,1,1,3.8,1.9,2.5
6269,0,Middle East & Africa,Manufacturing,Human Resources,Meets,Male,41,7,0,7,3.6,4.4,3.7,1,1,1,1,3.7,3.9,2.8
6270,0,Middle East & Africa,R&D,Legal & Compliance,Exceeds,Male,39,22,0,7,3.5,2.7,2.8,1,1,1,1,3.4,2.6,1.7
6271,0,Middle East & Africa,Commercial,Sales,Meets,Male,28,5,0,7,1.8,3.6,3.2,1,1,1,1,4.1,5,3.8
6272,0,North America,Commercial,Pharmacovigilance,Far Exceeds,Male,46,5,0,9,3.9,2,2.4,1,1,1,1,3.2,1.1,1.2
6273,0,Asia Pacific,Finance,Supply Chain,Exceeds,Female,39,18,0,9,3.1,4.3,1.6,0,0,0,0,4.6,4,1.8
6274,0,Middle East & Africa,Manufacturing,Pharmacovigilance,Meets,Male,29,12,0,10,4.7,3.3,2.3,1,1,1,1,4.1,4,1.1
6275,0,North America,Commercial,Legal & Compliance,Meets,Female,35,14,0,11,2.8,3.1,3.8,1,1,1,1,3.6,3.4,2.6
6276,0,Europe,HR,Human Resources,Meets,Female,37,25,0,11,3.5,4.5,3.8,1,1,1,1,3.2,4.2,3.2
6277,0,Middle East & Africa,R&D,Marketing,Meets,Male,54,1,0,10,4,3,1.6,0,0,0,0,3,3.5,2.9
6278,0,Middle East & Africa,HR,Communications,Below,Male,33,8,1,7,,3.5,1.1,1,1,1,1,2.6,4,1.9
6279,0,North America,Digital,Supply Chain,Far Below,Male,34,17,1,7,,2.8,2.1,0,0,0,0,4.5,2.6,3
6280,0,Asia Pacific,R&D,Market Access,Far Below,Female,39,28,0,11,2.4,2.9,1.3,0,0,0,0,4.5,4,1.6
6281,0,Europe,Digital,Sales,Far Exceeds,Female,51,7,0,8,3.7,2.3,5,1,1,1,1,2.9,3.4,2.3
6282,0,Middle East & Africa,Finance,Marketing,Below,Male,37,9,0,7,3.2,4.1,3.2,1,1,1,1,3.3,3.5,3.7
6283,0,Asia Pacific,Commercial,Clinical Operations,Far Below,Male,35,26,0,10,4.3,3.9,3.6,1,1,1,1,4,4.2,2.4
6284,0,Europe,Manufacturing,Clinical Operations,Meets,Female,39,11,0,8,3.6,3.9,3.7,1,1,1,1,3.7,4.1,4
6285,0,Latin America,HR,Regulatory Affairs,Meets,Male,36,2,0,11,3.8,1.6,2.1,1,1,1,1,3.2,3.3,2.5
6286,0,Latin America,Digital,Human Resources,Exceeds,Female,36,10,0,12,2.5,2.8,1,1,1,1,1,3.4,3.7,2.7
6287,0,Europe,Commercial,Legal & Compliance,Meets,Male,44,3,1,11,,2.1,3.7,0,0,0,0,3.5,2.9,3.6
6288,0,North America,HR,Medical Affairs,Meets,Male,35,7,0,6,4.3,2.2,2.2,1,1,1,1,4,3.6,2
6289,0,Europe,HR,Human Resources,Exceeds,Male,36,9,1,12,,3.1,3.9,1,1,1,1,4.3,4.8,3.6
6290,0,Europe,Finance,Pharmacovigilance,Far Below,Female,44,29,0,9,3.1,3.9,1,1,1,1,1,2.8,5,1.3
6291,0,North America,Finance,Supply Chain,Far Exceeds,Male,29,25,0,12,3.5,3,2.1,1,1,1,1,3.5,4.5,3.8
6292,0,North America,Digital,Marketing,Below,Male,36,30,0,12,2.5,1.5,2.5,1,1,1,1,4.3,2.2,2.5
6293,0,Asia Pacific,Commercial,Communications,Meets,Male,28,7,1,11,,3.9,3,1,1,1,1,1.3,4.1,2.4
6294,0,Asia Pacific,Manufacturing,Clinical Operations,Far Below,Male,35,9,0,6,1,3.2,2.3,1,1,1,1,3.2,2.4,3.4
6295,0,North America,Digital,Sales,Exceeds,Female,36,14,0,5,2.2,1.8,2.9,1,1,1,1,2.6,3.2,2.6
6296,0,Latin America,HR,Human Resources,Below,Male,36,21,0,11,3,2.8,2.3,1,1,1,1,3.3,3.8,1.5
6297,0,Latin America,HR,IT & Digital,Below,Female,36,14,0,7,4.5,3,4.7,1,1,1,1,4,2,4.1
6298,0,Europe,R&D,Finance & Accounting,Exceeds,Male,40,10,0,10,3.3,3.7,3.3,1,1,1,1,3.9,4.3,3
6299,0,Middle East & Africa,Commercial,Medical Affairs,Below,Female,31,11,0,9,3.8,3.7,4.6,1,1,1,1,2.8,3.5,3.2
6300,0,Europe,R&D,Sales,Meets,Female,40,13,0,11,3.2,4.1,3.1,1,1,1,1,3.8,2.7,4.4
6301,0,Europe,Finance,Human Resources,Meets,Female,35,18,0,6,2.7,2.4,3.3,0,0,0,0,3.5,4.4,3.4
6302,0,Middle East & Africa,Manufacturing,Pharmacovigilance,Meets,Female,43,4,1,8,,3.2,1.7,1,1,1,1,4.3,5,1.9
6303,0,North America,Digital,IT & Digital,Meets,Male,38,5,0,6,2.7,3.2,3.3,0,0,0,0,3.6,3.2,3.3
6304,0,Latin America,HR,Data Science,Exceeds,Non-Binary/Other,34,19,0,5,2.4,4.8,2.5,1,1,1,1,1.7,1.5,2.4
6305,0,Europe,Commercial,Medical Affairs,Exceeds,Male,30,4,0,12,3.9,2.7,4.8,1,1,1,1,4.4,2.4,4.2
6306,0,Middle East & Africa,HR,Quality Assurance,Meets,Male,40,15,0,10,3.1,3.3,2.5,1,0,0,0,5,1.3,2.2
6307,0,Asia Pacific,Finance,Data Science,Meets,Male,37,6,0,10,2.5,3.7,4.2,1,1,1,1,2.7,4.5,3.6
6308,0,Europe,R&D,Finance & Accounting,Meets,Male,47,14,0,12,3.5,2.6,1,1,1,1,1,3.7,2.7,2.1
6309,0,Latin America,R&D,Data Science,Meets,Female,47,8,0,11,4.1,2.9,2.6,1,1,1,1,4.3,2.4,2.1
6310,0,North America,Digital,Finance & Accounting,Meets,Male,35,7,0,9,2.6,3.1,2.7,1,1,1,1,1.7,3,2.6
6311,0,Europe,Commercial,Pharmacovigilance,Exceeds,Female,28,17,1,10,,2.1,2.9,1,1,1,1,2.7,2.3,4.9
6312,0,Europe,Finance,Sales,Meets,Male,43,11,0,12,3.4,2,2.7,1,1,1,1,4.2,2.8,4
6313,0,Middle East & Africa,Commercial,Market Access,Meets,Female,35,10,0,7,4.1,3.5,4.4,0,0,0,0,2.6,2.6,4.2
6314,0,Asia Pacific,Digital,Clinical Operations,Meets,Female,36,3,0,8,4.4,3,3.4,1,1,1,1,4.4,3.4,4
6315,0,Asia Pacific,Finance,Supply Chain,Meets,Female,45,9,0,5,2.2,3,2.8,1,1,0,0,3,3.7,3.6
6316,0,North America,Finance,Supply Chain,Meets,Male,40,10,0,6,2,3.8,3.4,1,1,1,1,4.4,1,3.9
6317,0,Latin America,R&D,Communications,Meets,Non-Binary/Other,43,8,0,10,2.7,1.4,2,1,1,1,1,3.2,1.7,1.6
6318,0,North America,R&D,Marketing,Meets,Female,44,17,0,12,3,3.7,2.4,1,1,1,1,2.6,3,2.5
6319,0,Europe,R&D,Marketing,Far Below,Non-Binary/Other,37,10,0,6,3.5,3.4,2.6,1,1,1,1,3.9,4.4,4.1
6320,1,Europe,HR,Data Science,Meets,Female,42,23,0,11,3.6,1.8,3.2,1,1,1,1,3.2,2.8,3
6321,0,Asia Pacific,Manufacturing,Data Science,Meets,Female,39,9,0,12,5,3.6,1,1,1,1,1,4.8,1.7,1.9
6322,0,Latin America,R&D,Market Access,Below,Female,41,13,0,8,1.5,3.6,3.1,1,1,1,1,3.2,4.7,3.1
6323,0,Middle East & Africa,Manufacturing,Human Resources,Meets,Female,39,8,0,7,3.5,3.4,2.1,1,1,1,1,3.2,3.2,3.4
6324,0,Latin America,Manufacturing,Pharmacovigilance,Meets,Female,46,15,0,11,4.1,3.7,3.6,1,1,1,1,4.2,3.8,4.5
6325,0,Europe,Commercial,Clinical Operations,Exceeds,Female,30,8,0,8,2.4,2.4,3.6,0,0,0,0,3.6,4.1,3.4
6326,0,Middle East & Africa,Digital,Supply Chain,Meets,Female,35,7,1,8,,2.5,2.7,1,1,1,1,2.9,1.8,1
6327,0,Latin America,HR,Finance & Accounting,Meets,Non-Binary/Other,37,7,0,12,4.3,4,1,0,0,0,0,3.5,4.1,2.4
6328,0,Latin America,Manufacturing,IT & Digital,Exceeds,Male,39,10,0,11,2,1,2.5,1,1,1,1,1.8,1.4,2.7
6329,0,Middle East & Africa,HR,Human Resources,Meets,Female,30,10,0,12,3.7,3.1,1.4,1,1,1,1,4.3,3.6,2.1
6330,0,Europe,Commercial,Market Access,Exceeds,Male,34,8,1,7,,3.2,2.6,1,1,1,1,3.3,2.8,3.3
6331,0,Latin America,R&D,Supply Chain,Meets,Male,38,17,0,7,1.5,1.5,2.9,1,1,1,1,2.1,3.3,2.8
6332,0,Middle East & Africa,Finance,Quality Assurance,Exceeds,Male,35,3,0,8,2.8,2.7,2.6,0,0,0,0,2.4,2.4,3.5
6333,0,Europe,Manufacturing,Marketing,Meets,Male,28,8,0,12,4.7,3.1,2.4,1,1,1,1,3.9,2.1,3.8
6334,0,Middle East & Africa,Digital,Quality Assurance,Below,Non-Binary/Other,36,9,1,6,,2.5,2.7,1,1,1,1,3.8,3.5,4.2
6335,0,Middle East & Africa,Finance,Clinical Operations,Meets,Male,31,25,0,12,3.5,3.4,2.4,1,1,1,0,3.3,4.7,2.5
6336,0,Latin America,Commercial,Clinical Operations,Meets,Female,42,14,0,10,4.1,3.3,4.1,1,1,1,1,1.8,3.6,3.8
6337,0,Europe,HR,Pharmacovigilance,Meets,Male,40,9,1,5,,3.1,3.6,1,1,1,1,2.7,4.3,4.2
6338,1,Latin America,R&D,IT & Digital,Meets,Female,43,5,1,8,,2.2,2,1,1,1,1,4,1.9,3.4
6339,0,North America,HR,Medical Affairs,Far Below,Female,39,8,1,6,,1,1.2,1,1,1,1,3.3,1.1,1.7
6340,0,North America,Digital,Data Science,Meets,Male,32,12,0,9,3.5,4.3,4.2,1,1,1,1,2.7,3.1,3.2
6341,0,Europe,Manufacturing,Marketing,Meets,Male,28,11,0,9,2.9,1,3.1,1,1,1,1,3.5,2.1,2.2
6342,0,Middle East & Africa,Digital,Market Access,Below,Male,45,12,1,6,,1.5,1.8,1,1,1,1,3,1.6,1
6343,0,Latin America,HR,IT & Digital,Meets,Male,35,23,0,9,3.7,2,1,0,0,0,0,3.1,1.8,2
6344,0,Latin America,HR,Finance & Accounting,Far Below,Male,28,9,0,9,2.6,3.3,2.5,1,1,1,0,3.9,3.5,1.8
6345,0,Europe,Finance,IT & Digital,Meets,Non-Binary/Other,47,2,0,5,3.5,2.8,2.7,1,1,1,1,2.3,2.9,1.9
6346,0,Europe,Digital,Pharmacovigilance,Exceeds,Female,41,5,0,10,3.3,3.6,3.1,1,1,0,0,2.8,3.6,4.8
6347,0,North America,Digital,Market Access,Meets,Male,47,4,0,7,2.7,4.6,3.7,1,1,1,1,3,4.2,3.9
6348,0,Asia Pacific,Digital,Human Resources,Far Below,Non-Binary/Other,41,25,0,12,2.6,3.2,2.5,1,1,1,1,3.2,3.1,2
6349,0,Europe,R&D,Medical Affairs,Meets,Male,42,4,0,11,5,1.9,2,1,1,1,1,4.1,1.7,2.8
6350,1,Asia Pacific,HR,Pharmacovigilance,Meets,Male,35,19,0,11,4.7,3.8,3.5,1,1,1,1,3.7,5,2.6
6351,0,Europe,Commercial,Communications,Meets,Female,42,26,0,11,3.3,4,2.3,0,0,0,0,3.3,5,2.6
6352,0,Middle East & Africa,R&D,Sales,Meets,Male,50,10,0,5,4.1,2.5,3.2,1,1,1,0,5,3,3.5
6353,0,Middle East & Africa,R&D,Finance & Accounting,Exceeds,Male,43,8,0,11,3.8,3.3,2.3,1,1,1,1,4,4.8,2.7
6354,0,North America,R&D,Supply Chain,Exceeds,Male,36,11,1,9,,2.6,3.1,1,0,0,0,3.8,2.3,2.3
6355,0,North America,Finance,Data Science,Below,Female,30,2,1,11,,3.3,1.9,1,1,1,1,1.8,2.3,2.4
6356,0,Asia Pacific,Commercial,Data Science,Below,Female,45,10,0,11,4,2.6,3.3,1,1,1,1,3.5,2.4,3.2
6357,0,Europe,Digital,IT & Digital,Meets,Female,38,5,0,12,4.2,3.2,3.5,1,1,1,1,4.5,2.5,2.4
6358,0,Latin America,Finance,Data Science,Meets,Female,39,13,0,12,4.1,2.8,3.4,1,1,1,1,3.7,2.6,2.8
6359,0,North America,HR,Quality Assurance,Meets,Female,28,10,0,5,1.7,4.9,2.7,1,1,1,1,2.8,3.4,2.3
6360,1,Latin America,Manufacturing,Legal & Compliance,Meets,Male,28,6,1,5,,1.3,2.9,1,1,1,1,5,2,3.3
6361,0,Latin America,Finance,Marketing,Below,Female,39,5,0,7,4.9,2.7,2.6,0,0,0,0,4.1,3.8,2.7
6362,0,Europe,Manufacturing,Pharmacovigilance,Exceeds,Female,33,16,1,12,,4.8,2.4,1,1,1,1,2.9,4.3,1.7
6363,0,Asia Pacific,HR,Pharmacovigilance,Meets,Male,39,10,0,11,2.4,4.5,1.1,1,1,1,1,1.9,3.2,1.5
6364,0,Europe,Commercial,Quality Assurance,Far Exceeds,Male,44,9,1,7,,3,1,0,0,0,0,2.6,2.2,1
6365,0,North America,Manufacturing,Clinical Operations,Meets,Non-Binary/Other,35,8,0,5,3.4,1.9,2.4,1,1,1,1,5,1.5,3.4
6366,1,Latin America,R&D,Marketing,Meets,Male,39,36,0,8,1.5,3.3,1.9,0,0,0,0,2.9,2.3,2.6
6367,0,Europe,Finance,Medical Affairs,Below,Female,37,6,0,12,3.6,2.8,1.3,1,1,1,1,2,3,1
6368,0,Europe,Manufacturing,Medical Affairs,Meets,Male,55,8,0,12,3.3,3.5,2.6,0,0,0,0,2.7,3.1,3.2
6369,0,Europe,HR,Data Science,Below,Female,35,6,0,9,2.7,3.4,4.6,1,1,1,1,2.1,3,3.9
6370,0,North America,R&D,IT & Digital,Meets,Male,34,15,0,12,4.4,3.2,1.6,1,1,1,1,4.1,4,3.2
6371,0,Asia Pacific,Manufacturing,Pharmacovigilance,Below,Female,35,20,0,12,3.1,2.8,4.3,1,1,1,1,4.3,4.6,3.8
6372,0,Europe,HR,Regulatory Affairs,Below,Female,45,11,1,8,,2.8,2.1,1,1,1,1,1.7,1.9,1.9
6373,0,North America,Commercial,Clinical Operations,Below,Male,35,6,0,12,4.3,3.9,3.4,1,1,1,1,3.4,4,3.4
6374,0,Latin America,HR,Legal & Compliance,Below,Male,42,8,1,12,,2,1.5,0,0,0,0,4,3.8,1.7
6375,0,Middle East & Africa,Commercial,Communications,Meets,Male,38,2,0,5,2.9,3.8,4,1,1,1,1,3.6,3.2,3.5
6376,0,North America,R&D,Market Access,Far Exceeds,Female,38,27,0,5,2.1,3.1,2.5,1,1,1,1,3.5,3.7,5
6377,0,Middle East & Africa,HR,Data Science,Meets,Female,48,1,1,11,,2.3,3.9,1,1,1,1,3.6,1.5,4.4
6378,0,Europe,Digital,Finance & Accounting,Meets,Female,28,10,0,5,2.5,4.3,2.7,0,0,0,0,4.4,3.6,4
6379,0,Europe,Finance,Communications,Below,Male,39,17,0,12,3.9,1.5,2,1,1,1,1,3.5,1,1.8
6380,0,North America,Digital,Medical Affairs,Meets,Female,42,7,1,12,,2.8,1.1,1,1,1,1,3.4,2.7,2.9
6381,0,Middle East & Africa,Digital,Medical Affairs,Below,Non-Binary/Other,40,6,1,5,,4.1,3.7,1,1,1,1,3.2,4.9,3.1
6382,0,Europe,Digital,Marketing,Below,Female,29,17,0,5,4.3,2.9,2.8,1,1,1,1,4.4,2.4,3.9
6383,0,Latin America,Finance,Clinical Operations,Below,Male,31,11,0,12,3.2,3.4,2.5,1,1,1,1,3.8,4.2,3.9
6384,0,Asia Pacific,Digital,Clinical Operations,Meets,Female,40,27,0,6,4,3.7,1.3,1,1,1,1,3.8,1.9,1
6385,0,Asia Pacific,Commercial,Regulatory Affairs,Below,Female,28,6,0,6,4.2,4.3,2.9,1,1,1,1,4,3.2,2.4
6386,0,Europe,HR,Medical Affairs,Exceeds,Female,35,7,1,7,,1,2.9,1,1,1,1,4,1.6,2
6387,0,Middle East & Africa,R&D,Supply Chain,Meets,Male,31,12,1,11,,3.9,1.4,1,1,1,1,2.6,3,2.8
6388,0,Europe,Digital,Marketing,Exceeds,Male,39,5,1,11,,3.3,3.8,1,1,1,1,5,2.2,2.6
6389,1,Middle East & Africa,Digital,Communications,Far Exceeds,Female,37,7,1,8,,3.7,1.6,1,0,0,0,3.8,3.9,2.7
6390,0,Latin America,R&D,Human Resources,Meets,Male,40,6,0,8,4.2,3.8,2.3,1,1,1,1,4.1,2.4,2.3
6391,0,Middle East & Africa,R&D,Pharmacovigilance,Exceeds,Male,33,24,0,11,3.8,1.1,1,1,1,1,1,2.4,1.5,3.6
6392,0,Europe,Digital,Supply Chain,Below,Female,40,6,0,11,4.2,4.1,2.6,1,1,1,1,4.6,4,2.7
6393,0,Latin America,Commercial,IT & Digital,Exceeds,Female,38,13,0,6,3.9,3.2,2,1,1,1,1,3,2.8,2.7
6394,0,North America,R&D,Sales,Meets,Non-Binary/Other,33,3,1,12,,3,3.8,1,1,1,1,3.5,2.3,3.6
6395,0,Asia Pacific,HR,Marketing,Meets,Male,45,11,1,10,,2.6,1.9,1,1,1,1,3.9,4.2,1.7
6396,0,Europe,HR,Market Access,Meets,Female,42,7,1,12,,2,2.3,1,1,1,1,3.2,2.2,1.8
6397,0,Europe,Commercial,Pharmacovigilance,Exceeds,Male,34,16,0,7,3.1,3.1,4.2,1,1,1,1,3.7,4.4,3.5
6398,0,Europe,Finance,Clinical Operations,Exceeds,Male,33,20,0,6,2.9,3.3,3.1,1,1,1,1,2.9,2.9,2.7
6399,0,Latin America,Manufacturing,Human Resources,Below,Male,44,10,1,11,,3.1,2.3,1,1,1,1,3.7,3.8,4
6400,0,North America,Commercial,Pharmacovigilance,Meets,Female,28,15,0,9,4.1,4.4,1.3,1,1,1,1,5,4.4,3.2
6401,0,Middle East & Africa,Digital,Marketing,Meets,Female,30,5,0,11,3.2,3.4,2.7,1,1,1,1,3.7,1.5,4
6402,0,North America,Manufacturing,IT & Digital,Meets,Male,41,18,0,7,3.5,2.8,2,1,1,1,1,2.7,3.4,2.2
6403,0,Latin America,Digital,Medical Affairs,Far Below,Male,49,3,0,5,1.6,3.7,2.4,1,1,1,1,1.2,4,3.8
6404,0,Europe,HR,IT & Digital,Meets,Female,34,16,0,9,3.5,2.6,2.7,1,1,1,1,2.9,2.3,4
6405,0,Asia Pacific,R&D,Sales,Exceeds,Male,35,13,0,5,3.5,1,4.6,1,1,1,1,3.5,2.8,2.5
6406,0,Europe,Digital,Finance & Accounting,Meets,Male,37,23,0,8,3.5,3.9,1.9,1,1,1,1,2.1,4.8,2.1
6407,0,Middle East & Africa,HR,Clinical Operations,Meets,Female,35,7,0,12,1.8,1.5,2.8,1,1,1,1,3.7,1.9,3.5
6408,0,Asia Pacific,Commercial,Supply Chain,Meets,Male,35,4,1,11,,4.6,1.6,1,1,1,1,2.5,3.8,2.2
6409,0,Europe,Digital,Finance & Accounting,Meets,Male,34,9,0,7,2,2.5,3.7,1,1,1,1,3.4,3.1,3.1
6410,0,Asia Pacific,HR,Communications,Exceeds,Female,39,7,0,8,2.8,1.8,2.4,1,1,1,1,3.5,2.7,1.8
6411,0,North America,R&D,Communications,Meets,Male,42,9,0,9,3.2,3,1.5,1,1,1,1,1.9,3.8,2
6412,0,Latin America,Digital,Finance & Accounting,Meets,Female,39,13,0,11,3.4,3.2,2.3,1,1,1,1,3.1,3.6,3.6
6413,0,Europe,Finance,Quality Assurance,Exceeds,Female,37,7,1,6,,4.5,3.7,1,1,1,1,2.9,2.9,3.5
6414,0,Middle East & Africa,HR,Human Resources,Far Below,Male,34,9,0,8,3.1,3.9,1.3,1,1,1,1,4.6,2.6,2.6
6415,0,North America,Digital,Sales,Exceeds,Female,31,13,0,6,3.1,3.6,3.7,1,1,1,1,2.8,3.5,5
6416,0,Europe,R&D,Regulatory Affairs,Meets,Male,30,11,0,12,2.2,2.6,1.9,0,0,0,0,4.2,3.5,2.6
6417,0,North America,Digital,Quality Assurance,Exceeds,Female,29,10,0,7,2.7,4.5,2.9,1,1,1,1,4.2,2.7,3.6
6418,0,Middle East & Africa,Digital,Market Access,Meets,Female,42,9,0,6,4,5,4,1,1,1,1,3.6,4,3.9
6419,0,Europe,Finance,Supply Chain,Meets,Female,35,17,0,5,4.4,2.5,3,1,1,1,1,4.3,3,3.9
6420,0,Middle East & Africa,HR,Market Access,Exceeds,Non-Binary/Other,40,9,0,6,3.2,2.4,2.9,1,1,1,1,3,3.1,3.4
6421,0,Asia Pacific,Manufacturing,Pharmacovigilance,Meets,Female,34,3,0,8,3.7,4.4,2.5,1,1,1,1,2.3,3.8,1.9
6422,0,Middle East & Africa,Digital,Medical Affairs,Meets,Female,38,19,0,7,3,3.3,1.3,1,1,1,1,4,2.2,2.5
6423,0,Asia Pacific,Manufacturing,Human Resources,Meets,Male,36,4,1,7,,3.9,2.9,1,1,1,1,3.1,3.4,3.3
6424,0,Europe,Commercial,Pharmacovigilance,Meets,Female,47,13,0,7,2.8,4.8,3,1,1,1,1,3,3.9,2.1
6425,0,Asia Pacific,Digital,Medical Affairs,Meets,Male,35,16,0,9,5,4.9,2.5,1,1,1,1,5,3.6,2.6
6426,0,Europe,Manufacturing,Data Science,Meets,Female,43,12,0,8,2.5,3.8,1,1,1,1,1,3,3.5,1.6
6427,0,Europe,Commercial,Communications,Meets,Male,30,7,1,8,,4,2.5,1,1,1,1,4.8,4.1,2.1
6428,0,Latin America,Finance,Human Resources,Exceeds,Male,46,20,1,8,,3.5,2.1,1,1,1,1,2.8,2.2,1.5
6429,0,Europe,HR,Data Science,Meets,Male,43,4,0,7,5,4.8,1.2,1,1,1,1,4.3,4.5,3.2
6430,0,Asia Pacific,Digital,Market Access,Far Below,Male,34,6,1,7,,3.7,2.6,0,0,0,0,4.7,4,3
6431,0,Latin America,HR,Regulatory Affairs,Far Below,Male,34,36,0,12,3.5,3.3,1.7,0,0,0,0,3,4.9,2.6
6432,0,Latin America,Commercial,Market Access,Meets,Male,45,14,1,9,,4.2,2.6,1,1,1,1,4.6,5,2.9
6433,0,Europe,HR,Data Science,Meets,Male,44,7,1,12,,1.5,2.4,1,1,0,0,3.6,3.8,3.7
6434,0,Middle East & Africa,HR,Legal & Compliance,Meets,Male,37,6,0,11,4,2.2,2.1,1,1,1,1,3.7,3.1,2.3
6435,0,Middle East & Africa,R&D,Quality Assurance,Meets,Male,33,15,1,6,,2.8,1.4,1,1,1,1,4.8,4,2.7
6436,0,Latin America,Commercial,Human Resources,Meets,Female,44,16,1,12,,1.6,4.2,1,1,1,1,4,2.9,5
6437,0,Europe,HR,Quality Assurance,Far Exceeds,Female,35,19,0,5,3.3,2,3.7,1,1,1,1,3.4,3.8,3
6438,0,Middle East & Africa,Manufacturing,Regulatory Affairs,Exceeds,Female,40,4,0,5,3.4,3,1.8,0,0,0,0,3.3,3.4,2.8
6439,0,Europe,Commercial,Human Resources,Far Below,Male,35,7,1,6,,2.1,2.8,1,1,1,1,3.7,1.9,3.1
6440,0,Europe,R&D,Regulatory Affairs,Exceeds,Male,37,23,0,7,3,2.9,3.1,1,1,1,1,3.7,3.6,3.5
6441,0,Latin America,Digital,Regulatory Affairs,Meets,Male,49,2,0,6,2.9,3,3.2,1,1,1,1,2.8,2,1.8
6442,0,Latin America,Finance,Market Access,Meets,Female,38,36,0,11,4.1,4.2,3,1,1,1,1,3.9,4,3.3
6443,0,North America,HR,Supply Chain,Meets,Male,47,5,0,11,2.3,2,2.9,0,0,0,0,3.8,4.6,2.7
6444,0,Middle East & Africa,Manufacturing,Communications,Exceeds,Female,29,20,1,6,,3.1,3.6,1,1,1,1,3.9,2.1,2.4
6445,0,Middle East & Africa,R&D,Marketing,Far Exceeds,Male,28,15,0,9,3.6,3,1,1,1,1,1,3.1,3.3,3.7
6446,1,Middle East & Africa,Commercial,IT & Digital,Meets,Male,41,9,0,9,2.1,3.8,2.4,1,1,1,1,3,3.3,4.1
6447,0,Asia Pacific,Finance,Human Resources,Below,Female,33,15,0,10,3.9,2,4.2,1,1,1,1,4.5,4.1,4.5
6448,0,Europe,Finance,Clinical Operations,Meets,Male,38,3,0,7,3.9,3.2,1.5,1,1,1,1,3.6,3.1,1.9
6449,0,Latin America,HR,Regulatory Affairs,Below,Male,28,15,1,8,,4.4,2.8,1,1,1,1,2.4,2.5,2.2
6450,0,Middle East & Africa,R&D,Legal & Compliance,Meets,Female,28,13,0,7,3.3,3.6,1.2,1,1,1,1,4.3,3,1.7
6451,0,North America,R&D,Clinical Operations,Exceeds,Male,38,20,0,9,2.5,3.4,2.7,1,1,1,1,3.3,4,2.6
6452,0,Middle East & Africa,Manufacturing,Communications,Meets,Female,35,11,1,9,,1.6,1.2,1,1,1,1,4.4,3.8,2.4
6453,0,Europe,Digital,IT & Digital,Below,Male,36,9,0,12,3.2,4,2.1,1,1,1,1,4,2.9,2.8
6454,0,Europe,Digital,Human Resources,Meets,Non-Binary/Other,48,13,0,7,3.3,3.4,2.1,0,0,0,0,2.2,3.2,3
6455,1,Latin America,Digital,Supply Chain,Meets,Female,41,12,0,6,3.5,2,3.5,1,1,1,1,5,2.8,3.8
6456,0,Asia Pacific,Finance,Marketing,Meets,Male,51,7,0,12,3.7,2.7,2.1,1,1,1,1,3.3,2.7,3.2
6457,0,Latin America,Finance,Regulatory Affairs,Meets,Female,38,10,0,9,3.7,3.5,2.8,1,1,1,1,2.7,3.1,2.8
6458,0,Middle East & Africa,Commercial,Regulatory Affairs,Far Exceeds,Male,47,16,0,12,3.4,3.2,2.4,1,1,1,1,5,3.7,4.7
6459,0,North America,Finance,Regulatory Affairs,Meets,Male,44,14,0,5,3,3,4.3,1,1,1,1,3.3,4.4,4.5
6460,0,Latin America,Finance,Quality Assurance,Meets,Female,35,4,0,8,3.6,4.5,1.2,1,1,1,1,4.5,4,2.5
6461,0,Asia Pacific,R&D,Legal & Compliance,Meets,Female,37,7,0,12,3.8,2,1,1,1,1,1,2.7,2.8,1
6462,0,Latin America,Commercial,Supply Chain,Below,Female,36,7,0,8,3.9,2.7,2.1,1,1,1,1,4.4,1.3,2.7
6463,0,Europe,R&D,Clinical Operations,Exceeds,Female,44,13,1,11,,2.6,4.4,1,1,1,1,1.8,4.1,2.2
6464,0,Middle East & Africa,Manufacturing,Medical Affairs,Meets,Female,40,13,0,5,3.5,3.7,1.8,0,0,0,0,3.5,4.2,1.2
6465,0,Middle East & Africa,Manufacturing,Human Resources,Far Exceeds,Non-Binary/Other,32,9,1,9,,3.1,3.7,1,1,1,1,4.7,1.8,4.4
6466,0,Middle East & Africa,Commercial,Medical Affairs,Far Exceeds,Female,30,7,1,11,,2.5,2.7,1,1,1,1,2.9,2.6,3.3
6467,0,Middle East & Africa,Commercial,Supply Chain,Meets,Female,30,11,0,5,2.1,2.9,3.3,1,1,1,1,3.2,1.5,4
6468,1,Middle East & Africa,Finance,Regulatory Affairs,Far Exceeds,Male,33,4,1,10,,3.4,4.4,1,1,1,1,2.7,4.3,4.1
6469,0,Middle East & Africa,Manufacturing,Medical Affairs,Far Exceeds,Female,32,24,0,9,3.6,3.3,3.4,1,0,0,0,3.6,2.7,3
6470,0,North America,HR,Clinical Operations,Meets,Female,31,10,0,7,5,2.5,4.2,1,1,1,1,3,2.6,3.4
6471,0,Asia Pacific,Digital,Finance & Accounting,Meets,Non-Binary/Other,45,19,0,12,4.3,1.1,4.7,1,1,1,1,3,1.4,3.5
6472,0,Middle East & Africa,Finance,Communications,Meets,Male,29,14,0,8,3.1,2.3,2.7,1,1,1,1,3.1,2.6,1.8
6473,0,Asia Pacific,Digital,Finance & Accounting,Meets,Female,40,15,0,5,3.4,3.5,2.6,1,1,1,1,3.6,1.4,3.4
6474,0,Middle East & Africa,Manufacturing,Human Resources,Meets,Non-Binary/Other,52,21,0,12,2.6,4.1,3.7,0,0,0,0,1.5,4.9,3.1
6475,0,Latin America,Digital,Human Resources,Far Below,Male,39,13,0,7,4.4,3.3,1.7,1,1,1,1,4.9,4.6,1.6
6476,0,Middle East & Africa,HR,Medical Affairs,Meets,Female,39,19,0,12,3.4,2.5,2.5,0,0,0,0,3.5,2.5,2
6477,1,Europe,HR,Human Resources,Far Exceeds,Non-Binary/Other,39,16,0,9,3,3.4,3.8,1,1,1,1,3.4,1.5,3.3
6478,1,North America,R&D,Communications,Meets,Female,29,9,0,11,2.9,4.1,4.4,1,1,1,1,4.8,2.8,3.4
6479,0,Latin America,Commercial,Legal & Compliance,Meets,Female,41,8,0,10,3.6,3.7,3.9,1,1,1,1,3.6,2.7,3.7
6480,1,Latin America,Digital,Clinical Operations,Meets,Male,40,12,1,7,,4.4,2.7,1,1,1,1,3.6,3.7,3.9
6481,0,Europe,HR,Regulatory Affairs,Meets,Female,38,10,1,8,,2.5,3.4,1,1,1,1,3,2.2,4.5
6482,1,Middle East & Africa,Commercial,Regulatory Affairs,Meets,Male,28,8,0,8,4.1,2.2,2.1,0,0,0,0,3.2,1.7,2.1
6483,0,North America,Commercial,IT & Digital,Below,Male,49,9,0,11,1.5,4.3,3.3,1,1,1,1,2,3.1,4.3
6484,0,Latin America,R&D,Market Access,Meets,Female,39,10,1,6,,3.8,1.5,1,1,1,1,3.1,3.4,1.4
6485,0,North America,Commercial,IT & Digital,Exceeds,Male,31,8,0,6,4.2,4.4,5,1,1,1,1,4,1.8,5
6486,0,Latin America,Commercial,Data Science,Meets,Female,32,19,0,5,4.3,3.5,4,1,1,1,1,3,4.3,4.2
6487,0,Middle East & Africa,Finance,Quality Assurance,Meets,Female,33,3,0,8,4.3,1.3,3.1,1,1,1,1,4,3.4,3.8
6488,0,Latin America,Manufacturing,Human Resources,Meets,Female,48,16,0,9,3.3,2.5,2.3,1,1,1,1,3.1,3.6,2.3
6489,0,Latin America,R&D,Marketing,Meets,Male,37,21,0,8,3.5,3,3.9,1,1,1,1,5,3.7,3.2
6490,0,Asia Pacific,R&D,Marketing,Exceeds,Male,37,34,0,12,4,2.3,1.2,1,1,1,1,4.1,1.3,2.2
6491,0,Middle East & Africa,Digital,Pharmacovigilance,Meets,Male,35,18,0,12,2.9,3.5,1.5,0,0,0,0,3,2.8,3.3
6492,0,Europe,Commercial,Quality Assurance,Meets,Male,44,6,0,10,3.1,2.6,1.6,1,1,1,1,4,2.6,1.1
6493,0,Europe,Digital,Regulatory Affairs,Below,Female,44,7,0,7,2.2,1.8,4.8,1,1,1,1,2.8,2.2,3.4
6494,0,Middle East & Africa,Finance,Communications,Meets,Female,29,18,0,11,2.5,4,1.4,1,1,1,1,2.7,4,3.4
6495,1,Europe,HR,Marketing,Meets,Female,37,14,0,11,3.6,3.6,1.5,1,1,1,1,2.9,3.4,2.3
6496,0,Middle East & Africa,Commercial,Clinical Operations,Meets,Female,37,9,0,8,3.2,2.5,4.3,0,0,0,0,2.9,3.4,3.9
6497,0,Europe,HR,Finance & Accounting,Meets,Female,32,8,1,12,,2.7,1.8,1,1,1,1,3.1,5,4.2
6498,0,Asia Pacific,Manufacturing,Legal & Compliance,Meets,Female,35,16,0,12,4.4,2.6,2.5,1,1,1,1,3.8,2.9,2.8
6499,0,Europe,Finance,Pharmacovigilance,Meets,Male,36,2,0,11,2.6,3.9,3.7,1,1,1,1,4.5,3.6,3.7
6500,0,Latin America,Commercial,Medical Affairs,Meets,Female,32,7,0,12,2.9,3.8,1.7,1,1,1,1,3.8,3.9,2.6
6501,1,Middle East & Africa,Digital,Medical Affairs,Far Exceeds,Male,40,9,1,7,,2.5,3.5,1,1,1,1,4.8,1.9,2.8
6502,0,North America,Digital,Pharmacovigilance,Far Exceeds,Female,40,21,0,9,3.2,2.8,2.5,1,1,1,1,3.7,4.4,3.3
6503,0,North America,Commercial,Data Science,Meets,Male,41,10,0,12,3.1,4.3,1,1,1,1,1,3.4,5,2.1
6504,0,Middle East & Africa,Digital,Sales,Meets,Female,35,4,0,10,2.3,3.5,2.5,0,0,0,0,3.2,2.7,4
6505,0,Asia Pacific,Commercial,Clinical Operations,Meets,Male,28,10,0,11,3.7,3.6,4.6,1,1,1,1,3.4,2.5,4.2
6506,0,Europe,R&D,Marketing,Below,Male,34,4,1,8,,4.6,1.2,1,1,1,1,3.3,2.8,2.3
6507,0,Asia Pacific,Digital,Data Science,Meets,Female,32,5,1,8,,3.4,4.8,1,0,0,0,4.8,3.5,4.2
6508,0,North America,Commercial,Clinical Operations,Meets,Male,37,18,0,10,3.4,2.8,2.8,1,1,1,1,2.9,3.7,2
6509,0,Middle East & Africa,Commercial,Market Access,Below,Male,41,5,0,8,4.9,2.8,2,1,1,1,1,3.6,2.5,2.3
6510,0,Middle East & Africa,Digital,Marketing,Meets,Male,49,8,0,6,4.2,2.7,2.4,1,1,1,1,3.8,3.6,2
6511,0,Asia Pacific,R&D,Legal & Compliance,Exceeds,Male,33,16,0,10,2.4,4,4.6,1,1,1,1,2.2,2.3,3.3
6512,0,Asia Pacific,Digital,IT & Digital,Exceeds,Female,39,15,1,6,,3.8,1.4,1,1,1,1,4.6,4,3.7
6513,0,Europe,Commercial,Market Access,Meets,Female,39,18,0,9,3,3.6,2.9,1,1,1,1,3.5,3.5,2.7
6514,0,Latin America,R&D,Regulatory Affairs,Meets,Female,47,9,0,11,2.8,3.3,2.2,1,1,1,1,4.2,1.5,2.6
6515,0,Latin America,HR,Quality Assurance,Below,Male,39,10,0,8,2.9,3.8,2.9,1,1,1,1,3.8,5,2.7
6516,0,Europe,Manufacturing,Legal & Compliance,Meets,Male,36,19,0,7,2.9,2,3.1,1,1,1,1,3.2,1.7,3
6517,0,Latin America,Digital,Finance & Accounting,Exceeds,Female,38,22,0,12,2.8,3.1,2.5,1,1,1,1,3.2,2.7,1.7
6518,1,North America,Finance,Communications,Exceeds,Male,40,8,0,7,3.7,2.9,3,1,1,1,1,4.6,3,3.4
6519,0,Latin America,Commercial,Human Resources,Meets,Male,42,12,0,9,3.8,1.8,2.4,1,1,1,1,3.2,2.3,4.1
6520,0,Europe,R&D,IT & Digital,Far Below,Female,48,12,0,5,3.2,3.8,2.3,0,0,0,0,2.2,3,3.6
6521,0,Latin America,R&D,Regulatory Affairs,Meets,Female,48,9,1,10,,3.2,2.8,1,1,1,1,2.7,4.5,2.8
6522,0,Middle East & Africa,HR,Medical Affairs,Meets,Male,33,15,0,11,3.4,3.4,2.7,1,1,1,1,2.3,2.5,2.9
6523,0,Asia Pacific,Digital,Legal & Compliance,Exceeds,Male,29,21,0,12,3.2,3.2,2.6,1,1,1,1,2.9,1.9,3
6524,0,North America,Finance,Data Science,Below,Female,31,18,0,11,1.9,2.3,3.4,1,1,1,1,1.3,3.3,3.6
6525,0,Middle East & Africa,R&D,Pharmacovigilance,Meets,Male,39,2,1,8,,1.9,3.6,1,1,1,1,3,1.5,3.8
6526,0,Middle East & Africa,HR,Regulatory Affairs,Below,Female,45,9,0,12,3.1,1.5,3.7,1,1,1,1,3.8,1,3
6527,0,Europe,Commercial,Data Science,Meets,Female,37,6,0,10,4.2,2.5,1.7,1,1,1,1,3.5,3.9,1.4
6528,0,Asia Pacific,HR,Supply Chain,Meets,Female,32,6,1,12,,3.3,2.7,1,1,1,1,3.9,3.2,2.9
6529,0,Asia Pacific,Digital,Medical Affairs,Meets,Male,29,3,0,7,3.4,4.5,1,1,0,0,0,3.4,3.8,1.7
6530,0,North America,HR,Marketing,Meets,Male,48,10,0,5,4,1.2,2.3,0,0,0,0,4.2,3.5,2.9
6531,0,Europe,R&D,Data Science,Meets,Female,35,3,1,11,,1.1,2.4,1,1,1,1,5,2.4,3.4
6532,0,North America,R&D,Clinical Operations,Below,Male,29,7,0,10,3.1,2.6,2.8,0,0,0,0,2.3,4.1,3.9
6533,0,Latin America,Manufacturing,Human Resources,Meets,Male,38,15,0,12,2.1,3.8,3,1,1,1,1,1.7,3.6,2.9
6534,1,Middle East & Africa,HR,Marketing,Far Exceeds,Male,38,15,1,10,,3.6,2.3,1,1,1,1,3.4,4.2,2.2
6535,0,North America,Commercial,Medical Affairs,Meets,Male,43,12,0,6,2.6,2.9,2.4,1,1,1,1,2,1.8,1.9
6536,0,Middle East & Africa,Finance,Regulatory Affairs,Below,Female,31,23,0,6,2.7,1.2,2,1,1,1,1,3.4,3.1,2.8
6537,0,Europe,Finance,Supply Chain,Meets,Female,45,28,0,6,2.5,1.6,1.3,0,0,0,0,2.2,2,2.2
6538,0,Latin America,Digital,Communications,Meets,Female,46,10,0,7,4.4,4.2,3.1,1,1,1,0,4.1,3.8,1
6539,0,Europe,Manufacturing,Market Access,Meets,Female,39,36,0,9,2.9,3.4,3.5,1,1,1,1,3.1,3.4,2.9
6540,0,Latin America,HR,Finance & Accounting,Meets,Male,42,21,0,11,3.4,4,1.3,0,0,0,0,4.7,4.6,1.7
6541,0,Latin America,Commercial,IT & Digital,Far Exceeds,Female,43,7,0,7,2.4,3.9,1.6,1,1,1,1,2.6,2.4,2.2
6542,0,Middle East & Africa,Manufacturing,Communications,Meets,Male,34,17,0,12,4.1,5,2.3,1,1,1,1,3.2,3.5,3.5
6543,0,Europe,R&D,Finance & Accounting,Far Below,Male,30,7,0,12,3.4,2.7,2.4,1,0,0,0,4,2.1,1
6544,0,Europe,Digital,Sales,Meets,Male,34,25,0,6,4.4,2.8,2.6,1,1,1,1,4.9,1.8,1.8
6545,0,North America,HR,Marketing,Exceeds,Female,28,18,0,5,2.6,3.4,3.8,1,0,0,0,4.3,5,3.1
6546,0,Europe,Finance,Marketing,Exceeds,Male,41,16,1,11,,4.2,1.7,1,1,1,1,3.9,3.6,1.9
6547,0,North America,Commercial,Legal & Compliance,Meets,Non-Binary/Other,48,7,0,10,2.8,1.5,4,1,1,1,1,3.9,2.6,3.6
6548,0,Asia Pacific,R&D,Pharmacovigilance,Meets,Non-Binary/Other,33,5,1,9,,2.6,1.1,1,1,1,1,3.5,1.8,3
6549,0,Asia Pacific,Manufacturing,IT & Digital,Exceeds,Male,35,4,1,8,,3,2.5,1,0,0,0,3.9,4.6,1.7
6550,0,Asia Pacific,Digital,Regulatory Affairs,Meets,Male,36,14,0,9,3.4,3.2,2.5,1,1,1,0,4.6,2.7,2.8
6551,0,Europe,Manufacturing,IT & Digital,Meets,Female,50,11,1,11,,3.8,4.1,1,1,1,1,4.4,3.2,4.5
6552,0,Europe,Finance,Marketing,Below,Female,35,6,1,12,,4.4,2.1,1,1,1,1,2.4,3.2,1.5
6553,0,North America,Manufacturing,Pharmacovigilance,Meets,Female,45,18,0,5,3.3,3.9,2.4,1,1,1,0,3.2,5,2.6
6554,0,Latin America,Commercial,IT & Digital,Below,Male,38,15,0,11,3,3.2,4.3,1,0,0,0,3.9,3.7,4.4
6555,0,North America,R&D,Medical Affairs,Below,Male,28,11,0,12,4.3,3.3,3.3,1,1,0,0,4.3,3.8,2.4
6556,0,Asia Pacific,HR,Finance & Accounting,Meets,Male,35,15,0,7,4.3,3.2,2.1,1,1,1,1,5,1.8,1.9
6557,0,North America,Commercial,IT & Digital,Meets,Male,43,15,0,6,3.7,4.9,3.9,1,1,1,1,3.9,3.6,3.2
6558,0,Latin America,Finance,Finance & Accounting,Meets,Male,35,10,0,10,3.8,3.9,2.1,0,0,0,0,4.1,4.8,3.3
6559,0,Europe,Digital,Finance & Accounting,Meets,Female,41,8,0,9,2.8,2.1,1.7,0,0,0,0,1.9,2.4,3.5
6560,0,North America,Finance,Human Resources,Far Below,Male,48,15,0,11,3.6,3,3.7,1,1,1,1,3.2,3.2,2.6
6561,0,Asia Pacific,Finance,Marketing,Below,Female,41,15,0,9,4,2.4,2,1,0,0,0,4.4,1.8,3.6
6562,0,Asia Pacific,Manufacturing,Supply Chain,Below,Male,34,7,0,6,3.1,4.2,2.2,1,1,1,1,2.9,2.9,2.6
6563,0,Europe,Digital,Clinical Operations,Meets,Male,42,24,0,9,4,1.5,3.5,1,1,1,1,4.2,3.3,4.4
6564,0,North America,Commercial,Sales,Meets,Male,41,14,0,5,3.1,2.6,3.7,1,1,1,1,2.6,2.6,4.4
6565,0,Latin America,Finance,Medical Affairs,Meets,Male,44,8,1,6,,2.7,1.6,1,1,1,1,3.3,4.4,1
6566,0,Europe,Commercial,Finance & Accounting,Meets,Female,37,8,1,10,,2.7,3.7,1,1,1,1,5,3.1,3.1
6567,0,North America,HR,Finance & Accounting,Meets,Male,33,6,1,5,,2.3,1.9,1,1,1,1,2.4,2.5,4.1
6568,0,Middle East & Africa,Manufacturing,Finance & Accounting,Meets,Female,41,12,0,11,2.9,2.8,1.2,0,0,0,0,3,2.1,2.8
6569,0,Asia Pacific,Commercial,Market Access,Exceeds,Non-Binary/Other,41,6,1,11,,4.1,2.6,1,1,1,1,5,4.1,1.9
6570,0,Latin America,Digital,Communications,Meets,Female,35,10,0,9,2,3.4,2.1,1,1,1,1,2,4.8,1.1
6571,0,Latin America,Finance,Communications,Exceeds,Female,29,14,0,5,4.2,3.5,3,1,1,1,1,4.7,3.4,1.8
6572,0,Latin America,HR,Regulatory Affairs,Meets,Female,35,9,0,6,2.7,4,3.4,1,1,1,1,4,3.8,3.6
6573,0,Asia Pacific,Digital,Regulatory Affairs,Exceeds,Male,31,12,0,12,2.5,3.8,2.7,1,1,1,1,4.1,3.4,3.2
6574,0,North America,Manufacturing,Regulatory Affairs,Meets,Female,36,13,0,7,2.9,1.4,2,1,1,1,1,3.8,2.9,1.2
6575,0,Europe,HR,Supply Chain,Meets,Female,43,8,0,7,2,3.1,3,1,1,1,1,1.8,3.8,3.2
6576,0,North America,HR,Human Resources,Meets,Male,28,16,0,9,2.6,3.1,2,0,0,0,0,4.8,3.2,1.5
6577,1,Europe,HR,Finance & Accounting,Exceeds,Female,40,16,0,10,4.3,1.8,3.2,1,1,1,1,5,1.5,3.8
6578,0,Latin America,Finance,Human Resources,Meets,Female,40,13,1,11,,4.5,4,1,1,1,0,5,4.8,2.6
6579,0,North America,R&D,Medical Affairs,Exceeds,Non-Binary/Other,32,18,0,12,2.5,2,3.2,1,1,1,1,1,2.2,2.6
6580,1,Latin America,HR,Communications,Meets,Male,40,4,0,6,3.1,2.6,1.7,0,0,0,0,3.2,4.1,3.4
6581,0,Middle East & Africa,Digital,Marketing,Meets,Male,45,8,0,10,3.6,2.9,3.9,1,1,1,1,4.6,2.1,3.6
6582,0,Latin America,Digital,Supply Chain,Exceeds,Male,41,8,0,5,3.9,3.9,1,1,1,0,0,3.3,4.9,3.3
6583,0,Latin America,Manufacturing,Pharmacovigilance,Far Exceeds,Female,50,28,0,8,4.5,2.8,1.3,0,0,0,0,4.2,2.8,2
6584,0,Europe,Commercial,Human Resources,Meets,Male,38,10,0,9,3,2.3,2.5,1,1,1,1,3.1,2.4,2.7
6585,0,Middle East & Africa,Commercial,Regulatory Affairs,Meets,Male,44,4,0,7,3.3,4.5,2.9,1,1,1,1,5,3.1,3.9
6586,0,Latin America,R&D,Market Access,Meets,Male,50,20,0,12,2.2,3.4,2.9,1,1,1,1,2.5,3.5,3.3
6587,1,Latin America,Finance,IT & Digital,Meets,Male,41,3,0,6,2.9,1.8,4.2,1,1,1,1,5,1.7,3.7
6588,0,Middle East & Africa,Finance,Finance & Accounting,Below,Male,49,3,0,12,2.9,3.2,2.5,1,1,1,1,3.9,4.3,3.1
6589,0,Middle East & Africa,HR,Pharmacovigilance,Below,Female,41,29,0,12,2.7,3.8,2.8,1,1,1,1,3.5,3,3.3
6590,0,North America,R&D,Human Resources,Meets,Female,47,9,0,7,3.7,3.4,1.6,1,1,1,1,3,4,1.9
6591,0,Europe,Manufacturing,Sales,Exceeds,Male,31,15,0,9,5,3.7,3.4,1,1,1,1,3.1,2.1,3.2
6592,0,Middle East & Africa,Manufacturing,Finance & Accounting,Far Below,Female,38,24,1,6,,3.4,1.3,0,0,0,0,2.2,4.9,2.9
6593,0,Middle East & Africa,Commercial,Marketing,Meets,Female,53,12,1,12,,2.5,1,1,1,1,1,2.8,3.2,2.4
6594,0,Asia Pacific,Manufacturing,Marketing,Meets,Male,28,27,0,12,3.2,1.6,2.7,1,1,1,1,3.6,2.9,2.6
6595,0,Middle East & Africa,HR,Human Resources,Exceeds,Female,33,15,0,7,4.6,4.3,3.3,1,1,1,1,4.1,4,4
6596,0,Europe,Digital,Data Science,Below,Male,51,9,1,12,,3,4.2,1,1,1,1,2.8,4.6,3.7
6597,0,Latin America,Manufacturing,Human Resources,Meets,Female,37,18,0,6,3.4,3.4,2.2,1,1,1,1,3.8,4,3
6598,1,Latin America,R&D,Human Resources,Far Exceeds,Female,37,2,0,11,3.3,2.9,3.7,1,1,1,1,4.1,3.2,3.7
6599,0,Latin America,HR,Market Access,Meets,Female,43,8,0,7,4.1,2.8,2.5,1,1,1,1,3,3.2,2.5
6600,0,Latin America,Manufacturing,Supply Chain,Meets,Male,46,7,0,10,4.2,4,3.8,1,1,1,1,4.9,2.2,2.1
6601,0,Asia Pacific,Finance,Communications,Exceeds,Female,36,10,0,6,2.9,3,2.8,1,1,1,1,2.3,4.3,3.8
6602,0,Middle East & Africa,Manufacturing,Finance & Accounting,Below,Female,28,11,0,10,2.8,3.8,3.9,1,1,1,1,2,3,3
6603,0,Latin America,Finance,Supply Chain,Far Exceeds,Female,32,8,1,12,,1.6,4,1,1,1,1,4.6,2.6,2.6
6604,0,North America,HR,Quality Assurance,Exceeds,Female,35,13,0,8,4.4,1.8,2.5,1,1,1,1,5,5,2.2
6605,0,Latin America,Manufacturing,Sales,Below,Female,31,4,1,5,,2.4,5,1,1,1,1,3.8,1,4.5
6606,0,Middle East & Africa,Finance,Regulatory Affairs,Meets,Male,33,17,0,11,3,1,3.9,1,1,1,1,4.1,3,2.5
6607,0,Latin America,Digital,Communications,Meets,Male,38,8,0,11,3.3,3.2,2.2,1,1,1,1,3.9,3.2,2.6
6608,0,Asia Pacific,Commercial,Finance & Accounting,Exceeds,Female,33,24,0,6,1.6,2,2,0,0,0,0,2.8,1.5,2.9
6609,0,Europe,HR,Data Science,Below,Female,49,4,0,5,2.8,2.8,3,1,1,1,1,3.9,2.8,3.4
6610,0,Europe,Finance,Pharmacovigilance,Meets,Male,36,6,1,9,,2.7,2.4,1,1,1,1,4.1,2.4,1.7
6611,0,Middle East & Africa,R&D,Communications,Meets,Male,29,4,1,7,,2.5,2.8,1,1,1,1,2.8,2.3,2.4
6612,0,Europe,Manufacturing,Marketing,Exceeds,Male,45,8,0,11,2.1,1.7,2.4,1,1,1,1,2.2,2.9,3.5
6613,0,Europe,Finance,Quality Assurance,Meets,Female,55,5,0,11,3.5,3.6,2.3,1,1,1,1,3.8,3,2.4
6614,0,North America,Finance,Quality Assurance,Meets,Female,36,30,0,7,3.6,3.7,2.7,1,1,1,1,3.3,3.5,3.6
6615,0,Middle East & Africa,Finance,Legal & Compliance,Meets,Female,40,13,0,11,2.7,3.6,3.3,1,1,1,1,3.2,3.5,2.9
6616,0,Middle East & Africa,Commercial,Sales,Exceeds,Male,46,5,1,9,,2.8,2.5,1,1,1,1,3,2,2.8
6617,0,Europe,R&D,Clinical Operations,Meets,Male,36,9,0,7,1.3,3,3.4,1,1,1,1,2.7,2.8,3.3
6618,0,Europe,R&D,Marketing,Meets,Female,49,8,0,8,3.7,1.9,1.5,1,1,1,1,2.6,2.6,4
6619,0,Europe,Digital,Supply Chain,Below,Male,28,7,0,8,4.5,2.9,3.5,1,1,1,1,3.9,3.3,3.3
6620,0,Asia Pacific,Commercial,Pharmacovigilance,Meets,Male,37,16,0,12,4.4,2.8,2.1,1,1,1,1,5,3.3,2
6621,0,Latin America,Finance,Regulatory Affairs,Meets,Female,33,15,0,12,3.3,3.3,2.9,1,1,1,1,4.4,3.7,2
6622,0,Asia Pacific,HR,IT & Digital,Meets,Female,31,6,1,12,,2.3,1.5,1,1,1,1,3.6,3.1,1.1
6623,0,Middle East & Africa,Commercial,Finance & Accounting,Meets,Male,33,21,0,8,3.2,3.1,1.1,1,1,1,1,2.8,3.7,1.8
6624,0,North America,Commercial,Regulatory Affairs,Meets,Female,41,14,0,10,4.1,2.8,2.6,0,0,0,0,4.2,2.9,2.7
6625,0,Latin America,R&D,Market Access,Exceeds,Male,44,4,0,10,2.4,3.7,1,1,0,0,0,2.5,2.3,2.1
6626,0,North America,Digital,Clinical Operations,Below,Male,42,12,1,11,,4.5,2.7,1,1,0,0,4.9,3.5,2
6627,0,Middle East & Africa,Digital,Sales,Below,Male,29,8,1,10,,3.8,4.8,1,1,1,1,4.1,3.1,3.6
6628,0,Middle East & Africa,Commercial,Regulatory Affairs,Exceeds,Female,41,21,0,11,3.6,3,4.7,1,0,0,0,2.7,2.3,3.2
6629,0,North America,Commercial,Data Science,Exceeds,Male,37,12,0,9,4,2.8,2.1,1,1,1,1,4.1,2.7,2.1
6630,0,North America,Manufacturing,Regulatory Affairs,Meets,Female,35,17,1,5,,3.5,2.5,1,1,1,1,4.2,2.9,4
6631,0,North America,Finance,Human Resources,Far Exceeds,Male,37,20,0,11,3.1,1.4,3.9,1,1,0,0,2.4,2.2,5
6632,0,Middle East & Africa,R&D,Medical Affairs,Meets,Male,48,15,0,9,4.4,2.6,3.8,1,1,1,1,3.9,2.4,3.6
6633,0,Europe,Finance,Human Resources,Far Exceeds,Male,36,3,0,5,2.6,3.4,2.6,1,1,1,1,2.6,2.5,4
6634,0,North America,HR,Data Science,Meets,Female,43,10,0,9,2.7,2.1,2.7,1,1,1,1,2.3,1.6,4.1
6635,0,Latin America,HR,Pharmacovigilance,Meets,Female,44,33,0,7,3.6,3,2.6,1,1,1,1,3.8,3.6,1.3
6636,0,Middle East & Africa,Digital,Market Access,Meets,Female,43,13,0,9,4.8,3.7,2.6,1,1,1,1,5,4.1,4.1
6637,0,Asia Pacific,R&D,IT & Digital,Far Exceeds,Female,35,10,0,8,1.8,3.7,2.5,1,1,1,1,2.7,4,3.1
6638,0,Asia Pacific,Finance,Regulatory Affairs,Meets,Female,36,7,0,11,2.3,1.9,3.1,1,1,1,1,3.7,3.9,4.1
6639,0,Latin America,Digital,Supply Chain,Far Exceeds,Female,40,25,0,8,3.4,2,1.1,1,1,1,1,3.8,1.4,1.8
6640,0,Europe,HR,Communications,Meets,Non-Binary/Other,35,2,0,8,3.7,2.6,1.8,1,1,1,1,4,3.7,3.4
6641,0,North America,Commercial,Human Resources,Meets,Female,33,8,0,12,3.6,4,2.6,0,0,0,0,3.5,3.8,2.6
6642,1,Middle East & Africa,R&D,Legal & Compliance,Meets,Female,39,2,1,11,,2.6,4.6,1,1,1,1,4.2,2,3.4
6643,0,North America,R&D,Data Science,Meets,Female,33,22,0,7,2.8,3.1,3,1,1,1,1,3.5,3.2,3.1
6644,0,Middle East & Africa,Finance,Market Access,Meets,Female,35,17,0,11,3.1,3.1,2.9,1,1,1,1,1.2,3.2,3.1
6645,0,Asia Pacific,Manufacturing,Quality Assurance,Below,Male,36,16,0,8,3.4,3.2,3.7,1,1,1,1,3.2,3.3,3.4
6646,0,North America,Finance,Medical Affairs,Exceeds,Female,35,15,0,8,4.7,3.3,3,1,1,1,1,4.3,3.6,2.3
6647,0,Latin America,Commercial,Legal & Compliance,Meets,Male,36,19,0,11,4.4,4.1,2.1,1,1,1,0,1.8,3.2,2
6648,0,Europe,Commercial,Medical Affairs,Exceeds,Male,35,12,0,12,5,3,3.2,1,1,1,1,3,3.6,2.3
6649,0,Latin America,Digital,Pharmacovigilance,Meets,Female,50,15,0,11,3.4,2.4,3.4,1,1,1,1,4.3,2.9,3.2
6650,0,Europe,R&D,Human Resources,Meets,Male,49,11,0,12,2.6,3.4,2.7,1,1,1,1,1.5,5,3.4
6651,0,North America,Digital,Data Science,Meets,Female,35,12,0,12,2.6,1,3.8,1,1,1,1,3,3.6,2.6
6652,0,North America,Commercial,Supply Chain,Exceeds,Female,35,10,0,8,3.5,2.9,4.7,1,1,1,1,3,2.8,4.3
6653,0,Europe,Manufacturing,Clinical Operations,Meets,Female,37,7,0,12,3.8,1.7,2.5,0,0,0,0,2.1,2.1,1.5
6654,0,Asia Pacific,R&D,Supply Chain,Far Exceeds,Male,39,8,0,8,4.7,2.8,2.4,0,0,0,0,5,2.3,4.1
6655,0,Middle East & Africa,Commercial,Market Access,Meets,Female,37,27,0,8,2.5,4,3.1,1,1,1,1,2.2,3.1,2.9
6656,0,Latin America,Manufacturing,Human Resources,Far Exceeds,Male,38,8,0,11,2.6,1.3,4.2,1,0,0,0,4.5,1.5,3.3
6657,0,Latin America,Finance,Regulatory Affairs,Exceeds,Male,43,12,0,12,4.2,2.2,2.3,1,1,1,1,3.6,2.2,2.5
6658,0,Latin America,HR,IT & Digital,Meets,Female,33,7,1,11,,3.2,2.5,1,1,1,1,2.5,1.4,2.8
6659,0,North America,Commercial,Legal & Compliance,Meets,Male,34,24,0,5,3.3,3.7,2.6,1,1,1,1,3.7,4,2.1
6660,0,Latin America,HR,Legal & Compliance,Meets,Female,29,4,0,7,4.7,4,3.1,1,1,1,1,2.1,1.6,2.8
6661,0,Middle East & Africa,Digital,Marketing,Exceeds,Female,36,5,1,9,,2.8,2.6,1,1,1,1,3.4,2.1,2
6662,0,Middle East & Africa,HR,Communications,Meets,Female,38,13,0,7,3.4,2.2,3.9,1,1,1,1,3,2.7,2
6663,0,Europe,Commercial,Finance & Accounting,Meets,Female,38,9,0,7,3.7,3.1,3.3,1,1,1,1,3,3.2,4.1
6664,0,North America,HR,Pharmacovigilance,Meets,Female,46,32,0,11,1.6,2.9,2.8,1,1,1,1,1.4,4.4,3.7
6665,0,Middle East & Africa,R&D,Marketing,Meets,Female,33,7,0,5,4.7,3.8,1.8,1,1,1,1,3.9,4.5,2.1
6666,0,Asia Pacific,Commercial,Data Science,Meets,Female,28,28,0,11,1.8,3.7,2.4,1,1,1,1,2.4,4.4,2.8
6667,0,North America,Manufacturing,Clinical Operations,Below,Female,39,8,0,8,2.9,3.2,3,1,1,1,1,2.7,4,3.2
6668,0,North America,HR,IT & Digital,Meets,Female,37,19,0,10,2.7,2.3,2.7,1,1,1,1,2.8,2.4,1.2
6669,0,Middle East & Africa,R&D,IT & Digital,Exceeds,Female,43,10,0,7,3.4,2.6,2.6,1,0,0,0,3.1,4.6,1.4
6670,0,Asia Pacific,Digital,Communications,Exceeds,Male,38,4,0,10,2.8,3.2,3.2,1,1,1,0,2.8,3.4,5
6671,0,Europe,Digital,Medical Affairs,Far Below,Male,46,19,0,10,2.6,4.2,2.9,1,1,1,1,3.7,2.2,3.7
6672,0,Middle East & Africa,HR,Medical Affairs,Exceeds,Female,37,21,0,9,2.6,2.5,1,1,1,1,1,3,1.2,1
6673,0,Asia Pacific,Digital,Finance & Accounting,Far Below,Male,35,23,0,9,5,3.4,4.3,1,1,1,1,3.6,3.4,2.5
6674,0,North America,Manufacturing,Quality Assurance,Meets,Female,42,6,0,6,3.1,3.7,2.1,1,1,1,1,3.8,3.2,2.4
6675,0,Asia Pacific,Commercial,Market Access,Below,Female,41,21,1,11,,4.8,2.7,1,1,1,1,2.6,1.9,2.5
6676,1,North America,R&D,Market Access,Far Exceeds,Male,34,17,0,8,4,4,3.2,1,1,1,1,4.6,4.4,4
6677,0,Middle East & Africa,Finance,Legal & Compliance,Far Exceeds,Male,41,12,0,7,3.4,2.7,3.9,1,1,1,1,2.8,3.7,5
6678,0,Middle East & Africa,HR,Finance & Accounting,Meets,Female,41,5,0,9,2.3,1,3,1,1,1,1,3.4,2.7,4
6679,0,Latin America,Digital,Supply Chain,Meets,Female,38,21,0,8,4,2.1,1,1,1,1,1,2,2.2,1
6680,0,Latin America,Commercial,Market Access,Meets,Female,45,4,1,6,,2.6,3.7,1,1,1,1,4.1,4,3.7
6681,0,Latin America,Finance,Supply Chain,Meets,Male,47,5,0,11,2.7,2.4,3.4,1,1,1,1,2.8,3.8,2.5
6682,0,Middle East & Africa,Manufacturing,Supply Chain,Meets,Female,35,4,0,5,2.4,2.5,4.5,1,1,1,1,1.9,1.5,3.9
6683,0,Europe,Digital,IT & Digital,Meets,Female,41,8,0,10,3.2,1.6,2.9,1,1,1,1,2.4,2.9,2.8
6684,1,Middle East & Africa,Digital,Regulatory Affairs,Meets,Female,38,13,0,6,5,3.4,2.8,1,1,1,1,2.9,4.5,3.5
6685,0,Asia Pacific,R&D,Pharmacovigilance,Meets,Male,35,3,0,6,3.1,3.1,3.7,1,1,1,1,2.6,2.5,3.4
6686,0,Middle East & Africa,Manufacturing,Marketing,Far Below,Male,37,4,1,6,,1.4,3.5,1,0,0,0,2.9,2.8,2.6
6687,0,Middle East & Africa,Manufacturing,Regulatory Affairs,Meets,Male,28,11,0,12,3.2,5,2.3,1,1,1,1,2.3,5,2.9
6688,0,North America,HR,Clinical Operations,Meets,Male,44,14,1,6,,4.3,1.1,1,1,1,1,3.6,4.3,3.1
6689,0,North America,Finance,Human Resources,Far Exceeds,Male,43,5,1,10,,3.8,3.6,1,1,1,1,3,3.5,3.9
6690,0,North America,R&D,Clinical Operations,Far Below,Female,28,10,1,7,,3,2.4,1,1,0,0,2.6,3.6,1.9
6691,0,Middle East & Africa,HR,Clinical Operations,Meets,Female,37,27,1,12,,2.9,3.8,1,1,1,1,3.3,4.4,4.1
6692,0,Europe,R&D,Medical Affairs,Meets,Female,40,6,0,5,5,3.5,2.6,1,1,0,0,4.7,3,1.4
6693,0,Asia Pacific,Manufacturing,Medical Affairs,Meets,Male,43,7,1,8,,3.6,3.6,1,1,1,1,3.4,4.2,3.1
6694,0,Asia Pacific,R&D,Legal & Compliance,Meets,Male,36,12,0,9,2.1,2,1.9,1,1,1,1,3.3,3.3,2.5
6695,0,Europe,R&D,IT & Digital,Below,Female,37,12,0,8,3.3,3.6,4,1,1,1,1,3.8,3.5,3.4
6696,0,Europe,R&D,Pharmacovigilance,Meets,Non-Binary/Other,40,19,0,12,3.1,3.1,4.6,1,0,0,0,3.2,2.5,2.4
6697,0,Asia Pacific,Commercial,Finance & Accounting,Meets,Male,34,12,1,12,,3.9,3,1,1,1,0,3.8,3.1,1
6698,0,Latin America,Commercial,IT & Digital,Meets,Male,48,10,1,9,,4.4,2.2,1,1,1,1,2.9,4.9,3
6699,0,North America,Finance,IT & Digital,Far Exceeds,Male,39,8,0,10,2.9,1.8,2.3,1,1,1,1,3,3.6,1.7
6700,0,North America,Finance,Clinical Operations,Meets,Female,39,21,0,7,2,3.6,2.5,0,0,0,0,4,3,1.8
6701,0,Asia Pacific,Manufacturing,Data Science,Meets,Non-Binary/Other,46,4,1,7,,3.3,2,1,1,1,1,4.1,3.1,2.1
6702,0,Europe,R&D,Data Science,Meets,Female,38,17,0,9,3.6,4.1,1.8,1,1,0,0,4.3,3.2,1.7
6703,0,Latin America,Manufacturing,Quality Assurance,Meets,Female,46,3,1,9,,3.3,2.9,1,1,1,1,4.2,3.4,3.3
6704,0,Asia Pacific,Commercial,Regulatory Affairs,Exceeds,Male,28,9,0,8,2.4,2.9,3.1,1,1,1,1,2.7,2.6,4.9
6705,0,North America,R&D,Marketing,Meets,Male,45,13,0,6,4.5,3,2.2,1,1,1,1,3.6,2.8,2.1
6706,0,Middle East & Africa,HR,Human Resources,Meets,Female,44,7,0,7,4.7,1.8,1.9,1,1,1,1,3.4,4,1.3
6707,0,Europe,Commercial,Medical Affairs,Meets,Male,28,3,0,10,2.1,2.8,2.6,1,1,1,1,2.2,3.1,1.7
6708,0,Middle East & Africa,Commercial,Finance & Accounting,Far Exceeds,Male,36,12,0,10,2.7,3.7,2.3,1,1,1,1,4.3,1.9,3.9
6709,0,Asia Pacific,Commercial,Market Access,Below,Non-Binary/Other,40,8,1,7,,3.7,1,1,1,1,1,2.9,1.6,1.2
6710,0,North America,R&D,Marketing,Meets,Male,43,5,0,11,2.9,2.9,3.5,1,1,1,1,2.3,3.8,3.2
6711,0,Latin America,Finance,Finance & Accounting,Meets,Male,46,17,0,12,3.5,4.5,1.6,1,1,1,1,4,4.7,2.7
6712,0,Middle East & Africa,Digital,Sales,Exceeds,Male,29,22,0,7,3.6,3,3.3,1,1,1,1,3.3,4.7,3.2
6713,0,Latin America,HR,IT & Digital,Below,Female,38,6,0,9,3.5,4,3.4,1,0,0,0,4.7,4.1,2.3
6714,0,North America,HR,Pharmacovigilance,Meets,Male,32,12,1,6,,1.8,1.2,1,1,1,1,4.2,1.3,2.5
6715,0,Middle East & Africa,Manufacturing,Pharmacovigilance,Meets,Male,34,5,1,7,,3.5,5,1,1,1,1,3.8,2.3,5
6716,0,Latin America,R&D,Clinical Operations,Meets,Female,43,5,0,9,2.5,3.2,1,1,0,0,0,2.7,4.4,1.4
6717,0,Latin America,Finance,Data Science,Exceeds,Female,33,6,0,7,4,2.8,2.8,1,1,1,1,2.6,4,3.6
6718,0,Middle East & Africa,Commercial,Clinical Operations,Meets,Male,38,5,0,6,3.8,3.6,4.7,1,1,1,1,3.9,3,3.7
6719,0,North America,Digital,Marketing,Meets,Female,35,9,1,8,,3.3,1.9,1,1,1,1,3.5,3.5,1.3
6720,1,Latin America,R&D,IT & Digital,Far Exceeds,Female,44,19,0,5,3.2,3.5,4.4,1,1,1,1,2.4,2.5,4
6721,0,Asia Pacific,R&D,Data Science,Meets,Male,28,10,0,8,1.9,3.6,3.3,1,1,1,1,3.1,2.4,2.9
6722,0,Middle East & Africa,Finance,Legal & Compliance,Meets,Male,45,24,0,12,4.1,2.5,2.7,1,1,1,1,3.5,1.7,3.9
6723,0,Europe,Digital,Clinical Operations,Meets,Female,47,19,0,9,4.3,4.8,2.3,0,0,0,0,3.4,3.9,1.8
6724,0,Europe,Commercial,Marketing,Meets,Female,42,6,0,8,2.4,4.5,3.7,1,1,1,1,2.6,3.7,2.9
6725,0,North America,R&D,Sales,Meets,Male,39,3,1,7,,3,3.3,1,1,1,1,2.8,2.9,2.8
6726,0,Asia Pacific,HR,IT & Digital,Meets,Male,28,17,1,9,,3.6,2.4,1,1,1,1,3.5,3.7,3.8
6727,0,Latin America,HR,IT & Digital,Meets,Male,42,4,1,10,,2.4,2,1,1,1,1,1.5,2,2.7
6728,0,Europe,Digital,Quality Assurance,Meets,Female,44,10,0,7,3.3,1.9,1,1,1,1,1,2.4,3.1,1
6729,0,North America,Commercial,Legal & Compliance,Exceeds,Female,39,15,0,12,3.8,3.7,4,1,1,1,1,5,3.8,2.8
6730,1,Asia Pacific,Digital,Regulatory Affairs,Exceeds,Female,34,13,0,8,2.9,4.5,1.6,1,1,1,1,3.7,4.4,1.6
6731,0,Asia Pacific,R&D,Quality Assurance,Meets,Female,47,10,0,12,2.9,2.8,2.3,1,1,1,1,3,3.3,2.5
6732,0,North America,HR,IT & Digital,Exceeds,Female,33,14,0,5,3.8,3.4,2,1,1,1,1,3.5,2.5,2.5
6733,0,North America,Manufacturing,Sales,Below,Non-Binary/Other,45,9,0,5,3.1,2.3,1.8,1,1,1,1,3.9,2.6,2.5
6734,0,Latin America,Digital,Quality Assurance,Exceeds,Female,41,18,0,8,3.3,1.6,2.1,1,1,1,1,3.8,3.6,2.5
6735,0,North America,Manufacturing,IT & Digital,Meets,Female,37,15,0,11,4.5,2.6,4.3,1,1,1,1,5,3.3,4.1
6736,0,Latin America,Manufacturing,Market Access,Meets,Male,53,12,0,8,3.3,3,1.3,0,0,0,0,4.3,2.9,3
6737,0,Latin America,Finance,Medical Affairs,Meets,Male,41,18,0,10,3.8,4,3,0,0,0,0,3.6,4.1,2
6738,0,Middle East & Africa,HR,Communications,Below,Female,42,30,0,9,3.3,1.9,3.8,1,1,1,1,4,2.5,3.8
6739,0,Asia Pacific,Digital,Medical Affairs,Far Below,Non-Binary/Other,41,15,0,10,3.5,2.1,5,1,1,1,1,4.3,2.1,3.5
6740,0,Asia Pacific,Manufacturing,Market Access,Meets,Male,40,20,0,9,1.9,2.1,1.5,1,1,0,0,1,1.9,2.1
6741,0,Asia Pacific,R&D,Communications,Exceeds,Female,37,12,0,5,1.1,4.4,2,1,1,1,1,1.9,3.6,2.8
6742,0,Middle East & Africa,Finance,Communications,Meets,Non-Binary/Other,43,15,0,11,2.9,4.7,1,1,1,1,1,3.9,2.9,1
6743,0,Latin America,Commercial,Medical Affairs,Meets,Female,39,7,0,12,4.2,4.9,2,1,1,1,0,3.7,1.8,2.3
6744,0,Latin America,Finance,Legal & Compliance,Exceeds,Female,28,13,0,5,3.6,4.4,3.1,1,1,1,1,3.2,3,2.7
6745,0,North America,Commercial,Human Resources,Meets,Male,33,13,1,10,,3.4,2.5,1,1,1,1,3.8,3.7,3.7
6746,0,Middle East & Africa,HR,Communications,Exceeds,Male,45,24,0,5,3.7,3.1,4.4,1,1,1,1,4.4,2.3,2.5
6747,0,North America,Digital,Marketing,Meets,Male,43,17,0,11,2.9,3.8,3.7,0,0,0,0,3.3,2.9,2.8
6748,0,Middle East & Africa,Digital,Medical Affairs,Meets,Female,32,22,0,9,3.7,2.9,2.3,0,0,0,0,3.3,1.3,2.6
6749,0,North America,Commercial,Pharmacovigilance,Meets,Male,35,4,0,9,2.6,4.5,1.4,1,1,1,1,3.1,4.1,2.5
6750,0,Europe,R&D,Pharmacovigilance,Exceeds,Male,34,8,1,12,,3.6,3,1,1,1,1,2.7,4,2.7
6751,0,Asia Pacific,Commercial,Data Science,Below,Female,47,1,1,8,,2.8,2.6,1,1,1,1,3.9,3.6,3.8
6752,0,Asia Pacific,Commercial,Supply Chain,Below,Female,29,11,1,9,,2.5,3.5,1,1,1,1,3.3,3.1,2.4
6753,0,Latin America,Digital,IT & Digital,Meets,Female,34,23,0,11,2.9,3.3,2.6,0,0,0,0,2.2,3.1,2.8
6754,0,Europe,Manufacturing,Sales,Exceeds,Non-Binary/Other,38,5,1,8,,3,3.2,1,1,1,1,2.7,3.3,1.3
6755,0,Asia Pacific,R&D,Communications,Below,Male,29,10,1,10,,3.8,2.7,1,1,1,1,3,2.6,2.7
6756,0,Latin America,Digital,IT & Digital,Meets,Female,38,19,0,11,3.2,3.4,3.4,1,1,1,1,2,4.8,2.3
6757,0,Europe,Finance,Pharmacovigilance,Meets,Female,32,6,0,10,4.5,3.2,4.4,1,1,1,1,4.3,4.6,3.3
6758,0,Asia Pacific,Commercial,Regulatory Affairs,Meets,Male,33,20,0,6,2.4,5,2,1,1,1,1,3,5,1.8
6759,1,North America,Manufacturing,Data Science,Meets,Female,35,17,0,8,2.6,3.9,3,1,1,1,1,3.2,3.6,3.5
6760,1,Middle East & Africa,R&D,Market Access,Meets,Female,37,8,1,6,,3.6,1.2,1,1,1,1,3.3,2.4,2.4
6761,0,Europe,HR,Sales,Meets,Female,35,6,0,9,3.5,2.5,3.6,1,1,1,1,3.8,3.1,3.7
6762,0,Latin America,R&D,IT & Digital,Meets,Male,39,3,1,11,,1.4,2.2,1,1,1,1,5,3.4,3.5
6763,0,Europe,R&D,Sales,Below,Female,45,18,1,5,,5,4.1,1,1,1,1,4.2,4,5
6764,0,Latin America,Commercial,Market Access,Meets,Female,43,9,0,8,3.2,2.9,2.4,1,1,1,1,3.5,3.3,2.3
6765,1,Europe,Commercial,IT & Digital,Meets,Male,47,4,0,7,2.4,1.9,3.6,1,1,1,1,5,1.6,1
6766,0,Latin America,HR,Communications,Meets,Male,38,12,1,10,,3,2.7,1,1,1,1,3.3,3.5,3.1
6767,0,Asia Pacific,HR,Legal & Compliance,Meets,Female,38,2,0,8,2.9,3.6,1,1,1,1,1,3.4,4.3,2.5
6768,0,North America,HR,Legal & Compliance,Exceeds,Male,39,11,0,9,4.4,3.6,2,1,0,0,0,4.7,3.6,2
6769,0,Asia Pacific,Digital,Supply Chain,Meets,Female,29,21,0,7,4,1.8,2.6,1,1,1,1,3.8,1.3,1.4
6770,0,North America,Digital,Finance & Accounting,Meets,Male,44,3,0,5,3.6,1,2.1,1,1,0,0,5,2,2.1
6771,0,Asia Pacific,Commercial,Legal & Compliance,Below,Female,36,5,0,8,2.1,4.3,4.1,1,1,1,1,3.4,3.8,2.8
6772,0,Asia Pacific,Commercial,Quality Assurance,Meets,Male,38,13,0,7,3.9,4.6,4.5,1,1,1,1,2.6,5,3.4
6773,0,Europe,HR,Quality Assurance,Meets,Non-Binary/Other,41,14,0,11,1.4,4.4,2.3,1,1,1,1,2,4.4,3.7
6774,0,Middle East & Africa,Digital,Legal & Compliance,Meets,Male,33,12,0,8,2.5,3,2.8,1,1,1,1,2.5,1.4,3.8
6775,0,Latin America,Manufacturing,Clinical Operations,Meets,Male,34,16,0,11,2.9,2.1,1.2,1,1,1,1,4.2,4.4,1.2
6776,0,Latin America,Digital,Legal & Compliance,Exceeds,Male,40,4,0,10,4.1,3.8,2.6,0,0,0,0,3,3,2.6
6777,0,Latin America,Commercial,Clinical Operations,Exceeds,Female,41,3,0,7,4.1,3.2,3.9,1,1,1,1,3.5,3.3,4.6
6778,0,North America,Digital,Data Science,Far Below,Female,52,5,1,11,,3.6,2.1,1,1,1,1,2.4,2.4,2.7
6779,0,Latin America,Commercial,Clinical Operations,Meets,Female,39,13,0,11,2.7,3.2,2.4,1,1,1,1,2.9,3,4.5
6780,0,Latin America,HR,Clinical Operations,Far Below,Male,41,4,1,7,,2.3,1,1,1,1,1,2.8,3.4,1
6781,0,Europe,HR,Market Access,Meets,Male,52,13,0,7,2.9,3.6,2.2,1,0,0,0,4.4,3.8,2.5
6782,0,Asia Pacific,HR,Quality Assurance,Meets,Female,40,12,0,7,3.3,3.2,1,1,1,1,1,3.3,3,3.5
6783,0,Latin America,Manufacturing,Clinical Operations,Meets,Female,41,17,0,5,3,2.4,1.1,1,1,1,1,4.5,4.6,2.1
6784,0,Middle East & Africa,Manufacturing,Pharmacovigilance,Meets,Male,28,9,1,6,,3,4.7,1,1,1,1,3.4,3.1,3
6785,0,Latin America,Commercial,Regulatory Affairs,Exceeds,Male,36,3,1,6,,3.5,2.1,1,1,1,1,3.6,2.7,2.7
6786,0,North America,R&D,Pharmacovigilance,Meets,Male,39,28,0,9,2.9,2.6,3.8,1,1,1,1,1.8,2.9,4.2
6787,0,North America,Finance,Legal & Compliance,Meets,Male,33,7,1,11,,4.6,2.2,1,1,1,1,2.7,4,3.7
6788,0,North America,Manufacturing,Supply Chain,Meets,Female,39,17,1,9,,1.9,2.1,1,1,1,1,1.7,2.1,3.7
6789,0,Latin America,Commercial,Pharmacovigilance,Meets,Male,42,12,1,11,,1.2,3.4,1,1,1,1,2.7,3.3,2.7
6790,0,Europe,Digital,Data Science,Below,Female,44,13,0,12,3.2,3.5,3.2,1,0,0,0,3.6,3.6,3.2
6791,0,Middle East & Africa,HR,Clinical Operations,Meets,Female,37,10,1,6,,2,1.7,1,1,1,1,3.1,3.1,2.2
6792,0,Latin America,HR,Clinical Operations,Meets,Female,29,12,0,9,3.2,3.5,1.8,1,0,0,0,3.5,3,3.9
6793,0,Europe,HR,Human Resources,Meets,Female,39,7,0,8,3.2,3.9,1.7,0,0,0,0,3.8,3.5,3.1
6794,0,Europe,Commercial,Communications,Below,Female,35,10,1,10,,2.6,3.7,1,1,1,1,2.6,3.2,2.7
6795,0,Latin America,HR,Market Access,Below,Female,33,25,0,8,3.5,4.2,4.1,1,1,1,1,2.3,3.3,4.1
6796,0,Latin America,Manufacturing,Marketing,Meets,Female,36,31,1,9,,2,3.5,1,1,1,0,3.5,2.9,3.1
6797,0,Europe,Digital,Supply Chain,Meets,Female,36,19,0,7,4.2,3.6,2.8,1,1,1,1,4.8,4,3.3
6798,0,Europe,HR,Pharmacovigilance,Meets,Male,37,13,0,12,2.4,1,2.4,1,1,1,1,2.3,1.6,1.3
6799,0,Europe,Commercial,Marketing,Meets,Male,35,7,0,8,5,2.9,3.1,1,1,1,1,2.7,2.4,2
6800,0,Latin America,Digital,Sales,Meets,Male,47,17,0,11,3,3,3.1,1,1,1,1,4.1,1.6,4.6
6801,0,Europe,HR,Legal & Compliance,Meets,Male,40,7,0,7,2.9,3.3,2.2,0,0,0,0,3.2,1.9,1.5
6802,0,North America,R&D,Regulatory Affairs,Meets,Female,40,11,0,8,2.3,3.3,2.1,0,0,0,0,3.5,2.7,2.3
6803,0,Latin America,HR,Regulatory Affairs,Meets,Female,40,13,0,12,2.4,5,2.9,0,0,0,0,2.2,3.4,2.8
6804,0,North America,Finance,Quality Assurance,Far Exceeds,Female,30,6,1,11,,4.5,3.4,1,1,1,1,1.5,4.1,1.2
6805,0,Asia Pacific,Manufacturing,Communications,Meets,Male,44,26,0,12,3.9,1.9,1.8,1,1,1,1,3.6,3.4,1
6806,0,Latin America,Digital,Clinical Operations,Exceeds,Female,55,15,0,6,4.2,3.5,3.6,1,1,1,1,3.2,1.9,1.4
6807,0,Asia Pacific,Manufacturing,Quality Assurance,Meets,Male,32,11,0,11,3.7,2.5,2.6,1,1,1,1,1.4,2,2.8
6808,0,Europe,R&D,Human Resources,Exceeds,Male,34,18,1,9,,4.5,2.3,1,1,1,1,2.7,2.6,2.6
6809,1,Europe,R&D,Market Access,Far Exceeds,Female,35,13,0,7,2.8,3.5,3.2,1,1,1,1,2.9,2.2,1.7
6810,0,Middle East & Africa,Finance,Human Resources,Far Below,Male,40,7,0,11,3.4,3,2.9,1,1,1,1,1.8,2.8,3.1
6811,0,Europe,Manufacturing,Supply Chain,Below,Male,37,20,1,7,,4.7,1,1,1,1,1,3,5,1.5
6812,0,Asia Pacific,Digital,Supply Chain,Meets,Male,35,21,0,7,4.2,4.1,4.2,0,0,0,0,2.8,4.1,4.2
6813,0,Europe,R&D,Sales,Meets,Male,42,4,1,12,,2.9,2.3,1,1,1,1,3,3.5,3.5
6814,0,Latin America,R&D,Data Science,Exceeds,Male,40,8,1,8,,2.9,2.8,1,1,1,1,2.6,2.3,2.2
6815,0,Europe,HR,Supply Chain,Far Below,Male,45,21,0,10,3.6,3.9,3.2,1,1,0,0,3.3,4.8,3.9
6816,0,Middle East & Africa,Finance,Supply Chain,Exceeds,Male,39,14,0,6,2.9,3,2.6,1,1,1,1,2.2,3.2,2.5
6817,0,Europe,Commercial,Supply Chain,Below,Male,38,11,0,9,4,2.1,1.7,0,0,0,0,4.2,1,2
6818,0,Asia Pacific,R&D,IT & Digital,Meets,Female,35,13,0,5,3.4,2.7,3.3,1,1,1,1,3.4,3,3.5
6819,0,Asia Pacific,Digital,Communications,Far Exceeds,Male,39,11,1,12,,3.4,2.8,1,1,1,1,3.6,3.7,2.4
6820,0,Europe,Digital,Communications,Below,Female,32,12,0,9,3.5,3.4,4,1,1,1,1,3.1,2.8,3.6
6821,0,Asia Pacific,HR,Human Resources,Meets,Male,45,7,0,7,4.8,1.6,1.5,1,1,1,1,4.7,2.3,2
6822,0,Asia Pacific,Digital,Regulatory Affairs,Below,Female,42,3,0,8,3.3,2.8,2.7,1,1,1,1,4.4,3.5,2.7
6823,0,Middle East & Africa,HR,Data Science,Exceeds,Female,39,11,0,10,4,2.3,2.5,1,1,1,1,3.1,5,5
6824,1,Latin America,R&D,Data Science,Meets,Male,36,4,0,7,3.2,4.5,5,1,1,1,1,4.3,2.8,4.1
6825,0,Middle East & Africa,R&D,Medical Affairs,Exceeds,Male,48,21,0,10,2.7,3.2,1.8,1,1,1,1,2.4,1,1.6
6826,0,North America,R&D,IT & Digital,Meets,Male,35,8,0,6,2.4,3.6,2.5,1,1,1,1,3.2,2.9,1
6827,1,Middle East & Africa,R&D,Pharmacovigilance,Meets,Female,33,17,0,5,3.6,2.4,2.9,1,1,1,1,3.5,1.8,3.5
6828,0,Europe,Commercial,Market Access,Far Below,Male,36,11,0,7,3.8,3.8,3.2,1,1,1,1,1.9,3,1.8
6829,0,Latin America,Finance,Communications,Meets,Male,43,22,0,11,2.6,2.5,1,1,1,1,1,3.6,2.9,1.3
6830,0,Europe,Finance,Clinical Operations,Meets,Female,47,11,0,12,2.6,3,2.8,1,1,1,1,3.6,3.6,2.6
6831,0,North America,Commercial,Communications,Meets,Male,44,15,0,10,4.5,2,2.6,0,0,0,0,4.4,1.5,3.2
6832,0,Latin America,R&D,Communications,Meets,Female,30,6,1,8,,3.4,2.7,1,1,1,1,4.1,3.1,2.2
6833,0,Asia Pacific,Digital,IT & Digital,Below,Female,38,17,0,5,3.9,1,4,0,0,0,0,4.7,2.9,2.8
6834,0,Middle East & Africa,HR,Supply Chain,Meets,Female,35,28,0,5,3.8,5,2.3,0,0,0,0,5,3.7,2
6835,0,Europe,Finance,Supply Chain,Meets,Female,40,11,0,7,4.2,4,3,1,1,1,1,3.4,3.2,3.9
6836,0,North America,Manufacturing,Human Resources,Below,Female,36,6,0,7,4.5,2.8,2.2,1,1,1,1,4.5,2.5,2.7
6837,0,Asia Pacific,HR,Medical Affairs,Below,Female,43,4,0,6,3.8,4.3,2.6,1,1,1,1,4.1,4.2,4
6838,0,Middle East & Africa,Manufacturing,Finance & Accounting,Far Below,Female,35,7,0,11,4.3,3.7,2.8,1,1,1,0,5,3.7,3.4
6839,0,Asia Pacific,Manufacturing,Human Resources,Exceeds,Male,33,3,1,6,,2.5,3.3,1,1,1,1,2.9,3.4,4.4
6840,0,Middle East & Africa,R&D,Clinical Operations,Meets,Male,46,13,0,8,2.7,2.7,1,1,1,1,1,2,4.6,1.6
6841,0,Latin America,Manufacturing,Data Science,Exceeds,Male,38,20,0,6,4.1,1.7,4.8,1,1,1,1,3.4,1,4.2
6842,0,Asia Pacific,R&D,Sales,Meets,Female,43,13,0,10,2.5,2.9,2.5,1,1,1,1,3.5,4.6,4.5
6843,0,Asia Pacific,Commercial,IT & Digital,Meets,Male,31,3,1,10,,2.6,1,1,1,1,1,3.6,2.4,2.7
6844,0,Asia Pacific,Digital,Regulatory Affairs,Below,Male,32,3,0,7,2.6,2.7,4.6,1,1,1,1,1.9,2.7,3.3
6845,0,Latin America,Manufacturing,Supply Chain,Meets,Male,30,10,1,10,,2.3,2.9,1,1,1,1,4.4,2.5,5
6846,0,North America,Digital,Legal & Compliance,Meets,Female,33,12,0,8,3.4,3.3,3,1,1,1,1,2.3,3.1,3.1
6847,0,Middle East & Africa,R&D,Market Access,Below,Female,34,15,0,12,2.7,2.6,1.5,1,1,1,1,2.7,4.3,1.9
6848,0,Asia Pacific,Manufacturing,Market Access,Exceeds,Male,33,13,0,7,3.3,2.1,1,1,1,1,1,2.9,2.4,2.1
6849,0,Latin America,HR,Supply Chain,Meets,Female,38,7,0,11,3.3,3.5,3.8,1,1,1,0,3.5,4,4.9
6850,0,North America,Commercial,IT & Digital,Meets,Male,32,9,0,10,3.6,3.3,3.4,1,1,1,1,3.4,4,2.8
6851,0,Middle East & Africa,Finance,Market Access,Meets,Male,33,3,0,8,2.4,1.7,3.1,1,0,0,0,3.4,2.4,1.9
6852,0,Latin America,Commercial,Sales,Meets,Female,39,7,1,10,,3.1,1.6,1,1,1,1,4.3,3.4,1.2
6853,0,Middle East & Africa,Manufacturing,Communications,Meets,Female,50,21,1,5,,3.7,2.1,1,1,1,1,3.6,1.7,4.9
6854,0,Asia Pacific,Commercial,IT & Digital,Meets,Male,41,10,0,7,4.4,2.1,4.7,1,1,1,1,4.1,1.8,2.7
6855,0,North America,Finance,Market Access,Far Below,Non-Binary/Other,40,11,0,7,2.1,3,1.4,1,1,1,1,4,2.4,1.4
6856,0,Latin America,HR,Communications,Below,Male,36,11,0,5,3.8,1.8,1.2,1,1,1,1,3.3,2.1,1.4
6857,1,North America,Digital,Marketing,Meets,Female,28,11,0,10,2.9,5,3,1,1,0,0,3.8,2.7,2.2
6858,0,Asia Pacific,HR,Clinical Operations,Meets,Female,37,10,0,10,4.4,4.3,3,1,1,1,1,3.1,4.6,4.5
6859,0,North America,Commercial,Medical Affairs,Meets,Male,32,10,0,9,3,2.3,2.5,1,0,0,0,3.9,3.2,1.9
6860,0,North America,Finance,Medical Affairs,Meets,Female,44,11,0,9,3.2,3.6,2.7,1,1,1,1,3.3,3.6,2.4
6861,0,Europe,Digital,Human Resources,Meets,Male,47,2,0,11,4.2,2.8,1.9,1,1,1,0,5,3.5,2.5
6862,0,North America,Finance,Quality Assurance,Meets,Male,33,22,0,5,2.8,3.1,1,1,1,1,1,3.5,2.6,2.3
6863,0,Middle East & Africa,HR,Communications,Exceeds,Male,38,2,0,12,2.2,4.1,2.2,1,1,1,1,2.1,5,3
6864,0,Latin America,R&D,Regulatory Affairs,Below,Female,30,10,0,9,1,4,1.8,1,0,0,0,2.1,3.1,1.7
6865,0,Europe,R&D,Clinical Operations,Meets,Female,43,2,0,9,3.3,2.7,4.4,1,1,1,1,4.6,3.9,4
6866,0,Latin America,Digital,Supply Chain,Exceeds,Female,45,23,0,6,1.4,2.3,3.6,1,0,0,0,4.9,4.5,4
6867,0,Latin America,Digital,Marketing,Meets,Female,41,5,0,9,2,4,2.7,1,1,1,1,3.4,4.2,2.1
6868,0,Asia Pacific,Digital,Sales,Meets,Male,40,7,1,10,,2.5,1.3,1,1,1,1,1.3,2.7,1.4
6869,0,Asia Pacific,R&D,IT & Digital,Below,Male,38,11,0,10,3.8,4.8,1,1,1,1,1,4.2,4.1,1
6870,0,Europe,HR,Finance & Accounting,Exceeds,Male,41,12,0,12,3,5,3,1,1,1,1,4.6,4.5,2.2
6871,0,Asia Pacific,Digital,Finance & Accounting,Meets,Non-Binary/Other,36,16,0,6,2.2,3.3,2.9,1,1,1,1,3.2,2.7,3.4
6872,0,Asia Pacific,R&D,Finance & Accounting,Meets,Female,36,21,0,9,2.9,2.5,2.6,1,1,1,1,5,3.5,1.4
6873,0,Asia Pacific,Digital,Quality Assurance,Below,Female,46,10,0,10,1.4,1,4.1,1,1,1,1,2.2,3.4,2.7
6874,0,Latin America,Digital,Human Resources,Far Below,Male,43,4,0,11,3.5,2.7,1.6,1,1,1,1,3.8,1.6,1.8
6875,0,Europe,Finance,Communications,Meets,Female,35,8,1,11,,1.7,3.6,1,1,1,1,2.3,1.6,2.6
6876,0,Latin America,Digital,Finance & Accounting,Meets,Female,49,6,1,11,,2.9,2.7,1,1,1,1,3.9,3.2,2.5
6877,0,Middle East & Africa,R&D,Regulatory Affairs,Exceeds,Female,34,23,0,6,2.3,3.8,2.3,1,1,0,0,2.2,3.9,3.2
6878,0,Latin America,HR,Regulatory Affairs,Exceeds,Female,50,8,1,11,,3.1,2.5,1,1,1,1,2.5,2.6,3.4
6879,0,Middle East & Africa,R&D,Pharmacovigilance,Meets,Male,30,13,0,5,2.2,3.4,2.8,1,1,1,1,3.9,4.1,1.8
6880,0,North America,R&D,Clinical Operations,Far Below,Female,37,19,0,6,2.2,2.6,2.7,1,1,1,1,3.2,2.5,3.1
6881,0,North America,Digital,Marketing,Meets,Female,41,7,0,9,2.4,2,2,0,0,0,0,3.3,2.4,2.2
6882,0,Middle East & Africa,Finance,Finance & Accounting,Meets,Male,40,14,0,11,2.5,4.2,3.8,1,1,1,1,3.1,1.9,3.9
6883,0,Middle East & Africa,Manufacturing,Finance & Accounting,Below,Female,39,11,1,10,,2.2,4,1,1,1,1,3.6,2.4,4.7
6884,0,Latin America,Manufacturing,Data Science,Meets,Female,46,19,0,8,4.1,1.7,2.2,1,1,1,1,4.3,3.8,1.2
6885,0,Middle East & Africa,Manufacturing,Communications,Far Below,Female,41,10,0,8,2.4,3.3,2.5,1,1,1,1,2.9,3.8,2
6886,1,Europe,R&D,Finance & Accounting,Meets,Female,41,11,0,7,2,2.2,1.6,1,1,1,1,3.9,3,1.4
6887,0,North America,Digital,Sales,Exceeds,Female,34,28,0,12,4,3.4,4.8,1,1,1,1,3.6,3.8,4.5
6888,0,North America,Manufacturing,Quality Assurance,Meets,Male,43,4,1,8,,3.5,3.7,1,1,1,1,4.3,3.3,3.1
6889,0,Middle East & Africa,Commercial,Supply Chain,Exceeds,Female,35,10,1,9,,3.6,2,0,0,0,0,4,3.1,1
6890,0,Asia Pacific,Commercial,Finance & Accounting,Meets,Male,45,4,0,8,2.7,2.7,4.4,1,1,1,1,3.2,3.1,2.7
6891,0,Asia Pacific,Commercial,IT & Digital,Meets,Non-Binary/Other,47,24,0,10,2.3,3,1.3,1,1,1,1,1.6,3.8,1
6892,0,Middle East & Africa,HR,Medical Affairs,Meets,Male,38,3,0,8,4,2.4,2.4,1,1,1,1,2.2,4.7,1.8
6893,0,Europe,Digital,Quality Assurance,Meets,Male,41,14,0,11,4.6,3.8,2.5,1,1,1,1,4.6,4.2,1
6894,0,Asia Pacific,R&D,Human Resources,Exceeds,Female,40,4,0,12,3.4,2.7,2.3,1,1,1,1,3.6,3.9,2.2
6895,0,Middle East & Africa,R&D,Human Resources,Meets,Male,38,15,0,7,4.5,1.6,1.7,1,1,1,1,3.8,1.5,1.7
6896,0,Europe,Digital,Market Access,Meets,Male,37,13,1,9,,2.7,3.3,1,1,1,1,2.5,2.5,2.8
6897,0,Europe,Finance,Human Resources,Meets,Female,31,12,0,8,3,3.2,4.3,1,1,1,1,3.7,4,3.9
6898,0,Latin America,Finance,Legal & Compliance,Below,Male,34,10,0,11,4.5,2.6,2.2,1,1,1,1,3.3,2.8,1.7
6899,0,Europe,HR,Regulatory Affairs,Far Exceeds,Male,39,25,0,7,3.4,2.5,1,1,1,0,0,3,3.3,1.7
6900,0,Asia Pacific,Digital,Supply Chain,Below,Male,47,3,1,8,,3.5,1.5,1,1,1,1,3.1,3.8,2.8
6901,0,Asia Pacific,Finance,Sales,Exceeds,Female,40,22,0,5,2.5,3.7,3,0,0,0,0,2,3.6,2.8
6902,0,Middle East & Africa,HR,Human Resources,Meets,Male,45,6,0,12,2.9,1.6,1.8,1,1,1,1,3.8,3.8,2.8
6903,0,Middle East & Africa,Manufacturing,Marketing,Meets,Female,28,14,0,7,2,4.3,1.7,0,0,0,0,2.6,2.4,2.6
6904,0,Europe,Manufacturing,Data Science,Meets,Male,46,10,0,12,3.3,2.5,2.6,1,1,1,1,3.4,4.4,3.8
6905,0,North America,HR,Human Resources,Exceeds,Male,42,5,0,5,2.7,3.2,2.6,1,1,1,1,1.1,2.9,1.6
6906,0,Latin America,Digital,Market Access,Exceeds,Male,44,6,1,9,,3.5,1.2,0,0,0,0,3.9,3.2,1
6907,0,North America,Manufacturing,Supply Chain,Exceeds,Non-Binary/Other,28,29,0,9,3,3.8,3,1,1,1,1,3,4.6,2.2
6908,0,Europe,Digital,Supply Chain,Meets,Female,36,14,0,11,4.9,2.4,2.3,1,1,1,1,4.3,2.7,1.5
6909,0,Europe,Finance,Regulatory Affairs,Far Below,Male,32,3,1,6,,3.2,2.8,0,0,0,0,2.7,4.9,3.7
6910,0,North America,Manufacturing,Clinical Operations,Meets,Male,42,21,0,8,3.4,2.5,3.1,1,1,1,1,4.2,3.8,2.8
6911,0,Latin America,Finance,Market Access,Meets,Male,41,11,0,11,2.7,2.7,1.5,1,1,1,1,3.2,3.3,2.7
6912,0,North America,Digital,Regulatory Affairs,Meets,Female,44,13,0,11,3.3,3.4,1.1,1,1,1,0,3.4,4.3,2.1
6913,0,Middle East & Africa,Digital,IT & Digital,Meets,Male,36,15,0,5,3.9,2.2,3.3,1,1,1,1,4.3,3.1,1.7
6914,0,Asia Pacific,Commercial,Quality Assurance,Meets,Male,43,6,1,10,,3.6,1.6,1,1,1,1,1.7,3.4,1.5
6915,0,Middle East & Africa,HR,Human Resources,Meets,Female,38,23,0,12,4.2,2.7,3.1,0,0,0,0,5,1.7,3.2
6916,0,Asia Pacific,R&D,Market Access,Exceeds,Male,45,20,0,7,4,3,2.1,0,0,0,0,3.7,3.4,1.8
6917,0,Europe,HR,Data Science,Exceeds,Male,42,12,0,7,3.5,3,3.4,1,1,1,1,2.4,3,2.8
6918,0,Latin America,Digital,Human Resources,Meets,Male,34,15,0,11,4.3,2.4,3.4,1,1,1,1,2.4,3.6,2.8
6919,0,North America,Digital,Medical Affairs,Meets,Male,40,8,0,8,2.7,3.3,2.7,1,1,1,1,3.6,3.7,2.3
6920,0,Latin America,HR,Quality Assurance,Meets,Male,30,12,1,6,,5,4.2,1,1,0,0,3.4,4.1,3.7
6921,0,North America,Digital,Data Science,Far Below,Male,45,20,0,7,3.7,4.5,3.2,1,1,1,1,4.4,3.8,2.9
6922,0,Middle East & Africa,Finance,Marketing,Below,Female,42,10,0,6,1.9,2.5,2,1,1,1,1,2.5,3.7,1.9
6923,0,Middle East & Africa,Manufacturing,Regulatory Affairs,Below,Female,42,7,0,10,2.3,1,4.1,1,1,1,1,1.7,1.7,3.3
6924,0,North America,Digital,Data Science,Below,Female,44,5,0,7,2.4,1.2,2.4,1,1,1,1,3.1,1.9,1.5
6925,0,Latin America,HR,Clinical Operations,Far Below,Female,39,16,0,12,3.2,1.1,2,1,1,1,1,4.1,3.9,2.5
6926,1,North America,HR,Pharmacovigilance,Exceeds,Female,29,11,0,7,3,2.4,2.6,1,1,1,1,3.1,3.7,2.4
6927,0,Europe,HR,Medical Affairs,Meets,Male,44,3,0,12,2.4,2.6,2.2,1,1,1,1,2.3,4.5,4.1
6928,0,Middle East & Africa,Commercial,Marketing,Meets,Male,34,14,1,10,,2.4,1.1,1,1,1,1,5,3.1,2.5
6929,0,Europe,Finance,Communications,Meets,Male,33,16,0,8,4.2,1,3.2,1,1,1,1,3.8,1.9,3.1
6930,0,Middle East & Africa,Finance,Supply Chain,Meets,Female,43,22,0,5,3.4,2.8,3.4,1,1,1,1,3,3.1,2.6
6931,0,Middle East & Africa,Commercial,Regulatory Affairs,Below,Female,35,8,0,7,4,4.1,2.7,1,1,1,1,3.4,3.7,2.9
6932,0,Asia Pacific,Finance,Quality Assurance,Meets,Male,39,7,0,12,3.2,4.6,3.5,1,1,1,1,3,3.2,3.7
6933,0,Europe,Commercial,IT & Digital,Exceeds,Male,42,8,0,6,4.8,3.6,3.5,1,1,1,1,4,2.9,3.7
6934,0,Europe,Finance,Pharmacovigilance,Meets,Female,42,22,0,11,5,2.9,3.6,1,0,0,0,4.2,3.2,3
6935,0,Asia Pacific,Commercial,Legal & Compliance,Meets,Male,45,4,1,5,,1.8,2,1,0,0,0,4.5,4.5,3.2
6936,0,Latin America,Commercial,Market Access,Meets,Female,35,12,0,7,1.6,3.7,3,1,1,1,1,2.7,3.5,3.2
6937,0,Europe,Finance,Human Resources,Meets,Female,36,19,0,9,3.5,1.2,2.1,1,1,1,1,4.2,3.9,1.2
6938,0,North America,Commercial,Regulatory Affairs,Meets,Male,40,8,1,8,,2.2,1.4,1,1,1,1,2.8,1.5,2.6
6939,0,Asia Pacific,Finance,Sales,Meets,Male,30,8,0,7,3.5,1.8,1,1,1,1,1,4,1.9,3.9
6940,0,Europe,Commercial,Regulatory Affairs,Meets,Male,33,21,0,12,4.3,3.6,4.3,1,1,1,1,3.9,2.9,3.6
6941,0,Latin America,HR,Human Resources,Below,Male,33,4,1,8,,3.7,2.6,1,1,1,1,2.6,3.9,4.2
6942,0,Europe,R&D,Sales,Exceeds,Female,28,3,0,5,3.2,2.3,1.6,1,1,1,1,2.6,1.7,2.1
6943,0,Middle East & Africa,Finance,Supply Chain,Meets,Male,35,8,0,8,3.4,2.9,1.5,1,1,1,1,3.8,3.4,2.5
6944,0,North America,Commercial,Marketing,Meets,Male,38,6,1,9,,4,1,1,1,1,1,3.5,4.3,1.8
6945,0,Asia Pacific,HR,Medical Affairs,Meets,Female,39,5,0,6,3.9,2.2,2.9,1,1,1,1,3.2,1.9,2
6946,0,Middle East & Africa,R&D,Legal & Compliance,Meets,Female,35,13,0,6,2.4,2.4,4.7,1,1,1,1,2.9,2.5,3.1
6947,0,Latin America,Commercial,Regulatory Affairs,Meets,Male,33,10,0,6,3.7,4.2,2,1,1,1,1,2.8,4.1,2
6948,0,Middle East & Africa,R&D,Supply Chain,Below,Male,37,8,0,5,4.1,3.1,2,1,1,1,1,4.1,1.9,1
6949,0,Middle East & Africa,Finance,IT & Digital,Meets,Male,35,10,0,9,4,3.8,1.2,1,1,1,1,4.6,3.8,2.8
6950,0,Latin America,R&D,Market Access,Meets,Female,28,19,1,10,,3.2,3.3,1,1,1,1,2.5,3.3,3.4
6951,0,Middle East & Africa,Manufacturing,Pharmacovigilance,Below,Male,33,14,1,11,,4.1,2.9,1,1,1,1,3.4,4.3,1.8
6952,0,Asia Pacific,Digital,Clinical Operations,Below,Male,40,6,1,10,,3.4,2.6,1,1,1,1,4.4,3,2
6953,0,Europe,Manufacturing,Data Science,Meets,Non-Binary/Other,38,7,1,5,,2.6,3.1,1,1,1,1,3.7,2.7,3.5
6954,0,Middle East & Africa,Finance,Supply Chain,Below,Male,39,12,1,7,,3.2,1.2,1,1,1,1,5,2.9,2.2
6955,0,Asia Pacific,Finance,Communications,Below,Male,42,12,0,8,4.5,4.2,1,1,1,1,1,5,3.4,2.7
6956,0,Europe,R&D,Legal & Compliance,Meets,Female,40,11,0,5,3.8,2.8,1.4,1,1,1,1,2.9,3.4,2.1
6957,0,Europe,HR,Pharmacovigilance,Exceeds,Male,39,35,0,12,4.1,4.1,1.6,1,1,1,1,3.1,4.2,1.5
6958,0,Middle East & Africa,Commercial,Finance & Accounting,Meets,Male,36,21,0,7,3.5,2.8,2.8,1,1,1,1,3.2,2.6,3
6959,0,Asia Pacific,Digital,Sales,Exceeds,Male,34,7,0,7,3.3,2.7,1.9,1,1,1,1,1.8,2.8,2.1
6960,0,Middle East & Africa,Commercial,Supply Chain,Meets,Female,38,6,1,7,,3.8,4.1,1,1,1,1,4.2,3.2,2.8
6961,0,Latin America,HR,Communications,Meets,Non-Binary/Other,32,4,1,9,,2.3,4.3,1,1,1,1,2.4,3.8,2.4
6962,0,Europe,Finance,Market Access,Meets,Female,42,6,0,9,4.4,4.4,2.2,1,1,1,1,4.1,3.4,1.6
6963,0,Middle East & Africa,Digital,Supply Chain,Meets,Male,32,17,0,8,3.3,4.2,2.5,1,1,1,1,3.7,4.4,1.6
6964,0,Europe,Manufacturing,Medical Affairs,Below,Male,46,17,0,5,3.4,2,1.8,1,1,1,1,4.5,1.5,1.5
6965,0,Asia Pacific,Finance,Sales,Meets,Female,38,11,0,7,4.4,4,3,1,1,1,1,4.9,3.5,3
6966,0,North America,Finance,Regulatory Affairs,Meets,Female,45,1,0,10,2.8,3.9,3.6,1,1,1,1,2.5,4.6,2.8
6967,1,Middle East & Africa,R&D,Quality Assurance,Meets,Female,32,21,0,11,3.4,3,3.5,1,1,1,1,4.3,2.2,4.2
6968,0,Middle East & Africa,HR,IT & Digital,Meets,Female,48,8,0,6,4.2,3.2,2.4,0,0,0,0,3,4.5,3.3
6969,0,Europe,R&D,Communications,Below,Non-Binary/Other,31,5,1,5,,1.7,2.2,1,1,1,0,2.7,2.9,3.7
6970,1,Asia Pacific,R&D,Communications,Exceeds,Male,38,8,1,6,,4.2,2,1,1,1,1,3.2,2.9,3.4
6971,0,Latin America,Commercial,Clinical Operations,Meets,Male,30,8,0,12,1.7,2.4,4.2,1,1,1,1,1,2.3,4.9
6972,0,Asia Pacific,Finance,Regulatory Affairs,Meets,Female,38,16,0,5,2.9,1.2,2.2,0,0,0,0,3.8,2.3,2
6973,0,Middle East & Africa,HR,IT & Digital,Exceeds,Male,37,6,0,5,2.6,2.6,3.6,1,1,1,1,3.2,3.7,3.1
6974,0,Latin America,R&D,Data Science,Below,Male,28,10,0,6,2.8,2.3,2.4,1,1,1,1,3.3,1,2.4
6975,0,Asia Pacific,Manufacturing,Supply Chain,Meets,Female,39,8,0,7,4.6,3.3,1,1,1,1,1,5,3.7,1.9
6976,0,North America,Digital,Marketing,Meets,Male,41,19,0,8,1.6,4.5,2.6,1,1,1,1,1.4,4.3,2.1
6977,0,Europe,HR,Legal & Compliance,Meets,Male,33,9,0,9,4,3.4,1.2,1,1,1,1,5,3.3,2.7
6978,0,Asia Pacific,Commercial,Supply Chain,Exceeds,Female,36,8,1,5,,3.8,2.1,1,1,1,1,2,4,2.8
6979,0,Asia Pacific,HR,Human Resources,Meets,Male,37,5,0,6,3.6,5,1.8,1,1,1,0,3,4.8,3.8
6980,0,North America,Finance,Sales,Far Below,Male,48,10,0,11,2.6,2.8,2.8,1,1,1,1,4.3,4.5,2.3
6981,0,Middle East & Africa,Commercial,Legal & Compliance,Far Below,Male,39,7,0,10,4.1,1.2,2.2,1,1,0,0,4.9,1.9,2.9
6982,0,Europe,Digital,Medical Affairs,Meets,Female,35,11,0,8,2.9,2.2,1.8,1,1,1,1,2.5,2.7,3
6983,0,Asia Pacific,Manufacturing,Communications,Meets,Male,31,35,0,8,2.2,3.4,3.4,1,1,1,1,2,3.5,2.2
6984,0,Latin America,R&D,Communications,Meets,Female,28,21,1,10,,2.2,2.2,1,1,1,1,2,2.6,2.9
6985,0,Asia Pacific,HR,Supply Chain,Meets,Male,37,7,0,12,3.1,3.9,2.8,1,1,1,1,3.1,4.1,4
6986,0,Europe,Commercial,Data Science,Meets,Male,39,9,0,11,2.7,2,2.8,1,1,1,1,4.4,2.7,2.6
6987,0,Asia Pacific,Digital,Finance & Accounting,Below,Female,31,17,0,9,3.3,2,1.9,1,1,1,1,4.5,2.7,2.4
6988,0,North America,R&D,Market Access,Exceeds,Male,29,16,0,5,2.5,1.8,2.6,1,1,1,1,3.7,2.1,2.6
6989,0,Asia Pacific,Digital,Supply Chain,Meets,Male,41,15,0,12,2.9,5,2,1,1,1,1,2.3,2,2.3
6990,0,Asia Pacific,Manufacturing,Regulatory Affairs,Below,Female,44,5,1,7,,2.9,2.5,1,1,1,1,2.7,3.4,2.9
6991,0,Latin America,R&D,IT & Digital,Below,Male,36,3,1,10,,2.8,2.2,1,1,1,1,2.9,2.9,3.2
6992,1,North America,R&D,IT & Digital,Far Exceeds,Female,41,18,0,9,3.3,3.9,3,1,1,1,1,2.9,4.1,1.5
6993,0,North America,R&D,Quality Assurance,Meets,Male,37,3,1,5,,3.7,3.2,1,1,1,1,4,4.1,3.3
6994,0,Asia Pacific,Commercial,IT & Digital,Meets,Female,54,6,0,10,4.5,4.5,1,1,1,1,1,4.4,3.2,2.6
6995,0,Latin America,R&D,Marketing,Meets,Female,38,4,1,5,,4.9,1.7,1,1,1,1,3.7,5,1.6
6996,0,Asia Pacific,Digital,IT & Digital,Meets,Male,46,8,0,6,3.3,4.2,1.8,0,0,0,0,3.5,5,3
6997,0,Asia Pacific,Commercial,Communications,Meets,Male,41,7,0,11,1.3,3.6,2.4,1,1,1,1,1,3.6,1.5
6998,0,Europe,R&D,Data Science,Meets,Male,35,6,1,11,,2.7,4.1,1,1,1,1,2.5,3.9,5
6999,0,Europe,Digital,Data Science,Meets,Non-Binary/Other,42,10,0,7,3.1,4,1,1,1,1,1,4.8,4,1
7000,0,Latin America,Digital,Sales,Below,Female,38,3,0,7,2.9,4.3,3.2,1,1,1,1,3.5,3,1.8
7001,0,Middle East & Africa,HR,Data Science,Meets,Male,32,24,0,8,3,2.8,3.6,1,1,1,1,4,4.3,3.2
7002,0,Europe,Digital,Marketing,Below,Male,39,17,0,5,4.5,2.9,2.1,1,1,1,1,4.5,2.9,2.9
7003,0,Middle East & Africa,Finance,Regulatory Affairs,Exceeds,Male,35,8,1,6,,4.2,2.9,1,1,1,1,3.3,4,2.7
7004,0,North America,Manufacturing,Quality Assurance,Far Below,Female,38,9,0,7,3.5,1,3.3,1,1,1,1,4.3,1.7,2
7005,0,Europe,R&D,Finance & Accounting,Meets,Female,38,11,0,7,3,3.7,2,0,0,0,0,2.4,1.3,1
7006,0,Europe,R&D,Human Resources,Meets,Male,37,12,0,9,4.4,2.4,1.7,1,1,1,0,4.5,2.8,2
7007,0,Latin America,R&D,IT & Digital,Exceeds,Female,32,12,1,9,,2.4,4.8,1,1,1,1,3.4,3.2,2.3
7008,0,Middle East & Africa,Digital,Human Resources,Below,Male,45,13,0,12,4.8,2.4,1.9,1,1,1,1,5,1,1.7
7009,1,Europe,Digital,Pharmacovigilance,Far Exceeds,Female,38,8,0,8,3.4,1.5,2.8,1,1,1,1,3.1,2.6,3.3
7010,0,Europe,R&D,Finance & Accounting,Below,Male,39,12,0,12,4.4,2.8,1.6,1,1,1,1,4,1.6,1
7011,0,Latin America,Finance,Communications,Meets,Female,37,33,0,7,2.6,3.9,3.6,1,1,1,1,2.9,5,3
7012,0,Latin America,Commercial,Supply Chain,Meets,Female,36,14,0,6,3.1,2.3,1,1,1,1,0,4.2,4.4,2.7
7013,0,Middle East & Africa,Commercial,Legal & Compliance,Meets,Female,39,11,1,12,,3.2,2.5,1,1,1,1,4.1,1.2,3
7014,0,North America,Manufacturing,Data Science,Meets,Female,46,12,0,12,4.7,2,2.3,1,1,1,1,5,2.3,2.5
7015,0,North America,HR,Human Resources,Exceeds,Male,29,18,0,7,4.5,1.3,2.5,1,1,1,1,4.7,3.3,3.9
7016,0,Asia Pacific,Manufacturing,Legal & Compliance,Below,Non-Binary/Other,31,10,0,11,3.5,1,4.4,1,1,1,1,3.9,3.1,3.8
7017,0,Europe,R&D,Market Access,Meets,Female,36,11,0,5,4.3,3.3,2.8,1,1,1,1,3.5,3.2,2.4
7018,0,Middle East & Africa,R&D,Medical Affairs,Meets,Male,33,15,0,6,5,4,1,1,1,1,1,3.2,4.4,3
7019,1,Europe,R&D,IT & Digital,Far Exceeds,Male,50,19,1,6,,3.5,2.1,1,1,1,1,4.3,3.7,2.3
7020,0,Middle East & Africa,HR,Market Access,Meets,Female,36,3,0,10,3.3,1.8,2.2,1,1,1,1,3.1,2.2,1
7021,0,Middle East & Africa,Digital,Regulatory Affairs,Below,Male,41,5,1,10,,4.6,4.2,1,1,1,1,3.8,3,4.1
7022,1,Middle East & Africa,HR,Pharmacovigilance,Meets,Male,36,10,1,9,,3.8,2.3,1,1,1,1,3.2,3.6,2.3
7023,0,Europe,Manufacturing,Legal & Compliance,Below,Female,28,16,0,9,2.1,4.1,2.3,1,1,1,1,2.7,3.9,1.6
7024,0,Latin America,Digital,Sales,Meets,Male,36,10,1,12,,4.1,3.3,1,1,1,1,1.9,4.8,3.3
7025,0,Europe,Digital,IT & Digital,Meets,Female,31,11,0,7,3.2,3.7,5,1,1,0,0,3.7,4.9,4.5
7026,0,Middle East & Africa,Manufacturing,Regulatory Affairs,Exceeds,Male,40,5,1,6,,2.8,1,0,0,0,0,3.8,2.3,2.1
7027,1,Asia Pacific,Digital,Market Access,Exceeds,Male,36,17,0,11,3.7,2.3,2.1,1,1,1,1,3.6,3.3,1
7028,0,North America,Commercial,Marketing,Far Below,Female,33,8,0,8,2.5,3.6,1.7,1,1,1,1,2.9,3.1,1.6
7029,0,Middle East & Africa,Manufacturing,Supply Chain,Meets,Female,37,11,0,11,2.3,2.5,2.1,1,1,1,1,4,3.1,4.1
7030,0,Asia Pacific,Manufacturing,Finance & Accounting,Meets,Female,35,23,0,8,3.5,3.3,2.7,1,1,1,1,4.1,4,3
7031,0,Latin America,Commercial,Regulatory Affairs,Meets,Female,44,18,0,6,1.6,3.1,4.7,1,1,1,1,2.5,2.5,3.2
7032,0,Middle East & Africa,HR,Communications,Far Below,Male,41,9,1,6,,2.6,4,1,1,1,1,4.2,1,4.1
7033,0,Asia Pacific,HR,Clinical Operations,Meets,Female,48,14,0,11,3.2,3.3,2.1,1,1,1,0,2.6,3.8,2.1
7034,1,Middle East & Africa,HR,Finance & Accounting,Far Exceeds,Female,42,16,0,8,2.2,3.5,4,1,1,1,1,2.6,3.5,4.4
7035,0,Europe,Digital,Supply Chain,Meets,Female,41,20,0,6,3.3,2.9,3.4,1,1,1,1,3.3,3.1,4.3
7036,0,Asia Pacific,Commercial,Clinical Operations,Meets,Female,42,8,0,6,3.8,1,4,1,0,0,0,4.9,3.1,3.5
7037,0,Europe,Manufacturing,Data Science,Meets,Female,42,7,0,7,3.6,3,4.2,1,1,1,1,3.8,2.8,4.3
7038,0,Europe,Manufacturing,Medical Affairs,Exceeds,Male,28,16,0,11,4.5,2.6,1.1,1,1,1,1,5,4.1,2
7039,0,Asia Pacific,Manufacturing,Regulatory Affairs,Far Below,Female,41,21,0,6,3.8,1.9,2.1,1,1,1,1,3.2,3.4,1.7
7040,0,North America,Digital,Supply Chain,Meets,Female,28,3,1,8,,4.9,3,1,1,1,1,3.5,3.7,2.6
7041,0,Asia Pacific,Digital,Sales,Exceeds,Male,28,2,0,8,3.1,2.3,2.5,1,1,1,1,2.2,4.2,3.8
7042,0,North America,Finance,Clinical Operations,Below,Female,31,5,0,8,2.7,4.3,3.3,1,1,1,1,1.5,4.7,3.4
7043,0,Middle East & Africa,HR,IT & Digital,Meets,Female,40,5,1,5,,3.1,1.6,0,0,0,0,2.1,2.3,2
7044,0,Middle East & Africa,Finance,IT & Digital,Below,Male,30,14,0,8,4.4,3,3.1,1,1,1,1,4.6,3.5,2.3
7045,0,Asia Pacific,Finance,Quality Assurance,Exceeds,Female,41,7,0,10,2.8,3.6,2.4,1,1,1,1,3.8,3.4,2
7046,0,Middle East & Africa,Digital,Market Access,Meets,Male,48,2,1,7,,4.8,2.8,1,1,1,1,4.5,3.6,2.4
7047,0,Latin America,HR,Supply Chain,Far Exceeds,Female,36,22,0,10,2.6,3.1,4.6,1,1,1,1,3.1,1.6,4.2
7048,0,Europe,HR,Medical Affairs,Exceeds,Male,39,6,1,7,,2.6,2.7,1,1,1,1,4.2,2.7,3.4
7049,1,Europe,Manufacturing,Regulatory Affairs,Meets,Male,34,3,1,10,,3.7,3.3,1,1,1,1,3.4,2.9,1.8
7050,0,North America,Digital,Communications,Meets,Male,31,9,0,11,2,4.1,2.4,1,1,1,1,2.8,2,1.9
7051,0,Middle East & Africa,HR,Supply Chain,Meets,Female,37,9,1,7,,3.6,1,1,1,1,1,3.9,2.8,2.3
7052,0,North America,Finance,Human Resources,Below,Male,33,10,0,7,3,3.9,2.7,1,1,1,1,4.1,2.3,2.5
7053,0,Europe,Commercial,Regulatory Affairs,Meets,Female,35,15,0,7,2,4.1,3.3,0,0,0,0,2.1,4.1,4.4
7054,0,Europe,Commercial,Marketing,Far Below,Male,34,9,0,5,2,4.1,3.4,1,1,1,1,2.9,2.3,3.4
7055,0,Middle East & Africa,Digital,Clinical Operations,Meets,Female,30,12,0,9,4.1,3.1,2.2,1,1,1,1,3,3.9,3.2
7056,0,Latin America,Manufacturing,Legal & Compliance,Exceeds,Female,37,17,0,12,4.5,4.4,2,1,1,1,1,4.6,2.9,1.9
7057,0,Latin America,Manufacturing,Supply Chain,Exceeds,Female,28,11,0,10,3.3,2.8,4.5,1,1,1,1,4,2.2,2.6
7058,0,Middle East & Africa,HR,Supply Chain,Meets,Male,41,4,0,8,4.8,4.4,4.9,1,1,1,1,4.6,3.2,3.4
7059,0,Middle East & Africa,Digital,IT & Digital,Meets,Male,28,5,1,6,,4.6,1,1,1,1,1,2.7,3.5,2.9
7060,0,North America,Commercial,Medical Affairs,Exceeds,Female,34,25,0,9,3.5,3.9,2.9,1,1,1,1,3.2,3.3,2.8
7061,0,Middle East & Africa,Finance,Medical Affairs,Exceeds,Female,45,3,1,6,,4.1,3.2,1,1,1,1,5,3.2,3.3
7062,0,Latin America,HR,Communications,Meets,Male,42,4,0,7,3.9,4.1,3.1,1,1,1,1,4.7,2.8,3.8
7063,0,Middle East & Africa,Finance,Market Access,Below,Male,38,16,0,11,1.8,3.2,3.5,1,1,1,1,2.9,2.3,2.9
7064,1,North America,HR,Sales,Meets,Male,51,5,1,11,,3.7,3.1,1,1,1,1,3.6,2.6,3.7
7065,0,North America,R&D,Regulatory Affairs,Meets,Male,39,21,1,7,,4.6,1.2,1,1,1,1,3.5,3.2,2
7066,0,North America,Finance,Pharmacovigilance,Meets,Male,44,12,1,10,,2.2,2.6,1,1,0,0,4.4,2.4,2.2
7067,1,North America,Digital,Market Access,Far Exceeds,Female,34,9,0,7,2.3,4.3,3,1,1,1,1,4,3.2,2.3
7068,0,Asia Pacific,Finance,Medical Affairs,Exceeds,Female,28,8,0,8,4.5,1,1.3,0,0,0,0,3.8,2.3,1.7
7069,0,Middle East & Africa,Finance,Human Resources,Meets,Non-Binary/Other,39,19,0,11,3.7,2.6,1.6,1,1,1,1,3.1,3.8,3.2
7070,0,Europe,HR,Pharmacovigilance,Below,Male,41,15,0,9,3.6,3.2,1.5,1,1,1,1,3.4,3.4,2
7071,0,Middle East & Africa,Commercial,Legal & Compliance,Meets,Female,40,6,1,6,,3,1,1,1,1,1,3.2,3.6,1
7072,0,Asia Pacific,R&D,Data Science,Below,Male,29,18,1,11,,4.1,3.1,1,1,1,1,2.8,1.4,1.8
7073,0,North America,Finance,Pharmacovigilance,Meets,Male,55,1,1,10,,1.6,1.7,1,1,1,1,3.9,2.7,2.4
7074,0,Asia Pacific,Commercial,Clinical Operations,Exceeds,Female,31,11,0,10,3.6,3.7,2.9,1,1,1,1,4.6,3.5,2
7075,0,Latin America,Manufacturing,Supply Chain,Meets,Female,39,5,0,12,3.5,2.3,2,1,1,1,1,3.9,3.8,3.1
7076,0,Latin America,R&D,Medical Affairs,Meets,Non-Binary/Other,40,19,0,8,3,4,4.3,1,1,1,1,4.2,5,4.1
7077,0,Middle East & Africa,R&D,Supply Chain,Below,Female,43,3,1,10,,2,2.3,1,1,1,1,4,3.4,2.8
7078,0,Middle East & Africa,HR,Legal & Compliance,Meets,Male,34,12,0,5,3.2,3.5,2.5,1,1,1,1,3.1,4.3,3.3
7079,0,Europe,Finance,Market Access,Exceeds,Male,41,25,1,10,,4.4,2.4,1,0,0,0,3.5,4.1,2.8
7080,1,Europe,Manufacturing,Communications,Meets,Female,48,20,1,11,,2.4,2.1,0,0,0,0,4,4.3,4
7081,0,Latin America,HR,Marketing,Below,Female,35,22,0,5,1.3,3.1,1.3,1,1,1,1,2.5,3.3,2.6
7082,0,North America,Digital,Medical Affairs,Exceeds,Male,35,7,0,6,4,3,3.2,0,0,0,0,5,2.9,4.9
7083,0,Asia Pacific,Commercial,Medical Affairs,Meets,Male,32,19,0,5,1.9,2.8,3.2,1,1,1,1,3.9,3.3,2.3
7084,0,Europe,Commercial,Quality Assurance,Meets,Female,39,9,1,11,,3,1.6,1,1,1,1,3.8,2.3,2.3
7085,0,Europe,HR,Supply Chain,Below,Female,33,9,0,10,4.1,1.6,2.6,1,1,1,1,3.6,1,1.8
7086,0,North America,Commercial,Medical Affairs,Meets,Male,42,5,0,7,2.9,3.6,4.2,1,1,1,1,4.4,2.6,3.9
7087,0,North America,Finance,Human Resources,Far Below,Non-Binary/Other,35,7,0,9,2.9,2.9,3.4,1,1,1,1,3.3,4.2,3.5
7088,0,Middle East & Africa,Commercial,Marketing,Meets,Female,37,6,0,8,2.9,3,3.2,1,0,0,0,3.3,3.5,3
7089,0,Asia Pacific,Finance,Marketing,Meets,Male,32,20,0,5,3.5,4,1.9,1,1,1,0,2.7,4.7,2.6
7090,0,North America,Digital,Clinical Operations,Meets,Male,51,5,1,6,,2.5,3.1,1,1,1,1,2.6,2.9,1.6
7091,0,Europe,Manufacturing,Finance & Accounting,Exceeds,Female,39,5,0,9,3.8,3.2,1.9,1,1,1,1,2.6,2.4,1
7092,0,Europe,R&D,Regulatory Affairs,Far Below,Male,31,9,1,9,,1,3.9,1,1,1,1,3.7,2.4,3.8
7093,0,Latin America,HR,Medical Affairs,Exceeds,Female,40,26,0,10,4.9,5,2.6,1,1,1,1,4.6,3.5,3.9
7094,0,North America,HR,Marketing,Meets,Female,28,12,0,6,3,4.3,4,1,1,1,1,2.3,3.3,2.1
7095,0,Middle East & Africa,Finance,Marketing,Meets,Male,34,7,0,6,4.5,2.8,2.8,1,1,1,1,4.4,4.2,3.5
7096,0,Asia Pacific,Digital,Clinical Operations,Meets,Female,41,7,0,5,3.3,4.9,1.4,1,0,0,0,2.9,5,2.7
7097,0,Middle East & Africa,Digital,Quality Assurance,Below,Female,41,5,0,6,3,3.5,2.3,1,1,1,1,3.2,3,3.5
7098,0,Europe,R&D,Regulatory Affairs,Meets,Male,43,12,0,11,3.4,1,1.2,0,0,0,0,4.6,2.3,1.9
7099,0,Middle East & Africa,Manufacturing,Finance & Accounting,Meets,Female,46,6,0,12,3.4,2.3,1.4,1,1,1,1,3.7,3.1,1.2
7100,1,Europe,HR,Sales,Exceeds,Female,37,14,0,7,3.6,3.6,1.7,1,1,1,1,2.9,3.9,3.1
7101,0,Europe,Finance,Medical Affairs,Far Exceeds,Female,43,1,1,9,,2.6,1.9,1,1,1,1,2.6,3.5,2.2
7102,0,Europe,Digital,Sales,Far Below,Male,43,16,0,6,3.4,2.6,3,1,1,1,1,2.3,3.3,1.9
7103,0,Europe,HR,Sales,Meets,Female,43,19,0,5,2.8,3.5,2.6,1,1,1,1,3.5,4.3,2.8
7104,0,Europe,Finance,Communications,Meets,Male,29,6,0,7,4.9,4,1.6,1,1,1,1,4.5,3.9,1
7105,0,Latin America,Commercial,Market Access,Meets,Female,40,13,0,7,2.6,2.4,2.7,1,1,1,1,3.5,1.8,4.3
7106,0,Middle East & Africa,HR,Quality Assurance,Exceeds,Male,36,7,0,9,2.8,4.9,2,1,1,1,1,1.8,5,2.1
7107,0,Latin America,Manufacturing,Market Access,Far Below,Female,46,7,0,6,2.8,3,1.5,0,0,0,0,4.5,2.5,1.3
7108,0,Latin America,Finance,Supply Chain,Meets,Male,39,6,1,6,,3.1,3.3,1,1,1,1,3.7,2.4,3.2
7109,0,North America,Manufacturing,IT & Digital,Meets,Male,36,27,1,6,,3,1.9,0,0,0,0,4.3,3.5,1.6
7110,0,North America,HR,Legal & Compliance,Meets,Male,36,10,0,5,2.7,1.9,3.3,1,1,1,1,4,2.8,3.5
7111,0,North America,Commercial,Pharmacovigilance,Meets,Female,36,20,1,9,,2.4,3.3,1,1,1,1,4.5,4,4.2
7112,0,Asia Pacific,Manufacturing,IT & Digital,Below,Male,39,13,0,5,2.5,1.7,2.7,1,1,0,0,3.2,1.5,2.7
7113,0,North America,Digital,Human Resources,Meets,Female,40,3,0,10,4.1,1.8,5,1,1,1,1,3,3.2,5
7114,0,Middle East & Africa,Finance,Finance & Accounting,Meets,Male,37,24,0,12,4.3,2.1,2.6,1,1,1,1,3,1.5,3.1
7115,0,Latin America,HR,Communications,Meets,Female,36,12,0,6,2.1,2.7,2.4,1,1,1,1,1.5,3.6,2.2
7116,0,Middle East & Africa,Commercial,Clinical Operations,Below,Female,32,13,0,6,2.9,2.3,1.5,1,1,1,1,3.3,1.1,3.3
7117,0,North America,Digital,Marketing,Far Exceeds,Male,47,17,0,12,4,2.6,4.1,1,1,1,1,3.8,5,2.7
7118,0,Asia Pacific,HR,Marketing,Exceeds,Male,36,10,0,11,2.6,3.2,3.4,1,1,1,1,2.9,2.9,3.6
7119,0,Asia Pacific,Commercial,Regulatory Affairs,Exceeds,Male,39,3,1,7,,2.4,3.4,1,1,1,1,3.8,3.1,3.4
7120,0,Latin America,Digital,Human Resources,Far Exceeds,Female,40,25,0,11,2.7,3.1,1.8,0,0,0,0,2.8,3.3,2.1
7121,0,Middle East & Africa,Manufacturing,Quality Assurance,Below,Male,40,16,0,8,3.9,4.6,3.2,1,1,1,1,3.3,3,4.3
7122,0,Europe,HR,Marketing,Below,Female,35,14,0,8,3.6,2.6,2.5,1,1,1,1,3.6,3.1,2.5
7123,0,Middle East & Africa,HR,Human Resources,Far Below,Male,42,21,0,6,4.1,2.8,3.2,1,1,1,1,3.9,2.9,3
7124,0,North America,Manufacturing,Finance & Accounting,Exceeds,Male,47,2,0,10,3.6,3.4,2.7,1,1,1,1,4.1,2.9,2.8
7125,0,Europe,R&D,Market Access,Meets,Female,42,18,1,8,,4,2.7,1,1,1,1,4.4,4.3,3.1
7126,0,Asia Pacific,Digital,Pharmacovigilance,Meets,Male,41,13,0,8,3.6,2.7,2.2,1,1,1,1,3.7,1.6,1.8
7127,0,Latin America,Manufacturing,Market Access,Exceeds,Female,42,13,1,5,,2.3,1.9,1,1,1,1,3.3,4,3
7128,0,Latin America,HR,Sales,Meets,Female,38,8,0,10,5,3.8,2.1,1,1,1,1,2.9,3.4,3.3
7129,0,Asia Pacific,Digital,Supply Chain,Below,Male,36,5,1,11,,3.8,3.6,1,1,1,1,3.3,2.8,3.5
7130,0,North America,Digital,Marketing,Below,Female,49,11,0,8,3.3,2.5,4.3,1,1,1,1,3.6,4,3.8
7131,0,Asia Pacific,R&D,Human Resources,Below,Male,47,13,1,10,,3.4,3.5,1,1,1,1,3.5,4.3,2.2
7132,0,North America,HR,Communications,Meets,Female,35,2,1,7,,4.3,3.8,1,1,1,1,4,2.7,3.9
7133,0,Europe,Commercial,Sales,Meets,Male,45,17,0,12,3.1,4.6,1.4,1,1,1,1,2.6,4.1,1
7134,0,Asia Pacific,R&D,Marketing,Meets,Female,41,12,0,10,3.5,4.2,3.1,1,0,0,0,3.8,3.3,3.8
7135,0,North America,R&D,Medical Affairs,Below,Male,39,12,0,5,3.2,3.5,1.7,1,1,1,1,1.9,4.2,1.9
7136,0,Europe,Commercial,Data Science,Meets,Female,47,9,1,11,,2.7,2.5,1,1,1,1,3.3,2.2,1.7
7137,0,Asia Pacific,Commercial,Finance & Accounting,Meets,Female,39,13,0,10,3.2,2.8,2.8,1,1,1,1,4.6,2.3,3.5
7138,0,Latin America,R&D,Clinical Operations,Far Exceeds,Male,40,16,0,9,3.9,3,2.4,1,1,1,1,3.4,2.9,2.5
7139,0,Asia Pacific,Digital,Clinical Operations,Meets,Male,41,25,0,10,4,3.2,4.1,1,1,1,1,4,3.2,2.8
7140,0,Middle East & Africa,Manufacturing,Marketing,Far Exceeds,Female,31,28,0,7,3.2,3.8,1.3,1,1,1,1,3,4.3,1.9
7141,0,Asia Pacific,Manufacturing,Legal & Compliance,Meets,Male,40,22,0,12,1.9,2.8,1,1,1,1,1,2.7,1.7,3.1
7142,0,Middle East & Africa,R&D,Pharmacovigilance,Below,Female,30,10,0,12,3.7,2.8,1.5,1,0,0,0,3.4,1.9,1
7143,0,Europe,Digital,Quality Assurance,Meets,Female,42,3,1,6,,3.8,2.4,0,0,0,0,2.6,3.6,3.2
7144,0,Asia Pacific,Commercial,IT & Digital,Below,Female,41,12,0,10,2.8,1.9,3.3,1,1,1,1,3.5,3.4,4
7145,0,Europe,Finance,Regulatory Affairs,Meets,Female,45,9,0,9,2.5,3.5,2.9,1,1,1,1,2.1,3.8,2.9
7146,0,Europe,R&D,Pharmacovigilance,Meets,Male,42,12,0,8,3.1,3.2,3.8,1,1,1,1,3.3,4.4,4.1
7147,0,North America,HR,Quality Assurance,Meets,Female,53,8,0,6,3.1,3,1,1,0,0,0,4.5,3.5,2
7148,0,Europe,Digital,Legal & Compliance,Exceeds,Male,30,10,0,11,3.3,2.3,3.4,1,1,1,1,3.4,2.8,4
7149,0,Europe,HR,Legal & Compliance,Meets,Male,38,6,1,6,,2.7,3,1,1,1,1,3.3,3.3,4
7150,0,Asia Pacific,HR,IT & Digital,Far Exceeds,Male,44,6,0,8,3.3,3.6,2.6,0,0,0,0,2.2,3.8,2.6
7151,0,Asia Pacific,R&D,Pharmacovigilance,Meets,Female,45,8,0,6,1.4,3.1,2.6,1,0,0,0,3.5,1.6,3
7152,0,Latin America,Digital,Medical Affairs,Meets,Male,35,11,0,9,4.2,3.9,3.4,0,0,0,0,4,3.3,2.8
7153,0,North America,HR,Pharmacovigilance,Meets,Female,45,6,0,6,2.4,3.9,3.6,1,1,1,1,4.7,4.4,3.7
7154,0,Europe,Digital,Regulatory Affairs,Exceeds,Male,29,2,0,6,2.9,2,2.4,1,1,1,1,1.9,2.8,2.1
7155,0,North America,Manufacturing,Finance & Accounting,Meets,Male,33,5,0,12,2.3,1,3.3,1,1,0,0,2.8,1,3.9
7156,0,Middle East & Africa,Finance,Clinical Operations,Meets,Female,40,9,1,5,,3.2,1.6,1,1,1,1,4.3,4.1,2.2
7157,0,Europe,HR,Finance & Accounting,Meets,Male,40,12,0,12,3.6,2.8,4.1,1,1,1,0,4,1,4.4
7158,0,North America,HR,Pharmacovigilance,Far Below,Male,46,10,0,9,3.1,2.9,3,1,1,1,1,2.8,2.2,3.2
7159,0,Latin America,Digital,Market Access,Below,Female,43,12,1,8,,3.1,2.3,1,1,1,1,1.9,3.1,2.1
7160,0,Latin America,Finance,Quality Assurance,Meets,Male,35,9,1,11,,2.3,4.2,1,1,1,1,3.8,2.6,4.9
7161,0,Europe,Manufacturing,Supply Chain,Far Exceeds,Male,46,7,1,7,,3.3,3.6,1,1,1,1,3.1,3,3.1
7162,0,Middle East & Africa,HR,Legal & Compliance,Exceeds,Male,41,10,1,7,,3.4,3.1,1,1,1,1,4.5,2.7,3.4
7163,0,Latin America,R&D,Finance & Accounting,Meets,Female,43,9,1,10,,2.6,1.7,1,1,0,0,4.2,2.7,1.6
7164,0,Latin America,Digital,Quality Assurance,Meets,Female,43,11,0,10,2,3.4,1.6,1,1,1,1,2.9,1.6,1.5
7165,0,Middle East & Africa,Digital,IT & Digital,Meets,Male,37,15,0,11,4,2,1.9,1,1,1,1,3.8,1.4,3.6
7166,0,North America,HR,Clinical Operations,Far Below,Male,44,10,1,6,,2.8,2.6,1,1,1,1,3.5,2.8,2.6
7167,0,Latin America,Manufacturing,Legal & Compliance,Meets,Male,40,28,0,9,3.9,2.8,2.7,1,1,1,1,4.6,4.8,1.9
7168,0,Asia Pacific,HR,Pharmacovigilance,Meets,Male,43,6,0,11,3.7,4.4,3.9,1,1,1,1,3.1,3.8,4.6
7169,0,Latin America,Commercial,IT & Digital,Meets,Female,47,10,0,6,1.3,3.3,1,1,1,1,1,2.5,4.7,2.8
7170,0,North America,HR,Market Access,Meets,Male,37,20,0,8,3.4,4.1,2.2,0,0,0,0,2.7,3.9,1
7171,0,North America,Finance,Human Resources,Exceeds,Female,44,16,0,6,2.5,3.1,3.3,1,1,1,1,3.6,3.8,3.4
7172,0,Europe,Finance,Pharmacovigilance,Meets,Female,36,17,1,6,,2.5,2.5,1,1,1,1,3.9,2.3,2.2
7173,0,Asia Pacific,Commercial,Communications,Meets,Female,35,2,1,5,,3,3.2,1,1,1,1,3.5,3.7,2.4
7174,0,North America,Finance,IT & Digital,Meets,Male,38,16,0,9,2.3,2.2,1.4,1,1,1,1,2.9,3.7,2.6
7175,0,Middle East & Africa,Finance,Human Resources,Meets,Female,38,9,1,9,,2.9,2.8,1,1,1,1,1.9,4.4,3.3
7176,1,Asia Pacific,R&D,Pharmacovigilance,Meets,Female,41,3,1,5,,4.4,1.6,1,0,0,0,3.6,3.5,3.9
7177,0,Asia Pacific,Digital,Finance & Accounting,Meets,Male,31,5,0,8,3,3.7,3.1,1,1,1,1,3.2,1.8,3
7178,0,Middle East & Africa,Finance,Legal & Compliance,Meets,Female,41,4,1,11,,3.7,2.7,1,1,1,1,4.1,4,3.7
7179,1,Latin America,Digital,Marketing,Meets,Female,37,6,0,7,4.6,3.9,1.8,1,1,1,1,5,5,1.9
7180,0,Middle East & Africa,Manufacturing,Medical Affairs,Meets,Male,28,13,1,11,,3,1.8,1,0,0,0,3.5,2.7,1.7
7181,0,Middle East & Africa,HR,Finance & Accounting,Below,Female,40,10,0,12,3.2,3.1,3.3,1,1,1,1,2.1,2.9,4.2
7182,0,Latin America,R&D,Regulatory Affairs,Meets,Male,46,5,0,6,2.5,3,2.6,1,1,1,1,2.2,2.9,2.3
7183,0,Latin America,Commercial,Human Resources,Meets,Male,44,7,0,8,2.4,3.8,3.8,1,1,1,1,2.9,2.6,3.1
7184,0,Latin America,Manufacturing,Medical Affairs,Meets,Female,38,19,0,7,4.3,2.9,2.6,1,1,0,0,4.7,1.4,2.8
7185,0,Latin America,R&D,Supply Chain,Meets,Non-Binary/Other,35,20,0,6,2.8,2.1,2.9,1,1,1,1,4.2,4.4,2.8
7186,0,Latin America,R&D,Clinical Operations,Meets,Female,43,19,0,8,3,2.6,3.2,1,1,1,1,2.7,3.2,4.2
7187,0,Middle East & Africa,Commercial,Legal & Compliance,Meets,Male,35,21,0,10,3.7,5,4.1,1,1,1,1,3.4,3.4,4.3
7188,0,Europe,Commercial,Pharmacovigilance,Exceeds,Female,38,12,0,11,4.2,4,3.2,1,1,1,1,2.4,4.5,3.2
7189,0,Europe,Digital,Data Science,Exceeds,Female,53,3,0,12,3.1,2.6,3.1,1,1,1,1,2,2.3,2.2
7190,0,North America,HR,Finance & Accounting,Meets,Female,47,8,0,11,2.6,1.3,2.4,1,1,1,1,1.7,2.9,2.3
7191,0,Europe,Manufacturing,Finance & Accounting,Meets,Female,37,6,0,10,1.9,3.6,3.2,1,1,1,1,2.5,3.6,3.3
7192,0,Europe,HR,Medical Affairs,Meets,Female,42,8,0,11,5,3.8,2.7,1,1,1,1,4.4,3.6,3.6
7193,0,Middle East & Africa,Manufacturing,IT & Digital,Far Below,Male,48,14,0,11,4,4.4,3.8,1,1,1,1,4.6,2.8,3.2
7194,0,Latin America,R&D,Sales,Meets,Male,41,14,0,11,3.9,3.2,3,1,1,1,1,4.5,3.2,2.4
7195,0,Latin America,Finance,IT & Digital,Meets,Male,31,15,1,7,,2.9,2.8,1,1,1,1,2.7,3.7,1.8
7196,0,Middle East & Africa,Finance,Finance & Accounting,Meets,Female,40,13,0,10,2.9,4,2.4,1,1,1,1,2.7,4.4,2.6
7197,0,Europe,Commercial,Data Science,Below,Male,37,10,0,9,3.5,3.8,3.1,1,1,0,0,3.1,3.1,1.6
7198,1,Middle East & Africa,Commercial,Medical Affairs,Far Exceeds,Female,37,9,0,9,2.9,3.9,3.5,1,1,1,1,3.3,3.7,2.6
7199,0,North America,R&D,Sales,Meets,Male,34,15,0,11,2.5,1.9,3.2,1,1,1,1,2.8,2.2,3.1
7200,0,Latin America,R&D,IT & Digital,Meets,Non-Binary/Other,31,18,0,10,2.3,4.3,1.8,0,0,0,0,3,3.1,3.6
7201,0,Asia Pacific,Manufacturing,Clinical Operations,Below,Male,35,6,0,9,3.3,3.3,2.6,1,1,1,1,3.7,2.9,2.1
7202,1,North America,R&D,Legal & Compliance,Meets,Male,43,5,1,11,,3,3.8,1,1,0,0,4,3.3,4.1
7203,0,North America,Manufacturing,Pharmacovigilance,Below,Male,44,13,0,10,2.9,2.6,1.8,1,1,1,1,2.7,3.9,2.6
7204,0,Middle East & Africa,HR,Market Access,Meets,Male,51,5,0,5,2.9,4.3,4.1,1,1,1,1,4.5,4.2,4
7205,0,Europe,Commercial,Finance & Accounting,Meets,Female,35,12,0,7,3.6,1.9,3.2,1,1,1,1,2.7,1.3,2.9
7206,0,Latin America,Commercial,Market Access,Exceeds,Female,33,24,0,7,2.1,1.4,2.4,1,1,1,1,1,2.3,2
7207,0,Asia Pacific,Finance,Finance & Accounting,Meets,Female,43,4,1,11,,1.8,3.4,1,1,1,1,5,3.4,2.9
7208,0,North America,Finance,Legal & Compliance,Meets,Female,29,20,0,12,2.3,4.2,2.1,1,1,1,1,3.9,2.8,2.7
7209,0,Asia Pacific,Commercial,Medical Affairs,Below,Male,28,13,0,10,3.8,2.7,3,1,1,1,0,5,1,2.5
7210,0,Europe,HR,Finance & Accounting,Meets,Female,43,19,0,7,1.2,1,2.5,1,1,1,1,3.5,2.5,2.3
7211,0,Europe,HR,Pharmacovigilance,Exceeds,Female,33,27,0,6,3.4,2.7,2.8,1,1,1,1,5,4,2.6
7212,0,Asia Pacific,Digital,Medical Affairs,Meets,Female,34,16,0,8,3,4.2,2.4,1,1,1,1,2.9,4.2,2.7
7213,1,Latin America,Manufacturing,Legal & Compliance,Meets,Male,42,8,0,6,4.1,2,1.1,1,1,1,1,3.8,4.1,1.1
7214,0,Europe,Finance,Clinical Operations,Meets,Male,38,21,0,5,2.9,3.3,2.5,1,1,1,1,2.8,3.6,2.8
7215,0,Asia Pacific,Manufacturing,IT & Digital,Meets,Male,36,5,0,6,3.7,2.2,2.9,1,1,1,1,3,2.2,3.3
7216,0,North America,Finance,Sales,Below,Male,30,16,0,7,3.3,5,3,1,1,1,1,2.9,3.7,2.5
7217,0,Asia Pacific,Digital,Finance & Accounting,Meets,Male,35,10,0,8,2.6,2.5,4.2,1,1,1,1,2.2,2.7,4.2
7218,0,Asia Pacific,Commercial,Pharmacovigilance,Below,Male,35,7,1,7,,1.8,4.8,1,1,1,1,2.9,3,2.5
7219,0,Middle East & Africa,Manufacturing,Data Science,Meets,Male,36,7,1,10,,3.2,2.1,0,0,0,0,5,2.3,1.9
7220,0,Europe,Finance,Sales,Below,Male,42,8,0,9,4.3,2.7,2.4,1,1,1,1,2.8,2.4,2.2
7221,0,Latin America,Manufacturing,Data Science,Below,Female,40,9,0,11,3.7,2.4,3.1,1,1,1,1,4.6,3.9,1.9
7222,0,Latin America,Commercial,IT & Digital,Meets,Female,37,8,1,6,,3.7,5,1,1,1,0,3,1.7,4.1
7223,0,Middle East & Africa,R&D,Data Science,Exceeds,Male,39,13,0,8,3.3,3,4.8,1,1,1,1,2.9,1.9,3.7
7224,0,Latin America,Finance,Clinical Operations,Far Exceeds,Female,49,26,0,8,2.1,2.5,3,1,1,1,1,2.5,1,2.7
7225,0,Asia Pacific,R&D,Regulatory Affairs,Exceeds,Female,40,10,0,10,2.7,2.4,1.8,1,1,1,1,1.6,1,1
7226,0,Middle East & Africa,Digital,Regulatory Affairs,Meets,Male,47,15,0,8,3.3,2.2,1.3,0,0,0,0,4.6,4.1,2.7
7227,0,North America,HR,Pharmacovigilance,Meets,Male,35,8,1,5,,3,1.3,1,1,1,1,2.6,2.4,2.5
7228,0,Europe,Manufacturing,Supply Chain,Exceeds,Male,37,9,1,10,,2.9,3.4,1,1,1,1,2.3,3.6,3.6
7229,0,Europe,Finance,Quality Assurance,Exceeds,Female,36,18,0,12,4.5,2.6,3.1,1,1,0,0,4.2,3.9,4.1
7230,0,Europe,Manufacturing,Regulatory Affairs,Meets,Male,40,9,0,6,2.6,2.9,3.6,1,1,1,1,3.7,4.2,1.8
7231,1,Asia Pacific,Digital,Pharmacovigilance,Meets,Female,41,10,0,5,4.3,2.1,3.8,1,1,1,1,4.4,2.6,2.2
7232,0,North America,Digital,Finance & Accounting,Meets,Female,41,28,0,12,2.5,3.3,3.5,1,0,0,0,3.4,3.8,3.8
7233,0,Middle East & Africa,Manufacturing,Data Science,Exceeds,Female,28,5,0,6,1.7,2.2,3.3,1,1,1,1,1.6,2.8,5
7234,0,Middle East & Africa,Finance,Market Access,Meets,Male,33,6,1,10,,5,3.5,1,1,1,1,3.4,4,3.1
7235,0,Europe,Commercial,Finance & Accounting,Meets,Male,40,5,1,8,,2.9,1.6,1,1,1,1,1.6,2.5,4.6
7236,0,North America,Commercial,Regulatory Affairs,Far Exceeds,Male,49,8,0,5,3.4,2.8,3.9,1,1,1,1,3.5,3.5,3
7237,0,North America,HR,IT & Digital,Meets,Male,35,12,0,5,2.7,3.8,2.7,1,1,1,1,3.2,4.8,2.6
7238,0,North America,Manufacturing,Clinical Operations,Meets,Female,51,27,0,6,4.5,3.6,3.6,1,1,1,1,3.5,3.5,2.2
7239,0,Latin America,Manufacturing,Pharmacovigilance,Meets,Female,30,7,0,9,4.1,1.6,3.1,1,1,1,1,5,3.9,3.4
7240,0,Latin America,Finance,Quality Assurance,Below,Female,39,12,0,5,3.8,3.9,3.9,1,1,1,1,3.4,5,4.8
7241,0,Europe,Manufacturing,Finance & Accounting,Meets,Male,37,12,0,6,3.4,2.2,3.8,1,1,1,1,3.8,2.9,4.1
7242,1,North America,Finance,Communications,Meets,Male,35,16,0,6,3.7,2.7,3.3,1,1,1,1,5,3.8,4.4
7243,0,North America,Manufacturing,IT & Digital,Meets,Female,43,1,1,10,,2.5,3.6,1,1,0,0,3.2,2.7,1.7
7244,1,Middle East & Africa,Digital,Human Resources,Meets,Female,38,12,0,12,2.3,2.9,4.7,1,1,1,1,4,3.6,3.7
7245,0,Middle East & Africa,R&D,Medical Affairs,Far Below,Male,29,10,1,6,,4.1,3.2,1,1,1,1,3.4,2.8,2.7
7246,0,Europe,Manufacturing,Supply Chain,Far Exceeds,Female,28,12,0,12,3.4,2.2,1.2,1,1,1,1,3.6,3.2,1
7247,1,North America,R&D,IT & Digital,Exceeds,Male,32,8,0,5,3.4,2.5,3.5,1,1,1,1,4.7,2.9,3.8
7248,0,Europe,Commercial,Legal & Compliance,Meets,Male,42,28,0,5,4.7,3,2.3,0,0,0,0,3.5,2.2,2.8
7249,0,Middle East & Africa,HR,Data Science,Exceeds,Female,37,5,1,6,,3.5,3.8,1,1,1,1,4.4,4,3
7250,0,Middle East & Africa,Commercial,Data Science,Meets,Female,44,7,1,9,,3.4,3.1,1,1,1,1,3.3,3.6,3.3
7251,0,Latin America,Manufacturing,Medical Affairs,Meets,Male,37,3,0,12,3.1,3,2.2,1,1,1,1,3.9,1.2,1.6
7252,0,Europe,Finance,Regulatory Affairs,Meets,Female,40,17,0,8,3.4,2.3,3.4,1,1,1,1,3.2,2.9,4.5
7253,0,Europe,Commercial,Legal & Compliance,Meets,Female,47,13,0,11,1.7,3.2,4.2,1,1,1,1,2.1,4.2,3.8
7254,0,North America,Digital,Market Access,Below,Female,37,9,0,5,3,5,2.5,1,1,1,1,2.4,3.1,2.4
7255,0,North America,R&D,Medical Affairs,Meets,Female,50,14,0,5,2.7,2.4,1.4,1,1,1,1,3,2.8,3.4
7256,0,Latin America,Finance,Market Access,Exceeds,Male,42,13,0,10,2.6,4.2,3.2,1,1,1,1,2.7,2.2,1.3
7257,0,Asia Pacific,Finance,Data Science,Far Below,Male,32,30,0,5,2.2,3.3,2.7,1,1,1,1,2.2,2.6,3.1
7258,0,Asia Pacific,Manufacturing,Quality Assurance,Below,Female,31,20,0,10,3.1,3.5,2.1,1,1,1,1,4.4,3.9,2.2
7259,0,Asia Pacific,Digital,Human Resources,Meets,Female,29,9,0,6,5,2.8,1.5,1,1,1,1,4.9,4.3,2.4
7260,1,Europe,R&D,Regulatory Affairs,Meets,Male,38,16,0,7,2.1,1.4,1.5,1,1,1,1,4.3,1.7,1.2
7261,0,Europe,Digital,Human Resources,Below,Female,28,9,0,6,2.6,3.8,3.3,1,1,1,1,2.4,3.1,4
7262,0,Middle East & Africa,Commercial,Pharmacovigilance,Meets,Female,49,3,1,5,,1.7,2.5,1,1,1,1,4.4,2.5,1.8
7263,0,Europe,Manufacturing,Data Science,Meets,Female,51,5,0,8,4.3,3.3,1.4,1,1,1,0,3.4,3.3,2.3
7264,0,Europe,Finance,Medical Affairs,Below,Female,28,8,0,8,1.8,2.1,4.7,1,1,1,1,2.2,2.7,3.4
7265,0,Europe,Finance,Finance & Accounting,Exceeds,Female,40,18,0,8,2.9,4.3,2.9,1,1,1,1,3.4,3.8,2.9
7266,0,Latin America,Commercial,Market Access,Meets,Male,28,16,0,6,3.6,2.5,3.2,1,1,1,1,4,2.2,1.5
7267,0,Europe,Finance,Legal & Compliance,Meets,Male,42,8,0,10,3.6,3.3,3.1,0,0,0,0,3,2.8,3.7
7268,0,North America,HR,Communications,Meets,Male,44,22,0,8,3,1.5,2.8,1,1,1,1,3.1,3.1,3.4
7269,0,North America,Manufacturing,Market Access,Meets,Female,38,11,0,7,4.2,1.8,1,1,1,1,1,3,3.4,1
7270,0,Middle East & Africa,Commercial,Communications,Meets,Female,40,2,1,8,,2.3,2.6,1,0,0,0,3.9,2.6,3.4
7271,0,Latin America,Manufacturing,Communications,Below,Male,34,11,1,11,,3.3,3.8,1,1,1,1,2,3.5,4.3
7272,1,North America,R&D,Data Science,Exceeds,Male,38,12,1,11,,3.8,2.5,1,1,1,1,3.7,4.1,3.6
7273,0,Latin America,Manufacturing,Data Science,Meets,Male,42,24,0,9,4.3,2.8,1.6,1,1,1,1,4.5,3.5,2.1
7274,0,Latin America,Manufacturing,Quality Assurance,Exceeds,Female,37,15,0,12,5,1.8,2.5,0,0,0,0,3.7,3.1,2.8
7275,0,Middle East & Africa,R&D,Quality Assurance,Below,Male,45,14,0,8,2.8,2.6,4.3,1,1,1,1,2.9,1.6,3.6
7276,0,Latin America,Commercial,Finance & Accounting,Below,Male,34,3,1,6,,3.3,2.9,0,0,0,0,3.9,1.9,2.4
7277,0,Europe,Manufacturing,Finance & Accounting,Meets,Female,36,24,0,9,3.5,3.9,1,1,1,1,1,4,3.9,2.8
7278,0,Latin America,Digital,Marketing,Below,Male,28,14,0,12,3.5,3.7,1.7,1,1,1,1,2.4,2.2,1.7
7279,0,Middle East & Africa,Manufacturing,Medical Affairs,Below,Male,52,8,0,6,5,3,1,0,0,0,0,3.1,5,2.1
7280,0,Middle East & Africa,Commercial,Clinical Operations,Below,Female,28,10,1,6,,4.1,2.4,1,1,1,1,3.7,4,3.2
7281,0,Middle East & Africa,Finance,Medical Affairs,Meets,Female,45,13,0,8,2.4,4.3,4.9,1,1,1,1,5,4.4,3.6
7282,0,North America,R&D,Quality Assurance,Far Below,Male,41,8,0,6,3.5,3.7,2.7,0,0,0,0,4.1,3.5,3.3
7283,0,Europe,Finance,Marketing,Below,Female,38,20,0,6,4.1,1.3,1.7,1,1,1,1,4.6,1.2,2.6
7284,0,North America,Commercial,Regulatory Affairs,Exceeds,Female,33,13,0,7,2.8,1,3.6,1,1,1,1,2.7,3.5,2.4
7285,0,Asia Pacific,HR,Data Science,Below,Female,35,11,1,11,,2.4,1.3,1,1,1,1,3.8,3.7,1.8
7286,0,Europe,Finance,IT & Digital,Meets,Female,36,24,0,7,2.2,1.8,3,1,1,1,1,3,2.2,3
7287,0,Latin America,Manufacturing,Supply Chain,Meets,Female,35,19,0,11,3.1,4.8,1.4,1,1,1,1,5,5,3.9
7288,0,Middle East & Africa,Manufacturing,Human Resources,Far Exceeds,Female,28,15,0,6,4.7,3.3,4.1,1,1,1,1,4.2,2.4,3.2
7289,0,Asia Pacific,R&D,Human Resources,Exceeds,Male,41,14,0,8,3.7,2.4,2.5,1,0,0,0,4.1,4.9,3.7
7290,0,Europe,Manufacturing,Medical Affairs,Meets,Female,42,4,1,12,,3.6,2,1,1,1,1,3.8,4,1.9
7291,0,North America,Digital,Medical Affairs,Exceeds,Male,36,5,0,10,3.4,1.6,2.4,0,0,0,0,3.1,3.8,3.1
7292,0,Middle East & Africa,Digital,Communications,Meets,Female,38,5,0,7,3.1,4.2,2.6,1,1,1,1,4.1,4.1,2.2
7293,0,North America,Finance,Communications,Meets,Non-Binary/Other,41,8,0,8,4.2,4.3,1.9,0,0,0,0,3.2,2.8,2.5
7294,0,Europe,Commercial,Sales,Meets,Male,30,12,0,10,4.9,2.6,1,1,1,0,0,4.4,3.1,1.9
7295,0,Europe,R&D,Quality Assurance,Meets,Male,28,7,1,7,,3,3,1,1,1,1,4.3,2.9,1.3
7296,0,Asia Pacific,HR,Legal & Compliance,Meets,Male,38,12,0,12,3.1,2.6,3.3,1,1,1,1,2.4,3,2.8
7297,0,Latin America,Finance,Legal & Compliance,Meets,Male,36,27,0,8,4.8,3.4,3.8,1,1,1,1,5,3.7,1.7
7298,0,North America,Commercial,Supply Chain,Meets,Female,35,6,0,7,4,2.7,4.7,1,1,1,1,4.9,2.5,5
7299,0,Asia Pacific,R&D,Pharmacovigilance,Below,Female,42,10,0,9,2.5,3.2,3.9,1,1,1,1,3,3.1,3.6
7300,0,Middle East & Africa,R&D,Communications,Meets,Female,36,20,0,7,3.4,3.3,3.3,1,1,1,1,4,3.1,4.4
7301,0,Latin America,Finance,Sales,Meets,Female,41,4,1,10,,1.9,4.1,1,1,0,0,4,2.5,2.5
7302,0,Asia Pacific,Commercial,Clinical Operations,Below,Male,49,13,0,12,3.7,4.7,2.2,1,1,1,1,2.9,4.1,2
7303,0,North America,Commercial,Medical Affairs,Meets,Female,51,4,1,6,,4,1.3,1,1,1,1,4.2,4.3,1.5
7304,0,Europe,Manufacturing,Marketing,Meets,Female,43,7,0,5,2.9,3,3.2,1,1,1,1,2.9,3.2,2.1
7305,1,Middle East & Africa,HR,Marketing,Exceeds,Male,28,16,0,12,3.4,2.2,1.3,1,1,1,1,3.8,2,1.6
7306,0,North America,Digital,Pharmacovigilance,Below,Male,42,8,1,6,,3.3,2.6,1,1,1,1,3.3,3.3,4
7307,0,Latin America,Manufacturing,Market Access,Meets,Male,47,6,0,12,3,4.3,2.3,0,0,0,0,3.6,5,3.8
7308,0,Latin America,R&D,Finance & Accounting,Below,Male,40,7,1,9,,1.4,2.8,1,1,0,0,3.7,1.4,2.6
7309,0,Europe,HR,Sales,Meets,Female,34,4,1,10,,2.4,2.9,1,1,1,1,3,3.7,3.3
7310,0,Europe,HR,Sales,Below,Male,36,3,1,12,,3.1,2.8,1,1,1,1,4.3,2.3,2.1
7311,0,Middle East & Africa,Commercial,Marketing,Meets,Female,45,25,0,10,3.9,4.5,1.8,1,1,1,1,2.8,4.3,3.5
7312,0,Middle East & Africa,HR,Human Resources,Meets,Female,35,19,0,9,2.7,3.1,1.7,1,1,1,1,3.7,3.6,1
7313,1,Europe,Finance,Marketing,Meets,Male,32,20,0,10,2.9,2.9,2.4,1,1,1,1,4.6,3.1,3.4
7314,0,Europe,HR,Data Science,Meets,Male,34,10,1,12,,3.4,2.9,0,0,0,0,3.4,2.5,3.7
7315,0,Latin America,R&D,Marketing,Meets,Female,38,27,0,5,3.8,4.1,2.9,1,1,1,1,4.1,4.5,3.8
7316,0,Europe,Finance,Quality Assurance,Meets,Female,37,9,1,9,,3.2,1.3,1,1,1,1,3.4,3.7,1.3
7317,0,Asia Pacific,Finance,IT & Digital,Meets,Male,28,23,0,7,4.1,2.4,2.7,1,1,1,1,4.3,3.7,3.3
7318,0,North America,Manufacturing,Marketing,Meets,Female,35,9,0,12,4.1,3.9,2.2,1,1,1,1,5,2.9,3.3
7319,0,Europe,HR,IT & Digital,Meets,Female,49,11,1,7,,3.9,2.6,1,1,1,1,2.1,3.6,2.4
7320,0,Middle East & Africa,Commercial,Human Resources,Meets,Male,39,2,0,10,2.9,4.6,3.3,1,1,1,1,2.4,3,3.9
7321,0,Asia Pacific,Manufacturing,Sales,Meets,Female,42,4,1,9,,3.4,3,1,1,1,1,2.8,3.6,1.9
7322,0,Middle East & Africa,Commercial,Data Science,Exceeds,Male,29,9,0,11,3.2,2.8,2.6,1,1,1,1,2.5,2.8,4.2
7323,0,Asia Pacific,HR,Clinical Operations,Meets,Male,42,6,0,9,3.7,2.6,2.5,1,1,1,1,3.7,3.2,3.7
7324,0,Europe,Manufacturing,Sales,Below,Female,47,15,0,9,4.7,2.5,1,1,1,1,1,4.1,2.1,2
7325,1,North America,HR,Marketing,Exceeds,Male,40,4,1,10,,2,3.1,1,1,1,1,4.2,1.7,3.6
7326,0,Middle East & Africa,R&D,Legal & Compliance,Meets,Male,31,19,0,6,2.8,3.3,2.8,0,0,0,0,1.7,3,3.2
7327,0,Asia Pacific,Manufacturing,Marketing,Meets,Male,42,12,0,8,2.1,5,1.4,1,1,0,0,2.4,5,3
7328,0,Latin America,Commercial,Legal & Compliance,Exceeds,Male,43,18,0,7,3.5,5,3.4,0,0,0,0,4.6,3.7,2.6
7329,0,Europe,R&D,Marketing,Meets,Male,34,11,1,6,,1.9,2.7,1,1,1,1,3.6,3.5,2.5
7330,0,North America,Digital,Data Science,Meets,Female,44,15,1,6,,3.5,3,1,1,1,1,3.2,3.8,2.6
7331,0,Europe,Commercial,Communications,Exceeds,Male,41,13,0,11,2,3,4.2,1,1,1,1,3.2,2.9,3.7
7332,0,Latin America,HR,Medical Affairs,Meets,Male,28,14,0,7,3.3,2.8,3.4,1,1,1,1,3.2,3.6,3.9
7333,0,North America,Commercial,Communications,Meets,Male,34,8,0,9,2.7,3.4,3.2,1,1,1,1,2.6,4.1,3.9
7334,0,Latin America,Digital,Data Science,Meets,Male,36,14,0,6,4.6,4.7,1.9,1,1,1,1,4,3.5,3.7
7335,0,Europe,Commercial,Regulatory Affairs,Far Below,Male,38,18,0,11,2.8,3.8,2.3,0,0,0,0,3.6,3,2.6
7336,1,Asia Pacific,R&D,Quality Assurance,Meets,Female,38,20,0,7,2.6,3.8,2.2,1,1,1,1,3.9,3.4,2.5
7337,0,Europe,Finance,Supply Chain,Exceeds,Female,43,7,0,9,3.3,1.9,3.2,1,1,1,1,3.9,3.1,3
7338,0,Europe,Commercial,Human Resources,Below,Non-Binary/Other,43,8,0,12,2.9,3.5,3.5,0,0,0,0,2.6,2.3,3.7
7339,0,Europe,Manufacturing,Quality Assurance,Meets,Male,48,3,0,6,2.5,3.1,2.4,0,0,0,0,3.2,4.2,2.6
7340,0,Middle East & Africa,Digital,Finance & Accounting,Meets,Female,40,18,0,11,3.9,4.3,2.1,1,1,1,1,4.2,2.5,3.4
7341,0,Latin America,Commercial,Marketing,Meets,Female,47,6,0,11,3.9,2,3,0,0,0,0,3.6,1.8,3
7342,1,Latin America,Digital,Human Resources,Meets,Female,44,17,0,10,3.9,1.8,2.1,1,1,1,1,3.5,3,3.6
7343,0,Latin America,Finance,Communications,Far Exceeds,Male,45,12,1,9,,3.8,2.2,1,1,1,1,4.5,4,2.1
7344,0,Middle East & Africa,R&D,IT & Digital,Meets,Male,48,13,0,10,4.8,4,3.9,1,1,1,1,3.4,4.3,3.4
7345,0,Asia Pacific,Manufacturing,Communications,Meets,Female,36,9,0,9,2.2,3.5,1.6,1,1,1,1,3.9,3.5,2.8
7346,0,Europe,HR,Legal & Compliance,Meets,Female,38,21,0,8,3,4.9,2.7,1,1,0,0,3.2,4.4,2.5
7347,0,Asia Pacific,Commercial,Supply Chain,Meets,Female,28,9,0,10,2.9,2.3,4.4,1,1,1,1,2.5,3.2,4.3
7348,0,Middle East & Africa,R&D,Clinical Operations,Below,Male,45,36,0,9,3.4,2.8,1,0,0,0,0,3.2,3.3,1.6
7349,0,Latin America,Digital,Market Access,Meets,Male,44,8,0,5,1.6,1.4,2.2,0,0,0,0,1.7,2.6,3.1
7350,0,Europe,Finance,Sales,Far Exceeds,Non-Binary/Other,39,17,0,6,3.5,2.6,2.9,1,1,1,1,1.9,4.3,1.9
7351,0,North America,Digital,Medical Affairs,Meets,Male,43,5,0,7,3.1,2.5,4.6,1,1,1,1,2.1,4.6,3.1
7352,0,North America,Finance,Market Access,Meets,Female,44,11,0,12,3.9,3.4,1.6,0,0,0,0,2.9,4.7,3.5
7353,0,Asia Pacific,Finance,Data Science,Far Exceeds,Male,38,18,0,6,5,3.7,2.5,1,1,1,1,5,3.7,3.4
7354,0,Latin America,R&D,Regulatory Affairs,Meets,Female,41,14,0,8,3.3,2.8,2,0,0,0,0,3.7,3.9,2
7355,0,North America,Commercial,Legal & Compliance,Meets,Male,38,17,0,11,3,4.2,4.6,1,1,1,1,2.7,3.4,3.8
7356,0,Asia Pacific,HR,Legal & Compliance,Far Exceeds,Male,37,19,0,8,3.3,3.1,2.4,0,0,0,0,4.8,5,3.2
7357,0,Middle East & Africa,Commercial,Pharmacovigilance,Below,Male,34,12,0,5,3.4,5,2,1,1,1,1,2.5,3.8,1
7358,0,Asia Pacific,Manufacturing,Quality Assurance,Meets,Female,30,9,1,8,,2.9,2.7,1,1,1,1,3.8,3.1,2.6
7359,0,Asia Pacific,Commercial,Market Access,Meets,Male,30,13,1,7,,4,3.3,1,1,1,1,3.2,4.8,1.7
7360,0,Asia Pacific,Finance,Communications,Meets,Female,38,16,1,6,,1.5,4.2,1,1,1,1,3.7,2,4.2
7361,0,Europe,Finance,Regulatory Affairs,Meets,Female,31,20,0,12,4.1,4.7,1.7,1,1,1,1,3.7,3.7,3.7
7362,0,Asia Pacific,Manufacturing,Marketing,Far Below,Female,32,10,0,5,3.2,2.8,3.7,1,1,1,1,3.2,3.1,3.3
7363,0,Asia Pacific,Digital,Data Science,Meets,Male,33,12,1,10,,4.8,3,1,1,1,1,2.5,4.1,3.2
7364,0,Europe,Finance,Data Science,Below,Male,36,5,1,7,,2.8,3.3,1,1,1,1,4.5,4.3,2.6
7365,0,Europe,Manufacturing,Sales,Below,Female,45,12,0,12,4,2.7,1.5,1,1,1,1,3,3.6,2
7366,0,Middle East & Africa,Finance,Supply Chain,Meets,Female,28,12,1,11,,3.6,2,1,1,1,1,3.7,3.1,3.9
7367,0,Latin America,HR,Supply Chain,Exceeds,Female,38,15,0,6,4.9,3.3,1.9,1,1,1,1,3.9,3.5,2.5
7368,0,North America,Finance,Human Resources,Meets,Male,32,13,1,11,,1.6,2.1,1,1,1,1,4.5,2.7,2.6
7369,0,North America,R&D,Market Access,Meets,Female,38,6,0,11,5,1.1,3.6,1,1,1,1,3.2,1.4,4
7370,0,Asia Pacific,Manufacturing,Clinical Operations,Meets,Female,34,9,0,9,3.3,3.9,3.2,1,1,1,1,3.7,2.8,2.4
7371,0,Middle East & Africa,Commercial,Human Resources,Meets,Female,37,31,0,10,3.8,3.5,2.2,1,1,1,1,2.9,4.3,2.4
7372,0,Asia Pacific,Manufacturing,Supply Chain,Exceeds,Female,29,28,0,9,3.2,3.7,1,1,1,1,1,2.5,3.1,2.6
7373,0,North America,Digital,Supply Chain,Exceeds,Female,40,11,1,10,,3.9,2.3,1,1,1,1,1.9,3.9,3.7
7374,0,Europe,Finance,Marketing,Meets,Male,38,6,1,8,,2.4,1.7,1,1,1,1,4.8,2.5,3
7375,0,Latin America,Manufacturing,Marketing,Far Exceeds,Female,39,7,0,11,3,2.6,4.3,1,1,0,0,3.2,1.7,5
7376,0,Middle East & Africa,HR,Finance & Accounting,Meets,Female,44,8,0,6,4,1.8,1.8,1,1,1,1,4.6,1,3.2
7377,0,Europe,Manufacturing,Finance & Accounting,Meets,Female,30,7,0,8,3,2.8,3.4,1,1,1,1,3.4,3,2.8
7378,0,Latin America,HR,Regulatory Affairs,Meets,Female,31,10,1,9,,3.9,3.7,1,1,1,1,2.9,3.8,2.5
7379,0,Middle East & Africa,Finance,Data Science,Meets,Male,48,6,0,5,3.1,2.7,2.9,1,1,1,1,3.4,3.9,4.2
7380,0,Middle East & Africa,Commercial,Data Science,Meets,Female,41,10,0,12,4,3.1,1.9,1,1,1,1,3.4,2.8,1.6
7381,0,North America,Finance,Finance & Accounting,Meets,Female,28,5,1,12,,3.6,2.1,0,0,0,0,4.6,4.8,3.8
7382,0,Europe,Digital,Data Science,Meets,Male,37,24,0,6,3.6,2.2,4.1,1,1,0,0,4.1,1.9,2.5
7383,0,Middle East & Africa,R&D,Regulatory Affairs,Far Exceeds,Female,44,17,0,8,2.4,2.6,3.5,1,1,1,1,3,3.8,4.3
7384,0,Middle East & Africa,Commercial,Pharmacovigilance,Exceeds,Non-Binary/Other,50,5,0,12,2.5,3.9,4.9,0,0,0,0,3,4,4.5
7385,0,Latin America,Commercial,Marketing,Meets,Male,47,14,0,7,4.3,1.7,1.7,1,1,1,0,4.9,1.9,2.3
7386,0,North America,R&D,Regulatory Affairs,Far Below,Male,35,13,1,8,,3.1,3.2,1,1,1,1,2.3,2.9,3.9
7387,0,Asia Pacific,Manufacturing,Data Science,Meets,Male,37,6,1,5,,3.7,3.3,1,1,1,1,5,3.9,2.8
7388,0,North America,Finance,Market Access,Meets,Male,28,9,0,11,3,3.5,2.8,1,1,1,1,3.4,3.9,4.1
7389,0,Asia Pacific,Manufacturing,Marketing,Exceeds,Male,39,11,1,9,,3.6,3.4,1,1,1,1,4.9,4.6,2.5
7390,0,Europe,Manufacturing,Medical Affairs,Exceeds,Female,39,12,0,9,4.1,2.7,3.2,1,1,1,1,5,4.2,3
7391,0,Europe,Finance,Supply Chain,Exceeds,Male,43,13,0,7,5,2.3,3.2,0,0,0,0,4.3,4,3.8
7392,0,Middle East & Africa,Digital,Marketing,Meets,Female,28,9,1,5,,3.6,2.1,1,1,1,1,2.7,2.9,2.7
7393,1,Europe,Commercial,Communications,Exceeds,Male,32,7,0,11,5,3.5,1.6,1,1,1,1,4.5,2.6,3.4
7394,0,Middle East & Africa,HR,Marketing,Far Below,Female,37,11,0,5,3.1,3.7,1,1,1,1,1,2.1,2.8,2.5
7395,0,North America,R&D,IT & Digital,Meets,Male,43,7,1,12,,1.9,1.6,1,1,1,1,3.3,2.5,2.4
7396,0,Europe,Commercial,Data Science,Below,Female,36,17,0,10,5,2,5,1,1,1,1,4.6,2,4.7
7397,0,North America,Manufacturing,Human Resources,Exceeds,Male,52,10,1,10,,2.6,2.2,1,1,1,1,3.8,2.2,1.9
7398,0,North America,R&D,Quality Assurance,Exceeds,Male,32,5,0,12,3.3,2.8,4.1,1,1,1,1,3.5,2.2,1.8
7399,0,Europe,HR,Pharmacovigilance,Meets,Male,35,19,0,6,3.9,3.4,2.6,1,1,1,1,4.9,4.2,3.4
7400,0,North America,Commercial,Marketing,Meets,Female,31,6,0,6,3.5,2.2,2.3,1,1,1,1,2.3,3.2,2.6
7401,0,Europe,Commercial,Regulatory Affairs,Far Exceeds,Male,37,4,0,6,3.8,3,3.8,0,0,0,0,3.8,3.1,2.9
7402,1,Europe,Digital,Clinical Operations,Meets,Female,41,24,0,8,3.1,3.8,2.6,1,1,1,1,4.7,2.4,2.7
7403,0,Europe,Commercial,Data Science,Meets,Male,39,13,0,9,3.2,3,2.4,1,1,1,1,4.3,4.1,2.7
7404,0,Asia Pacific,Commercial,Data Science,Meets,Male,33,24,0,5,3.5,4,2.7,1,1,1,1,5,2.5,2.1
7405,0,North America,HR,Quality Assurance,Meets,Male,45,11,0,9,2.8,3,2.2,1,1,1,1,3.6,3.8,3.2
7406,0,Latin America,HR,Sales,Far Exceeds,Female,46,15,0,10,4.8,3.7,4.1,1,1,1,1,3.8,3.1,1.9
7407,0,Europe,R&D,Clinical Operations,Meets,Male,34,6,1,8,,5,2.1,1,1,1,1,4,2.9,1.4
7408,0,North America,Manufacturing,Human Resources,Below,Male,55,10,1,8,,4.4,3.2,0,0,0,0,2.8,3.5,3.3
7409,0,Middle East & Africa,HR,Medical Affairs,Below,Female,31,8,0,12,4.2,1.4,4.3,1,1,1,1,3.7,1.5,3.6
7410,0,Europe,R&D,Supply Chain,Far Below,Male,38,23,0,10,3.7,4,3.3,1,1,1,1,3.4,3.5,3.8
7411,0,Europe,Commercial,Sales,Meets,Female,38,33,0,11,2.3,4.1,3,1,1,1,1,2.9,4.7,2.5
7412,0,Latin America,R&D,Market Access,Exceeds,Male,31,13,0,7,4.2,4.1,1.9,1,1,1,1,3.2,3.1,1.1
7413,0,Asia Pacific,R&D,Communications,Meets,Female,39,11,0,10,3.6,1.9,2.1,1,1,1,1,4,2,2.8
7414,0,Asia Pacific,R&D,Finance & Accounting,Far Exceeds,Non-Binary/Other,37,12,1,6,,3.5,3.7,1,1,1,1,2.9,3.7,3.7
7415,0,Europe,Finance,Marketing,Exceeds,Male,41,14,1,11,,2.5,1.1,0,0,0,0,3.9,1,2.7
7416,1,North America,R&D,Legal & Compliance,Meets,Male,38,10,1,8,,2.9,4.7,1,1,1,1,3.8,3.9,5
7417,0,Middle East & Africa,HR,Market Access,Meets,Female,43,36,0,8,2.4,3.6,2.5,1,1,1,1,3.4,3.8,3.5
7418,0,Middle East & Africa,Finance,Medical Affairs,Meets,Female,42,8,0,7,2.1,2.1,4.7,1,1,1,1,4.3,3.3,4
7419,0,North America,Manufacturing,Regulatory Affairs,Below,Female,32,5,0,7,3.4,3.5,2,1,1,1,1,3.6,2.7,3
7420,0,Europe,R&D,Pharmacovigilance,Meets,Female,36,12,0,10,3.6,2.2,2.6,1,1,1,1,4.9,1.8,3
7421,0,Middle East & Africa,Digital,Communications,Meets,Male,33,11,1,8,,1,1.9,1,1,1,1,3.2,3.7,3.2
7422,0,Asia Pacific,Commercial,Regulatory Affairs,Meets,Female,48,5,0,7,2.9,4.2,1.4,1,1,0,0,4.3,4.2,1.3
7423,0,North America,Commercial,Regulatory Affairs,Meets,Female,44,8,0,5,4.3,2.7,3.6,1,1,1,1,4.9,2.4,2.7
7424,0,Latin America,Finance,Finance & Accounting,Meets,Female,40,5,0,9,4.3,3,2.6,1,1,1,1,4,3.1,3.7
7425,0,Europe,Commercial,IT & Digital,Meets,Female,41,11,1,9,,5,4.2,1,1,1,1,3.5,2.7,2.4
7426,0,North America,Commercial,Regulatory Affairs,Meets,Female,37,13,0,8,4.1,3.8,3.1,1,1,1,0,3.7,5,3.3
7427,0,Middle East & Africa,Finance,Clinical Operations,Below,Female,39,14,0,10,4.1,4,1.6,1,0,0,0,3.6,3.1,2.8
7428,0,Europe,Commercial,Finance & Accounting,Meets,Non-Binary/Other,34,5,0,5,2.4,3.1,2.6,1,1,1,1,2.2,1.9,1.4
7429,0,Asia Pacific,R&D,IT & Digital,Meets,Male,34,6,0,8,3.4,2.2,1.7,1,1,1,1,3.8,3.3,3.7
7430,0,Europe,Manufacturing,IT & Digital,Exceeds,Male,42,9,0,7,3.2,3.6,3.1,1,1,1,1,2.2,4.2,3.6
7431,0,Europe,Finance,Data Science,Below,Male,32,10,0,7,3.6,4.2,1.9,1,1,1,1,4.5,4.7,2.7
7432,0,Asia Pacific,Digital,Marketing,Meets,Non-Binary/Other,34,9,0,6,1.6,3.7,2.4,1,1,1,1,3.1,2.9,1.7
7433,0,Asia Pacific,Finance,Supply Chain,Meets,Female,37,14,0,10,3.4,4.7,2.8,1,1,1,1,3.8,4,2.8
7434,0,Europe,HR,Clinical Operations,Below,Male,29,17,0,12,3.9,3.1,1.5,1,1,1,1,4,2.7,2.5
7435,0,Asia Pacific,Digital,Legal & Compliance,Meets,Male,44,4,0,9,2.8,3.8,2.4,1,1,1,1,1.6,4.1,1.7
7436,0,North America,HR,Sales,Meets,Male,42,20,0,9,3.5,4.1,4.1,1,1,1,1,3.3,3.6,3
7437,0,Asia Pacific,Finance,Sales,Meets,Male,41,13,0,5,4.4,3.3,3.3,1,1,1,1,4.3,4.8,2.5
7438,0,Asia Pacific,HR,Clinical Operations,Below,Female,36,3,0,12,2,2,3.8,1,1,1,1,4.4,2.8,3
7439,0,Europe,Digital,Medical Affairs,Meets,Female,45,7,0,11,3,5,1.5,0,0,0,0,4.1,4.8,2.3
7440,1,North America,R&D,Market Access,Meets,Female,40,19,0,10,3.3,3,2.4,1,1,1,0,3.8,3.5,4.2
7441,0,Latin America,Finance,Clinical Operations,Meets,Male,44,22,0,6,1.9,3.2,1.8,1,1,1,1,1.2,1.9,2.9
7442,1,Latin America,Finance,Finance & Accounting,Exceeds,Female,44,7,1,6,,2.8,3.2,1,1,1,1,4.6,2.6,4.6
7443,0,Middle East & Africa,Commercial,Legal & Compliance,Below,Female,35,12,0,9,2.6,2.8,1.1,0,0,0,0,3.1,2.3,1.1
7444,0,Asia Pacific,Finance,Communications,Meets,Female,33,11,0,8,1.8,3.8,3.2,1,1,1,1,3.1,3.5,2.3
7445,0,Asia Pacific,Finance,Clinical Operations,Meets,Non-Binary/Other,32,7,1,9,,1.9,3.8,1,1,1,1,4.2,2.8,2.8
7446,0,North America,R&D,IT & Digital,Meets,Female,38,3,0,7,5,1.6,3.1,0,0,0,0,4.8,3.4,1.9
7447,0,Latin America,Commercial,Communications,Meets,Female,28,11,0,11,2.4,3.3,2.3,1,1,1,1,2.9,1.8,3.2
7448,0,Middle East & Africa,Manufacturing,Supply Chain,Meets,Male,32,9,1,7,,3.5,4,1,0,0,0,4.7,4.8,3.6
7449,0,North America,HR,Supply Chain,Far Below,Female,34,16,0,11,3,2.3,2.2,1,1,1,1,2.2,2.7,2.6
7450,0,Asia Pacific,Digital,Data Science,Below,Male,34,11,0,5,4.4,2.3,2.8,0,0,0,0,3.5,3.8,3.5
7451,0,Latin America,Manufacturing,Supply Chain,Meets,Male,42,13,0,6,3.3,2.6,3.1,1,1,1,1,4.1,2.4,3.1
7452,0,Middle East & Africa,Commercial,Data Science,Meets,Male,29,19,0,11,1.9,4.7,1.6,1,1,1,1,2.9,3.2,2.8
7453,0,Europe,R&D,Regulatory Affairs,Below,Male,28,13,0,6,4.7,3.6,4.3,1,0,0,0,2,3.6,3.8
7454,1,Latin America,Digital,Market Access,Meets,Female,28,13,0,12,3.5,2,3,0,0,0,0,2.2,1.2,4.8
7455,0,Middle East & Africa,HR,Communications,Below,Male,41,16,0,5,2.8,2.8,3.4,1,1,1,1,3.3,4.5,1.3
7456,0,North America,Finance,Medical Affairs,Below,Male,35,7,1,8,,2.3,2.3,1,1,1,1,2.7,4.3,2.1
7457,0,Europe,Finance,Legal & Compliance,Meets,Male,34,4,1,12,,1,2.8,1,1,1,1,3.3,1.1,2.8
7458,0,Middle East & Africa,Manufacturing,Market Access,Below,Female,48,16,0,12,3.4,3.2,2.9,1,1,1,1,3.3,3.9,2.5
7459,0,Middle East & Africa,HR,Data Science,Meets,Female,41,5,0,10,1.6,4.1,2.7,1,1,1,1,1.5,2.5,2.7
7460,0,Asia Pacific,Commercial,IT & Digital,Below,Male,34,4,1,12,,3.2,3.3,1,1,1,1,2.3,3.4,2.8
7461,0,Latin America,HR,Supply Chain,Meets,Female,30,6,0,12,3.6,1.8,2.6,1,1,0,0,3.1,2.8,2.2
7462,0,Asia Pacific,R&D,IT & Digital,Meets,Female,49,8,0,11,2.9,4.3,1.8,0,0,0,0,3,5,2
7463,0,Europe,Manufacturing,IT & Digital,Meets,Female,39,17,0,5,4.3,2.1,2.1,1,1,1,1,3,3.3,1.4
7464,0,Middle East & Africa,Manufacturing,Clinical Operations,Below,Female,35,2,0,5,2,3.2,1.7,1,1,0,0,1.6,2.9,1.1
7465,0,Asia Pacific,R&D,Marketing,Exceeds,Female,39,5,0,10,2.9,1.8,2.8,0,0,0,0,4.6,1.9,3.7
7466,0,Latin America,HR,Communications,Meets,Male,35,9,0,12,3.3,5,4.8,1,1,1,1,3.6,4.3,4.8
7467,0,Europe,R&D,Legal & Compliance,Below,Female,41,18,0,11,3.4,3.3,2.8,1,1,1,1,3.9,3,2.8
7468,1,North America,Digital,Regulatory Affairs,Meets,Female,28,11,0,7,4,2.1,1.5,0,0,0,0,3,1.9,2.7
7469,0,Asia Pacific,R&D,Quality Assurance,Meets,Male,36,7,1,11,,3.3,2.5,0,0,0,0,2.8,4.3,3.3
7470,0,Europe,HR,Legal & Compliance,Exceeds,Female,32,15,0,12,3.2,2.8,2.9,0,0,0,0,2.6,3.5,3.1
7471,0,North America,R&D,Sales,Meets,Female,38,6,0,12,2.9,4.9,4.1,1,1,1,1,2.2,4.8,5
7472,0,Asia Pacific,Commercial,Data Science,Meets,Male,32,13,0,11,2.8,2.7,4.2,1,1,1,1,2.1,4.7,3
7473,0,Europe,Finance,Market Access,Meets,Female,34,10,0,7,4.2,1.9,3,1,1,1,1,3.2,1.8,3.7
7474,0,Europe,R&D,Supply Chain,Meets,Male,35,3,1,5,,2.3,4.1,1,1,1,1,3.7,2.5,4
7475,0,Asia Pacific,Finance,Legal & Compliance,Meets,Male,40,16,0,5,2.5,1.1,1.5,1,1,1,1,2.3,2.4,2.7
7476,0,Europe,R&D,Human Resources,Meets,Female,36,11,1,7,,3.1,2.6,1,1,1,1,4.7,3.8,3.1
7477,0,Middle East & Africa,HR,Communications,Far Below,Female,32,7,0,9,3.3,2.7,4.1,1,1,1,1,3.1,3.8,4.6
7478,0,Asia Pacific,Digital,Communications,Far Below,Male,40,12,0,11,3.3,3.3,2.1,1,1,1,1,3.6,3.7,1.6
7479,0,Europe,Digital,Regulatory Affairs,Meets,Female,51,12,0,9,4.1,3.4,1.1,1,1,1,1,4.4,2.8,1
7480,0,North America,Finance,Sales,Meets,Female,36,23,0,5,3,2.1,1.9,1,0,0,0,3.3,3,3.1
7481,0,North America,HR,Human Resources,Meets,Female,46,9,0,10,4.2,2.5,3.4,0,0,0,0,5,3.6,2
7482,0,Middle East & Africa,HR,Quality Assurance,Exceeds,Male,29,3,1,5,,5,1.9,1,1,1,1,2.6,4,3.5
7483,0,Asia Pacific,HR,Finance & Accounting,Meets,Female,33,21,0,5,3,2,1.4,1,1,1,1,3.2,3.1,1.3
7484,0,Europe,Commercial,Human Resources,Meets,Female,46,11,0,5,3,4.6,1.4,1,1,1,1,3.4,4.8,2.6
7485,0,Europe,Manufacturing,Clinical Operations,Meets,Non-Binary/Other,39,12,0,11,3.1,3.8,3.4,1,1,1,1,1.5,3.6,3
7486,1,North America,R&D,Communications,Meets,Female,34,17,1,6,,5,5,1,1,1,1,3.7,4.2,3.6
7487,0,Middle East & Africa,HR,Clinical Operations,Exceeds,Male,43,16,0,5,4.1,4,2.6,1,1,1,1,2.7,3.3,1.9
7488,0,North America,HR,Data Science,Far Below,Male,32,6,0,8,4.3,3.2,2.5,0,0,0,0,4.4,4.3,3.2
7489,0,North America,HR,Data Science,Below,Male,38,11,1,9,,3.6,2.7,1,1,1,1,1.4,3.9,2.7
7490,0,Middle East & Africa,Digital,Finance & Accounting,Meets,Female,44,17,0,12,2.6,3.6,1,1,1,1,1,4.1,3.6,1.9
7491,0,Asia Pacific,HR,Supply Chain,Meets,Female,40,5,1,5,,4,2.7,1,1,1,1,2.6,3.3,1.9
7492,0,Europe,R&D,Marketing,Far Below,Female,53,4,0,5,3.8,2.6,3.4,1,1,1,1,3.5,3.6,4.6
7493,0,Asia Pacific,HR,Supply Chain,Meets,Female,35,12,0,7,4,1.8,2.9,1,1,1,1,1.8,3.1,2.8
7494,0,Latin America,R&D,Medical Affairs,Meets,Male,42,4,1,12,,1.6,3.2,1,0,0,0,3.5,2.7,2
7495,0,Latin America,Commercial,Human Resources,Meets,Male,43,10,1,11,,2,2.5,1,1,1,1,4.7,3.6,1.6
7496,0,Latin America,Manufacturing,Regulatory Affairs,Meets,Male,37,17,1,12,,4.3,1,1,1,1,1,2.4,3.8,2.5
7497,0,Middle East & Africa,Digital,Regulatory Affairs,Far Below,Female,32,11,0,6,2.7,2.9,2.1,1,1,1,1,3,3.6,1
7498,0,North America,R&D,Market Access,Below,Female,45,12,0,12,3.3,4.5,3.3,1,1,1,1,5,3.4,3.5
7499,0,Asia Pacific,Finance,Clinical Operations,Meets,Female,35,4,0,8,2.5,1.9,3.1,1,1,1,1,2.3,3.1,1.8
7500,0,Europe,Commercial,Legal & Compliance,Meets,Male,42,7,1,7,,3.7,3.1,1,0,0,0,2.9,2.2,3
7501,0,Latin America,Manufacturing,Finance & Accounting,Exceeds,Female,41,11,1,11,,2.3,3.3,1,1,1,1,4.5,1.2,2.3
7502,0,Asia Pacific,Manufacturing,Legal & Compliance,Below,Male,39,6,1,8,,4.3,3.1,1,0,0,0,4.4,3,3.9
7503,0,Latin America,Manufacturing,Pharmacovigilance,Exceeds,Female,46,4,0,5,3.1,2.7,3.6,0,0,0,0,2.2,2.8,2.8
7504,0,Latin America,R&D,Legal & Compliance,Meets,Male,40,13,0,10,2.3,4,3.4,1,1,1,1,4,4.1,3.8
7505,0,Europe,Commercial,Legal & Compliance,Meets,Male,42,32,0,11,4,2.4,4.1,1,1,1,1,1.8,2.8,2.8
7506,0,Middle East & Africa,HR,Supply Chain,Meets,Female,40,10,0,12,3.9,2.4,3.5,1,1,1,1,3.3,3.3,4
7507,0,North America,Finance,Market Access,Meets,Female,38,11,1,10,,5,2.6,1,1,1,1,3.6,4.1,2.7
7508,0,Middle East & Africa,Commercial,Data Science,Meets,Male,36,8,0,7,2.1,4.7,3.9,1,1,0,0,2.8,3.2,4.8
7509,0,Asia Pacific,Commercial,Regulatory Affairs,Meets,Male,38,11,1,8,,1.8,3.9,1,1,1,1,2.6,4.1,3.1
7510,0,Middle East & Africa,Commercial,Legal & Compliance,Meets,Male,42,3,0,5,3.5,2.2,3.1,1,1,1,1,2.9,2.2,2.3
7511,0,Asia Pacific,R&D,Data Science,Meets,Male,41,9,0,12,3.7,2.3,3.7,1,1,1,1,3.6,2.6,3.8
7512,0,Asia Pacific,Finance,Supply Chain,Meets,Female,42,12,0,11,2.1,1.4,2.6,1,1,1,1,2.4,3.6,2.7
7513,0,North America,R&D,Sales,Meets,Female,55,7,0,11,3.4,1.1,1.8,1,1,1,1,4.5,2.2,1
7514,0,Europe,Finance,IT & Digital,Meets,Male,35,9,0,11,3.3,4.8,4.1,1,1,1,1,3.2,5,3.1
7515,0,North America,Finance,Data Science,Exceeds,Male,28,6,0,12,2.1,4.2,4.1,1,1,1,1,3.6,4.6,4
7516,0,Middle East & Africa,R&D,Pharmacovigilance,Meets,Male,36,6,0,9,2.7,1.5,1,1,1,1,1,2.7,1.3,1
7517,1,Asia Pacific,Finance,Regulatory Affairs,Far Exceeds,Male,36,12,0,5,4.6,1.2,2.1,1,1,1,1,5,2.9,3.3
7518,0,Latin America,Commercial,Supply Chain,Below,Female,41,12,1,5,,4.5,3.6,0,0,0,0,2.7,4.1,4.1
7519,0,Latin America,R&D,Communications,Exceeds,Non-Binary/Other,36,19,0,8,3.2,3.9,1,1,1,1,1,2.8,3.5,1.1
7520,0,Asia Pacific,Finance,Market Access,Exceeds,Male,42,12,0,9,2.8,3.7,4.4,1,1,1,1,3.5,1.7,2
7521,0,North America,Manufacturing,Marketing,Meets,Male,33,7,0,5,3.7,4.1,4.6,1,1,1,1,3.2,4.1,1.7
7522,1,Europe,R&D,Marketing,Meets,Male,41,15,0,10,4,3.3,1.3,1,1,1,1,3.1,3.3,3.7
7523,0,North America,Digital,Legal & Compliance,Far Exceeds,Male,29,15,0,10,4,2.8,3.4,1,1,1,1,4.4,2.8,3.4
7524,0,Asia Pacific,R&D,Supply Chain,Far Exceeds,Male,38,11,0,9,3.4,1,2.2,1,1,1,1,3.6,2.2,1.3
7525,0,Asia Pacific,R&D,Marketing,Meets,Female,33,5,0,12,4.3,2.7,2.5,1,1,1,1,4,2.9,2.8
7526,0,Europe,R&D,Regulatory Affairs,Meets,Female,36,6,0,8,2.6,2.9,1.2,0,0,0,0,3.7,2.8,2.5
7527,0,Middle East & Africa,Finance,Human Resources,Exceeds,Male,28,12,0,9,3.1,3.2,3.1,1,1,1,1,3.3,3.4,3.1
7528,0,Middle East & Africa,R&D,Sales,Below,Male,43,27,0,9,3.1,3.3,3.1,1,1,1,1,1.6,3.3,1.2
7529,0,Europe,Digital,Data Science,Meets,Male,36,7,1,7,,4.9,2.3,1,1,1,1,4.6,3.9,2.6
7530,0,Middle East & Africa,HR,Pharmacovigilance,Far Exceeds,Male,37,7,0,7,1.6,4.8,4.2,1,1,1,1,4.3,2.8,3.1
7531,1,Latin America,R&D,Quality Assurance,Exceeds,Female,41,7,0,9,2,2.3,4.8,1,1,1,1,3.2,3.3,3.1
7532,0,Middle East & Africa,Manufacturing,Market Access,Exceeds,Female,34,7,0,6,2,2.3,2.5,1,1,1,1,1.3,2.1,3.1
7533,0,Middle East & Africa,Digital,Human Resources,Meets,Male,35,18,0,5,3.2,2.9,1.5,1,0,0,0,4.3,2.9,3.6
7534,0,Middle East & Africa,HR,Regulatory Affairs,Meets,Female,28,8,0,6,3,5,1,1,1,1,1,3,5,1
7535,0,Latin America,Finance,Communications,Far Exceeds,Female,36,22,0,6,1.8,2.7,4.5,1,1,1,1,3.5,3.1,3.9
7536,0,Middle East & Africa,R&D,Clinical Operations,Meets,Male,47,9,0,11,3.9,1.9,2.4,1,1,0,0,3.5,3.3,2.1
7537,0,Latin America,HR,Communications,Meets,Male,40,25,0,5,4,3.8,2.7,1,1,0,0,3.5,2.5,2.5
7538,0,Europe,Manufacturing,Medical Affairs,Meets,Male,29,16,0,6,3.4,2.8,2.1,1,1,1,1,2.1,2.4,1.7
7539,0,North America,Digital,Medical Affairs,Meets,Female,41,15,0,11,2.2,3.3,2.1,1,1,1,1,2.4,5,2.2
7540,0,Europe,Digital,IT & Digital,Far Below,Female,46,10,0,10,5,2.6,3.3,1,1,1,1,3.1,4.7,4
7541,0,North America,Finance,Market Access,Meets,Female,32,12,0,12,4,3,2.5,1,1,1,1,3.4,1,2.1
7542,0,Europe,Finance,Human Resources,Meets,Female,37,17,0,11,4.3,3.9,1,1,1,1,1,4.4,3.3,1.6
7543,0,North America,Finance,Regulatory Affairs,Below,Female,37,11,0,8,2.5,3.1,3,1,1,1,1,2.4,2.8,3.5
7544,0,North America,HR,Supply Chain,Meets,Female,39,13,0,10,2.5,3.2,1.8,0,0,0,0,2.2,2.8,2.2
7545,0,Asia Pacific,R&D,Finance & Accounting,Meets,Female,39,7,0,11,2.3,3,3.4,1,1,1,1,2.7,2.2,2.3
7546,0,North America,Commercial,Communications,Meets,Female,42,11,0,11,2.9,2.2,2.2,1,0,0,0,3.2,2.9,2.9
7547,0,North America,Digital,Data Science,Below,Male,37,6,0,10,3,3.1,1.9,1,1,1,1,2.4,4.3,1
7548,0,Asia Pacific,Commercial,Supply Chain,Meets,Male,45,5,1,9,,2.8,2.1,1,1,1,1,1.8,4.2,2.7
7549,0,Middle East & Africa,Digital,Supply Chain,Below,Male,28,7,0,7,4.1,4.5,1,1,1,0,0,2.9,3.4,3.9
7550,0,Middle East & Africa,Finance,Clinical Operations,Far Below,Female,31,6,1,7,,5,3.3,1,1,1,1,4.2,2.6,1.5
7551,0,Asia Pacific,R&D,Marketing,Below,Female,47,13,1,9,,2.7,4.4,1,1,1,1,4,3.3,4.1
7552,0,Latin America,R&D,Medical Affairs,Meets,Male,35,16,0,9,4.4,2.8,3.4,1,1,1,1,4.8,2.1,2.8
7553,0,North America,Digital,Human Resources,Below,Female,41,16,0,9,3.5,4.2,2.7,1,1,1,1,5,4.4,5
7554,0,North America,HR,Quality Assurance,Far Below,Male,37,7,1,5,,2.5,2.6,1,1,1,1,5,4,2.1
7555,0,Asia Pacific,Finance,Quality Assurance,Below,Female,44,28,0,11,3.4,3.6,2.3,1,1,1,1,3,3.2,2.5
7556,1,Asia Pacific,R&D,Data Science,Exceeds,Female,40,8,1,10,,3.1,1.6,1,1,1,1,4,1.8,1.8
7557,1,Latin America,R&D,Medical Affairs,Exceeds,Non-Binary/Other,54,10,0,5,2.5,2.5,3.9,1,1,1,1,3.9,2.3,4
7558,0,Middle East & Africa,Manufacturing,Communications,Below,Male,38,2,0,8,2.6,4.3,2.2,1,1,1,1,2.6,3.9,1
7559,0,Europe,R&D,Clinical Operations,Meets,Female,35,5,1,11,,2.6,2.7,1,1,1,0,3.5,3.4,2.5
7560,0,Middle East & Africa,Manufacturing,Market Access,Exceeds,Male,46,12,0,11,3.2,2.6,4.5,1,1,1,1,2.5,3.2,3.9
7561,0,North America,R&D,Regulatory Affairs,Below,Female,42,6,1,6,,1,2.4,1,1,1,1,4.4,1,3.2
7562,0,Asia Pacific,R&D,Supply Chain,Below,Male,33,25,0,6,2.4,3.5,3,1,1,1,1,2.9,3.4,3.2
7563,0,Latin America,HR,Communications,Below,Female,43,5,0,10,2.2,2.6,5,1,1,1,1,2.5,3.9,3.8
7564,0,Middle East & Africa,HR,Legal & Compliance,Far Exceeds,Non-Binary/Other,39,14,0,7,3.6,2.2,2.2,0,0,0,0,4.2,1.9,1
7565,0,Latin America,Finance,Human Resources,Meets,Female,39,5,0,10,2.9,1.4,3.7,1,1,1,1,1.8,1.6,4.7
7566,0,Middle East & Africa,R&D,IT & Digital,Meets,Female,41,24,0,6,3.3,3.4,2.3,1,1,1,1,3.5,1.8,2.1
7567,0,North America,Finance,Communications,Far Below,Male,43,3,0,7,3.6,3.5,3.8,1,1,1,1,3.7,1.3,2.5
7568,0,Europe,Finance,Supply Chain,Far Exceeds,Male,39,12,0,9,3.6,1.9,3.3,1,1,1,1,2.9,2.5,3
7569,0,Latin America,Finance,Finance & Accounting,Meets,Male,36,13,0,11,2.9,3.3,5,1,1,1,1,1.8,2.8,3.5
7570,0,Latin America,Finance,Pharmacovigilance,Meets,Male,51,14,0,9,2.9,1.2,1.1,1,1,1,1,3,1.8,1.4
7571,0,Europe,Digital,Market Access,Meets,Female,38,11,0,12,4.1,4.8,2.1,1,1,1,1,4.1,4.6,1.6
7572,0,Latin America,Digital,Pharmacovigilance,Meets,Female,46,12,0,7,3.3,2.8,1.7,1,1,1,1,3.8,2.9,2
7573,0,Latin America,R&D,Pharmacovigilance,Below,Female,35,12,0,5,3.7,3.5,2.6,1,1,1,1,3.3,5,3.5
7574,0,Middle East & Africa,Digital,Marketing,Meets,Male,33,22,0,10,3.2,3.4,3.6,1,1,1,1,4.5,4.3,3.5
7575,0,Middle East & Africa,R&D,Quality Assurance,Meets,Female,44,3,1,5,,4.4,1,1,1,1,1,5,5,2.1
7576,0,Europe,HR,Pharmacovigilance,Below,Female,36,27,0,7,2.7,3,3.2,1,1,1,1,4.5,4.2,3.4
7577,0,North America,Commercial,IT & Digital,Meets,Female,28,13,0,5,3.8,2.1,2.8,1,1,1,1,3,3.9,2.8
7578,0,Latin America,Manufacturing,Legal & Compliance,Exceeds,Male,37,11,1,12,,3.5,2.6,1,1,1,1,2.5,3.1,3.8
7579,0,North America,Digital,Supply Chain,Meets,Female,41,6,0,11,2.5,4.4,2.5,1,1,1,1,2.7,2.6,2.4
7580,0,Europe,Digital,Medical Affairs,Far Below,Male,34,36,0,11,4,4.2,1.5,1,0,0,0,3.9,3.9,3.3
7581,0,Europe,HR,Legal & Compliance,Meets,Male,33,4,1,8,,2.2,5,0,0,0,0,2.2,2.7,3.4
7582,0,Middle East & Africa,Digital,Medical Affairs,Meets,Female,39,7,0,6,4.2,2.5,1,1,1,1,1,3,4.2,2.2
7583,1,Latin America,R&D,Marketing,Meets,Non-Binary/Other,31,1,0,8,2.7,3.3,2.7,1,1,1,1,5,3.7,3.3
7584,0,Asia Pacific,R&D,Legal & Compliance,Meets,Female,40,21,1,9,,3.8,3,1,1,1,1,4.8,4.2,2.3
7585,0,Europe,Commercial,Human Resources,Below,Male,44,4,1,10,,1.4,3.1,1,1,1,1,3.6,2,4
7586,0,Latin America,Commercial,Medical Affairs,Meets,Male,46,2,1,8,,3.3,3.8,1,1,1,1,4.6,2.4,3.6
7587,0,North America,Commercial,Human Resources,Meets,Male,34,9,0,5,3,3.6,2.9,1,1,1,0,2.7,2.7,4.1
7588,0,Middle East & Africa,R&D,Supply Chain,Exceeds,Non-Binary/Other,49,8,0,12,4.5,2.6,4.4,1,1,1,1,4.4,2.2,3.2
7589,0,North America,Finance,Quality Assurance,Meets,Male,42,26,0,11,4,3.4,1.8,1,1,1,1,4.3,2.7,1.8
7590,0,Europe,Finance,Quality Assurance,Meets,Female,34,4,0,5,4.4,4.6,3.7,1,1,1,1,4.4,4.2,2.8
7591,0,Europe,Commercial,Legal & Compliance,Meets,Female,35,9,0,6,2.6,3.6,2.1,1,1,1,1,3.1,3,2.1
7592,0,North America,Commercial,Quality Assurance,Meets,Female,34,7,0,12,2.7,2.5,1.9,1,1,1,1,2.9,3.7,3.3
7593,0,Europe,R&D,Regulatory Affairs,Meets,Male,28,15,0,7,3.1,3.7,3.5,1,1,1,1,3,4.3,2.4
7594,0,Latin America,HR,Legal & Compliance,Meets,Male,47,4,0,5,3.3,2.2,2.1,1,1,1,1,3.1,2.7,2.4
7595,0,Europe,Digital,Market Access,Exceeds,Female,39,22,0,12,2.6,4.2,1,1,1,1,1,4.2,5,2
7596,0,Middle East & Africa,Manufacturing,Regulatory Affairs,Meets,Female,42,26,0,8,3.3,3.6,3.3,1,1,1,1,3.1,3,2.4
7597,0,Latin America,Finance,Regulatory Affairs,Meets,Non-Binary/Other,39,14,0,6,3.6,5,2.5,1,1,1,1,3.6,4.1,2.8
7598,0,Asia Pacific,Finance,Regulatory Affairs,Below,Male,29,5,0,11,4.3,3.9,4.4,1,1,1,1,3.9,4.6,4.8
7599,0,Europe,R&D,Medical Affairs,Meets,Female,40,20,0,5,3.4,4.2,3.2,1,1,1,1,3.6,3.6,3.2
7600,0,Europe,R&D,Sales,Far Below,Female,44,8,0,5,3.6,2.9,3,1,1,1,1,4.1,3.7,3.7
7601,0,Middle East & Africa,Manufacturing,Medical Affairs,Meets,Male,44,9,1,7,,2.7,3.6,1,1,1,1,3.7,2.2,5
7602,0,Middle East & Africa,Manufacturing,Communications,Meets,Female,45,12,0,9,1.9,2.8,2.2,1,1,1,1,3.7,2.3,1.6
7603,0,North America,Commercial,Sales,Meets,Female,38,14,0,11,4.3,2.6,4.5,1,1,1,1,3.8,3.9,4.8
7604,0,North America,Manufacturing,Medical Affairs,Meets,Male,28,28,0,11,3.4,5,2.7,1,1,1,1,3.1,4.6,2.3
7605,0,North America,Digital,Supply Chain,Meets,Male,42,11,0,8,4.1,2.1,2.3,1,1,1,1,3.7,1,2.7
7606,0,Middle East & Africa,Digital,Market Access,Far Exceeds,Female,38,10,0,10,3,3.3,3.5,1,1,1,1,4.2,3.4,2.5
7607,0,North America,Finance,Clinical Operations,Meets,Male,50,6,1,5,,2.3,3.2,1,1,1,1,1.5,1.3,2.6
7608,1,North America,Digital,Legal & Compliance,Meets,Male,49,25,0,11,2.1,3.3,2.2,1,1,1,1,3.4,1.6,2.5
7609,0,Asia Pacific,Digital,Finance & Accounting,Meets,Male,45,9,1,7,,2.9,3.5,0,0,0,0,2.8,2.9,3.4
7610,0,North America,Digital,Clinical Operations,Meets,Female,30,11,0,11,2.5,2.7,2.1,1,1,1,1,2.6,2.7,1.7
7611,0,Europe,Commercial,Regulatory Affairs,Far Below,Female,31,17,1,9,,3.7,3.2,1,1,1,1,2.9,4.7,4.3
7612,0,Middle East & Africa,Finance,Finance & Accounting,Meets,Female,41,12,0,6,3.2,4.2,1.1,1,1,1,1,2.2,3.3,3.6
7613,0,Latin America,R&D,Clinical Operations,Meets,Male,31,7,1,7,,4.1,2.8,0,0,0,0,4.3,3.6,2.3
7614,0,Asia Pacific,Finance,IT & Digital,Meets,Male,43,26,0,7,3.1,3.2,1.9,1,1,1,1,3.9,4.3,2
7615,0,Middle East & Africa,Finance,Communications,Meets,Female,44,11,0,10,4.5,2.3,1.7,1,1,1,1,3.9,2.9,3.3
7616,0,Middle East & Africa,Finance,Market Access,Meets,Male,47,9,0,11,3.8,2.3,1.6,0,0,0,0,2.5,3,2.5
7617,0,Europe,Manufacturing,IT & Digital,Meets,Female,45,19,0,8,3.3,2.4,1.4,1,1,1,1,4,2.8,1.2
7618,0,North America,R&D,IT & Digital,Meets,Male,36,6,0,6,2.7,3.3,3,1,1,1,1,3.8,1.6,2.4
7619,0,Europe,Manufacturing,Market Access,Exceeds,Male,38,15,1,11,,3.5,3.3,1,1,1,1,5,5,3.1
7620,0,North America,Commercial,Finance & Accounting,Meets,Female,33,5,0,6,2.9,3.4,3.2,1,1,1,1,3.5,1.6,3.4
7621,0,North America,Commercial,Legal & Compliance,Meets,Female,40,3,0,11,3.9,3.2,1.9,0,0,0,0,4.2,3.3,1.1
7622,0,Middle East & Africa,HR,Human Resources,Meets,Non-Binary/Other,28,2,1,5,,3.2,2.7,1,1,1,1,2.4,4.1,1.8
7623,0,North America,HR,Data Science,Meets,Female,36,6,0,9,4.4,2.4,3.1,1,1,1,1,4.1,3.5,3.5
7624,0,Asia Pacific,Commercial,Marketing,Meets,Female,42,1,1,8,,1.3,4,1,1,1,1,2.6,3.6,3.7
7625,0,Asia Pacific,Commercial,Market Access,Exceeds,Male,42,17,0,8,5,3,5,1,1,1,1,2.6,4.2,4.4
7626,0,Asia Pacific,Manufacturing,Human Resources,Meets,Male,43,7,0,6,4.9,4.4,2,1,1,1,1,4.1,4.1,1.6
7627,0,Middle East & Africa,Commercial,Marketing,Exceeds,Female,32,19,0,5,3.8,3.5,3.5,1,1,1,1,3.2,3.4,3.5
7628,0,Europe,R&D,Clinical Operations,Below,Male,30,18,0,9,2.1,1.9,1.9,1,1,1,1,2.3,3.7,3.5
7629,0,Latin America,Manufacturing,Marketing,Meets,Female,42,23,1,8,,3.3,1.4,1,1,1,1,5,1.5,1.9
7630,0,North America,Commercial,Sales,Meets,Female,32,20,0,11,4,1.8,1.7,1,1,1,1,2.8,1.7,3
7631,0,Latin America,Manufacturing,Supply Chain,Meets,Female,31,11,0,11,2.2,3.4,2.9,1,1,1,1,2.3,3.7,2.1
7632,0,Europe,Manufacturing,Marketing,Exceeds,Female,39,7,0,10,3.2,3.2,2.6,1,1,1,1,3.2,3.1,1.8
7633,0,Europe,Digital,IT & Digital,Meets,Male,38,18,0,11,4.3,2,3.3,1,1,1,1,3.6,2.5,1.2
7634,0,Middle East & Africa,HR,IT & Digital,Far Exceeds,Female,52,9,1,5,,2.9,1,0,0,0,0,1.2,2.4,3.3
7635,0,Asia Pacific,Manufacturing,Supply Chain,Below,Female,40,13,0,5,3.6,2.3,2.8,1,1,1,1,4,1.7,2.4
7636,0,Asia Pacific,Finance,Regulatory Affairs,Meets,Female,39,5,1,9,,4.1,1.8,1,1,1,1,3,3.5,3.6
7637,0,Europe,Manufacturing,IT & Digital,Meets,Female,35,26,0,12,2.4,4.8,1,1,1,1,1,4.2,3.3,1.3
7638,0,Middle East & Africa,Finance,Clinical Operations,Far Below,Male,43,9,0,7,3.8,1.6,2.1,1,1,1,1,2.3,2.7,2.5
7639,0,Middle East & Africa,Digital,Legal & Compliance,Below,Female,38,10,0,9,3.3,3,2.3,1,1,1,1,2.9,3.4,3.2
7640,0,North America,Commercial,Supply Chain,Far Below,Male,35,6,0,8,3.3,2.2,4.6,1,1,1,1,2.8,2.1,4.8
7641,0,Asia Pacific,Manufacturing,Pharmacovigilance,Far Exceeds,Female,37,6,1,9,,2.4,2,1,1,1,1,4.5,4.1,2.9
7642,0,Europe,Digital,Regulatory Affairs,Meets,Female,36,16,0,11,3.2,4.1,1.9,1,1,1,1,4.2,2.3,1.9
7643,0,Latin America,R&D,IT & Digital,Meets,Male,38,8,0,8,3.1,3.2,2.4,1,1,1,1,2.8,3.8,1.6
7644,0,Asia Pacific,Digital,Supply Chain,Below,Non-Binary/Other,52,15,0,9,3,3.5,5,0,0,0,0,2.4,2,4.7
7645,0,North America,HR,Data Science,Below,Non-Binary/Other,42,8,1,5,,3.5,5,1,1,1,1,3.5,2.1,3.5
7646,0,Middle East & Africa,HR,Marketing,Meets,Female,37,7,0,9,2.7,2.9,2.2,1,1,1,1,3.3,3.2,2.3
7647,0,Europe,Commercial,Data Science,Far Exceeds,Female,38,21,0,6,5,1.4,1.7,1,0,0,0,4.7,3.8,2.2
7648,0,Asia Pacific,Finance,Finance & Accounting,Meets,Female,30,7,0,11,2.5,3.7,3,1,1,1,1,2.6,2.4,1.9
7649,0,Latin America,Commercial,Market Access,Meets,Male,28,8,0,9,3.8,1,2.1,1,1,1,1,3.2,1.9,1.2
7650,0,North America,Finance,Finance & Accounting,Meets,Female,42,5,1,10,,1.5,4.5,1,1,1,1,3.3,2.3,3.8
7651,0,North America,Finance,Human Resources,Far Exceeds,Female,42,16,0,7,5,1,4.4,1,1,1,1,5,2.8,4.6
7652,0,Asia Pacific,Finance,Human Resources,Meets,Female,40,12,1,12,,1.8,1.8,1,1,1,1,4.1,1.6,1.9
7653,0,Latin America,Finance,Human Resources,Far Exceeds,Female,47,9,0,11,4.9,2.5,2.6,0,0,0,0,3.9,1.7,2.4
7654,0,North America,HR,Sales,Far Below,Female,39,12,1,9,,3.3,2.6,0,0,0,0,2.4,3.9,4.1
7655,1,Europe,HR,Communications,Meets,Female,43,5,0,7,4,3.2,2.3,1,1,1,1,2.8,2.8,3.6
7656,0,North America,Manufacturing,Regulatory Affairs,Meets,Female,38,13,0,10,3.3,2.8,2.8,0,0,0,0,3.1,4,3.2
7657,0,Latin America,HR,Quality Assurance,Meets,Male,28,23,0,11,3.6,2.4,2,0,0,0,0,3.2,3.9,2.4
7658,0,Middle East & Africa,Commercial,Legal & Compliance,Meets,Female,45,9,1,9,,1.5,3.7,1,1,1,1,3.7,1.2,2.3
7659,0,Middle East & Africa,HR,Quality Assurance,Far Below,Female,32,14,0,10,3.9,2.8,4.2,1,1,1,1,3.3,3.1,1
7660,0,Asia Pacific,Commercial,Supply Chain,Below,Male,40,7,0,12,3.8,3.3,3.7,1,1,1,1,2.9,4.3,3.8
7661,1,Latin America,R&D,Marketing,Exceeds,Male,34,22,0,11,3.2,3.8,1.8,1,1,1,1,3.3,3.4,3.1
7662,0,North America,HR,Clinical Operations,Meets,Male,40,14,0,10,3.4,4,2.7,1,1,1,1,4,3.8,1.7
7663,0,North America,Commercial,Quality Assurance,Far Exceeds,Male,48,12,0,7,3.4,4.6,2.8,1,1,1,1,2,5,1.5
7664,0,Middle East & Africa,Finance,Clinical Operations,Meets,Male,42,8,0,9,3.3,3.1,3.3,1,1,1,1,3.4,3,3.2
7665,0,Middle East & Africa,Digital,Quality Assurance,Meets,Female,43,9,0,6,3.2,4.5,1.9,1,1,1,1,3.9,5,2.9
7666,0,Europe,Finance,Human Resources,Exceeds,Female,37,6,0,6,3.7,2.6,2,1,1,1,1,2.6,3.2,2.4
7667,0,Middle East & Africa,Manufacturing,Regulatory Affairs,Meets,Male,36,3,0,11,3,1.2,2.5,1,1,1,1,3.5,3.6,2.9
7668,0,Europe,Commercial,Quality Assurance,Meets,Male,36,9,0,5,4.1,4,2.1,1,1,1,1,4.7,4.3,2
7669,0,North America,Finance,Market Access,Below,Female,43,15,0,8,4.4,3.2,4.2,1,1,1,1,3.3,1.9,4.2
7670,0,Europe,HR,IT & Digital,Exceeds,Female,38,13,1,7,,3,4.4,1,1,1,1,3.2,4.1,3.8
7671,0,Europe,HR,Medical Affairs,Meets,Male,42,15,0,10,3.8,3.2,3.5,0,0,0,0,3.2,4.2,2.8
7672,0,Asia Pacific,R&D,Supply Chain,Meets,Male,37,10,0,9,3,2,3.1,1,1,1,1,3.2,3.2,4.8
7673,0,Middle East & Africa,Digital,Sales,Meets,Male,44,22,0,5,2.7,2,3.8,1,1,1,1,2.1,3,3.5
7674,0,Europe,Commercial,Quality Assurance,Meets,Female,42,13,0,6,2.8,3,2.7,1,1,1,1,2.4,3.6,2.6
7675,0,North America,Finance,IT & Digital,Exceeds,Female,39,4,0,12,2.7,3.7,3.4,1,1,1,1,3.9,2.7,3.2
7676,0,Latin America,Digital,Communications,Far Below,Male,42,11,0,12,2,2.9,1,0,0,0,0,2.2,2.8,1.6
7677,0,Europe,R&D,Marketing,Meets,Male,44,9,0,12,5,1,3,1,1,1,1,4.1,3.1,3.6
7678,0,Middle East & Africa,Manufacturing,Legal & Compliance,Far Below,Non-Binary/Other,49,22,0,7,3.3,1.4,3,1,1,1,1,3,1.3,2.6
7679,0,Asia Pacific,Digital,Communications,Below,Female,34,7,0,10,3.6,2.5,1.8,1,1,1,1,4.9,2.6,2.2
7680,0,North America,R&D,Sales,Meets,Male,43,36,0,7,2.8,3.3,3.7,1,1,1,1,1.7,3.9,1.8
7681,0,Asia Pacific,Commercial,Clinical Operations,Far Below,Female,42,10,1,8,,3,1.7,1,1,1,1,3.5,3.2,3.7
7682,0,Latin America,Manufacturing,Data Science,Below,Male,44,7,1,8,,2.7,1.2,1,1,1,1,2.1,3.5,1.3
7683,0,Europe,HR,Market Access,Meets,Female,35,11,0,9,4,1.9,3.5,1,1,1,1,3.5,2.2,2.4
7684,0,Europe,R&D,Pharmacovigilance,Meets,Male,39,11,1,6,,3.5,3,1,1,1,1,3.3,3,3.2
7685,0,Middle East & Africa,HR,Communications,Meets,Male,35,12,0,10,4.9,4.8,2.7,1,1,1,1,3.9,3.6,3.7
7686,0,Europe,Manufacturing,Legal & Compliance,Meets,Female,40,9,0,8,2.9,5,2.5,1,1,1,1,3.2,5,3.8
7687,0,North America,R&D,Pharmacovigilance,Meets,Male,33,17,0,7,3.7,2.6,3.7,1,1,1,1,3.1,4,2.5
7688,0,Latin America,R&D,Sales,Meets,Male,46,7,0,9,2.4,2,1.7,1,1,1,1,1.6,3,3.1
7689,0,Asia Pacific,Manufacturing,Data Science,Meets,Female,39,11,1,10,,2.5,3.3,1,1,1,1,3.2,4.3,3.5
7690,0,Latin America,Commercial,Marketing,Far Exceeds,Male,48,6,0,12,1.8,1.6,1.5,1,1,1,1,2.6,1.6,2.9
7691,0,Europe,R&D,Sales,Far Below,Female,34,8,0,7,2.4,2.7,2.4,1,1,1,1,2,2.8,3.7
7692,0,Asia Pacific,Manufacturing,Communications,Meets,Male,39,31,0,12,4.4,3.1,3.2,1,1,1,1,3.5,4.6,3.4
7693,0,Middle East & Africa,Digital,Clinical Operations,Meets,Female,39,13,0,12,4.6,2.4,2.5,1,1,1,1,4.1,2.7,4.8
7694,0,Latin America,HR,Regulatory Affairs,Meets,Non-Binary/Other,42,12,1,10,,1.8,3,1,1,1,1,3.3,2.8,2.7
7695,0,Asia Pacific,R&D,IT & Digital,Exceeds,Male,43,14,0,6,3.4,3,3.5,0,0,0,0,4,3.6,2.3
7696,0,Asia Pacific,Digital,Sales,Far Below,Female,30,19,0,11,4.1,4.3,3,1,1,1,1,3.3,4.3,2.4
7697,0,Asia Pacific,R&D,Legal & Compliance,Meets,Female,45,4,0,12,3.5,3.4,2.2,1,1,1,1,4.4,4.2,2.6
7698,0,North America,Commercial,Pharmacovigilance,Meets,Male,43,4,1,5,,2.8,1.6,1,1,1,1,2.6,3.6,2.1
7699,0,Latin America,Manufacturing,IT & Digital,Meets,Female,29,14,0,8,4,3.9,2.3,0,0,0,0,3.7,3.2,4.1
7700,0,Asia Pacific,R&D,Medical Affairs,Below,Female,47,14,0,9,3.8,3.1,4.7,1,1,1,1,2.6,2.5,3.8
7701,0,Latin America,Manufacturing,Pharmacovigilance,Meets,Male,30,10,0,9,4.5,1.8,1.7,1,1,1,1,3.4,3.2,2.8
7702,0,Asia Pacific,Finance,Data Science,Meets,Female,40,10,0,9,4.3,4,1.8,1,1,1,0,3.4,4.3,1.5
7703,0,Middle East & Africa,R&D,Clinical Operations,Far Below,Male,36,11,0,7,1.8,3,1,1,1,1,1,3.2,3.2,1.8
7704,0,Middle East & Africa,Commercial,Marketing,Meets,Female,37,7,0,11,2.5,1.8,2.3,1,1,1,1,1.7,3.2,3.2
7705,0,Middle East & Africa,Commercial,Communications,Far Below,Male,36,2,0,7,5,3.2,2.5,1,1,1,1,5,3.5,2.6
7706,0,Europe,Digital,Market Access,Meets,Male,41,11,1,11,,1.4,1.7,1,1,1,1,3.5,3.1,1
7707,0,Asia Pacific,Commercial,Legal & Compliance,Meets,Male,33,14,0,10,3.3,2.5,1.5,0,0,0,0,3.5,2.4,2
7708,0,Europe,Manufacturing,Supply Chain,Meets,Male,44,13,0,12,3.2,3.7,1.9,1,1,1,1,2.4,3.9,1
7709,0,Latin America,Finance,Medical Affairs,Exceeds,Female,41,4,0,12,3,1.8,1.6,1,1,1,1,5,2.1,1
7710,0,Europe,Commercial,Market Access,Meets,Male,37,15,1,6,,2.4,1.9,1,1,1,1,4.7,3.8,2.4
7711,0,Latin America,R&D,Sales,Meets,Male,43,21,0,6,3.4,3.4,2.8,1,1,1,1,5,3.8,1.2
7712,0,Latin America,Commercial,Medical Affairs,Far Exceeds,Male,35,10,0,7,2.5,3,2.6,1,1,1,1,3.2,3,1.3
7713,0,Latin America,Finance,Data Science,Exceeds,Male,38,32,0,5,3.1,4.8,1.9,1,1,1,1,3,5,2.7
7714,0,Europe,Manufacturing,Clinical Operations,Meets,Female,29,4,0,7,4.2,4.7,1.7,1,1,1,1,4.6,3.7,2.6
7715,0,Asia Pacific,R&D,Finance & Accounting,Meets,Male,35,21,0,10,2.7,3.3,3.4,1,1,1,1,1.3,4,3.3
7716,0,Europe,Digital,Marketing,Meets,Female,33,8,0,8,3.9,5,1,1,1,1,1,2.8,5,1.7
7717,0,Asia Pacific,Digital,Market Access,Exceeds,Female,28,5,0,5,2.8,1.7,3.6,1,1,1,1,2.1,2.2,3
7718,0,Asia Pacific,Digital,Sales,Far Below,Female,37,6,0,7,3.2,2.1,4.5,1,1,1,1,4.4,2.2,4.7
7719,0,Latin America,R&D,Human Resources,Meets,Male,37,10,0,11,4.5,3.1,2.3,1,1,1,1,2.4,4.1,2.3
7720,0,Europe,Digital,Clinical Operations,Exceeds,Female,40,26,0,10,4,4.2,1.9,1,1,1,0,4,2.5,1.8
7721,0,Asia Pacific,Commercial,Sales,Meets,Male,41,14,0,8,3.8,2.9,5,1,1,1,1,4.6,3.3,5
7722,0,Middle East & Africa,R&D,Marketing,Meets,Male,37,10,0,7,2.5,2.7,3.3,1,1,1,1,3.6,2.9,4.8
7723,0,Asia Pacific,R&D,Market Access,Meets,Female,41,5,0,7,4.3,1.4,1.1,1,1,1,1,5,1.9,1
7724,0,Middle East & Africa,R&D,Sales,Meets,Female,43,14,0,5,2.5,2.5,2.5,0,0,0,0,2.8,3,3.3
7725,0,Europe,HR,Clinical Operations,Meets,Male,45,20,0,11,3.2,2.6,1.6,1,1,1,1,4.3,2.7,1.8
7726,0,Europe,Manufacturing,Legal & Compliance,Meets,Female,41,9,0,11,3.5,3.5,2.3,0,0,0,0,4.1,4.6,3.3
7727,0,Europe,HR,Sales,Meets,Female,41,5,1,8,,2.4,1.9,0,0,0,0,2.6,2.3,1
7728,0,Asia Pacific,HR,Market Access,Exceeds,Male,32,29,0,6,3.6,3.1,3.9,1,1,1,1,2.8,4,3.3
7729,0,North America,HR,Clinical Operations,Meets,Male,43,6,0,6,3.6,3,3.3,1,1,1,1,1.7,2.2,2.7
7730,0,Asia Pacific,Manufacturing,Human Resources,Far Below,Male,32,18,0,10,2.7,1.4,3.4,1,1,1,1,1,2.4,2.6
7731,0,Asia Pacific,HR,Data Science,Meets,Male,40,18,0,9,4.3,2.7,1.4,0,0,0,0,4.3,4,2.4
7732,0,Latin America,Digital,IT & Digital,Meets,Male,42,7,1,11,,3.7,2.1,1,1,1,1,2.9,1.8,1.8
7733,1,Latin America,R&D,Finance & Accounting,Meets,Male,41,5,0,8,1.9,1.8,1.1,0,0,0,0,2.1,2,2.9
7734,0,Asia Pacific,R&D,Regulatory Affairs,Meets,Male,28,17,0,9,5,3.1,1.4,1,1,1,1,4.2,2.5,1.9
7735,0,Middle East & Africa,Commercial,Finance & Accounting,Meets,Male,43,14,1,10,,4.3,3.2,1,1,1,1,3.5,4.9,3.8
7736,0,Latin America,Finance,Clinical Operations,Meets,Male,47,22,1,12,,4.1,2.4,1,1,1,1,4.4,4.3,3.1
7737,1,Asia Pacific,Digital,Medical Affairs,Meets,Male,28,2,0,5,3,4,2.4,1,1,1,1,4,4.7,4.1
7738,0,North America,Manufacturing,Regulatory Affairs,Exceeds,Male,39,14,0,7,4.4,3.3,3.8,1,1,1,1,5,3,1.9
7739,0,Middle East & Africa,Finance,Sales,Below,Female,37,18,0,5,5,3.5,3.7,1,1,1,1,4.4,3.2,1.7
7740,0,Europe,R&D,Market Access,Meets,Male,38,13,0,12,3.5,2.3,3.5,1,1,1,1,3.1,2,2.8
7741,0,Asia Pacific,HR,Clinical Operations,Meets,Female,46,22,0,6,3.9,2.5,2.5,0,0,0,0,3.6,3.2,3.1
7742,0,Asia Pacific,Commercial,IT & Digital,Far Exceeds,Non-Binary/Other,39,10,0,8,3,3.3,2.4,0,0,0,0,3.7,4.6,3.1
7743,0,Middle East & Africa,Commercial,Market Access,Below,Male,32,6,0,9,4.6,3.4,2.5,1,1,1,1,2,2.3,3.3
7744,0,Latin America,R&D,Clinical Operations,Meets,Male,34,18,1,8,,3.6,2.3,1,1,1,1,3.3,3.2,2
7745,0,Latin America,Digital,Human Resources,Exceeds,Female,33,20,0,6,4.1,3.2,2,1,1,1,0,3.9,2,2.1
7746,0,Latin America,Finance,Market Access,Exceeds,Male,28,34,0,11,5,4.2,1,1,1,1,1,4.8,2.8,2.1
7747,0,Europe,Commercial,Medical Affairs,Exceeds,Male,35,10,0,9,4.3,4.5,2.7,1,1,1,1,5,5,3.1
7748,0,Middle East & Africa,R&D,Supply Chain,Meets,Male,42,7,0,12,3.6,3.4,4.5,1,0,0,0,3,2.9,3
7749,0,Middle East & Africa,Digital,Legal & Compliance,Exceeds,Male,40,17,0,9,2.8,3.5,1.9,0,0,0,0,2.8,3.5,1
7750,0,Latin America,R&D,Legal & Compliance,Meets,Male,39,4,1,11,,3.1,2.6,1,1,1,1,3.4,1.5,3.2
7751,0,Latin America,R&D,Regulatory Affairs,Meets,Non-Binary/Other,36,4,1,12,,1.3,2.8,1,1,1,1,2.6,2.5,2.9
7752,0,North America,Digital,Regulatory Affairs,Meets,Male,38,4,0,6,3.7,2,4.1,1,1,1,1,4.1,2.8,1.7
7753,0,North America,Digital,Clinical Operations,Meets,Female,41,2,1,6,,3.8,3.7,1,1,1,1,2.8,4.2,1.1
7754,0,Asia Pacific,Digital,Sales,Meets,Female,43,9,0,10,2.3,4.4,2.3,1,1,1,1,3.4,2.7,3.1
7755,0,Asia Pacific,R&D,Marketing,Meets,Male,40,34,0,7,3.6,3.8,1.6,1,1,1,1,3,2.8,2.5
7756,0,Middle East & Africa,Commercial,Finance & Accounting,Meets,Male,31,3,0,9,3.2,2.2,3.8,1,1,1,1,3.9,3,4.1
7757,0,Middle East & Africa,Manufacturing,Marketing,Meets,Female,35,3,0,10,2.3,2.2,3.9,1,1,1,1,4.4,2.1,3
7758,0,Europe,Manufacturing,Regulatory Affairs,Meets,Male,41,21,0,9,2.8,3.8,2.7,1,1,1,1,3.4,3.5,2.3
7759,0,Europe,R&D,IT & Digital,Meets,Male,34,15,0,10,2.4,4.2,2.7,0,0,0,0,3,4.3,4.3
7760,0,North America,R&D,IT & Digital,Meets,Male,34,15,0,11,3.1,3.5,3.8,1,1,1,1,3.5,2.4,3.2
7761,0,Asia Pacific,Commercial,Supply Chain,Meets,Male,42,8,0,5,3.4,4,1.9,1,1,1,1,2.2,1.9,3.4
7762,0,North America,Digital,Marketing,Meets,Male,43,11,0,11,2.6,4.6,2.9,1,1,1,1,2.2,4.4,2.9
7763,0,North America,R&D,Quality Assurance,Meets,Female,32,28,0,6,1.9,3.8,1.1,1,1,1,1,2.9,3.3,2
7764,0,Asia Pacific,HR,Marketing,Meets,Male,30,4,1,12,,3.4,2.6,1,1,1,1,4.1,3.2,3.9
7765,0,Europe,Digital,Pharmacovigilance,Meets,Male,31,4,1,6,,3.6,2.6,1,1,1,1,2.1,3.9,3.5
7766,0,Asia Pacific,R&D,Market Access,Meets,Female,42,14,0,8,3.9,3.2,1.8,1,1,1,1,3.9,3.5,3
7767,0,Latin America,HR,Regulatory Affairs,Far Below,Female,33,18,1,11,,2.9,1.7,1,1,1,1,3.4,3.9,2.8
7768,0,Latin America,Finance,Supply Chain,Meets,Female,35,16,0,12,3.8,2.6,2,1,1,1,1,3.5,3,3
7769,0,Latin America,Commercial,Sales,Meets,Female,31,8,0,12,3.1,3.1,1.1,0,0,0,0,2.2,4.3,1.8
7770,0,Middle East & Africa,HR,Clinical Operations,Far Exceeds,Male,38,17,0,8,4.4,3.2,1.3,1,1,1,1,3.9,3.1,2.3
7771,0,Europe,R&D,Data Science,Far Below,Female,37,14,1,7,,5,3.1,1,1,1,1,5,3.2,3.3
7772,0,Europe,Manufacturing,Medical Affairs,Meets,Female,41,5,1,12,,3.5,3.2,0,0,0,0,3,5,3.2
7773,0,Middle East & Africa,R&D,IT & Digital,Exceeds,Female,40,9,1,9,,3.2,3.4,1,1,1,1,3.2,3.3,3.4
7774,0,North America,Manufacturing,Regulatory Affairs,Exceeds,Female,28,5,1,6,,3.3,4.9,1,1,1,1,4.7,3,3.6
7775,0,Latin America,Commercial,Supply Chain,Far Below,Female,40,18,0,12,2.8,3.2,3.2,1,0,0,0,4,3.5,2.4
7776,0,Latin America,Commercial,Clinical Operations,Meets,Female,37,8,0,8,1,3.4,2.4,1,1,1,1,1.8,3.3,2.6
7777,0,North America,Digital,Data Science,Far Below,Female,45,8,1,9,,2.7,3.7,1,1,1,1,1.6,5,3
7778,0,Asia Pacific,Digital,IT & Digital,Meets,Female,33,7,0,10,4.4,3.4,2.3,1,1,1,1,2.5,2.2,2
7779,0,Asia Pacific,Manufacturing,Pharmacovigilance,Meets,Female,41,8,0,11,4.2,3.9,4.4,1,1,1,1,4.4,3.7,4.3
7780,0,Europe,Manufacturing,Human Resources,Meets,Male,39,12,1,7,,4.5,3.4,0,0,0,0,3.5,3.6,4.6
7781,0,Middle East & Africa,Commercial,Legal & Compliance,Exceeds,Male,33,17,0,10,4.9,3.3,5,1,1,1,1,5,2.7,4.6
7782,0,Europe,HR,Regulatory Affairs,Far Exceeds,Female,44,13,0,5,2.6,3.4,1.7,1,1,1,1,3.4,2.4,2.2
7783,0,Asia Pacific,Manufacturing,Sales,Exceeds,Female,40,14,0,6,5,4.1,2.4,1,1,1,1,4.9,2.7,2.2
7784,0,North America,Manufacturing,Medical Affairs,Meets,Male,36,5,1,11,,2.5,3.1,1,1,1,1,4.1,2.9,3.7
7785,0,Europe,HR,IT & Digital,Below,Female,33,8,0,11,3,4.5,4,1,1,1,1,2.8,3.9,3.6
7786,0,Latin America,Digital,Data Science,Meets,Male,45,22,0,7,1.7,2,1.7,0,0,0,0,1.6,3,2.7
7787,0,Latin America,Digital,Sales,Meets,Female,43,23,0,10,3,2.5,3.4,1,1,1,1,3.1,3.5,2.5
7788,0,North America,Manufacturing,Marketing,Far Below,Female,38,13,1,9,,4.2,3.2,1,1,1,1,4.3,3.5,3.4
7789,0,Asia Pacific,Digital,Clinical Operations,Meets,Female,38,1,0,9,3.1,3.5,2.3,1,1,1,1,4.6,2.6,1.2
7790,0,Latin America,Digital,Regulatory Affairs,Exceeds,Female,31,13,0,5,1.9,2.1,1,1,1,1,1,3.9,4.2,2.4
7791,0,Latin America,Finance,Clinical Operations,Exceeds,Male,46,6,0,5,3.5,4.6,4.7,1,1,0,0,5,4.3,3.1
7792,0,Middle East & Africa,Digital,Data Science,Meets,Male,31,18,0,5,3.3,4.5,2.5,1,1,1,1,4,4.8,3.1
7793,1,Europe,Commercial,Quality Assurance,Meets,Male,43,2,0,11,3.4,1.7,1.8,1,1,1,1,3.8,3,2.1
7794,0,Asia Pacific,R&D,Quality Assurance,Meets,Female,50,4,1,12,,3.8,2.1,1,1,1,1,4.7,3.7,3.2
7795,1,Europe,Manufacturing,Medical Affairs,Exceeds,Female,33,8,1,9,,2.1,3,1,1,0,0,4.3,2.3,3.8
7796,0,Asia Pacific,Manufacturing,Marketing,Meets,Male,35,21,0,9,3.4,4.3,2.8,1,1,1,1,3,2.5,3.7
7797,0,Latin America,Commercial,IT & Digital,Far Exceeds,Male,33,6,1,9,,4.6,2.2,1,1,1,1,4.6,4.2,3.5
7798,0,Middle East & Africa,R&D,Pharmacovigilance,Meets,Female,45,15,0,11,2.8,3.5,3.3,1,1,1,1,3.7,2.7,2.8
7799,0,Europe,R&D,Legal & Compliance,Far Exceeds,Female,39,11,1,11,,3,2.4,0,0,0,0,3.7,1.9,3.7
7800,0,Latin America,Commercial,Supply Chain,Meets,Female,29,14,0,10,3.4,2.4,1.1,1,1,1,1,4,2.8,1.3
7801,0,Asia Pacific,HR,Regulatory Affairs,Exceeds,Female,32,8,1,10,,3.3,3.5,1,1,1,1,2.8,3.8,3.9
7802,0,Europe,HR,Human Resources,Exceeds,Male,42,8,0,12,4.5,2.3,1.9,1,1,1,1,5,2.1,1
7803,0,Europe,R&D,Regulatory Affairs,Meets,Male,34,6,1,5,,4.2,2.3,0,0,0,0,3.7,4.2,1.2
7804,0,Latin America,HR,Data Science,Meets,Female,28,3,0,7,3.8,2,2,1,1,1,1,4.7,3.3,4.2
7805,0,Europe,HR,Quality Assurance,Exceeds,Male,41,8,0,8,2.4,2.4,2.6,0,0,0,0,4.1,2.7,3
7806,0,Middle East & Africa,HR,Market Access,Below,Male,40,5,1,12,,3.5,1.7,1,1,1,1,2.3,3.3,1.1
7807,0,Middle East & Africa,R&D,Communications,Meets,Male,33,17,0,10,4.1,3.2,2.5,1,1,1,1,4.2,3,3.8
7808,0,Latin America,HR,Pharmacovigilance,Exceeds,Male,36,9,0,5,1.5,3.7,3.8,1,1,1,1,3.5,4,4
7809,0,Asia Pacific,Manufacturing,Finance & Accounting,Exceeds,Male,36,11,0,8,2.1,3.3,4,1,1,1,1,3.3,1.9,2.6
7810,0,Latin America,Finance,Legal & Compliance,Below,Female,37,8,0,8,4.5,4.9,1.7,0,0,0,0,3.8,3.4,2.6
7811,0,Middle East & Africa,R&D,Data Science,Meets,Non-Binary/Other,46,9,0,5,5,3.6,3.1,1,1,1,1,4,2.9,3.5
7812,0,North America,Commercial,Pharmacovigilance,Meets,Male,42,6,0,12,4.4,4.2,3.4,0,0,0,0,2.8,4.2,2.6
7813,0,North America,HR,IT & Digital,Meets,Female,41,8,0,9,2.3,2.9,2.7,1,1,1,1,3.8,3.3,2.2
7814,0,Europe,Digital,IT & Digital,Exceeds,Male,37,7,0,5,3.7,2.4,2.2,1,1,1,0,3.1,2,1
7815,0,Europe,R&D,Market Access,Meets,Male,33,22,0,11,2.1,2.9,1.4,1,1,1,1,4.6,2.6,1.7
7816,1,North America,Commercial,IT & Digital,Far Exceeds,Female,47,17,1,5,,3,3.5,1,1,1,1,2.2,3.9,2.5
7817,0,Middle East & Africa,Finance,Quality Assurance,Below,Non-Binary/Other,38,3,0,5,2.7,3,3.5,1,0,0,0,1.6,3.3,2.7
7818,0,Europe,Manufacturing,Sales,Meets,Female,32,9,0,11,4.5,2.4,2.5,1,1,1,1,3.3,3.7,3.3
7819,0,Latin America,Commercial,Human Resources,Exceeds,Male,55,13,1,8,,2,2.1,1,1,1,1,2,4.1,3.5
7820,0,Latin America,HR,Market Access,Meets,Male,39,17,1,11,,2.5,1.9,1,1,1,1,2.4,2.7,3.1
7821,0,Middle East & Africa,Digital,Data Science,Meets,Female,31,15,0,12,3.7,3.8,1,1,1,1,1,3.5,2.5,2.2
7822,0,Europe,HR,Human Resources,Far Exceeds,Male,43,9,0,10,3,3.4,1.6,1,1,1,1,3.8,4.5,1.7
7823,0,Latin America,Commercial,Supply Chain,Exceeds,Female,44,6,0,5,2.9,3,2.8,1,1,1,1,1.8,3.2,2.4
7824,0,Europe,R&D,Pharmacovigilance,Meets,Male,36,13,0,6,4.5,3.8,2.4,1,1,1,1,3.3,3.8,3.4
7825,0,Europe,Digital,IT & Digital,Meets,Female,33,8,1,8,,1.4,1,1,1,1,1,5,2.6,2
7826,0,Latin America,Digital,Marketing,Far Below,Female,36,11,0,9,2.1,4.1,4.1,1,1,1,1,3,3.9,2.2
7827,0,North America,Commercial,Data Science,Far Exceeds,Male,42,2,0,7,2.9,4.4,1.4,1,1,1,1,4.2,4,1.5
7828,0,Latin America,Finance,Sales,Exceeds,Female,43,4,0,7,2.8,2.7,3,1,1,1,1,4.1,2.9,2
7829,0,Middle East & Africa,Finance,Supply Chain,Far Below,Male,34,7,1,6,,2.7,4.6,1,1,1,1,3.2,2.2,3.9
7830,0,Asia Pacific,HR,Quality Assurance,Below,Male,46,17,0,6,2.6,2.6,2.5,1,1,1,1,3.4,1.3,2.2
7831,0,Latin America,Commercial,Finance & Accounting,Exceeds,Male,29,10,0,9,3.3,1.7,3.3,1,1,1,1,4.4,1.2,3.9
7832,0,Europe,Digital,Legal & Compliance,Below,Male,34,16,0,10,3.7,3.2,3.5,1,1,1,1,4.5,2.9,3.2
7833,0,Europe,Commercial,IT & Digital,Exceeds,Male,37,21,0,9,3.8,1.2,1.4,1,1,1,1,2.4,1.1,2.1
7834,1,Latin America,Digital,Medical Affairs,Far Exceeds,Male,36,16,0,11,3.5,3.2,3,1,1,1,1,2.9,3.6,3.8
7835,0,Asia Pacific,HR,Regulatory Affairs,Exceeds,Male,35,6,1,6,,3.1,1.5,1,1,1,1,2.9,2.8,2.7
7836,0,Latin America,R&D,Market Access,Meets,Non-Binary/Other,46,10,0,8,3.7,3.8,1.9,1,1,1,1,3.7,3.9,3
7837,0,Asia Pacific,R&D,Regulatory Affairs,Meets,Male,37,6,1,10,,2.6,2.3,1,1,1,1,4.2,3.3,2.6
7838,0,Asia Pacific,Commercial,IT & Digital,Below,Female,40,11,0,10,1.8,3.8,1.7,1,1,1,1,2.6,2.1,2.3
7839,0,Middle East & Africa,Digital,Data Science,Meets,Female,40,12,0,9,2.9,2.9,2.1,1,1,1,1,3.4,3.5,2
7840,0,Europe,R&D,Quality Assurance,Meets,Female,40,8,0,8,3.5,3.9,2.2,1,1,1,1,4,4.6,2.1
7841,0,Europe,Digital,Clinical Operations,Meets,Female,37,10,0,5,3.1,3.4,2.8,1,1,1,1,4.3,3,2.9
7842,0,Asia Pacific,HR,Legal & Compliance,Meets,Male,28,10,0,5,2.6,3.9,3,0,0,0,0,3.3,3.9,4.2
7843,0,Europe,Commercial,Supply Chain,Meets,Male,43,5,0,9,1.5,3.4,3.9,1,1,1,1,2.2,3.1,2.5
7844,0,North America,Digital,Marketing,Meets,Male,38,19,0,7,4.1,2.8,2.5,1,1,1,1,3.3,2.4,1.5
7845,0,Asia Pacific,Commercial,Legal & Compliance,Exceeds,Female,35,11,0,7,3.9,3.6,2.9,0,0,0,0,3.1,4.5,1.7
7846,0,Europe,Digital,Regulatory Affairs,Meets,Female,35,15,1,12,,3.4,4.7,1,1,1,1,2.7,2.3,3.8
7847,0,North America,Finance,Pharmacovigilance,Meets,Female,40,5,0,8,4.9,3.4,2.4,1,1,1,1,4.8,2.5,2.5
7848,0,Middle East & Africa,Finance,Finance & Accounting,Meets,Male,35,7,0,12,3.4,2.1,4.6,1,1,1,1,3.1,3.3,2.6
7849,0,Europe,Digital,IT & Digital,Far Below,Female,37,15,0,10,2.8,3.9,3.7,1,1,1,1,4,2.9,2.2
7850,0,North America,HR,Sales,Exceeds,Female,42,6,1,7,,3.3,2.6,1,1,1,1,2.4,4,3
7851,0,Latin America,Commercial,Regulatory Affairs,Meets,Male,39,13,0,7,2.7,2.3,1.2,1,1,1,1,2.7,4,1.6
7852,0,Latin America,Manufacturing,Data Science,Below,Male,33,3,1,10,,3.3,2.4,1,1,1,1,1.8,2.6,4.2
7853,0,North America,Digital,Supply Chain,Meets,Female,41,23,0,8,3.3,3.2,1,1,1,1,1,2.5,3.4,2
7854,1,Asia Pacific,Digital,Supply Chain,Far Exceeds,Female,36,15,0,11,3.5,4.6,2.8,1,1,1,1,3.3,4.1,2.6
7855,0,Asia Pacific,Finance,Market Access,Meets,Male,43,9,1,10,,2.4,5,1,1,1,1,2.5,2.2,3.8
7856,1,Europe,R&D,Clinical Operations,Meets,Male,36,8,1,10,,3.3,2.4,1,1,1,1,4.4,2.7,2.7
7857,0,Latin America,Finance,Communications,Meets,Male,39,14,0,11,2.9,3.4,3.4,1,1,1,1,3.2,3.7,2.5
7858,0,Asia Pacific,Commercial,Market Access,Meets,Female,42,10,1,7,,1.7,2.5,1,1,1,1,2.9,2.6,1
7859,0,Asia Pacific,Finance,Legal & Compliance,Far Below,Female,33,4,0,12,2.6,2.6,3.9,1,1,1,1,2.3,1.5,3.7
7860,0,Latin America,Manufacturing,Human Resources,Exceeds,Male,42,14,0,7,3.5,3.1,1.6,1,1,1,1,3.9,3.1,2.9
7861,0,Middle East & Africa,HR,Human Resources,Meets,Female,48,6,1,10,,1,2.7,1,1,1,1,3.4,2.1,4.6
7862,0,Asia Pacific,Manufacturing,IT & Digital,Exceeds,Female,41,11,1,8,,3.8,1.4,1,1,1,1,3.6,3.2,1.5
7863,0,North America,HR,Medical Affairs,Meets,Female,39,12,1,11,,3.1,4.1,1,1,1,1,2.8,3.6,3.7
7864,0,Europe,Manufacturing,Marketing,Below,Male,43,16,0,5,2.4,3.5,2.7,1,1,1,1,3.8,3.1,2.6
7865,0,Asia Pacific,Finance,Quality Assurance,Exceeds,Male,43,15,0,8,3.1,3.8,3.2,1,1,1,1,2.8,4.3,3.6
7866,0,Asia Pacific,Manufacturing,Data Science,Meets,Male,39,11,0,8,3,2.6,3.2,0,0,0,0,2.9,2,3.3
7867,0,Middle East & Africa,Finance,Legal & Compliance,Meets,Male,32,15,1,6,,1.4,1.2,1,1,1,1,2.4,1.9,3.1
7868,1,North America,Finance,Data Science,Exceeds,Female,34,17,0,8,2.6,1,1.4,1,1,1,1,4.4,1.4,1.4
7869,0,Europe,Commercial,Quality Assurance,Far Exceeds,Male,36,25,0,7,2.5,4,3.3,1,1,1,1,3.8,1.7,2.4
7870,0,Asia Pacific,Finance,Quality Assurance,Below,Female,30,9,0,9,2.4,4.1,3.1,0,0,0,0,3.2,3.4,3
7871,0,Europe,R&D,Quality Assurance,Far Below,Female,46,15,1,9,,2.9,3.1,1,1,1,1,3.2,2.8,3.3
7872,0,Latin America,Manufacturing,Clinical Operations,Meets,Male,32,10,1,10,,4.1,3.5,1,1,1,1,3.1,2.4,4.2
7873,0,Asia Pacific,Digital,Quality Assurance,Meets,Female,38,8,1,10,,3.9,2.5,1,1,1,1,2,2.3,2
7874,0,Asia Pacific,Digital,Quality Assurance,Meets,Male,33,5,1,5,,3.9,2.2,1,1,1,1,3.6,3.5,1
7875,0,Latin America,Digital,Regulatory Affairs,Below,Male,42,8,0,9,4.9,3.7,1.2,1,1,1,1,5,2.4,3.1
7876,0,Middle East & Africa,R&D,IT & Digital,Meets,Female,44,17,0,8,1.9,2.3,4.1,1,1,1,1,2.6,2.6,3.2
7877,0,Asia Pacific,Finance,Pharmacovigilance,Below,Female,30,9,1,11,,5,2.8,1,1,1,1,2.1,4.1,2.3
7878,0,Europe,Manufacturing,Supply Chain,Exceeds,Male,42,14,1,6,,2.4,1.1,0,0,0,0,5,2.1,1.8
7879,0,North America,HR,Quality Assurance,Meets,Female,31,8,0,12,3.1,3.8,1.6,1,1,1,1,3.9,3.2,2.6
7880,0,Europe,HR,Regulatory Affairs,Below,Male,36,12,0,12,4.3,2.6,2.6,1,1,1,1,3.6,3.4,2.9
7881,0,Middle East & Africa,Commercial,Medical Affairs,Exceeds,Male,54,11,0,6,1,4.1,2.9,1,1,0,0,1.7,3.3,2.6
7882,0,North America,R&D,Supply Chain,Meets,Male,40,2,0,11,3.1,2.8,3.9,1,1,1,1,3.3,3.6,2.8
7883,0,Europe,Manufacturing,Marketing,Meets,Male,43,14,0,9,1.5,4.5,3.3,1,1,1,1,1.4,4.4,3.9
7884,0,Europe,Finance,Supply Chain,Below,Male,40,3,0,10,3.4,3.8,1.4,0,0,0,0,3.9,2.8,1.7
7885,1,Latin America,Digital,Clinical Operations,Exceeds,Female,37,13,0,10,3.4,5,2.8,1,1,1,1,3.5,3.5,3.4
7886,0,Middle East & Africa,R&D,Quality Assurance,Meets,Non-Binary/Other,34,10,0,7,2.3,1.4,2.4,1,1,1,1,3.8,3.4,3.8
7887,0,Latin America,R&D,Finance & Accounting,Far Below,Female,47,11,0,5,3.3,3.4,2.6,1,1,1,1,3.6,1.7,3.9
7888,0,North America,Manufacturing,Supply Chain,Far Exceeds,Female,50,4,1,9,,3.7,3.7,1,1,0,0,2.4,3.8,2.3
7889,1,Latin America,Finance,Finance & Accounting,Meets,Female,38,7,1,10,,2,4,1,1,1,1,3.3,2.9,4.1
7890,0,Middle East & Africa,Commercial,Medical Affairs,Exceeds,Female,45,8,0,12,4,4.4,4,1,1,1,1,2.9,3.9,2
7891,0,Asia Pacific,Finance,Clinical Operations,Meets,Male,43,2,1,6,,1.8,2.9,1,1,1,1,2,2,3
7892,0,Asia Pacific,Commercial,Communications,Exceeds,Female,37,24,0,11,4.3,2.5,3.4,0,0,0,0,3.3,2.8,4
7893,0,North America,Commercial,Quality Assurance,Meets,Non-Binary/Other,38,13,1,7,,3.7,2.9,1,1,1,1,3.8,3.8,2.6
7894,0,Asia Pacific,Digital,Market Access,Exceeds,Male,35,5,0,7,3.3,1,2.2,1,1,1,1,4.1,2.7,1.8
7895,1,Latin America,Digital,Supply Chain,Far Exceeds,Male,50,25,0,12,3.6,2.6,1.5,1,1,1,1,4,2.2,1.7
7896,0,North America,Manufacturing,Quality Assurance,Exceeds,Male,43,16,0,10,2.9,4.1,1.5,1,1,1,1,4.3,2.5,1
7897,0,Middle East & Africa,Finance,Market Access,Meets,Male,38,23,0,8,2.8,2.2,3.2,1,1,1,1,2.7,2.7,2.7
7898,0,North America,Commercial,Clinical Operations,Exceeds,Female,35,12,0,11,3.9,4,3.1,1,1,1,1,3,4.6,2.9
7899,0,North America,Manufacturing,Sales,Meets,Female,41,7,1,9,,3.8,3.2,1,1,1,1,1.6,4.6,5
7900,0,Europe,Commercial,Pharmacovigilance,Below,Male,30,7,1,11,,1.9,3.5,1,1,1,1,4.8,3.9,3.7
7901,1,Europe,R&D,Sales,Exceeds,Male,33,10,0,8,4.3,1.8,4.2,1,1,1,1,3.7,3.1,4.2
7902,0,North America,HR,Finance & Accounting,Meets,Female,37,10,1,6,,3,3.1,1,1,1,1,2.6,4.1,1
7903,0,Asia Pacific,HR,Legal & Compliance,Below,Female,35,17,0,5,3.5,3.1,2.4,1,1,1,1,4,1.6,3.5
7904,0,Europe,Commercial,Legal & Compliance,Meets,Female,37,11,0,9,3.8,3.5,1.3,1,1,1,1,3.6,3,2.4
7905,0,Middle East & Africa,Manufacturing,Market Access,Meets,Male,42,20,0,8,4.1,2.1,3.1,1,1,1,1,2.3,1.8,5
7906,0,Latin America,Digital,IT & Digital,Meets,Male,50,14,0,10,2.9,3.5,2,0,0,0,0,3.7,3.4,1.6
7907,0,Europe,Finance,Data Science,Meets,Male,42,28,0,5,3.4,4,2,1,1,1,1,3.2,3.8,1
7908,0,North America,Commercial,Pharmacovigilance,Meets,Male,37,6,1,5,,2.9,2.3,1,1,1,1,3.7,1.5,2.9
7909,0,Asia Pacific,Commercial,Finance & Accounting,Meets,Male,44,7,1,6,,5,3.1,1,1,1,1,2.4,3.1,3.9
7910,0,Latin America,Finance,Pharmacovigilance,Exceeds,Male,38,20,1,10,,2.4,2.9,1,1,1,1,2.8,2.1,4.1
7911,0,Europe,Digital,Medical Affairs,Meets,Female,28,13,0,12,3.1,3.3,4.2,1,1,1,1,2.6,1.1,4.3
7912,0,Asia Pacific,Commercial,Medical Affairs,Meets,Male,45,10,0,5,3.5,2.9,2.3,1,1,1,1,3.5,2.2,2.6
7913,0,Asia Pacific,R&D,Human Resources,Meets,Female,31,6,0,12,2.3,2.3,1.3,0,0,0,0,2.4,2.4,2.3
7914,0,Asia Pacific,Digital,Quality Assurance,Far Below,Male,39,4,0,8,4.1,5,1.5,1,1,1,1,3.6,4.1,1.7
7915,0,North America,R&D,Supply Chain,Meets,Male,33,28,0,10,2.7,3,1,1,1,1,1,3.1,2.1,4
7916,0,Middle East & Africa,HR,Human Resources,Far Below,Male,31,30,0,11,2.6,2.5,3.4,1,0,0,0,2.6,3.3,4.3
7917,0,Asia Pacific,Finance,Sales,Meets,Female,35,5,1,8,,2.1,3.5,1,1,1,1,3.6,2.5,2.2
7918,0,Latin America,Digital,Marketing,Meets,Male,28,15,0,12,3.8,4.1,2,0,0,0,0,3.7,3.4,3.1
7919,0,Europe,Digital,Communications,Meets,Male,34,18,0,7,4.3,4.4,2.1,1,1,1,1,3.1,4.4,4
7920,0,Latin America,Manufacturing,Data Science,Meets,Male,41,5,0,11,3.1,4.2,3,0,0,0,0,3.5,4.2,2.9
7921,0,North America,Manufacturing,Legal & Compliance,Exceeds,Female,40,27,0,12,2,2.9,1.5,1,1,1,1,2.9,2.6,2.2
7922,0,North America,Finance,Communications,Far Below,Female,28,12,0,6,2.3,3,1.8,1,1,1,1,3.2,1.9,1.2
7923,1,Latin America,Digital,Marketing,Meets,Male,44,10,0,11,3,3.3,2.9,1,1,1,0,4.8,2.8,2.6
7924,0,Middle East & Africa,HR,Finance & Accounting,Exceeds,Female,52,20,0,5,2.8,1.9,3.5,1,1,1,1,3.1,3,2.8
7925,0,North America,Commercial,Quality Assurance,Exceeds,Male,48,12,0,5,2,2.2,2.3,1,1,1,1,3.3,3.7,2.9
7926,0,North America,Finance,Market Access,Meets,Male,35,24,0,8,3.5,5,1.1,0,0,0,0,2.7,3.1,2.6
7927,0,Latin America,Finance,Legal & Compliance,Meets,Female,34,28,0,5,3,4.2,2.6,0,0,0,0,3.8,3.1,2.6
7928,0,North America,Manufacturing,Finance & Accounting,Below,Non-Binary/Other,33,6,0,12,3.9,2.6,2.4,1,1,1,1,2.4,4,2.7
7929,0,Middle East & Africa,HR,Human Resources,Below,Female,49,19,0,5,3.5,2.3,2.1,1,1,1,1,2.1,1.7,3.1
7930,0,Middle East & Africa,Finance,Pharmacovigilance,Meets,Male,35,9,1,12,,3.8,3.1,0,0,0,0,2.2,3.4,2.9
7931,0,Middle East & Africa,HR,Data Science,Far Below,Male,34,9,0,11,3.1,5,2.9,1,1,1,1,1.9,2.5,2.9
7932,1,Europe,Finance,Quality Assurance,Exceeds,Female,43,15,0,11,3.3,3,1.1,0,0,0,0,5,2.4,2.6
7933,0,Middle East & Africa,Manufacturing,IT & Digital,Meets,Male,45,13,0,12,4.6,3.1,1.6,1,1,1,0,4,3.6,2.7
7934,0,Middle East & Africa,Commercial,Data Science,Far Below,Female,44,7,1,6,,4.5,3,1,1,1,1,1.7,3.1,4.4
7935,0,Europe,Manufacturing,Regulatory Affairs,Meets,Female,32,14,0,10,3.5,2.7,2.9,1,1,1,1,3.1,1.9,1.1
7936,0,Asia Pacific,Finance,Sales,Meets,Female,41,15,1,5,,3.3,2.9,1,1,1,1,4.4,3.5,3.1
7937,0,North America,HR,Legal & Compliance,Far Below,Male,47,11,0,11,2.6,3.2,2.7,1,1,1,1,3,3.9,1
7938,1,Middle East & Africa,R&D,Medical Affairs,Meets,Male,38,5,0,10,3.8,1.9,2.9,1,1,1,1,4.6,2.9,3.2
7939,0,North America,Manufacturing,Finance & Accounting,Exceeds,Female,40,6,0,8,2.9,3.7,2.4,1,0,0,0,2.7,2.2,2.3
7940,0,Latin America,HR,Sales,Far Exceeds,Non-Binary/Other,39,12,0,8,2.1,1.8,3.1,1,1,1,1,1.2,3.3,1.2
7941,0,North America,Manufacturing,Marketing,Meets,Male,36,10,0,11,2.5,2.8,1.6,1,1,1,1,2.9,3.7,3.1
7942,0,Europe,Finance,Communications,Exceeds,Female,41,12,0,9,3.7,1,2.1,1,1,1,1,3.5,3.5,2.9
7943,0,North America,HR,Data Science,Meets,Female,43,12,0,11,3.5,3,3,1,1,1,1,4.8,4.2,4
7944,0,North America,Commercial,Clinical Operations,Meets,Female,46,9,0,12,2,4.3,4.3,1,1,1,1,1.7,3.1,1.7
7945,0,North America,HR,Communications,Meets,Female,38,9,0,7,1.8,3.3,1.9,0,0,0,0,2.7,2.9,1.9
7946,0,Asia Pacific,Digital,Medical Affairs,Meets,Female,38,9,0,11,3,1.8,1.2,1,1,1,1,3.7,1.6,2.8
7947,0,Asia Pacific,R&D,Marketing,Below,Female,35,20,0,12,1,4.4,2.3,1,1,1,1,2.5,2.9,2
7948,0,Latin America,Finance,Regulatory Affairs,Meets,Male,47,10,0,6,4.6,2,2.6,1,1,1,1,3.9,2.2,1.7
7949,0,Europe,HR,Regulatory Affairs,Far Exceeds,Female,35,12,0,12,3.1,2.5,2.2,1,1,1,1,3,3.5,2.8
7950,0,North America,Finance,Clinical Operations,Meets,Female,37,7,0,8,4,4.4,3.9,1,1,1,1,3.6,3.2,3.8
7951,0,North America,Manufacturing,Pharmacovigilance,Meets,Female,38,5,0,6,4,3.2,2.4,1,1,1,1,3.2,3.7,1.5
7952,0,North America,Manufacturing,Data Science,Meets,Male,39,9,0,12,2.5,4.2,2.4,1,1,1,1,2.6,2.7,2.9
7953,1,North America,HR,Regulatory Affairs,Meets,Female,29,12,0,7,3.5,3.1,3.5,1,1,1,0,4,2.9,2.7
7954,0,Asia Pacific,Digital,Medical Affairs,Meets,Male,41,9,0,8,3.4,4.1,3.3,1,1,1,1,4,3.4,4.6
7955,0,Latin America,HR,Marketing,Exceeds,Male,41,21,0,7,3.2,3.1,4.4,1,1,1,1,1.9,1.3,2.6
7956,0,Middle East & Africa,Commercial,Clinical Operations,Meets,Male,39,18,0,10,2.3,3,2.2,1,1,1,1,3.4,3.3,1.4
7957,0,Europe,Digital,Pharmacovigilance,Below,Female,40,6,0,5,4,4.7,3.1,1,1,1,0,3.8,2.6,3.8
7958,0,North America,Finance,Pharmacovigilance,Meets,Female,38,15,0,11,2.8,3.7,3.1,1,1,1,1,3.2,2.7,2.5
7959,0,Latin America,HR,Quality Assurance,Meets,Female,29,4,0,12,2.5,2.5,3.9,1,1,1,1,1.3,1.4,4.8
7960,0,Middle East & Africa,Finance,Marketing,Meets,Male,45,9,1,8,,2.3,2.3,1,1,1,1,4.6,4,5
7961,0,Latin America,R&D,Medical Affairs,Meets,Female,29,28,0,9,2.8,4.7,4.2,1,1,1,1,3.5,3.6,4.3
7962,0,Asia Pacific,Digital,Regulatory Affairs,Meets,Female,33,11,0,5,3.1,2.5,3.6,1,1,1,1,3.4,1.5,3.1
7963,0,Middle East & Africa,HR,Quality Assurance,Below,Male,45,8,0,8,3.7,3.5,3.8,1,1,1,1,3.2,4.3,3.2
7964,0,Latin America,R&D,Supply Chain,Far Below,Male,30,14,0,12,3.5,3.9,2.1,1,1,1,1,2.2,3,2
7965,0,Asia Pacific,HR,IT & Digital,Meets,Female,37,9,0,5,2.2,2.2,2.7,1,1,1,0,3.1,3.5,2.9
7966,1,Latin America,Commercial,Legal & Compliance,Meets,Male,49,9,0,9,2,2.4,2.5,1,1,1,1,3,1.9,4.4
7967,0,Latin America,Manufacturing,Medical Affairs,Meets,Non-Binary/Other,38,14,0,8,3.6,3.3,1.6,1,0,0,0,2.9,4.1,2.4
7968,0,Middle East & Africa,Finance,Data Science,Meets,Male,30,15,0,6,3.4,2.8,3,1,1,1,1,4,3.8,4.1
7969,0,Asia Pacific,HR,Communications,Far Exceeds,Male,43,10,1,5,,4.5,2.9,1,1,1,1,4.1,3.7,2.8
7970,0,North America,Digital,Marketing,Meets,Female,41,8,0,9,2.1,3.4,2.9,1,1,1,1,2.6,2,3.9
7971,0,Europe,HR,Communications,Exceeds,Male,39,6,1,10,,1.3,2.7,1,1,1,1,2.5,2.2,3.4
7972,0,Middle East & Africa,HR,Communications,Exceeds,Male,28,29,0,12,3.5,3.4,2.7,1,1,1,1,4,4.2,3.2
7973,1,Asia Pacific,HR,Clinical Operations,Exceeds,Male,46,7,0,6,1,3.3,2.8,1,1,0,0,2,4.1,5
7974,0,Latin America,HR,Regulatory Affairs,Exceeds,Female,49,21,0,9,2.9,4.2,2.7,0,0,0,0,2.4,2.9,3.6
7975,0,Asia Pacific,Digital,Supply Chain,Meets,Male,38,21,0,9,3.4,2.1,2,1,1,1,1,3.7,2.2,2.1
7976,0,Europe,Digital,Human Resources,Meets,Female,34,3,0,6,3.4,5,2.7,1,1,1,1,3.9,4.7,2.3
7977,0,Europe,HR,Data Science,Meets,Male,41,21,1,9,,2.6,2.8,1,1,1,1,5,3.1,3.3
7978,0,North America,Manufacturing,Legal & Compliance,Meets,Female,41,7,1,8,,4,1.4,0,0,0,0,3.2,2.2,1.6
7979,1,North America,HR,Finance & Accounting,Meets,Male,42,10,0,10,3.6,3.6,1.7,1,1,1,1,4.5,3.8,1.9
7980,0,Europe,Finance,Clinical Operations,Meets,Male,38,7,0,11,4.1,4.5,1.3,1,1,1,1,3.7,5,3.3
7981,0,Middle East & Africa,Finance,Regulatory Affairs,Meets,Female,41,7,1,5,,2.3,2.4,1,1,1,1,2.5,2.4,2.7
7982,0,Middle East & Africa,Digital,Market Access,Meets,Male,42,17,0,9,3.8,3.2,2.5,1,1,1,1,3.7,1.9,1.9
7983,0,Latin America,Finance,Market Access,Far Exceeds,Female,53,1,1,11,,3.1,1.7,0,0,0,0,3.7,3.2,1
7984,0,North America,Finance,Legal & Compliance,Exceeds,Male,41,23,0,10,1.9,2.8,4.1,1,1,0,0,1.7,4,5
7985,0,Latin America,Commercial,Pharmacovigilance,Meets,Female,39,10,0,7,4.9,1.4,1,1,1,1,1,4.6,3.4,1.5
7986,0,North America,HR,Supply Chain,Below,Female,29,7,0,8,3.1,4.2,2.8,1,1,1,1,3.6,3.3,2.6
7987,0,Europe,HR,Supply Chain,Meets,Female,29,3,1,10,,3.2,1.1,1,1,1,1,4.8,5,1.6
7988,0,Middle East & Africa,HR,Legal & Compliance,Meets,Non-Binary/Other,39,18,0,5,3.7,4.6,2,1,1,1,1,3.5,3.8,2.1
7989,0,Middle East & Africa,HR,Market Access,Exceeds,Male,38,5,0,8,3.6,1.1,2.5,1,1,1,1,2.6,1.8,2.8
7990,0,Europe,R&D,Quality Assurance,Meets,Female,32,3,1,10,,2.8,1.5,1,1,0,0,5,3.7,3.5
7991,0,Latin America,HR,Communications,Meets,Male,32,9,1,9,,2.8,2.6,1,1,1,1,4.6,3.1,2.8
7992,0,Latin America,Digital,IT & Digital,Meets,Male,42,18,0,6,4.2,2.6,1.2,1,1,1,1,3.3,5,1.4
7993,0,Asia Pacific,Digital,IT & Digital,Below,Male,35,5,0,10,3.6,3,2.5,1,1,0,0,2.6,4.1,1.6
7994,0,North America,R&D,Quality Assurance,Meets,Female,33,12,0,10,2.5,3.3,1.9,1,1,1,1,2.8,3.9,1.2
7995,0,Latin America,HR,Pharmacovigilance,Meets,Female,32,14,0,10,2.4,2.7,4.3,1,1,1,1,2.4,3.2,2.8
7996,0,Europe,Manufacturing,Regulatory Affairs,Far Exceeds,Male,33,14,0,11,3.7,3.3,3.6,1,1,1,1,2.7,4,4.5
7997,0,Latin America,HR,Legal & Compliance,Below,Female,36,5,0,5,2.7,2.6,3.5,1,1,1,1,1.8,2.8,3.8
7998,0,Middle East & Africa,Digital,Quality Assurance,Meets,Female,38,27,0,12,3.8,4.3,4.2,1,1,1,1,2.6,3.2,4.3
7999,0,North America,Commercial,Quality Assurance,Meets,Female,39,2,0,6,2.5,3.3,1.6,1,1,1,1,1,3.4,3.8
8000,0,Asia Pacific,Finance,Finance & Accounting,Meets,Male,35,11,1,12,,3.5,2,1,1,1,1,3.5,2.7,1.6
8001,0,North America,Commercial,Sales,Exceeds,Male,28,21,0,11,4.6,1.8,3.8,1,1,1,1,3.7,2.5,2.9
8002,0,Middle East & Africa,Manufacturing,Sales,Below,Male,31,2,1,9,,3.7,2.5,1,1,0,0,4.1,3,2.1
8003,0,Middle East & Africa,HR,Medical Affairs,Far Exceeds,Male,35,9,0,9,3.2,3.9,2.9,0,0,0,0,2.9,2.5,2.5
8004,0,Middle East & Africa,R&D,Legal & Compliance,Exceeds,Male,44,23,1,9,,4,2.6,1,1,1,1,3.3,3.7,2.6
8005,0,Middle East & Africa,HR,Sales,Exceeds,Male,37,9,0,5,3.6,1.6,3.8,1,1,1,1,3.1,3,3.2
8006,0,Europe,Manufacturing,Regulatory Affairs,Below,Non-Binary/Other,41,4,0,11,4.9,3.8,2.8,1,1,1,1,4.2,4,4.2
8007,0,Asia Pacific,Manufacturing,Regulatory Affairs,Meets,Female,46,4,1,11,,3.6,2.3,1,1,1,1,4.1,5,2.5
8008,0,Middle East & Africa,Finance,Sales,Exceeds,Female,37,6,0,10,4.1,3.1,3.7,1,1,1,1,3.8,3.9,2.2
8009,0,Middle East & Africa,Manufacturing,Human Resources,Exceeds,Female,38,9,0,6,2.6,3.2,1.6,0,0,0,0,2.5,3.1,2.1
8010,0,Latin America,Commercial,Finance & Accounting,Meets,Female,38,18,0,9,3.3,3.1,2.1,1,1,1,1,3.5,1.1,2.2
8011,0,Asia Pacific,Finance,Data Science,Meets,Male,38,11,0,12,4.6,2.6,1.3,1,1,1,1,3.7,2.4,2.2
8012,0,North America,HR,Clinical Operations,Meets,Female,32,9,0,8,4.8,2,2.6,1,1,1,1,4,3.4,2.8
8013,0,Asia Pacific,HR,Pharmacovigilance,Far Exceeds,Male,41,8,0,6,2.4,2.1,3.2,1,1,1,1,2.5,2,3.7
8014,0,Asia Pacific,R&D,Regulatory Affairs,Below,Male,39,14,1,12,,2.9,2.4,1,1,1,1,4,1.9,2
8015,0,Asia Pacific,Manufacturing,Legal & Compliance,Far Below,Male,33,10,1,12,,3.2,2,1,1,1,1,5,3.8,2.7
8016,0,Middle East & Africa,Manufacturing,IT & Digital,Far Below,Male,37,2,0,7,4.3,5,1.6,0,0,0,0,3.5,3.4,1.9
8017,1,Middle East & Africa,Digital,Legal & Compliance,Meets,Female,28,23,0,5,3.2,3.7,3.1,1,0,0,0,3.6,5,4.9
8018,0,Europe,Finance,Market Access,Below,Female,29,28,0,10,3.3,3.1,2.9,1,1,1,1,3.5,3.4,2.5
8019,0,North America,Digital,Regulatory Affairs,Meets,Male,43,1,1,6,,2.9,3.2,0,0,0,0,3.7,4.4,4
8020,0,Latin America,Finance,Legal & Compliance,Meets,Male,37,7,0,5,2,2.8,2.2,1,1,1,1,3,3.1,2.7
8021,0,Asia Pacific,Commercial,Medical Affairs,Below,Male,46,13,1,6,,3.4,4.6,1,1,1,1,3.7,3.2,2.5
8022,0,North America,Finance,Regulatory Affairs,Meets,Female,38,22,0,8,3.7,2.5,2.1,1,1,1,1,4.2,2.2,1.8
8023,0,North America,HR,Supply Chain,Below,Male,39,10,1,9,,3.3,3.3,1,1,1,1,2.6,4.2,3.6
8024,0,Europe,R&D,Communications,Meets,Non-Binary/Other,38,20,0,5,5,1.5,2.9,1,1,1,1,4.6,1.6,2.7
8025,0,Latin America,Finance,IT & Digital,Meets,Male,32,7,0,5,3.3,3.2,2.7,1,1,1,1,3.5,2.2,2.6
8026,0,Asia Pacific,Finance,Market Access,Meets,Non-Binary/Other,40,8,0,9,4.8,2.1,2,1,1,1,1,3.8,1.8,2.2
8027,0,Latin America,Finance,Communications,Meets,Male,34,8,0,12,3.8,1.7,1.1,1,0,0,0,4.4,3.2,1
8028,0,Europe,R&D,Clinical Operations,Exceeds,Male,40,9,0,6,4.4,3.6,1.6,1,1,1,1,3.8,2.9,1
8029,0,Middle East & Africa,Manufacturing,Human Resources,Exceeds,Male,33,16,0,10,2.3,2.8,2.4,1,1,1,1,2.3,3.4,3.5
8030,0,North America,R&D,Regulatory Affairs,Meets,Female,42,16,1,11,,2.9,4.3,1,1,1,1,4.2,4.6,2.6
8031,0,Asia Pacific,Manufacturing,Human Resources,Meets,Male,41,16,0,8,2.8,2,2.8,0,0,0,0,3.6,2.8,2.8
8032,0,Middle East & Africa,HR,Sales,Meets,Female,45,17,0,10,3.4,3.2,2.4,1,0,0,0,3.4,4.2,3.1
8033,0,Europe,R&D,Communications,Exceeds,Male,42,2,0,8,3.9,3.4,3,0,0,0,0,3.3,4.7,3
8034,0,Latin America,Manufacturing,Regulatory Affairs,Meets,Female,38,3,1,5,,4.4,2.4,0,0,0,0,2.3,3.3,3.7
8035,0,North America,HR,Pharmacovigilance,Below,Male,47,9,0,11,3,3.9,3.5,1,1,1,1,2.7,3.9,1.5
8036,0,Asia Pacific,HR,Medical Affairs,Exceeds,Male,40,3,0,12,3.4,3.3,4.9,1,1,1,1,3.5,4.5,4.4
8037,0,Middle East & Africa,Manufacturing,Pharmacovigilance,Meets,Male,28,20,0,8,4,3.3,1.3,1,1,1,1,3,3.4,2.5
8038,0,Middle East & Africa,Manufacturing,Human Resources,Meets,Non-Binary/Other,34,1,0,12,3.1,4.1,2.9,1,1,1,1,5,2.3,3.6
8039,1,North America,Commercial,IT & Digital,Meets,Male,37,17,0,9,3.6,2.7,2.5,1,0,0,0,3.8,2.7,2.9
8040,0,Latin America,HR,Clinical Operations,Below,Male,46,17,1,8,,2.7,2.6,1,1,1,1,2.3,3.2,1.7
8041,0,Europe,Manufacturing,Clinical Operations,Far Exceeds,Male,35,15,0,7,2.3,1.9,4.2,1,1,1,1,3.3,3.2,4.8
8042,0,Latin America,HR,Clinical Operations,Meets,Female,34,8,0,8,4.6,2,2.7,1,1,1,1,5,1.1,3.5
8043,0,Latin America,R&D,Legal & Compliance,Below,Male,28,14,0,9,4,3.8,1,1,1,1,1,4.7,3.7,2.3
8044,0,Latin America,Digital,Medical Affairs,Meets,Female,46,4,1,8,,3.3,4,1,1,1,1,3.8,2.9,4.5
8045,0,North America,Digital,Pharmacovigilance,Meets,Male,47,13,0,11,2.5,1,3.7,1,1,1,1,3.8,1.2,4.2
8046,0,North America,Finance,Quality Assurance,Below,Male,31,17,0,5,2.8,3.8,2.3,1,1,1,1,2.4,3.8,3.3
8047,0,Europe,Manufacturing,Supply Chain,Meets,Male,29,11,0,9,3.8,2.4,2.6,1,1,1,1,5,1.9,2.6
8048,0,Latin America,Manufacturing,Communications,Meets,Female,44,9,0,6,3.4,3.4,1.7,1,1,1,1,3.5,3.2,2.7
8049,0,North America,HR,Clinical Operations,Meets,Male,46,4,0,12,4.1,3.3,3.9,1,1,1,1,3.8,3.1,3
8050,0,Europe,Finance,Data Science,Meets,Male,34,10,0,9,2.4,3.9,2.5,1,1,1,1,3.1,4.5,1.4
8051,0,Europe,Manufacturing,Pharmacovigilance,Below,Male,37,7,0,12,3.5,1.9,3.7,1,0,0,0,3.4,1.9,4.1
8052,0,Latin America,HR,Communications,Meets,Female,41,28,0,12,3.2,2.1,2.2,1,1,1,1,4.2,3.1,4.1
8053,0,Asia Pacific,Manufacturing,Pharmacovigilance,Meets,Male,32,10,0,6,2.8,4.6,3.9,1,1,1,1,3.2,3.5,2.4
8054,0,Latin America,HR,Sales,Below,Male,33,17,0,8,4.6,4.7,4,1,1,1,1,3.4,5,1.6
8055,0,Asia Pacific,Manufacturing,IT & Digital,Meets,Female,36,17,0,6,3,3.7,2.1,1,1,1,1,1.5,3.4,1.4
8056,0,Europe,Commercial,Finance & Accounting,Meets,Male,32,33,0,12,3.3,2,1,0,0,0,0,2.4,1.5,2.4
8057,0,North America,HR,Marketing,Meets,Male,55,15,0,12,1.7,2.6,3,1,1,1,1,2.8,2.9,3.1
8058,0,Middle East & Africa,Commercial,Human Resources,Meets,Female,45,36,0,5,4.5,2.6,3.1,1,1,1,1,4,2.7,3.6
8059,0,Europe,Commercial,Finance & Accounting,Meets,Male,36,7,0,8,2.5,2.4,3.8,1,1,1,1,3,2.5,3.2
8060,0,North America,Commercial,Marketing,Meets,Male,39,6,1,7,,2.7,3.9,1,1,1,1,2.9,2.5,4.8
8061,0,Europe,Commercial,Market Access,Meets,Male,28,19,0,12,4.1,3.5,3.3,1,1,0,0,3.9,1,3
8062,0,Latin America,R&D,Medical Affairs,Meets,Male,40,8,0,12,4.2,4.9,1.3,1,1,1,1,5,5,2.8
8063,0,Asia Pacific,Finance,Clinical Operations,Below,Non-Binary/Other,42,8,0,5,3.9,2.3,3.4,1,1,1,1,2.9,2.6,2.9
8064,0,Europe,Digital,Sales,Far Exceeds,Male,34,5,1,7,,3.1,2.9,0,0,0,0,3.1,3.5,1.7
8065,0,North America,R&D,Finance & Accounting,Exceeds,Female,35,5,1,8,,4.2,2.9,1,1,1,1,5,4.6,3
8066,0,Latin America,Manufacturing,Clinical Operations,Meets,Female,33,7,1,8,,3.2,1.9,1,1,1,1,2.5,2.8,1
8067,0,Middle East & Africa,Manufacturing,Clinical Operations,Exceeds,Female,46,10,1,8,,5,1.4,0,0,0,0,3,4.5,1.8
8068,0,Latin America,Finance,Human Resources,Meets,Female,46,18,1,8,,3.8,2.3,1,1,1,1,4.7,2.5,2
8069,0,Asia Pacific,Digital,Sales,Far Below,Male,40,4,0,7,4.2,3.8,4.4,1,1,1,1,4.7,3.5,2.9
8070,1,Latin America,Digital,Sales,Meets,Male,39,6,0,5,3.6,3.8,1.3,1,1,1,1,4.1,3.8,2.2
8071,0,Middle East & Africa,Digital,Supply Chain,Exceeds,Female,31,12,1,7,,3.9,3.5,1,1,1,1,3,3.6,3.5
8072,0,North America,Commercial,Regulatory Affairs,Below,Female,34,13,0,12,2.8,3.6,3.4,1,1,1,1,3,3,2.7
8073,0,Europe,R&D,Communications,Meets,Male,36,5,1,11,,3.6,4.3,1,1,1,1,3.6,3,3
8074,0,Asia Pacific,Manufacturing,Marketing,Exceeds,Male,34,15,0,8,3.3,3,1.1,1,1,1,1,3.7,2.8,2.2
8075,0,Middle East & Africa,R&D,Regulatory Affairs,Exceeds,Male,41,2,0,12,3,4.2,3.1,1,1,1,1,3.2,4.8,2.4
8076,0,Asia Pacific,R&D,Communications,Meets,Female,28,21,1,7,,3.7,4.2,1,1,1,1,4.2,2.7,2.4
8077,0,Latin America,R&D,Finance & Accounting,Below,Female,30,5,1,11,,2.9,2,1,1,1,1,3.7,2.5,2.5
8078,0,Asia Pacific,Digital,Market Access,Meets,Female,34,3,0,8,4.2,4.1,3.9,1,1,1,1,3.1,4.5,5
8079,0,Middle East & Africa,Finance,Sales,Meets,Male,29,11,0,11,3.5,2.9,2.4,1,1,1,1,2.7,5,1.8
8080,0,Europe,Finance,Medical Affairs,Exceeds,Male,44,10,1,6,,1.5,3.5,0,0,0,0,3.8,2.4,4.6
8081,0,Europe,Digital,Human Resources,Meets,Male,45,7,0,10,3,3.4,2,1,1,1,1,4.1,4.1,1.4
8082,0,Asia Pacific,Manufacturing,Market Access,Exceeds,Male,28,6,0,12,3.5,3.4,2.1,1,1,1,1,2.7,2.9,2
8083,0,North America,Manufacturing,Sales,Meets,Male,40,26,0,6,4.9,2.5,3.2,1,1,1,1,4.2,5,2.8
8084,0,Asia Pacific,Manufacturing,Regulatory Affairs,Meets,Male,36,6,1,5,,3.5,2.9,1,1,1,1,3.3,4.3,2.2
8085,0,Latin America,Finance,Quality Assurance,Far Below,Male,38,19,0,8,3.2,1.7,1.9,1,1,1,1,4.5,2.4,1.7
8086,0,Europe,Finance,Quality Assurance,Meets,Female,41,12,0,10,4.3,4.6,3.9,1,1,1,1,3.2,4.6,3
8087,0,Europe,R&D,Marketing,Below,Male,28,19,0,9,5,2.1,3.8,1,1,1,1,4.2,2.1,2.6
8088,1,Europe,Digital,Data Science,Meets,Male,44,15,1,8,,4.4,1,1,1,1,1,2.9,2.3,1.7
8089,0,North America,Commercial,Medical Affairs,Below,Female,41,17,0,6,2.5,4.6,2,1,1,1,1,2.6,5,3.7
8090,0,North America,R&D,Clinical Operations,Below,Male,45,14,0,10,2.5,5,4.4,1,1,1,1,3,3.4,4.1
8091,0,Middle East & Africa,HR,Pharmacovigilance,Meets,Male,28,6,0,8,1.6,3.3,2,1,1,1,1,3.9,4,2.9
8092,0,Asia Pacific,Finance,Market Access,Meets,Female,38,5,1,6,,2.2,1,1,1,1,1,4,1.9,2.5
8093,0,Asia Pacific,R&D,Sales,Meets,Female,41,10,0,8,4.8,3.7,4.3,1,1,0,0,2.8,3.2,4.6
8094,0,Latin America,Digital,Legal & Compliance,Meets,Female,41,4,0,11,4.1,2.9,1.5,1,1,1,1,3.6,3.1,1.3
8095,0,Europe,HR,Quality Assurance,Meets,Male,43,3,1,10,,3.1,1,1,1,0,0,3.2,2,2.2
8096,1,North America,R&D,Data Science,Meets,Non-Binary/Other,41,9,0,12,4.3,4.5,1,1,1,1,1,5,3.3,1.9
8097,0,Latin America,Digital,Medical Affairs,Meets,Male,28,7,0,11,5,3.2,2.4,1,1,1,0,3.9,2.9,1.3
8098,0,Latin America,Digital,Medical Affairs,Meets,Non-Binary/Other,45,12,0,7,3.3,2.9,3.9,0,0,0,0,3,2,5
8099,0,North America,Finance,Quality Assurance,Exceeds,Female,35,13,0,5,3.3,2.7,2.9,1,1,1,1,2.8,2.8,1.8
8100,0,Asia Pacific,Commercial,Communications,Meets,Female,39,10,1,9,,3.2,3.8,1,1,1,1,4,3.6,2.7
8101,1,Europe,R&D,IT & Digital,Meets,Female,47,11,0,11,4,2.6,2.5,1,1,1,1,4,1.6,2.2
8102,0,Asia Pacific,Digital,Pharmacovigilance,Below,Female,38,17,0,7,4.6,2.9,1.1,1,1,1,1,5,2.3,2.3
8103,0,Latin America,Manufacturing,Data Science,Meets,Male,36,5,0,6,4.2,3.6,3.4,0,0,0,0,4.7,2.9,2.6
8104,0,Europe,Digital,Supply Chain,Meets,Female,31,7,1,5,,1.9,3.7,1,1,1,1,2.5,1.9,3.1
8105,0,Middle East & Africa,Commercial,Pharmacovigilance,Meets,Female,30,6,0,7,4,2.6,4,1,1,1,1,3,1.9,3
8106,0,Latin America,Digital,Regulatory Affairs,Below,Male,31,17,0,12,2.6,3.1,1.5,1,1,1,1,2.3,2.2,2.9
8107,0,Asia Pacific,Finance,Medical Affairs,Meets,Female,38,10,1,5,,4.7,1.9,1,1,1,1,2.8,3.8,2.4
8108,0,Asia Pacific,R&D,Data Science,Meets,Female,51,13,0,11,3.3,3.5,3.1,1,1,1,0,4.1,3.2,3.4
8109,0,Asia Pacific,Finance,Quality Assurance,Meets,Female,36,20,0,5,4.3,3.9,1,0,0,0,0,4.5,2.9,1.6
8110,0,North America,R&D,Medical Affairs,Meets,Male,38,14,0,6,2.8,3.1,1.8,1,1,1,1,3.1,4.4,2.4
8111,0,Latin America,HR,Pharmacovigilance,Exceeds,Male,42,18,0,12,2.8,3.5,2.6,1,1,1,1,1.8,3.6,2.9
8112,0,Europe,R&D,Clinical Operations,Meets,Female,34,4,1,6,,3.1,3,0,0,0,0,3.1,4.9,2.5
8113,0,Asia Pacific,HR,Clinical Operations,Meets,Male,46,16,0,11,3.4,3.2,1.2,1,1,1,1,3.7,3.2,2.7
8114,0,Asia Pacific,Finance,Medical Affairs,Exceeds,Female,35,19,0,10,3.2,1.7,2.9,1,1,1,1,2.3,2.9,3.9
8115,0,North America,Manufacturing,Data Science,Below,Female,45,9,1,8,,2.7,3.3,1,1,1,1,2.9,3.8,3.2
8116,0,Europe,Commercial,Data Science,Meets,Male,42,14,1,12,,3.5,4.3,1,1,1,1,4.3,3.8,3.9
8117,0,Latin America,Manufacturing,Market Access,Below,Female,39,7,0,7,3.1,4.1,3.5,1,1,1,1,3.2,2.7,2.4
8118,0,Middle East & Africa,HR,IT & Digital,Exceeds,Male,34,15,0,10,2.9,3.6,1,0,0,0,0,3.1,4.3,1
8119,0,North America,Digital,Regulatory Affairs,Far Below,Female,44,14,0,8,3.6,2.2,3.7,1,1,1,1,4.4,2.9,4.8
8120,0,Latin America,Digital,Legal & Compliance,Below,Male,37,13,0,7,2.2,3.5,2.2,1,1,1,1,1.8,2.4,2.7
8121,0,Middle East & Africa,Manufacturing,Market Access,Exceeds,Female,35,7,1,6,,3.5,3.9,1,1,1,1,3.5,3.8,2.9
8122,0,Asia Pacific,Digital,Market Access,Meets,Female,48,21,0,5,3.6,3.6,4.1,1,1,1,1,4,4.2,4.3
8123,0,Asia Pacific,HR,Regulatory Affairs,Meets,Male,28,10,1,7,,3.3,2.4,1,1,1,1,2.8,4.2,2.1
8124,0,Europe,Finance,Quality Assurance,Far Below,Male,47,15,0,6,3.6,1.3,2.2,1,1,1,1,4.3,2,2
8125,0,Middle East & Africa,Commercial,Clinical Operations,Meets,Male,50,13,0,12,2.3,1.7,2.3,1,1,1,1,2.6,2.8,1.7
8126,1,Asia Pacific,R&D,Legal & Compliance,Far Exceeds,Male,33,19,0,10,1.9,2.3,3.5,1,1,1,1,3.6,3.1,3.7
8127,0,Asia Pacific,HR,Communications,Meets,Female,34,14,0,5,3.1,2.2,2.8,0,0,0,0,3.6,3.5,2.6
8128,0,Europe,HR,Quality Assurance,Exceeds,Female,31,2,1,6,,3.6,2.4,1,1,1,0,3.6,3.1,2.5
8129,0,Latin America,R&D,Market Access,Far Exceeds,Non-Binary/Other,43,4,1,7,,1.2,2.4,1,1,1,1,4,2.2,2.7
8130,0,Asia Pacific,R&D,Data Science,Meets,Male,34,9,0,12,1.8,4.6,2,1,1,1,1,3.6,4.5,2.5
8131,0,North America,Commercial,Regulatory Affairs,Meets,Female,37,3,0,9,3.7,4.8,4.2,1,0,0,0,2.6,5,1.1
8132,0,North America,Commercial,Pharmacovigilance,Meets,Female,42,6,1,12,,3.5,2.3,1,1,1,1,3.9,3,3.9
8133,0,Latin America,Commercial,Sales,Below,Non-Binary/Other,28,6,1,7,,3,2.8,1,1,1,1,3.7,5,3.7
8134,0,Middle East & Africa,Digital,Communications,Meets,Male,29,11,0,5,3.7,2.1,2.1,1,1,1,0,4.1,4,2.2
8135,1,Europe,HR,Legal & Compliance,Exceeds,Female,40,8,0,6,4.3,2.4,3.5,1,1,1,1,4.2,3.2,2.7
8136,0,North America,Finance,Sales,Meets,Female,36,13,0,12,2.7,3.4,4.6,1,1,1,1,3.5,3.9,2
8137,0,North America,R&D,Finance & Accounting,Exceeds,Female,32,5,1,7,,3.3,3,1,1,1,1,3.6,4.2,2.7
8138,0,Latin America,HR,Marketing,Exceeds,Female,38,19,0,12,2.5,4.2,2.7,1,1,1,1,3.3,2.3,3.1
8139,0,Middle East & Africa,HR,Medical Affairs,Far Exceeds,Male,37,14,0,5,2.1,2.7,3.6,1,1,1,1,2.4,1.6,4.1
8140,0,Middle East & Africa,Commercial,Supply Chain,Exceeds,Female,33,5,0,10,3.2,2.6,3.4,1,1,1,1,3.7,4.2,5
8141,0,Latin America,Commercial,Supply Chain,Meets,Male,39,21,0,7,2.2,4.5,1.7,1,1,1,1,3.1,2.8,1.2
8142,0,North America,HR,Human Resources,Exceeds,Male,32,12,0,12,3.2,2.5,2.2,1,1,1,1,3.2,4.5,2.9
8143,0,Europe,Commercial,Pharmacovigilance,Meets,Male,42,10,1,7,,2.8,1.6,1,1,1,1,1.4,1.9,2.9
8144,0,North America,Digital,Marketing,Meets,Male,37,20,0,7,4.6,4,2.7,1,1,1,1,4.3,3.8,2.4
8145,0,Middle East & Africa,R&D,Finance & Accounting,Meets,Male,49,3,0,8,2.9,4.3,1.6,1,1,1,1,2.6,4.9,3.1
8146,0,North America,HR,Clinical Operations,Meets,Male,30,14,0,7,3.6,2.9,4,1,1,1,1,3.8,2.7,2.7
8147,0,Europe,R&D,Pharmacovigilance,Meets,Male,34,17,1,5,,1.6,2.4,1,1,1,1,4.8,2.4,2.9
8148,0,Asia Pacific,Digital,IT & Digital,Meets,Male,44,5,0,8,3.5,5,3.9,1,1,1,1,4.8,5,3.1
8149,0,North America,Commercial,Finance & Accounting,Meets,Male,32,27,0,8,2.8,2.2,4.4,1,1,1,1,3.1,1.5,2.6
8150,0,Latin America,Manufacturing,Market Access,Below,Female,38,21,1,12,,3.5,3.3,1,1,1,1,4.4,3,2.6
8151,0,Asia Pacific,Digital,Pharmacovigilance,Meets,Female,28,6,0,7,4.3,3.8,3.4,0,0,0,0,4.3,4.1,2.9
8152,1,Latin America,Manufacturing,Sales,Exceeds,Female,32,8,0,11,3.9,2.9,2.1,1,1,1,0,4.9,2,2.1
8153,0,Latin America,R&D,Supply Chain,Meets,Male,32,4,0,9,4.2,2.3,1.5,1,1,1,1,3.1,1.4,1.6
8154,0,Latin America,HR,Clinical Operations,Below,Female,37,5,0,11,2.7,2.1,3.8,1,1,1,1,3.5,3.4,3
8155,0,North America,Commercial,Medical Affairs,Exceeds,Female,44,6,1,6,,3.9,2.9,1,1,1,1,3.6,4.4,3.8
8156,0,Middle East & Africa,Digital,IT & Digital,Exceeds,Male,36,4,1,9,,1.5,4.6,1,1,1,1,3.9,2.2,3.3
8157,0,Asia Pacific,Commercial,Market Access,Exceeds,Male,36,19,0,5,4.2,3.2,3,1,1,1,1,4.8,2.7,2.7
8158,0,Europe,Manufacturing,Medical Affairs,Meets,Female,33,19,0,9,4.4,3,1.9,1,1,1,1,3.1,3.4,2.8
8159,0,Middle East & Africa,Manufacturing,Sales,Below,Female,31,7,1,11,,3.5,2.5,1,1,1,0,2.1,3.8,2.9
8160,0,North America,Finance,Marketing,Meets,Male,44,15,0,5,3.4,2.9,1.5,1,1,1,1,3.4,3.5,2.5
8161,0,Latin America,HR,Medical Affairs,Meets,Female,39,3,0,7,2.3,3.9,2.5,1,1,1,1,3.7,4.5,3
8162,0,Europe,Manufacturing,Marketing,Below,Male,36,15,0,8,3.1,3.1,1.3,1,1,1,1,3,3.7,1
8163,0,Asia Pacific,HR,Market Access,Below,Female,48,10,0,7,4.3,3,1.7,1,1,1,1,4,3.8,3.6
8164,0,Middle East & Africa,Finance,Supply Chain,Exceeds,Male,28,10,0,5,2.2,1.6,3.5,1,1,1,1,1.9,2.4,3.3
8165,0,Middle East & Africa,Digital,Data Science,Meets,Male,44,13,0,6,3.4,3.4,1.6,1,1,1,1,3.6,4.8,2.3
8166,0,Europe,Finance,Pharmacovigilance,Meets,Male,29,14,0,8,3.7,3.5,3.3,1,1,1,1,2.4,4.9,3.8
8167,1,North America,HR,Quality Assurance,Meets,Male,39,11,0,8,4.7,3.1,1.7,1,1,1,1,4.7,4.1,1
8168,0,Asia Pacific,Manufacturing,Clinical Operations,Meets,Non-Binary/Other,44,2,1,12,,3.4,2.8,1,1,1,1,3.8,2.4,3.7
8169,0,Europe,R&D,Finance & Accounting,Below,Female,28,8,1,7,,2.7,2.5,1,1,1,1,4.8,2.2,1.5
8170,0,Latin America,HR,Regulatory Affairs,Meets,Female,45,14,0,5,3.1,1.1,3,1,1,1,1,2.5,4,2.4
8171,0,Asia Pacific,Commercial,Regulatory Affairs,Below,Female,37,20,0,12,3.8,2.8,2.7,1,1,1,1,3.3,2.9,3.3
8172,0,Middle East & Africa,R&D,Market Access,Exceeds,Male,33,17,0,12,3.2,2.4,2,1,1,1,1,3.1,3.1,3.1
8173,0,Europe,HR,Pharmacovigilance,Exceeds,Male,39,10,1,10,,3.4,3.9,1,1,1,1,3.7,5,3.8
8174,0,Middle East & Africa,Commercial,IT & Digital,Meets,Female,41,12,0,12,3.4,2.1,1.3,1,1,1,1,3.9,3.4,1
8175,0,Middle East & Africa,Finance,Pharmacovigilance,Meets,Female,52,20,0,11,4.1,4.1,1.8,1,1,1,1,5,3.8,2.1
8176,0,Middle East & Africa,R&D,Pharmacovigilance,Below,Female,37,11,0,6,4.2,3.5,1.2,1,1,1,1,4.4,3.2,1.1
8177,0,North America,HR,Clinical Operations,Meets,Male,43,6,1,6,,3.8,1.8,1,1,1,1,3.3,2.5,2.7
8178,0,Middle East & Africa,Digital,Supply Chain,Meets,Female,39,23,0,9,2,2.9,2.5,1,1,0,0,4,3.1,3.2
8179,0,Latin America,Finance,Communications,Meets,Female,40,20,0,7,3.6,3.3,1,0,0,0,0,2.9,2.6,1.3
8180,0,Latin America,Commercial,IT & Digital,Below,Female,36,13,0,7,3,3.5,3.3,1,1,1,1,3,3.5,3.3
8181,0,Asia Pacific,Digital,Human Resources,Meets,Non-Binary/Other,33,12,1,5,,2.4,3.9,1,1,1,1,4.7,3.1,3.5
8182,0,Middle East & Africa,Manufacturing,Finance & Accounting,Meets,Female,40,5,1,8,,3.5,3.9,1,1,1,1,2.5,3.2,4.5
8183,0,Middle East & Africa,Finance,Data Science,Meets,Female,32,25,0,5,5,2,1,0,0,0,0,4.4,2.7,1
8184,0,Europe,Finance,Human Resources,Meets,Male,28,11,1,6,,4.5,2.4,1,1,1,1,3.2,4.6,2.8
8185,0,North America,HR,Pharmacovigilance,Meets,Male,39,13,0,11,2.9,2.7,3.1,1,1,1,1,3.7,3.1,4.1
8186,0,Asia Pacific,HR,Quality Assurance,Meets,Female,33,7,0,11,2.5,3.3,3.6,1,1,1,1,1.7,2.2,3.2
8187,0,Middle East & Africa,Commercial,Data Science,Below,Male,36,4,0,6,2.9,2.5,2.7,1,1,1,1,1.8,3.1,2.4
8188,0,Europe,Finance,Clinical Operations,Exceeds,Female,28,6,0,7,1,2,1.9,1,1,1,1,2.6,2.2,1.4
8189,0,North America,HR,Pharmacovigilance,Meets,Female,44,18,0,6,3.5,4.3,3.3,1,1,1,1,3.8,5,4
8190,0,Asia Pacific,Manufacturing,Finance & Accounting,Far Below,Female,28,9,1,11,,3.4,3.3,1,1,1,1,1.9,3.3,3.1
8191,0,Asia Pacific,HR,Market Access,Meets,Male,41,14,1,7,,1,3.3,1,0,0,0,4.4,2.9,3
8192,0,Middle East & Africa,Finance,Clinical Operations,Meets,Female,41,9,1,10,,1.6,3.3,1,0,0,0,5,1.6,2.6
8193,0,Asia Pacific,R&D,Communications,Meets,Female,39,23,0,8,2.6,3,4.2,1,1,1,1,2.5,2.9,4.5
8194,0,Europe,Digital,Data Science,Meets,Female,44,8,0,9,4.4,3.7,2.6,1,1,1,1,4.7,4.1,1.9
8195,0,Asia Pacific,Finance,Finance & Accounting,Exceeds,Male,31,12,0,5,3.1,3.1,1.7,1,0,0,0,3.6,2.3,2.5
8196,0,Latin America,Manufacturing,Marketing,Meets,Female,50,7,0,12,2.6,3.4,2.7,1,1,1,1,3,4.4,1.6
8197,0,Europe,Finance,Marketing,Meets,Female,33,14,0,5,3.3,2,1.8,1,1,1,1,3.5,1.3,1
8198,0,North America,Manufacturing,Legal & Compliance,Below,Male,42,4,0,7,5,4.9,3.3,1,1,1,1,3.1,3.4,2.2
8199,0,North America,Finance,Human Resources,Exceeds,Male,49,6,0,7,2.8,2.9,3.9,1,1,1,1,3.8,3.2,3.2
8200,1,Middle East & Africa,Digital,Market Access,Meets,Female,37,9,0,7,2,3.4,3.4,1,1,1,1,3,2.8,3.6
8201,0,Middle East & Africa,Digital,Medical Affairs,Below,Male,34,16,0,6,3.4,2,1.4,1,1,1,1,5,3.2,2.4
8202,0,Latin America,Manufacturing,Regulatory Affairs,Meets,Male,43,2,1,5,,3,3.3,1,1,1,1,1.9,3.2,4.9
8203,0,North America,Finance,Finance & Accounting,Far Below,Male,35,18,0,8,3.8,4.4,5,1,1,1,1,4,2.5,5
8204,0,North America,Digital,Market Access,Meets,Female,33,5,0,7,1.4,3.5,2.2,1,1,1,1,1.6,3.5,2
8205,0,North America,Commercial,Marketing,Below,Female,42,8,1,9,,1.9,2.6,1,1,1,1,4,1.3,3.3
8206,0,North America,Finance,Market Access,Below,Male,43,5,1,12,,4,2.7,1,1,1,1,2.2,4.1,1
8207,0,Asia Pacific,Digital,Sales,Below,Male,38,9,0,5,5,2.2,3,1,1,1,1,3.8,2,2.3
8208,0,Europe,R&D,Finance & Accounting,Exceeds,Female,38,7,0,11,2.5,1,2,1,1,1,1,2.7,1.1,1
8209,0,Europe,R&D,Marketing,Exceeds,Male,39,10,1,10,,3.1,3.9,1,1,1,1,3.1,3.1,4.3
8210,0,Latin America,Commercial,Supply Chain,Meets,Male,37,3,0,7,3.8,1.3,4.6,1,1,1,1,4,1.7,4.1
8211,0,Asia Pacific,Digital,Human Resources,Meets,Male,36,12,0,11,2.7,3.3,1.5,1,1,0,0,2.5,4,1.9
8212,0,North America,R&D,Pharmacovigilance,Meets,Male,30,23,0,12,3.8,1,2.7,1,1,1,1,3.6,2.3,4
8213,0,North America,Finance,IT & Digital,Meets,Female,34,29,0,9,4,2.5,2.6,1,1,0,0,4.8,2.5,2.9
8214,0,Middle East & Africa,HR,IT & Digital,Meets,Female,38,14,0,7,2,4.4,1.8,1,1,1,1,2.9,2.9,3.2
8215,0,Middle East & Africa,Digital,Legal & Compliance,Meets,Female,51,9,0,12,3.1,3.9,4.3,1,1,1,1,4.2,2.8,2.6
8216,0,Latin America,Commercial,Supply Chain,Meets,Male,31,17,0,9,3.8,3.8,2.9,1,1,1,1,4.5,2.4,1.9
8217,0,North America,Digital,Medical Affairs,Meets,Male,35,10,1,8,,3.7,2.5,1,1,1,1,3.8,4.1,2
8218,0,Latin America,Manufacturing,Market Access,Meets,Male,30,13,1,12,,4.3,1.6,1,1,1,1,2.3,5,1
8219,1,Asia Pacific,Manufacturing,Sales,Meets,Male,28,5,1,5,,1.6,2.8,1,0,0,0,4.4,1.8,3.8
8220,0,Europe,R&D,Communications,Exceeds,Male,46,5,1,6,,5,2.7,1,1,1,1,3.5,5,4.3
8221,0,North America,Manufacturing,Finance & Accounting,Meets,Female,41,6,1,7,,3.2,3.7,1,1,1,1,2.8,3.2,2.1
8222,0,Asia Pacific,Commercial,Marketing,Far Exceeds,Male,46,36,0,6,2.9,2,3.2,1,1,1,1,3.1,2.4,2.2
8223,0,North America,R&D,Finance & Accounting,Meets,Female,28,6,1,5,,2.6,3.7,1,1,1,1,2,3,3.8
8224,0,Middle East & Africa,Commercial,Pharmacovigilance,Below,Female,42,14,0,5,2.8,2.4,2.8,1,1,1,1,5,4.1,2.1
8225,0,Latin America,Finance,Sales,Meets,Male,51,11,1,11,,4.5,3.9,1,1,1,1,3.5,3.2,4.1
8226,0,Middle East & Africa,Commercial,Sales,Meets,Male,44,5,0,12,4.1,4,3.2,1,1,1,1,3.8,3.1,3.2
8227,0,Europe,Manufacturing,Supply Chain,Meets,Female,41,29,0,6,2.5,4.1,4.3,1,1,1,1,2.1,1.7,3.6
8228,0,Middle East & Africa,Finance,Regulatory Affairs,Meets,Female,33,4,0,9,5,4.2,1.6,1,1,1,1,3.2,3.2,3.4
8229,0,North America,Manufacturing,Data Science,Below,Female,47,9,0,8,4.1,4.1,3.2,1,1,1,1,4.2,3,1.5
8230,0,Middle East & Africa,Commercial,IT & Digital,Far Exceeds,Male,34,16,0,10,3,3.1,2.1,1,1,1,1,2.6,3.2,4
8231,0,North America,Manufacturing,Regulatory Affairs,Exceeds,Female,41,27,0,9,2.7,3.8,2.7,1,1,1,1,3.8,3.1,3
8232,0,Europe,Manufacturing,Market Access,Meets,Male,32,2,1,7,,4.2,3.5,1,1,1,1,4.6,2.8,4.3
8233,0,Middle East & Africa,Manufacturing,Market Access,Below,Female,37,12,0,8,3.2,3.8,2.3,1,1,1,1,3.1,3.7,4.2
8234,0,Latin America,Digital,IT & Digital,Exceeds,Female,44,17,0,10,2.8,3.1,2.1,1,1,1,1,3.4,2.8,1.5
8235,0,Latin America,Finance,Legal & Compliance,Meets,Female,43,12,0,11,2.5,3.4,4.1,1,1,1,1,3.1,1.5,3
8236,0,Latin America,Finance,Regulatory Affairs,Meets,Male,38,13,0,7,2.9,3.7,2.6,1,1,1,1,4.4,3.4,2.2
8237,0,Middle East & Africa,Finance,Data Science,Meets,Female,51,5,0,7,4.2,1.7,3.3,1,1,0,0,3.3,2.8,2.2
8238,0,Middle East & Africa,Commercial,Marketing,Meets,Female,37,11,1,9,,2.3,3.2,1,1,1,1,2.4,3.1,2.9
8239,0,Middle East & Africa,HR,Sales,Below,Male,45,15,1,12,,3,3,0,0,0,0,4.1,1.5,2.9
8240,0,North America,Commercial,Human Resources,Meets,Female,35,6,1,5,,4.8,2.5,1,1,1,1,3.9,3.9,3
8241,0,Europe,Finance,Communications,Meets,Male,31,13,0,8,3.8,2.6,4.4,1,1,1,1,3.4,4.9,4.5
8242,0,Latin America,R&D,Legal & Compliance,Meets,Male,37,11,0,12,3.9,5,3.6,1,1,1,1,3.9,5,3.9
8243,0,North America,Manufacturing,Finance & Accounting,Meets,Male,28,13,1,8,,1.8,2.4,1,1,1,1,2.4,1.1,3.6
8244,0,Latin America,Manufacturing,Sales,Below,Male,40,7,0,12,3.6,3.2,1.6,1,1,1,1,3.3,1.5,2.4
8245,0,North America,HR,Regulatory Affairs,Below,Male,39,14,1,9,,4.9,1.5,1,1,1,1,3.5,4.4,4
8246,0,Middle East & Africa,R&D,Regulatory Affairs,Far Below,Male,42,7,1,10,,3.4,3.2,1,1,1,1,3.6,1.7,2.7
8247,0,Latin America,Digital,IT & Digital,Meets,Female,38,8,0,11,2.6,2.5,4.2,1,1,1,1,4.2,2.2,4.1
8248,0,Middle East & Africa,Commercial,Clinical Operations,Meets,Male,36,12,0,12,3.2,3.7,1.2,1,1,1,1,1.9,4.5,2.4
8249,0,Latin America,Digital,Data Science,Meets,Non-Binary/Other,38,7,1,11,,2.3,1,1,1,1,1,2.8,2.7,2.1
8250,0,Asia Pacific,R&D,IT & Digital,Meets,Male,45,25,0,10,3,3.4,1.2,1,1,1,1,3.7,1.3,1.5
8251,0,North America,HR,IT & Digital,Meets,Female,44,12,1,7,,1.3,4.7,1,1,1,1,4.2,2.6,5
8252,0,Asia Pacific,R&D,Human Resources,Meets,Male,46,12,0,9,3,3,3.3,1,1,1,1,3.9,2.9,3.1
8253,0,North America,HR,Legal & Compliance,Meets,Male,28,8,0,7,2.5,2.8,2.4,1,1,1,1,3.6,3.7,3.4
8254,0,Europe,Digital,Supply Chain,Meets,Female,44,23,0,8,2.5,3.1,1.3,1,1,1,1,2.4,2.8,3.3
8255,0,Latin America,Digital,Human Resources,Far Below,Female,42,25,0,11,3,3.9,2.7,1,1,1,1,3.3,5,2.7
8256,0,Europe,R&D,Sales,Meets,Female,50,11,1,11,,3.6,2.2,1,1,1,1,3,3.3,3.4
8257,0,Europe,R&D,Supply Chain,Meets,Female,35,10,0,7,3.4,2.8,1.9,1,1,1,1,2.8,3.6,1.3
8258,0,North America,Manufacturing,Pharmacovigilance,Meets,Female,36,27,0,6,3.9,3.6,3,1,1,1,1,4.4,4.3,2.5
8259,0,Asia Pacific,HR,Marketing,Exceeds,Male,40,20,0,5,2.6,5,1,1,1,1,1,1.5,5,3
8260,0,Middle East & Africa,Manufacturing,Regulatory Affairs,Meets,Female,28,12,1,9,,1.7,3.7,1,1,1,1,3.1,1.2,1.7
8261,0,North America,Commercial,Clinical Operations,Meets,Male,28,15,1,7,,2.6,1.4,1,1,1,1,3.4,4.3,3.1
8262,0,Middle East & Africa,Commercial,Clinical Operations,Meets,Male,40,5,0,5,3.4,4.7,4,1,1,1,1,2.7,3.6,4.7
8263,0,Europe,R&D,Market Access,Meets,Male,31,8,1,9,,2.1,1,1,1,1,1,3.5,3.1,2.4
8264,0,Middle East & Africa,Digital,Pharmacovigilance,Below,Male,30,26,0,9,4.6,1.8,2.4,0,0,0,0,3.4,1,3.1
8265,0,Asia Pacific,Commercial,Legal & Compliance,Meets,Male,41,1,0,5,3.5,1.9,2.5,1,1,1,1,3.7,1,2.7
8266,0,North America,Commercial,Marketing,Meets,Female,28,15,0,11,4.1,2.5,3.8,1,1,1,1,3.1,3.1,3.9
8267,0,Asia Pacific,Manufacturing,Marketing,Exceeds,Female,42,13,0,10,3.9,3.2,3.6,0,0,0,0,3.2,4.4,1.5
8268,0,Asia Pacific,Manufacturing,Medical Affairs,Meets,Male,33,7,1,6,,1.6,3.8,1,1,1,1,4.5,1.3,4.6
8269,0,North America,Commercial,IT & Digital,Meets,Female,33,22,0,7,3.2,3.9,2.6,1,1,0,0,2.9,2,1.2
8270,0,Asia Pacific,R&D,Legal & Compliance,Below,Male,40,17,1,10,,4.3,3.8,1,1,1,1,2.6,3.8,1.1
8271,1,Latin America,Manufacturing,Regulatory Affairs,Meets,Male,31,3,1,7,,3.1,1.8,1,1,0,0,4.7,2.4,2.8
8272,0,Latin America,Commercial,Market Access,Meets,Female,48,3,1,12,,2.5,1.1,1,1,1,1,1.2,3.5,2.8
8273,0,Latin America,Digital,Data Science,Meets,Female,37,18,0,8,3.4,4,4.6,1,1,1,1,3.9,2.8,2.7
8274,0,Middle East & Africa,Manufacturing,Data Science,Meets,Female,38,17,0,10,4.4,3,3.3,1,1,1,1,3.8,3,4.3
8275,0,Asia Pacific,Commercial,Quality Assurance,Meets,Female,42,12,0,7,3,2.6,1.6,1,1,1,1,3.9,4.3,1.1
8276,0,North America,HR,Marketing,Meets,Female,44,19,0,5,2.7,2.9,3.2,1,1,1,1,2,4,2.3
8277,0,North America,Manufacturing,Supply Chain,Meets,Female,35,9,0,10,2.8,2.2,1.9,1,1,1,1,3.8,1.3,2.4
8278,0,Middle East & Africa,HR,Pharmacovigilance,Meets,Female,42,20,0,8,2.3,2.6,3.5,1,1,1,1,1.2,3,4.1
8279,0,North America,Manufacturing,Clinical Operations,Exceeds,Female,43,28,0,12,2.9,4,2.3,1,1,1,1,3.3,3.5,2.1
8280,0,Latin America,Manufacturing,Regulatory Affairs,Meets,Male,47,10,0,11,2.4,3.9,2.5,1,1,1,1,1.9,2.6,2.9
8281,0,Asia Pacific,Finance,Communications,Meets,Female,35,8,0,7,3.6,3.5,2.7,1,1,1,1,2.7,4.1,2.9
8282,0,North America,Finance,Pharmacovigilance,Meets,Male,43,19,0,9,3.8,4.2,4,0,0,0,0,3.7,4.2,1.1
8283,0,North America,HR,Sales,Meets,Female,41,7,0,5,4.7,3.8,4.2,1,1,1,1,2.8,4.6,3.3
8284,0,Europe,R&D,Medical Affairs,Far Exceeds,Male,41,10,0,10,3.7,4.2,2.4,1,1,0,0,3.9,3.3,2.3
8285,0,Europe,Commercial,Clinical Operations,Meets,Male,28,18,0,9,3,2.9,1.2,1,1,1,1,3.4,3.1,1
8286,0,Europe,R&D,Pharmacovigilance,Meets,Female,46,5,0,6,2.4,4.3,2,0,0,0,0,2.9,5,2.3
8287,0,Asia Pacific,R&D,Human Resources,Meets,Male,44,6,1,8,,4.2,3.3,1,1,0,0,2.3,4.9,3.2
8288,0,Latin America,Finance,Finance & Accounting,Meets,Female,42,6,0,11,2.5,4,1.5,1,1,1,1,3.3,3.4,1
8289,0,Latin America,Commercial,Pharmacovigilance,Below,Male,34,10,0,10,4.3,2.9,4.8,1,1,1,1,5,3.2,4.9
8290,0,Latin America,Finance,Medical Affairs,Meets,Male,48,23,0,8,2.9,2.1,1.1,1,1,1,1,3.7,1.6,2.4
8291,0,Asia Pacific,Finance,Pharmacovigilance,Below,Female,38,12,1,5,,2.8,1.7,1,1,1,1,5,4.4,2.6
8292,0,Asia Pacific,Finance,Market Access,Below,Male,41,13,0,10,3.5,2.3,1.1,1,1,1,1,4.8,3.9,1.8
8293,0,Europe,Digital,Finance & Accounting,Far Below,Female,31,18,0,7,2.7,1.5,3,1,1,1,1,1,2.8,2.5
8294,0,North America,R&D,Clinical Operations,Meets,Male,36,12,0,6,3.6,2.8,1.9,0,0,0,0,3.6,4,3.4
8295,0,Middle East & Africa,R&D,Communications,Meets,Female,38,11,1,11,,3.3,3,1,1,1,1,2.5,1.6,3.2
8296,1,Middle East & Africa,R&D,Sales,Exceeds,Female,33,7,1,8,,3.3,3.1,1,1,1,1,4.4,4,3.8
8297,0,North America,Digital,Clinical Operations,Meets,Female,34,12,0,7,4.2,5,3.2,1,1,1,1,2.2,4.9,2.8
8298,0,Europe,Manufacturing,Medical Affairs,Exceeds,Female,41,9,0,11,3.3,2.2,1.5,1,1,1,1,4.6,2.8,1
8299,0,North America,HR,IT & Digital,Meets,Male,44,16,0,7,2.9,1.6,2.4,0,0,0,0,2.1,2.2,2
8300,0,North America,HR,Sales,Below,Female,29,15,0,11,4.5,3.9,4.3,1,1,1,1,4.4,3.1,4.3
8301,0,Middle East & Africa,Digital,Legal & Compliance,Meets,Female,52,6,1,5,,4.6,1.7,1,1,1,1,4.4,4.4,3.5
8302,0,Europe,R&D,Human Resources,Meets,Male,33,27,0,8,2.5,3.7,2,1,1,1,1,3,3.4,4.1
8303,0,Asia Pacific,HR,Data Science,Meets,Female,32,8,0,11,3,3.4,2.5,1,1,1,1,2.4,4.1,2.1
8304,0,Middle East & Africa,Digital,Regulatory Affairs,Exceeds,Female,47,19,0,5,2.8,3.4,3,1,1,1,1,3.2,3.6,1
8305,0,Asia Pacific,Finance,Marketing,Meets,Female,42,25,0,11,5,2,2,1,1,1,1,5,3,3.1
8306,0,Europe,Commercial,Human Resources,Meets,Male,44,8,0,12,3.3,4.2,2.9,1,1,1,0,3.6,3.3,2.6
8307,0,North America,HR,Finance & Accounting,Exceeds,Male,33,15,1,7,,3.5,3,0,0,0,0,4.6,4.7,2.1
8308,0,Latin America,Commercial,Data Science,Meets,Male,41,7,0,12,2.9,2.2,3.5,1,1,1,1,3.8,3.4,3.4
8309,0,Latin America,R&D,Market Access,Below,Male,53,23,0,7,2.4,1.9,3.5,1,1,1,1,3.5,2.3,2.5
8310,1,Europe,HR,Clinical Operations,Meets,Male,33,8,1,6,,3.5,1,1,1,1,1,3.9,3.8,1.4
8311,0,Latin America,Digital,Human Resources,Meets,Female,42,18,0,11,3.4,2.3,3,1,1,1,1,3,3.1,3.5
8312,0,Asia Pacific,Manufacturing,Finance & Accounting,Meets,Male,33,14,0,6,4.5,3.1,2.2,1,1,1,1,5,3.7,3
8313,0,Latin America,HR,Sales,Exceeds,Female,32,22,0,8,3.2,3.5,1.3,1,1,1,1,3.3,3.5,1.6
8314,0,Europe,HR,Regulatory Affairs,Below,Female,37,12,0,10,3,2.3,3.9,1,1,1,1,3.5,4,4
8315,0,Europe,HR,Communications,Meets,Male,38,18,0,7,2.4,3.6,1.4,1,1,1,1,4.3,3.2,2.2
8316,0,Asia Pacific,HR,Regulatory Affairs,Exceeds,Male,37,7,0,7,2.9,3.2,1.1,1,1,1,1,4.2,3.8,1
8317,0,Latin America,Digital,Communications,Meets,Female,38,11,0,10,3.3,3.3,2.1,1,1,1,1,3.8,3.1,1.8
8318,0,Latin America,Digital,Medical Affairs,Meets,Female,51,5,0,10,3.9,2.5,2.5,1,1,1,1,3.7,2.7,2.6
8319,0,North America,Manufacturing,Medical Affairs,Meets,Female,48,8,1,8,,2.7,2.2,1,1,1,1,4.5,2.9,1.5
8320,0,Middle East & Africa,Digital,Medical Affairs,Meets,Female,39,36,0,12,3.5,4.9,5,1,1,1,1,3.9,4,3.9
8321,0,Europe,Digital,Supply Chain,Meets,Male,39,9,0,6,3.2,4.5,2.3,1,1,1,1,2.7,3.4,2.6
8322,0,North America,R&D,Clinical Operations,Exceeds,Female,47,4,1,6,,1.8,1.5,1,1,1,1,3.3,2.9,1.3
8323,0,Europe,R&D,Finance & Accounting,Below,Female,42,2,1,9,,3.8,3.3,1,1,1,1,3.2,2.6,4.2
8324,0,North America,Commercial,Quality Assurance,Meets,Male,40,5,1,10,,2.3,1,1,1,1,1,3.8,3.7,1.7
8325,0,Middle East & Africa,Manufacturing,IT & Digital,Below,Male,51,9,0,7,3.7,2.9,1.1,1,1,1,1,4.8,4.3,2.9
8326,1,North America,R&D,Finance & Accounting,Meets,Male,33,6,0,9,5,1.9,3.9,1,1,1,1,3.6,1,3.8
8327,0,Europe,Manufacturing,Market Access,Meets,Female,38,16,0,8,2.9,2.8,4,1,1,1,1,2.2,3,3.7
8328,0,Latin America,Manufacturing,Pharmacovigilance,Below,Female,37,11,0,10,3.5,2.8,1.5,1,1,1,1,3.1,3.2,2.8
8329,0,Europe,HR,Market Access,Meets,Female,41,5,1,8,,2.1,5,1,1,1,1,5,2.9,1.8
8330,0,Asia Pacific,Finance,Finance & Accounting,Below,Male,32,13,1,12,,2.3,2.2,1,1,1,1,1.9,3.3,1.6
8331,0,Asia Pacific,Finance,Legal & Compliance,Meets,Female,41,12,0,10,4.6,2.8,1.3,1,0,0,0,3.8,3.1,1
8332,1,Asia Pacific,Finance,Communications,Meets,Non-Binary/Other,36,5,1,6,,3.6,3.1,1,1,1,1,5,3.1,3.5
8333,0,Asia Pacific,Manufacturing,Marketing,Meets,Female,44,16,0,12,3.2,2.7,2.2,1,1,0,0,3.8,2.4,3.1
8334,0,Middle East & Africa,HR,Medical Affairs,Below,Female,36,6,0,5,3.2,3.5,2,1,1,1,1,4,3.9,2.8
8335,0,Latin America,Commercial,Marketing,Meets,Male,35,18,0,9,3.2,1.3,1.8,1,1,0,0,3,2.8,2.2
8336,0,Latin America,Commercial,Market Access,Meets,Female,42,7,0,11,4.2,2.5,1.8,1,1,1,1,4.4,3.9,2.4
8337,0,Europe,Finance,Supply Chain,Below,Male,39,15,0,6,4,2.6,3.3,1,1,1,1,3.4,3.6,3.6
8338,0,North America,Commercial,Marketing,Meets,Male,36,15,1,9,,3.2,3.4,1,1,1,1,2.6,2.9,1.3
8339,0,Europe,HR,Human Resources,Meets,Male,37,5,0,5,3.5,3.5,2.7,1,1,1,1,3.3,3.9,1.6
8340,0,Europe,Finance,Clinical Operations,Meets,Male,35,12,0,5,4.2,2.3,4.1,1,1,1,1,2.7,2.9,5
8341,1,Europe,HR,Sales,Meets,Female,50,6,1,7,,3.8,2.4,1,1,1,1,3.9,2.4,2.8
8342,0,Europe,Commercial,Quality Assurance,Below,Female,41,6,0,8,3.4,3.8,3.3,1,1,1,1,3.7,4.6,3.4
8343,0,Latin America,Finance,Communications,Below,Female,43,18,0,10,3.5,3.6,3.8,1,1,1,1,2.7,4.3,2.8
8344,0,North America,HR,Quality Assurance,Meets,Male,41,9,0,8,4.1,2.6,4,1,1,1,1,3.7,3,3.6
8345,0,Europe,Digital,IT & Digital,Far Below,Female,40,9,1,8,,1.9,2,0,0,0,0,2.8,2,1
8346,0,Latin America,Digital,Market Access,Below,Female,35,8,0,6,3.5,3.8,2.6,1,1,1,1,3.5,2.9,2.5
8347,0,Europe,HR,Pharmacovigilance,Meets,Female,34,6,0,10,3,3.3,2.9,1,1,1,1,3.7,3.2,2
8348,0,Asia Pacific,HR,Medical Affairs,Meets,Male,35,7,1,5,,3.2,5,0,0,0,0,3.1,3.7,3
8349,0,Europe,R&D,Market Access,Meets,Male,42,21,0,10,3.6,2.7,2.7,0,0,0,0,3.5,2.9,2.1
8350,0,Europe,R&D,Marketing,Meets,Female,35,9,0,5,4.7,2.9,1.1,1,1,1,1,3,2.9,1.7
8351,0,Middle East & Africa,Manufacturing,Supply Chain,Meets,Female,46,5,0,6,2.6,2.1,4.5,0,0,0,0,4,1.2,3.9
8352,0,Asia Pacific,Finance,Sales,Meets,Female,48,10,1,8,,4.5,2,1,1,1,1,3.8,2.3,1.8
8353,0,North America,Manufacturing,Communications,Meets,Male,28,13,0,10,2.8,3.3,2.8,1,1,1,1,2.5,1,2.5
8354,0,Europe,Manufacturing,Human Resources,Exceeds,Female,48,10,0,5,3,3.4,1.3,1,1,1,0,4.1,3.9,1.5
8355,0,North America,Commercial,Quality Assurance,Meets,Male,31,11,0,9,3.5,1,2.9,1,1,1,1,4.2,2.9,3
8356,0,Asia Pacific,Digital,Data Science,Meets,Male,36,10,0,7,4.2,2.4,3.6,1,1,1,1,3.4,3.2,1.8
8357,0,Europe,Commercial,Quality Assurance,Far Below,Female,39,4,1,6,,3.3,1.7,1,1,1,1,3.9,4.6,1.3
8358,0,Middle East & Africa,Finance,Communications,Below,Female,28,4,0,12,2.8,2.9,3.8,1,1,1,1,3.9,2.5,3.9
8359,0,Latin America,HR,Legal & Compliance,Below,Female,34,7,0,7,2.2,2.6,4,1,1,1,1,4.4,3.2,3.6
8360,0,Middle East & Africa,R&D,Sales,Meets,Male,39,7,0,8,3.3,3.1,3.4,0,0,0,0,2.8,2.1,2.6
8361,0,Middle East & Africa,Finance,Clinical Operations,Meets,Male,31,14,1,6,,2.4,2.2,1,1,1,1,3.1,3.4,1.6
8362,0,Latin America,HR,Finance & Accounting,Far Below,Male,30,8,0,9,3,3,2.6,1,1,1,1,3.4,3.5,3.3
8363,0,Latin America,Finance,Marketing,Meets,Male,49,20,0,12,3.3,2.5,2,1,1,1,1,2.2,3,2.4
8364,0,Latin America,HR,Regulatory Affairs,Meets,Female,39,14,0,6,4.2,4.1,1.9,1,1,1,1,3.3,3.4,2.3
8365,0,Europe,R&D,Communications,Far Exceeds,Female,44,28,0,7,2,2.6,3.5,1,1,1,0,3.5,3,3.8
8366,0,North America,HR,Supply Chain,Meets,Female,50,6,0,6,3.2,2.9,3.5,1,1,1,1,3.3,2.7,3.1
8367,0,North America,Manufacturing,Communications,Meets,Female,43,13,0,9,3.7,2.7,2.7,1,1,1,1,3.6,3.1,2.5
8368,0,Latin America,Finance,Communications,Exceeds,Female,35,7,0,5,3,3.1,3.5,1,1,1,1,4.1,2.4,4
8369,0,Middle East & Africa,R&D,Pharmacovigilance,Exceeds,Female,34,8,0,8,3.4,5,2.7,1,1,1,1,3.3,4.1,2.3
8370,0,Asia Pacific,HR,Data Science,Meets,Male,41,8,0,12,3.6,5,2.2,1,1,1,1,3.2,5,1.4
8371,0,Latin America,Manufacturing,Legal & Compliance,Meets,Male,42,6,1,9,,4.1,1.4,1,1,1,1,3,2.9,2
8372,0,Middle East & Africa,Manufacturing,Market Access,Meets,Male,40,5,0,8,4.6,3.7,1.9,1,1,1,1,2.7,4,4.5
8373,0,Middle East & Africa,Digital,Legal & Compliance,Meets,Female,43,8,1,8,,2.8,2.9,1,1,1,1,4.8,4.5,2
8374,0,Europe,Manufacturing,Medical Affairs,Meets,Female,37,7,0,9,3.6,3.3,2.5,1,1,1,1,2.7,3.6,2.3
8375,0,Europe,Commercial,Medical Affairs,Meets,Female,38,34,0,6,3.3,3.2,1.6,1,1,1,1,2.7,3.8,1.9
8376,0,North America,R&D,Medical Affairs,Meets,Female,35,6,1,11,,3.5,3.3,1,1,1,1,5,4.3,2.7
8377,0,North America,R&D,Data Science,Meets,Female,33,16,0,6,3.5,2.3,3.5,1,1,1,1,2.8,2.4,3.7
8378,0,Asia Pacific,R&D,Sales,Below,Male,33,12,1,10,,2.4,2.4,1,1,1,1,3.7,1.2,1.9
8379,0,Asia Pacific,HR,Pharmacovigilance,Meets,Male,36,11,0,10,3.8,2.5,3.8,1,1,1,1,4.1,2.9,3.1
8380,0,Asia Pacific,Finance,Communications,Meets,Male,42,9,0,11,2.8,2.3,1,1,1,1,1,2.5,2.3,1.8
8381,0,Asia Pacific,HR,Human Resources,Meets,Non-Binary/Other,38,7,0,9,3.7,2.6,3.4,1,1,1,1,3.7,4.2,4
8382,0,Middle East & Africa,Commercial,Quality Assurance,Meets,Male,35,4,0,12,4.2,3.7,5,1,1,1,1,4.8,2.6,3
8383,0,Middle East & Africa,Finance,Market Access,Meets,Female,36,5,0,11,1.3,3.1,3.4,1,1,1,1,3.6,4.1,3.8
8384,0,North America,Manufacturing,Regulatory Affairs,Far Exceeds,Female,28,11,0,7,2.6,3.2,1.3,1,1,1,1,3.1,3.1,2.1
8385,0,Europe,HR,IT & Digital,Below,Male,35,12,0,6,4.6,3.9,2.8,1,1,1,1,3.8,4.1,3.4
8386,0,Europe,Finance,Pharmacovigilance,Exceeds,Female,43,7,1,7,,2.3,3.9,1,1,1,1,3.1,2,3.4
8387,0,Latin America,Manufacturing,IT & Digital,Meets,Female,31,10,0,8,4.6,3.7,1.2,1,1,1,1,3.5,2.2,2.2
8388,0,Middle East & Africa,Finance,Market Access,Exceeds,Female,29,29,0,9,2.9,4.5,1.2,1,1,1,1,3.8,4,2.5
8389,0,Asia Pacific,Manufacturing,Regulatory Affairs,Meets,Female,31,33,0,12,3.5,3.4,4.8,0,0,0,0,4.3,3.3,3.6
8390,0,Asia Pacific,Finance,Supply Chain,Meets,Male,35,11,0,12,4,2.1,2.6,1,0,0,0,4.5,2.4,3.7
8391,0,Latin America,HR,Sales,Below,Female,38,18,1,8,,2.5,2,1,1,1,1,3.6,3.9,1.6
8392,0,Europe,HR,Communications,Meets,Male,39,14,0,10,3.3,2.1,1.3,1,1,1,1,3.1,3.3,1.6
8393,0,Asia Pacific,Commercial,Finance & Accounting,Meets,Male,42,1,1,6,,2.2,3,1,1,1,1,4.5,3.2,1.7
8394,0,Europe,Digital,Supply Chain,Meets,Female,37,23,0,10,2.9,2.9,2.7,0,0,0,0,3.2,2.3,3.4
8395,0,Latin America,R&D,Sales,Meets,Male,42,13,0,6,2,3,2.4,1,1,1,1,3.5,3.2,2.5
8396,0,Europe,HR,IT & Digital,Exceeds,Female,31,15,0,6,4,1.9,4.2,1,1,1,1,3.6,1.4,5
8397,0,Europe,HR,Marketing,Meets,Male,45,2,0,11,3.9,3.1,1.7,1,1,1,1,3.2,4.3,1.6
8398,0,Europe,Manufacturing,Quality Assurance,Meets,Female,40,8,1,8,,3.1,2.8,1,1,1,1,2.5,3.7,3.5
8399,0,Asia Pacific,Digital,Clinical Operations,Below,Male,28,30,0,8,3.1,3.1,1.6,1,1,1,1,3.6,2.2,2.7
8400,0,North America,HR,Finance & Accounting,Meets,Female,39,7,0,6,2,4.3,2.9,0,0,0,0,3.8,1.5,2.7
8401,0,Middle East & Africa,Finance,Human Resources,Below,Male,52,6,1,9,,2.5,3,1,1,1,1,3.8,3.4,2.1
8402,0,Europe,Digital,Finance & Accounting,Exceeds,Male,50,30,0,6,3,1.5,2.6,0,0,0,0,3.2,1.8,2.4
8403,0,Europe,R&D,IT & Digital,Meets,Female,38,23,0,5,2.7,3.1,1,0,0,0,0,3,3,2
8404,0,Europe,Finance,Clinical Operations,Meets,Female,42,23,0,12,4,4,2.8,1,1,1,1,3.7,4,2.1
8405,0,North America,Manufacturing,Sales,Meets,Female,31,8,0,9,3.4,1.3,4.6,1,1,1,1,5,1.5,3
8406,0,Latin America,Commercial,Communications,Meets,Male,30,14,1,11,,3,1,1,1,1,1,5,3.2,2.6
8407,0,Asia Pacific,Finance,Clinical Operations,Meets,Female,37,8,1,11,,3.1,2.7,1,1,1,1,2.8,2.8,2.5
8408,0,North America,R&D,Data Science,Meets,Female,35,9,1,6,,2.4,4.4,1,1,1,1,2.1,2.4,5
8409,0,Europe,Finance,Market Access,Far Below,Female,39,13,0,5,2.7,1.6,1.8,1,1,1,1,3.5,2.7,2.8
8410,0,North America,Digital,Communications,Far Exceeds,Female,42,8,1,12,,4.7,1.9,0,0,0,0,3.6,3.8,2.6
8411,1,North America,Digital,Pharmacovigilance,Meets,Male,42,24,0,7,3.3,2.9,4.1,1,1,1,1,3.3,5,4.5
8412,0,North America,R&D,Legal & Compliance,Meets,Female,44,10,0,5,2.7,2.2,2.5,1,0,0,0,4.2,2.8,4.4
8413,0,Latin America,Digital,Finance & Accounting,Meets,Female,41,16,1,10,,4.2,3.2,1,1,1,1,3.5,2.9,2.3
8414,0,Middle East & Africa,Finance,Supply Chain,Meets,Female,45,10,0,12,4.1,1.8,2.6,1,0,0,0,4.1,2,2.7
8415,0,Asia Pacific,Commercial,IT & Digital,Below,Female,44,13,0,9,3.1,2.4,2.9,1,1,1,1,3.1,1.4,4.7
8416,0,Latin America,Finance,Marketing,Meets,Female,37,13,0,12,5,1.6,5,1,1,1,1,5,2.1,3.8
8417,0,Latin America,Commercial,Quality Assurance,Meets,Male,28,11,0,9,3,2.1,1,1,1,1,1,2,2.7,2.2
8418,1,Middle East & Africa,Digital,Quality Assurance,Meets,Female,31,6,0,5,3.4,2.3,3.1,1,1,1,1,3.8,3.7,4.2
8419,0,Latin America,Finance,Marketing,Far Exceeds,Female,42,12,0,10,3.8,3.5,4.9,1,1,1,1,2.6,4.6,4.5
8420,0,North America,Digital,Medical Affairs,Below,Male,39,4,1,7,,4,2.8,1,1,1,1,2.7,3.3,2.1
8421,0,North America,Commercial,Medical Affairs,Meets,Female,50,5,0,5,1.4,4,3.6,1,1,1,1,1,3.2,3.7
8422,0,Europe,Digital,Medical Affairs,Meets,Female,29,12,0,12,4.5,2.7,3.5,1,1,1,1,2.4,2.9,4
8423,0,Latin America,HR,Marketing,Meets,Female,43,6,0,12,3.2,4.2,2.9,1,1,1,1,3.6,3.3,3.5
8424,0,Europe,Manufacturing,Clinical Operations,Meets,Male,38,6,1,7,,1.9,4.3,1,1,1,1,3.4,2.7,4.4
8425,0,Asia Pacific,Finance,IT & Digital,Meets,Female,33,3,0,9,3.2,4.4,2.3,1,1,1,1,4.5,5,1.8
8426,0,North America,HR,Regulatory Affairs,Meets,Female,49,5,0,12,4,3,1.7,1,1,1,1,4.4,2.1,3.7
8427,0,Asia Pacific,Digital,Marketing,Meets,Male,31,14,0,9,3.7,4,1.1,1,1,1,1,2.3,5,2.7
8428,0,Middle East & Africa,Digital,Legal & Compliance,Meets,Female,40,11,1,8,,3.5,1.8,1,1,1,1,3.7,1.4,3.4
8429,0,North America,Manufacturing,Legal & Compliance,Far Below,Non-Binary/Other,45,11,0,7,3.3,3.2,3.6,0,0,0,0,4.2,3.9,2.3
8430,1,Asia Pacific,Digital,Human Resources,Meets,Female,33,27,0,5,3.3,4,2.9,1,1,1,1,3.3,3.7,3.6
8431,0,Middle East & Africa,Manufacturing,Clinical Operations,Meets,Non-Binary/Other,28,15,0,7,2.6,2.7,3.9,1,1,1,1,5,3.5,2.9
8432,0,Asia Pacific,Finance,Pharmacovigilance,Meets,Female,42,11,0,5,2.3,4,3.7,0,0,0,0,3.4,3.7,3.9
8433,0,Middle East & Africa,Commercial,IT & Digital,Below,Male,45,24,0,9,2.5,2.8,1.5,1,1,1,1,2.8,4.1,2.6
8434,0,Middle East & Africa,Manufacturing,Marketing,Exceeds,Male,35,23,0,9,2.8,5,2.7,1,1,1,1,3.7,3.3,3.6
8435,0,North America,Manufacturing,Supply Chain,Below,Female,29,17,0,10,2.6,1.9,3.6,1,1,1,1,4.3,3.7,3.2
8436,0,Europe,HR,Legal & Compliance,Meets,Male,39,5,0,6,3.9,3.6,3.8,1,1,1,1,3.8,5,2.7
8437,0,Middle East & Africa,Digital,IT & Digital,Below,Female,36,10,1,9,,3.4,2.3,1,1,1,1,4.3,4.4,2.8
8438,0,Middle East & Africa,Finance,Clinical Operations,Meets,Male,28,22,1,11,,3.9,3,1,1,1,1,2.7,2.7,2.7
8439,0,North America,Commercial,Quality Assurance,Meets,Non-Binary/Other,41,16,0,9,3.1,2.3,4.2,1,1,1,1,3.5,2.5,4.3
8440,0,Europe,R&D,IT & Digital,Meets,Male,34,4,0,9,2.3,2.7,2.3,1,1,1,1,3.6,3.8,3
8441,0,Latin America,Manufacturing,IT & Digital,Below,Female,42,6,1,5,,2.2,2.7,1,1,1,1,3.3,1,2.4
8442,0,Latin America,R&D,IT & Digital,Far Below,Female,52,5,0,5,3.7,3.5,2,1,1,1,1,3.2,3.7,2.5
8443,0,Europe,Digital,IT & Digital,Meets,Female,38,7,0,6,4.3,4.4,2,1,1,1,1,3.8,3.8,3.1
8444,0,Asia Pacific,Manufacturing,IT & Digital,Exceeds,Male,39,4,1,6,,3,2.3,1,1,1,1,3,2.4,1.6
8445,0,North America,R&D,Sales,Exceeds,Female,39,12,0,11,4.2,3.9,1.6,1,1,1,1,4.4,3.2,3.8
8446,0,Europe,HR,Sales,Meets,Female,37,4,1,12,,5,2.2,1,1,1,1,2.6,3.9,2.9
8447,0,Latin America,R&D,Legal & Compliance,Meets,Male,31,5,1,7,,3.1,2.2,1,1,1,1,4.7,3.1,3.3
8448,0,Middle East & Africa,HR,Marketing,Exceeds,Female,40,7,1,7,,1,2.2,1,1,1,1,2.7,2.7,2
8449,0,Latin America,Commercial,Supply Chain,Meets,Female,35,7,0,11,3.9,3.3,2.3,1,1,1,1,2.9,4.2,2.6
8450,0,Middle East & Africa,Digital,Supply Chain,Exceeds,Female,35,4,0,12,2.7,4.1,2,1,1,1,1,1.6,1.9,1
8451,0,North America,Finance,Sales,Meets,Female,34,17,0,7,5,2.2,2.9,0,0,0,0,2.9,2.6,3.1
8452,0,Middle East & Africa,R&D,Clinical Operations,Meets,Male,41,22,0,8,3.6,2.4,4.1,1,1,1,1,4.1,2.9,3.9
8453,0,Europe,Manufacturing,Human Resources,Meets,Male,33,13,0,7,2.3,2.2,1.6,1,1,1,1,2.4,2.8,2.9
8454,0,Middle East & Africa,Digital,Pharmacovigilance,Meets,Male,40,19,0,6,3.3,3.6,1.6,1,1,1,1,3,4,3.2
8455,0,Asia Pacific,R&D,Communications,Meets,Female,41,11,0,11,3.6,2.5,1.4,1,1,1,1,3.7,2.4,2.4
8456,0,Europe,Manufacturing,Marketing,Below,Female,38,19,0,8,3.1,4.6,3.4,1,1,1,1,1.9,4,3.4
8457,0,North America,Manufacturing,Finance & Accounting,Meets,Male,30,6,1,7,,3.9,3.4,1,1,1,1,2.3,3.3,4.4
8458,1,Europe,Finance,Pharmacovigilance,Meets,Male,34,3,1,6,,4.9,1.9,1,1,1,1,3.6,4.3,1.1
8459,0,Asia Pacific,Finance,Human Resources,Meets,Male,37,16,0,6,3.1,3.5,3.9,1,1,1,1,3.7,3.3,2.4
8460,0,North America,Manufacturing,Medical Affairs,Meets,Female,30,10,0,6,2,4,3.8,1,1,1,1,2.8,3.4,4.7
8461,0,Latin America,Finance,Regulatory Affairs,Meets,Male,40,22,0,8,3.1,3.9,2.8,1,1,1,1,3.8,2.2,2.7
8462,0,Asia Pacific,Manufacturing,Finance & Accounting,Meets,Female,47,8,0,12,5,2.4,1.1,1,1,1,1,5,2.8,1
8463,1,North America,R&D,Finance & Accounting,Far Exceeds,Male,41,10,0,9,3.5,4,2.2,1,1,1,1,5,3.5,3.3
8464,0,Middle East & Africa,Commercial,Data Science,Meets,Female,31,15,0,12,2.3,3.9,2.8,1,1,1,1,3.2,2.7,3.4
8465,0,Europe,Finance,IT & Digital,Meets,Male,53,11,1,11,,2.2,2.3,0,0,0,0,2.5,2.4,3.9
8466,0,North America,HR,Medical Affairs,Meets,Male,35,7,0,7,2.9,1.3,3.4,0,0,0,0,2.9,1,4.4
8467,0,Europe,HR,Market Access,Meets,Female,40,22,0,9,4.8,3.2,1.8,0,0,0,0,3.6,2.2,3.4
8468,0,Middle East & Africa,HR,IT & Digital,Exceeds,Female,34,18,0,10,2.4,3.3,2.5,1,1,1,1,3.4,4.8,2
8469,0,North America,Commercial,Quality Assurance,Meets,Female,39,27,0,10,3,2.1,1.9,1,1,1,1,2.2,2.6,2.1
8470,0,Latin America,Manufacturing,Data Science,Meets,Male,46,2,0,6,2.4,3.5,1.5,0,0,0,0,1.7,3.1,3.1
8471,0,Asia Pacific,Manufacturing,Quality Assurance,Meets,Female,32,8,1,11,,3.4,1.8,0,0,0,0,5,2.9,3.7
8472,0,North America,Digital,Marketing,Below,Male,35,1,0,12,1.8,3.5,3,1,1,1,1,1.6,3.2,3.9
8473,0,Middle East & Africa,HR,Medical Affairs,Below,Female,39,12,0,11,2.4,2.4,1.5,1,1,1,1,1.7,1,2.7
8474,0,North America,HR,Legal & Compliance,Meets,Male,28,13,0,12,3.5,3.4,4,1,1,1,1,4.2,4.5,4.1
8475,0,Europe,Manufacturing,Supply Chain,Meets,Male,43,10,1,12,,3.7,3.4,1,1,1,1,3.1,3.4,2.8
8476,1,North America,HR,Communications,Meets,Male,34,18,0,5,4.2,4.3,2.1,1,1,1,1,4.5,5,2.4
8477,0,Latin America,Manufacturing,Legal & Compliance,Meets,Male,38,8,0,5,4,1.5,2.4,1,1,1,1,3.4,2.9,1.4
8478,0,North America,Manufacturing,Human Resources,Far Below,Female,31,24,0,8,3.5,5,3.4,1,1,1,1,3.5,2.7,3.3
8479,0,Asia Pacific,Finance,Finance & Accounting,Meets,Female,31,13,0,11,3.4,4.5,1.1,1,1,1,1,3.7,4.2,2.5
8480,0,North America,Manufacturing,Sales,Meets,Male,38,6,0,11,4.4,3.4,1,1,1,1,1,3,4.7,1.6
8481,0,Europe,R&D,Sales,Meets,Male,47,8,1,9,,3.5,2.1,1,1,1,1,4.4,1.5,2.6
8482,0,North America,R&D,Pharmacovigilance,Meets,Male,32,19,0,9,3,1.6,1.5,1,1,1,1,4.5,2.2,1
8483,1,Latin America,R&D,Finance & Accounting,Exceeds,Male,43,5,1,10,,2.9,2,1,1,1,1,3.4,3.1,2.2
8484,0,Middle East & Africa,R&D,Data Science,Meets,Male,46,6,0,10,2.1,4,1,1,1,1,1,3,4.3,2.9
8485,0,North America,Commercial,Market Access,Meets,Male,44,13,0,5,3.5,2.8,1,1,1,1,1,2.7,2.8,3.6
8486,0,North America,Digital,Communications,Far Below,Male,37,4,1,5,,2.6,3,1,1,1,1,3.7,1.4,2.4
8487,1,Asia Pacific,Digital,Medical Affairs,Far Exceeds,Female,39,7,1,9,,3.1,3.4,1,1,1,1,3.4,4,3.9
8488,0,Latin America,Manufacturing,Sales,Meets,Female,47,15,0,5,3.8,3.4,1.3,0,0,0,0,3.7,2.1,1.3
8489,0,Middle East & Africa,HR,Clinical Operations,Meets,Female,44,3,1,9,,2.5,3.5,1,1,1,1,3.1,3.4,1.2
8490,0,Europe,R&D,Supply Chain,Exceeds,Female,38,10,1,10,,3.3,3.5,1,1,1,1,2.9,4.2,3.4
8491,0,North America,Digital,Quality Assurance,Meets,Non-Binary/Other,31,9,0,6,4.2,3.5,2.3,1,1,1,1,4.5,2.3,2.2
8492,0,Middle East & Africa,Digital,Communications,Meets,Male,49,9,0,7,4.4,2.4,1.4,1,1,1,1,3.7,3.5,2.2
8493,0,Europe,R&D,Marketing,Meets,Male,39,7,0,5,2.4,2.1,3,1,1,1,1,3.5,1.9,3.5
8494,0,Latin America,Commercial,Pharmacovigilance,Meets,Non-Binary/Other,35,19,0,10,2.8,3.2,2.5,1,1,1,1,3.1,2.8,2.2
8495,0,Latin America,Commercial,Data Science,Meets,Female,41,8,0,8,4.1,3.1,2.8,1,1,1,1,3.6,2.3,2.3
8496,0,Middle East & Africa,Digital,Regulatory Affairs,Meets,Female,28,12,1,7,,2.5,2.8,1,1,1,1,4,3,3.1
8497,0,Europe,Commercial,Sales,Meets,Female,42,36,0,7,3.9,3.3,3.7,1,1,1,1,3.1,2.6,4.2
8498,0,Latin America,Finance,Finance & Accounting,Exceeds,Female,42,7,0,11,1,3.6,2.7,1,1,1,1,2.4,2.6,2.9
8499,0,Middle East & Africa,R&D,Pharmacovigilance,Meets,Female,40,27,0,7,2.3,2.3,1.7,1,1,1,1,1.9,3.7,2.5
8500,1,Latin America,Digital,Human Resources,Meets,Female,44,7,1,9,,2.8,4.3,1,0,0,0,4.2,2.5,3.9
8501,0,Latin America,R&D,Clinical Operations,Meets,Male,40,11,0,8,4.6,3.2,3,1,1,1,1,3.3,4.4,3.6
8502,0,Latin America,Commercial,Clinical Operations,Meets,Female,42,31,0,10,2.8,4.3,1.1,1,1,1,1,4.2,1.6,2.2
8503,0,Asia Pacific,R&D,Market Access,Meets,Female,42,36,0,10,3.3,3.4,4.3,1,1,1,1,4.9,3.4,3.8
8504,0,Europe,Commercial,Data Science,Meets,Female,44,20,0,9,2.4,3.7,2.8,1,1,1,1,3,5,1.7
8505,0,Middle East & Africa,Commercial,Market Access,Far Below,Male,36,8,0,11,4.6,2.2,2.6,0,0,0,0,3.9,2.8,3.7
8506,1,Middle East & Africa,R&D,Data Science,Meets,Female,41,16,0,7,2.4,4.8,1.7,1,1,1,1,3.7,5,3.3
8507,0,Europe,Commercial,Sales,Far Exceeds,Male,35,4,1,10,,2.2,2,1,1,1,1,3.9,2.9,3.4
8508,0,Europe,Finance,Medical Affairs,Below,Non-Binary/Other,40,23,0,11,2.5,3.8,3,1,1,1,1,2,4.9,2.5
8509,0,Europe,Manufacturing,Marketing,Meets,Female,38,36,0,8,1.3,3.2,1,0,0,0,0,1.2,3.3,2.1
8510,0,Europe,R&D,IT & Digital,Meets,Male,33,9,1,5,,2.7,3.1,1,1,1,1,2.5,2.7,1
8511,1,North America,Manufacturing,Quality Assurance,Exceeds,Female,41,11,0,5,3.2,2.6,3,1,1,1,1,2.6,1.2,3
8512,0,Middle East & Africa,R&D,Quality Assurance,Meets,Female,28,7,1,8,,3.6,1.4,1,1,1,1,2.7,2.5,1.8
8513,0,North America,Commercial,Communications,Exceeds,Male,31,22,0,9,3.5,2.3,2.8,1,1,1,0,3,2.6,4
8514,0,Latin America,Commercial,Human Resources,Meets,Male,42,17,0,11,2.4,2.8,2.6,1,1,0,0,3.2,2.1,2.7
8515,0,Latin America,Digital,Medical Affairs,Exceeds,Female,34,18,0,11,3.1,1.9,2.5,1,1,1,1,3.7,1.4,2.1
8516,0,Middle East & Africa,Finance,Clinical Operations,Meets,Female,41,5,0,8,4.3,2.8,2.7,1,1,1,1,4,3.7,2.9
8517,0,Latin America,Digital,Finance & Accounting,Meets,Male,52,2,0,7,3.9,3.7,2.4,1,0,0,0,2.3,2.6,2.7
8518,1,Europe,Manufacturing,Legal & Compliance,Exceeds,Female,28,20,0,9,3.8,3.2,2.9,0,0,0,0,4.5,3.2,1.3
8519,0,North America,Commercial,Legal & Compliance,Meets,Male,40,10,1,12,,2,2.5,1,1,1,1,3.5,2.6,1.8
8520,0,Europe,Digital,Supply Chain,Exceeds,Male,49,7,0,9,3.8,3.1,4.2,1,1,1,0,4.1,4.5,5
8521,1,Latin America,Commercial,Marketing,Meets,Male,39,10,1,5,,5,1.4,1,0,0,0,3.8,2.6,2.3
8522,0,North America,R&D,Sales,Meets,Male,38,4,0,8,2,1.8,1,1,1,1,0,3.3,3.3,1.4
8523,1,Europe,Digital,Medical Affairs,Meets,Female,36,31,0,8,4.1,3.3,1.1,0,0,0,0,4.7,1.1,3.1
8524,0,Middle East & Africa,Manufacturing,Marketing,Meets,Non-Binary/Other,33,10,0,12,3.6,4,1,1,1,0,0,3.1,3.5,1.4
8525,0,Europe,Digital,Quality Assurance,Below,Male,28,19,0,12,3.9,1.9,2.5,1,1,1,1,3.8,2.7,2.6
8526,0,Latin America,Commercial,Marketing,Far Below,Male,35,21,0,7,3.5,2.6,1.9,1,1,1,1,2.8,4.8,2.8
8527,0,North America,HR,Data Science,Exceeds,Non-Binary/Other,38,17,0,11,4,4.2,3.5,1,1,1,1,3.6,3.1,2.8
8528,0,Middle East & Africa,HR,Pharmacovigilance,Exceeds,Male,39,15,0,6,3.5,2.2,2.7,0,0,0,0,4.2,3.3,3.7
8529,0,North America,Finance,Data Science,Below,Male,44,17,1,6,,3.7,2.3,1,1,1,1,3.3,2.8,3.2
8530,0,Middle East & Africa,Commercial,Medical Affairs,Meets,Male,43,6,0,8,4.8,3.8,3,1,1,1,1,3.5,3.4,2.6
8531,0,North America,R&D,Finance & Accounting,Meets,Female,39,5,1,11,,2.4,2.2,1,1,1,1,2.2,1.8,2.1
8532,0,Latin America,Digital,Sales,Meets,Male,40,10,0,5,4.7,3.1,3.5,1,1,1,1,3.5,2.4,4
8533,0,Middle East & Africa,HR,Human Resources,Meets,Female,38,17,0,12,3.8,5,1,1,1,1,1,4.3,5,1.7
8534,1,Asia Pacific,R&D,Regulatory Affairs,Meets,Female,33,14,1,11,,2.6,1.8,1,1,1,1,3.4,3.5,1.7
8535,0,North America,Commercial,Human Resources,Meets,Male,44,9,1,11,,4.4,2.6,1,1,1,1,3.3,3.9,3.7
8536,0,North America,R&D,Market Access,Meets,Male,37,13,0,10,2.8,3.7,2.9,1,1,1,1,3.1,4.8,2.4
8537,0,Europe,Commercial,Communications,Meets,Female,40,11,0,10,2.8,3.2,3.1,1,1,1,1,3,3.2,2.7
8538,0,Middle East & Africa,Finance,Human Resources,Meets,Female,54,3,0,6,3.1,3.4,4,1,1,1,1,2.7,4.5,4.9
8539,0,Asia Pacific,Digital,Market Access,Meets,Female,43,10,0,7,1.6,4,2.9,1,1,1,1,2.6,4.5,1.4
8540,0,Latin America,R&D,Regulatory Affairs,Meets,Male,37,12,0,7,2.5,2.5,3.5,1,1,1,1,2.9,2.9,3.8
8541,0,Europe,Digital,Marketing,Meets,Male,29,5,0,10,4.2,3.1,5,1,0,0,0,5,3.4,3.3
8542,0,Asia Pacific,R&D,Communications,Meets,Female,45,11,0,5,4.1,1,3.8,1,1,1,1,3.2,3.7,3.5
8543,0,Middle East & Africa,Commercial,Legal & Compliance,Meets,Male,28,16,1,7,,5,2.9,1,1,1,1,3.8,2.4,2.4
8544,0,Asia Pacific,Commercial,Regulatory Affairs,Meets,Female,35,6,0,10,5,3,1.5,1,1,1,1,3.4,2.6,1
8545,0,North America,R&D,Market Access,Meets,Male,28,10,0,7,2.7,3.8,4.1,1,1,1,1,3.7,3.4,3.8
8546,0,North America,Finance,Clinical Operations,Meets,Female,35,5,0,12,3.7,3.8,4.3,1,1,0,0,4.1,2.9,3.6
8547,0,Europe,Commercial,Quality Assurance,Meets,Male,35,17,0,6,3.9,3.3,3.6,1,1,1,1,3.5,3.3,3.6
8548,0,Middle East & Africa,Manufacturing,Market Access,Meets,Female,39,9,1,11,,2.6,4.7,1,1,1,1,2.4,2.2,2.9
8549,0,Middle East & Africa,Manufacturing,Legal & Compliance,Meets,Female,37,14,1,6,,2,2.7,0,0,0,0,3.3,2.7,2.3
8550,0,Asia Pacific,Digital,Market Access,Meets,Male,44,4,0,11,3.3,1.8,2.9,1,1,1,1,3.9,2.1,3.4
8551,0,Europe,Manufacturing,Finance & Accounting,Meets,Male,42,8,1,6,,2.3,3.7,1,1,1,1,3.5,3.6,2.9
8552,0,Middle East & Africa,Manufacturing,Clinical Operations,Far Below,Female,43,8,0,7,5,3.5,2.9,1,1,1,1,4.2,4.4,2.7
8553,0,North America,Finance,Market Access,Meets,Female,30,20,0,7,3.2,3.9,5,1,1,1,1,2.9,4.7,2.9
8554,0,Asia Pacific,Finance,Legal & Compliance,Below,Female,37,10,0,12,3.7,2.8,4.7,1,1,1,1,4.2,3,3.7
8555,0,Latin America,HR,Marketing,Meets,Male,42,18,0,5,3,3.2,2.8,1,1,1,1,2.8,1.5,1.2
8556,0,North America,HR,IT & Digital,Meets,Female,39,8,0,11,5,3.1,1.5,1,1,1,0,3.2,3.3,1.8
8557,0,Europe,Finance,Legal & Compliance,Meets,Male,34,11,1,9,,2.4,3.5,1,1,1,1,4.2,1.4,2.5
8558,0,Middle East & Africa,HR,Clinical Operations,Meets,Male,33,5,1,5,,3.7,3.3,1,1,1,1,1.9,4.4,3.3
8559,0,North America,Finance,Quality Assurance,Meets,Male,49,9,0,7,2.6,3.9,3.4,1,1,1,1,3.5,3.8,2.8
8560,0,Latin America,HR,Legal & Compliance,Meets,Male,41,7,1,9,,1,2.9,1,1,1,1,3,2,3.7
8561,0,Latin America,Commercial,Sales,Meets,Male,28,6,1,12,,4.3,3,1,1,1,1,3.4,3.4,5
8562,0,Europe,Finance,Data Science,Below,Female,30,9,0,12,4.1,2.5,2.1,1,1,1,1,4.8,3.5,2.2
8563,0,North America,Digital,Sales,Meets,Male,28,12,0,11,4.2,4.1,3.6,1,1,1,1,4.2,2.9,3.5
8564,0,Asia Pacific,Digital,Communications,Below,Male,30,10,0,5,3.1,3.5,1,1,1,1,1,4.1,3.2,2.9
8565,0,North America,Finance,Finance & Accounting,Below,Male,31,6,1,11,,3.3,3,1,1,1,1,3.8,2.3,2.9
8566,0,Latin America,Manufacturing,Clinical Operations,Below,Female,45,6,1,6,,2.7,3.9,1,1,1,1,2.3,3.3,3.7
8567,0,Europe,Digital,Clinical Operations,Meets,Male,41,8,0,7,3.7,1.9,1.9,1,1,1,1,3.3,2.7,2.4
8568,0,Europe,Manufacturing,IT & Digital,Exceeds,Male,33,14,0,11,2.1,1.8,3.5,1,1,1,1,2.6,2.2,2.2
8569,0,Asia Pacific,Digital,Legal & Compliance,Meets,Male,33,7,1,5,,1.2,2.6,1,1,1,1,4.3,1.3,3.3
8570,0,Europe,R&D,Medical Affairs,Meets,Male,34,7,0,6,3,3.2,1.4,0,0,0,0,4.7,3.5,2.1
8571,0,Europe,R&D,Pharmacovigilance,Far Exceeds,Male,33,5,0,7,3.4,2.9,1,1,1,1,1,3.6,4.5,1
8572,0,Europe,Finance,Legal & Compliance,Meets,Female,36,36,0,8,3,4,1,1,1,1,1,2.7,4.1,3
8573,1,Europe,Digital,Pharmacovigilance,Meets,Male,33,7,1,10,,3.4,2.8,1,1,1,1,3.4,3.3,3.2
8574,0,Europe,Commercial,Clinical Operations,Exceeds,Male,37,13,0,6,4.4,3.1,4.6,1,1,1,1,5,4,3.9
8575,0,Latin America,Manufacturing,Data Science,Exceeds,Male,30,12,0,9,4.5,2.4,1.9,1,1,1,1,4.3,2.3,1.8
8576,0,North America,Digital,Finance & Accounting,Below,Female,38,29,0,12,3,3.7,1.2,1,1,1,1,2.8,2.7,2
8577,0,Middle East & Africa,Finance,IT & Digital,Meets,Female,39,14,0,6,4.2,2.1,3.9,1,1,1,1,4.2,1.8,3.7
8578,0,Europe,Manufacturing,Medical Affairs,Meets,Female,32,13,0,12,1.3,3,1.6,1,1,1,1,3.6,2.5,1.4
8579,1,Middle East & Africa,HR,Regulatory Affairs,Meets,Non-Binary/Other,34,9,0,5,3.8,4.5,1.3,0,0,0,0,3.7,3.8,3.5
8580,0,Middle East & Africa,Finance,Supply Chain,Meets,Female,37,9,0,6,2.2,3.6,2.3,0,0,0,0,1.9,5,2.3
8581,0,Latin America,Digital,Data Science,Meets,Male,43,9,0,9,4.2,1.9,4.3,1,1,1,1,3.2,4.3,3.7
8582,0,Europe,Commercial,Clinical Operations,Below,Male,45,22,0,10,4.4,2.8,2.1,0,0,0,0,4.1,3.5,3.8
8583,0,Middle East & Africa,HR,Clinical Operations,Below,Female,37,4,0,8,3.9,2.2,1,1,1,1,1,3.1,3,1
8584,0,Europe,Finance,Data Science,Below,Male,40,5,0,6,3,3.6,4.5,1,1,1,1,2.8,4,3.1
8585,0,Asia Pacific,Digital,Marketing,Meets,Female,37,8,1,9,,3.2,2.8,1,1,1,1,2,3.9,3.1
8586,0,Asia Pacific,R&D,Medical Affairs,Below,Female,45,19,0,11,3.4,4.2,3.7,1,1,1,1,2,3,2.3
8587,1,Asia Pacific,Digital,Clinical Operations,Exceeds,Female,48,4,0,6,3.2,4.5,1.9,1,1,1,1,3.4,2.8,2.1
8588,0,Middle East & Africa,R&D,Supply Chain,Meets,Male,43,27,0,8,3.3,2.4,2.3,1,1,1,1,4.6,2.7,1.5
8589,0,Asia Pacific,R&D,Regulatory Affairs,Below,Female,41,3,1,9,,3.6,2.3,0,0,0,0,1.7,2.6,1.3
8590,0,Latin America,Finance,IT & Digital,Meets,Male,41,2,0,9,4.3,2.3,1,0,0,0,0,4.2,3.2,1.8
8591,0,Latin America,Digital,Sales,Meets,Female,39,18,0,10,2.7,3.9,3.1,1,1,1,1,2.2,1,3.1
8592,0,Middle East & Africa,Digital,Quality Assurance,Meets,Male,33,6,1,12,,3.6,2.4,1,1,1,1,1,3.5,3.1
8593,0,Europe,R&D,Supply Chain,Meets,Male,35,8,0,10,3.3,3.4,2.4,1,1,1,1,4.2,4.3,2.5
8594,0,North America,Manufacturing,Human Resources,Below,Female,40,15,0,11,3.3,2.8,3,1,1,1,1,3,1.7,4.9
8595,0,Europe,HR,IT & Digital,Meets,Male,35,3,0,7,3.4,3.1,3.2,1,1,1,1,2.3,1.7,3.2
8596,0,Europe,Commercial,Quality Assurance,Meets,Male,30,19,0,7,3.6,1.5,3.1,1,1,1,1,3.5,2.5,2.8
8597,0,Europe,Digital,Finance & Accounting,Meets,Male,37,12,0,10,3.4,4.1,2.3,1,1,1,1,4,3.7,1.8
8598,0,Europe,HR,Market Access,Far Exceeds,Female,28,7,0,10,2.6,1,1.7,1,0,0,0,2.7,2.4,1
8599,0,North America,HR,Legal & Compliance,Exceeds,Female,49,4,1,10,,4.4,3.6,1,0,0,0,3,3.4,5
8600,0,Asia Pacific,Manufacturing,Human Resources,Exceeds,Male,35,17,0,10,4.6,1.9,1.2,1,1,1,1,4.4,2,1.7
8601,0,Europe,HR,Marketing,Below,Male,38,10,0,9,3.3,4.2,2.9,1,1,1,0,5,3.9,3.2
8602,0,Latin America,Digital,Supply Chain,Meets,Female,45,18,0,12,3.5,2.7,2.9,1,0,0,0,2.5,2,4.3
8603,0,Middle East & Africa,Finance,Pharmacovigilance,Exceeds,Male,53,11,0,10,4.4,3,1.6,0,0,0,0,5,2.7,1.1
8604,0,Middle East & Africa,Finance,Marketing,Meets,Female,37,6,1,7,,2.8,2.1,1,1,1,1,2.7,2.1,2.5
8605,0,Latin America,HR,Pharmacovigilance,Below,Male,33,9,0,5,3.2,2.1,3.5,1,1,1,1,3.6,2,4.4
8606,0,Europe,Digital,Communications,Meets,Male,42,10,0,5,4.3,2.3,1.8,1,1,1,1,5,1,2.1
8607,0,North America,Digital,Finance & Accounting,Far Below,Male,38,10,1,10,,5,3.1,1,1,1,1,3.5,4.3,3.1
8608,0,Asia Pacific,R&D,IT & Digital,Meets,Male,37,16,0,7,4,2,1.6,0,0,0,0,2.4,4,1.9
8609,0,Middle East & Africa,Manufacturing,Regulatory Affairs,Exceeds,Female,39,16,0,10,1.4,3.6,2.4,1,1,1,1,1.5,4.8,2.8
8610,0,Asia Pacific,Commercial,Finance & Accounting,Meets,Male,41,7,0,5,2.7,2.4,2.2,1,1,1,1,2.7,2.4,1.7
8611,0,North America,R&D,Regulatory Affairs,Meets,Female,50,12,1,10,,4,3.1,1,1,1,1,2.8,3.6,2.7
8612,0,Middle East & Africa,Commercial,Legal & Compliance,Meets,Female,30,14,0,11,4.5,3.1,2.2,1,1,1,1,4.6,3.6,2.4
8613,0,Asia Pacific,Digital,Regulatory Affairs,Exceeds,Male,50,16,0,7,3.8,3.8,3,0,0,0,0,4.3,3.1,1.8
8614,0,North America,Finance,Marketing,Meets,Female,37,8,0,7,3.3,3.5,1.3,1,1,1,1,3.3,2.2,2.9
8615,0,Asia Pacific,R&D,Regulatory Affairs,Meets,Male,43,9,1,7,,2.4,2.9,1,1,1,1,3.2,3.1,2.3
8616,0,Europe,HR,Data Science,Meets,Female,39,20,0,7,3,2.7,2.5,0,0,0,0,3.8,2.5,2.9
8617,0,North America,HR,Finance & Accounting,Meets,Male,38,8,0,11,5,2.9,1.6,1,1,1,1,4.8,3.4,1.8
8618,1,Asia Pacific,Commercial,Quality Assurance,Meets,Male,39,12,0,9,3.3,2.7,1.8,1,1,1,1,3.5,3.4,1
8619,0,Europe,Digital,Quality Assurance,Meets,Female,33,2,1,7,,2.2,2.6,1,1,1,1,4.1,1.9,3.1
8620,0,Europe,Finance,Human Resources,Far Exceeds,Non-Binary/Other,48,18,0,9,2.3,4.3,1.9,1,1,0,0,3.4,4.3,3.3
8621,0,North America,Commercial,IT & Digital,Far Below,Female,41,16,1,8,,3.6,1.8,1,1,1,1,5,2.5,3.2
8622,0,Latin America,Finance,Medical Affairs,Far Below,Male,40,7,0,11,3.3,2.7,4.2,1,1,1,1,2,3.9,4.2
8623,0,Middle East & Africa,Manufacturing,Pharmacovigilance,Meets,Female,36,23,0,6,3,2.1,2.7,0,0,0,0,3.1,2.3,2.7
8624,0,North America,Finance,Quality Assurance,Meets,Female,30,27,0,7,2.2,2.9,3.8,1,1,1,1,3,2.9,5
8625,0,Europe,HR,Clinical Operations,Meets,Male,42,9,0,10,2.5,1.7,2,1,1,1,1,3.2,1.7,2.5
8626,0,Europe,R&D,Quality Assurance,Far Exceeds,Male,42,6,0,6,4.3,3.5,2.5,1,1,1,1,2.3,3.3,3.1
8627,0,North America,R&D,Clinical Operations,Below,Female,42,16,1,8,,2.7,1.4,1,1,1,1,1.8,2.3,3.3
8628,0,Latin America,R&D,Communications,Far Below,Female,39,13,0,11,2.3,2.6,4.1,1,1,1,1,2.1,2.4,3.3
8629,0,Middle East & Africa,Finance,Medical Affairs,Below,Female,37,28,0,10,3,4.2,1.9,1,1,1,1,4.5,3.2,2.2
8630,0,Asia Pacific,HR,Market Access,Exceeds,Male,45,12,0,8,3.7,2.6,3.2,1,1,1,1,3.7,3.9,2.8
8631,0,North America,Finance,Marketing,Below,Female,41,5,0,6,3.4,4.7,2.7,1,1,1,1,2.3,5,2.4
8632,0,Middle East & Africa,Digital,Supply Chain,Meets,Male,40,12,1,12,,2.2,4.4,1,1,1,1,2.6,3.3,4.4
8633,0,Middle East & Africa,HR,Market Access,Meets,Female,29,15,0,8,2.8,2.2,3.5,1,1,1,1,2.1,2.1,2.8
8634,0,Europe,HR,Finance & Accounting,Meets,Female,28,12,0,12,2.8,2.8,2.7,1,1,0,0,4,3.2,2
8635,0,Asia Pacific,Finance,Medical Affairs,Below,Male,52,12,0,11,3.2,3.1,2.2,1,1,1,1,3.8,3.6,2.2
8636,0,North America,Finance,Quality Assurance,Meets,Female,43,11,0,5,2.6,2.3,3.9,1,1,1,1,3,2.3,3.7
8637,0,Europe,R&D,Quality Assurance,Meets,Male,46,12,1,10,,4.5,1,1,1,1,1,3,5,1
8638,0,Europe,HR,Legal & Compliance,Exceeds,Male,28,17,0,5,4.4,3.4,2.2,1,1,1,1,3.7,2.9,1.5
8639,1,Latin America,R&D,Legal & Compliance,Exceeds,Male,44,14,0,11,4.2,2.2,3.6,1,1,1,1,4.6,1.1,2.1
8640,0,Middle East & Africa,Digital,Legal & Compliance,Meets,Female,36,9,1,8,,2.6,2.2,1,1,1,1,3.2,3,2.3
8641,0,North America,Manufacturing,Pharmacovigilance,Far Exceeds,Male,39,6,0,12,2.5,3.4,2.3,1,1,1,1,5,4.3,1
8642,0,North America,R&D,Legal & Compliance,Below,Male,41,9,1,9,,2.9,3.8,1,1,1,1,4.5,3.8,5
8643,0,North America,Finance,Marketing,Meets,Male,39,8,0,11,3.5,2.3,5,1,1,1,1,3.4,2.1,5
8644,0,Europe,Commercial,Medical Affairs,Meets,Female,39,9,0,5,3.5,4,2.3,0,0,0,0,2.3,5,1.7
8645,0,Latin America,Manufacturing,Regulatory Affairs,Meets,Male,33,10,0,11,4.6,4.8,1.5,1,1,1,1,4.3,2.2,2.4
8646,0,Asia Pacific,Digital,Communications,Below,Female,42,6,1,10,,3,2.7,1,1,1,1,4.7,2.3,2.8
8647,0,Europe,Finance,Supply Chain,Meets,Female,33,18,0,9,4,3.5,3,1,1,1,1,3.5,2.8,3.2
8648,0,Asia Pacific,Manufacturing,Market Access,Below,Female,33,6,1,6,,4.3,2.6,1,1,1,1,3.6,3.4,4.8
8649,0,Latin America,Finance,Data Science,Meets,Female,39,16,0,9,3.2,2.4,2.1,1,1,1,1,3.3,2.9,2.6
8650,0,Middle East & Africa,R&D,Human Resources,Meets,Male,30,15,0,9,4.5,4.8,2.9,1,1,1,1,3.6,2.6,3
8651,0,North America,Finance,Finance & Accounting,Meets,Male,45,9,1,9,,2,2.2,1,1,1,1,5,2.4,1
8652,0,Asia Pacific,Digital,IT & Digital,Meets,Male,45,16,0,5,3.1,3.5,1.6,1,1,1,1,3.2,3.9,2.1
8653,0,Europe,Commercial,Data Science,Meets,Female,35,11,0,12,3.8,2.4,2.4,1,1,1,1,4.2,3,3.2
8654,0,Asia Pacific,R&D,Data Science,Meets,Female,36,4,0,6,3.9,2,3,1,1,1,1,3.2,2.7,1.8
8655,0,Middle East & Africa,R&D,Medical Affairs,Below,Female,38,11,1,8,,2.5,3.8,1,1,1,1,3.3,3.7,3.4
8656,0,North America,Digital,Regulatory Affairs,Far Below,Female,28,6,0,9,4.3,2.7,4.2,1,1,1,1,3.3,2.4,2.8
8657,0,Asia Pacific,Digital,Finance & Accounting,Meets,Non-Binary/Other,29,28,0,5,1.1,2.5,2.6,1,1,1,1,3.5,2.9,2.9
8658,0,Middle East & Africa,Manufacturing,Finance & Accounting,Exceeds,Male,42,7,0,7,3.9,4,2,1,1,1,1,2.2,3.8,3.9
8659,0,Europe,Commercial,Sales,Meets,Male,40,8,0,6,3.2,3.1,2.8,1,1,1,1,5,1.5,1.5
8660,0,Latin America,Finance,Data Science,Meets,Male,36,10,0,7,3.5,3.7,3.2,1,1,1,1,2.7,1.3,3
8661,0,Europe,Manufacturing,Market Access,Exceeds,Female,35,5,1,10,,3.7,1.1,1,1,1,1,1.9,4.6,2.3
8662,0,North America,Finance,Sales,Exceeds,Male,42,9,0,11,2.6,3,2.4,1,1,1,1,2.1,4.1,2.8
8663,0,Europe,Finance,IT & Digital,Meets,Female,28,6,1,11,,1.9,2.3,1,1,1,1,3.9,2.9,1.6
8664,0,Europe,Finance,Finance & Accounting,Meets,Female,49,5,1,11,,3.9,3.4,1,1,1,1,3.7,2.6,4.2
8665,0,Europe,Manufacturing,Supply Chain,Exceeds,Female,44,22,0,12,2.1,2.3,2.9,0,0,0,0,2.4,3.9,1.6
8666,0,Europe,R&D,Pharmacovigilance,Exceeds,Male,36,10,0,10,3.4,4.6,2.8,1,1,1,1,2.6,2.4,1.7
8667,1,North America,Digital,Regulatory Affairs,Meets,Male,40,14,1,10,,4.1,4.4,1,1,1,1,4.8,4.2,2.9
8668,1,Middle East & Africa,R&D,Pharmacovigilance,Meets,Male,46,6,1,8,,3.1,2.1,1,1,1,1,4.4,3,4.4
8669,0,Asia Pacific,Commercial,Market Access,Meets,Non-Binary/Other,32,7,0,7,3.4,1,2.1,1,1,1,1,2.2,1.7,2.6
8670,0,Latin America,Manufacturing,Marketing,Meets,Male,46,8,0,7,3,3.4,3.1,1,1,1,0,3.1,2.6,4.9
8671,0,Asia Pacific,Commercial,IT & Digital,Exceeds,Female,38,8,1,9,,5,1.9,1,1,1,1,2.6,4.1,4
8672,0,Asia Pacific,Digital,Marketing,Meets,Non-Binary/Other,42,12,1,10,,2.9,2.8,1,0,0,0,4.4,1.6,4.4
8673,0,Latin America,Digital,Human Resources,Meets,Male,43,10,0,9,3.9,2.5,4.5,1,1,1,1,3.5,3.5,5
8674,0,North America,HR,Data Science,Meets,Male,39,32,0,9,3.1,3.1,3.9,1,1,1,1,3.6,3.7,3.5
8675,0,Latin America,Commercial,Legal & Compliance,Exceeds,Female,45,12,0,12,2.7,3.6,1.7,1,1,1,1,3.1,3.4,2.1
8676,0,North America,R&D,Market Access,Meets,Female,35,8,1,5,,4,1,1,1,1,1,2.3,4.2,2.6
8677,0,Asia Pacific,Commercial,Finance & Accounting,Meets,Female,38,8,1,11,,2.9,1,1,1,1,1,3.5,3.2,3.2
8678,0,North America,Manufacturing,Pharmacovigilance,Below,Male,33,14,0,12,4.3,2.3,3,1,1,1,1,2.8,2.4,3.1
8679,0,Middle East & Africa,Digital,Medical Affairs,Meets,Male,34,14,0,8,2.7,4.9,1.9,1,1,1,1,4.2,3.5,3.6
8680,0,Latin America,Digital,Sales,Below,Male,39,35,0,11,2.9,1.5,2.4,1,1,1,1,2.5,2,4.4
8681,0,Middle East & Africa,Commercial,Data Science,Meets,Female,43,6,0,10,3.2,4,2.2,1,1,1,1,4.4,3.7,2.7
8682,0,Asia Pacific,Commercial,Sales,Meets,Male,30,16,0,12,2.6,3.7,2.6,1,1,1,1,4,3.7,3.6
8683,0,Latin America,Finance,Quality Assurance,Meets,Female,40,17,0,6,5,3.9,1.9,1,1,1,1,3.3,3.2,1.4
8684,0,Asia Pacific,Commercial,Quality Assurance,Exceeds,Female,45,6,0,11,3.8,2.4,2,1,1,1,1,3.5,3.8,2.3
8685,0,Middle East & Africa,Finance,Legal & Compliance,Far Below,Female,46,8,1,6,,2.1,5,1,1,1,1,3.7,3.5,3.1
8686,0,Asia Pacific,Manufacturing,Quality Assurance,Meets,Male,37,8,0,9,2.3,3.2,2.5,1,1,0,0,3.1,4.6,1.7
8687,0,Latin America,Manufacturing,Marketing,Below,Male,32,11,0,9,3.1,2.3,2.8,1,1,1,0,2.3,4.8,3.9
8688,0,Latin America,R&D,Communications,Below,Female,42,22,0,10,4,2.2,2.5,1,0,0,0,3.1,2.4,1.4
8689,0,Asia Pacific,Commercial,Communications,Below,Male,41,19,0,5,3.6,2.6,3.3,1,1,1,1,4.6,3,1.4
8690,1,Latin America,R&D,Clinical Operations,Meets,Male,38,12,1,12,,3.1,4,1,1,1,0,3.3,2.5,5
8691,0,Latin America,HR,Human Resources,Meets,Female,36,17,0,5,3.9,3.8,1,0,0,0,0,3.1,4.7,1.6
8692,0,Asia Pacific,Manufacturing,Market Access,Exceeds,Female,40,27,0,6,2.8,2.1,1.8,1,1,1,1,2.3,3,3
8693,0,Middle East & Africa,Digital,IT & Digital,Far Below,Male,41,23,0,12,3.3,4.8,3,1,1,1,1,3.4,4.1,2.7
8694,0,Latin America,Finance,Marketing,Meets,Female,36,12,0,10,3.7,1,3.9,1,1,1,1,3.5,1.7,3.5
8695,0,Latin America,HR,IT & Digital,Far Exceeds,Male,37,10,1,8,,3.8,1,1,1,1,1,4.6,2.8,1
8696,0,Latin America,Digital,Human Resources,Below,Male,30,15,0,9,1.2,4.1,2,1,1,1,1,3.6,5,2.9
8697,0,Latin America,HR,Market Access,Meets,Male,40,7,0,8,2.6,4.3,2.7,1,1,1,1,3.1,3.3,2.4
8698,0,Asia Pacific,R&D,Supply Chain,Meets,Female,40,1,0,11,3.6,2.9,2.1,0,0,0,0,4.1,3.5,2.4
8699,0,Middle East & Africa,R&D,Legal & Compliance,Meets,Female,31,13,0,5,1.3,2.7,4.1,1,1,1,1,1,1.3,4.3
8700,0,Middle East & Africa,Finance,Pharmacovigilance,Meets,Male,37,9,1,12,,4.9,3.4,1,1,1,1,3.9,2.7,2.7
8701,0,North America,Manufacturing,IT & Digital,Meets,Male,35,6,0,12,3.4,1.3,4.3,1,1,1,1,2.9,3.3,3.5
8702,0,Latin America,Finance,Quality Assurance,Meets,Male,45,10,0,7,3.2,2.5,3,1,1,1,1,2.9,3.2,3.9
8703,0,Latin America,Digital,Human Resources,Meets,Male,30,8,0,12,2.1,2.1,5,1,1,1,1,1.7,2.5,4.1
8704,0,North America,HR,IT & Digital,Below,Female,45,9,1,10,,4,3.2,1,1,1,1,3.6,4.3,2.8
8705,0,Middle East & Africa,Finance,Quality Assurance,Far Exceeds,Male,46,6,0,11,2.2,3.1,2.7,1,1,1,1,2.9,3.9,3.6
8706,0,Europe,Commercial,Communications,Meets,Male,28,12,0,11,4.3,1.6,4.3,1,0,0,0,3.8,1.7,2
8707,0,Europe,Commercial,Supply Chain,Meets,Male,42,11,0,8,5,2.3,2.6,1,1,1,1,3.6,3.3,3.4
8708,0,Middle East & Africa,Manufacturing,Regulatory Affairs,Exceeds,Male,41,22,0,6,4.8,2.7,2.1,1,1,1,1,5,3.6,2.7
8709,0,Latin America,Finance,Clinical Operations,Meets,Male,29,10,1,9,,3.6,1.9,1,1,1,1,4.3,4.6,2.9
8710,0,Europe,Digital,Communications,Below,Female,36,9,1,8,,1.7,2.3,1,1,1,1,3.8,2.4,1.7
8711,0,Asia Pacific,Commercial,Regulatory Affairs,Meets,Male,35,27,0,6,4.1,4.8,1.7,1,1,1,1,3.5,4.7,2.2
8712,0,Asia Pacific,Manufacturing,Communications,Meets,Male,32,15,1,8,,3.4,2.5,1,1,1,1,3.1,3,2
8713,0,North America,Finance,Marketing,Meets,Male,34,7,1,9,,3.7,3,1,1,1,1,2.3,4.5,2.5
8714,0,Middle East & Africa,Manufacturing,Finance & Accounting,Far Exceeds,Female,43,12,0,8,2.3,3.4,3.2,1,0,0,0,3.3,2.1,2.8
8715,0,Middle East & Africa,Digital,Regulatory Affairs,Far Below,Male,39,11,0,9,4.1,3.8,2.4,1,1,1,1,3.9,4.4,3.6
8716,0,Europe,Commercial,Market Access,Meets,Male,34,6,1,6,,1.2,1,1,1,1,1,3.3,1.2,1.3
8717,0,Latin America,Commercial,Medical Affairs,Meets,Male,31,10,1,9,,4.5,3.1,1,1,1,1,4.6,5,4.3
8718,0,Middle East & Africa,Commercial,Communications,Meets,Male,43,13,0,12,2.2,4.3,2.8,1,1,1,1,3.4,3.2,2.7
8719,0,Europe,R&D,Market Access,Meets,Male,48,3,1,5,,3.6,1.4,1,1,1,1,3.5,2.6,2.4
8720,0,Europe,Commercial,Data Science,Exceeds,Male,37,14,0,9,3.1,4.9,2.1,0,0,0,0,2.2,5,3.1
8721,0,Middle East & Africa,HR,Marketing,Below,Male,37,5,1,11,,2.2,3.2,1,1,1,1,3.6,3.6,2.5
8722,0,Europe,R&D,IT & Digital,Far Below,Male,53,16,1,12,,2.2,3.4,1,1,1,1,3.3,1.4,3.9
8723,0,North America,Finance,IT & Digital,Far Exceeds,Male,43,5,0,11,3.4,3,1,1,1,1,1,3,2.8,1.3
8724,0,North America,R&D,Finance & Accounting,Meets,Female,45,5,0,8,2.8,2.4,3.9,1,1,1,1,3.7,3.3,3.7
8725,0,Middle East & Africa,R&D,Legal & Compliance,Far Exceeds,Female,35,8,0,6,2.7,3.2,3.5,0,0,0,0,3.9,2.2,2
8726,0,Latin America,R&D,Quality Assurance,Meets,Male,33,4,1,8,,4.2,3,1,1,1,1,3,3.6,2.4
8727,0,North America,Manufacturing,Human Resources,Below,Female,46,3,0,9,4.1,3.4,2,1,1,1,1,5,2.9,2.2
8728,0,North America,HR,Marketing,Meets,Female,41,26,0,9,4.4,3.4,3.9,1,1,1,1,3.6,4.1,3.5
8729,0,Middle East & Africa,Digital,Regulatory Affairs,Exceeds,Non-Binary/Other,39,10,0,10,2.8,2,1.7,0,0,0,0,3.3,2.1,1.2
8730,1,Asia Pacific,Commercial,Sales,Meets,Female,41,13,0,12,3.5,3,2.9,1,1,1,1,2.8,2.4,3.6
8731,0,Europe,R&D,Human Resources,Below,Female,48,23,0,8,3.6,3,1.7,0,0,0,0,3.7,2.4,1.6
8732,0,North America,Digital,Finance & Accounting,Meets,Female,34,15,0,6,4.5,2.8,1.7,1,1,0,0,3.8,2.1,1.5
8733,0,Asia Pacific,Manufacturing,Marketing,Below,Male,39,9,1,5,,4.2,1,1,0,0,0,4.3,3.4,1.5
8734,0,Latin America,Digital,Pharmacovigilance,Exceeds,Male,34,7,1,10,,3.5,3,1,1,1,1,2.5,3,2.7
8735,0,Asia Pacific,R&D,Marketing,Meets,Male,40,13,0,8,1.7,2.1,2,1,1,1,1,3.5,1.5,2
8736,0,Middle East & Africa,Finance,Market Access,Exceeds,Male,43,10,0,6,3.2,3.1,2.1,1,1,1,1,4,3.9,2.2
8737,0,Latin America,HR,Sales,Meets,Male,40,8,1,11,,4,3.1,1,1,1,1,2.9,4.8,5
8738,0,Latin America,Digital,Clinical Operations,Meets,Male,48,4,0,8,2.6,3.4,4.2,1,1,1,1,2.4,3.2,2.4
8739,0,Asia Pacific,R&D,Market Access,Meets,Male,35,7,0,10,2.1,3.4,2.7,1,1,1,1,2.2,3.2,3.3
8740,0,Middle East & Africa,R&D,Sales,Far Below,Non-Binary/Other,41,7,0,9,3.6,2.3,2.5,1,1,1,1,3.4,2.3,1
8741,0,North America,Commercial,Sales,Exceeds,Male,46,32,0,10,3,4,2.6,1,1,1,1,2.3,2.8,3.9
8742,0,Asia Pacific,Finance,Marketing,Below,Female,36,25,0,8,4.3,2,2.9,1,1,1,1,3.5,3.6,2.2
8743,0,North America,Commercial,Supply Chain,Meets,Female,35,9,0,8,3.1,3,3,1,1,1,1,3.6,2.9,3.7
8744,0,Asia Pacific,Finance,Finance & Accounting,Meets,Female,37,21,0,7,3.4,3.3,3.8,1,1,1,1,3.2,3.5,3.6
8745,0,North America,HR,Finance & Accounting,Exceeds,Female,29,4,0,7,4.7,3.7,1.8,1,1,0,0,3,3.1,1.5
8746,0,Asia Pacific,Commercial,Medical Affairs,Far Below,Female,45,13,0,10,3.5,3.1,1.2,1,1,1,1,2.6,3.5,2.5
8747,0,Latin America,HR,Supply Chain,Meets,Male,39,13,0,11,3.4,3,2,0,0,0,0,3.7,3.9,1.8
8748,0,Europe,Manufacturing,Sales,Meets,Male,28,9,0,11,2.3,1.8,2.3,0,0,0,0,3,4.8,3.2
8749,0,Latin America,Manufacturing,Marketing,Meets,Female,35,12,0,9,3.4,2.8,1.3,1,1,1,1,4.3,4.2,3.5
8750,0,North America,Finance,Medical Affairs,Meets,Male,46,14,0,6,2.8,4,3.8,1,1,1,1,1.7,2.6,2.1
8751,0,Middle East & Africa,Finance,IT & Digital,Meets,Female,36,28,0,7,3.4,3.7,3.3,1,1,1,1,4.5,3.7,2.2
8752,0,Latin America,Commercial,Quality Assurance,Below,Male,47,18,0,12,2,3,2,1,1,1,1,3.3,3.7,2.6
8753,0,Europe,Manufacturing,Pharmacovigilance,Meets,Female,36,12,1,12,,3.9,2.2,1,1,1,0,2.7,3.8,1.8
8754,0,North America,Digital,Regulatory Affairs,Meets,Male,29,17,0,10,2.3,3.6,1.1,1,1,1,1,3.6,2.9,2.2
8755,0,Latin America,Digital,IT & Digital,Exceeds,Non-Binary/Other,28,10,0,12,4.7,5,1,1,1,1,1,4.1,3.9,1.8
8756,0,Asia Pacific,Digital,Human Resources,Meets,Male,51,11,0,10,4.1,2.7,2,1,1,1,1,3.2,3.5,3.1
8757,0,Middle East & Africa,Manufacturing,Medical Affairs,Meets,Female,33,15,0,11,3.3,2.9,2,1,1,0,0,2.9,2.9,1.8
8758,0,North America,Digital,Human Resources,Far Below,Male,34,4,0,5,3.4,2.7,1.5,1,1,1,1,4.9,3.9,3.1
8759,0,Latin America,HR,Quality Assurance,Meets,Female,37,7,1,11,,3.2,3.8,1,1,0,0,3.5,1.8,2.9
8760,0,North America,R&D,Quality Assurance,Far Exceeds,Female,39,2,1,9,,2.5,2.4,1,1,1,1,2.8,2,3.3
8761,0,Asia Pacific,Finance,Communications,Meets,Male,32,13,1,11,,3.2,2,1,1,1,1,3.2,2.1,4.1
8762,0,Europe,Commercial,Pharmacovigilance,Meets,Female,46,17,0,12,5,3.8,2.1,1,1,0,0,5,4.2,2
8763,0,Latin America,HR,Data Science,Meets,Male,40,16,1,5,,4.6,2.7,1,1,0,0,3,3.9,3.4
8764,0,North America,Digital,Clinical Operations,Meets,Male,45,8,0,7,1.9,3.6,1.3,1,1,1,1,2.8,2.5,2.6
8765,0,North America,R&D,Pharmacovigilance,Meets,Female,28,2,1,8,,4.7,3.2,1,1,1,1,3.7,2.2,3.3
8766,0,North America,Commercial,Clinical Operations,Below,Female,41,17,0,9,3.4,2.4,2.2,1,1,1,1,4.2,2.8,1.9
8767,0,Europe,HR,Data Science,Meets,Female,40,7,0,9,2.9,4.4,3.1,1,1,1,1,3.3,4.7,1.5
8768,0,North America,Commercial,Data Science,Meets,Female,38,13,0,9,2.5,3,2.1,1,1,1,1,3.5,3.5,1.1
8769,0,Middle East & Africa,Finance,Pharmacovigilance,Meets,Female,35,26,0,8,1.9,1.1,3.3,0,0,0,0,3.8,1.6,2.2
8770,0,Middle East & Africa,Manufacturing,Communications,Meets,Female,29,3,1,8,,1.1,3.7,1,1,1,1,2.7,2.9,4.1
8771,1,North America,Digital,Clinical Operations,Exceeds,Non-Binary/Other,30,14,0,10,3.7,3.2,3,1,1,1,1,4.9,3.9,2.6
8772,0,Middle East & Africa,HR,Supply Chain,Below,Female,46,16,0,8,4.1,1.7,1.6,0,0,0,0,4.7,1.2,2.4
8773,0,Latin America,HR,Regulatory Affairs,Meets,Male,40,13,0,6,4.9,3.1,1,1,0,0,0,3.3,3.4,1
8774,0,Middle East & Africa,R&D,Supply Chain,Meets,Male,37,8,0,5,4.9,3.3,1,0,0,0,0,3.6,2.6,2.2
8775,0,North America,R&D,Communications,Below,Male,36,18,0,10,2.3,3.2,3,1,1,1,1,4.5,2.7,2.3
8776,0,Asia Pacific,R&D,Communications,Meets,Female,44,4,0,9,2.2,2.6,1,1,1,1,1,3,4.7,1.6
8777,0,Latin America,Commercial,Clinical Operations,Meets,Non-Binary/Other,44,10,0,6,2.6,5,2.7,0,0,0,0,3.1,2.3,2.2
8778,1,Europe,Digital,Finance & Accounting,Meets,Female,33,4,0,8,3.5,3.4,2.6,1,1,1,0,3.5,3.1,2.7
8779,0,North America,Commercial,Market Access,Below,Female,29,23,0,5,2.6,3.8,2.5,1,1,1,1,2.9,4.5,1.9
8780,0,Europe,Digital,Market Access,Meets,Male,40,10,0,12,3.2,3.9,1.9,0,0,0,0,3.3,1.2,1.4
8781,0,Asia Pacific,HR,Quality Assurance,Exceeds,Female,45,14,0,9,3.1,1.7,1.7,1,1,1,1,3.4,3.9,1.5
8782,0,Europe,Commercial,Market Access,Far Below,Female,42,9,1,6,,3.9,3.5,1,1,1,1,2.1,4.2,3.2
8783,0,North America,Commercial,Finance & Accounting,Exceeds,Female,48,17,0,6,3.3,3.8,2.4,1,1,1,1,3,2.5,1.6
8784,0,North America,Commercial,Market Access,Meets,Female,37,10,0,5,4,2.6,3.6,1,1,1,1,2.8,2.6,3.7
8785,0,Asia Pacific,Manufacturing,Regulatory Affairs,Meets,Male,40,7,0,5,3.1,3.6,2.9,1,1,1,1,2.7,4,2.5
8786,0,North America,Finance,Data Science,Meets,Female,38,8,0,11,4.1,3.5,2.5,1,0,0,0,4.8,2.3,3.5
8787,0,Asia Pacific,Digital,Legal & Compliance,Exceeds,Female,43,23,0,10,1.7,3.8,2.2,1,1,1,1,2.1,2.3,2.9
8788,0,Asia Pacific,Digital,Quality Assurance,Meets,Female,34,19,0,5,3,4.4,2.1,1,1,1,1,4.6,3.2,2.1
8789,1,North America,Commercial,Data Science,Far Exceeds,Female,39,14,0,11,3.7,3.7,2.5,1,1,1,1,3.5,4.8,3.7
8790,0,Middle East & Africa,Manufacturing,Clinical Operations,Meets,Male,48,11,0,9,3.2,2.5,2.5,1,1,1,1,4.3,4.7,2.6
8791,0,Asia Pacific,Commercial,Pharmacovigilance,Meets,Male,34,7,0,10,1.8,2.7,3.1,0,0,0,0,3.7,3.2,2.8
8792,0,North America,Digital,Quality Assurance,Far Exceeds,Male,28,11,0,10,2.3,3,2.5,1,1,1,1,3.5,3.2,3.3
8793,1,Middle East & Africa,Finance,Communications,Far Exceeds,Male,41,8,0,5,2.6,2.4,4.2,1,1,1,1,4.2,3.6,3.7
8794,0,Asia Pacific,Finance,Medical Affairs,Below,Female,51,16,0,10,2.4,2.2,3.9,1,1,1,1,1.7,2.8,3.9
8795,0,Middle East & Africa,HR,Quality Assurance,Exceeds,Male,34,11,0,10,3.3,3.1,2.5,1,1,1,1,3,2.3,2.6
8796,0,Latin America,Manufacturing,Legal & Compliance,Meets,Female,46,16,0,7,2.3,1.7,2.4,1,1,1,1,1.3,1.4,2.5
8797,0,Latin America,Finance,Sales,Exceeds,Male,38,17,0,6,4.2,2.5,2.6,1,1,1,1,4.2,2.8,4.1
8798,0,Middle East & Africa,Manufacturing,Data Science,Exceeds,Male,32,4,1,11,,3.3,1.1,1,1,1,1,2.7,2.3,3.1
8799,0,Asia Pacific,Commercial,Clinical Operations,Exceeds,Male,42,36,0,9,2.4,4,2.8,1,1,1,1,1.6,2.5,2.6
8800,0,North America,HR,Finance & Accounting,Exceeds,Male,29,9,0,12,4.1,3,1.4,1,1,1,1,2.6,4.3,2
8801,0,Europe,Digital,Market Access,Below,Male,47,13,1,12,,1.9,1.3,1,1,1,1,3.3,2.4,3
8802,0,North America,Finance,Sales,Below,Male,39,10,0,11,2.5,3,2.8,1,1,1,1,2.6,4.2,1.3
8803,0,Europe,Finance,Human Resources,Below,Male,28,22,0,5,3.8,2.6,3.4,0,0,0,0,3.9,2.7,3
8804,0,Europe,R&D,Marketing,Below,Male,49,9,1,6,,3.1,2.5,0,0,0,0,2.6,1.8,2.1
8805,0,Asia Pacific,Digital,Medical Affairs,Meets,Male,43,4,0,5,3.7,4,5,1,1,1,0,4,3.1,1.4
8806,0,Middle East & Africa,Finance,Supply Chain,Meets,Male,40,15,0,12,3,3,3,1,1,1,1,2.4,2.8,3.9
8807,0,North America,Finance,Data Science,Meets,Male,43,20,0,10,1.6,3.3,2.9,0,0,0,0,2.7,3.2,4.4
8808,0,Middle East & Africa,Digital,Supply Chain,Meets,Male,28,7,1,5,,3.8,2.6,1,1,1,1,3.9,3.3,3
8809,0,Latin America,HR,Legal & Compliance,Exceeds,Female,34,15,0,6,5,4,2.3,1,1,1,1,5,3.6,3.3
8810,0,Asia Pacific,Manufacturing,Clinical Operations,Meets,Male,53,13,1,7,,2.5,2.6,1,1,0,0,5,3.1,2.4
8811,0,Asia Pacific,Digital,Supply Chain,Meets,Female,39,15,0,9,4,3.6,3.9,1,1,1,0,3.6,4.6,2.9
8812,0,Latin America,Manufacturing,Clinical Operations,Meets,Male,34,22,1,6,,3,2.3,1,1,1,1,3,3.8,2.1
8813,0,North America,HR,Finance & Accounting,Below,Non-Binary/Other,39,20,0,10,3.3,2.7,2,1,1,1,1,2.7,4,2.6
8814,0,Latin America,HR,Human Resources,Meets,Male,31,11,0,9,3.7,1.1,1,1,1,1,1,3.2,1.3,2.5
8815,0,North America,Commercial,Clinical Operations,Meets,Female,47,11,1,8,,4.4,3.6,1,1,1,1,2,3.5,2.7
8816,0,Europe,R&D,Regulatory Affairs,Meets,Male,35,18,0,12,2.6,5,4.1,1,1,1,1,1.8,4.8,3.2
8817,0,Asia Pacific,HR,Regulatory Affairs,Meets,Female,29,14,0,6,2.5,2.5,4.4,1,1,1,1,2.6,2.7,1.7
8818,0,North America,HR,Medical Affairs,Meets,Female,39,13,1,12,,3.6,2.6,1,0,0,0,3.1,2.8,3.1
8819,0,Middle East & Africa,Manufacturing,Finance & Accounting,Below,Male,44,10,1,7,,2.7,2.3,1,1,1,1,3.7,4,3.8
8820,0,Middle East & Africa,HR,Clinical Operations,Meets,Male,42,13,1,6,,3.8,3.7,1,1,1,1,2.3,1.8,2.4
8821,0,Asia Pacific,Digital,Medical Affairs,Meets,Non-Binary/Other,30,14,0,5,4,3.2,2.6,0,0,0,0,4,3.2,2.6
8822,0,Latin America,Commercial,Regulatory Affairs,Meets,Female,32,6,0,11,4.8,4.5,1.7,0,0,0,0,3.3,3.7,5
8823,0,Latin America,Commercial,Medical Affairs,Exceeds,Female,28,13,0,9,4.1,3.4,3.5,1,1,1,1,3.9,3.5,3.5
8824,0,North America,Digital,Medical Affairs,Below,Female,42,14,0,10,2.6,1.2,1,1,1,1,1,3.4,4.3,2.7
8825,0,Latin America,Finance,Pharmacovigilance,Meets,Male,41,6,1,11,,1,4.4,1,1,1,1,2.5,3.4,3.2
8826,0,Asia Pacific,HR,Pharmacovigilance,Meets,Female,41,7,1,10,,2.8,1.3,1,1,1,1,4.1,3.3,2.2
8827,0,North America,R&D,Clinical Operations,Meets,Male,35,20,0,9,3.3,1,3.6,1,1,1,1,3.4,2.3,4.3
8828,0,Europe,HR,Sales,Below,Female,28,8,1,8,,3.2,1,1,1,1,1,3.7,2.5,2.4
8829,0,Latin America,Commercial,Supply Chain,Exceeds,Female,33,14,0,8,2.3,3.2,2.8,1,1,1,1,2.9,4.4,3.4
8830,0,Latin America,R&D,Medical Affairs,Below,Male,45,21,0,6,3.1,2.1,1.2,1,1,1,1,3.8,2.1,2.4
8831,0,North America,Finance,IT & Digital,Meets,Female,40,9,1,12,,3.7,2.3,1,0,0,0,2.9,3.4,2.3
8832,0,Middle East & Africa,Manufacturing,Sales,Meets,Male,28,3,0,5,2.9,3.4,2.9,1,1,1,1,3.9,2.8,3.3
8833,0,Latin America,Manufacturing,Regulatory Affairs,Meets,Male,36,21,0,6,3.4,3.3,2,1,1,1,1,3.4,2.9,1.4
8834,0,Asia Pacific,HR,Data Science,Meets,Female,41,5,1,12,,4.1,2.9,1,1,0,0,1.6,5,2.8
8835,0,Latin America,HR,Supply Chain,Below,Female,37,4,1,6,,3.4,3.7,1,1,1,1,4.1,3.4,3.5
8836,0,Europe,R&D,Market Access,Meets,Male,29,5,0,8,2.7,2.1,2.2,1,1,0,0,3.9,2.5,4
8837,0,Latin America,R&D,Finance & Accounting,Far Below,Female,35,17,0,7,2.1,2.8,2.7,1,1,1,1,1,2.7,3
8838,0,Middle East & Africa,Finance,Communications,Exceeds,Male,34,31,0,8,5,2.4,4.4,1,1,1,1,3.7,2.5,5
8839,0,Latin America,HR,Supply Chain,Below,Male,38,9,0,9,3.1,1,2.6,0,0,0,0,2.6,1.6,2.9
8840,1,North America,Commercial,Medical Affairs,Exceeds,Female,40,9,0,5,4.2,4,3.2,1,1,1,1,3.5,4.5,2.3
8841,0,Latin America,Manufacturing,IT & Digital,Exceeds,Male,34,15,0,5,2.4,4.3,2.1,1,1,1,1,2.7,4,1.6
8842,0,Middle East & Africa,Finance,Clinical Operations,Meets,Male,42,6,0,10,2.5,3.6,4.3,1,1,0,0,3.7,1.8,2.5
8843,0,North America,R&D,Clinical Operations,Meets,Male,48,18,0,7,2.2,2.4,2.6,1,1,1,1,2.2,2.1,3.2
8844,0,Asia Pacific,Commercial,Medical Affairs,Meets,Male,55,6,1,12,,2.4,2.3,1,1,1,1,3.9,2,1.8
8845,0,North America,HR,Medical Affairs,Far Exceeds,Male,32,14,0,11,2.6,3.5,2.3,1,1,1,1,3.8,3.2,3.2
8846,0,Europe,Digital,Marketing,Meets,Female,38,7,0,12,3.4,2.6,1.5,1,1,1,1,4.2,3.4,3.2
8847,0,North America,R&D,Supply Chain,Far Exceeds,Male,28,7,0,6,3.3,4.1,1,1,1,1,1,4,3.3,2.5
8848,0,Asia Pacific,Finance,Pharmacovigilance,Meets,Male,35,11,0,9,3.7,5,1.1,1,1,1,1,3.7,3.4,3.2
8849,0,Latin America,Digital,Pharmacovigilance,Exceeds,Male,46,3,0,9,2.7,2.8,2.4,1,1,1,1,1.7,1.7,3.2
8850,0,North America,Commercial,Market Access,Meets,Male,28,14,0,7,2.9,4.6,1.7,1,1,1,0,4.5,5,2.7
8851,1,North America,Manufacturing,IT & Digital,Exceeds,Male,35,19,0,12,5,4.1,3.3,1,1,1,1,3.9,2.7,4
8852,0,North America,Commercial,Communications,Below,Male,38,20,0,7,2.2,2.8,3,1,1,1,1,2.1,3.3,1.7
8853,0,North America,Manufacturing,IT & Digital,Meets,Male,29,24,0,11,3.4,2.5,1,1,1,1,1,3.6,2.2,3
8854,0,Asia Pacific,Commercial,Sales,Meets,Male,40,33,0,5,3.4,3.6,3.5,1,1,1,1,2.9,3.3,3.1
8855,0,Middle East & Africa,R&D,Market Access,Meets,Male,40,6,0,10,2.9,3,3.1,1,1,1,1,1.7,4.6,4.5
8856,0,Middle East & Africa,R&D,Human Resources,Meets,Female,34,5,0,7,2,3.3,2.6,1,1,1,1,3.5,4.7,2.7
8857,0,North America,Finance,Data Science,Meets,Male,42,8,0,7,2.5,4.7,4.4,1,1,1,1,1.2,4.7,4
8858,0,Asia Pacific,Digital,Data Science,Meets,Male,33,8,0,5,2.9,2.4,3.1,1,1,1,1,3.2,2.2,3.3
8859,0,Asia Pacific,Commercial,Communications,Meets,Female,41,10,0,9,2.9,2.3,3.2,1,1,1,1,2.8,3.3,1.9
8860,0,North America,Commercial,Marketing,Meets,Non-Binary/Other,38,11,0,12,2.4,3.3,2.2,1,0,0,0,3.8,2.8,3
8861,0,Europe,Digital,Clinical Operations,Meets,Female,39,7,0,11,3,2.9,3,1,0,0,0,3.4,2.2,3.8
8862,0,North America,HR,Supply Chain,Meets,Female,37,23,0,12,3.5,3.2,1.9,1,1,1,1,2.9,3.5,2.4
8863,0,Europe,Finance,Data Science,Below,Female,30,14,0,12,2.1,3.1,3.2,1,1,1,1,3.1,3.2,2.4
8864,0,North America,Commercial,Sales,Below,Female,30,4,0,12,3.2,2.2,3,1,1,1,0,4,1.9,1.9
8865,0,Europe,Finance,Supply Chain,Meets,Female,33,26,0,11,3.2,2.5,3.5,1,1,1,1,3.3,2.5,3.1
8866,0,Europe,Commercial,Supply Chain,Exceeds,Female,35,21,0,10,3.1,2.9,2.5,1,1,1,1,2.4,3.9,2
8867,0,North America,Commercial,Pharmacovigilance,Meets,Male,40,5,0,8,4.2,2.7,2.7,0,0,0,0,4.6,2,2.1
8868,0,Europe,HR,Clinical Operations,Exceeds,Male,38,22,0,11,4.2,2.9,2.4,1,1,1,1,3.6,3.7,3.1
8869,0,Latin America,R&D,Data Science,Meets,Female,35,8,0,6,3.7,3.3,2,0,0,0,0,2.8,3.1,1.7
8870,0,Middle East & Africa,Finance,Pharmacovigilance,Meets,Female,28,7,0,6,4,3,3.6,1,1,1,0,3.9,2.1,3.2
8871,0,Asia Pacific,Digital,Quality Assurance,Meets,Male,34,14,1,5,,2.1,2.1,1,1,1,0,2.6,2.6,1.4
8872,1,Europe,Finance,Regulatory Affairs,Exceeds,Male,31,11,0,11,3.6,3,3.6,1,1,1,1,3.6,3.2,3.2
8873,0,Europe,HR,Quality Assurance,Meets,Female,48,22,0,8,2.4,4.3,2.8,1,1,1,1,3.4,3,3
8874,0,Asia Pacific,Manufacturing,Quality Assurance,Meets,Female,38,8,0,7,3.2,5,3.5,1,1,1,1,2.4,4.3,3.5
8875,0,Europe,Manufacturing,Regulatory Affairs,Below,Female,47,7,1,12,,4.4,1.2,1,1,1,1,3.6,4.7,3.2
8876,0,Asia Pacific,HR,Quality Assurance,Exceeds,Non-Binary/Other,38,17,0,7,3,1.6,2.9,1,1,1,1,2.9,4.2,2.7
8877,0,North America,HR,Data Science,Meets,Male,49,6,1,11,,2,4.3,0,0,0,0,3.8,3.6,3.6
8878,0,Latin America,R&D,Supply Chain,Exceeds,Male,40,12,0,11,4.2,1.7,1.7,1,1,1,1,5,3.1,3
8879,0,Latin America,Finance,Finance & Accounting,Meets,Male,40,22,0,6,3.2,4.3,2.2,1,1,1,1,3.2,4,3.1
8880,0,Middle East & Africa,Finance,Pharmacovigilance,Below,Female,50,11,0,6,3.2,4.2,2.4,1,1,1,1,3.2,4.4,3.8
8881,0,Europe,Manufacturing,Medical Affairs,Meets,Male,34,11,0,6,3.3,3.4,3,1,1,1,1,3.7,5,3.6
8882,0,Middle East & Africa,Digital,Communications,Meets,Male,34,13,0,12,3,5,2.2,1,0,0,0,3.7,4,2
8883,0,North America,Finance,Human Resources,Exceeds,Male,39,10,1,11,,2.8,3.1,1,1,0,0,4.1,2.7,3.3
8884,0,Latin America,Commercial,Marketing,Meets,Male,55,11,0,12,2.9,3.3,3.7,1,1,1,1,1.9,3.2,4.3
8885,0,North America,Commercial,Pharmacovigilance,Meets,Male,36,11,0,11,2.8,3.4,3.8,1,1,1,1,3.1,2.9,4.4
8886,0,North America,R&D,Human Resources,Meets,Female,40,3,1,7,,1.8,2.3,1,1,1,1,2.8,3.3,4
8887,0,Europe,R&D,Human Resources,Meets,Female,43,19,0,12,2.6,2,2.6,1,1,1,1,2.8,2.9,1.4
8888,0,North America,Manufacturing,Sales,Meets,Female,48,10,1,11,,2.9,4.1,1,1,1,1,3.7,4.3,2.4
8889,0,Latin America,Digital,IT & Digital,Far Exceeds,Male,43,25,0,9,1.9,1.4,1,1,1,1,1,2.8,2.3,2.4
8890,0,Middle East & Africa,Digital,Clinical Operations,Below,Female,47,7,0,5,1.5,2.4,2.3,1,1,1,1,2.8,1.6,3.6
8891,0,Latin America,HR,Data Science,Meets,Female,43,29,0,11,3,4.3,3,1,1,1,1,2.4,3.8,4.2
8892,0,Europe,R&D,Human Resources,Meets,Male,39,8,0,9,3.5,2.8,1.4,1,1,1,1,3.1,3.3,1
8893,0,Latin America,Finance,Communications,Meets,Male,32,12,0,12,2,4.4,2.3,1,1,1,1,4.4,4.1,2
8894,0,Asia Pacific,Commercial,Pharmacovigilance,Meets,Female,35,4,1,7,,3.8,3.1,0,0,0,0,3.1,4.2,2.3
8895,0,Middle East & Africa,Finance,Data Science,Meets,Female,36,13,0,8,3.3,3.6,2.4,0,0,0,0,2.8,3.6,4
8896,0,Asia Pacific,Commercial,Human Resources,Meets,Male,40,6,1,5,,4.7,3.8,1,1,1,1,3.1,3.4,4
8897,0,Asia Pacific,Manufacturing,Human Resources,Meets,Male,41,3,1,6,,2.9,2.4,1,1,1,1,2.6,3.5,4.1
8898,0,Europe,Commercial,Market Access,Below,Male,49,10,0,6,3.2,2.9,2.2,1,1,1,1,3,2.9,1.6
8899,0,North America,Finance,Regulatory Affairs,Exceeds,Male,28,7,0,10,3.6,2.7,2.5,1,0,0,0,2.5,2.1,2.8
8900,0,Asia Pacific,Finance,Medical Affairs,Meets,Male,38,11,0,11,3.6,2.8,2.9,1,1,1,1,4,2.7,1.4
8901,0,Latin America,Digital,Sales,Meets,Male,49,4,1,5,,1.2,1,1,1,1,1,3.4,1.3,1.6
8902,0,North America,Digital,Supply Chain,Meets,Male,30,8,1,12,,2.7,3.1,1,1,1,1,3.3,3.7,2.9
8903,0,Latin America,R&D,Supply Chain,Below,Female,34,5,0,10,3.6,5,1.3,1,1,1,1,2.9,3.7,1.5
8904,0,Latin America,Finance,Pharmacovigilance,Meets,Non-Binary/Other,41,18,0,10,4.2,2.6,2.6,1,0,0,0,4.1,2.6,1.8
8905,1,North America,Manufacturing,Finance & Accounting,Exceeds,Male,43,12,1,7,,3.7,1,1,1,0,0,2.8,3.4,2
8906,0,North America,Commercial,Quality Assurance,Exceeds,Male,30,8,0,8,2.4,2.8,3.6,1,1,1,1,4.4,3.8,2.4
8907,0,Latin America,R&D,Finance & Accounting,Meets,Male,47,23,0,7,2.7,2.2,1.1,1,1,1,0,2.4,4,1
8908,0,Europe,HR,Communications,Meets,Female,41,10,0,12,3.9,3.6,3.7,1,1,1,1,3.9,3.9,2
8909,0,Middle East & Africa,HR,Regulatory Affairs,Meets,Female,30,5,0,5,3.5,1.7,3.1,1,1,1,1,3.9,2.9,3.1
8910,0,Middle East & Africa,Commercial,IT & Digital,Meets,Female,45,15,0,11,2.4,4.6,2.9,1,0,0,0,3.7,2.6,3.4
8911,0,Europe,Commercial,Quality Assurance,Exceeds,Female,44,4,1,8,,3.6,4,1,1,1,1,3.8,2.5,4.2
8912,0,North America,Commercial,Quality Assurance,Far Below,Female,38,13,0,9,2.8,2.7,1.4,1,1,1,1,2,3.8,2.1
8913,0,Latin America,Digital,Sales,Far Below,Non-Binary/Other,35,15,0,7,2.9,3.4,2.2,1,1,1,0,1.8,3.2,3.9
8914,0,Middle East & Africa,Commercial,Communications,Meets,Male,31,10,0,9,2.7,2.5,3.5,1,0,0,0,4.3,3.4,2.6
8915,0,Latin America,HR,Finance & Accounting,Below,Non-Binary/Other,36,16,0,9,2.6,2.9,4.9,1,1,1,1,3,4.3,2.4
8916,0,Europe,Commercial,Data Science,Exceeds,Female,44,11,0,6,2,4.1,3.2,1,1,1,1,2.7,4.7,3.3
8917,0,Latin America,Finance,Pharmacovigilance,Meets,Female,28,18,0,6,3.8,3.7,2,1,1,1,1,4.4,2.8,1.7
8918,0,Europe,Manufacturing,IT & Digital,Exceeds,Female,33,4,0,9,5,4.4,2.6,1,1,1,1,5,4.1,2.9
8919,0,North America,HR,Supply Chain,Below,Female,40,19,0,9,3.2,3.8,4,1,1,1,1,3.9,2.5,4.7
8920,0,Europe,Manufacturing,Clinical Operations,Meets,Female,42,14,0,9,3.6,3.5,3.7,1,1,1,1,1.5,3.7,4.3
8921,0,Europe,HR,Quality Assurance,Meets,Male,42,13,0,11,3.5,1.8,1,1,1,1,1,2.7,2.7,1.7
8922,0,Middle East & Africa,R&D,Market Access,Meets,Female,33,2,0,10,3.7,2.4,2.8,1,0,0,0,3.4,4.1,1
8923,0,Latin America,Finance,Finance & Accounting,Meets,Female,37,15,0,10,2.4,2.8,3.4,1,1,1,1,3,2.6,2.5
8924,0,Middle East & Africa,HR,Sales,Meets,Male,35,15,0,9,3.1,1,2.6,1,1,1,1,2.8,1.9,3.6
8925,0,Asia Pacific,Finance,Marketing,Exceeds,Male,40,3,0,12,2.9,2.8,1.7,0,0,0,0,3.6,3.2,3.5
8926,0,Europe,HR,Pharmacovigilance,Below,Male,41,4,0,8,3.8,3.2,4.6,1,1,0,0,2.8,2.8,4.1
8927,0,Asia Pacific,Manufacturing,Market Access,Exceeds,Female,37,15,0,12,3.4,3.6,2.3,0,0,0,0,2.9,2.5,2
8928,0,Middle East & Africa,Manufacturing,Communications,Far Exceeds,Female,39,8,0,12,4.1,1.6,4,1,1,1,1,4.3,3.7,3.7
8929,0,Latin America,HR,Legal & Compliance,Meets,Male,38,16,0,9,3.5,2.3,2.1,1,1,0,0,3.3,5,3.9
8930,0,Middle East & Africa,HR,Quality Assurance,Meets,Female,29,2,0,12,4.3,2.9,2.6,1,1,1,1,3.7,3.9,2.5
8931,0,Latin America,Digital,Legal & Compliance,Meets,Female,46,11,0,6,4,4.9,2.6,1,1,0,0,3,4.4,1.9
8932,0,Latin America,Finance,Human Resources,Meets,Male,44,15,0,9,3.2,4.3,3.5,1,1,1,1,3.3,3.8,5
8933,0,North America,Finance,Legal & Compliance,Meets,Male,28,10,0,9,2,2.6,2.3,1,1,0,0,2.3,3.3,3.5
8934,0,Europe,Finance,Legal & Compliance,Meets,Female,51,15,0,8,3.8,3.8,2.7,1,1,1,1,3.8,4.9,4.2
8935,0,Middle East & Africa,Finance,Data Science,Meets,Female,40,20,1,8,,2.1,1,1,0,0,0,2.3,3.1,2.6
8936,0,Latin America,R&D,Finance & Accounting,Exceeds,Male,41,8,0,7,3.3,1.7,2.3,1,1,1,1,3.2,3.3,4.2
8937,0,Middle East & Africa,R&D,Sales,Meets,Female,35,6,0,12,3.2,2.5,1,1,1,1,1,2.5,2.2,2.2
8938,0,Middle East & Africa,Commercial,Medical Affairs,Far Exceeds,Female,39,19,0,12,3.1,3.1,2.4,0,0,0,0,2.8,3.5,4.4
8939,0,Latin America,HR,Legal & Compliance,Meets,Male,41,6,1,9,,3.2,2.3,1,1,1,1,4.4,2.3,1.9
8940,0,Asia Pacific,HR,Clinical Operations,Meets,Female,49,15,0,6,3.3,4.6,3.2,1,0,0,0,3.3,3.8,4
8941,0,Europe,HR,Sales,Meets,Male,31,9,0,12,4.1,1.7,2.7,1,1,1,1,4,2.8,3
8942,0,Europe,HR,Market Access,Meets,Female,45,10,0,8,3,4.3,4.5,1,1,1,1,2.8,4.9,3.1
8943,0,North America,Finance,Supply Chain,Far Below,Male,35,6,0,12,3.7,4.8,4,1,1,1,1,3.5,3.6,4.6
8944,0,North America,Finance,Clinical Operations,Below,Female,47,8,0,9,3.7,4.5,4.1,1,1,1,1,3.7,4.7,4.2
8945,0,North America,R&D,Medical Affairs,Meets,Male,29,11,0,10,3.5,4.7,4,1,1,1,1,2.9,4,4.1
8946,0,Europe,Manufacturing,Marketing,Exceeds,Male,38,19,0,6,4.3,2.6,2.7,1,1,1,1,4,3.7,2.4
8947,0,Asia Pacific,Digital,Human Resources,Meets,Male,28,18,0,11,2.2,4,2,1,1,1,1,2.9,2.9,3
8948,0,Europe,Finance,IT & Digital,Meets,Male,34,8,0,7,2.1,4.5,3.2,1,1,1,1,3.8,3.8,1.5
8949,0,Europe,Finance,Pharmacovigilance,Meets,Female,35,3,0,8,2.6,3.4,1.2,1,1,1,1,2.4,4.1,1
8950,1,Europe,Finance,Human Resources,Meets,Male,41,18,0,8,2.9,2.9,4.6,1,1,1,1,4.8,3.8,5
8951,0,Europe,Manufacturing,Quality Assurance,Meets,Female,29,3,0,12,3.7,1.8,1,1,1,1,0,3.4,4.4,2.2
8952,0,Asia Pacific,Manufacturing,Regulatory Affairs,Far Exceeds,Female,48,4,1,6,,5,2.9,1,1,1,1,3.7,5,2.4
8953,0,North America,R&D,Human Resources,Meets,Female,49,5,1,11,,2.1,2.7,1,1,1,1,3,3.7,2.9
8954,0,Middle East & Africa,Finance,Data Science,Meets,Male,39,23,0,6,4.5,4.4,3.3,1,1,1,1,4,3.1,3.9
8955,0,North America,Digital,Market Access,Meets,Female,30,2,1,9,,2.4,3.3,1,1,1,1,4.8,2.1,4.4
8956,0,North America,HR,Finance & Accounting,Meets,Female,29,32,0,7,3.5,4.1,3.1,1,1,1,1,4.9,2.7,3.6
8957,0,Middle East & Africa,Finance,Sales,Meets,Male,39,7,1,5,,2.3,3.3,1,0,0,0,4.7,2.4,3.2
8958,0,Europe,R&D,Human Resources,Meets,Male,33,16,0,5,4.8,3.2,3.3,1,1,1,1,5,2.9,1.6
8959,0,Asia Pacific,R&D,Supply Chain,Meets,Female,46,7,1,6,,3.6,1,1,1,1,1,4,4.2,1
8960,0,Asia Pacific,Digital,Data Science,Meets,Female,36,36,0,9,3.9,3.6,3.3,1,1,0,0,3.5,2.5,2.6
8961,0,North America,Commercial,IT & Digital,Below,Female,41,24,1,7,,1.7,2,1,1,1,1,4.4,2.8,1.6
8962,0,Middle East & Africa,R&D,Supply Chain,Meets,Male,38,16,0,8,4.6,2.3,2.2,1,1,1,1,5,4.2,2.4
8963,0,Latin America,Manufacturing,Sales,Below,Female,35,12,0,5,3.9,2.6,3.8,1,1,1,1,2.2,5,5
8964,0,Europe,Manufacturing,Market Access,Exceeds,Male,33,12,0,5,2.5,3.7,1.6,1,1,1,1,3.3,5,1.4
8965,0,North America,HR,Marketing,Below,Male,31,12,0,10,3.4,4.2,3.6,1,1,1,1,2.5,3.7,3.2
8966,0,Asia Pacific,R&D,Marketing,Meets,Female,36,9,0,9,4.7,2.3,1,1,0,0,0,3.7,4,1
8967,0,Middle East & Africa,HR,Human Resources,Meets,Male,38,8,0,6,4.5,2.8,2,1,1,1,1,4.9,4.1,1.7
8968,0,Middle East & Africa,R&D,Human Resources,Meets,Male,39,17,0,7,1.4,1,2.4,1,1,1,1,3.6,3.2,2.1
8969,0,North America,Digital,Legal & Compliance,Meets,Female,38,21,0,10,3.1,2.7,3.3,1,1,1,1,2.1,3,3.3
8970,0,Latin America,Finance,IT & Digital,Meets,Male,37,15,0,11,3.2,4.1,2.9,1,1,1,1,2.4,3.4,2.9
8971,0,Asia Pacific,R&D,Medical Affairs,Meets,Female,28,20,0,12,3.2,3.5,3.3,1,1,1,1,3.1,4,4.5
8972,0,North America,Commercial,IT & Digital,Meets,Female,45,10,0,8,2.3,2.2,5,1,1,1,1,3.1,2.4,3.9
8973,0,Latin America,Manufacturing,Quality Assurance,Meets,Male,29,12,0,11,3.4,3.4,2.7,1,1,1,1,2.8,2.4,4
8974,0,Middle East & Africa,Digital,Pharmacovigilance,Exceeds,Female,41,14,0,6,2.7,2.1,3.1,1,1,1,1,4.1,2.5,3.8
8975,0,Europe,Finance,Regulatory Affairs,Exceeds,Female,45,23,0,12,4.4,2.4,3.8,1,1,1,1,3.6,3.4,3.1
8976,0,Asia Pacific,Finance,Pharmacovigilance,Meets,Female,45,8,1,9,,4.5,3,1,1,1,1,3.6,2.5,2.5
8977,0,Asia Pacific,Manufacturing,Human Resources,Exceeds,Male,43,13,0,6,1.8,3.1,1.3,1,1,1,1,2.8,2.6,1.5
8978,0,Latin America,Finance,IT & Digital,Far Exceeds,Non-Binary/Other,38,1,0,8,4.3,3,1.5,0,0,0,0,3,2.6,1.9
8979,0,North America,HR,Medical Affairs,Meets,Female,33,7,0,5,2.4,3.6,3.4,0,0,0,0,3.1,2.1,3.6
8980,0,Middle East & Africa,Digital,Marketing,Meets,Female,30,16,0,10,4.1,3.6,3.2,1,1,1,1,4.1,3.9,3.4
8981,0,Latin America,Commercial,Legal & Compliance,Meets,Female,38,33,0,5,2,3.4,3,1,1,1,1,2.6,2.2,2.5
8982,0,Europe,Manufacturing,Supply Chain,Exceeds,Male,34,7,0,5,2.2,3.9,3.6,1,1,1,1,2.7,4.4,4.1
8983,0,Europe,R&D,Medical Affairs,Meets,Female,35,30,0,9,1.8,1,2.3,1,1,1,1,1.2,1,2.5
8984,0,Europe,R&D,Quality Assurance,Exceeds,Female,42,26,0,8,3.4,3.4,1,1,1,1,1,4.2,4.1,2.6
8985,0,Latin America,R&D,Finance & Accounting,Below,Male,37,17,0,11,4.6,4.1,3.5,1,1,1,0,3.9,3.9,1.7
8986,0,Middle East & Africa,Digital,Legal & Compliance,Below,Female,33,7,0,8,1.9,3.5,2.1,1,1,1,1,2.4,4.4,3.2
8987,0,Asia Pacific,Commercial,Market Access,Meets,Male,55,11,0,7,2.5,1.9,4.3,1,1,1,1,1,2.9,3.1
8988,0,North America,Finance,Quality Assurance,Below,Female,36,7,0,7,4.3,3.3,4.2,1,1,1,1,3.8,2.6,2.5
8989,0,Asia Pacific,Commercial,Clinical Operations,Exceeds,Female,43,9,1,7,,3.6,2.7,1,1,1,1,3.6,3.9,1.8
8990,0,Middle East & Africa,Commercial,Quality Assurance,Meets,Male,42,4,0,8,3.5,2.9,3.8,1,1,1,1,4.4,4.1,5
8991,0,Asia Pacific,Manufacturing,Market Access,Meets,Male,35,3,1,10,,4,2.6,1,1,1,1,2.9,4.9,3.5
8992,0,Latin America,Digital,Legal & Compliance,Below,Male,34,16,0,10,3.7,2.3,1.8,1,1,1,1,3.5,2.6,2.7
8993,0,Europe,R&D,IT & Digital,Below,Female,28,17,0,9,3.3,3,2.9,1,1,1,1,3.6,3.6,2.5
8994,0,Middle East & Africa,Manufacturing,Data Science,Meets,Female,39,7,0,10,3.9,4.2,2.7,1,1,1,1,4.3,3,3.1
8995,0,Middle East & Africa,Finance,Sales,Far Exceeds,Female,38,4,0,10,3.3,2.6,3.1,0,0,0,0,3.4,1.8,3.6
8996,0,Asia Pacific,Commercial,Legal & Compliance,Meets,Male,31,4,0,6,2.8,2.7,2.4,0,0,0,0,1.6,2.3,1.9
8997,0,Latin America,R&D,Market Access,Meets,Female,46,10,0,6,2.4,2.2,2.1,1,1,1,0,2.7,2.5,2
8998,0,Asia Pacific,Digital,Quality Assurance,Exceeds,Male,42,9,0,12,2.6,2.6,1.4,1,1,1,1,3.2,2.3,4.6
8999,1,Asia Pacific,HR,Human Resources,Far Exceeds,Male,38,26,0,8,3.5,2.7,3.7,1,1,1,1,3.2,3.8,4.8
9000,0,Middle East & Africa,Commercial,Marketing,Meets,Male,36,11,0,11,2.4,3,1,1,0,0,0,2.4,3.1,3.6
